activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	105520	CHEMBL823698	Inhibition of [3H]-phorbol 12,13-dibutyrate (PDBu) binding to human recombinant protein kinase C alpha	B	CCCCCCCCC#Cc1ccc2c(c1)[C@](C)(C(C)C)[C@H]1C(=O)N[C@H](CO)[C@@H]21		CHEMBL440201	=	Ki	nM	580.0	CHEMBL299	Homo sapiens	Ki	nM	580.0
	105520	CHEMBL823698	Inhibition of [3H]-phorbol 12,13-dibutyrate (PDBu) binding to human recombinant protein kinase C alpha	B	CCCCCCCCC#Cc1ccc2c(c1)[C@](C)(C(C)C)[C@H]1C(=O)N[C@H](CO)[C@@H]21		CHEMBL440201	=	Ki	nM	580.0	CHEMBL299	Homo sapiens	Ki	nM	580.0
	105654	CHEMBL763602	Binding affinity with protein kinase C (PK-C) alpha bound to labeled [20-3H]-PDBU at a conc of 30 ug/mL	B	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(/C(CO)=N/NC(=O)c1ccc(Cl)c(Cl)c1)C[C@@H]3OC1CC(N)C(O)C(C)O1		CHEMBL139324	=	Inhibition	%	30.0	CHEMBL299	Homo sapiens	Inhibition	%	30.0
	113232	CHEMBL763602	Binding affinity with protein kinase C (PK-C) alpha bound to labeled [20-3H]-PDBU at a conc of 30 ug/mL	B	CC(=O)O[C@@H]1CC2C(C)(C)C(=O)C=CC2(C)C2CCC3(C)C(=CCC3C(CO)CCC(O)C(=O)C(C)(C)O)C21		CHEMBL139972	=	Inhibition	%	27.0	CHEMBL299	Homo sapiens	Inhibition	%	27.0
	118347	CHEMBL763602	Binding affinity with protein kinase C (PK-C) alpha bound to labeled [20-3H]-PDBU at a conc of 30 ug/mL	B	O=C1c2c(NCCCNCCO)cccc2C(=O)c2c(NCCCNCCO)ccc(O)c21		CHEMBL138736	=	Inhibition	%	30.0	CHEMBL299	Homo sapiens	Inhibition	%	30.0
	119274	CHEMBL769588	Inhibition of Protein kinase C alpha at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	Inhibition	%	0.0
	119373	CHEMBL823698	Inhibition of [3H]-phorbol 12,13-dibutyrate (PDBu) binding to human recombinant protein kinase C alpha	B	CCCCCCCCC#Cc1ccc2c(c1)C[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL6453	=	Ki	nM	23.0	CHEMBL299	Homo sapiens	Ki	nM	23.0
	120816	CHEMBL763602	Binding affinity with protein kinase C (PK-C) alpha bound to labeled [20-3H]-PDBU at a conc of 30 ug/mL	B	CC(=O)C(C(=O)CCSCCO)C(SCCO)c1ccc(Cl)c(Cl)c1		CHEMBL138797	=	Inhibition	%	30.0	CHEMBL299	Homo sapiens	Inhibition	%	30.0
	121807	CHEMBL823698	Inhibition of [3H]-phorbol 12,13-dibutyrate (PDBu) binding to human recombinant protein kinase C alpha	B	CCCCCCCCCCCC(=O)Oc1ccc2c(c1)[C@@](C)(C(C)C)[C@H]1C(=O)N[C@H](CO)[C@@H]21		CHEMBL173348	=	Ki	nM	674.0	CHEMBL299	Homo sapiens	Ki	nM	674.0
	125655	CHEMBL763602	Binding affinity with protein kinase C (PK-C) alpha bound to labeled [20-3H]-PDBU at a conc of 30 ug/mL	B	O=C1c2cccc(O)c2C(=O)c2c(OCCN(CCO)Cc3ccccc3)cccc21		CHEMBL141582	=	Inhibition	%	25.0	CHEMBL299	Homo sapiens	Inhibition	%	25.0
	125813	CHEMBL763603	Binding affinity with protein kinase C (PK-C) alpha bound to labeled [20-3H]-PDBU at a conc of 30 ug/mL	B	O=C(OCC(O)C(OC(=O)c1ccccc1)C(CO)OC(=O)c1ccccc1)c1ccccc1		CHEMBL138868	=	Ki	nM	12900.0	CHEMBL299	Homo sapiens	Ki	uM	12.9
	129526	CHEMBL763603	Binding affinity with protein kinase C (PK-C) alpha bound to labeled [20-3H]-PDBU at a conc of 30 ug/mL	B	O=C1c2ccccc2C(=O)c2c(Nc3cccc(S(=O)(=O)N(CCO)CCO)c3)ccc(O)c21		CHEMBL342927	=	Ki	nM	26600.0	CHEMBL299	Homo sapiens	Ki	uM	26.6
	133233	CHEMBL769588	Inhibition of Protein kinase C alpha at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	62.0	CHEMBL299	Homo sapiens	Inhibition	%	62.0
	134554	CHEMBL823698	Inhibition of [3H]-phorbol 12,13-dibutyrate (PDBu) binding to human recombinant protein kinase C alpha	B	CCCCCCCCCCCC(=O)Oc1ccc2c(c1)[C@](C)(C(C)C)[C@H]1C(=O)N[C@H](CO)[C@@H]21		CHEMBL368720	=	Ki	nM	395.0	CHEMBL299	Homo sapiens	Ki	nM	395.0
	138058	CHEMBL769588	Inhibition of Protein kinase C alpha at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccccc3)c(Br)cc12)C1CC1		CHEMBL259270	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	Inhibition	%	0.0
	138229	CHEMBL763603	Binding affinity with protein kinase C (PK-C) alpha bound to labeled [20-3H]-PDBU at a conc of 30 ug/mL	B	C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)/C(=C\N(CCO)CCO)C[C@@]43C)[C@@H]1CC[C@@H]2O		CHEMBL3085524	=	Ki	nM	16100.0	CHEMBL299	Homo sapiens	Ki	uM	16.1
	141695	CHEMBL823698	Inhibition of [3H]-phorbol 12,13-dibutyrate (PDBu) binding to human recombinant protein kinase C alpha	B	CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(C)=O		CHEMBL279115	=	Ki	nM	2.5	CHEMBL299	Homo sapiens	Ki	nM	2.5
	141726	CHEMBL763603	Binding affinity with protein kinase C (PK-C) alpha bound to labeled [20-3H]-PDBU at a conc of 30 ug/mL	B	O=C1c2ccccc2C(=O)c2c(Nc3ccc(S(=O)(=O)N(CCO)CCO)cc3)ccc(O)c21		CHEMBL128547	=	Ki	nM	7800.0	CHEMBL299	Homo sapiens	Ki	uM	7.8
	141727	CHEMBL763603	Binding affinity with protein kinase C (PK-C) alpha bound to labeled [20-3H]-PDBU at a conc of 30 ug/mL	B	CC(=O)OC[C@@]1(C)C(OC(C)=O)CC[C@]2(C)[C@H](CC(OC(C)=O)C3=CCOC3=O)[C@](C)(CO)CC[C@@H]12		CHEMBL422466	=	Ki	nM	37700.0	CHEMBL299	Homo sapiens	Ki	uM	37.7
	144076	CHEMBL769588	Inhibition of Protein kinase C alpha at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)ccc12)C1CC1		CHEMBL405145	=	Inhibition	%	83.0	CHEMBL299	Homo sapiens	Inhibition	%	83.0
	144282	CHEMBL763602	Binding affinity with protein kinase C (PK-C) alpha bound to labeled [20-3H]-PDBU at a conc of 30 ug/mL	B	O=C1c2cccc(O)c2C(=O)c2c(OCCN(CCO)Cc3ccccc3)ccc(O)c21		CHEMBL335156	=	Inhibition	%	34.0	CHEMBL299	Homo sapiens	Inhibition	%	34.0
	145867	CHEMBL759472	Inhibitory activity of 10 uM compound against protein kinase C-alpha using histone as substrate	B	COc1ccccc1C1=C(c2cn(CCCO)c3ncccc23)C(=O)NC1=O		CHEMBL111298	=	Inhibition	%	50.0	CHEMBL299	Homo sapiens	Inhibition	%	50.0
	145871	CHEMBL759471	Inhibitory concentration against protein kinase C-alpha using histone as substrate	B	CN(C)CCCn1cc(C2=C(c3cccc4ccccc34)C(=O)NC2=O)c2cccnc21		CHEMBL326688	=	IC50	nM	1400.0	CHEMBL299	Homo sapiens	IC50	uM	1.4
	147026	CHEMBL759472	Inhibitory activity of 10 uM compound against protein kinase C-alpha using histone as substrate	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ccccc1C(F)(F)F		CHEMBL325817	=	Inhibition	%	50.0	CHEMBL299	Homo sapiens	Inhibition	%	50.0
	147030	CHEMBL759471	Inhibitory concentration against protein kinase C-alpha using histone as substrate	B	COc1ccccc1C1=C(c2cn(CCCNS(C)(=O)=O)c3ncccc23)C(=O)NC1=O		CHEMBL326208	=	IC50	nM	4700.0	CHEMBL299	Homo sapiens	IC50	uM	4.7
	147725	CHEMBL856062	Inhibition of human recombinant PKCalpha	B	Cc1cc(N)c2ccccc2[n+]1CCCCCCCC[n+]1c(C)cc(N)c2ccccc21.[I-].[I-]		CHEMBL2113341	=	IC50	nM	25000.0	CHEMBL299	Homo sapiens	IC50	uM	25.0
	148942	CHEMBL856062	Inhibition of human recombinant PKCalpha	B	Cc1cc(N)c2ccccc2[n+]1CCCCCC[n+]1c(C)cc(N)c2ccccc21		CHEMBL2113332	=	IC50	nM	54000.0	CHEMBL299	Homo sapiens	IC50	uM	54.0
	148999	CHEMBL769624	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from recombinant Protein kinase C alpha	B	CC(C)C(CC(=O)OC[C@H](CO)OC(=O)CC(C(C)C)C(C)C)C(C)C		CHEMBL289230	=	Ki	nM	28.6	CHEMBL299	Homo sapiens	Ki	nM	28.6
	149001	CHEMBL769624	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from recombinant Protein kinase C alpha	B	CC(C)C(=CC(=O)O[C@@H](CO)COC(=O)CC(C(C)C)C(C)C)C(C)C		CHEMBL38644	=	Ki	nM	31.1	CHEMBL299	Homo sapiens	Ki	nM	31.1
	151291	CHEMBL856062	Inhibition of human recombinant PKCalpha	B	Cc1cc(N)c2ccccc2[n+]1CCCC/C=C\CCCC[n+]1c(C)cc(N)c2ccccc21.[I-].[I-]		CHEMBL2112065	=	IC50	nM	52000.0	CHEMBL299	Homo sapiens	IC50	uM	52.0
	154962	CHEMBL856062	Inhibition of human recombinant PKCalpha	B	Cc1cc(N)c2ccccc2[n+]1C.[I-]	Outside typical range	CHEMBL2113335	=	IC50	nM	3590000.0	CHEMBL299	Homo sapiens	IC50	uM	3590.0
	157959	CHEMBL759472	Inhibitory activity of 10 uM compound against protein kinase C-alpha using histone as substrate	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cccs1		CHEMBL333829	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	Inhibition	%	50.0
	158782	CHEMBL769624	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from recombinant Protein kinase C alpha	B	CC(C)=C1CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O		CHEMBL295426	=	Ki	nM	29.5	CHEMBL299	Homo sapiens	Ki	nM	29.5
	159122	CHEMBL759471	Inhibitory concentration against protein kinase C-alpha using histone as substrate	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ccc(F)cc1Cl		CHEMBL111005	=	IC50	nM	4500.0	CHEMBL299	Homo sapiens	IC50	uM	4.5
	159841	CHEMBL856062	Inhibition of human recombinant PKCalpha	B	Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21.[I-].[I-]		CHEMBL2113330	=	IC50	nM	2800.0	CHEMBL299	Homo sapiens	IC50	uM	2.8
	161159	CHEMBL769624	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from recombinant Protein kinase C alpha	B	CC(C)CC(=O)OCC1(CO)C/C(=C\CC(C(C)C)C(C)C)C(=O)O1		CHEMBL39489	=	Ki	nM	30.1	CHEMBL299	Homo sapiens	Ki	nM	30.1
	161205	CHEMBL767032	Inhibition of Protein kinase C alpha	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)Cc3ccc(CNC(CO)CO)cc3)s2)o1		CHEMBL300936	>	IC50	nM	45000.0	CHEMBL299	Homo sapiens	IC50	nM	45000.0
	162348	CHEMBL856062	Inhibition of human recombinant PKCalpha	B	Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21.[I-].[I-]		CHEMBL1256847	=	IC50	nM	11000.0	CHEMBL299	Homo sapiens	IC50	uM	11.0
	162411	CHEMBL769624	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from recombinant Protein kinase C alpha	B	CC(C)C(C/C=C1/CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O)C(C)C		CHEMBL290876	=	Ki	nM	2.89	CHEMBL299	Homo sapiens	Ki	nM	2.89
	164824	CHEMBL769624	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from recombinant Protein kinase C alpha	B	CC(C)CC(=O)OC[C@H](CO)OC(=O)C=C(C(C)C)C(C)C		CHEMBL40602	=	Ki	nM	330.0	CHEMBL299	Homo sapiens	Ki	nM	330.0
	165232	CHEMBL759472	Inhibitory activity of 10 uM compound against protein kinase C-alpha using histone as substrate	B	COc1ccccc1C1=C(c2cn(CCCN)c3ncccc23)C(=O)NC1=O		CHEMBL324268	=	Inhibition	%	50.0	CHEMBL299	Homo sapiens	Inhibition	%	50.0
	166087	CHEMBL769624	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from recombinant Protein kinase C alpha	B	CC(C)C/C=C1/CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O		CHEMBL291104	=	Ki	nM	15.1	CHEMBL299	Homo sapiens	Ki	nM	15.1
	170246	CHEMBL759472	Inhibitory activity of 10 uM compound against protein kinase C-alpha using histone as substrate	B	CCn1cc(C2=C(c3cn(CCCO)c4ncccc34)C(=O)NC2=O)c2cccnc21		CHEMBL110000	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	Inhibition	%	50.0
	171445	CHEMBL759472	Inhibitory activity of 10 uM compound against protein kinase C-alpha using histone as substrate	B	COc1ccccc1C1=C(c2cn(CCCNC=O)c3ncccc23)C(=O)NC1=O		CHEMBL109977	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	Inhibition	%	50.0
	173341	CHEMBL856062	Inhibition of human recombinant PKCalpha	B	CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21.[I-]	Outside typical range	CHEMBL2113334	=	IC50	nM	117000.0	CHEMBL299	Homo sapiens	IC50	uM	117.0
	173754	CHEMBL759471	Inhibitory concentration against protein kinase C-alpha using histone as substrate	B	CN(C)CCCn1cc(C2=C(c3ccccc3Cl)C(=O)NC2=O)c2cccnc21		CHEMBL109834	=	IC50	nM	4000.0	CHEMBL299	Homo sapiens	IC50	uM	4.0
	174920	CHEMBL759472	Inhibitory activity of 10 uM compound against protein kinase C-alpha using histone as substrate	B	COc1ccccc1C1=C(c2cn(CCCNS(N)(=O)=O)c3ncccc23)C(=O)NC1=O		CHEMBL423323	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	Inhibition	%	50.0
	177037	CHEMBL769624	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from recombinant Protein kinase C alpha	B	CC(C)CC(=O)OCC1(CO)C/C(=C/CC(C(C)C)C(C)C)C(=O)O1		CHEMBL38724	=	Ki	nM	11.0	CHEMBL299	Homo sapiens	Ki	nM	11.0
	177434	CHEMBL759472	Inhibitory activity of 10 uM compound against protein kinase C-alpha using histone as substrate	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	Inhibition	%	50.0
	177484	CHEMBL759067	Inhibition of PKCalpha	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	70.0	CHEMBL299	Homo sapiens	Activity	%	70.0
	178743	CHEMBL759471	Inhibitory concentration against protein kinase C-alpha using histone as substrate	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ccccc1Cl		CHEMBL326971	=	IC50	nM	4400.0	CHEMBL299	Homo sapiens	IC50	uM	4.4
	178747	CHEMBL759472	Inhibitory activity of 10 uM compound against protein kinase C-alpha using histone as substrate	B	COCCCn1cc(C2=C(c3ccccc3O)C(=O)NC2=O)c2cccnc21		CHEMBL109944	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	Inhibition	%	50.0
	178797	CHEMBL759067	Inhibition of PKCalpha	B	COCCCn1cc(C2=C(c3ccccc3O)C(=O)NC2=O)c2cccnc21		CHEMBL109944	=	Activity	%	46.0	CHEMBL299	Homo sapiens	Activity	%	46.0
	178825	CHEMBL759472	Inhibitory activity of 10 uM compound against protein kinase C-alpha using histone as substrate	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ccccn1		CHEMBL450340	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	Inhibition	%	50.0
	179521	CHEMBL856062	Inhibition of human recombinant PKCalpha	B	CCCC/C=C/CCCC[n+]1c(C)cc(N)c2ccccc21	Outside typical range	CHEMBL2113333	=	IC50	nM	137000.0	CHEMBL299	Homo sapiens	IC50	uM	137.0
	179522	CHEMBL856062	Inhibition of human recombinant PKCalpha	B	Cc1cc(N)c2ccccc2[n+]1CCCC/C=C/CCCC[n+]1c(C)cc(N)c2ccccc21.[I-].[I-]		CHEMBL2113331	=	IC50	nM	12000.0	CHEMBL299	Homo sapiens	IC50	uM	12.0
	179615	CHEMBL769624	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from recombinant Protein kinase C alpha	B	CC(C)C/C=C1\CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O		CHEMBL39488	=	Ki	nM	15.1	CHEMBL299	Homo sapiens	Ki	nM	15.1
	180006	CHEMBL759471	Inhibitory concentration against protein kinase C-alpha using histone as substrate	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cccc2ccccc12		CHEMBL430694	=	IC50	nM	3600.0	CHEMBL299	Homo sapiens	IC50	uM	3.6
	180664	CHEMBL856062	Inhibition of human recombinant PKCalpha	B	Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21.[I-].[I-]		CHEMBL1315457	=	IC50	nM	2600.0	CHEMBL299	Homo sapiens	IC50	uM	2.6
	181878	CHEMBL856062	Inhibition of human recombinant PKCalpha	B	Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21.[I-].[I-]		CHEMBL2113338	=	IC50	nM	5000.0	CHEMBL299	Homo sapiens	IC50	uM	5.0
	182056	CHEMBL767032	Inhibition of Protein kinase C alpha	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	IC50	nM	2800.0	CHEMBL299	Homo sapiens	IC50	nM	2800.0
	182494	CHEMBL759472	Inhibitory activity of 10 uM compound against protein kinase C-alpha using histone as substrate	B	COc1ccccc1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ncccc23)C(=O)NC1=O		CHEMBL109981	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	Inhibition	%	50.0
	182544	CHEMBL759067	Inhibition of PKCalpha	B	COc1ccccc1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ncccc23)C(=O)NC1=O		CHEMBL109981	=	Activity	%	38.0	CHEMBL299	Homo sapiens	Activity	%	38.0
	183460	CHEMBL769624	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from recombinant Protein kinase C alpha	B	CC(C)=CC(=O)O[C@@H](CO)COC(=O)CC(C(C)C)C(C)C		CHEMBL40482	=	Ki	nM	39.9	CHEMBL299	Homo sapiens	Ki	nM	39.9
	183869	CHEMBL766771	Displacement of [3H]PDBu from protein kinase C alpha at 100 uM; Range 40 to 60	B	CC(=O)OC[C@@]1(CO)OC(=O)c2c(OCCCCCCCCCCOc3cccc4c3C(=O)O[C@]4(CO)COC(C)=O)cccc21		CHEMBL322457	=	Inhibition	%	45.0	CHEMBL299	Homo sapiens	Inhibition	%	45.0
	183870	CHEMBL766772	Displacement of [3H]PDBu from protein kinase C alpha at 100 uM; Range 60 to 80	B	CCCCCCCCCCCCOc1cccc2c1C(=O)O[C@]2(CO)COC(C)=O		CHEMBL102106	=	Inhibition	%	70.0	CHEMBL299	Homo sapiens	Inhibition	%	70.0
	185159	CHEMBL766773	Displacement of [3H]PDBu from protein kinase C alpha at 100 uM; Range 80 to 100	B	CC(=O)OC[C@@]1(CO)OC(=O)c2c(OCCCCCCCCCCCCCCOc3cccc4c3C(=O)O[C@]4(CO)COC(C)=O)cccc21		CHEMBL100583	=	Inhibition	%	90.0	CHEMBL299	Homo sapiens	Inhibition	%	90.0
	185448	CHEMBL757412	Displacement of [20-3H]phorbol-12,13-dibutyrate from a recombinant PK-C alpha	B	CCCCCCCCCCCCC/C=C1\CC(CO)(COS(C)(=O)=O)OC1=O		CHEMBL48577	=	Ki	nM	823.0	CHEMBL299	Homo sapiens	Ki	nM	823.0
	186618	CHEMBL766772	Displacement of [3H]PDBu from protein kinase C alpha at 100 uM; Range 60 to 80	B	O=C(CCCCCCCCCCC(=O)OC[C@@]1(CO)OC(=O)c2c(OCc3ccccc3)cccc21)CC[C@@]1(CO)OC(=O)c2c(OCc3ccccc3)cccc21		CHEMBL99627	=	Inhibition	%	70.0	CHEMBL299	Homo sapiens	Inhibition	%	70.0
	186619	CHEMBL766770	Displacement of [3H]PDBu from protein kinase C alpha at 100 uM; Range 20 to 40	B	CC(=O)OC[C@@]1(CO)OC(=O)c2c(OCCCCCCCCCCCCCCCCCCCCCCOc3cccc4c3C(=O)O[C@]4(CO)COC(C)=O)cccc21		CHEMBL320239	=	Inhibition	%	25.0	CHEMBL299	Homo sapiens	Inhibition	%	25.0
	189076	CHEMBL766771	Displacement of [3H]PDBu from protein kinase C alpha at 100 uM; Range 40 to 60	B	O=C(CCCCCCCCC(=O)OC[C@@]1(CO)OC(=O)c2c(OCc3ccccc3)cccc21)CC[C@@]1(CO)OC(=O)c2c(OCc3ccccc3)cccc21		CHEMBL321941	=	Inhibition	%	41.0	CHEMBL299	Homo sapiens	Inhibition	%	41.0
	189324	CHEMBL757412	Displacement of [20-3H]phorbol-12,13-dibutyrate from a recombinant PK-C alpha	B	CCCCCCCCCCCCC/C=C1\CC(CO)(COC(C)=O)OC1=O		CHEMBL49904	=	Ki	nM	77.9	CHEMBL299	Homo sapiens	Ki	nM	77.9
	190196	CHEMBL766767	Displacement of [3H]PDBu from protein kinase C alpha at 100 uM; Range 0 to 20	B	O=C(CC[C@@]1(CO)OC(=O)c2c(OCc3ccccc3)cccc21)c1ccc(C(=O)OC[C@@]2(CO)OC(=O)c3c(OCc4ccccc4)cccc32)cc1		CHEMBL318695	=	Inhibition	%	2.0	CHEMBL299	Homo sapiens	Inhibition	%	2.0
	190497	CHEMBL757412	Displacement of [20-3H]phorbol-12,13-dibutyrate from a recombinant PK-C alpha	B	CCCCCCCCCCCCCCS(=O)(=O)OCC1(CO)CCC(=O)O1		CHEMBL49945	=	Ki	nM	90.7	CHEMBL299	Homo sapiens	Ki	nM	90.7
	191468	CHEMBL766771	Displacement of [3H]PDBu from protein kinase C alpha at 100 uM; Range 40 to 60	B	O=C(CCCCCCCCCCCCCCC(=O)OC[C@@]1(CO)OC(=O)c2c(OCc3ccccc3)cccc21)CC[C@@]1(CO)OC(=O)c2c(OCc3ccccc3)cccc21		CHEMBL102105	=	Inhibition	%	54.0	CHEMBL299	Homo sapiens	Inhibition	%	54.0
	191469	CHEMBL766769	Displacement of [3H]PDBu from protein kinase C alpha at 100 uM; Range 20 to 30	B	O=C(CCCCCCCCCCCCCCCCC(=O)OC[C@@]1(CO)OC(=O)c2c(OCc3ccccc3)cccc21)CC[C@@]1(CO)OC(=O)c2c(OCc3ccccc3)cccc21		CHEMBL103882	=	Inhibition	%	30.0	CHEMBL299	Homo sapiens	Inhibition	%	30.0
	192597	CHEMBL766767	Displacement of [3H]PDBu from protein kinase C alpha at 100 uM; Range 0 to 20	B	CC(=O)OC[C@@]1(CO)OC(=O)c2c(OCCCCCCCCCCCCCCCCCCCCCCCCOc3cccc4c3C(=O)O[C@]4(CO)COC(C)=O)cccc21		CHEMBL101191	=	Inhibition	%	19.0	CHEMBL299	Homo sapiens	Inhibition	%	19.0
	192996	CHEMBL768374	Inhibition of human Protein kinase C alpha	B	O=C(N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL60254	=	IC50	nM	74.0	CHEMBL299	Homo sapiens	IC50	uM	0.074
	193786	CHEMBL766773	Displacement of [3H]PDBu from protein kinase C alpha at 100 uM; Range 80 to 100	B	CC(=O)OC[C@@]1(CO)OC(=O)c2c(OCCCCCCCCCCCCCCCOc3cccc4c3C(=O)O[C@]4(CO)COC(C)=O)cccc21		CHEMBL317575	=	Inhibition	%	92.0	CHEMBL299	Homo sapiens	Inhibition	%	92.0
	194914	CHEMBL766773	Displacement of [3H]PDBu from protein kinase C alpha at 100 uM; Range 80 to 100	B	CC(=O)OC[C@@]1(CO)OC(=O)c2c(OCCCCCCCCCCCCCCCCOc3cccc4c3C(=O)O[C@]4(CO)COC(C)=O)cccc21		CHEMBL316707	=	Inhibition	%	91.0	CHEMBL299	Homo sapiens	Inhibition	%	91.0
	196127	CHEMBL766771	Displacement of [3H]PDBu from protein kinase C alpha at 100 uM; Range 40 to 60	B	CC(=O)OC[C@@]1(CO)OC(=O)c2c(OCCCCCCCCCCCOc3cccc4c3C(=O)O[C@]4(CO)COC(C)=O)cccc21		CHEMBL100299	=	Inhibition	%	60.0	CHEMBL299	Homo sapiens	Inhibition	%	60.0
	199635	CHEMBL766768	Displacement of [3H]PDBu from protein kinase C alpha at 100 uM; Range 2 to 40	B	CC(=O)OC[C@@]1(CO)OC(=O)c2c(OCc3ccccc3)cccc21		CHEMBL322865	=	Inhibition	%	30.0	CHEMBL299	Homo sapiens	Inhibition	%	30.0
	200836	CHEMBL766767	Displacement of [3H]PDBu from protein kinase C alpha at 100 uM; Range 0 to 20	B	O=C(CC[C@@]1(CO)OC(=O)c2c(OCc3ccccc3)cccc21)c1ccccc1C(=O)OC[C@@]1(CO)OC(=O)c2c(OCc3ccccc3)cccc21		CHEMBL101508	=	Inhibition	%	4.0	CHEMBL299	Homo sapiens	Inhibition	%	4.0
	200837	CHEMBL766767	Displacement of [3H]PDBu from protein kinase C alpha at 100 uM; Range 0 to 20	B	O=C(CC[C@@]1(CO)OC(=O)c2c(OCc3ccccc3)cccc21)c1cccc(C(=O)OC[C@@]2(CO)OC(=O)c3c(OCc4ccccc4)cccc32)c1		CHEMBL101336	=	Inhibition	%	4.0	CHEMBL299	Homo sapiens	Inhibition	%	4.0
	202150	CHEMBL766771	Displacement of [3H]PDBu from protein kinase C alpha at 100 uM; Range 40 to 60	B	CC(=O)OC[C@@]1(CO)OC(=O)c2c(OCCCCCCCCCOc3cccc4c3C(=O)O[C@]4(CO)COC(C)=O)cccc21		CHEMBL316606	=	Inhibition	%	42.0	CHEMBL299	Homo sapiens	Inhibition	%	42.0
	203310	CHEMBL766767	Displacement of [3H]PDBu from protein kinase C alpha at 100 uM; Range 0 to 20	B	O=C(CCCCCCCCCCCCCCCCCCC(=O)OC[C@@]1(CO)OC(=O)c2c(OCc3ccccc3)cccc21)CC[C@@]1(CO)OC(=O)c2c(OCc3ccccc3)cccc21		CHEMBL100292	=	Inhibition	%	10.0	CHEMBL299	Homo sapiens	Inhibition	%	10.0
	205694	CHEMBL766774	Displacement of [3H]PDBu from protein kinase C alpha at 100 uM; Range 80 to 100	B	CCCCCCCCCCCC(=O)OC[C@@]1(CO)OC(=O)c2c(OCc3ccccc3)cccc21		CHEMBL102089	=	Inhibition	%	90.0	CHEMBL299	Homo sapiens	Inhibition	%	90.0
	205975	CHEMBL757412	Displacement of [20-3H]phorbol-12,13-dibutyrate from a recombinant PK-C alpha	B	CCCCCCCCCCCCCC(=O)OCC1(CO)CCS(=O)(=O)O1		CHEMBL51992	=	Ki	nM	1040.0	CHEMBL299	Homo sapiens	Ki	nM	1040.0
	206917	CHEMBL766767	Displacement of [3H]PDBu from protein kinase C alpha at 100 uM; Range 0 to 20	B	O=C(CCCCCCC(=O)OC[C@@]1(CO)OC(=O)c2c(OCc3ccccc3)cccc21)CC[C@@]1(CO)OC(=O)c2c(OCc3ccccc3)cccc21		CHEMBL327968	=	Inhibition	%	19.0	CHEMBL299	Homo sapiens	Inhibition	%	19.0
	207120	CHEMBL757412	Displacement of [20-3H]phorbol-12,13-dibutyrate from a recombinant PK-C alpha	B	CCCCCCCCCCCCCC(=O)OCC1(CO)CCC(=O)O1		CHEMBL299225	=	Ki	nM	138.0	CHEMBL299	Homo sapiens	Ki	nM	138.0
	207170	CHEMBL768374	Inhibition of human Protein kinase C alpha	B	O=C(N[C@@H]1CNC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL59828	=	IC50	nM	22.0	CHEMBL299	Homo sapiens	IC50	uM	0.022
	208325	CHEMBL757412	Displacement of [20-3H]phorbol-12,13-dibutyrate from a recombinant PK-C alpha	B	CCCCCCCCCCCCC/C=C1\CC(CO)(COC(C)=O)OS1(=O)=O		CHEMBL52329	=	Ki	nM	320.0	CHEMBL299	Homo sapiens	Ki	nM	320.0
	209246	CHEMBL766773	Displacement of [3H]PDBu from protein kinase C alpha at 100 uM; Range 80 to 100	B	CC(=O)OC[C@@]1(CO)OC(=O)c2c(OCCCCCCCCCCCCCOc3cccc4c3C(=O)O[C@]4(CO)COC(C)=O)cccc21		CHEMBL99602	=	Inhibition	%	85.0	CHEMBL299	Homo sapiens	Inhibition	%	85.0
	212754	CHEMBL766772	Displacement of [3H]PDBu from protein kinase C alpha at 100 uM; Range 60 to 80	B	O=C(CCCCCCCCCCCCC(=O)OC[C@@]1(CO)OC(=O)c2c(OCc3ccccc3)cccc21)CC[C@@]1(CO)OC(=O)c2c(OCc3ccccc3)cccc21		CHEMBL100300	=	Inhibition	%	70.0	CHEMBL299	Homo sapiens	Inhibition	%	70.0
	215031	CHEMBL766767	Displacement of [3H]PDBu from protein kinase C alpha at 100 uM; Range 0 to 20	B	O=C(CCCCC(=O)OC[C@@]1(CO)OC(=O)c2c(OCc3ccccc3)cccc21)CC[C@@]1(CO)OC(=O)c2c(OCc3ccccc3)cccc21		CHEMBL101735	=	Inhibition	%	18.0	CHEMBL299	Homo sapiens	Inhibition	%	18.0
	217784	CHEMBL768374	Inhibition of human Protein kinase C alpha	B	O=C(N[C@@H]1CCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL52529	=	IC50	nM	40.0	CHEMBL299	Homo sapiens	IC50	uM	0.04
	218983	CHEMBL768374	Inhibition of human Protein kinase C alpha	B	O=C(N[C@@H]1CNCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL67442	=	IC50	nM	5100.0	CHEMBL299	Homo sapiens	IC50	uM	5.1
	219984	CHEMBL766772	Displacement of [3H]PDBu from protein kinase C alpha at 100 uM; Range 60 to 80	B	CC(=O)OC[C@@]1(CO)OC(=O)c2c(OCCCCCCCCCCCCOc3cccc4c3C(=O)O[C@]4(CO)COC(C)=O)cccc21		CHEMBL101549	=	Inhibition	%	70.0	CHEMBL299	Homo sapiens	Inhibition	%	70.0
	221443	CHEMBL768374	Inhibition of human Protein kinase C alpha	B	O=C(N[C@@H]1CCCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL304549	=	IC50	nM	270.0	CHEMBL299	Homo sapiens	IC50	uM	0.27
	223168	CHEMBL760366	Displacement of [20-3H]-PDBU ligand from recombinant protein kinase C (baculovirus)	B	CC(C)CC(C/C=C1\CC(CO)(CNC(=O)C(C)(C)C)OC1=O)CC(C)C		CHEMBL439979	=	Ki	nM	1260.0	CHEMBL299	Homo sapiens	Ki	nM	1260.0
	224586	CHEMBL760366	Displacement of [20-3H]-PDBU ligand from recombinant protein kinase C (baculovirus)	B	CC(C)CC(C/C=C1/CC(CO)(CNC(=O)C(C)(C)C)OC1=O)CC(C)C		CHEMBL136786	=	Ki	nM	429.7	CHEMBL299	Homo sapiens	Ki	nM	429.7
	226772	CHEMBL767704	Inhibition of Protein kinase C alpha	B	CCN1CCC(n2cc(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c3ccccc32)CC1		CHEMBL54382	=	IC50	nM	400.0	CHEMBL299	Homo sapiens	IC50	uM	0.4
	227210	CHEMBL760366	Displacement of [20-3H]-PDBU ligand from recombinant protein kinase C (baculovirus)	B	CC(C)CC(C/C=C1\CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O)CC(C)C		CHEMBL138171	=	Ki	nM	4.46	CHEMBL299	Homo sapiens	Ki	nM	4.46
	230964	CHEMBL760366	Displacement of [20-3H]-PDBU ligand from recombinant protein kinase C (baculovirus)	B	CC(C)CC(C/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O)CC(C)C		CHEMBL137386	=	Ki	nM	4.51	CHEMBL299	Homo sapiens	Ki	nM	4.51
	233201	CHEMBL767704	Inhibition of Protein kinase C alpha	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1.CS(=O)(=O)O		CHEMBL432130	=	IC50	nM	360.0	CHEMBL299	Homo sapiens	IC50	uM	0.36
	233455	CHEMBL760366	Displacement of [20-3H]-PDBU ligand from recombinant protein kinase C (baculovirus)	B	CC(C)CC(C/C=C1\CC(CO)(CN(O)C(=O)C(C)(C)C)OC1=O)CC(C)C		CHEMBL135779	=	Ki	nM	4.81	CHEMBL299	Homo sapiens	Ki	nM	4.81
	236060	CHEMBL760366	Displacement of [20-3H]-PDBU ligand from recombinant protein kinase C (baculovirus)	B	CC(C)C(C/C=C1/CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O)C(C)C		CHEMBL290876	=	Ki	nM	2.89	CHEMBL299	Homo sapiens	Ki	nM	2.89
	245473	CHEMBL760366	Displacement of [20-3H]-PDBU ligand from recombinant protein kinase C (baculovirus)	B	CC(C)CC(C/C=C1\CC(CO)(COC(=O)C(C)(C)C)NC1=O)CC(C)C		CHEMBL137484	=	Ki	nM	4840.0	CHEMBL299	Homo sapiens	Ki	nM	4840.0
	246813	CHEMBL760366	Displacement of [20-3H]-PDBU ligand from recombinant protein kinase C (baculovirus)	B	CC(C)C(C/C=C1\CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O)C(C)C		CHEMBL137288	=	Ki	nM	2.7	CHEMBL299	Homo sapiens	Ki	nM	2.7
	247733	CHEMBL767704	Inhibition of Protein kinase C alpha	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccc5)C4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL291975	=	IC50	nM	3800.0	CHEMBL299	Homo sapiens	IC50	uM	3.8
	248106	CHEMBL760366	Displacement of [20-3H]-PDBU ligand from recombinant protein kinase C (baculovirus)	B	CC(C)C(C/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O)C(C)C		CHEMBL136760	=	Ki	nM	11.25	CHEMBL299	Homo sapiens	Ki	nM	11.25
	249190	CHEMBL767704	Inhibition of Protein kinase C alpha	B	Cn1cc(C2=C(c3cn(C4CCNCC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL55788	=	IC50	nM	300.0	CHEMBL299	Homo sapiens	IC50	uM	0.3
	249625	CHEMBL760366	Displacement of [20-3H]-PDBU ligand from recombinant protein kinase C (baculovirus)	B	CC(C)CC(C/C=C1/CC(CO)(COC(=O)C(C)(C)C)OC1=O)CC(C)C		CHEMBL96766	=	Ki	nM	2.9	CHEMBL299	Homo sapiens	Ki	nM	2.9
	249627	CHEMBL760366	Displacement of [20-3H]-PDBU ligand from recombinant protein kinase C (baculovirus)	B	CC(C)CC(C/C=C1/CC(CO)(CN(O)C(=O)C(C)(C)C)OC1=O)CC(C)C		CHEMBL94505	=	Ki	nM	5.42	CHEMBL299	Homo sapiens	Ki	nM	5.42
	250563	CHEMBL767704	Inhibition of Protein kinase C alpha	B	CC(C)N1CCC(n2cc(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c3ccccc32)CC1		CHEMBL301860	=	IC50	nM	340.0	CHEMBL299	Homo sapiens	IC50	uM	0.34
	251938	CHEMBL767704	Inhibition of Protein kinase C alpha	B	CN1CCC(n2cc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc32)CC1		CHEMBL52654	=	IC50	nM	200.0	CHEMBL299	Homo sapiens	IC50	uM	0.2
	254629	CHEMBL767704	Inhibition of Protein kinase C alpha	B	Cn1cc(C2=C(c3cn(C4CCN(CC5CC5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL55394	=	IC50	nM	300.0	CHEMBL299	Homo sapiens	IC50	uM	0.3
	256022	CHEMBL767704	Inhibition of Protein kinase C alpha	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	IC50	nM	800.0	CHEMBL299	Homo sapiens	IC50	uM	0.8
	256328	CHEMBL760366	Displacement of [20-3H]-PDBU ligand from recombinant protein kinase C (baculovirus)	B	CC(C)C(C/C=C1/CC(CO)(COC(=O)C(C)(C)C)OC1=O)C(C)C		CHEMBL137701	=	Ki	nM	8.32	CHEMBL299	Homo sapiens	Ki	nM	8.32
	256330	CHEMBL760366	Displacement of [20-3H]-PDBU ligand from recombinant protein kinase C (baculovirus)	B	CC(C)CC(C/C=C1/CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O)CC(C)C		CHEMBL137597	=	Ki	nM	6.87	CHEMBL299	Homo sapiens	Ki	nM	6.87
	257371	CHEMBL767704	Inhibition of Protein kinase C alpha	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccc5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300549	=	IC50	nM	6000.0	CHEMBL299	Homo sapiens	IC50	uM	6.0
	257384	CHEMBL767704	Inhibition of Protein kinase C alpha	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	45.0	CHEMBL299	Homo sapiens	IC50	uM	0.045
	258768	CHEMBL767704	Inhibition of Protein kinase C alpha	B	CN1CCC(n2cc(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c3ccccc32)CC1		CHEMBL53596	=	IC50	nM	400.0	CHEMBL299	Homo sapiens	IC50	uM	0.4
	259103	CHEMBL760366	Displacement of [20-3H]-PDBU ligand from recombinant protein kinase C (baculovirus)	B	CC(C)CC(C/C=C1/CC(CO)(COC(=O)C(C)(C)C)NC1=O)CC(C)C		CHEMBL336926	=	Ki	nM	4330.0	CHEMBL299	Homo sapiens	Ki	nM	4330.0
	261778	CHEMBL760366	Displacement of [20-3H]-PDBU ligand from recombinant protein kinase C (baculovirus)	B	CC(C)CC(C/C=C1\CC(CO)(COC(=O)C(C)(C)C)N(O)C1=O)CC(C)C		CHEMBL138279	=	Ki	nM	10430.0	CHEMBL299	Homo sapiens	Ki	nM	10430.0
	262660	CHEMBL767704	Inhibition of Protein kinase C alpha	B	Cn1cc(C2=C(c3cn(C4CCN(C(=O)OC(C)(C)C)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL293805	=	IC50	nM	6000.0	CHEMBL299	Homo sapiens	IC50	uM	6.0
	265153	CHEMBL767035	Inhibition of Protein kinase C alpha	B	O=C(N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL60254	=	IC50	nM	30.0	CHEMBL299	Homo sapiens	IC50	uM	0.03
	273991	CHEMBL767035	Inhibition of Protein kinase C alpha	B	CN(C(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)[C@H]1CCCNC[C@H]1NC(=O)c1ccc(O)cc1		CHEMBL2310935	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	276553	CHEMBL767035	Inhibition of Protein kinase C alpha	B	O=C(N[C@@H]1CNC[C@H]1NC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL59677	=	IC50	nM	920.0	CHEMBL299	Homo sapiens	IC50	uM	0.92
	278868	CHEMBL760365	Displacement of [20-3H]-phorbol 12,13-dibutyrate (PDBU) from PKCalpha (C1b domain)	B	CCCCCCCCCCCCC/C=C1/CC(CO)(COC(C)=O)OC1=O		CHEMBL420450	=	Ki	nM	35.0	CHEMBL299	Homo sapiens	Ki	nM	35.0
	278916	CHEMBL767035	Inhibition of Protein kinase C alpha	B	O=C(N[C@@H]1CNC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL59828	=	IC50	nM	22.0	CHEMBL299	Homo sapiens	IC50	uM	0.022
	280017	CHEMBL760365	Displacement of [20-3H]-phorbol 12,13-dibutyrate (PDBU) from PKCalpha (C1b domain)	B	CCCCCCCCCCCCC/C=C1\CC(CO)(COC(C)=O)OC1=O		CHEMBL49904	=	Ki	nM	78.0	CHEMBL299	Homo sapiens	Ki	nM	78.0
	281266	CHEMBL760365	Displacement of [20-3H]-phorbol 12,13-dibutyrate (PDBU) from PKCalpha (C1b domain)	B	CCCCCCCCCCCCC/C=C1\CC(CO)(COCC)OC1=O		CHEMBL115868	=	Ki	nM	4979.0	CHEMBL299	Homo sapiens	Ki	nM	4979.0
	281886	CHEMBL769627	Inhibition of Protein kinase C alpha	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	>	Ki	nM	1000.0	CHEMBL299	Homo sapiens	Ki	nM	1000.0
	284837	CHEMBL767035	Inhibition of Protein kinase C alpha	B	C[C@@]1(OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)CCCNC[C@H]1NC(=O)c1ccc(O)cc1		CHEMBL433101	=	IC50	nM	220.0	CHEMBL299	Homo sapiens	IC50	uM	0.22
	289620	CHEMBL767035	Inhibition of Protein kinase C alpha	B	O=C(NC[C@@H]1CCC[C@H]1NC(=O)c1ccc(O)cc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL293500	=	IC50	nM	35000.0	CHEMBL299	Homo sapiens	IC50	uM	35.0
	294577	CHEMBL760365	Displacement of [20-3H]-phorbol 12,13-dibutyrate (PDBU) from PKCalpha (C1b domain)	B	CCCCCCCCCCCCC/C=C1/CC(CO)(COCC)OC1=O		CHEMBL324172	=	Ki	nM	7460.0	CHEMBL299	Homo sapiens	Ki	nM	7460.0
	294625	CHEMBL767035	Inhibition of Protein kinase C alpha	B	O=C(N[C@@H]1CCCNC[C@H]1NC(=O)c1ccc(O)cc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL59687	=	IC50	nM	3200.0	CHEMBL299	Homo sapiens	IC50	uM	3.2
	294633	CHEMBL767035	Inhibition of Protein kinase C alpha	B	O=C(N[C@@H]1CCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL52529	=	IC50	nM	40.0	CHEMBL299	Homo sapiens	IC50	uM	0.04
	297263	CHEMBL767035	Inhibition of Protein kinase C alpha	B	O=C(N[C@@H]1CCC[C@H]1OCc1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL294303	=	IC50	nM	460.0	CHEMBL299	Homo sapiens	IC50	uM	0.46
	299835	CHEMBL767035	Inhibition of Protein kinase C alpha	B	O=C(N[C@@H]1CCC[C@H]1COC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL60455	=	IC50	nM	40.0	CHEMBL299	Homo sapiens	IC50	uM	0.04
	302137	CHEMBL760365	Displacement of [20-3H]-phorbol 12,13-dibutyrate (PDBU) from PKCalpha (C1b domain)	B	CCCCCCCCCCCCC/C=C1/COC(CO)(COC(C)=O)C1		CHEMBL114138	=	Ki	nM	7582.0	CHEMBL299	Homo sapiens	Ki	nM	7582.0
Not Active	302286	CHEMBL767041	Inhibition of Protein kinase C alpha at 10 uM Histone H1 substrate	B	COn1cc2c3c(cccc31)[C@@H]1C=C(C)CN(C)[C@@H]1C2		CHEMBL435240		Inhibition	%		CHEMBL299	Homo sapiens	Inhibition	%	
	303403	CHEMBL767035	Inhibition of Protein kinase C alpha	B	O=C(N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL60254	=	IC50	nM	67.0	CHEMBL299	Homo sapiens	IC50	uM	0.067
	308746	CHEMBL762478	Displacement of [3H]PDBu from protein kinase C Alpha-C1A domain	B	CCCCCCCCCCCN1c2ccccc2C[C@@H](CO)OC(=O)[C@@H]1C(C)C		CHEMBL102991	=	Ki	nM	4580.0	CHEMBL299	Homo sapiens	Ki	nM	4580.0
	308747	CHEMBL762480	Displacement of [3H]PDBu from protein kinase C Alpha-C1B domain	B	CCCCCCCCCCCN1c2ccccc2C[C@@H](CO)OC(=O)[C@@H]1C(C)C		CHEMBL102991	>	Ki	nM	10000.0	CHEMBL299	Homo sapiens	Ki	nM	10000.0
	308760	CHEMBL762316	Binding affinity for protein kinase C Alpha-C1A domain	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Kd	nM	1.12	CHEMBL299	Homo sapiens	Kd	nM	1.12
	308761	CHEMBL762479	Binding affinity for protein kinase C Alpha-C1B domain	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Kd	nM	7.44	CHEMBL299	Homo sapiens	Kd	nM	7.44
	312745	CHEMBL762478	Displacement of [3H]PDBu from protein kinase C Alpha-C1A domain	B	CCCCCCCCCCc1ccc2c(c1)N(C)[C@@H](C(C)C)C(=O)O[C@H](CO)C2		CHEMBL102858	=	Ki	nM	412.0	CHEMBL299	Homo sapiens	Ki	nM	412.0
	312746	CHEMBL762480	Displacement of [3H]PDBu from protein kinase C Alpha-C1B domain	B	CCCCCCCCCCc1ccc2c(c1)N(C)[C@@H](C(C)C)C(=O)O[C@H](CO)C2		CHEMBL102858	=	Ki	nM	4050.0	CHEMBL299	Homo sapiens	Ki	nM	4050.0
	320098	CHEMBL769626	Inhibition of [20-3H]phorbol-12,13-dibutyrate(PDBU) binding to purified PK-C alpha	B	CCCCCCCCCCCCCC(=O)O[C@@H]1CC(=O)O[C@H]1CCO		CHEMBL281660	=	Ki	nM	880.0	CHEMBL299	Homo sapiens	Ki	uM	0.88
	327604	CHEMBL769613	Displacement of [3H]PDBu from PKC alpha expressed in Sf9 cells	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2coc3cccc(c23)N1C		CHEMBL348378	=	Ki	nM	17.3	CHEMBL299	Homo sapiens	Ki	nM	17.3
	330319	CHEMBL762478	Displacement of [3H]PDBu from protein kinase C Alpha-C1A domain	B	CCCCCCCCCCc1cccc2c1C[C@@H](CO)OC(=O)[C@H](C(C)C)N2C		CHEMBL103091	=	Ki	nM	870.0	CHEMBL299	Homo sapiens	Ki	nM	870.0
	330320	CHEMBL762480	Displacement of [3H]PDBu from protein kinase C Alpha-C1B domain	B	CCCCCCCCCCc1cccc2c1C[C@@H](CO)OC(=O)[C@H](C(C)C)N2C		CHEMBL103091	>	Ki	nM	10000.0	CHEMBL299	Homo sapiens	Ki	nM	10000.0
	330333	CHEMBL762478	Displacement of [3H]PDBu from protein kinase C Alpha-C1A domain	B	CCCCCCCCCCc1ccc2c(c1)C[C@@H](CO)OC(=O)[C@H](C(C)C)N2C		CHEMBL318971	>	Ki	nM	10000.0	CHEMBL299	Homo sapiens	Ki	nM	10000.0
	330334	CHEMBL762480	Displacement of [3H]PDBu from protein kinase C Alpha-C1B domain	B	CCCCCCCCCCc1ccc2c(c1)C[C@@H](CO)OC(=O)[C@H](C(C)C)N2C		CHEMBL318971	>	Ki	nM	10000.0	CHEMBL299	Homo sapiens	Ki	nM	10000.0
	335572	CHEMBL769613	Displacement of [3H]PDBu from PKC alpha expressed in Sf9 cells	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL27266	=	Ki	nM	10.96	CHEMBL299	Homo sapiens	Ki	nM	10.96
	340837	CHEMBL769626	Inhibition of [20-3H]phorbol-12,13-dibutyrate(PDBU) binding to purified PK-C alpha	B	CCCCCCCCCCCCCC(=O)O[C@@H]1CC(=O)O[C@H]1CO		CHEMBL276429	=	Ki	nM	1500.0	CHEMBL299	Homo sapiens	Ki	uM	1.5
	340838	CHEMBL768499	Inhibition of [3H]phorbol-12,13-dibutyrate binding to PK-C	B	CCCCCCCCCCCCCC(=O)O[C@@H]1CC(=O)O[C@H]1CO		CHEMBL276429	=	Ki	nM	2500.0	CHEMBL299	Homo sapiens	Ki	uM	2.5
	348439	CHEMBL766779	Displacement of [3H]PDBu from human recombinant Protein kinase C alpha	B	CC(C)CCCC(C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4CC(=O)N[C@H](CO)C[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL301704	>	Ki	nM	500.0	CHEMBL299	Homo sapiens	Ki	uM	0.5
	352638	CHEMBL766779	Displacement of [3H]PDBu from human recombinant Protein kinase C alpha	B	CCCCC1(CCCC)CC[C@H]2CC(=O)N[C@@H](CO)C[C@]2(C)C1		CHEMBL50658	=	Ki	nM	190.0	CHEMBL299	Homo sapiens	Ki	nM	190.0
	353334	CHEMBL769437	Displacement of [20-3H]-phorbol 12,13-dibutyrate from protein kinase C alpha at 30 FM	B	COc1cc2c3c(cc[n+](Cc4ccccc4)c3c1OC)N(Cc1ccccc1)C=C2.[Cl-]		CHEMBL49982	=	Inhibition	%	11.8	CHEMBL299	Homo sapiens	Inhibition	%	11.8
	353335	CHEMBL769436	Inhibition of PKC alpha at 30 FM	B	COc1cc2c3c(cc[n+](Cc4ccccc4)c3c1OC)N(Cc1ccccc1)C=C2.[Cl-]		CHEMBL49982	=	Inhibition	%	71.1	CHEMBL299	Homo sapiens	Inhibition	%	71.1
	353336	CHEMBL767039	Inhibition of PKC alpha	B	COc1cc2c3c(cc[n+](Cc4ccccc4)c3c1OC)N(Cc1ccccc1)C=C2.[Cl-]	Non standard unit for type	CHEMBL49982	=	ID50	fM	20.8	CHEMBL299	Homo sapiens	ID50	fM	20.8
	353355	CHEMBL769437	Displacement of [20-3H]-phorbol 12,13-dibutyrate from protein kinase C alpha at 30 FM	B	COc1ccc(CN2C=Cc3cc(OC)c(OC)c4c3c2cc[n+]4Cc2ccccc2)cc1.[Br-]		CHEMBL299077	=	Inhibition	%	12.6	CHEMBL299	Homo sapiens	Inhibition	%	12.6
	353356	CHEMBL769436	Inhibition of PKC alpha at 30 FM	B	COc1ccc(CN2C=Cc3cc(OC)c(OC)c4c3c2cc[n+]4Cc2ccccc2)cc1.[Br-]		CHEMBL299077	=	Inhibition	%	84.6	CHEMBL299	Homo sapiens	Inhibition	%	84.6
	353357	CHEMBL767040	Inhibition of PKC alpha	B	COc1ccc(CN2C=Cc3cc(OC)c(OC)c4c3c2cc[n+]4Cc2ccccc2)cc1.[Br-]	Non standard unit for type	CHEMBL299077	=	ID50	fM	7.4	CHEMBL299	Homo sapiens	ID50	fM	7.4
	353375	CHEMBL769436	Inhibition of PKC alpha at 30 FM	B	COc1cc(CN2C=Cc3cc(OC)c(OC)c4c3c2cc[n+]4-c2ccccc2)cc(OC)c1OC.[Br-]		CHEMBL301500	=	Inhibition	%	19.5	CHEMBL299	Homo sapiens	Inhibition	%	19.5
	354903	CHEMBL769436	Inhibition of PKC alpha at 30 FM	B	COc1cc2c3c(cc[n+](C)c3c1OC)N(C)C=C2.[I-]		CHEMBL50890	<	Inhibition	%	6.0	CHEMBL299	Homo sapiens	Inhibition	%	6.0
	368376	CHEMBL766779	Displacement of [3H]PDBu from human recombinant Protein kinase C alpha	B	CCCCC1(CCCC)CC[C@H]2[C@H](C)C(=O)N[C@H](CO)C[C@]2(C)C1		CHEMBL52263	=	Ki	nM	21.0	CHEMBL299	Homo sapiens	Ki	nM	21.0
	372509	CHEMBL766779	Displacement of [3H]PDBu from human recombinant Protein kinase C alpha	B	CC(C)CCCC(C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4CC(=O)N[C@@H](CO)C[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL49250	>	Ki	nM	500.0	CHEMBL299	Homo sapiens	Ki	uM	0.5
	373311	CHEMBL769437	Displacement of [20-3H]-phorbol 12,13-dibutyrate from protein kinase C alpha at 30 FM	B	COc1ccc(CN2C=Cc3cc(OC)c(OC)c4nccc2c34)cc1.Cl		CHEMBL301975	=	Inhibition	%	9.2	CHEMBL299	Homo sapiens	Inhibition	%	9.2
	373312	CHEMBL769436	Inhibition of PKC alpha at 30 FM	B	COc1ccc(CN2C=Cc3cc(OC)c(OC)c4nccc2c34)cc1.Cl		CHEMBL301975	<	Inhibition	%	6.0	CHEMBL299	Homo sapiens	Inhibition	%	6.0
	377452	CHEMBL769436	Inhibition of PKC alpha at 30 FM	B	COc1cc(CN2C=Cc3cc(OC)c(OC)c4nccc2c34)cc(OC)c1OC.Cl		CHEMBL301279	<	Inhibition	%	6.0	CHEMBL299	Homo sapiens	Inhibition	%	6.0
	380292	CHEMBL769437	Displacement of [20-3H]-phorbol 12,13-dibutyrate from protein kinase C alpha at 30 FM	B	COc1ccc(C[n+]2ccc3c4c(cc(OC)c(OC)c42)C=CN3Cc2cc(OC)c(OC)c(OC)c2)cc1O.[Br-]		CHEMBL301950	=	Inhibition	%	16.0	CHEMBL299	Homo sapiens	Inhibition	%	16.0
	380293	CHEMBL769436	Inhibition of PKC alpha at 30 FM	B	COc1ccc(C[n+]2ccc3c4c(cc(OC)c(OC)c42)C=CN3Cc2cc(OC)c(OC)c(OC)c2)cc1O.[Br-]		CHEMBL301950	=	Inhibition	%	43.2	CHEMBL299	Homo sapiens	Inhibition	%	43.2
	381033	CHEMBL766779	Displacement of [3H]PDBu from human recombinant Protein kinase C alpha	B	C[C@@]12CCC[C@H]1[C@@H]1CC[C@H]3CC(=O)N[C@@H](CO)C[C@]3(C)[C@H]1CC2		CHEMBL52428	>	Ki	nM	500.0	CHEMBL299	Homo sapiens	Ki	uM	0.5
	381035	CHEMBL766779	Displacement of [3H]PDBu from human recombinant Protein kinase C alpha	B	CCCC[C@@H]1C(=O)N[C@H](CO)C[C@]2(C)CC(CCCC)(CCCC)CC[C@@H]12		CHEMBL50717	=	Ki	nM	17.0	CHEMBL299	Homo sapiens	Ki	nM	17.0
	381037	CHEMBL766779	Displacement of [3H]PDBu from human recombinant Protein kinase C alpha	B	CCCCCCCC[C@@H]1C(=O)N[C@H](CO)C[C@]2(C)CC(CCCC)(CCCC)CC[C@@H]12		CHEMBL51313	=	Ki	nM	11.0	CHEMBL299	Homo sapiens	Ki	nM	11.0
	381699	CHEMBL769436	Inhibition of PKC alpha at 30 FM	B	COc1cc2c3c(ccnc3c1OC)N(C)C=C2		CHEMBL300740	<	Inhibition	%	6.0	CHEMBL299	Homo sapiens	Inhibition	%	6.0
	381717	CHEMBL769437	Displacement of [20-3H]-phorbol 12,13-dibutyrate from protein kinase C alpha at 30 FM	B	COc1cc2c3c(ccnc3c1OC)N(Cc1ccccc1)C=C2.Cl		CHEMBL51632	=	Inhibition	%	6.4	CHEMBL299	Homo sapiens	Inhibition	%	6.4
	381718	CHEMBL769436	Inhibition of PKC alpha at 30 FM	B	COc1cc2c3c(ccnc3c1OC)N(Cc1ccccc1)C=C2.Cl		CHEMBL51632	<	Inhibition	%	6.0	CHEMBL299	Homo sapiens	Inhibition	%	6.0
	389831	CHEMBL766779	Displacement of [3H]PDBu from human recombinant Protein kinase C alpha	B	C[C@@]12CCC[C@H]1[C@@H]1CC[C@H]3CC(=O)N[C@H](CO)C[C@]3(C)[C@H]1CC2		CHEMBL48622	>	Ki	nM	500.0	CHEMBL299	Homo sapiens	Ki	uM	0.5
	389833	CHEMBL766779	Displacement of [3H]PDBu from human recombinant Protein kinase C alpha	B	CCCCC1(CCCC)CC[C@H]2CC(=O)N[C@H](CO)C[C@]2(C)C1		CHEMBL49902	=	Ki	nM	60.0	CHEMBL299	Homo sapiens	Ki	nM	60.0
	389834	CHEMBL768537	Displacement of [3H]PDBu from human recombinant Protein kinase C alpha	B	CCCCC1(CCCC)CC[C@H]2CC(=O)N[C@H](CO)C[C@]2(C)C1		CHEMBL49902	=	Ki	nM	80.0	CHEMBL299	Homo sapiens	Ki	nM	80.0
	390981	CHEMBL767029	Inhibition of Protein kinase C alpha	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	IC50	nM	10.0	CHEMBL299	Homo sapiens	IC50	uM	0.01
	392477	CHEMBL769628	Displacement phorbol 12,13-dibutyrate(PDBU) binding from recombinant Protein kinase C alpha	B	CCCCCCCCC#Cc1ccc2c(c1)C[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL6453	=	Ki	nM	15.0	CHEMBL299	Homo sapiens	Ki	nM	15.0
	394908	CHEMBL760369	Inhibition of PKCalpha kinase	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	=	IC50	nM	83.0	CHEMBL299	Homo sapiens	IC50	nM	83.0
	395335	CHEMBL763597	Inhibition of protein kinase C alpha	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	396152	CHEMBL763600	Inhibition of Protein kinase C alpha	B	O=C(NC1CN2CCC(CC2)C1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL306884	=	IC50	nM	415.0	CHEMBL299	Homo sapiens	IC50	uM	0.415
	397391	CHEMBL763600	Inhibition of Protein kinase C alpha	B	O=C(NC1CCC[C@@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL71331	=	IC50	nM	40.0	CHEMBL299	Homo sapiens	IC50	uM	0.04
	398565	CHEMBL767029	Inhibition of Protein kinase C alpha	B	CN(C)CCCNC(=O)c1cc(NC(=O)c2cc(NC(=O)c3cc(NC(=O)Cn4cc(C5=C(c6c[nH]c7ccccc67)C(=O)NC5=O)c5ccccc54)cn3C)cn2C)cn1C		CHEMBL268744	=	IC50	nM	460.0	CHEMBL299	Homo sapiens	IC50	uM	0.46
	402627	CHEMBL763600	Inhibition of Protein kinase C alpha	B	O=C(N[C@@H]1CNCCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL311399	=	IC50	nM	74.0	CHEMBL299	Homo sapiens	IC50	uM	0.074
	402636	CHEMBL767029	Inhibition of Protein kinase C alpha	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	4.0	CHEMBL299	Homo sapiens	IC50	uM	0.004
	403967	CHEMBL763600	Inhibition of Protein kinase C alpha	B	O=C(NC1C2CCC(C2)C1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL305667	=	IC50	nM	55.0	CHEMBL299	Homo sapiens	IC50	uM	0.055
	403976	CHEMBL767029	Inhibition of Protein kinase C alpha	B	COC(=O)c1cc(NC(=O)c2cc(NC(=O)Cn3cc(C4=C(c5c[nH]c6ccccc56)C(=O)NC4=O)c4ccccc43)cn2C)cn1C		CHEMBL269437	=	IC50	nM	280.0	CHEMBL299	Homo sapiens	IC50	uM	0.28
	406669	CHEMBL767029	Inhibition of Protein kinase C alpha	B	COC(=O)c1cc(NC(=O)c2cc(C(=O)c3cc(NC(=O)Cn4cc(C5=C(c6c[nH]c7ccccc67)C(=O)NC5=O)c5ccccc54)cn3C)cn2C)cn1C		CHEMBL149237	=	IC50	nM	170.0	CHEMBL299	Homo sapiens	IC50	uM	0.17
	411576	CHEMBL768406	Activation of purified human recombinant Protein Kinase C alpha	B	CCCCCCCC/C=C\CCCCCCCC(=O)O		CHEMBL8659	=	Km	nM	102000.0	CHEMBL299	Homo sapiens	Km	uM	102.0
	412742	CHEMBL767029	Inhibition of Protein kinase C alpha	B	CN(C)CCCNC(=O)c1cc(NC(=O)Cn2cc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc32)cn1C		CHEMBL9333	=	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	uM	1.0
	413926	CHEMBL763600	Inhibition of Protein kinase C alpha	B	CN1C2CCC1C(NC(=O)c1ccc(O)cc1)C(OC(=O)c1cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c1)C2		CHEMBL306883	=	IC50	nM	35000.0	CHEMBL299	Homo sapiens	IC50	uM	35.0
	413935	CHEMBL767029	Inhibition of Protein kinase C alpha	B	COC(=O)c1cc(NC(=O)Cn2cc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc32)cn1C		CHEMBL9680	=	IC50	nM	500.0	CHEMBL299	Homo sapiens	IC50	uM	0.5
	415315	CHEMBL769628	Displacement phorbol 12,13-dibutyrate(PDBU) binding from recombinant Protein kinase C alpha	B	CCCCCCCCC#Cc1ccc2c(c1OC)C[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL7078	=	Ki	nM	45.6	CHEMBL299	Homo sapiens	Ki	nM	45.6
	416452	CHEMBL768406	Activation of purified human recombinant Protein Kinase C alpha	B	O=Cc1ccc(C2(C(F)(F)F)N=N2)cc1OCCCCCCCC/C=C/CCCCCCCC(=O)O		CHEMBL37532	=	Km	nM	186000.0	CHEMBL299	Homo sapiens	Km	uM	186.0
	416453	CHEMBL768406	Activation of purified human recombinant Protein Kinase C alpha	B	O=C(O)CCCCCCC/C=C/CCCCCCCCOc1cc(C2(C(F)(F)F)N=N2)ccc1I		CHEMBL40222	=	Km	nM	140000.0	CHEMBL299	Homo sapiens	Km	uM	140.0
	416454	CHEMBL842281	Effect on diacylglycerol induced (DAG) PKC activation at 1-10 uM	F	O=C(O)CCCCCCC/C=C/CCCCCCCCOc1cc(C2(C(F)(F)F)N=N2)ccc1I		CHEMBL40222	=	Activity	%	40.0	CHEMBL299	Homo sapiens	Activity	%	40.0
	418749	CHEMBL763600	Inhibition of Protein kinase C alpha	B	O=C(NC1C2CCC(C2)C1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL305667	=	IC50	nM	24000.0	CHEMBL299	Homo sapiens	IC50	uM	24.0
	418758	CHEMBL763600	Inhibition of Protein kinase C alpha	B	O=C(NC1C2CC(C3CCCC32)C1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL72480	=	IC50	nM	100.0	CHEMBL299	Homo sapiens	IC50	uM	0.1
	418889	CHEMBL760369	Inhibition of PKCalpha kinase	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL97162	=	IC50	nM	83.0	CHEMBL299	Homo sapiens	IC50	nM	83.0
	419945	CHEMBL763600	Inhibition of Protein kinase C alpha	B	O=C(NC1CN2CCC(CC2)C1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL306884	=	IC50	nM	12000.0	CHEMBL299	Homo sapiens	IC50	uM	12.0
	419954	CHEMBL763600	Inhibition of Protein kinase C alpha	B	O=C(NC1C2CC(C3CCCC32)C1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL72480	=	IC50	nM	2700.0	CHEMBL299	Homo sapiens	IC50	uM	2.7
	422828	CHEMBL763600	Inhibition of Protein kinase C alpha	B	CN1C2CCC1C(NC(=O)c1ccc(O)cc1)C(OC(=O)c1cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c1)C2		CHEMBL306883	=	IC50	nM	34000.0	CHEMBL299	Homo sapiens	IC50	uM	34.0
	424243	CHEMBL769628	Displacement phorbol 12,13-dibutyrate(PDBU) binding from recombinant Protein kinase C alpha	B	COc1cccc2c1C[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL6644	=	Ki	nM	7162.0	CHEMBL299	Homo sapiens	Ki	nM	7162.0
	426587	CHEMBL763600	Inhibition of Protein kinase C alpha	B	O=C(NC1CNC[C@@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL422056	=	IC50	nM	22.0	CHEMBL299	Homo sapiens	IC50	uM	0.022
	426747	CHEMBL769628	Displacement phorbol 12,13-dibutyrate(PDBU) binding from recombinant Protein kinase C alpha	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2ccccc2N1C		CHEMBL267144	=	Ki	nM	334.0	CHEMBL299	Homo sapiens	Ki	nM	334.0
	427204	CHEMBL766775	Binding affinity for human Protein kinase C alpha with [Ca2+]	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2cc(NC(=O)CCCCCCCCCCCCC(=O)Nc3ccc4c(c3)N(C)[C@@H](C(C)C)C(=O)N[C@H](CO)C4)ccc2N1C		CHEMBL337834	=	Kd	nM	0.28	CHEMBL299	Homo sapiens	Kd	nM	0.28
	427209	CHEMBL766781	Inhibition of human Protein kinase C alpha with [Ca2+]	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2cc(NC(=O)CCCCCCCCCCCCC(=O)Nc3ccc4c(c3)N(C)[C@@H](C(C)C)C(=O)N[C@H](CO)C4)ccc2N1C		CHEMBL337834	=	Ki	nM	0.93	CHEMBL299	Homo sapiens	Ki	nM	0.93
	427860	CHEMBL767029	Inhibition of Protein kinase C alpha	B	CN(C)CCCNC(=O)c1cc(NC(=O)c2cc(NC(=O)Cn3cc(C4=C(c5c[nH]c6ccccc56)C(=O)NC4=O)c4ccccc43)cn2C)cn1C		CHEMBL429569	=	IC50	nM	630.0	CHEMBL299	Homo sapiens	IC50	uM	0.63
	427913	CHEMBL768406	Activation of purified human recombinant Protein Kinase C alpha	B	O=C(O)CCCCCCC/C=C/CCCCCCCCOc1cccc(C2(C(F)(F)F)N=N2)c1		CHEMBL39303	=	Km	nM	174000.0	CHEMBL299	Homo sapiens	Km	uM	174.0
	429118	CHEMBL763600	Inhibition of Protein kinase C alpha	B	CC1(C)C2CCC1(C)C(OC(=O)c1cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c1)C2NC(=O)c1ccc(O)cc1		CHEMBL306170	=	IC50	nM	410.0	CHEMBL299	Homo sapiens	IC50	uM	0.41
	433482	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CCCCCC(=O)OCC1(CO)C/C(=C\CC(C(C)C)C(C)C)C(=O)O1		CHEMBL367682	=	Ki	nM	11.0	CHEMBL299	Homo sapiens	Ki	nM	11.0
	439866	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CCCCCC(=O)OCC1(CO)C/C(=C/CC(C(C)C)C(C)C)C(=O)O1		CHEMBL368346	=	Ki	nM	5.9	CHEMBL299	Homo sapiens	Ki	nM	5.9
	439867	CHEMBL768407	Activation of PKC-alpha-dependent peptide phosphorylation	B	CCCCCC(=O)OCC1(CO)C/C(=C/CC(C(C)C)C(C)C)C(=O)O1	Non standard unit for type	CHEMBL368346	=	ED50	uM	2.33	CHEMBL299	Homo sapiens	ED50	uM	2.33
	439869	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CC(C)C(C/C=C1/CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O)C(C)C		CHEMBL290876	=	Ki	nM	2.9	CHEMBL299	Homo sapiens	Ki	nM	2.9
	439870	CHEMBL768407	Activation of PKC-alpha-dependent peptide phosphorylation	B	CC(C)C(C/C=C1/CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O)C(C)C	Non standard unit for type	CHEMBL290876	=	ED50	uM	0.55	CHEMBL299	Homo sapiens	ED50	uM	0.55
	439877	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CCCCCCOC(=O)/C=C/[C@]1(CO)C/C(=C/CC(C(C)C)C(C)C)C(=O)O1		CHEMBL355787	=	Ki	nM	3.5	CHEMBL299	Homo sapiens	Ki	nM	3.5
	439878	CHEMBL768407	Activation of PKC-alpha-dependent peptide phosphorylation	B	CCCCCCOC(=O)/C=C/[C@]1(CO)C/C(=C/CC(C(C)C)C(C)C)C(=O)O1	Non standard unit for type	CHEMBL355787	=	ED50	uM	0.95	CHEMBL299	Homo sapiens	ED50	uM	0.95
	441155	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CC(=O)OCC1(CO)C/C(=C/C=C(C(C)C)C(C)C)C(=O)O1		CHEMBL173670	=	Ki	nM	390.0	CHEMBL299	Homo sapiens	Ki	nM	390.0
	441156	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CCCCC/C=C1/CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O		CHEMBL425676	=	Ki	nM	7.3	CHEMBL299	Homo sapiens	Ki	nM	7.3
	441157	CHEMBL768407	Activation of PKC-alpha-dependent peptide phosphorylation	B	CCCCC/C=C1/CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O	Non standard unit for type	CHEMBL425676	=	ED50	uM	0.34	CHEMBL299	Homo sapiens	ED50	uM	0.34
	442595	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CC(C)C(C/C=C1\CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O)C(C)C		CHEMBL137288	=	Ki	nM	2.7	CHEMBL299	Homo sapiens	Ki	nM	2.7
	442596	CHEMBL768407	Activation of PKC-alpha-dependent peptide phosphorylation	B	CC(C)C(C/C=C1\CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O)C(C)C	Non standard unit for type	CHEMBL137288	=	ED50	uM	0.68	CHEMBL299	Homo sapiens	ED50	uM	0.68
	443851	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CCCCCCCC(=O)OC[C@]1(CO)C/C(=C\CC(C(C)C)C(C)C)C(=O)O1		CHEMBL3085533	=	Ki	nM	5.9	CHEMBL299	Homo sapiens	Ki	nM	5.9
	446729	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CCCCC/C=C1\CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O		CHEMBL172433	=	Ki	nM	5.5	CHEMBL299	Homo sapiens	Ki	nM	5.5
	446730	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CCCCCCCC/C=C\CCCCCCC/C=C1/C[C@](/C=C/C(=O)OC)(CO)OC1=O		CHEMBL170120	=	Ki	nM	11.0	CHEMBL299	Homo sapiens	Ki	nM	11.0
	446731	CHEMBL768407	Activation of PKC-alpha-dependent peptide phosphorylation	B	CCCCCCCC/C=C\CCCCCCC/C=C1/C[C@](/C=C/C(=O)OC)(CO)OC1=O	Non standard unit for type	CHEMBL170120	=	ED50	uM	1.07	CHEMBL299	Homo sapiens	ED50	uM	1.07
	446733	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CCCCCCC/C=C\CCCCCCC/C=C1\C[C@](/C=C/C(=O)OC)(CO)OC1=O		CHEMBL173130	=	Ki	nM	20.0	CHEMBL299	Homo sapiens	Ki	nM	20.0
	447985	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CCCC(=O)OCC1(CO)C/C(=C\CC(C(C)C)C(C)C)C(=O)O1		CHEMBL175389	=	Ki	nM	54.0	CHEMBL299	Homo sapiens	Ki	nM	54.0
	449268	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CC(=O)OCC1(CO)C/C(=C\CC(C(C)C)C(C)C)C(=O)O1		CHEMBL176579	=	Ki	nM	359.0	CHEMBL299	Homo sapiens	Ki	nM	359.0
	451810	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CCCC(=O)OCC1(CO)C/C(=C\C=C(C(C)C)C(C)C)C(=O)O1		CHEMBL174028	=	Ki	nM	51.0	CHEMBL299	Homo sapiens	Ki	nM	51.0
	453088	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CCCCCCCCC/C=C1\CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O		CHEMBL369061	=	Ki	nM	9.5	CHEMBL299	Homo sapiens	Ki	nM	9.5
	453089	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CC(=O)OCC1(CO)C/C(=C/CC(C(C)C)C(C)C)C(=O)O1		CHEMBL369163	=	Ki	nM	123.0	CHEMBL299	Homo sapiens	Ki	nM	123.0
	454445	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CCCCCCCCCC(=O)OCC1(CO)C/C(=C/CC(C(C)C)C(C)C)C(=O)O1		CHEMBL111625	=	Ki	nM	2.3	CHEMBL299	Homo sapiens	Ki	nM	2.3
	454446	CHEMBL768407	Activation of PKC-alpha-dependent peptide phosphorylation	B	CCCCCCCCCC(=O)OCC1(CO)C/C(=C/CC(C(C)C)C(C)C)C(=O)O1	Non standard unit for type	CHEMBL111625	=	ED50	uM	0.66	CHEMBL299	Homo sapiens	ED50	uM	0.66
	454456	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Ki	nM	0.2	CHEMBL299	Homo sapiens	Ki	nM	0.2
	454457	CHEMBL768407	Activation of PKC-alpha-dependent peptide phosphorylation	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC	Non standard unit for type	CHEMBL27768	=	ED50	uM	0.02	CHEMBL299	Homo sapiens	ED50	uM	0.02
	457093	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CCCCCC(=O)OCC1(CO)C/C(=C\C=C(C(C)C)C(C)C)C(=O)O1		CHEMBL173821	=	Ki	nM	8.4	CHEMBL299	Homo sapiens	Ki	nM	8.4
	459641	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CC(=O)OCC1(CO)C/C(=C\C=C(C(C)C)C(C)C)C(=O)O1		CHEMBL369665	=	Ki	nM	409.0	CHEMBL299	Homo sapiens	Ki	nM	409.0
	462244	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CCC/C=C1\CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O		CHEMBL440555	=	Ki	nM	28.0	CHEMBL299	Homo sapiens	Ki	nM	28.0
	462245	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CCCCCCOC(=O)/C=C/[C@]1(CO)C/C(=C\CC(C(C)C)C(C)C)C(=O)O1		CHEMBL368472	=	Ki	nM	29.5	CHEMBL299	Homo sapiens	Ki	nM	29.5
	463478	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CCC/C=C1/CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O		CHEMBL173516	=	Ki	nM	24.0	CHEMBL299	Homo sapiens	Ki	nM	24.0
	464748	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CCCCCC(=O)OCC1(CO)C/C(=C/C=C(C(C)C)C(C)C)C(=O)O1		CHEMBL172715	=	Ki	nM	12.0	CHEMBL299	Homo sapiens	Ki	nM	12.0
	467444	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	C/C=C1\CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O		CHEMBL172182	=	Ki	nM	138.0	CHEMBL299	Homo sapiens	Ki	nM	138.0
	467445	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CCCC(=O)OCC1(CO)C/C(=C/C=C(C(C)C)C(C)C)C(=O)O1		CHEMBL173241	=	Ki	nM	68.0	CHEMBL299	Homo sapiens	Ki	nM	68.0
	470277	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CCCCCCCC(=O)OC[C@]1(CO)C/C(=C/CC(C(C)C)C(C)C)C(=O)O1		CHEMBL3085534	=	Ki	nM	3.5	CHEMBL299	Homo sapiens	Ki	nM	3.5
	471734	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CCCCCCCCCC(=O)OCC1(CO)C/C(=C\CC(C(C)C)C(C)C)C(=O)O1		CHEMBL171577	=	Ki	nM	6.6	CHEMBL299	Homo sapiens	Ki	nM	6.6
	471735	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CCCC(=O)OCC1(CO)C/C(=C/CC(C(C)C)C(C)C)C(=O)O1		CHEMBL170464	=	Ki	nM	19.0	CHEMBL299	Homo sapiens	Ki	nM	19.0
	471736	CHEMBL768407	Activation of PKC-alpha-dependent peptide phosphorylation	B	CCCC(=O)OCC1(CO)C/C(=C/CC(C(C)C)C(C)C)C(=O)O1	Non standard unit for type	CHEMBL170464	=	ED50	uM	1.95	CHEMBL299	Homo sapiens	ED50	uM	1.95
	471738	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	C/C=C1/CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O		CHEMBL173414	=	Ki	nM	164.0	CHEMBL299	Homo sapiens	Ki	nM	164.0
	471739	CHEMBL766516	Binding Affinity against protein kinase C alpha	B	CCCCCCCCC/C=C1/CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O		CHEMBL107614	=	Ki	nM	13.0	CHEMBL299	Homo sapiens	Ki	nM	13.0
	471740	CHEMBL768407	Activation of PKC-alpha-dependent peptide phosphorylation	B	CCCCCCCCC/C=C1/CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O	Non standard unit for type	CHEMBL107614	=	ED50	uM	0.43	CHEMBL299	Homo sapiens	ED50	uM	0.43
	473611	CHEMBL766777	Binding affinity for protein kinase C alpha	B	CCCCCCCCCCOc1cccc2c1C(=O)O[C@@]2(CO)COC(C)=O		CHEMBL100914	=	Ki	nM	122.0	CHEMBL299	Homo sapiens	Ki	nM	122.0
	473612	CHEMBL768378	Displacement of [3H]PDBu from PKC alpha at 100 uM; range 20 to 40	B	CCCCCCCCCCOc1cccc2c1C(=O)O[C@@]2(CO)COC(C)=O		CHEMBL100914	=	Inhibition	%	21.0	CHEMBL299	Homo sapiens	Inhibition	%	21.0
	475039	CHEMBL767702	Inhibition of Human Protein kinase C alpha	B	O=C(N[C@@H]1CCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2NS(=O)(=O)C(F)(F)F)c(O)c1)c1ccc(O)cc1		CHEMBL52869	=	IC50	nM	100.0	CHEMBL299	Homo sapiens	IC50	uM	0.1
	475822	CHEMBL766777	Binding affinity for protein kinase C alpha	B	CCCCCCCCCCCCOc1cccc2c1C(=O)O[C@]2(CO)COC(C)=O		CHEMBL102106	=	Ki	nM	540.0	CHEMBL299	Homo sapiens	Ki	nM	540.0
	475823	CHEMBL874021	Displacement of [3H]PDBu from PKC alpha at 100 uM; range 60 to 80	B	CCCCCCCCCCCCOc1cccc2c1C(=O)O[C@]2(CO)COC(C)=O		CHEMBL102106	=	Inhibition	%	75.0	CHEMBL299	Homo sapiens	Inhibition	%	75.0
	477011	CHEMBL766777	Binding affinity for protein kinase C alpha	B	CCCCCCCCCCCCOc1cccc2c1C(=O)O[C@@]2(CO)COC(=O)C(C)(C)C		CHEMBL433207	=	Ki	nM	122.0	CHEMBL299	Homo sapiens	Ki	nM	122.0
	478257	CHEMBL766777	Binding affinity for protein kinase C alpha	B	CC(=O)OC[C@@]1(CO)OC(=O)c2c(OCc3ccccc3)cccc21		CHEMBL322865	=	Ki	nM	540.0	CHEMBL299	Homo sapiens	Ki	nM	540.0
	478258	CHEMBL768377	Displacement of [3H]PDBu from PKC alpha at 100 uM; range 0 to 20	B	CC(=O)OC[C@@]1(CO)OC(=O)c2c(OCc3ccccc3)cccc21		CHEMBL322865	=	Inhibition	%	9.0	CHEMBL299	Homo sapiens	Inhibition	%	9.0
	478625	CHEMBL767702	Inhibition of Human Protein kinase C alpha	B	O=C(N[C@@H]1CCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2-c2nn[nH]n2)c(O)c1)c1ccc(O)cc1		CHEMBL298872	=	IC50	nM	340.0	CHEMBL299	Homo sapiens	IC50	uM	0.34
	479800	CHEMBL767702	Inhibition of Human Protein kinase C alpha	B	CS(=O)(=O)Nc1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL294166	=	IC50	nM	450.0	CHEMBL299	Homo sapiens	IC50	uM	0.45
	479806	CHEMBL767702	Inhibition of Human Protein kinase C alpha	B	CC(C)(C)C(=O)OCn1nnc(-c2cccc(O)c2C(=O)c2c(O)cc(C(=O)O[C@@H]3CCC[C@H]3NC(=O)c3ccc(O)cc3)cc2O)n1		CHEMBL300658	=	IC50	nM	37000.0	CHEMBL299	Homo sapiens	IC50	uM	37.0
	482377	CHEMBL767702	Inhibition of Human Protein kinase C alpha	B	O=C(N[C@@H]1CCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2NC(=O)C(F)(F)F)c(O)c1)c1ccc(O)cc1		CHEMBL55890	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	484816	CHEMBL767702	Inhibition of Human Protein kinase C alpha	B	Cn1nnnc1-c1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL53025	=	IC50	nM	11000.0	CHEMBL299	Homo sapiens	IC50	uM	11.0
	486760	CHEMBL766777	Binding affinity for protein kinase C alpha	B	CCCCCCCCCCCCOc1cccc2c1C(=O)O[C@@]2(CO)COC(C)=O		CHEMBL100739	=	Ki	nM	540.0	CHEMBL299	Homo sapiens	Ki	nM	540.0
	486761	CHEMBL768378	Displacement of [3H]PDBu from PKC alpha at 100 uM; range 20 to 40	B	CCCCCCCCCCCCOc1cccc2c1C(=O)O[C@@]2(CO)COC(C)=O		CHEMBL100739	=	Inhibition	%	35.0	CHEMBL299	Homo sapiens	Inhibition	%	35.0
	487101	CHEMBL767702	Inhibition of Human Protein kinase C alpha	B	O=C(N[C@@H]1CCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL52529	=	IC50	nM	40.0	CHEMBL299	Homo sapiens	IC50	uM	0.04
	489091	CHEMBL766777	Binding affinity for protein kinase C alpha	B	CCCCCCCCCCOc1cccc2c1C(=O)O[C@]2(CO)COC(C)=O		CHEMBL99115	=	Ki	nM	122.0	CHEMBL299	Homo sapiens	Ki	nM	122.0
	489092	CHEMBL768379	Displacement of [3H]PDBu from PKC alpha at 100 uM; range 40 to 60	B	CCCCCCCCCCOc1cccc2c1C(=O)O[C@]2(CO)COC(C)=O		CHEMBL99115	=	Inhibition	%	59.0	CHEMBL299	Homo sapiens	Inhibition	%	59.0
	489530	CHEMBL762308	Inhibition of [3H]phorbol-12,13-dibutyrate (PDBu) binding to Protein kinase C alpha C1a domain	B	CCCCCCCCCCc1ccc2c(c1)C[C@@H](CO)OC(=O)[C@H](C(C)C)N2C		CHEMBL318971	>	Ki	nM	10000.0	CHEMBL299	Homo sapiens	Ki	nM	10000.0
	489531	CHEMBL762313	Inhibition of [3H]phorbol-12,13-dibutyrate (PDBu) binding to Protein kinase C alpha C1b domain	B	CCCCCCCCCCc1ccc2c(c1)C[C@@H](CO)OC(=O)[C@H](C(C)C)N2C		CHEMBL318971	>	Ki	nM	10000.0	CHEMBL299	Homo sapiens	Ki	nM	10000.0
	490608	CHEMBL767702	Inhibition of Human Protein kinase C alpha	B	CC(C)(C)C(=O)OCn1nnnc1-c1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL293722	=	IC50	nM	14000.0	CHEMBL299	Homo sapiens	IC50	uM	14.0
	495313	CHEMBL767702	Inhibition of Human Protein kinase C alpha	B	CC(=O)Nc1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL299987	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	495319	CHEMBL767702	Inhibition of Human Protein kinase C alpha	B	Cn1nnc(-c2cccc(O)c2C(=O)c2c(O)cc(C(=O)O[C@@H]3CCC[C@H]3NC(=O)c3ccc(O)cc3)cc2O)n1		CHEMBL298159	=	IC50	nM	3600.0	CHEMBL299	Homo sapiens	IC50	uM	3.6
	506163	CHEMBL767028	Inhibition of protein kinase C alpha	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	IC50	nM	1200.0	CHEMBL299	Homo sapiens	IC50	uM	1.2
	506204	CHEMBL762308	Inhibition of [3H]phorbol-12,13-dibutyrate (PDBu) binding to Protein kinase C alpha C1a domain	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL27266	=	Ki	nM	126.9	CHEMBL299	Homo sapiens	Ki	nM	126.9
	506205	CHEMBL762313	Inhibition of [3H]phorbol-12,13-dibutyrate (PDBu) binding to Protein kinase C alpha C1b domain	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL27266	=	Ki	nM	4000.0	CHEMBL299	Homo sapiens	Ki	nM	4000.0
	507433	CHEMBL762309	Inhibition of [3H]phorbol-12,13-dibutyrate (PDBu) binding to Protein kinase C alpha C1a domain	B	CCCCCCCCCCc1ccc2c(c1)C[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL28205	=	Ki	nM	322.5	CHEMBL299	Homo sapiens	Ki	nM	322.5
	507434	CHEMBL762313	Inhibition of [3H]phorbol-12,13-dibutyrate (PDBu) binding to Protein kinase C alpha C1b domain	B	CCCCCCCCCCc1ccc2c(c1)C[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL28205	=	Ki	nM	4690.0	CHEMBL299	Homo sapiens	Ki	nM	4690.0
	509482	CHEMBL766777	Binding affinity for protein kinase C alpha	B	CCCCCCCC(=O)OC[C@H](CO)OC(C)=O		CHEMBL102042	=	Ki	nM	540.0	CHEMBL299	Homo sapiens	Ki	nM	540.0
	510690	CHEMBL766777	Binding affinity for protein kinase C alpha	B	C=CCC(=O)Oc1cccc2c1C(=O)O[C@]2(CO)COC(C)=O		CHEMBL101616	=	Ki	nM	122.0	CHEMBL299	Homo sapiens	Ki	nM	122.0
	510691	CHEMBL768376	Displacement of [3H]PDBu from PKC alpha at 100 uM.	B	C=CCC(=O)Oc1cccc2c1C(=O)O[C@]2(CO)COC(C)=O		CHEMBL101616	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	Inhibition	%	0.0
	515463	CHEMBL763595	Inhibition of Protein kinase C alpha at 10 uM	B	CN1CCC(c2c(O)cc(O)c3c2O/C(=C\c2ccccc2Cl)C3=O)CC1		CHEMBL48614	=	Inhibition	%	22.0	CHEMBL299	Homo sapiens	Inhibition	%	22.0
	515532	CHEMBL768985	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from a recombinant protein kinase C alpha with phosphatidylserine	B	CCCCCCCCC/C=C1/CC(CO)(COC(=O)c2ccccc2)OC1=O		CHEMBL110256	=	Ki	nM	20.3	CHEMBL299	Homo sapiens	Ki	nM	20.3
	515533	CHEMBL768824	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from a recombinant protein kinase C alpha with phosphatidylserine	B	CCCCCCCCC/C=C1/CC(CO)(COC(=O)c2ccccc2)OC1=O		CHEMBL110256	=	Ki	nM	37.0	CHEMBL299	Homo sapiens	Ki	nM	37.0
	516671	CHEMBL767036	Inhibition of Protein kinase C alpha	B	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H](O)C1		CHEMBL418203	=	IC50	nM	23000.0	CHEMBL299	Homo sapiens	IC50	uM	23.0
	519344	CHEMBL768985	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from a recombinant protein kinase C alpha with phosphatidylserine	B	CCCCCCCC/C=C1/CC(CO)(COC(=O)Cc2ccccc2)OC1=O		CHEMBL109997	=	Ki	nM	43.3	CHEMBL299	Homo sapiens	Ki	nM	43.3
	519345	CHEMBL768823	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from a recombinant protein kinase C alpha with phosphatidylserine	B	CCCCCCCC/C=C1/CC(CO)(COC(=O)Cc2ccccc2)OC1=O		CHEMBL109997	=	Ki	nM	145.0	CHEMBL299	Homo sapiens	Ki	nM	145.0
	520579	CHEMBL768985	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from a recombinant protein kinase C alpha with phosphatidylserine	B	CCCCCCCCC/C=C1/CC(CO)(COC(=O)Cc2ccccc2)OC1=O		CHEMBL321665	=	Ki	nM	43.8	CHEMBL299	Homo sapiens	Ki	nM	43.8
	520580	CHEMBL768824	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from a recombinant protein kinase C alpha with phosphatidylserine	B	CCCCCCCCC/C=C1/CC(CO)(COC(=O)Cc2ccccc2)OC1=O		CHEMBL321665	=	Ki	nM	92.5	CHEMBL299	Homo sapiens	Ki	nM	92.5
	523238	CHEMBL768985	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from a recombinant protein kinase C alpha with phosphatidylserine	B	CCCCCCCC/C=C1/CC(CO)(COC(=O)c2ccccc2)OC1=O		CHEMBL111711	=	Ki	nM	25.7	CHEMBL299	Homo sapiens	Ki	nM	25.7
	523239	CHEMBL768823	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from a recombinant protein kinase C alpha with phosphatidylserine	B	CCCCCCCC/C=C1/CC(CO)(COC(=O)c2ccccc2)OC1=O		CHEMBL111711	=	Ki	nM	45.6	CHEMBL299	Homo sapiens	Ki	nM	45.6
	527159	CHEMBL768985	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from a recombinant protein kinase C alpha with phosphatidylserine	B	O=C1OC(CO)(COC(=O)c2ccc(-c3ccccc3)cc2)C/C1=C/c1ccc(-c2ccccc2)cc1		CHEMBL442009	=	Ki	nM	22.7	CHEMBL299	Homo sapiens	Ki	nM	22.7
	527160	CHEMBL768823	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from a recombinant protein kinase C alpha with phosphatidylserine	B	O=C1OC(CO)(COC(=O)c2ccc(-c3ccccc3)cc2)C/C1=C/c1ccc(-c2ccccc2)cc1		CHEMBL442009	=	Ki	nM	83.9	CHEMBL299	Homo sapiens	Ki	nM	83.9
	528179	CHEMBL766778	Displacement of phorbol 12,13-dibutyrate (PDBU) from Protein kinase C alpha	B	CCCCCCCC/C=C\CCCCCCC/C=C1/C[C@@](CO)(COC(C)=O)OC1=O		CHEMBL116029	=	Ki	nM	12.0	CHEMBL299	Homo sapiens	Ki	nM	12.0
	528180	CHEMBL766778	Displacement of phorbol 12,13-dibutyrate (PDBU) from Protein kinase C alpha	B	CCCCCCCCCCCCCC(=O)OCC1(CO)CCC(=O)O1		CHEMBL299225	=	Ki	nM	138.0	CHEMBL299	Homo sapiens	Ki	nM	138.0
	528181	CHEMBL766778	Displacement of phorbol 12,13-dibutyrate (PDBU) from Protein kinase C alpha	B	CCCCCCCC/C=C\CCCCCCC/C=C1\CC(CO)(COC(C)=O)OC1=O		CHEMBL94718	=	Ki	nM	28.0	CHEMBL299	Homo sapiens	Ki	nM	28.0
	537594	CHEMBL766778	Displacement of phorbol 12,13-dibutyrate (PDBU) from Protein kinase C alpha	B	CCCCCCCC/C=C\CCCCCCC/C=C1\C[C@@](CO)(COC(C)=O)OC1=O		CHEMBL119303	=	Ki	nM	13.0	CHEMBL299	Homo sapiens	Ki	nM	13.0
	540082	CHEMBL766778	Displacement of phorbol 12,13-dibutyrate (PDBU) from Protein kinase C alpha	B	CCCCCCCC/C=C\CCCCCCC/C=C1/CC(CO)(COC(C)=O)OC1=O		CHEMBL321823	=	Ki	nM	24.0	CHEMBL299	Homo sapiens	Ki	nM	24.0
	541709	CHEMBL763595	Inhibition of Protein kinase C alpha at 10 uM	B	CN1CCC(c2c(O)cc(O)c3c2O/C(=C\c2ccc(S(N)(=O)=O)cc2)C3=O)CC1		CHEMBL48362	=	Inhibition	%	42.0	CHEMBL299	Homo sapiens	Inhibition	%	42.0
	541812	CHEMBL768985	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from a recombinant protein kinase C alpha with phosphatidylserine	B	CCCCCCCC/C=C1/CC(CO)(COC(=O)c2ccc(-c3ccccc3)cc2)OC1=O		CHEMBL112401	=	Ki	nM	28.0	CHEMBL299	Homo sapiens	Ki	nM	28.0
	541813	CHEMBL768823	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from a recombinant protein kinase C alpha with phosphatidylserine	B	CCCCCCCC/C=C1/CC(CO)(COC(=O)c2ccc(-c3ccccc3)cc2)OC1=O		CHEMBL112401	=	Ki	nM	41.8	CHEMBL299	Homo sapiens	Ki	nM	41.8
	543175	CHEMBL768985	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from a recombinant protein kinase C alpha with phosphatidylserine	B	O=C(Cc1ccccc1)OCC1(CO)C/C(=C/c2ccc(-c3ccccc3)cc2)C(=O)O1		CHEMBL321189	=	Ki	nM	48.0	CHEMBL299	Homo sapiens	Ki	nM	48.0
	543176	CHEMBL768823	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from a recombinant protein kinase C alpha with phosphatidylserine	B	O=C(Cc1ccccc1)OCC1(CO)C/C(=C/c2ccc(-c3ccccc3)cc2)C(=O)O1		CHEMBL321189	=	Ki	nM	152.3	CHEMBL299	Homo sapiens	Ki	nM	152.3
	545674	CHEMBL768985	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from a recombinant protein kinase C alpha with phosphatidylserine	B	O=C1OC(CO)(COC(=O)c2ccccc2)C/C1=C/c1ccc(-c2ccccc2)cc1		CHEMBL112543	=	Ki	nM	14.1	CHEMBL299	Homo sapiens	Ki	nM	14.1
	545675	CHEMBL768823	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from a recombinant protein kinase C alpha with phosphatidylserine	B	O=C1OC(CO)(COC(=O)c2ccccc2)C/C1=C/c1ccc(-c2ccccc2)cc1		CHEMBL112543	=	Ki	nM	41.0	CHEMBL299	Homo sapiens	Ki	nM	41.0
	546718	CHEMBL766778	Displacement of phorbol 12,13-dibutyrate (PDBU) from Protein kinase C alpha	B	CCCCCCCCCCCCCC(=O)OC[C@]1(CO)CCC(=O)O1		CHEMBL119907	=	Ki	nM	96.0	CHEMBL299	Homo sapiens	Ki	nM	96.0
	549306	CHEMBL763595	Inhibition of Protein kinase C alpha at 10 uM	B	CN1CCC(c2c(O)cc(O)c3c2O/C(=C\c2ccc(N4CCN(C)CC4)cc2)C3=O)CC1		CHEMBL46181	=	Inhibition	%	21.0	CHEMBL299	Homo sapiens	Inhibition	%	21.0
	549381	CHEMBL768985	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from a recombinant protein kinase C alpha with phosphatidylserine	B	CCCCCCCCC/C=C1/CC(CO)(COC(=O)c2ccc(-c3ccccc3)cc2)OC1=O		CHEMBL109354	=	Ki	nM	19.1	CHEMBL299	Homo sapiens	Ki	nM	19.1
	549382	CHEMBL768824	Displacement of [20-3H]phorbol-12,13-dibutyrate (PDBu) from a recombinant protein kinase C alpha with phosphatidylserine	B	CCCCCCCCC/C=C1/CC(CO)(COC(=O)c2ccc(-c3ccccc3)cc2)OC1=O		CHEMBL109354	=	Ki	nM	52.4	CHEMBL299	Homo sapiens	Ki	nM	52.4
	551666	CHEMBL763595	Inhibition of Protein kinase C alpha at 10 uM	B	CN1CCC(c2c(O)cc(O)c3c2O/C(=C\c2ccccc2)C3=O)CC1		CHEMBL51709	=	Inhibition	%	19.0	CHEMBL299	Homo sapiens	Inhibition	%	19.0
	553008	CHEMBL767036	Inhibition of Protein kinase C alpha	B	CN1CCC(c2c(O)cc(O)c3c2O/C(=C\c2ccc([N+](=O)[O-])cc2)C3=O)CC1		CHEMBL45477	=	IC50	nM	22000.0	CHEMBL299	Homo sapiens	IC50	uM	22.0
	554439	CHEMBL763599	Inhibition of Protein kinase C alpha	B	CO[C@@H]1[C@@H](CO)O[C@@H](n2c3c(Cl)cccc3c3c4c(c5c6cccc(Cl)c6[nH]c5c32)C(=O)NC4=O)[C@H](O)[C@H]1O		CHEMBL370100	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	554903	CHEMBL768380	Inhibition of PKCalpha in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Inhibition	%	11.0	CHEMBL299	Homo sapiens	Inhibition	%	11.0
	555300	CHEMBL762305	Affinity for protein kinase C alpha	B	CC(C)C/C=C1/CC([C@H](CO)OC(=O)CC(C)C)OC1=O		CHEMBL440707	=	Ki	nM	327.0	CHEMBL299	Homo sapiens	Ki	nM	327.0
	556409	CHEMBL762305	Affinity for protein kinase C alpha	B	CCCCCCCC/C=C1/CC([C@H](CO)OC(=O)CCCCCCCC)OC1=O		CHEMBL109630	=	Ki	nM	1.758	CHEMBL299	Homo sapiens	Ki	nM	1.758
	558893	CHEMBL762305	Affinity for protein kinase C alpha	B	CCCCCCCC/C=C1\CC([C@H](CO)OC(=O)CC(C)C)OC1=O		CHEMBL2111705	=	Ki	nM	579.0	CHEMBL299	Homo sapiens	Ki	nM	579.0
	559747	CHEMBL769586	Inhibition of PKCalpha in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL288143	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	Inhibition	%	0.0
	560146	CHEMBL762305	Affinity for protein kinase C alpha	B	CC(C)C/C=C1/CC(CO)(COC(=O)CC(C)C)OC1=O		CHEMBL108145	=	Ki	nM	2.9	CHEMBL299	Homo sapiens	Ki	nM	2.9
	561403	CHEMBL763599	Inhibition of Protein kinase C alpha	B	CO[C@@H]1[C@@H](CO)O[C@@H](n2c3c(Cl)cccc3c3c4c(c5c6cccc(Cl)c6[nH]c5c32)C(=O)N(C)C4=O)[C@H](O)[C@H]1O		CHEMBL3350558	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	563461	CHEMBL763598	Inhibition of Protein kinase C alpha	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	563495	CHEMBL762305	Affinity for protein kinase C alpha	B	CCCCCCCCCCCCCC(=O)O[C@@H](CO)C1CCC(=O)O1		CHEMBL108443	=	Ki	nM	1000.0	CHEMBL299	Homo sapiens	Ki	nM	1000.0
	564604	CHEMBL763598	Inhibition of Protein kinase C alpha	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	565748	CHEMBL763598	Inhibition of Protein kinase C alpha	B	O=c1c(-c2cccc(Cl)c2)coc2cc(O)cc(O)c12		CHEMBL7827	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	566927	CHEMBL763598	Inhibition of Protein kinase C alpha	B	COc1cc(O)c2c(O)c(-c3cccc(Cl)c3)cnc2c1		CHEMBL440453	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	569978	CHEMBL763599	Inhibition of Protein kinase C alpha	B	CN1C(=O)c2c(c3c4ccccc4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4ccccc4c23)C1=O		CHEMBL326711	=	IC50	nM	59000.0	CHEMBL299	Homo sapiens	IC50	uM	59.0
	571284	CHEMBL763599	Inhibition of Protein kinase C alpha	B	CC1OC(n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)C(=O)N(C)C4=O)C(O)C(O)C1O		CHEMBL117114	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	572083	CHEMBL763598	Inhibition of Protein kinase C alpha	B	COC(=O)Cn1cc(-c2cccc(Cl)c2)c(=O)c2c(O)cc(OC)cc21		CHEMBL7866	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	572134	CHEMBL762305	Affinity for protein kinase C alpha	B	CCCCCCCCC(=O)O[C@@H](CO)C1C/C(=C\CC(C)C)C(=O)O1		CHEMBL2111704	=	Ki	nM	1088.0	CHEMBL299	Homo sapiens	Ki	nM	1088.0
	572990	CHEMBL768381	Inhibition of PKCalpha in presence of 10 uM ATP	B	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL259744	=	Inhibition	%	5.0	CHEMBL299	Homo sapiens	Inhibition	%	5.0
	574529	CHEMBL762305	Affinity for protein kinase C alpha	B	CCCCCCCCC(=O)O[C@@H](CO)C1C/C(=C/CC(C)C)C(=O)O1		CHEMBL439594	=	Ki	nM	499.0	CHEMBL299	Homo sapiens	Ki	nM	499.0
	575684	CHEMBL762305	Affinity for protein kinase C alpha	B	CCCCCCCC/C=C1/CC([C@H](CO)OC(=O)CC(C)C)OC1=O		CHEMBL110213	=	Ki	nM	565.0	CHEMBL299	Homo sapiens	Ki	nM	565.0
	577030	CHEMBL762305	Affinity for protein kinase C alpha	B	CCCCCCCC/C=C1\CC([C@H](CO)OC(=O)CCCCCCCC)OC1=O		CHEMBL108303	=	Ki	nM	1.202	CHEMBL299	Homo sapiens	Ki	nM	1.202
	577031	CHEMBL762305	Affinity for protein kinase C alpha	B	CC(C)C/C=C1\CC([C@H](CO)OC(=O)CC(C)C)OC1=O		CHEMBL2111703	=	Ki	nM	679.0	CHEMBL299	Homo sapiens	Ki	nM	679.0
	577433	CHEMBL763599	Inhibition of Protein kinase C alpha	B	CO[C@@H]1[C@@H](CO)O[C@@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)C(=O)NC4=O)[C@H](O)[C@H]1O		CHEMBL3350557	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	578206	CHEMBL763598	Inhibition of Protein kinase C alpha	B	COc1cc(O)c2c(=O)c(-c3cccc(Cl)c3)cn(C)c2c1		CHEMBL7819	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	578659	CHEMBL763599	Inhibition of Protein kinase C alpha	B	CN1C(=O)c2c(c3c4ccccc4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4ccccc4c23)C1=O		CHEMBL326711	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	580674	CHEMBL762305	Affinity for protein kinase C alpha	B	CCCCCCCC/C=C/CCCCCCCC(=O)OCC1(CO)CCC(=O)O1		CHEMBL323750	=	Ki	nM	96.0	CHEMBL299	Homo sapiens	Ki	nM	96.0
	583360	CHEMBL763599	Inhibition of Protein kinase C alpha	B	CC(=O)OCC1OC(n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)C(=O)N(C)C4=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O		CHEMBL332728	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	583366	CHEMBL763599	Inhibition of Protein kinase C alpha	B	CN1C(=O)c2c(c3c4ccccc4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4ccccc4c23)C1=O		CHEMBL326711	=	IC50	nM	62000.0	CHEMBL299	Homo sapiens	IC50	uM	62.0
	584261	CHEMBL763598	Inhibition of Protein kinase C alpha	B	COc1cc(O)c2c(=O)c(-c3cccc(Cl)c3)coc2c1		CHEMBL7339	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	584304	CHEMBL762305	Affinity for protein kinase C alpha	B	CCCCCCCCCC(=O)OCC1(CO)C/C(=C/CC(C)C)C(=O)O1		CHEMBL110779	=	Ki	nM	2.3	CHEMBL299	Homo sapiens	Ki	nM	2.3
	586381	CHEMBL768380	Inhibition of PKCalpha in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccccc3)cc12		CHEMBL258701	=	Inhibition	%	12.0	CHEMBL299	Homo sapiens	Inhibition	%	12.0
	586951	CHEMBL767031	Inhibition of Protein kinase C alpha	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	IC50	nM	40000.0	CHEMBL299	Homo sapiens	IC50	uM	40.0
	587163	CHEMBL763599	Inhibition of Protein kinase C alpha	B	CN1C(=O)c2c(c3c4ccccc4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4ccccc4c23)C1=O		CHEMBL326711	=	IC50	nM	99000.0	CHEMBL299	Homo sapiens	IC50	uM	99.0
	587979	CHEMBL763598	Inhibition of Protein kinase C alpha	B	Oc1cc(O)c2c(O)c(-c3cccc(Cl)c3)cnc2c1		CHEMBL266995	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	588010	CHEMBL762305	Affinity for protein kinase C alpha	B	CCCCCCCCC/C=C1/CC(CO)(COC(=O)CC(C)C)OC1=O		CHEMBL108479	=	Ki	nM	13.0	CHEMBL299	Homo sapiens	Ki	nM	13.0
	589717	CHEMBL763599	Inhibition of Protein kinase C alpha	B	CC1OC(n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)C(=O)N(C)C4=O)C(O)C(O)C1O		CHEMBL117114	=	IC50	nM	82000.0	CHEMBL299	Homo sapiens	IC50	uM	82.0
	590219	CHEMBL768382	Inhibition of PKCalpha in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccccc3F)cc12		CHEMBL407373	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	Inhibition	%	0.0
	590636	CHEMBL762305	Affinity for protein kinase C alpha	B	CCCCCCC/C=C/CCCCCCC/C=C1/CC(CO)(COC(C)=O)OC1=O		CHEMBL278654	=	Ki	nM	24.0	CHEMBL299	Homo sapiens	Ki	nM	24.0
	591021	CHEMBL763599	Inhibition of Protein kinase C alpha	B	CO[C@@H]1[C@@H](CO)O[C@@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)C(=O)N(C)C4=O)[C@H](O)[C@H]1O		CHEMBL3350560	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	592314	CHEMBL763599	Inhibition of Protein kinase C alpha	B	CC(=O)OCC1OC(n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)C(=O)N(C)C4=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O		CHEMBL332728	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	594154	CHEMBL763592	Relative binding affinity for Protein kinase C alpha	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(COC)C[C@@H]3C(=O)C(C)=C[C@H]32)C2C(C)(C)[C@@]21OC(=O)CCC		CHEMBL314460	=	Relative binding affinity		5.0	CHEMBL299	Homo sapiens	Relative binding affinity		5.0
	599345	CHEMBL763592	Relative binding affinity for Protein kinase C alpha	B	CCCCCCCCCCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCCCCCCCCCC		CHEMBL87852	=	Relative binding affinity		1500.0	CHEMBL299	Homo sapiens	Relative binding affinity		1500.0
	599346	CHEMBL763592	Relative binding affinity for Protein kinase C alpha	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(COC)C[C@]3(O)C(=O)C(C)=C[C@@H]23)C2C(C)(C)[C@@]21OC(=O)CCC		CHEMBL313121	>	Relative binding affinity		7000.0	CHEMBL299	Homo sapiens	Relative binding affinity		7000.0
	600516	CHEMBL763592	Relative binding affinity for Protein kinase C alpha	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(OC)C(=O)C(C)=C[C@@H]23)C2C(C)(C)[C@@]21OC(=O)CCC		CHEMBL82851	=	Relative binding affinity		1100.0	CHEMBL299	Homo sapiens	Relative binding affinity		1100.0
	600517	CHEMBL763592	Relative binding affinity for Protein kinase C alpha	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	>	Relative binding affinity		10000.0	CHEMBL299	Homo sapiens	Relative binding affinity		10000.0
	600518	CHEMBL763592	Relative binding affinity for Protein kinase C alpha	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(C)C[C@]3(O)C(=O)C(C)=C[C@@H]23)C2C(C)(C)[C@@]21OC(=O)CCC		CHEMBL263276	>	Relative binding affinity		7000.0	CHEMBL299	Homo sapiens	Relative binding affinity		7000.0
Not Active	601778	CHEMBL763593	Relative binding affinity for Protein kinase C alpha (Inactive)	B	CCCCCCCCCCCCCCCC(=O)OC[C@@H](CO)OC(=O)CCCCCCCCCCCCCCC		CHEMBL86122		Relative binding affinity			CHEMBL299	Homo sapiens	Relative binding affinity		
	611249	CHEMBL768373	Inhibition of human Protein kinase C alpha	B	O=C(N[C@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL307747	=	IC50	nM	74.0	CHEMBL299	Homo sapiens	IC50	uM	0.074
	615191	CHEMBL768373	Inhibition of human Protein kinase C alpha	B	O=C(N[C@H]1CSCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL67788	=	IC50	nM	3300.0	CHEMBL299	Homo sapiens	IC50	uM	3.3
	615199	CHEMBL768373	Inhibition of human Protein kinase C alpha	B	O=C(N[C@H]1CS(=O)(=O)CCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL303205	=	IC50	nM	9600.0	CHEMBL299	Homo sapiens	IC50	uM	9.6
	616484	CHEMBL768373	Inhibition of human Protein kinase C alpha	B	O=C(N[C@H]1CCCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL302998	=	IC50	nM	270.0	CHEMBL299	Homo sapiens	IC50	uM	0.27
	616533	CHEMBL767024	Inhibition of Protein kinase C alpha at 100 nM	B	Cn1ccc2ccc3c4[nH]c5c(CCCN[C@H]6CC[C@H](O)CC6)cccc5c4c4c(c3c21)C(=O)NC4=O		CHEMBL307152	=	Control	%	100.0	CHEMBL299	Homo sapiens	Control	%	100.0
	621709	CHEMBL763592	Relative binding affinity for Protein kinase C alpha	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Relative binding affinity		1.0	CHEMBL299	Homo sapiens	Relative binding affinity		1.0
	621710	CHEMBL769612	Dissociation constant for Protein kinase C alpha	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Kd	nM	0.8	CHEMBL299	Homo sapiens	Kd	nM	0.8
	625258	CHEMBL768373	Inhibition of human Protein kinase C alpha	B	O=C(N[C@H]1COCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL70078	=	IC50	nM	6700.0	CHEMBL299	Homo sapiens	IC50	uM	6.7
	679655	CHEMBL822646	Displacement of [3H]PDBU from protein kinase C-alpha	B	O=C(O[C@H]1CCC23CCCC[C@H](C=C(CO)C[C@H]12)C3=O)c1ccccc1		CHEMBL156719	=	Ki	nM	165.0	CHEMBL299	Homo sapiens	Ki	nM	165.0
	681074	CHEMBL770276	Displacement of [3H]-PDBU from protein kinase C-alpha	B	CC1=CC23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]2(O)[C@H]1O)[C@H]1[C@@H](C[C@H]3C)C1(C)C		CHEMBL346507	=	Ki	nM	240.0	CHEMBL299	Homo sapiens	Ki	nM	240.0
	681340	CHEMBL766780	Displacement of [3H-20]-PDBU from recombinant Protein kinase C alpha	B	CCCCCCCC/C=C\CCCCCCCC/C=C1/C[C@@](CO)(COC(C)=O)OC1=O		CHEMBL342430	=	Ki	nM	12.0	CHEMBL299	Homo sapiens	Ki	nM	12.0
	682930	CHEMBL766780	Displacement of [3H-20]-PDBU from recombinant Protein kinase C alpha	B	CCCCCCCCCCCCCCOC(=O)CC[C@]1(CO)CCC(=O)O1		CHEMBL138827	=	Ki	nM	260.0	CHEMBL299	Homo sapiens	Ki	nM	260.0
	682931	CHEMBL766780	Displacement of [3H-20]-PDBU from recombinant Protein kinase C alpha	B	CCCCCCCCCCCCCCOC(=O)/C=C/[C@]1(CO)CCC(=O)O1		CHEMBL141784	=	Ki	nM	109.0	CHEMBL299	Homo sapiens	Ki	nM	109.0
	682932	CHEMBL766780	Displacement of [3H-20]-PDBU from recombinant Protein kinase C alpha	B	CCCCCCCCCCCCCCOC(=O)/C=C/[C@@]1(CO)CCC(=O)O1		CHEMBL138209	=	Ki	nM	27200.0	CHEMBL299	Homo sapiens	Ki	nM	27200.0
	686284	CHEMBL769617	Displacement of [3H]- PDBu from recombinant PKC alpha expressed in baculovirus	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL27266	=	Ki	nM	11.0	CHEMBL299	Homo sapiens	Ki	nM	11.0
	688013	CHEMBL770276	Displacement of [3H]-PDBU from protein kinase C-alpha	B	CCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCCC		CHEMBL346228	=	Ki	nM	0.54	CHEMBL299	Homo sapiens	Ki	nM	0.54
	688348	CHEMBL766780	Displacement of [3H-20]-PDBU from recombinant Protein kinase C alpha	B	CCCCCCCC/C=C\CCCCCCCC/C=C1\C[C@](/C=C/C(=O)OC)(CO)OC1=O		CHEMBL139409	=	Ki	nM	20.0	CHEMBL299	Homo sapiens	Ki	nM	20.0
	689718	CHEMBL766780	Displacement of [3H-20]-PDBU from recombinant Protein kinase C alpha	B	CCCCCCCCCCCCCCOC(=O)CCC1(CO)CCC(=O)O1		CHEMBL136296	=	Ki	nM	489.0	CHEMBL299	Homo sapiens	Ki	nM	489.0
	692264	CHEMBL766780	Displacement of [3H-20]-PDBU from recombinant Protein kinase C alpha	B	CCCCCCCC/C=C\CCCCCCC/C=C1\C[C@](/C=C2/CCOC2=O)(CO)OC1=O		CHEMBL140550	=	Ki	nM	2020.0	CHEMBL299	Homo sapiens	Ki	nM	2020.0
	696246	CHEMBL766780	Displacement of [3H-20]-PDBU from recombinant Protein kinase C alpha	B	CCCCCCCC/C=C\CCCCCCCC/C=C1\C[C@@](CO)(COC(C)=O)OC1=O		CHEMBL138351	=	Ki	nM	13.0	CHEMBL299	Homo sapiens	Ki	nM	13.0
	696247	CHEMBL766780	Displacement of [3H-20]-PDBU from recombinant Protein kinase C alpha	B	CCCCCCCC/C=C\CCCCCCC/C=C1/C[C@](/C=C2\CCOC2=O)(CO)OC1=O		CHEMBL344379	=	Ki	nM	19.0	CHEMBL299	Homo sapiens	Ki	nM	19.0
	698422	CHEMBL769617	Displacement of [3H]- PDBu from recombinant PKC alpha expressed in baculovirus	B	CCCCCCCCCCc1ccc2c(c1)C[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL28205	=	Ki	nM	46.6	CHEMBL299	Homo sapiens	Ki	nM	46.6
	698880	CHEMBL822646	Displacement of [3H]PDBU from protein kinase C-alpha	B	CC1=CC23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]2(O)[C@H]1OC(=O)c1ccccc1)[C@H]1[C@@H](C[C@H]3C)C1(C)C		CHEMBL46094	=	Ki	nM	0.14	CHEMBL299	Homo sapiens	Ki	nM	0.14
	702320	CHEMBL769617	Displacement of [3H]- PDBu from recombinant PKC alpha expressed in baculovirus	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2ccccc2N1C		CHEMBL267144	=	Ki	nM	334.0	CHEMBL299	Homo sapiens	Ki	nM	334.0
	703617	CHEMBL769617	Displacement of [3H]- PDBu from recombinant PKC alpha expressed in baculovirus	B	CCCCCCCCc1ccc2c3c(c[nH]c13)C[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL285801	=	Ki	nM	0.5	CHEMBL299	Homo sapiens	Ki	nM	0.5
	707033	CHEMBL766780	Displacement of [3H-20]-PDBU from recombinant Protein kinase C alpha	B	CCCCCCCCCCCCCCOC(=O)CC[C@@]1(CO)CCC(=O)O1		CHEMBL344808	=	Ki	nM	27300.0	CHEMBL299	Homo sapiens	Ki	nM	27300.0
	708177	CHEMBL766780	Displacement of [3H-20]-PDBU from recombinant Protein kinase C alpha	B	CCCCCCCC/C=C\CCCCCCC/C=C1/C[C@](/C=C2/CCOC2=O)(CO)OC1=O		CHEMBL138350	=	Ki	nM	746.0	CHEMBL299	Homo sapiens	Ki	nM	746.0
Not Active	709251	CHEMBL770277	Displacement of [3H]PDBU from protein kinase C-alpha (Inactive)	B	CC1=CC23CCCC[C@@H](C=C(CO)[C@@H](O)[C@]2(O)[C@H]1O)C3=O		CHEMBL155501		Ki	nM		CHEMBL299	Homo sapiens	Ki	nM	
	709507	CHEMBL766780	Displacement of [3H-20]-PDBU from recombinant Protein kinase C alpha	B	CCCCCCCC/C=C\CCCCCCC/C=C1\C[C@](/C=C2\CCOC2=O)(CO)OC1=O		CHEMBL138352	=	Ki	nM	26.0	CHEMBL299	Homo sapiens	Ki	nM	26.0
	711448	CHEMBL769617	Displacement of [3H]- PDBu from recombinant PKC alpha expressed in baculovirus	B	CCCCCCCCC#Cc1ccc2c(c1)C[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL6453	=	Ki	nM	14.7	CHEMBL299	Homo sapiens	Ki	nM	14.7
	712130	CHEMBL766780	Displacement of [3H-20]-PDBU from recombinant Protein kinase C alpha	B	CCCCCCCC/C=C\CCCCCCCC/C=C1/C[C@](/C=C/C(=O)OC)(CO)OC1=O		CHEMBL422468	=	Ki	nM	11.0	CHEMBL299	Homo sapiens	Ki	nM	11.0
	753996	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(NC1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)C2CCCC[C@@H]2C(=O)O)c(O)c1)c1ccc(O)cc1	Outside typical range	CHEMBL88848	>	IC50	nM	150000.0	CHEMBL299	Homo sapiens	IC50	uM	150.0
	754000	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(NC1CCCC1OCc1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL89833	=	IC50	nM	460.0	CHEMBL299	Homo sapiens	IC50	uM	0.46
	754004	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(NC1CNCC1OC(=O)c1cc(O)c(-c2ccccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL315545	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	754006	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	N#Cc1cccc(O)c1C(=O)c1c(O)cc(C(=O)OC2CCCC2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL89280	=	IC50	nM	3700.0	CHEMBL299	Homo sapiens	IC50	uM	3.7
	754011	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	NCCOc1cccc(O)c1C(=O)c1c(O)cc(C(=O)OC2CCCC2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL316088	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	754641	CHEMBL768517	Inhibition of Protein kinase C alpha expressed in Sf-9 cells	B	O=C(N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL60254	=	IC50	nM	74.0	CHEMBL299	Homo sapiens	IC50	uM	0.074
	755044	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(NC1CNCC1OC(=O)c1ccc(-c2c(O)cccc2C(=O)O)cc1)c1ccc(O)cc1		CHEMBL85129	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	755779	CHEMBL768517	Inhibition of Protein kinase C alpha expressed in Sf-9 cells	B	COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL66923	=	IC50	nM	210.0	CHEMBL299	Homo sapiens	IC50	uM	0.21
	755796	CHEMBL767037	Inhibition of Protein kinase C alpha	B	CN1CCOCCOCCN(C)CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CC1		CHEMBL105620	=	IC50	nM	770.0	CHEMBL299	Homo sapiens	IC50	uM	0.77
	756885	CHEMBL768517	Inhibition of Protein kinase C alpha expressed in Sf-9 cells	B	CC(C)(C)C(=O)OCOC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CNC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL304175	=	IC50	nM	160.0	CHEMBL299	Homo sapiens	IC50	uM	0.16
	758126	CHEMBL768517	Inhibition of Protein kinase C alpha expressed in Sf-9 cells	B	CCOC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL66452	=	IC50	nM	920.0	CHEMBL299	Homo sapiens	IC50	uM	0.92
	759117	CHEMBL767037	Inhibition of Protein kinase C alpha	B	CCN1CCOCCOCCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CC1		CHEMBL103506	=	IC50	nM	290.0	CHEMBL299	Homo sapiens	IC50	uM	0.29
	759505	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	COc1cc(C(=O)O[C@@H]2CCCNCC2NC(=O)c2ccc(O)cc2)cc(OC)c1C(=O)c1c(O)cccc1O	Outside typical range	CHEMBL89191	>	IC50	nM	150000.0	CHEMBL299	Homo sapiens	IC50	uM	150.0
	759509	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(NC1CCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2NS(=O)(=O)C(F)(F)F)c(O)c1)c1ccc(O)cc1		CHEMBL312846	=	IC50	nM	100.0	CHEMBL299	Homo sapiens	IC50	uM	0.1
	760149	CHEMBL768517	Inhibition of Protein kinase C alpha expressed in Sf-9 cells	B	O=C(N[C@@H]1CNC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)OCC2CCCCC2)c(O)c1)c1ccc(O)cc1		CHEMBL302304	=	IC50	nM	17000.0	CHEMBL299	Homo sapiens	IC50	uM	17.0
	760586	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(NC1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2ccccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL433175	=	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	760591	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(NC1CNCCC[C@H]1OC(=O)c1cc(O)c(Cc2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL313814	>	IC50	nM	5000.0	CHEMBL299	Homo sapiens	IC50	uM	5.0
	760595	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(NC1CCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2-c2nn[nH]n2)c(O)c1)c1ccc(O)cc1		CHEMBL89384	=	IC50	nM	340.0	CHEMBL299	Homo sapiens	IC50	uM	0.34
	761722	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(O)CN(C(=O)c1c(O)cc(C(=O)OC2CNCC2NC(=O)c2ccc(O)cc2)cc1O)c1ccccc1	Outside typical range	CHEMBL88962	>	IC50	nM	150000.0	CHEMBL299	Homo sapiens	IC50	uM	150.0
	762303	CHEMBL768517	Inhibition of Protein kinase C alpha expressed in Sf-9 cells	B	O=C(N[C@@H]1CCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL52529	=	IC50	nM	40.0	CHEMBL299	Homo sapiens	IC50	uM	0.04
	762676	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(NC1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)C2CCCC[C@H]2C(=O)O)c(O)c1)c1ccc(O)cc1	Outside typical range	CHEMBL313550	>	IC50	nM	150000.0	CHEMBL299	Homo sapiens	IC50	uM	150.0
Not Active	763419	CHEMBL768518	Inhibition of Protein kinase C alpha expressed in Sf-9 cells (inactive)	B	CC(C)(C)C(=O)OCOC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL67980		IC50	nM		CHEMBL299	Homo sapiens	IC50	uM	
	763516	CHEMBL763594	Inhibition of Protein kinase C alpha at 10 uM	B	Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Cc2ccncc2)cc1		CHEMBL288812	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	Inhibition	%	0.0
	764582	CHEMBL762306	Binding affinity for Protein kinase C alpha C1a domain	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Kd	nM	1.12	CHEMBL299	Homo sapiens	Kd	nM	1.12
	764583	CHEMBL762311	Binding affinity for Protein kinase C alpha C1b domain	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Kd	nM	7.44	CHEMBL299	Homo sapiens	Kd	nM	7.44
	764956	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	Cn1nnc(-c2cccc(O)c2C(=O)c2c(O)cc(C(=O)OC3CCCC3NC(=O)c3ccc(O)cc3)cc2O)n1		CHEMBL89355	=	IC50	nM	3600.0	CHEMBL299	Homo sapiens	IC50	uM	3.6
	765657	CHEMBL767037	Inhibition of Protein kinase C alpha	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	28.0	CHEMBL299	Homo sapiens	IC50	uM	0.028
	766005	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(NC1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2ccc3ccccc3c2O)c(O)c1)c1ccc(O)cc1	Outside typical range	CHEMBL91412	>	IC50	nM	150000.0	CHEMBL299	Homo sapiens	IC50	uM	150.0
	767059	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(NC1CCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2NC(=O)C(F)(F)F)c(O)c1)c1ccc(O)cc1		CHEMBL91932	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	768154	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(NC1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL89648	=	IC50	nM	67.0	CHEMBL299	Homo sapiens	IC50	uM	0.067
	768945	CHEMBL768517	Inhibition of Protein kinase C alpha expressed in Sf-9 cells	B	COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CNC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL304626	=	IC50	nM	250.0	CHEMBL299	Homo sapiens	IC50	uM	0.25
	768951	CHEMBL768517	Inhibition of Protein kinase C alpha expressed in Sf-9 cells	B	CC(C)COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CNC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL68418	=	IC50	nM	19000.0	CHEMBL299	Homo sapiens	IC50	uM	19.0
	769080	CHEMBL762310	Displacement of [3H]- PDBu from Protein kinase C alpha C1a domain	B	CC(C)[C@H]1/C(S)=N/[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL63262	=	Ki	nM	261.5	CHEMBL299	Homo sapiens	Ki	nM	261.5
	769081	CHEMBL762314	Displacement of [3H]- PDBu from Protein kinase C alpha C1b domain	B	CC(C)[C@H]1/C(S)=N/[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL63262	=	Ki	nM	2140.0	CHEMBL299	Homo sapiens	Ki	nM	2140.0
	769331	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	CS(=O)(=O)Nc1cccc(O)c1C(=O)c1c(O)cc(C(=O)OC2CCCC2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL88749	=	IC50	nM	500.0	CHEMBL299	Homo sapiens	IC50	uM	0.5
	770038	CHEMBL762310	Displacement of [3H]- PDBu from Protein kinase C alpha C1a domain	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL27266	=	Ki	nM	126.9	CHEMBL299	Homo sapiens	Ki	nM	126.9
	770039	CHEMBL762314	Displacement of [3H]- PDBu from Protein kinase C alpha C1b domain	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL27266	=	Ki	nM	4000.0	CHEMBL299	Homo sapiens	Ki	nM	4000.0
	771119	CHEMBL767037	Inhibition of Protein kinase C alpha	B	CC(C)N1CCOCCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCOCC1		CHEMBL421217	=	IC50	nM	170.0	CHEMBL299	Homo sapiens	IC50	uM	0.17
	771127	CHEMBL767037	Inhibition of Protein kinase C alpha	B	CN1CCOCCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCN(C)CC1		CHEMBL106384	=	IC50	nM	570.0	CHEMBL299	Homo sapiens	IC50	uM	0.57
	771137	CHEMBL767037	Inhibition of Protein kinase C alpha	B	CCN1CCOCCN(CC)CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCOCC1		CHEMBL103421	=	IC50	nM	910.0	CHEMBL299	Homo sapiens	IC50	uM	0.91
	771537	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(NC1CNCCC[C@H]1OC(=O)c1cc(O)c(C2OC(=O)c3cccc(O)c32)c(O)c1)c1ccc(O)cc1		CHEMBL86680	=	IC50	nM	18000.0	CHEMBL299	Homo sapiens	IC50	uM	18.0
	771541	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(NC1CNCC1OC(=O)c1cc(O)c(C(=O)c2c(O)ccc3c2CCCC3)c(O)c1)c1ccc(O)cc1		CHEMBL91126	=	IC50	nM	430.0	CHEMBL299	Homo sapiens	IC50	uM	0.43
	772741	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	COc1cccc(OC)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CCCNCC2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL327994	=	IC50	nM	31000.0	CHEMBL299	Homo sapiens	IC50	uM	31.0
	772745	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	Cn1nnnc1-c1cccc(O)c1C(=O)c1c(O)cc(C(=O)OC2CCCC2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL89591	=	IC50	nM	11000.0	CHEMBL299	Homo sapiens	IC50	uM	11.0
	773555	CHEMBL767037	Inhibition of Protein kinase C alpha	B	CN1CCCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCOCCOCC1		CHEMBL321315	=	IC50	nM	250.0	CHEMBL299	Homo sapiens	IC50	uM	0.25
Not Determined	773565	CHEMBL767038	Inhibition of Protein kinase C alpha (not determined)	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714		IC50	nM		CHEMBL299	Homo sapiens	IC50	uM	
	774002	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(NC1CNCC1OC(=O)c1cc(O)c2c(c1)C(=O)c1cccc(O)c1C2=O)c1ccc(O)cc1		CHEMBL88812	=	IC50	nM	43000.0	CHEMBL299	Homo sapiens	IC50	uM	43.0
	775053	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(NC1CCCC1OC(=O)c1cc(O)c(-c2nnc(O)c3cccc(O)c23)c(O)c1)c1ccc(O)cc1		CHEMBL313902	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	776189	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(NC1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2ccccc2O)c(O)c1)c1ccc(O)cc1		CHEMBL88466	=	IC50	nM	97000.0	CHEMBL299	Homo sapiens	IC50	uM	97.0
	776743	CHEMBL768517	Inhibition of Protein kinase C alpha expressed in Sf-9 cells	B	CCOC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CNC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL307543	=	IC50	nM	2200.0	CHEMBL299	Homo sapiens	IC50	uM	2.2
	776787	CHEMBL767037	Inhibition of Protein kinase C alpha	B	CCN1CCOCCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCOCC1		CHEMBL103055	=	IC50	nM	110.0	CHEMBL299	Homo sapiens	IC50	uM	0.11
	777202	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(NC1CNCC1OC(=O)c1cc(O)c(C(=O)c2c(C(=O)O)ccc3ccccc23)c(O)c1)c1ccc(O)cc1		CHEMBL421539	=	IC50	nM	7800.0	CHEMBL299	Homo sapiens	IC50	uM	7.8
	778315	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(NC1CNCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL265559	=	IC50	nM	22.0	CHEMBL299	Homo sapiens	IC50	uM	0.022
	780228	CHEMBL768517	Inhibition of Protein kinase C alpha expressed in Sf-9 cells	B	CCCCOC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CNC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL66750	=	IC50	nM	3100.0	CHEMBL299	Homo sapiens	IC50	uM	3.1
	780267	CHEMBL767037	Inhibition of Protein kinase C alpha	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCOCCN(CCO)CCOCCn1cc2c2ccccc21		CHEMBL321529	=	IC50	nM	440.0	CHEMBL299	Homo sapiens	IC50	uM	0.44
	780717	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(NC1CNCC1OC(=O)c1cc(O)c(C(=O)Nc2ccccc2C(=O)O)c(O)c1)c1ccc(O)cc1	Outside typical range	CHEMBL88454	>	IC50	nM	150000.0	CHEMBL299	Homo sapiens	IC50	uM	150.0
	781826	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	COc1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CCCNCC2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL91541	=	IC50	nM	25000.0	CHEMBL299	Homo sapiens	IC50	uM	25.0
	782444	CHEMBL767037	Inhibition of Protein kinase C alpha	B	CN1CCOCCN(C)CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CC1		CHEMBL105477	=	IC50	nM	490.0	CHEMBL299	Homo sapiens	IC50	uM	0.49
	782811	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(NC1CCCC1OC(=O)c1ccc(C(=O)c2c(O)cccc2C(=O)O)cc1)c1ccc(O)cc1		CHEMBL433361	=	IC50	nM	34000.0	CHEMBL299	Homo sapiens	IC50	uM	34.0
	782869	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(NC1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2O)c(O)c1)c1ccc(O)cc1		CHEMBL328747	=	IC50	nM	860.0	CHEMBL299	Homo sapiens	IC50	uM	0.86
	783558	CHEMBL767037	Inhibition of Protein kinase C alpha	B	CN1CCOCCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCOCC1		CHEMBL106061	=	IC50	nM	300.0	CHEMBL299	Homo sapiens	IC50	uM	0.3
	783566	CHEMBL769611	Inhibition of Protein kinase C alpha	B	CN1CCN(C)CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CC1		CHEMBL319265	=	Inhibition	%	35.0	CHEMBL299	Homo sapiens	Inhibition	%	35.0
	783869	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(NC1CCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL48636	=	IC50	nM	40.0	CHEMBL299	Homo sapiens	IC50	uM	0.04
	785841	CHEMBL768517	Inhibition of Protein kinase C alpha expressed in Sf-9 cells	B	COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL66923	=	IC50	nM	320.0	CHEMBL299	Homo sapiens	IC50	uM	0.32
	785848	CHEMBL768517	Inhibition of Protein kinase C alpha expressed in Sf-9 cells	B	COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL66923	=	IC50	nM	4200.0	CHEMBL299	Homo sapiens	IC50	uM	4.2
	785854	CHEMBL768517	Inhibition of Protein kinase C alpha expressed in Sf-9 cells	B	CC(C)OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL431568	=	IC50	nM	4700.0	CHEMBL299	Homo sapiens	IC50	uM	4.7
	786277	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	Cc1cc(C(=O)OC2CCCC2NC(=O)c2ccc(O)cc2)cc(C)c1C(=O)c1c(O)cccc1C(=O)O		CHEMBL87075	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	786349	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	CC(=O)Nc1cccc(O)c1C(=O)c1c(O)cc(C(=O)OC2CCCC2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL329178	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	786995	CHEMBL768517	Inhibition of Protein kinase C alpha expressed in Sf-9 cells	B	O=C(N[C@@H]1CNC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL59828	=	IC50	nM	22.0	CHEMBL299	Homo sapiens	IC50	uM	0.022
	787346	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(NC1CCCC1OC(=O)c1ccc(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL90330	=	IC50	nM	2600.0	CHEMBL299	Homo sapiens	IC50	uM	2.6
	787398	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(NC1CNCC1OC(=O)c1cc(O)c(C(=O)c2c(O)ccc3ccccc23)c(O)c1)c1ccc(O)cc1		CHEMBL89639	=	IC50	nM	5600.0	CHEMBL299	Homo sapiens	IC50	uM	5.6
	788134	CHEMBL768517	Inhibition of Protein kinase C alpha expressed in Sf-9 cells	B	CC(=O)OCOC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)O[C@@H]2CNC[C@H]2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL67528	=	IC50	nM	130.0	CHEMBL299	Homo sapiens	IC50	uM	0.13
	788143	CHEMBL767037	Inhibition of Protein kinase C alpha	B	CN1CCN(C)CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCN(C)CC1		CHEMBL103628	=	IC50	nM	290.0	CHEMBL299	Homo sapiens	IC50	uM	0.29
	788413	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(NC1CNCCC[C@H]1OC(=O)c1cc(O)c2c(=O)c3c(C(=O)O)cccc3oc2c1)c1ccc(O)cc1	Outside typical range	CHEMBL329437	>	IC50	nM	150000.0	CHEMBL299	Homo sapiens	IC50	uM	150.0
	788425	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(NC1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2ncccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL88533	=	IC50	nM	37000.0	CHEMBL299	Homo sapiens	IC50	uM	37.0
	788428	CHEMBL767703	Inhibition of partially purified recombinant human calcium sensitive protein kinase C alpha	B	O=C(O)COc1cccc(O)c1C(=O)c1c(O)cc(C(=O)OC2CCCC2NC(=O)c2ccc(O)cc2)cc1O		CHEMBL89210	=	IC50	nM	2200.0	CHEMBL299	Homo sapiens	IC50	uM	2.2
	789699	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	N[C@@H]1C[C@@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL432168	=	IC50	nM	20.0	CHEMBL299	Homo sapiens	IC50	uM	0.02
	790565	CHEMBL769614	Displacement of [3H-20]-phorbol 12,13-dibutyrate(PDBU) from recombinant Protein kinase C alpha	B	CCCCCCCCCCCCCCOC(=O)C[C@H]1CC[C@@](CO)(COC(=O)CCCCC)O1		CHEMBL133960	=	Ki	nM	2380.0	CHEMBL299	Homo sapiens	Ki	uM	2.38
	793576	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	NC[C@H]1C[C@@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL307708	=	IC50	nM	20.0	CHEMBL299	Homo sapiens	IC50	uM	0.02
	794646	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	O=C(N[C@@H]1CN2CCC(CC2)[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL78129	=	IC50	nM	410.0	CHEMBL299	Homo sapiens	IC50	uM	0.41
	794655	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	O=C(N[C@@H]1CC(C(=O)C(F)(F)F)C[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL262980	=	IC50	nM	430.0	CHEMBL299	Homo sapiens	IC50	uM	0.43
	795781	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	CC(=O)C1C[C@@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL441802	=	IC50	nM	1200.0	CHEMBL299	Homo sapiens	IC50	uM	1.2
	797995	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	O=C(N[C@@H]1COCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL306373	=	IC50	nM	6700.0	CHEMBL299	Homo sapiens	IC50	uM	6.7
	798004	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	O=C(N[C@@H]1CNCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL67442	=	IC50	nM	5100.0	CHEMBL299	Homo sapiens	IC50	uM	5.1
	798013	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	O=C(N[C@@H]1C[C@H](CO)C[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL75661	=	IC50	nM	10.0	CHEMBL299	Homo sapiens	IC50	uM	0.01
	800435	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	O=C(N[C@@H]1C[C@@H](CO)C[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL75004	=	IC50	nM	80.0	CHEMBL299	Homo sapiens	IC50	uM	0.08
	804148	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	O=C(N[C@@H]1CC(O)C[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL306580	=	IC50	nM	40.0	CHEMBL299	Homo sapiens	IC50	uM	0.04
	809504	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	O=C(N[C@@H]1CNC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL59828	=	IC50	nM	22.0	CHEMBL299	Homo sapiens	IC50	uM	0.022
	809513	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	CC1(C)C2CCC1(C)[C@@H](OC(=O)c1cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c1)[C@@H]2NC(=O)c1ccc(O)cc1		CHEMBL309078	=	IC50	nM	410.0	CHEMBL299	Homo sapiens	IC50	uM	0.41
	810665	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	CN1C2CCC1C(NC(=O)c1ccc(O)cc1)C(OC(=O)c1cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c1)C2		CHEMBL306883	=	IC50	nM	34000.0	CHEMBL299	Homo sapiens	IC50	uM	34.0
	811834	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	O=C(N[C@@H]1CSCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL76537	=	IC50	nM	3300.0	CHEMBL299	Homo sapiens	IC50	uM	3.3
	811843	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	O=C(N[C@@H]1CS(=O)(=O)CCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL305718	=	IC50	nM	9600.0	CHEMBL299	Homo sapiens	IC50	uM	9.6
	812713	CHEMBL769614	Displacement of [3H-20]-phorbol 12,13-dibutyrate(PDBU) from recombinant Protein kinase C alpha	B	CCCCCCCCCCCCCCCCCCOC(=O)/C=C1\COC(CO)(COC(C)=O)C1		CHEMBL133269	=	Ki	nM	580.0	CHEMBL299	Homo sapiens	Ki	uM	0.58
	813171	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	O=C(N[C@H]1CNCCC[C@@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL77970	=	IC50	nM	3000.0	CHEMBL299	Homo sapiens	IC50	uM	3.0
	813180	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	O=C(N[C@@H]1CCCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL304549	=	IC50	nM	270.0	CHEMBL299	Homo sapiens	IC50	uM	0.27
	813189	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	COC(=O)C1C[C@@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL77399	=	IC50	nM	540.0	CHEMBL299	Homo sapiens	IC50	uM	0.54
	815146	CHEMBL769614	Displacement of [3H-20]-phorbol 12,13-dibutyrate(PDBU) from recombinant Protein kinase C alpha	B	CCCCCCCCCCCCCCCCCCOC(=O)/C=C1/COC(CO)(COC(C)=O)C1		CHEMBL132843	=	Ki	nM	1860.0	CHEMBL299	Homo sapiens	Ki	uM	1.86
	818003	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	CC(C)C1C[C@@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL76920	=	IC50	nM	240.0	CHEMBL299	Homo sapiens	IC50	uM	0.24
	818012	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	CNC(=O)C1C[C@@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL312067	=	IC50	nM	2200.0	CHEMBL299	Homo sapiens	IC50	uM	2.2
	818826	CHEMBL769614	Displacement of [3H-20]-phorbol 12,13-dibutyrate(PDBU) from recombinant Protein kinase C alpha	B	CCCCCCCCCCCCCC(=O)OCC1(CO)C/C(=C/C(=O)OC)CO1		CHEMBL132879	=	Ki	nM	350.0	CHEMBL299	Homo sapiens	Ki	uM	0.35
	820324	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	O=C(N[C@@H]1CCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL52529	=	IC50	nM	40.0	CHEMBL299	Homo sapiens	IC50	uM	0.04
	820333	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	CS(=O)(=O)C1C[C@@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL306623	=	IC50	nM	910.0	CHEMBL299	Homo sapiens	IC50	uM	0.91
	821377	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	O=C(N[C@@H]1C2CCC(C2)[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL80525	=	IC50	nM	60.0	CHEMBL299	Homo sapiens	IC50	uM	0.06
	821386	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	O=C(N[C@@H]1C2CC(C3CCCC32)[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL263910	=	IC50	nM	100.0	CHEMBL299	Homo sapiens	IC50	uM	0.1
	822477	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	O=C(N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL60254	=	IC50	nM	30.0	CHEMBL299	Homo sapiens	IC50	uM	0.03
	823717	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	O=C(N[C@@H]1C[C@@H](O)C[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL309034	=	IC50	nM	50.0	CHEMBL299	Homo sapiens	IC50	uM	0.05
	824547	CHEMBL769614	Displacement of [3H-20]-phorbol 12,13-dibutyrate(PDBU) from recombinant Protein kinase C alpha	B	CCCCCCCCCCCCCC(=O)OCC1(CO)C/C(=C\C(=O)OC)CO1		CHEMBL133165	=	Ki	nM	350.0	CHEMBL299	Homo sapiens	Ki	uM	0.35
	825773	CHEMBL769614	Displacement of [3H-20]-phorbol 12,13-dibutyrate(PDBU) from recombinant Protein kinase C alpha	B	CCCCCCCCCCCCCC(=O)OC[C@]1(CO)CC[C@H](CC(=O)OC)O1		CHEMBL131645	=	Ki	nM	2720.0	CHEMBL299	Homo sapiens	Ki	uM	2.72
	825774	CHEMBL769614	Displacement of [3H-20]-phorbol 12,13-dibutyrate(PDBU) from recombinant Protein kinase C alpha	B	CCCCCCCCCCCCCCOC(=O)C[C@@H]1CC[C@@](CO)(COC(=O)CCCCC)O1		CHEMBL133170	=	Ki	nM	12780.0	CHEMBL299	Homo sapiens	Ki	uM	12.78
	826266	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	O=C(NC1CNCCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL49354	=	IC50	nM	70.0	CHEMBL299	Homo sapiens	IC50	uM	0.07
	826274	CHEMBL768372	Inhibitory concentration against recombinant human Protein kinase C alpha isozyme	B	NC[C@@H]1C[C@@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL308263	=	IC50	nM	20.0	CHEMBL299	Homo sapiens	IC50	uM	0.02
	827058	CHEMBL769614	Displacement of [3H-20]-phorbol 12,13-dibutyrate(PDBU) from recombinant Protein kinase C alpha	B	CCCCCCCCCCCCCC(=O)OC[C@]1(CO)CC[C@@H](CC(=O)OC)O1		CHEMBL422089	=	Ki	nM	10800.0	CHEMBL299	Homo sapiens	Ki	uM	10.8
	829354	CHEMBL770293	Binding affinity (Ki) towards Protein kinase C	B	CCCCCCCCCCC[C@@H]1C(=O)O[C@]2(CO)COC(=O)[C@H]12		CHEMBL286962	=	Ki	nM	7700.0	CHEMBL299	Homo sapiens	Ki	uM	7.7
	829368	CHEMBL766776	Displacement of [H-20]phorbol12,13-dibutyrate (PDBU) from Protein kinase C alpha	B	CCCCCCCC/C=C\CCCCCCC/C=C1\CC(CO)(COC(C)=O)OC1=O		CHEMBL94718	=	Ki	nM	24.0	CHEMBL299	Homo sapiens	Ki	nM	24.0
	830452	CHEMBL770293	Binding affinity (Ki) towards Protein kinase C	B	CCCCCCCCCCCCC1C(=O)O[C@@H](CO)[C@@]12CCC(=O)O2		CHEMBL28120	=	Ki	nM	75300.0	CHEMBL299	Homo sapiens	Ki	uM	75.3
	835112	CHEMBL770293	Binding affinity (Ki) towards Protein kinase C	B	CCCCCCCCCCCCCC[C@H]1C(=O)O[C@@H](CO)[C@@H]1OC(C)=O		CHEMBL12988	=	Ki	nM	500.0	CHEMBL299	Homo sapiens	Ki	uM	0.5
	835113	CHEMBL770293	Binding affinity (Ki) towards Protein kinase C	B	CCCCCCCCCCCCCC(=O)O[C@@H]1CC(=O)O[C@@H]1CO	Outside typical range	CHEMBL28285	=	Ki	nM	300000.0	CHEMBL299	Homo sapiens	Ki	uM	300.0
	835175	CHEMBL766776	Displacement of [H-20]phorbol12,13-dibutyrate (PDBU) from Protein kinase C alpha	B	CCCCCCCCCCCCC/C=C1/CC(CO)(COC(C)=O)OC1=O		CHEMBL420450	=	Ki	nM	35.0	CHEMBL299	Homo sapiens	Ki	nM	35.0
	837664	CHEMBL766776	Displacement of [H-20]phorbol12,13-dibutyrate (PDBU) from Protein kinase C alpha	B	CCCC/C=C\CCCCCCC/C=C1\CC(CO)(COC(C)=O)OC1=O		CHEMBL97661	=	Ki	nM	28.0	CHEMBL299	Homo sapiens	Ki	nM	28.0
	838661	CHEMBL767706	Inhibition of Protein kinase C alpha	B	O=C1NC(=O)c2c1c1c3ccccc3ccc1c1[nH]c3ccccc3c21		CHEMBL332575	=	IC50	nM	52750.0	CHEMBL299	Homo sapiens	IC50	uM	52.75
	842492	CHEMBL770293	Binding affinity (Ki) towards Protein kinase C	B	CCCCCCC(=O)O[C@@H]1CC(=O)O[C@H]1CO	Outside typical range	CHEMBL26671	=	Ki	nM	187000.0	CHEMBL299	Homo sapiens	Ki	uM	187.0
	842518	CHEMBL770293	Binding affinity (Ki) towards Protein kinase C	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Ki	nM	0.78	CHEMBL299	Homo sapiens	Ki	uM	0.00078
	842525	CHEMBL766776	Displacement of [H-20]phorbol12,13-dibutyrate (PDBU) from Protein kinase C alpha	B	CCCCCCCCCCCCCC(=O)OCC1(CO)CCC(=O)O1		CHEMBL299225	=	Ki	nM	138.0	CHEMBL299	Homo sapiens	Ki	nM	138.0
	842526	CHEMBL766776	Displacement of [H-20]phorbol12,13-dibutyrate (PDBU) from Protein kinase C alpha	B	CCCCCCCCCCCCCC(=O)OCC1(CO)COC(=O)C1		CHEMBL96773	=	Ki	nM	9810.0	CHEMBL299	Homo sapiens	Ki	nM	9810.0
	844977	CHEMBL770293	Binding affinity (Ki) towards Protein kinase C	B	CCCCCCCCCCC[C@H]1C(=O)O[C@@]2(CO)COC(=O)[C@@H]12		CHEMBL27505	=	Ki	nM	22000.0	CHEMBL299	Homo sapiens	Ki	uM	22.0
	844978	CHEMBL770293	Binding affinity (Ki) towards Protein kinase C	B	CCCCCCCCCCCCCC(=O)C1CC(=O)O[C@H]1CO		CHEMBL27815	=	Ki	nM	2500.0	CHEMBL299	Homo sapiens	Ki	uM	2.5
	845010	CHEMBL770293	Binding affinity (Ki) towards Protein kinase C	B	CCCCCCCCCCCCCC(=O)OC[C@H](CO)OC(C)=O		CHEMBL13259	=	Ki	nM	1300.0	CHEMBL299	Homo sapiens	Ki	uM	1.3
	846168	CHEMBL770293	Binding affinity (Ki) towards Protein kinase C	B	CCCCCCCCCCCC[C@@H]1C(=O)O[C@]2(CO)CC(=O)O[C@H]12		CHEMBL26971	=	Ki	nM	7600.0	CHEMBL299	Homo sapiens	Ki	uM	7.6
	849629	CHEMBL770293	Binding affinity (Ki) towards Protein kinase C	B	CCCCCCCCCCC/C=C1/C(=O)O[C@@H](CO)[C@@]12CCC(=O)O2		CHEMBL26811	=	Ki	nM	13600.0	CHEMBL299	Homo sapiens	Ki	uM	13.6
	849636	CHEMBL766776	Displacement of [H-20]phorbol12,13-dibutyrate (PDBU) from Protein kinase C alpha	B	CCCCCCCCCCCCC/C=C1\C(=O)OCC1(CO)COC(C)=O		CHEMBL94857	=	Ki	nM	6510.0	CHEMBL299	Homo sapiens	Ki	nM	6510.0
	849641	CHEMBL766776	Displacement of [H-20]phorbol12,13-dibutyrate (PDBU) from Protein kinase C alpha	B	CCCCCCCCCCCCC/C=C1\CC(CO)(COC(C)=O)OC1=O		CHEMBL49904	=	Ki	nM	78.0	CHEMBL299	Homo sapiens	Ki	nM	78.0
	852966	CHEMBL770293	Binding affinity (Ki) towards Protein kinase C	B	CO[C@@H](CC[C@H](C)[C@H]1O[C@@]23CC(OC(=O)C[C@H]([C@@H](C)O)OC(=O)C[C@](O)(O2)[C@H](C)CC3(C)C)[C@@H]1C)c1cccc(O)c1		CHEMBL282159	=	Ki	nM	20.0	CHEMBL299	Homo sapiens	Ki	uM	0.02
	852967	CHEMBL766776	Displacement of [H-20]phorbol12,13-dibutyrate (PDBU) from Protein kinase C alpha	B	CCCCCCCCCCCCC/C=C1/C(=O)OCC1(O)COC(C)=O		CHEMBL94549	=	Ki	nM	6500.0	CHEMBL299	Homo sapiens	Ki	nM	6500.0
	854108	CHEMBL766776	Displacement of [H-20]phorbol12,13-dibutyrate (PDBU) from Protein kinase C alpha	B	CCCCCCCC/C=C\CCCCCCCC(=O)OCC1(CO)CCC(=O)O1		CHEMBL94492	=	Ki	nM	96.0	CHEMBL299	Homo sapiens	Ki	nM	96.0
	857407	CHEMBL770293	Binding affinity (Ki) towards Protein kinase C	B	CCCCCCCCCCCCCCCCCCC(=O)O[C@@H]1CC(=O)O[C@H]1CO		CHEMBL282101	=	Ki	nM	8700.0	CHEMBL299	Homo sapiens	Ki	uM	8.7
	860824	CHEMBL770293	Binding affinity (Ki) towards Protein kinase C	B	CCCCCCCCCCCCCC(=O)O[C@H]1CC(=O)O[C@H]1CO		CHEMBL26372	=	Ki	nM	31000.0	CHEMBL299	Homo sapiens	Ki	uM	31.0
	860872	CHEMBL770293	Binding affinity (Ki) towards Protein kinase C	B	CCCCCCCCCCC[C@@H]1C(=O)O[C@@H]2[C@@H](CO)OC(=O)[C@H]12		CHEMBL27582	=	Ki	nM	27800.0	CHEMBL299	Homo sapiens	Ki	uM	27.8
	862063	CHEMBL770293	Binding affinity (Ki) towards Protein kinase C	B	CCCCCCCCCCCCCC(=O)O[C@H]1CC(=O)O[C@@H]1CO		CHEMBL13044	=	Ki	nM	5300.0	CHEMBL299	Homo sapiens	Ki	uM	5.3
	862064	CHEMBL770293	Binding affinity (Ki) towards Protein kinase C	B	CC(=O)O[C@@H]1CC(=O)O[C@H]1CO	Outside typical range	CHEMBL28341	>	Ki	nM	1700000.0	CHEMBL299	Homo sapiens	Ki	uM	1700.0
	863259	CHEMBL770293	Binding affinity (Ki) towards Protein kinase C	B	CCCCCCCCCCC(=O)O[C@@H]1CC(=O)O[C@H]1CO		CHEMBL26734	=	Ki	nM	4100.0	CHEMBL299	Homo sapiens	Ki	uM	4.1
	866914	CHEMBL762307	Displacement of 3[H]PDBu from Protein kinase C alpha C1a domain	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@@H]3C(=O)C(C)=C[C@H]32)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL265998	=	Ki	nM	4.05	CHEMBL299	Homo sapiens	Ki	nM	4.05
	866915	CHEMBL762315	Displacement of 3[H]PDBu from Protein kinase C alpha C1b domain	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@@H]3C(=O)C(C)=C[C@H]32)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL265998	=	Ki	nM	13.9	CHEMBL299	Homo sapiens	Ki	nM	13.9
	867395	CHEMBL769625	Displacement of PDBU from recombinant Protein kinase C alpha with phosphatidylserine	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2cc(NC(=O)CCCCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)ccc2N1C		CHEMBL333323	=	Ki	nM	7.8	CHEMBL299	Homo sapiens	Ki	nM	7.8
	867966	CHEMBL759068	Inhibition of serine/threonine kinase(PKC-alpha)	B	Cc1ccc(NC(=O)c2ccc(Cl)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL21162	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	871164	CHEMBL769625	Displacement of PDBU from recombinant Protein kinase C alpha with phosphatidylserine	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2cc(NC(=O)CCCCc3ccc(CCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)cc3)ccc2N1C		CHEMBL123244	=	Ki	nM	9.2	CHEMBL299	Homo sapiens	Ki	nM	9.2
	871771	CHEMBL759068	Inhibition of serine/threonine kinase(PKC-alpha)	B	Cc1ccc([N+](=O)[O-])cc1Nc1nccc(-c2cccnc2)n1	Outside typical range	CHEMBL20426	>	IC50	nM	500000.0	CHEMBL299	Homo sapiens	IC50	uM	500.0
	872442	CHEMBL769625	Displacement of PDBU from recombinant Protein kinase C alpha with phosphatidylserine	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2cc(NC(=O)/C=C/C=C/c3ccccc3)ccc2N1C		CHEMBL333240	=	Ki	nM	15.8	CHEMBL299	Homo sapiens	Ki	nM	15.8
	873086	CHEMBL759068	Inhibition of serine/threonine kinase(PKC-alpha)	B	COc1ccccc1C(=O)Nc1ccc(C)c(Nc2nccc(-c3cccnc3)n2)c1		CHEMBL418010	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	873092	CHEMBL759068	Inhibition of serine/threonine kinase(PKC-alpha)	B	Cc1ccc(NC(=O)c2ccccc2)cc1Nc1nccc(-c2ccc[n+]([O-])c2)n1		CHEMBL21079	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	875261	CHEMBL759068	Inhibition of serine/threonine kinase(PKC-alpha)	B	COc1ccc(NC(=O)c2ccccc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL21086	=	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	879645	CHEMBL769625	Displacement of PDBU from recombinant Protein kinase C alpha with phosphatidylserine	B	CCCCCC(=O)Nc1ccc2c(c1)C[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL334195	=	Ki	nM	225.0	CHEMBL299	Homo sapiens	Ki	nM	225.0
	881616	CHEMBL759068	Inhibition of serine/threonine kinase(PKC-alpha)	B	Cc1ccc(N)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL278103	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	882801	CHEMBL759068	Inhibition of serine/threonine kinase(PKC-alpha)	B	Cc1ccc(N(C)C(=O)c2ccccc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL278287	=	IC50	nM	85000.0	CHEMBL299	Homo sapiens	IC50	uM	85.0
	883860	CHEMBL759068	Inhibition of serine/threonine kinase(PKC-alpha)	B	Cc1ccc(N(C(=O)c2ccccc2)C(=O)c2ccccc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL277430	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	883866	CHEMBL759068	Inhibition of serine/threonine kinase(PKC-alpha)	B	CNc1ccc(C)c(Nc2nccc(-c3cccnc3)n2)c1		CHEMBL21215	=	IC50	nM	71000.0	CHEMBL299	Homo sapiens	IC50	uM	71.0
	886646	CHEMBL759068	Inhibition of serine/threonine kinase(PKC-alpha)	B	O=C(Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1)c1ccccc1		CHEMBL277931	=	IC50	nM	1200.0	CHEMBL299	Homo sapiens	IC50	uM	1.2
	887201	CHEMBL769625	Displacement of PDBU from recombinant Protein kinase C alpha with phosphatidylserine	B	C/C=C/C=C/C(=O)Nc1ccc2c(c1)C[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL420170	=	Ki	nM	1970.0	CHEMBL299	Homo sapiens	Ki	nM	1970.0
	888937	CHEMBL759068	Inhibition of serine/threonine kinase(PKC-alpha)	B	Cc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL20867	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	890222	CHEMBL759068	Inhibition of serine/threonine kinase(PKC-alpha)	B	Cc1ccc(NC(=O)c2ccc3ccccc3c2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL20252	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	890816	CHEMBL769625	Displacement of PDBU from recombinant Protein kinase C alpha with phosphatidylserine	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2cc(NC(=O)CCCCc3ccc(C(F)(F)F)cc3)ccc2N1C		CHEMBL123159	=	Ki	nM	12.5	CHEMBL299	Homo sapiens	Ki	nM	12.5
	891452	CHEMBL759068	Inhibition of serine/threonine kinase(PKC-alpha)	B	Cc1ccc(NC(=O)c2ccccc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL20926	=	IC50	nM	72000.0	CHEMBL299	Homo sapiens	IC50	uM	72.0
	891954	CHEMBL769625	Displacement of PDBU from recombinant Protein kinase C alpha with phosphatidylserine	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2cc(NC(=O)/C=C/C=C/c3ccc(C(F)(F)F)cc3)ccc2N1C		CHEMBL331344	=	Ki	nM	11.9	CHEMBL299	Homo sapiens	Ki	nM	11.9
	892576	CHEMBL759068	Inhibition of serine/threonine kinase(PKC-alpha)	B	Cc1ccc(NC(=O)c2ccccc2)cc1Nc1nccc(-c2cccs2)n1		CHEMBL21078	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	895311	CHEMBL769625	Displacement of PDBU from recombinant Protein kinase C alpha with phosphatidylserine	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2cc(NC(=O)/C=C/C=C/c3ccc(/C=C/C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)cc3)ccc2N1C		CHEMBL123355	=	Ki	nM	11.2	CHEMBL299	Homo sapiens	Ki	nM	11.2
	896595	CHEMBL769625	Displacement of PDBU from recombinant Protein kinase C alpha with phosphatidylserine	B	CCCCCCCCC#Cc1ccc2c(c1)C[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL6453	=	Ki	nM	14.7	CHEMBL299	Homo sapiens	Ki	nM	14.7
	897196	CHEMBL759068	Inhibition of serine/threonine kinase(PKC-alpha)	B	CC(=O)Nc1ccc(C)c(Nc2nccc(-c3cccnc3)n2)c1		CHEMBL423288	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	899646	CHEMBL759068	Inhibition of serine/threonine kinase(PKC-alpha)	B	O=C(Nc1ccc(Cl)c(Nc2nccc(-c3cccnc3)n2)c1)c1ccccc1		CHEMBL278630	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	902307	CHEMBL762307	Displacement of 3[H]PDBu from Protein kinase C alpha C1a domain	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Ki	nM	1.55	CHEMBL299	Homo sapiens	Ki	nM	1.55
	902308	CHEMBL762315	Displacement of 3[H]PDBu from Protein kinase C alpha C1b domain	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Ki	nM	17.2	CHEMBL299	Homo sapiens	Ki	nM	17.2
	902754	CHEMBL769625	Displacement of PDBU from recombinant Protein kinase C alpha with phosphatidylserine	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2cc(NC(=O)CCCCc3ccccc3)ccc2N1C		CHEMBL333801	=	Ki	nM	34.2	CHEMBL299	Homo sapiens	Ki	nM	34.2
	902757	CHEMBL769625	Displacement of PDBU from recombinant Protein kinase C alpha with phosphatidylserine	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2cc(NC(=O)/C=C/C=C/c3cc(C(F)(F)F)cc(C(F)(F)F)c3)ccc2N1C		CHEMBL330952	=	Ki	nM	5.6	CHEMBL299	Homo sapiens	Ki	nM	5.6
	905961	CHEMBL769353	In vitro activity evaluated against protein kinase C (using histone II-As as a substrate)	B	O=C1c2c(c3c4cccc(O)c4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4c(O)cccc4c23)C(=O)N1NCC(O)CO	Outside typical range	CHEMBL266182	>	IC50	nM	200000.0	CHEMBL299	Homo sapiens	IC50	uM	200.0
	905996	CHEMBL767025	Inhibition of protein kinase C alpha.	B	O=[N+]([O-])c1cccc(Nc2nccc(-c3ccccn3)n2)c1		CHEMBL60816	=	IC50	nM	2500.0	CHEMBL299	Homo sapiens	IC50	uM	2.5
	907479	CHEMBL767025	Inhibition of protein kinase C alpha.	B	Cc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL20867	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	907693	CHEMBL768515	Evaluated against recombinant human Protein kinase C alpha	B	O=C(OC1CCCC1Oc1ccc(O)cc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL48988	=	IC50	nM	220.0	CHEMBL299	Homo sapiens	IC50	uM	0.22
	908510	CHEMBL769353	In vitro activity evaluated against protein kinase C (using histone II-As as a substrate)	B	CNN1C(=O)c2c(c3c4cccc(O)c4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4c(O)cccc4c23)C1=O		CHEMBL277667	=	IC50	nM	55000.0	CHEMBL299	Homo sapiens	IC50	uM	55.0
	908794	CHEMBL768515	Evaluated against recombinant human Protein kinase C alpha	B	O=C(OC[C@@H](Cc1ccc(O)cc1)NS(=O)(=O)c1ccccc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL345767	=	IC50	nM	210.0	CHEMBL299	Homo sapiens	IC50	uM	0.21
	908802	CHEMBL768515	Evaluated against recombinant human Protein kinase C alpha	B	O=C(OCCCc1ccc(O)cc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL151800	=	IC50	nM	1900.0	CHEMBL299	Homo sapiens	IC50	uM	1.9
	909931	CHEMBL769353	In vitro activity evaluated against protein kinase C (using histone II-As as a substrate)	B	O=C1c2c(c3c4cccc(O)c4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4c(O)cccc4c23)C(=O)N1NCCO	Outside typical range	CHEMBL20811	>	IC50	nM	200000.0	CHEMBL299	Homo sapiens	IC50	uM	200.0
	909968	CHEMBL767025	Inhibition of protein kinase C alpha.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	909977	CHEMBL767025	Inhibition of protein kinase C alpha.	B	FC(F)C(F)(F)Oc1cccc(Nc2nccc(-c3ccc(Cl)cc3)n2)c1		CHEMBL57581	=	IC50	nM	850.0	CHEMBL299	Homo sapiens	IC50	uM	0.85
	910227	CHEMBL768515	Evaluated against recombinant human Protein kinase C alpha	B	CC(CCc1ccc(O)cc1)OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL148745	=	IC50	nM	410.0	CHEMBL299	Homo sapiens	IC50	uM	0.41
	910299	CHEMBL769620	Affinity for protein kinase-C alpha (PK-C alpha)	B	CCCCCCCCC/C=C1/CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O		CHEMBL107614	=	Ki	nM	13.0	CHEMBL299	Homo sapiens	Ki	nM	13.0
	910414	CHEMBL767708	Inhibition of Protein kinase C alpha	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCOCCOCCOCCn1cc2c2cccnc21		CHEMBL340935	=	IC50	nM	673.0	CHEMBL299	Homo sapiens	IC50	uM	0.673
	911219	CHEMBL769353	In vitro activity evaluated against protein kinase C (using histone II-As as a substrate)	B	Cc1ccc(S(=O)(=O)NN2C(=O)c3c(c4c5cccc(O)c5n(C5OC(CO)C(O)C(O)C5O)c4c4[nH]c5c(O)cccc5c34)C2=O)cc1		CHEMBL21267	=	IC50	nM	12000.0	CHEMBL299	Homo sapiens	IC50	uM	12.0
	911623	CHEMBL769620	Affinity for protein kinase-C alpha (PK-C alpha)	B	CC(C)C(C/C=C1\CC([C@H](CO)OC(=O)CC(C(C)C)C(C)C)OC1=O)C(C)C		CHEMBL320520	=	Ki	nM	679.0	CHEMBL299	Homo sapiens	Ki	nM	679.0
	912529	CHEMBL767025	Inhibition of protein kinase C alpha.	B	Cc1ccc(NC(=O)c2ccc(Cl)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL21162	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	912536	CHEMBL767025	Inhibition of protein kinase C alpha.	B	Clc1cccc(Nc2nccc(-c3cccnc3)n2)c1		CHEMBL300817	=	IC50	nM	1600.0	CHEMBL299	Homo sapiens	IC50	uM	1.6
	912839	CHEMBL768515	Evaluated against recombinant human Protein kinase C alpha	B	O=C(OCC(Cc1ccc(O)cc1)NS(=O)(=O)c1ccc2ccccc2c1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL151823	=	IC50	nM	3200.0	CHEMBL299	Homo sapiens	IC50	uM	3.2
	913858	CHEMBL769353	In vitro activity evaluated against protein kinase C (using histone II-As as a substrate)	B	O=C(NN1C(=O)c2c(c3c4cccc(O)c4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4c(O)cccc4c23)C1=O)c1ccccn1		CHEMBL20255	=	IC50	nM	41000.0	CHEMBL299	Homo sapiens	IC50	uM	41.0
	913865	CHEMBL769353	In vitro activity evaluated against protein kinase C (using histone II-As as a substrate)	B	O=C(Nc1ccccc1)NN1C(=O)c2c(c3c4cccc(O)c4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4c(O)cccc4c23)C1=O		CHEMBL19978	=	IC50	nM	6800.0	CHEMBL299	Homo sapiens	IC50	uM	6.8
	913914	CHEMBL767025	Inhibition of protein kinase C alpha.	B	O=C(Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1)c1ccccc1		CHEMBL277931	=	IC50	nM	1200.0	CHEMBL299	Homo sapiens	IC50	uM	1.2
	913921	CHEMBL767025	Inhibition of protein kinase C alpha.	B	O=C(O)c1cccc(Nc2nccc(-c3cccnc3)n2)c1		CHEMBL57556	=	IC50	nM	45000.0	CHEMBL299	Homo sapiens	IC50	uM	45.0
	915175	CHEMBL769353	In vitro activity evaluated against protein kinase C (using histone II-As as a substrate)	B	O=C(CO)NN1C(=O)c2c(c3c4cccc(O)c4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4c(O)cccc4c23)C1=O	Outside typical range	CHEMBL21221	>	IC50	nM	200000.0	CHEMBL299	Homo sapiens	IC50	uM	200.0
	915578	CHEMBL769620	Affinity for protein kinase-C alpha (PK-C alpha)	B	CC(C)C(C/C=C1/CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O)C(C)C		CHEMBL290876	=	Ki	nM	2.9	CHEMBL299	Homo sapiens	Ki	nM	2.9
	915579	CHEMBL769620	Affinity for protein kinase-C alpha (PK-C alpha)	B	CCCCCCCC/C=C1/CC([C@H](CO)OC(=O)CC(C(C)C)C(C)C)OC1=O		CHEMBL420668	=	Ki	nM	565.0	CHEMBL299	Homo sapiens	Ki	nM	565.0
	915580	CHEMBL769620	Affinity for protein kinase-C alpha (PK-C alpha)	B	CCCCCCCCC(=O)O[C@@H](CO)C1C/C(=C\CC(C(C)C)C(C)C)C(=O)O1		CHEMBL108397	=	Ki	nM	1088.0	CHEMBL299	Homo sapiens	Ki	nM	1088.0
	915721	CHEMBL767708	Inhibition of Protein kinase C alpha	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCn1cc2c2cccnc21		CHEMBL340776	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	915735	CHEMBL768514	Inhibition of human Protein kinase C alpha at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCn1cc2c2cccnc21		CHEMBL340776	=	Activity	%	51.0	CHEMBL299	Homo sapiens	Activity	%	51.0
	917703	CHEMBL769353	In vitro activity evaluated against protein kinase C (using histone II-As as a substrate)	B	CN(C)CC(=O)NN1C(=O)c2c(c3c4cccc(O)c4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4c(O)cccc4c23)C1=O	Outside typical range	CHEMBL278757	>	IC50	nM	200000.0	CHEMBL299	Homo sapiens	IC50	uM	200.0
	917720	CHEMBL767025	Inhibition of protein kinase C alpha.	B	Cc1ccc(NC(=O)c2ccc3ccccc3c2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL20252	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	917727	CHEMBL767025	Inhibition of protein kinase C alpha.	B	CC(=O)Nc1ccc(C)c(Nc2nccc(-c3cccnc3)n2)c1	Outside typical range	CHEMBL423288	=	IC50	nM	500000.0	CHEMBL299	Homo sapiens	IC50	uM	500.0
	918241	CHEMBL767708	Inhibition of Protein kinase C alpha	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCOCCOCCOCCn1cc2c2ccccc21		CHEMBL340259	=	IC50	nM	86.0	CHEMBL299	Homo sapiens	IC50	uM	0.086
	919027	CHEMBL769353	In vitro activity evaluated against protein kinase C (using histone II-As as a substrate)	B	CN(C)N1C(=O)c2c(c3c4cccc(O)c4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4c(O)cccc4c23)C1=O		CHEMBL278071	=	IC50	nM	59000.0	CHEMBL299	Homo sapiens	IC50	uM	59.0
	919034	CHEMBL769353	In vitro activity evaluated against protein kinase C (using histone II-As as a substrate)	B	O=C(O)CNN1C(=O)c2c(c3c4cccc(O)c4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4c(O)cccc4c23)C1=O	Outside typical range	CHEMBL21263	=	IC50	nM	110000.0	CHEMBL299	Homo sapiens	IC50	uM	110.0
Not Determined	919074	CHEMBL767027	Inhibition of protein kinase C alpha (not determined)	B	O=C(Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1)c1ccc(F)cc1		CHEMBL418279		IC50	nM		CHEMBL299	Homo sapiens	IC50	uM	
	919081	CHEMBL767025	Inhibition of protein kinase C alpha.	B	O=[N+]([O-])c1cccc(Nc2nccc(-c3ccncc3)n2)c1		CHEMBL55683	=	IC50	nM	2600.0	CHEMBL299	Homo sapiens	IC50	uM	2.6
	920394	CHEMBL768515	Evaluated against recombinant human Protein kinase C alpha	B	COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)OC2CNCC2Cc2ccc(O)cc2)cc1O		CHEMBL48546	=	IC50	nM	2200.0	CHEMBL299	Homo sapiens	IC50	uM	2.2
	921266	CHEMBL769353	In vitro activity evaluated against protein kinase C (using histone II-As as a substrate)	B	NN1C(=O)c2c(c3c4cccc(O)c4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4c(O)cccc4c23)C1=O	Outside typical range	CHEMBL21265	>	IC50	nM	200000.0	CHEMBL299	Homo sapiens	IC50	uM	200.0
	921273	CHEMBL769353	In vitro activity evaluated against protein kinase C (using histone II-As as a substrate)	B	N#CCC(=O)NN1C(=O)c2c(c3c4cccc(O)c4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4c(O)cccc4c23)C1=O		CHEMBL278526	=	IC50	nM	65000.0	CHEMBL299	Homo sapiens	IC50	uM	65.0
Not Determined	921291	CHEMBL767026	Inhibition of protein kinase C alpha (Not determined)	B	NCCCNC(=O)c1cccc(Nc2nccc(-c3cccnc3)n2)c1		CHEMBL59099		IC50	nM		CHEMBL299	Homo sapiens	IC50	uM	
	921554	CHEMBL768515	Evaluated against recombinant human Protein kinase C alpha	B	COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)OCCCc2ccc(O)cc2)cc1O		CHEMBL149313	=	IC50	nM	7800.0	CHEMBL299	Homo sapiens	IC50	uM	7.8
	922522	CHEMBL769353	In vitro activity evaluated against protein kinase C (using histone II-As as a substrate)	B	O=C(O)c1ccc(NN2C(=O)c3c(c4c5cccc(O)c5n(C5OC(CO)C(O)C(O)C5O)c4c4[nH]c5c(O)cccc5c34)C2=O)cc1		CHEMBL279035	=	IC50	nM	23000.0	CHEMBL299	Homo sapiens	IC50	uM	23.0
Not Determined	922567	CHEMBL767027	Inhibition of protein kinase C alpha (not determined)	B	Nc1cccc(Nc2nccc(-c3ccncc3)n2)c1		CHEMBL57443		IC50	nM		CHEMBL299	Homo sapiens	IC50	uM	
	924025	CHEMBL768515	Evaluated against recombinant human Protein kinase C alpha	B	O=C(OC1CNCC1Cc1ccc(O)cc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL300422	=	IC50	nM	260.0	CHEMBL299	Homo sapiens	IC50	uM	0.26
	924111	CHEMBL769620	Affinity for protein kinase-C alpha (PK-C alpha)	B	CCCCCCCC/C=C1/CC([C@H](CO)OC(=O)CCCCCCCC)OC1=O		CHEMBL109630	=	Ki	nM	1758.0	CHEMBL299	Homo sapiens	Ki	nM	1758.0
	925208	CHEMBL769353	In vitro activity evaluated against protein kinase C (using histone II-As as a substrate)	B	CCCNN1C(=O)c2c(c3c4cccc(O)c4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4c(O)cccc4c23)C1=O		CHEMBL21096	=	IC50	nM	65000.0	CHEMBL299	Homo sapiens	IC50	uM	65.0
	925519	CHEMBL768515	Evaluated against recombinant human Protein kinase C alpha	B	O=C(OCC(NS(=O)(=O)c1ccccc1)c1ccc(O)cc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL150422	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	926578	CHEMBL769353	In vitro activity evaluated against protein kinase C (using histone II-As as a substrate)	B	O=C1NC(=O)c2c1c1c3cccc(O)c3[nH]c1c1[nH]c3c(O)cccc3c21		CHEMBL279481	=	IC50	nM	40000.0	CHEMBL299	Homo sapiens	IC50	uM	40.0
	926585	CHEMBL769353	In vitro activity evaluated against protein kinase C (using histone II-As as a substrate)	B	O=C1NC(=O)c2c1c1c3cccc(O)c3[nH]c1c1c2c2cccc(O)c2n1C1OC(CO)C(O)C(O)C1O		CHEMBL21108	=	IC50	nM	3800.0	CHEMBL299	Homo sapiens	IC50	uM	3.8
	926592	CHEMBL769353	In vitro activity evaluated against protein kinase C (using histone II-As as a substrate)	B	O=CNN1C(=O)c2c(c3c4cccc(O)c4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4c(O)cccc4c23)C1=O	Outside typical range	CHEMBL282436	>	IC50	nM	200000.0	CHEMBL299	Homo sapiens	IC50	uM	200.0
	926603	CHEMBL769353	In vitro activity evaluated against protein kinase C (using histone II-As as a substrate)	B	N#CCCNN1C(=O)c2c(c3c4cccc(O)c4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4c(O)cccc4c23)C1=O	Outside typical range	CHEMBL283766	>	IC50	nM	200000.0	CHEMBL299	Homo sapiens	IC50	uM	200.0
	926657	CHEMBL767025	Inhibition of protein kinase C alpha.	B	CCCCCC(=O)Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1		CHEMBL56669	=	IC50	nM	2000.0	CHEMBL299	Homo sapiens	IC50	uM	2.0
	926978	CHEMBL769620	Affinity for protein kinase-C alpha (PK-C alpha)	B	CCCCCCCC/C=C\CCCCCCCC(=O)OCC1(CO)CCC(=O)O1		CHEMBL94492	=	Ki	nM	96.0	CHEMBL299	Homo sapiens	Ki	nM	96.0
	926979	CHEMBL769620	Affinity for protein kinase-C alpha (PK-C alpha)	B	CCCCCCCC/C=C\CCCCCCC/C=C1/CC(CO)(COC(C)=O)OC1=O		CHEMBL321823	=	Ki	nM	24.0	CHEMBL299	Homo sapiens	Ki	nM	24.0
	926980	CHEMBL769620	Affinity for protein kinase-C alpha (PK-C alpha)	B	CCCCCCCCC(=O)O[C@@H](CO)C1C/C(=C/CC(C(C)C)C(C)C)C(=O)O1		CHEMBL109099	=	Ki	nM	499.0	CHEMBL299	Homo sapiens	Ki	nM	499.0
	928031	CHEMBL769353	In vitro activity evaluated against protein kinase C (using histone II-As as a substrate)	B	NC(=O)NN1C(=O)c2c(c3c4cccc(O)c4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4c(O)cccc4c23)C1=O	Outside typical range	CHEMBL277039	>	IC50	nM	200000.0	CHEMBL299	Homo sapiens	IC50	uM	200.0
	928096	CHEMBL767025	Inhibition of protein kinase C alpha.	B	c1cc(Nc2nccc(-c3cccnc3)n2)cc(OCCn2ccnc2)c1		CHEMBL58436	=	IC50	nM	1500.0	CHEMBL299	Homo sapiens	IC50	uM	1.5
Not Determined	928103	CHEMBL767027	Inhibition of protein kinase C alpha (not determined)	B	Cc1ccc(C(=O)Nc2cccc(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL59036		IC50	nM		CHEMBL299	Homo sapiens	IC50	uM	
	928337	CHEMBL768515	Evaluated against recombinant human Protein kinase C alpha	B	O=C(NC1CNCCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL49354	=	IC50	nM	67.0	CHEMBL299	Homo sapiens	IC50	uM	0.067
	928345	CHEMBL768515	Evaluated against recombinant human Protein kinase C alpha	B	Cc1ccc(S(=O)(=O)N2CCC[C@@H](OC(=O)c3cc(O)c(C(=O)c4c(O)cccc4C(=O)O)c(O)c3)[C@H](NC(=O)c3ccc(O)cc3)C2)cc1		CHEMBL146846	=	IC50	nM	6100.0	CHEMBL299	Homo sapiens	IC50	uM	6.1
	928353	CHEMBL768515	Evaluated against recombinant human Protein kinase C alpha	B	O=C(OCC(Cc1ccc(O)cc1)NS(=O)(=O)c1ccccc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL358264	=	IC50	nM	110.0	CHEMBL299	Homo sapiens	IC50	uM	0.11
	929359	CHEMBL767025	Inhibition of protein kinase C alpha.	B	COc1ccccc1C(=O)Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1		CHEMBL299707	=	IC50	nM	320.0	CHEMBL299	Homo sapiens	IC50	uM	0.32
	929366	CHEMBL767025	Inhibition of protein kinase C alpha.	B	c1cncc(-c2ccnc(Nc3cccc(-n4ccnc4)c3)n2)c1		CHEMBL291963	=	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	uM	1.0
Not Determined	929373	CHEMBL767027	Inhibition of protein kinase C alpha (not determined)	B	O=C(Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1)c1ccccn1		CHEMBL292866		IC50	nM		CHEMBL299	Homo sapiens	IC50	uM	
	930588	CHEMBL769353	In vitro activity evaluated against protein kinase C (using histone II-As as a substrate)	B	CCC(=O)NN1C(=O)c2c(c3c4cccc(O)c4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4c(O)cccc4c23)C1=O		CHEMBL278101	=	IC50	nM	36000.0	CHEMBL299	Homo sapiens	IC50	uM	36.0
	930595	CHEMBL769353	In vitro activity evaluated against protein kinase C (using histone II-As as a substrate)	B	CS(=O)(=O)NN1C(=O)c2c(c3c4cccc(O)c4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4c(O)cccc4c23)C1=O	Outside typical range	CHEMBL277408	>	IC50	nM	200000.0	CHEMBL299	Homo sapiens	IC50	uM	200.0
Not Determined	930632	CHEMBL767027	Inhibition of protein kinase C alpha (not determined)	B	COC(=O)c1cccc(Nc2nccc(-c3cccnc3)n2)c1		CHEMBL56671		IC50	nM		CHEMBL299	Homo sapiens	IC50	uM	
	930968	CHEMBL768515	Evaluated against recombinant human Protein kinase C alpha	B	O=C(NC1CCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL48636	=	IC50	nM	40.0	CHEMBL299	Homo sapiens	IC50	uM	0.04
	930976	CHEMBL768515	Evaluated against recombinant human Protein kinase C alpha	B	O=C(NC(COC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)Cc1ccc(O)cc1)c1ccc(O)cc1		CHEMBL151731	=	IC50	nM	18000.0	CHEMBL299	Homo sapiens	IC50	uM	18.0
	931182	CHEMBL767708	Inhibition of Protein kinase C alpha	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCOCCn1cc2c2cccnc21		CHEMBL337642	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	931196	CHEMBL768514	Inhibition of human Protein kinase C alpha at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCOCCn1cc2c2cccnc21		CHEMBL337642	=	Activity	%	94.0	CHEMBL299	Homo sapiens	Activity	%	94.0
	931961	CHEMBL769353	In vitro activity evaluated against protein kinase C (using histone II-As as a substrate)	B	O=C1c2c(c3c4cccc(O)c4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4c(O)cccc4c23)C(=O)N1NCc1cccc(O)c1		CHEMBL282655	=	IC50	nM	13000.0	CHEMBL299	Homo sapiens	IC50	uM	13.0
	931995	CHEMBL767025	Inhibition of protein kinase C alpha.	B	FC(F)C(F)(F)Oc1cccc(Nc2nccc(-c3c[nH]c4ccccc34)n2)c1		CHEMBL55379	=	IC50	nM	290.0	CHEMBL299	Homo sapiens	IC50	uM	0.29
Not Determined	932002	CHEMBL767027	Inhibition of protein kinase C alpha (not determined)	B	O=C(O)c1ccccc1C(=O)Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1		CHEMBL55742		IC50	nM		CHEMBL299	Homo sapiens	IC50	uM	
	932331	CHEMBL768515	Evaluated against recombinant human Protein kinase C alpha	B	O=C(NC(COC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)Cc1ccc(O)cc1)c1ccccc1		CHEMBL343362	=	IC50	nM	45000.0	CHEMBL299	Homo sapiens	IC50	uM	45.0
Not Determined	933466	CHEMBL767027	Inhibition of protein kinase C alpha (not determined)	B	CN1CCN(Cc2ccc(C(=O)Nc3cccc(Nc4nccc(-c5cccnc5)n4)c3)cc2)CC1		CHEMBL56904		IC50	nM		CHEMBL299	Homo sapiens	IC50	uM	
	933474	CHEMBL767025	Inhibition of protein kinase C alpha.	B	O=C(Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1)c1cccnc1		CHEMBL418270	=	IC50	nM	1700.0	CHEMBL299	Homo sapiens	IC50	uM	1.7
	933482	CHEMBL767025	Inhibition of protein kinase C alpha.	B	NCCCn1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)C(F)F)c4)n3)cccc21		CHEMBL293991	=	IC50	nM	180.0	CHEMBL299	Homo sapiens	IC50	uM	0.18
	933489	CHEMBL767025	Inhibition of protein kinase C alpha.	B	COc1ccccc1C(=O)Nc1ccc(C)c(Nc2nccc(-c3cccnc3)n2)c1		CHEMBL418010	=	IC50	nM	80000.0	CHEMBL299	Homo sapiens	IC50	uM	80.0
	933776	CHEMBL768515	Evaluated against recombinant human Protein kinase C alpha	B	O=C(OCCCCc1ccc(O)cc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL439996	=	IC50	nM	3300.0	CHEMBL299	Homo sapiens	IC50	uM	3.3
	933840	CHEMBL769620	Affinity for protein kinase-C alpha (PK-C alpha)	B	CCCCCCCC/C=C1\CC([C@H](CO)OC(=O)CC(C(C)C)C(C)(C)C)OC1=O		CHEMBL320984	=	Ki	nM	579.0	CHEMBL299	Homo sapiens	Ki	nM	579.0
	933842	CHEMBL769620	Affinity for protein kinase-C alpha (PK-C alpha)	B	CC(C)C(C/C=C1/CC([C@H](CO)OC(=O)CC(C(C)C)C(C)C)OC1=O)C(C)C		CHEMBL107602	=	Ki	nM	327.0	CHEMBL299	Homo sapiens	Ki	nM	327.0
	935229	CHEMBL768515	Evaluated against recombinant human Protein kinase C alpha	B	O=C(NCCOC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL149873	=	IC50	nM	11000.0	CHEMBL299	Homo sapiens	IC50	uM	11.0
	935326	CHEMBL769620	Affinity for protein kinase-C alpha (PK-C alpha)	B	CCCCCCCCCC(=O)OCC1(CO)C/C(=C/CC(C(C)C)C(C)C)C(=O)O1		CHEMBL111625	=	Ki	nM	2.3	CHEMBL299	Homo sapiens	Ki	nM	2.3
Not Determined	936350	CHEMBL767027	Inhibition of protein kinase C alpha (not determined)	B	O=C(Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1)c1cccs1		CHEMBL56359		IC50	nM		CHEMBL299	Homo sapiens	IC50	uM	
	936654	CHEMBL768515	Evaluated against recombinant human Protein kinase C alpha	B	O=C(OC1CCCC1Cc1ccc(O)cc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL295806	=	IC50	nM	30.0	CHEMBL299	Homo sapiens	IC50	uM	0.03
	936740	CHEMBL769620	Affinity for protein kinase-C alpha (PK-C alpha)	B	CCCCCCCCCCCCCC(=O)O[C@@H](CO)C1CCC(=O)O1		CHEMBL108443	=	Ki	nM	1000.0	CHEMBL299	Homo sapiens	Ki	nM	1000.0
	937782	CHEMBL769353	In vitro activity evaluated against protein kinase C (using histone II-As as a substrate)	B	CC(=O)NN1C(=O)c2c(c3c4cccc(O)c4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4c(O)cccc4c23)C1=O	Outside typical range	CHEMBL428453	=	IC50	nM	130000.0	CHEMBL299	Homo sapiens	IC50	uM	130.0
	937789	CHEMBL769353	In vitro activity evaluated against protein kinase C (using histone II-As as a substrate)	B	CCNN1C(=O)c2c(c3c4cccc(O)c4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4c(O)cccc4c23)C1=O	Outside typical range	CHEMBL277011	>	IC50	nM	200000.0	CHEMBL299	Homo sapiens	IC50	uM	200.0
	937800	CHEMBL769353	In vitro activity evaluated against protein kinase C (using histone II-As as a substrate)	B	O=C1c2c(c3c4cccc(O)c4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4c(O)cccc4c23)C(=O)N1NC(CO)CO	Outside typical range	CHEMBL277008	>	IC50	nM	200000.0	CHEMBL299	Homo sapiens	IC50	uM	200.0
	937854	CHEMBL767025	Inhibition of protein kinase C alpha.	B	Cc1ccc(NC(=O)c2ccccc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL20926	=	IC50	nM	72000.0	CHEMBL299	Homo sapiens	IC50	uM	72.0
	938247	CHEMBL768515	Evaluated against recombinant human Protein kinase C alpha	B	CN(C)C(COC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)Cc1ccc(O)cc1		CHEMBL421790	=	IC50	nM	4000.0	CHEMBL299	Homo sapiens	IC50	uM	4.0
	938255	CHEMBL768515	Evaluated against recombinant human Protein kinase C alpha	B	O=C(OCC(COc1ccc(O)cc1)NS(=O)(=O)c1ccccc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL150264	=	IC50	nM	18000.0	CHEMBL299	Homo sapiens	IC50	uM	18.0
	939140	CHEMBL767025	Inhibition of protein kinase C alpha.	B	Cc1ccc(N)cc1Nc1nccc(-c2cccnc2)n1	Outside typical range	CHEMBL278103	=	IC50	nM	240000.0	CHEMBL299	Homo sapiens	IC50	uM	240.0
	939147	CHEMBL767025	Inhibition of protein kinase C alpha.	B	c1ccc(Nc2nccc(-c3cccnc3)n2)cc1		CHEMBL57690	=	IC50	nM	10500.0	CHEMBL299	Homo sapiens	IC50	uM	10.5
	939393	CHEMBL768515	Evaluated against recombinant human Protein kinase C alpha	B	CS(=O)(=O)NC(COC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)Cc1ccc(O)cc1		CHEMBL149604	=	IC50	nM	23000.0	CHEMBL299	Homo sapiens	IC50	uM	23.0
	939401	CHEMBL768515	Evaluated against recombinant human Protein kinase C alpha	B	O=C(OC1CCCC1Cc1ccc(O)cc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL295806	=	IC50	nM	160.0	CHEMBL299	Homo sapiens	IC50	uM	0.16
	939409	CHEMBL768515	Evaluated against recombinant human Protein kinase C alpha	B	COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)OC2CCCC2Cc2ccc(O)cc2)cc1O		CHEMBL48665	=	IC50	nM	1400.0	CHEMBL299	Homo sapiens	IC50	uM	1.4
	939419	CHEMBL768515	Evaluated against recombinant human Protein kinase C alpha	B	O=C(N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL60254	=	IC50	nM	30.0	CHEMBL299	Homo sapiens	IC50	uM	0.03
	939606	CHEMBL767708	Inhibition of Protein kinase C alpha	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	IC50	nM	360.0	CHEMBL299	Homo sapiens	IC50	uM	0.36
	940393	CHEMBL767025	Inhibition of protein kinase C alpha.	B	FC(F)C(F)(F)Oc1cccc(Nc2nccc(-c3ccncc3)n2)c1		CHEMBL55662	=	IC50	nM	300.0	CHEMBL299	Homo sapiens	IC50	uM	0.3
	940708	CHEMBL769620	Affinity for protein kinase-C alpha (PK-C alpha)	B	CCCCCCCC/C=C1\CC([C@H](CO)OC(=O)CCCCCCCC)OC1=O		CHEMBL108303	=	Ki	nM	1202.0	CHEMBL299	Homo sapiens	Ki	nM	1202.0
	941675	CHEMBL769353	In vitro activity evaluated against protein kinase C (using histone II-As as a substrate)	B	O=C(NN1C(=O)c2c(c3c4cccc(O)c4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4c(O)cccc4c23)C1=O)c1ccccc1		CHEMBL277432	=	IC50	nM	35000.0	CHEMBL299	Homo sapiens	IC50	uM	35.0
	941713	CHEMBL767025	Inhibition of protein kinase C alpha.	B	O=C(Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1)c1ccncc1		CHEMBL55592	=	IC50	nM	1300.0	CHEMBL299	Homo sapiens	IC50	uM	1.3
	941720	CHEMBL767025	Inhibition of protein kinase C alpha.	B	Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1	Outside typical range	CHEMBL57553	=	IC50	nM	210000.0	CHEMBL299	Homo sapiens	IC50	uM	210.0
	942027	CHEMBL768515	Evaluated against recombinant human Protein kinase C alpha	B	COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)OC[C@@H](Cc2ccc(O)cc2)NS(=O)(=O)c2ccccc2)cc1O		CHEMBL146847	=	IC50	nM	18000.0	CHEMBL299	Homo sapiens	IC50	uM	18.0
	942931	CHEMBL767025	Inhibition of protein kinase C alpha.	B	O=[N+]([O-])c1cccc(Nc2nccc(-c3cccnc3)n2)c1		CHEMBL56081	=	IC50	nM	790.0	CHEMBL299	Homo sapiens	IC50	uM	0.79
Not Determined	944419	CHEMBL767027	Inhibition of protein kinase C alpha (not determined)	B	O=C(Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1)C1CCCCC1		CHEMBL58142		IC50	nM		CHEMBL299	Homo sapiens	IC50	uM	
	945635	CHEMBL767025	Inhibition of protein kinase C alpha.	B	N#Cc1ccc(C(=O)Nc2cccc(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL58580	=	IC50	nM	350.0	CHEMBL299	Homo sapiens	IC50	uM	0.35
	945932	CHEMBL768515	Evaluated against recombinant human Protein kinase C alpha	B	O=C(OC[C@H](Cc1ccc(O)cc1)NS(=O)(=O)c1ccccc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL151822	=	IC50	nM	1900.0	CHEMBL299	Homo sapiens	IC50	uM	1.9
	948186	CHEMBL769621	Displacement of [20-3H] phorbol 12,13-dibutyrate from protein kinase C alpha	B	CCCCCCCC/C=C/CCCCCCCC(=O)O[C@@H](CO)COC(C)=O		CHEMBL158666	=	Ki	nM	50.4	CHEMBL299	Homo sapiens	Ki	nM	50.4
	948662	CHEMBL769623	Displacement of [20-3H]-phorbol 12,13-dibutyrate (PDBU) from protein kinase C alpha with phosphatidylserine	B	CCCCCCCCCOC(=O)CC1(CO)C/C(=C\CC(C(C)C)C(C)C)C(=O)O1		CHEMBL1169398	=	Ki	nM	62.2	CHEMBL299	Homo sapiens	Ki	nM	62.2
	950733	CHEMBL769621	Displacement of [20-3H] phorbol 12,13-dibutyrate from protein kinase C alpha	B	CC(C)(C)C(=O)OCC(CO)OC(=O)C(C)(C)C		CHEMBL157482	=	Ki	nM	3430.0	CHEMBL299	Homo sapiens	Ki	nM	3430.0
	952144	CHEMBL769621	Displacement of [20-3H] phorbol 12,13-dibutyrate from protein kinase C alpha	B	CC(C)C(CC(=O)OC[C@H](CO)OC(=O)CC(C(C)C)C(C)C)C(C)C		CHEMBL289230	=	Ki	nM	28.6	CHEMBL299	Homo sapiens	Ki	nM	28.6
	952648	CHEMBL769623	Displacement of [20-3H]-phorbol 12,13-dibutyrate (PDBU) from protein kinase C alpha with phosphatidylserine	B	CCCCCCCCC(=O)OCCC1(CO)C/C(=C/CC(C(C)C)C(C)C)C(=O)O1		CHEMBL158957	=	Ki	nM	208.0	CHEMBL299	Homo sapiens	Ki	nM	208.0
	953096	CHEMBL768511	Inhibition of Protein kinase C alpha	B	Nc1nccc(-c2c[nH]c3c(Br)ccc(O)c23)n1		CHEMBL296682	=	IC50	nM	1300.0	CHEMBL299	Homo sapiens	IC50	uM	1.3
	957434	CHEMBL769621	Displacement of [20-3H] phorbol 12,13-dibutyrate from protein kinase C alpha	B	CCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCC		CHEMBL55267	=	Ki	nM	33.0	CHEMBL299	Homo sapiens	Ki	nM	33.0
	962341	CHEMBL769621	Displacement of [20-3H] phorbol 12,13-dibutyrate from protein kinase C alpha	B	CC(C)C(C/C=C1/CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O)C(C)C		CHEMBL290876	=	Ki	nM	2.9	CHEMBL299	Homo sapiens	Ki	nM	2.9
	964148	CHEMBL769623	Displacement of [20-3H]-phorbol 12,13-dibutyrate (PDBU) from protein kinase C alpha with phosphatidylserine	B	CCCCCCCCCC(=O)OCC1(CO)C/C(=C/CC(C(C)C)C(C)C)C(=O)O1		CHEMBL111625	=	Ki	nM	2.3	CHEMBL299	Homo sapiens	Ki	nM	2.3
	964149	CHEMBL769623	Displacement of [20-3H]-phorbol 12,13-dibutyrate (PDBU) from protein kinase C alpha with phosphatidylserine	B	CCCCCCCCCC(=O)OCC1(CO)C/C(=C\CC(C(C)C)C(C)C)C(=O)O1		CHEMBL171577	=	Ki	nM	6.6	CHEMBL299	Homo sapiens	Ki	nM	6.6
	967648	CHEMBL769621	Displacement of [20-3H] phorbol 12,13-dibutyrate from protein kinase C alpha	B	CCCCCCCC/C=C/CCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCC/C=C/CCCCCCCC		CHEMBL57517	=	Ki	nM	87.2	CHEMBL299	Homo sapiens	Ki	nM	87.2
	968108	CHEMBL769623	Displacement of [20-3H]-phorbol 12,13-dibutyrate (PDBU) from protein kinase C alpha with phosphatidylserine	B	CCCCCCCCC(=O)OCCC1(CO)C/C(=C\CC(C(C)C)C(C)C)C(=O)O1		CHEMBL1169397	=	Ki	nM	459.0	CHEMBL299	Homo sapiens	Ki	nM	459.0
	970139	CHEMBL763596	Inhibition of protein kinase C alpha	B	Oc1cc2c(c(O)c1O)-c1c(cc(O)c(O)c1O)COC2		CHEMBL294037	=	IC50	nM	37000.0	CHEMBL299	Homo sapiens	IC50	uM	37.0
	971942	CHEMBL769623	Displacement of [20-3H]-phorbol 12,13-dibutyrate (PDBU) from protein kinase C alpha with phosphatidylserine	B	CCCCCCCC(=O)OCCCC1(CO)C/C(=C\CC(C(C)C)C(C)C)C(=O)O1		CHEMBL1169396	=	Ki	nM	1430.0	CHEMBL299	Homo sapiens	Ki	nM	1430.0
	975588	CHEMBL769623	Displacement of [20-3H]-phorbol 12,13-dibutyrate (PDBU) from protein kinase C alpha with phosphatidylserine	B	CCCCCCCC(=O)OCCCC1(CO)C/C(=C/CC(C(C)C)C(C)C)C(=O)O1		CHEMBL160544	=	Ki	nM	736.0	CHEMBL299	Homo sapiens	Ki	nM	736.0
	976336	CHEMBL769621	Displacement of [20-3H] phorbol 12,13-dibutyrate from protein kinase C alpha	B	O=C(OC[C@H](CO)OC(=O)C12CC3CC(CC(C3)C1)C2)C12CC3CC(CC(C3)C1)C2		CHEMBL345343	=	Ki	nM	38.7	CHEMBL299	Homo sapiens	Ki	nM	38.7
	976383	CHEMBL763596	Inhibition of protein kinase C alpha	B	COCc1cc(O)c(O)c(O)c1-c1c(COC)cc(O)c(O)c1O		CHEMBL59451	=	IC50	nM	43000.0	CHEMBL299	Homo sapiens	IC50	uM	43.0
	980592	CHEMBL769623	Displacement of [20-3H]-phorbol 12,13-dibutyrate (PDBU) from protein kinase C alpha with phosphatidylserine	B	CCCCCCCCCOC(=O)CC1(CO)C/C(=C/CC(C(C)C)C(C)C)C(=O)O1		CHEMBL443035	=	Ki	nM	55.7	CHEMBL299	Homo sapiens	Ki	nM	55.7
	990889	CHEMBL759470	Inhibition of protein kinase C alpha	B	O=C(N[C@@H]1c2ccccc2CC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL177308	=	IC50	nM	160.0	CHEMBL299	Homo sapiens	IC50	uM	0.16
	993182	CHEMBL759470	Inhibition of protein kinase C alpha	B	O=C(N[C@@H]1CNCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL177635	=	IC50	nM	22.0	CHEMBL299	Homo sapiens	IC50	uM	0.022
	995774	CHEMBL759470	Inhibition of protein kinase C alpha	B	O=C(N[C@@H]1Cc2ccccc2C1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL367162	=	IC50	nM	70.0	CHEMBL299	Homo sapiens	IC50	uM	0.07
	995845	CHEMBL767023	Inhibition of Protein kinase C alpha	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@@H](N)CC3)nc21		CHEMBL173459	=	IC50	nM	38500.0	CHEMBL299	Homo sapiens	IC50	uM	38.5
	1001891	CHEMBL767707	Inhibition of protein kinase C alpha	B	O=C(NC1CNCCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL49354	=	IC50	nM	370.0	CHEMBL299	Homo sapiens	IC50	uM	0.37
	1003154	CHEMBL767023	Inhibition of Protein kinase C alpha	B	CCn1cnc2c(Nc3cccc(C(F)(F)F)c3)nc(NCCN)nc21.Cl		CHEMBL534909	=	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	1003159	CHEMBL767023	Inhibition of Protein kinase C alpha	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	IC50	nM	13500.0	CHEMBL299	Homo sapiens	IC50	uM	13.5
	1003164	CHEMBL767023	Inhibition of Protein kinase C alpha	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CCC[C@@H](N)C3)nc21		CHEMBL368278	=	IC50	nM	6000.0	CHEMBL299	Homo sapiens	IC50	uM	6.0
	1004348	CHEMBL759470	Inhibition of protein kinase C alpha	B	O=C(N[C@@H]1CCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL427118	=	IC50	nM	40.0	CHEMBL299	Homo sapiens	IC50	uM	0.04
	1004356	CHEMBL759470	Inhibition of protein kinase C alpha	B	O=C(N[C@H]1c2ccccc2CC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL367457	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	1004486	CHEMBL767707	Inhibition of protein kinase C alpha	B	O=C(N[C@H]1CNCCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL367488	=	IC50	nM	3000.0	CHEMBL299	Homo sapiens	IC50	uM	3.0
	1004507	CHEMBL767023	Inhibition of Protein kinase C alpha	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N3CCC[C@@H]3CO)nc21		CHEMBL366734	=	IC50	nM	38500.0	CHEMBL299	Homo sapiens	IC50	uM	38.5
	1005820	CHEMBL759470	Inhibition of protein kinase C alpha	B	O=C(N[C@@H]1c2ccccc2C[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL444877	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	1005898	CHEMBL767023	Inhibition of Protein kinase C alpha	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(NCCN)nc21		CHEMBL173647	=	IC50	nM	31500.0	CHEMBL299	Homo sapiens	IC50	uM	31.5
	1010792	CHEMBL767023	Inhibition of Protein kinase C alpha	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	IC50	nM	30000.0	CHEMBL299	Homo sapiens	IC50	uM	30.0
	1014349	CHEMBL759470	Inhibition of protein kinase C alpha	B	O=C(N[C@@H]1c2ccccc2C[C@@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL367127	=	IC50	nM	290.0	CHEMBL299	Homo sapiens	IC50	uM	0.29
	1017308	CHEMBL767707	Inhibition of protein kinase C alpha	B	O=C(N[C@@H]1CNCCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL311399	=	IC50	nM	30.0	CHEMBL299	Homo sapiens	IC50	uM	0.03
	1019166	CHEMBL767033	Inhibition of Protein kinase C alpha	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	IC50	nM	33.0	CHEMBL299	Homo sapiens	IC50	uM	0.033
	1021682	CHEMBL767033	Inhibition of Protein kinase C alpha	B	CN(C)CCCn1cc(C2=C(c3cn(C)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL268769	=	IC50	nM	20.0	CHEMBL299	Homo sapiens	IC50	uM	0.02
	1024837	CHEMBL767023	Inhibition of Protein kinase C alpha	B	CCn1cnc2c(Nc3cccc(C#N)c3)nc(NCCN)nc21.Cl		CHEMBL557975	=	IC50	nM	78000.0	CHEMBL299	Homo sapiens	IC50	uM	78.0
	1034889	CHEMBL769587	Inhibition of Protein kinase C alpha at 10 uM	B	COc1ccc(C2=C(Nc3cccc(Cl)c3)C(=O)NC2=O)cc1		CHEMBL158208	=	Inhibition	%	8.0	CHEMBL299	Homo sapiens	Inhibition	%	8.0
	1036284	CHEMBL769587	Inhibition of Protein kinase C alpha at 10 uM	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Inhibition	%	30.0	CHEMBL299	Homo sapiens	Inhibition	%	30.0
	1048350	CHEMBL769587	Inhibition of Protein kinase C alpha at 10 uM	B	COc1ccccc1C1=C(N2CCc3ccccc32)C(=O)NC1=O		CHEMBL160585	=	Inhibition	%	28.0	CHEMBL299	Homo sapiens	Inhibition	%	28.0
	1055596	CHEMBL769587	Inhibition of Protein kinase C alpha at 10 uM	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160586	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	Inhibition	%	0.0
	1058282	CHEMBL769587	Inhibition of Protein kinase C alpha at 10 uM	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156379	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	Inhibition	%	0.0
	1109692	CHEMBL769622	Binding affinity for Protein kinase C alpha C1a or C1b domain	B	CC(C)CC(C/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O)CC(C)C		CHEMBL137386	=	Ki	nM	4.51	CHEMBL299	Homo sapiens	Ki	nM	4.51
	1138838	CHEMBL769622	Binding affinity for Protein kinase C alpha C1a or C1b domain	B	CC(C)CC(C/C=C1\CC(CO)(CN(O)C(=O)C(C)(C)C)OC1=O)CC(C)C		CHEMBL135779	=	Ki	nM	6790.0	CHEMBL299	Homo sapiens	Ki	nM	6790.0
	1140232	CHEMBL769622	Binding affinity for Protein kinase C alpha C1a or C1b domain	B	CC(C)CC(C/C=C1/CC(CO)(COC(=O)C(C)(C)C)OC1=O)CC(C)C		CHEMBL96766	=	Ki	nM	2.9	CHEMBL299	Homo sapiens	Ki	nM	2.9
	1141502	CHEMBL769622	Binding affinity for Protein kinase C alpha C1a or C1b domain	B	CC(C)CC(C/C=C1/CC(CO)(CN(O)C(=O)C(C)(C)C)OC1=O)CC(C)C		CHEMBL94505	=	Ki	nM	6980.0	CHEMBL299	Homo sapiens	Ki	nM	6980.0
	1143390	CHEMBL769615	Displacement of phorbol 12,13-dibutyrate (PDBU) from recombinant Protein kinase C alpha	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL27266	=	Ki	nM	11.0	CHEMBL299	Homo sapiens	Ki	nM	11.0
	1143391	CHEMBL769615	Displacement of phorbol 12,13-dibutyrate (PDBU) from recombinant Protein kinase C alpha	B	CCCCCCCCC#Cc1ccc2c(c1)C[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL6453	=	Ki	nM	15.0	CHEMBL299	Homo sapiens	Ki	nM	15.0
	1144371	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	Nc1ccc(Nc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1		CHEMBL332612	>	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	uM	1.0
	1144379	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	O=[N+]([O-])c1cccc(-c2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)c1		CHEMBL118904	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	1145607	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	c1ccc(Nc2nc[nH]c3nnc(Nc4ccccc4)c2-3)cc1		CHEMBL332333	=	IC50	nM	6900.0	CHEMBL299	Homo sapiens	IC50	uM	6.9
	1145614	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	Nc1cccc(-c2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)c1		CHEMBL332882	=	IC50	nM	1500.0	CHEMBL299	Homo sapiens	IC50	uM	1.5
	1146032	CHEMBL769615	Displacement of phorbol 12,13-dibutyrate (PDBU) from recombinant Protein kinase C alpha	B	CC(C)[C@H]1C(=O)N[C@H](CO)c2ccccc2N1C	Outside typical range	CHEMBL283673	=	Ki	nM	127000.0	CHEMBL299	Homo sapiens	Ki	uM	127.0
	1146408	CHEMBL768516	Inhibition of Protein kinase C alpha	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCO[C@H](CN1CCCC1)CCn1cc2c2ccccc21		CHEMBL419866	=	IC50	nM	3500.0	CHEMBL299	Homo sapiens	IC50	uM	3.5
	1148292	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	COc1cccc(Nc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)c1		CHEMBL120979	=	IC50	nM	4700.0	CHEMBL299	Homo sapiens	IC50	uM	4.7
	1148917	CHEMBL768516	Inhibition of Protein kinase C alpha	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	45.0	CHEMBL299	Homo sapiens	IC50	uM	0.045
	1149520	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	Nc1ncnc2c1c(-c1ccccc1)nn2-c1ccccc1		CHEMBL122243	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1149526	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	COc1ccc(CNc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1		CHEMBL122245	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1150225	CHEMBL769619	Displacement of [3H-20] phorbol 12,13-dibutyrate(PDBU) from recombinant Protein kinase C alpha	B	CCCCCCCCCCCCCC(=O)O[C@@H](CO)[C@H]1CCC(=O)O1		CHEMBL344779	=	Ki	nM	28000.0	CHEMBL299	Homo sapiens	Ki	uM	28.0
	1151422	CHEMBL768516	Inhibition of Protein kinase C alpha	B	CNC[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL311543	=	IC50	nM	240.0	CHEMBL299	Homo sapiens	IC50	uM	0.24
	1151455	CHEMBL769619	Displacement of [3H-20] phorbol 12,13-dibutyrate(PDBU) from recombinant Protein kinase C alpha	B	CCCCCCCCCCCCCCOC(=O)C[C@@]1(CCO)COC(=O)C1		CHEMBL145502	=	Ki	nM	18400.0	CHEMBL299	Homo sapiens	Ki	uM	18.4
	1152555	CHEMBL769619	Displacement of [3H-20] phorbol 12,13-dibutyrate(PDBU) from recombinant Protein kinase C alpha	B	CCCCCCCCCCCCCCOC(=O)C[C@]1(CCO)COC(=O)C1		CHEMBL144316	=	Ki	nM	10400.0	CHEMBL299	Homo sapiens	Ki	uM	10.4
	1153157	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	CN(C)c1ccc(Nc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1		CHEMBL332765	=	IC50	nM	2900.0	CHEMBL299	Homo sapiens	IC50	uM	2.9
	1153570	CHEMBL769615	Displacement of phorbol 12,13-dibutyrate (PDBU) from recombinant Protein kinase C alpha	B	CCCCCCCCC#Cc1ccc2c(c1)[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL28567	=	Ki	nM	21000.0	CHEMBL299	Homo sapiens	Ki	uM	21.0
	1153804	CHEMBL768516	Inhibition of Protein kinase C alpha	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	IC50	nM	360.0	CHEMBL299	Homo sapiens	IC50	uM	0.36
	1155869	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	Clc1cccc(Nc2[nH]cnc3nnc(NCc4ccccc4)c2-3)c1		CHEMBL121796	=	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	1156614	CHEMBL769619	Displacement of [3H-20] phorbol 12,13-dibutyrate(PDBU) from recombinant Protein kinase C alpha	B	CCCCCCCCCCCCCCOC(=O)C[C@@]1(CO)COC(=O)C1		CHEMBL148405	=	Ki	nM	16900.0	CHEMBL299	Homo sapiens	Ki	uM	16.9
	1157758	CHEMBL769618	Displacement of [3H-20] phorbol 12,13-dibutyrate(PDBU) from recombinant Protein kinase C alpha	B	CCCCCCCCCCCCCC(=O)O[C@@H](CO)[C@@H]1CCC(=O)O1		CHEMBL359399	=	Ki	nM	1070.0	CHEMBL299	Homo sapiens	Ki	uM	1.07
	1158330	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	Nc1[nH]cnc2nnc(Nc3cccc(Cl)c3)c1-2		CHEMBL121190	=	IC50	nM	24000.0	CHEMBL299	Homo sapiens	IC50	uM	24.0
	1158337	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	Oc1cccc(-c2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)c1		CHEMBL331906	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	1158345	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	Nc1ccc(-c2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1		CHEMBL332906	=	IC50	nM	3600.0	CHEMBL299	Homo sapiens	IC50	uM	3.6
	1161778	CHEMBL768516	Inhibition of Protein kinase C alpha	B	CN1CCN(C[C@@H]2CCn3cc(c4ccccc43)C3=C(C(=O)NC3=O)c3cn(c4ccccc34)CCO2)CC1		CHEMBL91959	=	IC50	nM	1800.0	CHEMBL299	Homo sapiens	IC50	uM	1.8
	1161789	CHEMBL768516	Inhibition of Protein kinase C alpha	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCO[C@H](CN1CCOCC1)CCn1cc2c2ccccc21		CHEMBL315357	=	IC50	nM	3500.0	CHEMBL299	Homo sapiens	IC50	uM	3.5
	1162566	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	Nc1nc(N)c2c(Nc3cccc(Cl)c3)[nH]nc2n1		CHEMBL122068	=	IC50	nM	24000.0	CHEMBL299	Homo sapiens	IC50	uM	24.0
	1162573	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	Clc1cccc(CNc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)c1		CHEMBL333231	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	1162581	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	COc1ccc(-c2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1		CHEMBL332971	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	1163291	CHEMBL768516	Inhibition of Protein kinase C alpha	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCO[C@H](CNCc1ccccc1)CCn1cc2c2ccccc21		CHEMBL328229	=	IC50	nM	6300.0	CHEMBL299	Homo sapiens	IC50	uM	6.3
	1166652	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	CC(C)(C)OC(=O)Nc1ccc(Nc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1		CHEMBL120703	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	1167951	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	COc1cccc(CNc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)c1		CHEMBL123189	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1168339	CHEMBL769615	Displacement of phorbol 12,13-dibutyrate (PDBU) from recombinant Protein kinase C alpha	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2ccccc2N1C		CHEMBL267144	=	Ki	nM	334.0	CHEMBL299	Homo sapiens	Ki	nM	334.0
	1168631	CHEMBL768516	Inhibition of Protein kinase C alpha	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCO[C@H](CNS(=O)(=O)c1ccccc1)CCn1cc2c2ccccc21		CHEMBL315389	>	IC50	nM	5000.0	CHEMBL299	Homo sapiens	IC50	uM	5.0
	1169281	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	CC(C)(C)OC(=O)Nc1ccc(-c2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1		CHEMBL420885	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	1169289	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	Clc1cccc(Nc2[nH]nc3ncnc(Oc4cccc(Cl)c4)c23)c1		CHEMBL334026	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
Not Active	1169684	CHEMBL769616	Displacement of phorbol 12,13-dibutyrate (PDBU) from recombinant Protein kinase C alpha (Inactive at 300 nM)	B	CC(C)[C@H]1C(=O)N[C@@H](CO)c2ccccc2N1C		CHEMBL2114362		Ki	nM		CHEMBL299	Homo sapiens	Ki	nM	
	1169943	CHEMBL768516	Inhibition of Protein kinase C alpha	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCO[C@H](CO)CCn1cc2c2ccccc21		CHEMBL292495	=	IC50	nM	720.0	CHEMBL299	Homo sapiens	IC50	uM	0.72
	1171618	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	Clc1cccc(Nc2nc[nH]c3nnc(Nc4cccc(Cl)c4)c2-3)c1		CHEMBL333038	=	IC50	nM	5900.0	CHEMBL299	Homo sapiens	IC50	uM	5.9
	1171629	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	Clc1cccc(Nc2[nH]nc3ncnc(NCc4ccccc4)c23)c1		CHEMBL119982	=	IC50	nM	4500.0	CHEMBL299	Homo sapiens	IC50	uM	4.5
	1173029	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	Clc1cccc(Nc2[nH]nc3ncnc(Nc4cccc(Br)c4)c23)c1		CHEMBL120319	=	IC50	nM	3800.0	CHEMBL299	Homo sapiens	IC50	uM	3.8
	1174287	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	Clc1cccc(Nc2[nH]nc3ncnc(Nc4ccccc4)c23)c1		CHEMBL121260	=	IC50	nM	7800.0	CHEMBL299	Homo sapiens	IC50	uM	7.8
	1174294	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	Oc1cccc(Nc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)c1		CHEMBL121954	=	IC50	nM	560.0	CHEMBL299	Homo sapiens	IC50	uM	0.56
	1179477	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	COc1ccc(Nc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1		CHEMBL122411	=	IC50	nM	19000.0	CHEMBL299	Homo sapiens	IC50	uM	19.0
	1179485	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL29197	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1180280	CHEMBL768516	Inhibition of Protein kinase C alpha	B	NC[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL316239	=	IC50	nM	1100.0	CHEMBL299	Homo sapiens	IC50	uM	1.1
	1182245	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	Oc1ccc(Nc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1		CHEMBL122182	>	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	uM	1.0
	1182929	CHEMBL769619	Displacement of [3H-20] phorbol 12,13-dibutyrate(PDBU) from recombinant Protein kinase C alpha	B	CCCCCCCCCCCCCCOC(=O)C[C@]1(CCO)COC(=O)C1		CHEMBL144316	=	Ki	nM	24100.0	CHEMBL299	Homo sapiens	Ki	uM	24.1
	1183558	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	Cc1cccc(Nc2[nH]cnc3nnc(Nc4cccc(Cl)c4)c2-3)c1		CHEMBL120069	=	IC50	nM	4700.0	CHEMBL299	Homo sapiens	IC50	uM	4.7
	1183569	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	Clc1cccc(Nc2[nH]cnc3nnc(-c4ccccc4)c2-3)c1		CHEMBL119977	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	1183577	CHEMBL767705	Inhibitory activity against protein kinase C alpha tyrosine kinase.	B	Oc1ccc(-c2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1		CHEMBL118130	=	IC50	nM	1850.0	CHEMBL299	Homo sapiens	IC50	uM	1.85
	1187115	CHEMBL760367	Binding affinity for PKC alpha (C1b domain)	B	CC1=CC[C@H](C)C(C)(C)[C@@H]1/C=C/C(C)=C\CC[C@@]1(CO)[C@H](CCCO)/C(=C(/C)C=O)CC[C@]1(C)O		CHEMBL339911	=	Ki	nM	75.6	CHEMBL299	Homo sapiens	Ki	nM	75.6
	1189626	CHEMBL873409	Displacement of [3H]PDBu from protein kinase C alpha C1b domain	B	CCCCCCCC(=O)O[C@H]1/C(=C/C(=O)OC)CC2C[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H]3CCC[C@H](C[C@@H]4CCO[C@H](/C=C/C(C)(C)[C@]1(O)O2)O4)O3		CHEMBL46252	=	Ki	nM	125.8	CHEMBL299	Homo sapiens	Ki	nM	125.8
	1189852	CHEMBL769346	Inhibition of Protein Kinase C(PKC)	B	NN1C(=O)c2c(c3c4ccccc4[nH]c3c3[nH]c4ccccc4c23)C1=O		CHEMBL138041	=	IC50	nM	43500.0	CHEMBL299	Homo sapiens	IC50	uM	43.5
	1190075	CHEMBL767034	Inhibition of Protein kinase C alpha	B	O=C(N[C@@H]1COCCCC1OC(=O)c1ccc(C(=O)C2C(O)=CC=CC2C(=O)O)c(O)c1)c1ccc(O)cc1	Non standard unit for type	CHEMBL287775	=	IC50		6.7	CHEMBL299	Homo sapiens	IC50		6.7
	1190957	CHEMBL769346	Inhibition of Protein Kinase C(PKC)	B	O=CNN1C(=O)c2c(c3c4ccccc4[nH]c3c3[nH]c4ccccc4c23)C1=O		CHEMBL343990	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1192002	CHEMBL873409	Displacement of [3H]PDBu from protein kinase C alpha C1b domain	B	CCCCCCCC(=O)O[C@H]1/C(=C/C(=O)OC)CC2C[C@H]([C@@H](C)O)OC(=O)C[C@@H](O)C[C@@H]3CCC[C@H](C[C@@H]4CCO[C@H](/C=C/C(C)(C)[C@]1(O)O2)O4)O3		CHEMBL46053	>	Ki	nM	500.0	CHEMBL299	Homo sapiens	Ki	nM	500.0
	1192279	CHEMBL769346	Inhibition of Protein Kinase C(PKC)	B	O=C1NC(=O)c2c1c1c3cccc(Cl)c3[nH]c1c1[nH]c3c(Cl)cccc3c21		CHEMBL139517	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1192286	CHEMBL769346	Inhibition of Protein Kinase C(PKC)	B	O=C1c2c(c3c4ccccc4[nH]c3c3[nH]c4ccccc4c23)C(=O)N1O		CHEMBL140891	=	IC50	nM	79200.0	CHEMBL299	Homo sapiens	IC50	uM	79.2
	1192462	CHEMBL767034	Inhibition of Protein kinase C alpha	B	O=C(N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1	Non standard unit for type	CHEMBL60254	=	IC50		0.074	CHEMBL299	Homo sapiens	IC50		0.074
	1193501	CHEMBL769346	Inhibition of Protein Kinase C(PKC)	B	COC1C(CO)OC(n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)C(=O)N(N)C4=O)C(O)C1O		CHEMBL137842	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1196055	CHEMBL769346	Inhibition of Protein Kinase C(PKC)	B	COC1C(CO)OC(n2c3c(Cl)cccc3c3c4c(c5c6cccc(Cl)c6[nH]c5c32)C(=O)N(N)C4=O)C(O)C1O		CHEMBL138757	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1196062	CHEMBL769346	Inhibition of Protein Kinase C(PKC)	B	COC1C(CO)OC(n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)C(=O)N(O)C4=O)C(O)C1O		CHEMBL335373	=	IC50	nM	40000.0	CHEMBL299	Homo sapiens	IC50	uM	40.0
	1197024	CHEMBL873409	Displacement of [3H]PDBu from protein kinase C alpha C1b domain	B	CCCCCCCC(=O)O[C@H]1/C(=C/C(=O)OC)CC2C[C@H]([C@@H](C)O)OC(=O)C[C@H](O)CCO[C@H](C(C)(C)C)C[C@@H]3CCO[C@H](/C=C/C(C)(C)[C@]1(O)O2)O3		CHEMBL45053	>	Ki	nM	500.0	CHEMBL299	Homo sapiens	Ki	nM	500.0
	1198872	CHEMBL767034	Inhibition of Protein kinase C alpha	B	O=C(N[C@@H]1CS(=O)(=O)CCCC1OC(=O)c1ccc(C(=O)C2C(O)=CC=CC2C(=O)O)c(O)c1)c1ccc(O)cc1	Non standard unit for type	CHEMBL38575	=	IC50		9.6	CHEMBL299	Homo sapiens	IC50		9.6
	1202751	CHEMBL769346	Inhibition of Protein Kinase C(PKC)	B	O=C1NC(O)c2c1c1c3cccc(Cl)c3[nH]c1c1[nH]c3c(Cl)cccc3c21		CHEMBL422107	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1204061	CHEMBL769346	Inhibition of Protein Kinase C(PKC)	B	COC1C(CO)OC(n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)C(O)C1O		CHEMBL337535	=	IC50	nM	3700.0	CHEMBL299	Homo sapiens	IC50	uM	3.7
	1206986	CHEMBL767034	Inhibition of Protein kinase C alpha	B	O=C(N[C@@H]1CSCCCC1OC(=O)c1ccc(C(=O)C2C(O)=CC=CC2C(=O)O)c(O)c1)c1ccc(O)cc1	Non standard unit for type	CHEMBL38726	=	IC50		3.3	CHEMBL299	Homo sapiens	IC50		3.3
	1208024	CHEMBL769346	Inhibition of Protein Kinase C(PKC)	B	O=C1NCc2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL16958	=	IC50	nM	2450.0	CHEMBL299	Homo sapiens	IC50	uM	2.45
	1208043	CHEMBL769346	Inhibition of Protein Kinase C(PKC)	B	NN1C(=O)c2c(c3c4cccc(Cl)c4[nH]c3c3[nH]c4c(Cl)cccc4c23)C1=O		CHEMBL335122	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1209334	CHEMBL769346	Inhibition of Protein Kinase C(PKC)	B	O=CNN1C(=O)c2c(c3c4cccc(Cl)c4[nH]c3c3[nH]c4c(Cl)cccc4c23)C1=O		CHEMBL139266	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1210621	CHEMBL769346	Inhibition of Protein Kinase C(PKC)	B	NNC(=O)NN1C(=O)c2c(c3c4ccccc4[nH]c3c3[nH]c4ccccc4c23)C1=O		CHEMBL142141	=	IC50	nM	78000.0	CHEMBL299	Homo sapiens	IC50	uM	78.0
	1212063	CHEMBL769346	Inhibition of Protein Kinase C(PKC)	B	COC1C(CO)OC(n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)C(=O)N(NC=O)C4=O)C(O)C1O		CHEMBL137907	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1214205	CHEMBL762312	Displacement of [3H]PDBu from Protein kinase C alpha C1b domain	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Kd	nM	46.7	CHEMBL299	Homo sapiens	Kd	nM	46.7
	1214523	CHEMBL769346	Inhibition of Protein Kinase C(PKC)	B	O=C1NC(O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL127277	=	IC50	nM	22100.0	CHEMBL299	Homo sapiens	IC50	uM	22.1
	1215935	CHEMBL769346	Inhibition of Protein Kinase C(PKC)	B	COC1C(CO)OC(n2c3c(Cl)cccc3c3c4c(c5c6cccc(Cl)c6[nH]c5c32)C(=O)N(O)C4=O)C(O)C1O		CHEMBL138039	=	IC50	nM	68000.0	CHEMBL299	Homo sapiens	IC50	uM	68.0
	1218573	CHEMBL769346	Inhibition of Protein Kinase C(PKC)	B	CO[C@@H]1[C@@H](CO)O[C@@H](n2c3ccccc3c3c4c(c5c6ccccc6[nH]c5c32)C(=O)NC4=O)[C@H](O)[C@H]1O		CHEMBL3350557	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1218580	CHEMBL769346	Inhibition of Protein Kinase C(PKC)	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL268368	=	IC50	nM	44700.0	CHEMBL299	Homo sapiens	IC50	uM	44.7
	1219925	CHEMBL769346	Inhibition of Protein Kinase C(PKC)	B	CO[C@@H]1[C@@H](CO)O[C@@H](n2c3c(Cl)cccc3c3c4c(c5c6cccc(Cl)c6[nH]c5c32)C(=O)NC4=O)[C@H](O)[C@H]1O		CHEMBL370100	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1219944	CHEMBL769346	Inhibition of Protein Kinase C(PKC)	B	COC1C(CO)OC(n2c3c(Cl)cccc3c3c4c(c5c6cccc(Cl)c6[nH]c5c32)C(=O)N(NC=O)C4=O)C(O)C1O		CHEMBL138203	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1220020	CHEMBL769346	Inhibition of Protein Kinase C(PKC)	B	O=C1c2c(c3c4ccccc4[nH]c3c3[nH]c4ccccc4c23)C(=O)N1CCO		CHEMBL435422	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1220112	CHEMBL767034	Inhibition of Protein kinase C alpha	B	O=C(N[C@@H]1CCCCCC1OC(=O)c1ccc(C(=O)C2C(O)=CC=CC2C(=O)O)c(O)c1)c1ccc(O)cc1	Non standard unit for type	CHEMBL38655	=	IC50		0.27	CHEMBL299	Homo sapiens	IC50		0.27
	1221149	CHEMBL769346	Inhibition of Protein Kinase C(PKC)	B	O=C1NCc2c1c1c3cccc(Cl)c3[nH]c1c1[nH]c3c(Cl)cccc3c21		CHEMBL335822	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1222422	CHEMBL760367	Binding affinity for PKC alpha (C1b domain)	B	C=C(/C=C/C=C(/CCC=C(C)C)COC(C)=O)[C@@H]1CC[C@]2([C@H](CCCO)/C(=C(/C)C=O)CC[C@]2(C)O)[C@@H]1O		CHEMBL123519	=	Ki	nM	83.6	CHEMBL299	Homo sapiens	Ki	nM	83.6
	1225098	CHEMBL769346	Inhibition of Protein Kinase C(PKC)	B	COC1C(CO)OC(n2c3c(Cl)cccc3c3c4c(c5c6cccc(Cl)c6[nH]c5c32)CNC4=O)C(O)C1O		CHEMBL343788	=	IC50	nM	28800.0	CHEMBL299	Homo sapiens	IC50	uM	28.8
	1227203	CHEMBL772072	Inhibition of [20-3H]phorbol-12,13-dibutyrate (PDBU) binding to protein kinase C (alpha)	B	CCCCCCCCCCCCCC[C@H]1C(=O)O[C@@H](CO)[C@@H]1OC(C)=O		CHEMBL12988	=	Ki	nM	500.0	CHEMBL299	Homo sapiens	Ki	uM	0.5
	1228423	CHEMBL759069	Inhibition of protein kinase C alpha	B	O=C(NC1CCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL48636	=	IC50	nM	40.0	CHEMBL299	Homo sapiens	IC50	uM	0.04
	1233139	CHEMBL759069	Inhibition of protein kinase C alpha	B	O=C(NC1CNCCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL49354	=	IC50	nM	67.0	CHEMBL299	Homo sapiens	IC50	uM	0.067
	1239795	CHEMBL772072	Inhibition of [20-3H]phorbol-12,13-dibutyrate (PDBU) binding to protein kinase C (alpha)	B	CCCCCCCCCCCCC/C=C1\C(=O)O[C@@H](CO)[C@@H]1OC(C)=O		CHEMBL422215	=	Ki	nM	200.0	CHEMBL299	Homo sapiens	Ki	uM	0.2
	1245250	CHEMBL759069	Inhibition of protein kinase C alpha	B	O=C(OC1CNCC1Cc1ccc(O)cc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL300422	=	IC50	nM	260.0	CHEMBL299	Homo sapiens	IC50	uM	0.26
	1245259	CHEMBL759069	Inhibition of protein kinase C alpha	B	O=C(OC1CCCC1Cc1ccc(O)cc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL295806	=	IC50	nM	30.0	CHEMBL299	Homo sapiens	IC50	uM	0.03
	1250291	CHEMBL759069	Inhibition of protein kinase C alpha	B	O=C(NC1CNCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL265559	=	IC50	nM	22.0	CHEMBL299	Homo sapiens	IC50	uM	0.022
	1252603	CHEMBL772072	Inhibition of [20-3H]phorbol-12,13-dibutyrate (PDBU) binding to protein kinase C (alpha)	B	CCCCCCCCCCCCCC[C@@H]1C(=O)O[C@@H](CO)[C@@H]1OC(C)=O		CHEMBL13221	=	Ki	nM	600.0	CHEMBL299	Homo sapiens	Ki	uM	0.6
	1255028	CHEMBL759069	Inhibition of protein kinase C alpha	B	O=C(NC1CNCCCC1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL49354	=	IC50	nM	30.0	CHEMBL299	Homo sapiens	IC50	uM	0.03
	1256469	CHEMBL759069	Inhibition of protein kinase C alpha	B	O=C(OC1CCCC1Oc1ccc(O)cc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL48988	=	IC50	nM	220.0	CHEMBL299	Homo sapiens	IC50	uM	0.22
	1259044	CHEMBL759069	Inhibition of protein kinase C alpha	B	COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)OC2CNCC2Cc2ccc(O)cc2)cc1O		CHEMBL48546	=	IC50	nM	2200.0	CHEMBL299	Homo sapiens	IC50	uM	2.2
	1259053	CHEMBL759069	Inhibition of protein kinase C alpha	B	O=C(OC1CCCC1Cc1ccc(O)cc1)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1		CHEMBL295806	=	IC50	nM	160.0	CHEMBL299	Homo sapiens	IC50	uM	0.16
	1261393	CHEMBL772072	Inhibition of [20-3H]phorbol-12,13-dibutyrate (PDBU) binding to protein kinase C (alpha)	B	CCCCCCCCCCCCC/C=C1/C(=O)O[C@@H](CO)[C@@H]1OC(C)=O		CHEMBL13306	=	Ki	nM	300.0	CHEMBL299	Homo sapiens	Ki	uM	0.3
	1265099	CHEMBL759069	Inhibition of protein kinase C alpha	B	COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(C(=O)OC2CCCC2Cc2ccc(O)cc2)cc1O		CHEMBL48665	=	IC50	nM	1400.0	CHEMBL299	Homo sapiens	IC50	uM	1.4
	1269306	CHEMBL768375	Inhibition of human Protein kinase C alpha	B	O=C(N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL60254	=	IC50	nM	70.0	CHEMBL299	Homo sapiens	IC50	uM	0.07
	1269314	CHEMBL768375	Inhibition of human Protein kinase C alpha	B	O=C(N[C@@H]1CCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL52529	=	IC50	nM	40.0	CHEMBL299	Homo sapiens	IC50	uM	0.04
	1269322	CHEMBL768375	Inhibition of human Protein kinase C alpha	B	NC[C@@H]1C[C@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL67290	=	IC50	nM	20.0	CHEMBL299	Homo sapiens	IC50	uM	0.02
	1271116	CHEMBL767030	Inhibition of Protein kinase C alpha	B	Clc1cccc(Nc2ncnc3[nH]c4ccccc4c23)c1		CHEMBL306315	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1272222	CHEMBL767030	Inhibition of Protein kinase C alpha	B	c1ccc(Nc2ncnc3[nH]c4c(c23)CCCC4)cc1		CHEMBL433305	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1275865	CHEMBL768375	Inhibition of human Protein kinase C alpha	B	O=C(N[C@H]1C[C@@H](CO)C[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL431955	=	IC50	nM	80.0	CHEMBL299	Homo sapiens	IC50	uM	0.08
	1276125	CHEMBL767030	Inhibition of Protein kinase C alpha	B	Cc1cccc(Nc2ncnc3[nH]c4c(c23)CCCC4)c1		CHEMBL307062	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1278517	CHEMBL768375	Inhibition of human Protein kinase C alpha	B	O=C(N[C@@H]1CNC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL59828	=	IC50	nM	22.0	CHEMBL299	Homo sapiens	IC50	uM	0.022
	1279710	CHEMBL768375	Inhibition of human Protein kinase C alpha	B	O=C(N[C@H]1C[C@H](CO)C[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL306427	=	IC50	nM	10.0	CHEMBL299	Homo sapiens	IC50	uM	0.01
	1280021	CHEMBL767030	Inhibition of Protein kinase C alpha	B	Brc1cccc(Nc2ncnc3[nH]c4c(c23)CCCC4)c1		CHEMBL72393	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1285810	CHEMBL768375	Inhibition of human Protein kinase C alpha	B	N[C@@H]1C[C@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL417051	=	IC50	nM	20.0	CHEMBL299	Homo sapiens	IC50	uM	0.02
	1288834	CHEMBL767030	Inhibition of Protein kinase C alpha	B	Clc1cccc(Nc2ncnc3[nH]c4c(c23)CCCC4)c1		CHEMBL75177	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1298451	CHEMBL767030	Inhibition of Protein kinase C alpha	B	Cc1[nH]c2ncnc(Nc3ccccc3)c2c1C		CHEMBL75049	=	IC50	nM	75000.0	CHEMBL299	Homo sapiens	IC50	uM	75.0
	1298458	CHEMBL767030	Inhibition of Protein kinase C alpha	B	Cc1[nH]c2ncnc(Nc3cccc(Cl)c3)c2c1C		CHEMBL306081	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1300776	CHEMBL768375	Inhibition of human Protein kinase C alpha	B	O=C(N[C@H]1C[C@H](O)C[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL67716	=	IC50	nM	50.0	CHEMBL299	Homo sapiens	IC50	uM	0.05
	1300784	CHEMBL768375	Inhibition of human Protein kinase C alpha	B	O=C(N[C@H]1C[C@@H](O)C[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1.O=C(N[C@H]1C[C@H](O)C[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL1794808	=	IC50	nM	40.0	CHEMBL299	Homo sapiens	IC50	uM	0.04
	1301112	CHEMBL767030	Inhibition of Protein kinase C alpha	B	Cc1[nH]c2ncnc(Nc3cccc(Br)c3)c2c1C		CHEMBL74722	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1302359	CHEMBL767030	Inhibition of Protein kinase C alpha	B	Cc1cccc(Nc2ncnc3[nH]c(C)c(C)c23)c1		CHEMBL307026	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1305091	CHEMBL768375	Inhibition of human Protein kinase C alpha	B	NC[C@H]1C[C@H](NC(=O)c2ccc(O)cc2)[C@H](OC(=O)c2cc(O)c(C(=O)c3c(O)cccc3C(=O)O)c(O)c2)C1		CHEMBL421866	=	IC50	nM	20.0	CHEMBL299	Homo sapiens	IC50	uM	0.02
	1305401	CHEMBL767030	Inhibition of Protein kinase C alpha	B	Cc1[nH]c2ncnc(Nc3cccc(F)c3)c2c1C		CHEMBL308582	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1306873	CHEMBL767030	Inhibition of Protein kinase C alpha	B	Cc1c(-c2ccccc2)[nH]c2ncnc(Nc3cccc(Cl)c3)c12		CHEMBL311129	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1403554	CHEMBL827979	Inhibition of human Protein kinase C alpha using [gamma-33P]-ATP	B	C=Cn1cc(C2=C(c3nn(CCCN(C)C)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL368193	=	IC50	nM	250.0	CHEMBL299	Homo sapiens	IC50	uM	0.25
	1403559	CHEMBL827979	Inhibition of human Protein kinase C alpha using [gamma-33P]-ATP	B	CN(C)CCCn1nc(C2=C(c3cn(-c4ccccc4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL366668	=	IC50	nM	150.0	CHEMBL299	Homo sapiens	IC50	uM	0.15
	1403574	CHEMBL827979	Inhibition of human Protein kinase C alpha using [gamma-33P]-ATP	B	CN(C)CCCn1nc(C2=C(c3cn(-c4cccs4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL178945	=	IC50	nM	220.0	CHEMBL299	Homo sapiens	IC50	uM	0.22
	1403594	CHEMBL827979	Inhibition of human Protein kinase C alpha using [gamma-33P]-ATP	B	CN(C)CCCn1nc(C2=C(c3cn(-c4cccnc4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL368416	=	IC50	nM	120.0	CHEMBL299	Homo sapiens	IC50	uM	0.12
	1403604	CHEMBL827979	Inhibition of human Protein kinase C alpha using [gamma-33P]-ATP	B	O=C1NC(=O)C(c2cn(-c3cccnc3)c3ccccc23)=C1c1[nH]nc2ccccc12		CHEMBL175956	=	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	uM	1.0
	1403619	CHEMBL827979	Inhibition of human Protein kinase C alpha using [gamma-33P]-ATP	B	CN(C)CCCn1nc(C2=C(c3cn(-c4ccc5ccccc5c4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL368895	=	IC50	nM	57.0	CHEMBL299	Homo sapiens	IC50	uM	0.057
	1403640	CHEMBL827979	Inhibition of human Protein kinase C alpha using [gamma-33P]-ATP	B	CN(C)CCCn1nc(C2=C(c3cn(-c4cccc5ccccc45)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL360304	=	IC50	nM	1200.0	CHEMBL299	Homo sapiens	IC50	uM	1.2
	1403654	CHEMBL827979	Inhibition of human Protein kinase C alpha using [gamma-33P]-ATP	B	CN(C)CCCn1nc(C2=C(c3cn(-c4cncc5ccccc45)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL359808	=	IC50	nM	290.0	CHEMBL299	Homo sapiens	IC50	uM	0.29
	1403671	CHEMBL827979	Inhibition of human Protein kinase C alpha using [gamma-33P]-ATP	B	CN(C)CCCn1nc(C2=C(c3cn(-c4cnc5ccccc5c4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL359486	=	IC50	nM	11.0	CHEMBL299	Homo sapiens	IC50	uM	0.011
	1404539	CHEMBL827979	Inhibition of human Protein kinase C alpha using [gamma-33P]-ATP	B	CN(C)CCCn1nc(C2=C(c3cn(-c4csc5ccccc45)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL426587	=	IC50	nM	610.0	CHEMBL299	Homo sapiens	IC50	uM	0.61
	1404549	CHEMBL827979	Inhibition of human Protein kinase C alpha using [gamma-33P]-ATP	B	O=C1NC(=O)C(c2nn(CCCN3CCOCC3)c3ccccc23)=C1c1cn(-c2ccc3ccccc3c2)c2ccccc12		CHEMBL367106	=	IC50	nM	260.0	CHEMBL299	Homo sapiens	IC50	uM	0.26
	1404556	CHEMBL827979	Inhibition of human Protein kinase C alpha using [gamma-33P]-ATP	B	O=C1NC(=O)C(c2nn(CCCN3CCCC3)c3ccccc23)=C1c1cn(-c2ccc3ccccc3c2)c2ccccc12		CHEMBL367107	=	IC50	nM	480.0	CHEMBL299	Homo sapiens	IC50	uM	0.48
	1404563	CHEMBL827979	Inhibition of human Protein kinase C alpha using [gamma-33P]-ATP	B	CN1CCN(CCCn2nc(C3=C(c4cn(-c5ccc6ccccc6c5)c5ccccc45)C(=O)NC3=O)c3ccccc32)CC1		CHEMBL175845	=	IC50	nM	320.0	CHEMBL299	Homo sapiens	IC50	uM	0.32
	1404687	CHEMBL827979	Inhibition of human Protein kinase C alpha using [gamma-33P]-ATP	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	28.0	CHEMBL299	Homo sapiens	IC50	uM	0.028
	1406063	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Cn1cnc2c(-c3ccc(F)cc3)ncnc21		CHEMBL539424	=	Inhibition	%	8.0	CHEMBL299	Homo sapiens	Inhibition	%	8.0
	1406078	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Cn1c(-c2ccccc2)nc2c(-c3ccc(F)cc3)ncnc21		CHEMBL368896	=	Inhibition	%	17.0	CHEMBL299	Homo sapiens	Inhibition	%	17.0
	1406199	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Cn1c(-c2ccccc2)nc2c(Sc3ccccc3)ncnc21		CHEMBL367389	=	Inhibition	%	13.0	CHEMBL299	Homo sapiens	Inhibition	%	13.0
	1406214	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Cn1c(-c2ccccc2)nc2c(Sc3ccc(F)cc3)ncnc21		CHEMBL175541	=	Inhibition	%	17.0	CHEMBL299	Homo sapiens	Inhibition	%	17.0
	1406339	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	CSc1ccc(-c2nc3c(Sc4ccccc4)ncnc3n2C)cc1		CHEMBL175868	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	Inhibition	%	0.0
	1406354	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	CSc1ccc(-c2nc3c(Sc4ccc(F)cc4)ncnc3n2C)cc1		CHEMBL175619	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	Inhibition	%	0.0
	1406369	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Cn1c(-c2ccc([S+](C)[O-])cc2)nc2c(Sc3ccccc3)ncnc21		CHEMBL353740	=	Inhibition	%	8.0	CHEMBL299	Homo sapiens	Inhibition	%	8.0
	1406457	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	c1ccc(Nc2ncnc3[nH]cnc23)cc1		CHEMBL359730	=	Inhibition	%	6.0	CHEMBL299	Homo sapiens	Inhibition	%	6.0
	1406472	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Fc1ccc(Nc2[nH]cnc3ncnc2-3)cc1		CHEMBL361227	=	Inhibition	%	17.0	CHEMBL299	Homo sapiens	Inhibition	%	17.0
	1406501	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Cn1c(-c2ccc([S+](C)[O-])cc2)nc2c(Sc3ccc(F)cc3)ncnc21		CHEMBL180373	=	Inhibition	%	15.0	CHEMBL299	Homo sapiens	Inhibition	%	15.0
	1406516	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Cn1c(-c2ccc(S(C)(=O)=O)cc2)nc2c(Sc3ccccc3)ncnc21		CHEMBL177060	=	Inhibition	%	18.0	CHEMBL299	Homo sapiens	Inhibition	%	18.0
	1406604	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	c1ccc(Oc2ncnc3[nH]cnc23)cc1		CHEMBL366984	=	Inhibition	%	8.0	CHEMBL299	Homo sapiens	Inhibition	%	8.0
	1406619	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Fc1ccc(Oc2[nH]cnc3ncnc2-3)cc1		CHEMBL367695	=	Inhibition	%	3.0	CHEMBL299	Homo sapiens	Inhibition	%	3.0
	1406634	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Cn1cnc2c(Nc3ccccc3)ncnc21		CHEMBL321749	=	Inhibition	%	2.0	CHEMBL299	Homo sapiens	Inhibition	%	2.0
	1406648	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Cn1c(-c2ccc(S(C)(=O)=O)cc2)nc2c(Sc3ccc(F)cc3)ncnc21		CHEMBL367018	=	Inhibition	%	7.0	CHEMBL299	Homo sapiens	Inhibition	%	7.0
	1406663	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Cn1c(Br)nc2c(Sc3ccccc3)ncnc21		CHEMBL177289	=	Inhibition	%	5.0	CHEMBL299	Homo sapiens	Inhibition	%	5.0
	1406769	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Cn1cnc2c(Nc3ccc(F)cc3)ncnc21		CHEMBL362629	=	Inhibition	%	11.0	CHEMBL299	Homo sapiens	Inhibition	%	11.0
	1406784	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	c1ccc(Sc2ncnc3[nH]cnc23)cc1		CHEMBL175600	=	Inhibition	%	3.0	CHEMBL299	Homo sapiens	Inhibition	%	3.0
	1406902	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Fc1ccc(Sc2ncnc3[nH]cnc23)cc1		CHEMBL175603	=	Inhibition	%	9.0	CHEMBL299	Homo sapiens	Inhibition	%	9.0
	1406917	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	c1ccc(Sc2[nH]cnc3nccc2-3)cc1		CHEMBL360302	=	Inhibition	%	23.0	CHEMBL299	Homo sapiens	Inhibition	%	23.0
	1407028	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Fc1ccc(Sc2[nH]cnc3nccc2-3)cc1		CHEMBL367533	=	Inhibition	%	15.0	CHEMBL299	Homo sapiens	Inhibition	%	15.0
	1407043	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Cn1cnc2c(Sc3ccccc3)ncnc21		CHEMBL179751	=	Inhibition	%	13.0	CHEMBL299	Homo sapiens	Inhibition	%	13.0
	1407058	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Cn1cnc2c(Sc3ccc(F)cc3)ncnc21		CHEMBL175622	=	Inhibition	%	7.0	CHEMBL299	Homo sapiens	Inhibition	%	7.0
	1407163	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	c1ccc(CSc2ncnc3[nH]cnc23)cc1		CHEMBL397434	=	Inhibition	%	11.0	CHEMBL299	Homo sapiens	Inhibition	%	11.0
	1407178	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Fc1ccc(CSc2[nH]cnc3ncnc2-3)cc1		CHEMBL175451	=	Inhibition	%	4.0	CHEMBL299	Homo sapiens	Inhibition	%	4.0
	1407289	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Cn1cnc2c(SCc3ccccc3)ncnc21		CHEMBL176384	=	Inhibition	%	13.0	CHEMBL299	Homo sapiens	Inhibition	%	13.0
	1407304	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Cn1cnc2c(SCc3ccc(F)cc3)ncnc21		CHEMBL175730	=	Inhibition	%	12.0	CHEMBL299	Homo sapiens	Inhibition	%	12.0
	1407420	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	c1ccc(-[n+]2c[nH]c3ncncc32)cc1		CHEMBL175816	=	Inhibition	%	4.0	CHEMBL299	Homo sapiens	Inhibition	%	4.0
	1407435	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Fc1ccc(-[n+]2c[nH]c3ncncc32)cc1		CHEMBL175817	=	Inhibition	%	2.0	CHEMBL299	Homo sapiens	Inhibition	%	2.0
	1407451	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	c1ccc(C[n+]2c[nH]c3ncncc32)cc1		CHEMBL369622	=	Inhibition	%	18.0	CHEMBL299	Homo sapiens	Inhibition	%	18.0
	1407566	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Fc1ccc(C[n+]2c[nH]c3ncncc32)cc1		CHEMBL179515	=	Inhibition	%	15.0	CHEMBL299	Homo sapiens	Inhibition	%	15.0
	1407581	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Clc1ncnc2c1ncn2Cc1ccccc1		CHEMBL7944	=	Inhibition	%	17.0	CHEMBL299	Homo sapiens	Inhibition	%	17.0
	1407692	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Clc1ncnc2ncn(Cc3ccccc3)c12		CHEMBL368715	=	Inhibition	%	12.0	CHEMBL299	Homo sapiens	Inhibition	%	12.0
	1407707	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Fc1ccc(Cn2cnc3c(Cl)ncnc32)cc1		CHEMBL369181	=	Inhibition	%	14.0	CHEMBL299	Homo sapiens	Inhibition	%	14.0
	1407815	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Fc1ccc(Cn2cnc3ncnc(Cl)c32)cc1		CHEMBL175528	=	Inhibition	%	13.0	CHEMBL299	Homo sapiens	Inhibition	%	13.0
	1407830	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Nc1ncnc2c1ncn2Cc1ccccc1		CHEMBL266094	=	Inhibition	%	2.0	CHEMBL299	Homo sapiens	Inhibition	%	2.0
	1407845	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Nc1ncnc2c1ncn2Cc1ccc(F)cc1		CHEMBL426037	=	Inhibition	%	16.0	CHEMBL299	Homo sapiens	Inhibition	%	16.0
	1407958	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Nc1ncnc2ncn(Cc3ccc(F)cc3)c12		CHEMBL180422	=	Inhibition	%	14.0	CHEMBL299	Homo sapiens	Inhibition	%	14.0
	1407973	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	COc1ncnc2ncn(Cc3ccc(F)cc3)c12		CHEMBL368714	=	Inhibition	%	7.0	CHEMBL299	Homo sapiens	Inhibition	%	7.0
	1408088	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	c1ccc(Cc2[nH]cnc3ncnc2-3)cc1		CHEMBL367930	=	Inhibition	%	7.0	CHEMBL299	Homo sapiens	Inhibition	%	7.0
	1408103	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Fc1ccc(Cc2[nH]cnc3ncnc2-3)cc1		CHEMBL179158	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	Inhibition	%	0.0
	1408217	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Fc1ccc(/C=C/c2[nH]cnc3ncnc2-3)cc1		CHEMBL367470	=	Inhibition	%	13.0	CHEMBL299	Homo sapiens	Inhibition	%	13.0
	1408232	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Cn1cnc2c(/C=C/c3ccccc3)ncnc21		CHEMBL176186	=	Inhibition	%	7.0	CHEMBL299	Homo sapiens	Inhibition	%	7.0
	1408247	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Cn1cnc2c(-c3ccccc3)ncnc21		CHEMBL179217	=	Inhibition	%	14.0	CHEMBL299	Homo sapiens	Inhibition	%	14.0
	1408883	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Cn1c(C#CCCO)nc2c(Sc3ccccc3)ncnc21		CHEMBL177784	=	Inhibition	%	18.0	CHEMBL299	Homo sapiens	Inhibition	%	18.0
	1408898	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	c1ccc(Cn2cnc3c(Sc4ccccc4)ncnc32)cc1		CHEMBL180020	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	Inhibition	%	0.0
	1408913	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Fc1ccc(Sc2ncnc3c2ncn3Cc2ccccc2)cc1		CHEMBL179768	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	Inhibition	%	0.0
	1409023	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Fc1ccc(Cn2cnc3c(Sc4ccccc4)ncnc32)cc1		CHEMBL176245	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	Inhibition	%	0.0
	1409038	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Fc1ccc(Cn2cnc3c(Sc4ccc(F)cc4)ncnc32)cc1		CHEMBL175665	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	Inhibition	%	0.0
	1409149	CHEMBL831280	Inhibition of human Protein kinase C alpha	B	Nc1ncnc2[nH]cnc12		CHEMBL226345	=	Inhibition	%	6.0	CHEMBL299	Homo sapiens	Inhibition	%	6.0
Not Determined	1441909	CHEMBL831992	Inhibition of Protein kinase C alpha at 10 uM with 100 uM ATP	B	O=C(Nc1ncnc2oc(-c3cccnc3)cc12)C1CCCC1		CHEMBL182419		Inhibition	%		CHEMBL299	Homo sapiens	Inhibition	%	
	1442936	CHEMBL828395	In vitro inhibitory concentration against human protein kinase C alpha (PKCa) by using [gamma-33P]-ATP] as radioligand	B	Nc1nc(C2=C3C(=Nc4ccccc43)C(=O)NCC2)c(O)[nH]1		CHEMBL332551	=	IC50	nM	2539.0	CHEMBL299	Homo sapiens	IC50	nM	2539.0
	1443235	CHEMBL828395	In vitro inhibitory concentration against human protein kinase C alpha (PKCa) by using [gamma-33P]-ATP] as radioligand	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	IC50	nM	700.0	CHEMBL299	Homo sapiens	IC50	nM	700.0
Not Determined	1443242	CHEMBL830857	In vitro inhibitory concentration against human protein kinase C alpha (PKCa) by using [gamma-33P]-ATP] as radioligand; NA is value not available	B	NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1		CHEMBL255465		IC50	nM		CHEMBL299	Homo sapiens	IC50	nM	
	1451056	CHEMBL831115	Inhibitory concentration against recombinant human Protein kinase C alpha	B	Cc1cccc(NC2=C(c3cn(CCCN(C)C)c4ccccc34)C(=O)NC2=O)c1		CHEMBL369114	=	IC50	nM	727.0	CHEMBL299	Homo sapiens	IC50	nM	727.0
	1451059	CHEMBL831115	Inhibitory concentration against recombinant human Protein kinase C alpha	B	CN(C)CCCn1cc(C2=C(Nc3cccc(Cl)c3)C(=O)NC2=O)c2ccccc21		CHEMBL364337	=	IC50	nM	558.0	CHEMBL299	Homo sapiens	IC50	nM	558.0
	1451062	CHEMBL831115	Inhibitory concentration against recombinant human Protein kinase C alpha	B	O=C1NC(=O)C(c2cn(CCCN3CCCC3)c3ccccc23)=C1Nc1ccccc1		CHEMBL184042	=	IC50	nM	662.0	CHEMBL299	Homo sapiens	IC50	nM	662.0
	1451065	CHEMBL831115	Inhibitory concentration against recombinant human Protein kinase C alpha	B	O=C1NC(=O)C(c2cn(CCCN3CCCCC3)c3ccccc23)=C1Nc1ccccc1		CHEMBL187235	=	IC50	nM	726.0	CHEMBL299	Homo sapiens	IC50	nM	726.0
	1451068	CHEMBL831115	Inhibitory concentration against recombinant human Protein kinase C alpha	B	CN1CCN(CCCn2cc(C3=C(Nc4ccccc4)C(=O)NC3=O)c3ccccc32)CC1		CHEMBL184146	=	IC50	nM	968.0	CHEMBL299	Homo sapiens	IC50	nM	968.0
	1451071	CHEMBL831115	Inhibitory concentration against recombinant human Protein kinase C alpha	B	Br.N=C(N)SCCCn1cc(C2=C(Nc3ccccc3)C(=O)NC2=O)c2ccccc21		CHEMBL540357	=	IC50	nM	27.0	CHEMBL299	Homo sapiens	IC50	nM	27.0
	1451075	CHEMBL831115	Inhibitory concentration against recombinant human Protein kinase C alpha	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	IC50	nM	331.0	CHEMBL299	Homo sapiens	IC50	nM	331.0
	1452427	CHEMBL831115	Inhibitory concentration against recombinant human Protein kinase C alpha	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1Nc1ccccc1		CHEMBL183310	=	IC50	nM	7233.0	CHEMBL299	Homo sapiens	IC50	nM	7233.0
	1452440	CHEMBL831115	Inhibitory concentration against recombinant human Protein kinase C alpha	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	IC50	nM	1599.0	CHEMBL299	Homo sapiens	IC50	nM	1599.0
	1452443	CHEMBL831115	Inhibitory concentration against recombinant human Protein kinase C alpha	B	CN(C)CCn1cc(C2=C(Nc3ccccc3)C(=O)NC2=O)c2ccccc21		CHEMBL184649	=	IC50	nM	2157.0	CHEMBL299	Homo sapiens	IC50	nM	2157.0
	1452820	CHEMBL831115	Inhibitory concentration against recombinant human Protein kinase C alpha	B	CN(C)CCCn1cc(C2=C(Nc3ccccc3)C(=O)NC2=O)c2ccccc21		CHEMBL365656	=	IC50	nM	460.0	CHEMBL299	Homo sapiens	IC50	nM	460.0
	1452823	CHEMBL831115	Inhibitory concentration against recombinant human Protein kinase C alpha	B	CN(C)CCCCn1cc(C2=C(Nc3ccccc3)C(=O)NC2=O)c2ccccc21		CHEMBL184548	=	IC50	nM	730.0	CHEMBL299	Homo sapiens	IC50	nM	730.0
	1452826	CHEMBL831115	Inhibitory concentration against recombinant human Protein kinase C alpha	B	CN(C)CCCCCn1cc(C2=C(Nc3ccccc3)C(=O)NC2=O)c2ccccc21		CHEMBL184647	=	IC50	nM	2232.0	CHEMBL299	Homo sapiens	IC50	nM	2232.0
	1452829	CHEMBL831115	Inhibitory concentration against recombinant human Protein kinase C alpha	B	O=C1NC(=O)C(c2cn(CCCO)c3ccccc23)=C1Nc1ccccc1		CHEMBL185221	=	IC50	nM	1620.0	CHEMBL299	Homo sapiens	IC50	nM	1620.0
	1475824	CHEMBL830718	Percent inhibition against PKCalpha at 10 uM using 100 uM ATP	B	CCn1c(-c2nonc2N)nc2cnccc21		CHEMBL189657	=	Inhibition	%	56.0	CHEMBL299	Homo sapiens	Inhibition	%	56.0
	1479410	CHEMBL829916	Inhibition of Protein kinase C alpha (PKCalpha) at 1 uM	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Inhibition	%	4.0	CHEMBL299	Homo sapiens	Inhibition	%	4.0
	1479418	CHEMBL831994	Inhibition of Protein kinase C alpha (PKCalpha) at 50 uM	B	CN1C(=O)C(c2c[nH]c3ccccc23)=C(c2cn(CCCN)c3ccccc23)C1=O		CHEMBL188282	=	Inhibition	%	66.0	CHEMBL299	Homo sapiens	Inhibition	%	66.0
	1483090	CHEMBL835537	Percentage inhibition of Protein kinase C alpha at 50 uM	B	CN1C(=O)C(c2c[nH]c3ccccc23)=C(c2cn(CCCN)c3ccccc23)C1=O		CHEMBL188282	=	Activity	%	66.0	CHEMBL299	Homo sapiens	Activity	%	66.0
	1483102	CHEMBL835537	Percentage inhibition of Protein kinase C alpha at 50 uM	B	CCCCCNC1=C(c2cn(C)c3ccccc23)C(=O)N(C)C1=O		CHEMBL365337	=	Activity	%	95.0	CHEMBL299	Homo sapiens	Activity	%	95.0
	1489984	CHEMBL826965	Inhibition of protein kinase C alpha	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F		CHEMBL1788116	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	1512259	CHEMBL827159	Inhibition of human protein kinase C alpha	B	CONC(=O)c1cc(Nc2ncnn3cc(NC(=O)OCCCS(C)(=O)=O)c(C(C)C)c23)c(F)cc1F		CHEMBL195218	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	1512379	CHEMBL827159	Inhibition of human protein kinase C alpha	B	CONC(=O)c1cc(Nc2ncnn3cc(NC(=O)OCC4CCCO4)c(C(C)C)c23)c(F)cc1F		CHEMBL370266	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	1512516	CHEMBL827159	Inhibition of human protein kinase C alpha	B	CONC(=O)c1cc(Nc2ncnn3cc(-c4nnc(C)o4)c(C(C)C)c23)c(F)cc1F		CHEMBL365318	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	1512658	CHEMBL827159	Inhibition of human protein kinase C alpha	B	CONC(=O)c1cc(Nc2ncnn3cc(-c4nnc(C(F)F)o4)c(C(C)C)c23)c(F)cc1F		CHEMBL194498	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	1512799	CHEMBL827159	Inhibition of human protein kinase C alpha	B	CONC(=O)c1cc(Nc2ncnn3cc(-c4nnc(C(F)(F)S(C)(=O)=O)o4)c(C(C)C)c23)c(F)cc1F		CHEMBL195903	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	1606454	CHEMBL872399	Inhibition of [3H]PDBu binding to recombinant protein kinase C alpha was determined at pH 7.4, 37 degree C for 5 min	B	CC(C)CC(C/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O)CC(C)C		CHEMBL137386	=	Ki	nM	3.25	CHEMBL299	Homo sapiens	Ki	nM	3.25
	1606457	CHEMBL872399	Inhibition of [3H]PDBu binding to recombinant protein kinase C alpha was determined at pH 7.4, 37 degree C for 5 min	B	CC(C)CC(C/C=C1/CC(CO)(COC(=O)C(C)(C)C)OC1=O)CC(C)C		CHEMBL96766	=	Ki	nM	2.9	CHEMBL299	Homo sapiens	Ki	nM	2.9
	1606459	CHEMBL872399	Inhibition of [3H]PDBu binding to recombinant protein kinase C alpha was determined at pH 7.4, 37 degree C for 5 min	B	CC(C)CC(C/C=C1/COC(CO)(COC(=O)C(C)(C)C)C1)CC(C)C		CHEMBL194257	=	Ki	nM	622.0	CHEMBL299	Homo sapiens	Ki	nM	622.0
	1606462	CHEMBL872399	Inhibition of [3H]PDBu binding to recombinant protein kinase C alpha was determined at pH 7.4, 37 degree C for 5 min	B	CC(C)CC(C/C=C1\CC(CO)(COCC(C)(C)C)OC1=O)CC(C)C		CHEMBL363418	=	Ki	nM	14290.0	CHEMBL299	Homo sapiens	Ki	nM	14290.0
	1606465	CHEMBL872399	Inhibition of [3H]PDBu binding to recombinant protein kinase C alpha was determined at pH 7.4, 37 degree C for 5 min	B	CC(C)CC(C/C=C1/CC(CO)(COCC(C)(C)C)OC1=O)CC(C)C		CHEMBL194357	=	Ki	nM	5874.0	CHEMBL299	Homo sapiens	Ki	nM	5874.0
	1606467	CHEMBL872399	Inhibition of [3H]PDBu binding to recombinant protein kinase C alpha was determined at pH 7.4, 37 degree C for 5 min	B	CC(C)CC(C/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=S)CC(C)C		CHEMBL370130	=	Ki	nM	23.7	CHEMBL299	Homo sapiens	Ki	nM	23.7
	1606476	CHEMBL872399	Inhibition of [3H]PDBu binding to recombinant protein kinase C alpha was determined at pH 7.4, 37 degree C for 5 min	B	CC(C)CC(C/C=C1\CC(CO)(COC(=S)C(C)(C)C)OC1=O)CC(C)C		CHEMBL434938	=	Ki	nM	113.0	CHEMBL299	Homo sapiens	Ki	nM	113.0
	1614496	CHEMBL882920	Inhibitory concentration against protein kinase C alpha	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1614821	CHEMBL882920	Inhibitory concentration against protein kinase C alpha	B	O=C(Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1)c1ccccc1		CHEMBL277931	=	IC50	nM	1200.0	CHEMBL299	Homo sapiens	IC50	uM	1.2
	1615156	CHEMBL882920	Inhibitory concentration against protein kinase C alpha	B	Cc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL20867	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
Not Active	1650891	CHEMBL860891	Average Binding Constant for PRKACA; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL299	Homo sapiens	Kd		
Not Active	1650892	CHEMBL860891	Average Binding Constant for PRKACA; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707		Kd			CHEMBL299	Homo sapiens	Kd		
Not Active	1650893	CHEMBL860891	Average Binding Constant for PRKACA; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL299	Homo sapiens	Kd		
	1650894	CHEMBL860891	Average Binding Constant for PRKACA; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	6000.0	CHEMBL299	Homo sapiens	Kd	uM	6.0
Not Active	1650895	CHEMBL860891	Average Binding Constant for PRKACA; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL299	Homo sapiens	Kd		
Not Active	1650896	CHEMBL860891	Average Binding Constant for PRKACA; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL299	Homo sapiens	Kd		
Not Active	1650897	CHEMBL860891	Average Binding Constant for PRKACA; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL299	Homo sapiens	Kd		
Not Active	1650898	CHEMBL860891	Average Binding Constant for PRKACA; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL299	Homo sapiens	Kd		
Not Active	1650899	CHEMBL860891	Average Binding Constant for PRKACA; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL299	Homo sapiens	Kd		
	1652171	CHEMBL860891	Average Binding Constant for PRKACA; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	50.0	CHEMBL299	Homo sapiens	Kd	uM	0.05
Not Active	1652172	CHEMBL860891	Average Binding Constant for PRKACA; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL299	Homo sapiens	Kd		
Not Active	1652173	CHEMBL860891	Average Binding Constant for PRKACA; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL299	Homo sapiens	Kd		
Not Active	1652174	CHEMBL860891	Average Binding Constant for PRKACA; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL299	Homo sapiens	Kd		
Not Active	1652175	CHEMBL860891	Average Binding Constant for PRKACA; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL299	Homo sapiens	Kd		
Not Active	1652176	CHEMBL860891	Average Binding Constant for PRKACA; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL299	Homo sapiens	Kd		
Not Active	1652177	CHEMBL860891	Average Binding Constant for PRKACA; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL299	Homo sapiens	Kd		
Not Active	1652178	CHEMBL860891	Average Binding Constant for PRKACA; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL299	Homo sapiens	Kd		
Not Active	1652179	CHEMBL860891	Average Binding Constant for PRKACA; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL299	Homo sapiens	Kd		
Not Active	1652180	CHEMBL860891	Average Binding Constant for PRKACA; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828		Kd			CHEMBL299	Homo sapiens	Kd		
Not Active	1652181	CHEMBL860891	Average Binding Constant for PRKACA; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL299	Homo sapiens	Kd		
	1665741	CHEMBL860239	Inhibition of PKCalpha at 10 uM	B	CN1C(=O)C(C(=O)Nc2nncs2)c2cc3occc3cc21		CHEMBL200906	=	Inhibition	%	13.0	CHEMBL299	Homo sapiens	Inhibition	%	13.0
	1666382	CHEMBL865775	Inhibition of PKCalpha activity at 10 uM	B	Oc1cc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)ccc1Cl		CHEMBL373011	=	Inhibition	%	2.0	CHEMBL299	Homo sapiens	Inhibition	%	2.0
	1666383	CHEMBL865775	Inhibition of PKCalpha activity at 10 uM	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1		CHEMBL477989	=	Inhibition	%	10.0	CHEMBL299	Homo sapiens	Inhibition	%	10.0
	1671495	CHEMBL869959	Inhibition of PKCa at 10 uM	B	Cc1c(Nc2ccc(Br)cc2F)c(C(=O)NOCCO)cn(C)c1=O		CHEMBL199860	=	Inhibition	%	-3.0	CHEMBL299	Homo sapiens	Inhibition	%	-3.0
	1671524	CHEMBL869959	Inhibition of PKCa at 10 uM	B	CCONC(=O)c1cn(C)c(=O)c(F)c1Nc1ccc(Br)cc1F		CHEMBL201426	=	Inhibition	%	6.0	CHEMBL299	Homo sapiens	Inhibition	%	6.0
	1671548	CHEMBL869959	Inhibition of PKCa at 10 uM	B	CONC(=O)c1cn(C)c(=O)c(C)c1Nc1ccc(Br)cc1F		CHEMBL426840	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	Inhibition	%	0.0
	1671640	CHEMBL869959	Inhibition of PKCa at 10 uM	B	CCONC(=O)c1cn(C)c(=O)c(C)c1Nc1ccc(Br)cc1F		CHEMBL203138	=	Inhibition	%	7.0	CHEMBL299	Homo sapiens	Inhibition	%	7.0
	1689303	CHEMBL860607	Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserine	B	CC(C)CC(C/C=C1/CC(CO)(COC(=O)C(C)(C)C)OC1=O)CC(C)C		CHEMBL96766	=	Ki	nM	2.9	CHEMBL299	Homo sapiens	Ki	nM	2.9
	1689304	CHEMBL860607	Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserine	B	CCCCCCCC(=O)OCC1(CO)CC/C(=C\CC(CC(C)C)CC(C)C)C(=O)O1		CHEMBL205248	=	Ki	nM	129.0	CHEMBL299	Homo sapiens	Ki	nM	129.0
	1689305	CHEMBL860607	Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserine	B	CCCCCC(=O)OCC1(CO)CC/C(=C\CC(CC(C)C)CC(C)C)C(=O)O1		CHEMBL205670	=	Ki	nM	147.0	CHEMBL299	Homo sapiens	Ki	nM	147.0
	1689306	CHEMBL860607	Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserine	B	CC(C)CC(C/C=C1\CCC(CO)(COC(=O)C(C)(C)C)OC1=O)CC(C)C		CHEMBL205619	=	Ki	nM	48.0	CHEMBL299	Homo sapiens	Ki	nM	48.0
	1689307	CHEMBL860607	Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserine	B	CC(C)CC(C/C=C1/CCC(CO)(COC(=O)C(C)(C)C)OC1=O)CC(C)C		CHEMBL206605	=	Ki	nM	28.0	CHEMBL299	Homo sapiens	Ki	nM	28.0
	1689308	CHEMBL860607	Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserine	B	CC(C)CCC1(CCC(C)C)CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL378380	=	Ki	nM	18300.0	CHEMBL299	Homo sapiens	Ki	nM	18300.0
	1689309	CHEMBL860607	Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserine	B	CC(C)=CCC1(CC=C(C)C)CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL206485	=	Ki	nM	2100.0	CHEMBL299	Homo sapiens	Ki	nM	2100.0
	1689310	CHEMBL860607	Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserine	B	CC(C)CC(C/C=C1\CC(/C=C\C(=O)OC(C)(C)C)(CO)OC1=O)CC(C)C		CHEMBL436943	=	Ki	nM	21700.0	CHEMBL299	Homo sapiens	Ki	nM	21700.0
	1689311	CHEMBL860607	Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserine	B	CC(C)CC(C/C=C1\CC(/C=C/C(=O)OC(C)(C)C)(CO)OC1=O)CC(C)C		CHEMBL381693	=	Ki	nM	173.0	CHEMBL299	Homo sapiens	Ki	nM	173.0
	1689312	CHEMBL860607	Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserine	B	CC(C)CC(C/C=C1/CC(/C=C/C(=O)OC(C)(C)C)(CO)OC1=O)CC(C)C		CHEMBL204134	=	Ki	nM	18.0	CHEMBL299	Homo sapiens	Ki	nM	18.0
	1689313	CHEMBL860607	Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserine	B	CC(C)CC(C/C=C1/CC(CO)(COC(=O)CC(CC(C)C)CC(C)C)OC1=O)CC(C)C		CHEMBL203607	=	Ki	nM	6.88	CHEMBL299	Homo sapiens	Ki	nM	6.88
	1689314	CHEMBL860607	Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserine	B	CC(C)CC(C/C=C1\CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O)CC(C)C		CHEMBL138171	=	Ki	nM	4.46	CHEMBL299	Homo sapiens	Ki	nM	4.46
	1689315	CHEMBL860607	Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserine	B	CC(C)CC(C/C=C1/CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O)CC(C)C		CHEMBL137597	=	Ki	nM	6.87	CHEMBL299	Homo sapiens	Ki	nM	6.87
	1689316	CHEMBL860607	Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserine	B	CC(C)CC(C/C=C1\CC(CO)(COC(=O)c2ccccc2)OC1=O)CC(C)C		CHEMBL380661	=	Ki	nM	16.1	CHEMBL299	Homo sapiens	Ki	nM	16.1
	1689317	CHEMBL860607	Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserine	B	CC(C)CC(C/C=C1/CC(CO)(COC(=O)c2ccccc2)OC1=O)CC(C)C		CHEMBL382784	=	Ki	nM	6.66	CHEMBL299	Homo sapiens	Ki	nM	6.66
	1689318	CHEMBL860607	Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserine	B	CCCCCCCC(=O)OCC1(CO)C/C(=C\CC(CC(C)C)CC(C)C)C(=O)O1		CHEMBL383708	=	Ki	nM	6.04	CHEMBL299	Homo sapiens	Ki	nM	6.04
	1689319	CHEMBL860607	Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserine	B	CCCCCCCC(=O)OCC1(CO)C/C(=C/CC(CC(C)C)CC(C)C)C(=O)O1		CHEMBL206332	=	Ki	nM	4.97	CHEMBL299	Homo sapiens	Ki	nM	4.97
	1689320	CHEMBL860607	Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserine	B	CCCCCC(=O)OCC1(CO)C/C(=C\CC(CC(C)C)CC(C)C)C(=O)O1		CHEMBL203521	=	Ki	nM	6.18	CHEMBL299	Homo sapiens	Ki	nM	6.18
	1689321	CHEMBL860607	Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserine	B	CCCCCC(=O)OCC1(CO)C/C(=C/CC(CC(C)C)CC(C)C)C(=O)O1		CHEMBL383615	=	Ki	nM	3.78	CHEMBL299	Homo sapiens	Ki	nM	3.78
	1689322	CHEMBL860607	Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserine	B	CC(C)CC(C/C=C1/C[C@@](CO)(COC(=O)C(C)(C)C)OC1=O)CC(C)C		CHEMBL203524	=	Ki	nM	1.45	CHEMBL299	Homo sapiens	Ki	nM	1.45
	1689323	CHEMBL860607	Displacement of [20-3H]PDBu from recombinant PKC alpha in presence of phosphatidylserine	B	CC(C)CC(C/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O)CC(C)C		CHEMBL137386	=	Ki	nM	4.51	CHEMBL299	Homo sapiens	Ki	nM	4.51
	1699570	CHEMBL861579	Inhibition of PKC A at 10 uM in presence of 100 uM ATP	B	O=C(NC1CCOCC1)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202887	=	Inhibition	%	6.0	CHEMBL299	Homo sapiens	Inhibition	%	6.0
	1699826	CHEMBL860744	Inhibitory activity against PKC alpha	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	IC50	nM	25000.0	CHEMBL299	Homo sapiens	IC50	nM	25000.0
	1704014	CHEMBL861205	Inhibitory activity against PKC alpha	B	COc1ccc(N2Cc3cnc(Nc4ccc(F)cc4)nc3N([C@@H]3CC[C@@H](O)C3)C2=O)cc1	Outside typical range	CHEMBL606964	>	IC50	nM	125000.0	CHEMBL299	Homo sapiens	IC50	nM	125000.0
	1711412	CHEMBL867848	Displacement of [3H]phorbol 12,13-dibutyrate from PKC alpha-C1A	B	CCCCCCCCc1cccc2c1CC[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL206866	>	Ki	nM	10000.0	CHEMBL299	Homo sapiens	Ki	nM	10000.0
	1711413	CHEMBL867849	Displacement of [3H]phorbol 12,13-dibutyrate from PKC alpha-C1B	B	CCCCCCCCc1cccc2c1CC[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL206866	>	Ki	nM	10000.0	CHEMBL299	Homo sapiens	Ki	nM	10000.0
	1711426	CHEMBL868476	Induction of GFP-tagged PKC alpha translocation in HeLa cells measured as ratio of fluorescence intensity in plasma membrane to cytosol at 10 uM	B	CCCCCCN1C[C@H]2C[C@@H](CO)NC(=O)[C@H](C(C)C)N(C)c3cccc1c32		CHEMBL207363	=	Ratio		1.79	CHEMBL299	Homo sapiens	Ratio		1.79
	1711432	CHEMBL868478	Induction of GFP-tagged PKC alpha translocation in HeLa cells measured as ratio of fluorescence intensity in plasma membrane to cytosol at 1 uM	B	CCCCCCN1C[C@H]2C[C@@H](CO)NC(=O)[C@H](C(C)C)N(C)c3cccc1c32		CHEMBL207363	=	Ratio		0.97	CHEMBL299	Homo sapiens	Ratio		0.97
Not Determined	1711438	CHEMBL869672	Induction of GFP-tagged PKC alpha translocation in HeLa cells measured as ratio of fluorescence intensity in plasma membrane to cytosol at 0.5 uM	B	CCCCCCN1C[C@H]2C[C@@H](CO)NC(=O)[C@H](C(C)C)N(C)c3cccc1c32		CHEMBL207363		Ratio			CHEMBL299	Homo sapiens	Ratio		
	1711444	CHEMBL868474	Induction of GFP-tagged PKC alpha translocation in HeLa cells measured as ratio of fluorescence intensity in plasma membrane to cytosol at 30 uM	B	CCCCCCCCc1cccc2c1CC[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL206866	=	Ratio		0.98	CHEMBL299	Homo sapiens	Ratio		0.98
	1711450	CHEMBL868475	Induction of GFP-tagged PKC alpha translocation in HeLa cells measured as ratio of fluorescence intensity in plasma membrane to cytosol at 20 uM	B	CCCCCCCCc1cccc2c1CC[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL206866	=	Ratio		0.97	CHEMBL299	Homo sapiens	Ratio		0.97
	1711456	CHEMBL868476	Induction of GFP-tagged PKC alpha translocation in HeLa cells measured as ratio of fluorescence intensity in plasma membrane to cytosol at 10 uM	B	CCCCCCCCc1cccc2c1CC[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL206866	=	Ratio		0.98	CHEMBL299	Homo sapiens	Ratio		0.98
Not Determined	1711462	CHEMBL868477	Induction of GFP-tagged PKC alpha translocation in HeLa cells measured as ratio of fluorescence intensity in plasma membrane to cytosol at 5 uM	B	CCCCCCCCc1cccc2c1CC[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL206866		Ratio			CHEMBL299	Homo sapiens	Ratio		
Not Determined	1711468	CHEMBL868478	Induction of GFP-tagged PKC alpha translocation in HeLa cells measured as ratio of fluorescence intensity in plasma membrane to cytosol at 1 uM	B	CCCCCCCCc1cccc2c1CC[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL206866		Ratio			CHEMBL299	Homo sapiens	Ratio		
Not Determined	1711472	CHEMBL869672	Induction of GFP-tagged PKC alpha translocation in HeLa cells measured as ratio of fluorescence intensity in plasma membrane to cytosol at 0.5 uM	B	CCCCCCCCc1cccc2c1CC[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL206866		Ratio			CHEMBL299	Homo sapiens	Ratio		
	1718843	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	CCCCCC/C=C1\CC(CO)(COC(=O)CCCc2ccccc2)OC1=O		CHEMBL210432	=	Ki	nM	27.0	CHEMBL299	Homo sapiens	Ki	nM	27.0
	1718906	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	CC(C)C(CC(=O)OCC1(CO)C/C(=C\c2ccc(O)cc2)C(=O)O1)C(C)C		CHEMBL380645	=	Ki	nM	19.0	CHEMBL299	Homo sapiens	Ki	nM	19.0
	1718907	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	CC(C)C(CC(=O)OCC1(CO)C/C(=C\c2cccc(O)c2)C(=O)O1)C(C)C		CHEMBL206889	=	Ki	nM	17.0	CHEMBL299	Homo sapiens	Ki	nM	17.0
	1718908	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	CC(C)C(CC(=O)OCC1(CO)C/C(=C\c2ccccc2O)C(=O)O1)C(C)C		CHEMBL209308	=	Ki	nM	22.0	CHEMBL299	Homo sapiens	Ki	nM	22.0
	1718909	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	COc1ccc(/C=C2\CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC2=O)cc1		CHEMBL209666	=	Ki	nM	7.0	CHEMBL299	Homo sapiens	Ki	nM	7.0
	1718910	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	COc1cccc(/C=C2\CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC2=O)c1		CHEMBL377577	=	Ki	nM	12.0	CHEMBL299	Homo sapiens	Ki	nM	12.0
	1718911	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	COc1ccccc1/C=C1\CC(CO)(COC(=O)CC(C(C)C)C(C)C)OC1=O		CHEMBL379822	=	Ki	nM	16.0	CHEMBL299	Homo sapiens	Ki	nM	16.0
	1718912	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	CC(C)C(CC(=O)OCC1(CO)C/C(=C\CCc2ccccc2)C(=O)O1)C(C)C		CHEMBL210666	=	Ki	nM	9.0	CHEMBL299	Homo sapiens	Ki	nM	9.0
	1718913	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	CC(C)C(CC(=O)OCC1(CO)C/C(=C\Cc2ccccc2)C(=O)O1)C(C)C		CHEMBL209779	=	Ki	nM	14.0	CHEMBL299	Homo sapiens	Ki	nM	14.0
	1718914	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	CC(C)C(CC(=O)OCC1(CO)C/C(=C\c2ccccc2)C(=O)O1)C(C)C		CHEMBL378783	=	Ki	nM	12.0	CHEMBL299	Homo sapiens	Ki	nM	12.0
	1718915	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	CC(C)C(C/C=C1/CC(CO)(COC(=O)c2ccc(O)cc2)OC1=O)C(C)C		CHEMBL209665	=	Ki	nM	983.0	CHEMBL299	Homo sapiens	Ki	nM	983.0
	1718916	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	CC(C)C(C/C=C1\CC(CO)(COC(=O)c2ccc(O)cc2)OC1=O)C(C)C		CHEMBL210547	=	Ki	nM	2400.0	CHEMBL299	Homo sapiens	Ki	nM	2400.0
	1718917	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	CC(C)C(C/C=C1/CC(CO)(COC(=O)c2cccc(O)c2)OC1=O)C(C)C		CHEMBL209615	=	Ki	nM	406.0	CHEMBL299	Homo sapiens	Ki	nM	406.0
	1718918	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	CC(C)C(C/C=C1\CC(CO)(COC(=O)c2cccc(O)c2)OC1=O)C(C)C		CHEMBL209616	=	Ki	nM	670.0	CHEMBL299	Homo sapiens	Ki	nM	670.0
	1718919	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	CC(C)C(C/C=C1/CC(CO)(COC(=O)c2ccccc2O)OC1=O)C(C)C		CHEMBL210460	=	Ki	nM	30.0	CHEMBL299	Homo sapiens	Ki	nM	30.0
	1718920	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	CC(C)C(C/C=C1\CC(CO)(COC(=O)c2ccccc2O)OC1=O)C(C)C		CHEMBL211049	=	Ki	nM	67.0	CHEMBL299	Homo sapiens	Ki	nM	67.0
	1718921	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	COc1ccc(C(=O)OCC2(CO)C/C(=C/CC(C(C)C)C(C)C)C(=O)O2)cc1		CHEMBL209938	=	Ki	nM	18.0	CHEMBL299	Homo sapiens	Ki	nM	18.0
	1718922	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	COc1ccc(C(=O)OCC2(CO)C/C(=C\CC(C(C)C)C(C)C)C(=O)O2)cc1		CHEMBL210196	=	Ki	nM	36.0	CHEMBL299	Homo sapiens	Ki	nM	36.0
	1718923	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	COc1cccc(C(=O)OCC2(CO)C/C(=C/CC(C(C)C)C(C)C)C(=O)O2)c1		CHEMBL208417	=	Ki	nM	24.0	CHEMBL299	Homo sapiens	Ki	nM	24.0
	1718924	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	COc1cccc(C(=O)OCC2(CO)C/C(=C\CC(C(C)C)C(C)C)C(=O)O2)c1		CHEMBL208568	=	Ki	nM	39.0	CHEMBL299	Homo sapiens	Ki	nM	39.0
	1718925	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	COc1ccccc1C(=O)OCC1(CO)C/C(=C/CC(C(C)C)C(C)C)C(=O)O1		CHEMBL206786	=	Ki	nM	23.0	CHEMBL299	Homo sapiens	Ki	nM	23.0
	1718926	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	COc1ccccc1C(=O)OCC1(CO)C/C(=C\CC(C(C)C)C(C)C)C(=O)O1		CHEMBL209184	=	Ki	nM	73.0	CHEMBL299	Homo sapiens	Ki	nM	73.0
	1718927	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	CC(C)C(C/C=C1/CC(CO)(COC(=O)C2CCCCC2)OC1=O)C(C)C		CHEMBL208618	=	Ki	nM	8.0	CHEMBL299	Homo sapiens	Ki	nM	8.0
	1718928	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	CC(C)C(C/C=C1\CC(CO)(COC(=O)C2CCCCC2)OC1=O)C(C)C		CHEMBL380039	=	Ki	nM	10.0	CHEMBL299	Homo sapiens	Ki	nM	10.0
	1718929	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	CC(C)C(C/C=C1/CC(CO)(COC(=O)c2ccccc2)OC1=O)C(C)C		CHEMBL210495	=	Ki	nM	16.0	CHEMBL299	Homo sapiens	Ki	nM	16.0
	1718930	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	CC(C)C(C/C=C1\CC(CO)(COC(=O)c2ccccc2)OC1=O)C(C)C		CHEMBL210725	=	Ki	nM	28.0	CHEMBL299	Homo sapiens	Ki	nM	28.0
	1718931	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	CCCCCCCCC/C=C1/CC(CO)(COC(=O)C2CCCCC2)OC1=O		CHEMBL210746	=	Ki	nM	5.0	CHEMBL299	Homo sapiens	Ki	nM	5.0
	1718932	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	CCCCCCCCC/C=C1\CC(CO)(COC(=O)C2CCCCC2)OC1=O		CHEMBL379945	=	Ki	nM	9.0	CHEMBL299	Homo sapiens	Ki	nM	9.0
	1718933	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	CCCCCCCCC/C=C1/CC(CO)(COC(=O)c2ccccc2)OC1=O		CHEMBL110256	=	Ki	nM	9.0	CHEMBL299	Homo sapiens	Ki	nM	9.0
	1718934	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	CCCCCCCCC/C=C1\CC(CO)(COC(=O)c2ccccc2)OC1=O		CHEMBL209140	=	Ki	nM	14.0	CHEMBL299	Homo sapiens	Ki	nM	14.0
	1718935	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	CCCCCCCC/C=C1/CC(CO)(COC(=O)Cc2ccccc2)OC1=O		CHEMBL109997	=	Ki	nM	45.0	CHEMBL299	Homo sapiens	Ki	nM	45.0
	1718936	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	CCCCCCCC/C=C1\CC(CO)(COC(=O)Cc2ccccc2)OC1=O		CHEMBL206735	=	Ki	nM	44.0	CHEMBL299	Homo sapiens	Ki	nM	44.0
	1718937	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	CCCCCCC/C=C1/CC(CO)(COC(=O)CCc2ccccc2)OC1=O		CHEMBL209013	=	Ki	nM	14.0	CHEMBL299	Homo sapiens	Ki	nM	14.0
	1718938	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	CCCCCCC/C=C1\CC(CO)(COC(=O)CCc2ccccc2)OC1=O		CHEMBL377690	=	Ki	nM	18.0	CHEMBL299	Homo sapiens	Ki	nM	18.0
	1718939	CHEMBL871202	Displacement of [20-3H]PDBU from recombinant PKCalpha in presence of phosphatidylserine	B	CCCCCC/C=C1/CC(CO)(COC(=O)CCCc2ccccc2)OC1=O		CHEMBL209830	=	Ki	nM	17.0	CHEMBL299	Homo sapiens	Ki	nM	17.0
	1734124	CHEMBL854410	Residual activity at human PKCalpha at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	98.0	CHEMBL299	Homo sapiens	Activity	%	98.0
	1735023	CHEMBL854496	Activity against PKCalpha at 10 uM in the presence of 100 uM ATP relative to control	B	COc1cc(/C=C2\C(=O)NN(c3ccc(Cl)c(Cl)c3)C2=O)ccc1O		CHEMBL380093	=	Activity	%	78.0	CHEMBL299	Homo sapiens	Activity	%	78.0
	1735042	CHEMBL854496	Activity against PKCalpha at 10 uM in the presence of 100 uM ATP relative to control	B	COc1cccc(NC(=O)Nc2nnc(-c3ccncc3)s2)c1		CHEMBL377430	=	Activity	%	83.0	CHEMBL299	Homo sapiens	Activity	%	83.0
	1744602	CHEMBL866839	Inhibition of PKCalpha	B	O=C(NC1CC1)c1cc(NCc2cnc(Nc3ccccn3)s2)c(F)cc1F		CHEMBL377734	>	IC50	nM	40000.0	CHEMBL299	Homo sapiens	IC50	nM	40000.0
	1751565	CHEMBL869141	Inhibition of PKCalpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3Cl)cn12		CHEMBL215652	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	1751566	CHEMBL869141	Inhibition of PKCalpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3cc(F)c(F)cc3F)cn12		CHEMBL213423	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	1751567	CHEMBL869141	Inhibition of PKCalpha	B	CCNc1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12		CHEMBL213451	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	1751568	CHEMBL869141	Inhibition of PKCalpha	B	CC(C)(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3F)cn12		CHEMBL212382	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	1751569	CHEMBL869141	Inhibition of PKCalpha	B	CC(C)(C)c1nnc2ccc(-c3ocnc3-c3cc(F)c(F)cc3F)cn12		CHEMBL212968	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	1751570	CHEMBL869141	Inhibition of PKCalpha	B	CC(C)c1nnc2ccc(-c3c[nH]nc3-c3cc(F)ccc3F)cn12		CHEMBL214198	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	1751654	CHEMBL869141	Inhibition of PKCalpha	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccccc3)cn12		CHEMBL379929	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	1755313	CHEMBL868613	Inhibition of PKCa	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.0	CHEMBL299	Homo sapiens	IC50	nM	1.0
	1755333	CHEMBL868613	Inhibition of PKCa	B	CNc1nccc(-c2ccc(C(=O)N[C@H](CN)Cc3ccc(Cl)cc3Cl)s2)n1		CHEMBL213618	=	IC50	nM	66.0	CHEMBL299	Homo sapiens	IC50	nM	66.0
	1769421	CHEMBL910936	Inhibition of PKCalpha	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	>	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	uM	1.0
	1777528	CHEMBL908834	Inhibition of PKC alpha	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Ki	nM	5000.0	CHEMBL299	Homo sapiens	Ki	uM	5.0
	1779369	CHEMBL854985	Inhibition of PKCalpha	B	Clc1ccc2c(c1Nc1ncnc3cc(OCCCN4CCCC4)cc(OC4CCOCC4)c13)OCO2		CHEMBL217090	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	1782050	CHEMBL911857	Inhibition of PKAalpha	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	1790036	CHEMBL854704	Percentage activity of human PKC alpha -His in the presence of 10 uM of compound and 10 uM of ATP in comparison with control	B	O=C(NCc1ccc(S(=O)(=O)N2CCC(n3nnc4ccccc43)CC2)s1)c1ccc(Cl)cc1		CHEMBL383955	=	Activity	%	101.0	CHEMBL299	Homo sapiens	Activity	%	101.0
	1790344	CHEMBL873781	Percent residual activity, relative to control, of PKC alpha at 1uM concentration of inhibitor in presence of 20uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)NC(=O)CCCCCNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL413460	=	Activity	%	15.0	CHEMBL299	Homo sapiens	Activity	%	15.0
	1790398	CHEMBL873781	Percent residual activity, relative to control, of PKC alpha at 1uM concentration of inhibitor in presence of 20uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL279185	=	Activity	%	31.0	CHEMBL299	Homo sapiens	Activity	%	31.0
	1819278	CHEMBL914810	Displacement of [3H]PDBu from PKCalpha	B	C#Cc1ccc(C#Cc2ccc(C(=O)OCC3(CO)CC(=C(C)C)C(=O)O3)cc2)cc1		CHEMBL223747	=	Ki	nM	5.23	CHEMBL299	Homo sapiens	Ki	nM	5.23
	1819279	CHEMBL914810	Displacement of [3H]PDBu from PKCalpha	B	CCCCCCCCCC(=O)OCC1(CO)CC(=C(C)C)C(=O)O1		CHEMBL413585	=	Ki	nM	15.9	CHEMBL299	Homo sapiens	Ki	nM	15.9
	1819280	CHEMBL914810	Displacement of [3H]PDBu from PKCalpha	B	CC(C)=C1CC(CO)(COC(=O)c2ccc(C#Cc3ccc(C#Cc4ccc(OCCOCCOCCOC(=O)N(CC(=O)O)CC(=O)O)cc4)cc3)cc2)OC1=O		CHEMBL220881	=	Ki	nM	1391.0	CHEMBL299	Homo sapiens	Ki	nM	1391.0
	1819281	CHEMBL914810	Displacement of [3H]PDBu from PKCalpha	B	CC(C)=C1CC(CO)(COC(=O)c2ccc(C#Cc3ccc(C#Cc4ccc(OCCOCCOCCOC(=O)N(CC(=O)OC(C)(C)C)CC(=O)OC(C)(C)C)cc4)cc3)cc2)OC1=O		CHEMBL1162941	=	Ki	nM	18.3	CHEMBL299	Homo sapiens	Ki	nM	18.3
	1819282	CHEMBL914810	Displacement of [3H]PDBu from PKCalpha	B	CC(C)=C1CC(CO)(COC(=O)c2ccc(C#Cc3ccc(C#Cc4ccc(OCCOCCOCCN(CC(=O)OC(C)(C)C)CC(=O)OC(C)(C)C)cc4)cc3)cc2)OC1=O		CHEMBL220099	=	Ki	nM	111.1	CHEMBL299	Homo sapiens	Ki	nM	111.1
	1819283	CHEMBL914810	Displacement of [3H]PDBu from PKCalpha	B	COC(=O)CCCCCCCCCCCCCCCOc1ccc(C#Cc2ccc(C#Cc3ccc(C(=O)OCC4(CO)CC(=C(C)C)C(=O)O4)cc3)cc2)cc1		CHEMBL220962	=	Ki	nM	52.7	CHEMBL299	Homo sapiens	Ki	nM	52.7
	1819284	CHEMBL914810	Displacement of [3H]PDBu from PKCalpha	B	COC(=O)COc1ccc(C#Cc2ccc(C#Cc3ccc(C#Cc4ccc(C(=O)OCC5(CO)CC(=C(C)C)C(=O)O5)cc4)cc3)cc2)cc1		CHEMBL221290	=	Ki	nM	126.9	CHEMBL299	Homo sapiens	Ki	nM	126.9
	1819285	CHEMBL914810	Displacement of [3H]PDBu from PKCalpha	B	COC(=O)COc1ccc(C#Cc2ccc(C#Cc3ccc(C(=O)OCC4(CO)CC(=C(C)C)C(=O)O4)cc3)cc2)cc1		CHEMBL221289	=	Ki	nM	15.8	CHEMBL299	Homo sapiens	Ki	nM	15.8
	1819286	CHEMBL914810	Displacement of [3H]PDBu from PKCalpha	B	COc1ccc(C#Cc2ccc(C#Cc3ccc(C(=O)OCC4(CO)CC(=C(C)C)C(=O)O4)cc3)cc2)cc1		CHEMBL221332	=	Ki	nM	5.88	CHEMBL299	Homo sapiens	Ki	nM	5.88
	1819287	CHEMBL914810	Displacement of [3H]PDBu from PKCalpha	B	C#Cc1ccc(C#Cc2ccc(C#Cc3ccc(C(=O)OCC4(CO)CC(=C(C)C)C(=O)O4)cc3)cc2)cc1		CHEMBL223570	=	Ki	nM	11.6	CHEMBL299	Homo sapiens	Ki	nM	11.6
	1837924	CHEMBL920460	Inhibition of PKCalpha at 10 uM relative to control	B	CN(C)c1nc2c(Br)c(Br)c(Br)c(Br)c2[nH]1		CHEMBL376505	=	Inhibition	%	95.0	CHEMBL299	Homo sapiens	Inhibition	%	95.0
	1837963	CHEMBL920460	Inhibition of PKCalpha at 10 uM relative to control	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Inhibition	%	102.0	CHEMBL299	Homo sapiens	Inhibition	%	102.0
	1838313	CHEMBL904282	Inhibition of PKCalpha	B	CONC(=O)c1ccc(C)c(Nc2nc(N(C)CC(C)(C)C)nc(N3CCCN(C)CC3)n2)c1		CHEMBL225088	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	1841828	CHEMBL913900	Inhibition of PKCalpha	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	nM	50000.0
Not Determined	1897582	CHEMBL887593	Inhibition of PKCalpha	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350		IC50			CHEMBL299	Homo sapiens	IC50		
	1897589	CHEMBL887593	Inhibition of PKCalpha	B	Cl.Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL538346	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1897597	CHEMBL887593	Inhibition of PKCalpha	B	Cl.Oc1cccc(-c2nc(N3CCOCC3)c3sccc3n2)c1	Outside typical range	CHEMBL541643	=	IC50	nM	466000.0	CHEMBL299	Homo sapiens	IC50	uM	466.0
	1898417	CHEMBL887688	Inhibition of PKCalpha	B	Cc1cc(Nc2ncnc3cnc(N4CCOCC4)cc23)ccc1Oc1ccc(C(=O)NCC(C)(C)C)cc1		CHEMBL375671	>	Activity	uM	10.0	CHEMBL299	Homo sapiens	Activity	uM	10.0
	1917486	CHEMBL895140	Inhibition of PKCalpha at 1 uM	B	O=c1ccc(=O)c2c1c1[nH]c3ccc(O)cc3c1c1c(=O)[nH]c(=O)c21		CHEMBL243931	=	Inhibition	%	66.0	CHEMBL299	Homo sapiens	Inhibition	%	66.0
	1917508	CHEMBL895140	Inhibition of PKCalpha at 1 uM	B	Cc1ccc2[nH]c3c4c(O)ccc(O)c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL244141	=	Inhibition	%	102.0	CHEMBL299	Homo sapiens	Inhibition	%	102.0
	1923306	CHEMBL896199	Inhibition of PKCalpha	B	N#Cc1cnc2c(F)cc(NCc3c[nH]cn3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL245212	>	IC50	nM	40000.0	CHEMBL299	Homo sapiens	IC50	uM	40.0
	1923346	CHEMBL896199	Inhibition of PKCalpha	B	Cn1cnc(CNc2cc(Br)c3ncc(C#N)c(Nc4ccc(F)c(Cl)c4)c3c2)c1		CHEMBL230761	>	IC50	nM	40000.0	CHEMBL299	Homo sapiens	IC50	uM	40.0
	1923347	CHEMBL896199	Inhibition of PKCalpha	B	CCCc1[nH]cnc1CNc1cc(Cl)c2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2c1		CHEMBL230654	>	IC50	nM	40000.0	CHEMBL299	Homo sapiens	IC50	uM	40.0
	1923348	CHEMBL896199	Inhibition of PKCalpha	B	CN(C)CCCn1cc(CNc2cc(Br)c3ncc(C#N)c(Nc4ccc(F)c(Cl)c4)c3c2)nn1		CHEMBL425834	>	IC50	nM	40000.0	CHEMBL299	Homo sapiens	IC50	uM	40.0
	1923349	CHEMBL896199	Inhibition of PKCalpha	B	N#Cc1cnc2c(Br)cc(NCc3c[nH]nn3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL230232	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	1923350	CHEMBL896199	Inhibition of PKCalpha	B	N#Cc1cnc2c(Cl)cc(NCc3cccc[n+]3[O-])cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL395573	>	IC50	nM	40000.0	CHEMBL299	Homo sapiens	IC50	uM	40.0
	1923351	CHEMBL896199	Inhibition of PKCalpha	B	N#Cc1cnc2c(Cl)cc(NCc3cnc[nH]3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL436817	=	IC50	nM	23400.0	CHEMBL299	Homo sapiens	IC50	uM	23.4
	1960610	CHEMBL892534	Inhibition of PKCa	B	NC1=NC(=O)/C(=C/c2ccc3ncccc3c2)S1		CHEMBL396377	>	Ki	nM	2000.0	CHEMBL299	Homo sapiens	Ki	uM	2.0
	1960623	CHEMBL892534	Inhibition of PKCa	B	O=C1N=C(N[C@@H]2C[C@H]2c2ccccc2)S/C1=C\c1ccc2ncccc2c1		CHEMBL235345	>	Ki	nM	2000.0	CHEMBL299	Homo sapiens	Ki	uM	2.0
	1960624	CHEMBL892534	Inhibition of PKCa	B	O=C1N=C(NCc2cccs2)S/C1=C\c1ccc2ncccc2c1		CHEMBL393929	>	Ki	nM	2000.0	CHEMBL299	Homo sapiens	Ki	uM	2.0
	1975569	CHEMBL898649	Inhibition of PKCalpha at 1 uM	B	O=C1NC(=O)c2c1c1c3cc(Cl)ccc3[nH]c1c1cccn21		CHEMBL392052	=	Inhibition	%	75.0	CHEMBL299	Homo sapiens	Inhibition	%	75.0
	1975576	CHEMBL898649	Inhibition of PKCalpha at 1 uM	B	O=C1NC(=O)c2c1c1c3cc(Br)ccc3[nH]c1c1cccn21		CHEMBL238625	=	Inhibition	%	85.0	CHEMBL299	Homo sapiens	Inhibition	%	85.0
	1981744	CHEMBL899259	Inhibition of PKCalpha assessed as residual activity at 0.01 uM	B	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(N)=O		CHEMBL397521	=	Activity	%	96.0	CHEMBL299	Homo sapiens	Activity	%	96.0
	1981745	CHEMBL899260	Inhibition of PKCalpha assessed as residual activity at 1 uM	B	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(N)=O		CHEMBL397521	=	Activity	%	30.0	CHEMBL299	Homo sapiens	Activity	%	30.0
	1989383	CHEMBL898065	Inhibition of PKCalpha at 1 uM	B	CC(C)NCc1ccc(Nc2cc(-c3ccc(-c4ccc(O)cc4O)cc3)[nH]n2)cc1		CHEMBL398606	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	Inhibition	%	0.0
	2015697	CHEMBL885504	Inhibition of PKCalpha at 10 uM	B	NC[C@H]1CC[C@H](c2nc(-c3cccc(OCc4ccccc4)c3)c3c(N)nccn32)CC1		CHEMBL392284	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	Inhibition	%	50.0
	2025178	CHEMBL887005	Inhibition of human PKCalpha at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	74.0	CHEMBL299	Homo sapiens	Inhibition	%	74.0
	2025426	CHEMBL887005	Inhibition of human PKCalpha at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	68.0	CHEMBL299	Homo sapiens	Inhibition	%	68.0
	2025427	CHEMBL887005	Inhibition of human PKCalpha at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	83.0	CHEMBL299	Homo sapiens	Inhibition	%	83.0
	2025428	CHEMBL887005	Inhibition of human PKCalpha at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	82.0	CHEMBL299	Homo sapiens	Inhibition	%	82.0
	2064405	CHEMBL926253	Displacement of [3H]PDBu from PKCalpha C1A domain	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL27266	=	Ki	nM	21.0	CHEMBL299	Homo sapiens	Ki	nM	21.0
	2064406	CHEMBL927258	Displacement of [3H]PDBu from PKCalpha C1B domain	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL27266	=	Ki	nM	4000.0	CHEMBL299	Homo sapiens	Ki	nM	4000.0
	2064415	CHEMBL926253	Displacement of [3H]PDBu from PKCalpha C1A domain	B	CCCCCCCCc1cccc2c1CC[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL206866	>	Ki	nM	10000.0	CHEMBL299	Homo sapiens	Ki	nM	10000.0
	2064417	CHEMBL927258	Displacement of [3H]PDBu from PKCalpha C1B domain	B	CCCCCCCCc1cccc2c1CC[C@@H](CO)NC(=O)[C@H](C(C)C)N2C		CHEMBL206866	>	Ki	nM	10000.0	CHEMBL299	Homo sapiens	Ki	nM	10000.0
	2064425	CHEMBL926253	Displacement of [3H]PDBu from PKCalpha C1A domain	B	CCCCCCn1cc2c3c(cccc31)N(C)[C@@H](C(C)C)C(=O)N[C@H](CO)C2		CHEMBL399981	=	Ki	nM	5.8	CHEMBL299	Homo sapiens	Ki	nM	5.8
	2064426	CHEMBL927258	Displacement of [3H]PDBu from PKCalpha C1B domain	B	CCCCCCn1cc2c3c(cccc31)N(C)[C@@H](C(C)C)C(=O)N[C@H](CO)C2		CHEMBL399981	=	Ki	nM	43.0	CHEMBL299	Homo sapiens	Ki	nM	43.0
	2064435	CHEMBL926253	Displacement of [3H]PDBu from PKCalpha C1A domain	B	CCCCCCn1cc2c3c(cccc31)N(C)[C@@H](C(C)C)C(=O)N[C@H](CO)CC2		CHEMBL401369	=	Ki	nM	6700.0	CHEMBL299	Homo sapiens	Ki	nM	6700.0
	2064436	CHEMBL927258	Displacement of [3H]PDBu from PKCalpha C1B domain	B	CCCCCCn1cc2c3c(cccc31)N(C)[C@@H](C(C)C)C(=O)N[C@H](CO)CC2		CHEMBL401369	>	Ki	nM	10000.0	CHEMBL299	Homo sapiens	Ki	nM	10000.0
	2064461	CHEMBL927271	Induction of GFP-tagged PKCalpha translocation in HeLa cells assessed as ratio of protein level in plasma membrane to cytosol at 10 uM	B	CCCCCCn1cc2c3c(cccc31)N(C)[C@@H](C(C)C)C(=O)N[C@H](CO)CC2		CHEMBL401369	=	Ratio		1.77	CHEMBL299	Homo sapiens	Ratio		1.77
	2064462	CHEMBL927272	Induction of GFP-tagged PKCalpha translocation in HeLa cells assessed as ratio of protein level in plasma membrane to cytosol at 1 uM	B	CCCCCCn1cc2c3c(cccc31)N(C)[C@@H](C(C)C)C(=O)N[C@H](CO)CC2		CHEMBL401369	=	Ratio		0.97	CHEMBL299	Homo sapiens	Ratio		0.97
Not Determined	2064463	CHEMBL927273	Induction of GFP-tagged PKCalpha translocation in HeLa cells assessed as ratio of protein level in plasma membrane to cytosol at 500 nM	B	CCCCCCn1cc2c3c(cccc31)N(C)[C@@H](C(C)C)C(=O)N[C@H](CO)CC2		CHEMBL401369		Ratio			CHEMBL299	Homo sapiens	Ratio		
Not Determined	2064464	CHEMBL927274	Induction of GFP-tagged PKCalpha translocation in HeLa cells assessed as ratio of protein level in plasma membrane to cytosol at 100 nM	B	CCCCCCn1cc2c3c(cccc31)N(C)[C@@H](C(C)C)C(=O)N[C@H](CO)CC2		CHEMBL401369		Ratio			CHEMBL299	Homo sapiens	Ratio		
	2064485	CHEMBL927272	Induction of GFP-tagged PKCalpha translocation in HeLa cells assessed as ratio of protein level in plasma membrane to cytosol at 1 uM	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL27266	=	Ratio		2.86	CHEMBL299	Homo sapiens	Ratio		2.86
	2081809	CHEMBL928833	Inhibition of PKCalpha at 10 uM	B	CC[C@@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)n[nH]c3N)cc2s1		CHEMBL404115	<=	Inhibition	%	20.0	CHEMBL299	Homo sapiens	Inhibition	%	20.0
	2085328	CHEMBL930942	Displacement of [3H]PDBu from PKCalpha C1A domain	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2cn3nc(C(F)(F)F)c4ccc(c2c43)N1C		CHEMBL261387	=	Ki	nM	112.0	CHEMBL299	Homo sapiens	Ki	nM	112.0
	2085329	CHEMBL930942	Displacement of [3H]PDBu from PKCalpha C1A domain	B	Cc1nn2cc3c4c(ccc1c42)N(C)[C@@H](C(C)C)C(=O)N[C@H](CO)C3		CHEMBL441897	=	Ki	nM	1090.0	CHEMBL299	Homo sapiens	Ki	nM	1090.0
	2085330	CHEMBL930942	Displacement of [3H]PDBu from PKCalpha C1A domain	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2cn3ncc4ccc(c2c43)N1C		CHEMBL271403	=	Ki	nM	85.5	CHEMBL299	Homo sapiens	Ki	nM	85.5
	2085337	CHEMBL930945	Displacement of [3H]PDBu from PKCalpha C1B domain	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2cn3nc(C(F)(F)F)c4ccc(c2c43)N1C		CHEMBL261387	=	Ki	nM	721.0	CHEMBL299	Homo sapiens	Ki	nM	721.0
	2085356	CHEMBL930945	Displacement of [3H]PDBu from PKCalpha C1B domain	B	Cc1nn2cc3c4c(ccc1c42)N(C)[C@@H](C(C)C)C(=O)N[C@H](CO)C3		CHEMBL441897	=	Ki	nM	2620.0	CHEMBL299	Homo sapiens	Ki	nM	2620.0
	2085357	CHEMBL930945	Displacement of [3H]PDBu from PKCalpha C1B domain	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2cn3ncc4ccc(c2c43)N1C		CHEMBL271403	=	Ki	nM	357.0	CHEMBL299	Homo sapiens	Ki	nM	357.0
	2085358	CHEMBL930942	Displacement of [3H]PDBu from PKCalpha C1A domain	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL27266	=	Ki	nM	21.0	CHEMBL299	Homo sapiens	Ki	nM	21.0
	2085361	CHEMBL930945	Displacement of [3H]PDBu from PKCalpha C1B domain	B	CC(C)[C@H]1C(=O)N[C@H](CO)Cc2c[nH]c3cccc(c23)N1C		CHEMBL27266	=	Ki	nM	140.0	CHEMBL299	Homo sapiens	Ki	nM	140.0
	2099520	CHEMBL948234	Inhibition of PKCalpha at 10 uM	B	CN(C)CCCOc1cc2c(cc1O)c1c3c(c(-c4ccccc4Cl)cc1n2C)C(=O)NC3=O		CHEMBL410261	=	Inhibition	%	36.0	CHEMBL299	Homo sapiens	Inhibition	%	36.0
	2099596	CHEMBL948234	Inhibition of PKCalpha at 10 uM	B	Cn1c2cc(C(=O)NCCN3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL272267	=	Inhibition	%	35.0	CHEMBL299	Homo sapiens	Inhibition	%	35.0
	2099597	CHEMBL948234	Inhibition of PKCalpha at 10 uM	B	Cn1c2cc(SCCCN3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL404335	=	Inhibition	%	32.0	CHEMBL299	Homo sapiens	Inhibition	%	32.0
	2099598	CHEMBL948234	Inhibition of PKCalpha at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)c(OCCCN3CCOCC3)cc2n1CCO		CHEMBL271715	=	Inhibition	%	11.0	CHEMBL299	Homo sapiens	Inhibition	%	11.0
	2099599	CHEMBL948234	Inhibition of PKCalpha at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)c(OCCCN3CCCC3)cc2n1CCO		CHEMBL270021	=	Inhibition	%	15.0	CHEMBL299	Homo sapiens	Inhibition	%	15.0
	2099600	CHEMBL948234	Inhibition of PKCalpha at 10 uM	B	Cn1c2cc(OCCCN3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL255427	=	Inhibition	%	18.0	CHEMBL299	Homo sapiens	Inhibition	%	18.0
	2115487	CHEMBL950119	Inhibition of PKCalpha	B	Nc1nnc(-c2cnc(-c3ccc(CN4CCC(n5ncc6c(N)ncnc65)CC4)cc3)c(-c3ccccc3)c2)s1		CHEMBL258276	>	Selectivity ratio	nM	10000.0	CHEMBL299	Homo sapiens	Selectivity ratio	nM	10000.0
	2132672	CHEMBL938206	Inhibition of PKCalpha	B	Nc1nccn2c1c(-c1ccc3ccc(-c4ccccc4)nc3c1)nc2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL410659	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	2136853	CHEMBL939359	Inhibition of PKCalpha	B	CCn1cnc2c(N)nc(N(c3cccc(Cl)c3)[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL411901	=	IC50	nM	6100.0	CHEMBL299	Homo sapiens	IC50	nM	6100.0
	2136969	CHEMBL939359	Inhibition of PKCalpha	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	IC50	nM	2.0	CHEMBL299	Homo sapiens	IC50	nM	2.0
	2137081	CHEMBL939359	Inhibition of PKCalpha	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	IC50	nM	331.0	CHEMBL299	Homo sapiens	IC50	nM	331.0
	2137134	CHEMBL939359	Inhibition of PKCalpha	B	O=C1N=C(NCc2cccs2)S/C1=C/c1ccc2ncccc2c1		CHEMBL261644	>	Ki	nM	2000.0	CHEMBL299	Homo sapiens	Ki	nM	2000.0
	2137409	CHEMBL939359	Inhibition of PKCalpha	B	Cl.Oc1cccc(-c2nc(N3CCOCC3)c3sccc3n2)c1		CHEMBL541643	>=	IC50	nM	3400.0	CHEMBL299	Homo sapiens	IC50	nM	3400.0
	2147352	CHEMBL922038	Activity of human PKCalpha kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	108.0	CHEMBL299	Homo sapiens	Activity	%	108.0
Not Evaluated	2149601	CHEMBL931298	Inhibition of human PKCalpha	B	NC(=O)c1c(NC(=O)C2CC2)sc2c1CCCC2		CHEMBL379367		Activity			CHEMBL299	Homo sapiens	Activity		
	2153733	CHEMBL935770	Inhibition of PKCalpha at 20 uM	B	CN(C)CCOc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL409525	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	Inhibition	%	50.0
	2153768	CHEMBL935770	Inhibition of PKCalpha at 20 uM	B	c1ccc(-c2nn3c(c2-c2ccnc4cc(OCCN5CCOCC5)ccc24)CCC3)nc1		CHEMBL260015	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	Inhibition	%	50.0
	2158778	CHEMBL922541	Inhibition of PKCalpha	B	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1	Outside typical range	CHEMBL259922	=	IC50	nM	188000.0	CHEMBL299	Homo sapiens	IC50	uM	188.0
	2164865	CHEMBL929429	Inhibition of PKCalpha	B	Cc1nnc(-c2cn3ncnc(Nc4cnc5[nH]ccc5c4)c3c2C(C)C)o1		CHEMBL258694	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	nM	50000.0
	2164874	CHEMBL929429	Inhibition of PKCalpha	B	Cc1cc2cc(Nc3ncnn4cc(-c5nnc(C)o5)c(C(C)C)c34)cnc2[nH]1		CHEMBL261592	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	nM	50000.0
Not Active	2170337	CHEMBL927896	Activity at PKCalpha at 3 uM	B	COc1c(NC(=O)c2ccc(C)c(N3C=C(C(=O)NCC(C)(C)CN(C)C)NN3)c2)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL254992		Activity			CHEMBL299	Homo sapiens	Activity		
	2182369	CHEMBL950790	Inhibition of PKCalpha	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	IC50	nM	2.3	CHEMBL299	Homo sapiens	IC50	nM	2.3
	2182441	CHEMBL941341	Inhibition of human PKCalpha at 1 uM	B	CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4c(c3)CCC(=O)N4)ncc2C(F)(F)F)c1		CHEMBL514554	=	Inhibition	%	12.0	CHEMBL299	Homo sapiens	INH	%	12.0
	2182443	CHEMBL941342	Inhibition of human ROCK2 at 1 uM	B	CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4c(c3)CCC(=O)N4)ncc2C(F)(F)F)c1		CHEMBL514554	=	Inhibition	%	8.0	CHEMBL299	Homo sapiens	INH	%	8.0
	2186737	CHEMBL966659	Inhibition of human PKCalpha by scintiplate assay	B	N#Cc1cnc2c(Cl)cc(NCc3cnc[nH]3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL436817	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	2204091	CHEMBL991514	Agonist activity at protein kinase C alpha at 50 pg/mL	F	CC(CCCCCCCCc1ccccc1)C[C@]1(C)C[C@]2(C)OC(=O)C[C@@H]2OO1		CHEMBL460022	=	Activity	%	19.0	CHEMBL299	Homo sapiens	Activity	%	19.0
	2204097	CHEMBL991520	Antagonist activity at protein kinase C alpha	F	CCCCCCCCCCCCCCCC[C@@]1(OC)C=C[C@@H](CC(=O)OC)OO1		CHEMBL163015	=	IC50	ug.mL-1	36.0	CHEMBL299	Homo sapiens	IC50	ug ml-1	36.0
	2234586	CHEMBL1003895	Inhibition of PKCalpha	B	O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL509101	>	IC50	nM	30000.0	CHEMBL299	Homo sapiens	IC50	nM	30000.0
	2239717	CHEMBL996946	Inhibition of PKCalpha at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)ccc2n1CCCc1nnn[nH]1		CHEMBL471329	=	Inhibition	%	63.0	CHEMBL299	Homo sapiens	INH	%	63.0
	2239745	CHEMBL996946	Inhibition of PKCalpha at 10 uM	B	CS(=O)(=O)NC(=O)CCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL460940	=	Inhibition	%	32.0	CHEMBL299	Homo sapiens	INH	%	32.0
	2239773	CHEMBL996946	Inhibition of PKCalpha at 10 uM	B	CN(C)CCNC(=O)CCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL462011	=	Inhibition	%	39.0	CHEMBL299	Homo sapiens	INH	%	39.0
	2239801	CHEMBL996946	Inhibition of PKCalpha at 10 uM	B	CNCCCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL508541	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2239829	CHEMBL996946	Inhibition of PKCalpha at 10 uM	B	CNCCCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4)cc21)C(=O)NC3=O		CHEMBL455192	=	Inhibition	%	5.0	CHEMBL299	Homo sapiens	INH	%	5.0
	2239857	CHEMBL996946	Inhibition of PKCalpha at 10 uM	B	O=C1NC(=O)c2c1c(-c1c(Cl)cccc1Cl)cc1c2c2cc(O)ccc2n1CCCO		CHEMBL471163	=	Inhibition	%	12.0	CHEMBL299	Homo sapiens	INH	%	12.0
	2239884	CHEMBL996946	Inhibition of PKCalpha at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)ccc2n1CCCO		CHEMBL411662	=	Inhibition	%	20.0	CHEMBL299	Homo sapiens	INH	%	20.0
	2239912	CHEMBL996946	Inhibition of PKCalpha at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	=	Inhibition	%	58.0	CHEMBL299	Homo sapiens	INH	%	58.0
	2251057	CHEMBL1011932	Inhibition of PKCalpha at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL525385	=	Inhibition	%	94.0	CHEMBL299	Homo sapiens	INH	%	94.0
	2279743	CHEMBL958308	Inhibition of PKCalpha at 10 uM	B	CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1		CHEMBL493937	>	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
Not Active	2298914	CHEMBL1018060	Inhibition of human PKCalpha at 10 umol/L	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C(=O)N(C)C)cc1)c1ccccc1		CHEMBL525203		Activity			CHEMBL299	Homo sapiens	Activity		
Not Active	2298940	CHEMBL1018060	Inhibition of human PKCalpha at 10 umol/L	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL497049		Activity			CHEMBL299	Homo sapiens	Activity		
Not Active	2298941	CHEMBL1018060	Inhibition of human PKCalpha at 10 umol/L	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835		Activity			CHEMBL299	Homo sapiens	Activity		
Not Active	2302157	CHEMBL950826	Inhibition of PKCalpha at 10 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL299	Homo sapiens	INH		
	2325288	CHEMBL997395	Inhibition of human recombinant PKCalpha	B	OC[C@H]1O[C@@H](O[C@H](CCCCc2ccc(O)c(O)c2)CCc2ccc(O)c(O)c2)[C@H](O)[C@@H](O)[C@@H]1O		CHEMBL464362	=	IC50	ug.mL-1	1.4	CHEMBL299	Homo sapiens	IC50	ug ml-1	1.4
	2325289	CHEMBL997395	Inhibition of human recombinant PKCalpha	B	O=C(CCc1ccc(O)c(O)c1)C[C@@H](O)CCc1ccc(O)c(O)c1		CHEMBL455297	=	IC50	ug.mL-1	4.6	CHEMBL299	Homo sapiens	IC50	ug ml-1	4.6
	2325290	CHEMBL997395	Inhibition of human recombinant PKCalpha	B	O=C(CCc1ccc(O)c(O)c1)C[C@H](CCc1ccc(O)c(O)c1)O[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O		CHEMBL464570	=	IC50	ug.mL-1	8.6	CHEMBL299	Homo sapiens	IC50	ug ml-1	8.6
	2325291	CHEMBL997395	Inhibition of human recombinant PKCalpha	B	O=C(/C=C/CCc1ccc(O)c(O)c1)CCc1ccc(O)c(O)c1		CHEMBL464274	=	IC50	ug.mL-1	1.4	CHEMBL299	Homo sapiens	IC50	ug ml-1	1.4
	2325292	CHEMBL997395	Inhibition of human recombinant PKCalpha	B	Oc1ccc(CCCC[C@@H](O)CCc2ccc(O)c(O)c2)cc1O		CHEMBL464363	=	IC50	ug.mL-1	1.6	CHEMBL299	Homo sapiens	IC50	ug ml-1	1.6
	2325293	CHEMBL997396	Inhibition of human recombinant PKCalpha	B	COc1ccc(CCO[C@@H]2O[C@H](CO[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@@H](OC(=O)/C=C/c3ccc(O)c(OC)c3)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@H]2O)cc1O	Outside typical range	CHEMBL506920	=	IC50	nM	125000.0	CHEMBL299	Homo sapiens	IC50	uM	125.0
	2325294	CHEMBL997396	Inhibition of human recombinant PKCalpha	B	C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCc3ccc(O)c(O)c3)O[C@H](CO)[C@H]2OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O		CHEMBL444478	=	IC50	nM	9300.0	CHEMBL299	Homo sapiens	IC50	uM	9.3
	2325295	CHEMBL997396	Inhibition of human recombinant PKCalpha	B	COc1cc(/C=C/C(=O)O[C@@H]2[C@@H](CO)O[C@@H](OCCc3ccc(O)c(O)c3)[C@H](O)[C@H]2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)ccc1O		CHEMBL450121	=	IC50	nM	19000.0	CHEMBL299	Homo sapiens	IC50	uM	19.0
	2325296	CHEMBL997396	Inhibition of human recombinant PKCalpha	B	O=C(/C=C/c1ccc(O)c(O)c1)OC[C@H]1O[C@@H](OCCc2ccc(O)c(O)c2)[C@H](O)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]1O		CHEMBL452413	=	IC50	nM	14800.0	CHEMBL299	Homo sapiens	IC50	uM	14.8
	2325297	CHEMBL997396	Inhibition of human recombinant PKCalpha	B	C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OCCc3ccc(O)c(O)c3)[C@H](O)[C@@H](O)[C@@H]2OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O		CHEMBL504363	=	IC50	nM	1900.0	CHEMBL299	Homo sapiens	IC50	uM	1.9
	2325298	CHEMBL997396	Inhibition of human recombinant PKCalpha	B	O=C(/C=C/c1ccc(O)c(O)c1)OC[C@H]1O[C@@H](OCCc2ccc(O)c(O)c2)[C@H](O)[C@@H](O)[C@@H]1O		CHEMBL518414	=	IC50	nM	4600.0	CHEMBL299	Homo sapiens	IC50	uM	4.6
	2325299	CHEMBL997396	Inhibition of human recombinant PKCalpha	B	O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1[C@@H](CO)O[C@@H](OCCc2ccc(O)c(O)c2)[C@H](O)[C@H]1O		CHEMBL481635	=	IC50	nM	600.0	CHEMBL299	Homo sapiens	IC50	uM	0.6
	2325300	CHEMBL997396	Inhibition of human recombinant PKCalpha	B	C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCc3ccc(O)c(O)c3)O[C@H](CO[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@H]2OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O		CHEMBL499145	=	IC50	nM	24400.0	CHEMBL299	Homo sapiens	IC50	uM	24.4
	2336806	CHEMBL1028405	Displacement of [3H]PDBu form PKCalpha	B	COC(=O)/C=C1/C[C@H]2C[C@]3(O)O[C@@H](C[C@H](OC(=O)C(C)(C)C)C3(C)C)C[C@@H](O)CC(=O)O[C@@H]([C@@H](C)O)C[C@@H]3C/C(=C\C(=O)OC)C[C@@](O)(O3)C(C)(C)/C=C/[C@@H](C1)O2		CHEMBL501262	=	Ki	nM	1.56	CHEMBL299	Homo sapiens	Ki	nM	1.56
	2336807	CHEMBL1028405	Displacement of [3H]PDBu form PKCalpha	B	COC(=O)/C=C1/C[C@H]2C[C@]3(O)O[C@@H](C[C@H](OC(=O)C(C)(C)C)C3(C)C)C[C@@H](O)CC(=O)O[C@@H]([C@@H](C)O)C[C@@H]3C/C(=C/C(=O)OC)C[C@@](O)(O3)C(C)(C)/C=C/[C@@H](C1)O2		CHEMBL505767	=	Ki	nM	4.82	CHEMBL299	Homo sapiens	Ki	nM	4.82
	2336808	CHEMBL1028405	Displacement of [3H]PDBu form PKCalpha	B	COC(=O)/C=C1\C=C2O[C@@H](C1)C[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H]1C[C@H](OC(=O)C(C)(C)C)C(C)(C)[C@](O)(C[C@@H]3C/C(=C/C(=O)OC)C[C@H](/C=C/C2(C)C)O3)O1		CHEMBL452391	=	Ki	nM	188.0	CHEMBL299	Homo sapiens	Ki	nM	188.0
	2336809	CHEMBL1028405	Displacement of [3H]PDBu form PKCalpha	B	COC(=O)/C=C1/C[C@H]2C[C@]3(O)O[C@@H](C[C@H](OC(=O)C(C)(C)C)C3(C)C)C[C@@H](O)CC(=O)O[C@@H]([C@@H](C)O)C[C@@H]3C/C(=C\C(=O)OC)C=C(O3)C(C)(C)/C=C/[C@@H](C1)O2		CHEMBL509516	=	Ki	nM	118.0	CHEMBL299	Homo sapiens	Ki	nM	118.0
	2341429	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(C(=O)Cc4c[nH]c5ccccc45)CC3)ncn2)c1		CHEMBL524898	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2341470	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL501459	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2341511	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCCc3ccc(O)cc3)CC2)n1		CHEMBL501728	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2341552	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	O=C(NCCc1ccc(O)cc1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL499617	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2341593	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2cc(Nc3cccc(Br)c3)ncn2)CC1		CHEMBL501200	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2341634	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)N[C@@H](CO)c2ccccc2)n1		CHEMBL525070	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2341675	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)NCCc2cccc(I)c2)n1		CHEMBL501463	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2341716	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	O=C(NC1Cc2ccccc2C1)c1cccc(Nc2ccnc(N3CCN(c4ccccc4)CC3)n2)c1		CHEMBL499624	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2341757	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)ncn2)c1		CHEMBL502826	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2341798	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3ccc(CC(=O)Nc4ccc5ncsc5c4)cc3)ncn2)c1		CHEMBL502827	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2341839	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	COc1ccc(NC(=O)Cc2ccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)cc2)cn1		CHEMBL526914	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2341880	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)n2)c1		CHEMBL501471	=	Inhibition	%	3.0	CHEMBL299	Homo sapiens	INH	%	3.0
	2341921	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	O=C(NCc1cccnc1)c1cccc(-c2ccc(Nc3ccc4ncsc4c3)nn2)c1		CHEMBL501182	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2341962	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N4CCCC5CCCCC54)c3)ncn2)c1		CHEMBL499606	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2342003	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)nc(N)n2)c1		CHEMBL499865	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2342044	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)n2)c1		CHEMBL499866	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2342085	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	O=C(CN1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1)Nc1cc(F)ccc1F		CHEMBL520451	=	Inhibition	%	4.0	CHEMBL299	Homo sapiens	INH	%	4.0
	2342126	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	O=C(NCc1ccncc1)c1cccc(Nc2cc(Nc3cccc(Br)c3)ncn2)c1		CHEMBL482513	=	Inhibition	%	2.0	CHEMBL299	Homo sapiens	INH	%	2.0
	2342167	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2cc(Nc3cccc(C(=O)N(CC(C)O)CC(C)O)c3)ncn2)c1		CHEMBL483318	=	Inhibition	%	1.0	CHEMBL299	Homo sapiens	INH	%	1.0
	2342218	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)ncn2)c1		CHEMBL520971	=	Inhibition	%	7.0	CHEMBL299	Homo sapiens	INH	%	7.0
	2342256	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)ncn2)c1		CHEMBL521469	=	Inhibition	%	5.0	CHEMBL299	Homo sapiens	INH	%	5.0
	2342290	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	CC(=O)N1CCN(C(=O)c2cccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)c2)CC1		CHEMBL521478	=	Inhibition	%	6.0	CHEMBL299	Homo sapiens	INH	%	6.0
	2342331	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccncc4)c3)ncn2)c1		CHEMBL483506	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2342372	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL483507	=	Inhibition	%	5.0	CHEMBL299	Homo sapiens	INH	%	5.0
	2342413	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)nc(N)n2)c1		CHEMBL520980	=	Inhibition	%	2.0	CHEMBL299	Homo sapiens	INH	%	2.0
	2342454	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1cc(Nc2cccc(OC)c2)nc(N)n1		CHEMBL519962	=	Inhibition	%	5.0	CHEMBL299	Homo sapiens	INH	%	5.0
	2342495	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCN3CCCCC3)nc(N)n2)c1		CHEMBL526526	=	Inhibition	%	5.0	CHEMBL299	Homo sapiens	INH	%	5.0
	2342536	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	O=C(COc1ccccc1)N1CCN(c2nccc(Nc3ccc4ncsc4c3)n2)CC1		CHEMBL482488	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2342809	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	O=C(NC[C@@H]1CCCO1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL500661	=	Inhibition	%	1.0	CHEMBL299	Homo sapiens	INH	%	1.0
	2342842	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Clc1ccc2sc(CN3CCN(c4ncnc5c4CN(Cc4ccccc4)CC5)CC3)cc2c1		CHEMBL483710	=	Inhibition	%	8.0	CHEMBL299	Homo sapiens	INH	%	8.0
	2342983	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccccc2)cc(N2CCC(C(=O)NCCc3ccccn3)CC2)n1		CHEMBL521002	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2342984	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Cc1ccc(CN2CCN(c3nccc(C(C#N)c4ccccn4)n3)CC2)cc1		CHEMBL521145	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2342985	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	CN(CCCn1ccnc1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519658	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2342986	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(CC(C)C)CC(C)C)c3)ncn2)c1		CHEMBL484707	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2342987	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	O=C(C1CCN(c2nccc(Nc3ccccc3)n2)CC1)N1CC[C@@H](O)C1		CHEMBL484706	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2342988	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521000	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2342989	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519349	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2342990	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)C1CCCN1c1cc(Nc2cccc(Br)c2)ncn1		CHEMBL484521	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2342991	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2ncnc3c2CN(C(=O)c2ccc(N(C)C)c4ccccc24)CC3)c1		CHEMBL484324	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2342992	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	CN(C)c1ccc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c2ccccc12		CHEMBL520331	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2342993	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1		CHEMBL446637	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2342994	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCCCn3ccnc3)n2)c1		CHEMBL482722	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2342995	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)C1CCN(c2cc(N3CCOCC3)nc(N)n2)CC1		CHEMBL519311	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2342996	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(C(=O)c4c(C)noc4C)CC3)n2)c1		CHEMBL482721	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2342997	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	COC(=O)C(CO)NC(=O)[C@@H]1CCCN1c1nccc(Oc2cccc(C)c2)n1		CHEMBL519310	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2342998	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCc3cccnc3)n2)c1		CHEMBL482717	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2342999	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCc3ccc(O)cc3)nc(N)n2)c1		CHEMBL483518	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2343000	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCc3cccs3)CC2)n1		CHEMBL482910	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2343001	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Cc1cc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c(C)n1C		CHEMBL482710	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2343002	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc(C(=O)NCCc3ccncc3)cc2)cc(N2CCOCC2)n1		CHEMBL485524	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2343003	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	COc1ccc(-c2noc(CN3CCN(c4cc(Nc5cccc(O)c5)ncn4)CC3)n2)cc1		CHEMBL483715	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2343004	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	CC(=O)CCCCC(=O)N1CCN(c2nccc(Oc3cccc(C)c3)n2)CC1		CHEMBL484713	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2343005	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(CC(=O)Nc4cccc5c4CCCC5)CC3)n2)c1		CHEMBL520512	=	Inhibition	%	3.0	CHEMBL299	Homo sapiens	INH	%	3.0
	2343006	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(CN2CCN(c3cc(N(C)c4cccc(C)c4)ncn3)CC2)c1		CHEMBL446087	=	Inhibition	%	3.0	CHEMBL299	Homo sapiens	INH	%	3.0
	2343007	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc3c2CN(C(=O)c2cc(C)n(C)c2C)CC3)c1		CHEMBL519146	=	Inhibition	%	1.0	CHEMBL299	Homo sapiens	INH	%	1.0
	2343008	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(CC(=O)Nc4nc(-c5ccccc5)cs4)CC3)ncn2)c1		CHEMBL519534	=	Inhibition	%	3.0	CHEMBL299	Homo sapiens	INH	%	3.0
	2343009	CHEMBL953390	Inhibition of PKCalpha at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521479	=	Inhibition	%	1.0	CHEMBL299	Homo sapiens	INH	%	1.0
	2356955	CHEMBL959102	Inhibition of PKCalpha at 1 uM relative to control	B	Cc1ccn(-c2cccc(C(F)(F)F)c2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL504805	>	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
	2361591	CHEMBL971636	Inhibition of PKCalpha	B	Cc1cc(C2CCN(CCCF)CC2)cc2[nH]c(-c3c(NCCn4cc(Cl)cn4)cc[nH]c3=O)nc12		CHEMBL459729	=	IC50	nM	11000.0	CHEMBL299	Homo sapiens	IC50	uM	11.0
	2376848	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	CN(C)c1ccc(C(=O)OCC2(CO)C/C(=C\c3ccccn3)C(=O)O2)cc1		CHEMBL487483	=	Ki	nM	1020.0	CHEMBL299	Homo sapiens	Ki	nM	1020.0
	2376849	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	CCCC(CCC)C(=O)OCC1(CO)C/C(=C\c2cn(C)c3ccccc23)C(=O)O1		CHEMBL519741	=	Ki	nM	29.7	CHEMBL299	Homo sapiens	Ki	nM	29.7
	2376850	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	CCCC(CCC)C(=O)OCC1(CO)C/C(=C/c2cnc3ccccc3c2)C(=O)O1		CHEMBL488707	=	Ki	nM	177.0	CHEMBL299	Homo sapiens	Ki	nM	177.0
	2376851	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	CCCC(CCC)C(=O)OCC1(CO)C/C(=C\c2cnc3ccccc3c2)C(=O)O1		CHEMBL488872	=	Ki	nM	13.8	CHEMBL299	Homo sapiens	Ki	nM	13.8
	2376852	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	CCCC(CCC)C(=O)OCC1(CO)C/C(=C/c2ccc3ccccc3n2)C(=O)O1		CHEMBL488871	=	Ki	nM	78.8	CHEMBL299	Homo sapiens	Ki	nM	78.8
	2376853	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	CCCC(CCC)C(=O)OCC1(CO)C/C(=C\c2ccc3ccccc3n2)C(=O)O1		CHEMBL529000	=	Ki	nM	51.9	CHEMBL299	Homo sapiens	Ki	nM	51.9
	2376854	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	CCCC(CCC)C(=O)OCC1(CO)C/C(=C/c2ccncc2)C(=O)O1		CHEMBL443643	=	Ki	nM	870.0	CHEMBL299	Homo sapiens	Ki	nM	870.0
	2376855	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	CCCC(CCC)C(=O)OCC1(CO)C/C(=C\c2ccncc2)C(=O)O1		CHEMBL472523	=	Ki	nM	627.0	CHEMBL299	Homo sapiens	Ki	nM	627.0
	2376856	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	CCCC(CCC)C(=O)OCC1(CO)C/C(=C/c2cccnc2)C(=O)O1		CHEMBL511847	=	Ki	nM	3270.0	CHEMBL299	Homo sapiens	Ki	nM	3270.0
	2376857	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	CCCC(CCC)C(=O)OCC1(CO)C/C(=C\c2cccnc2)C(=O)O1		CHEMBL472522	=	Ki	nM	76.0	CHEMBL299	Homo sapiens	Ki	nM	76.0
	2376858	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	CCCC(CCC)C(=O)OCC1(CO)C/C(=C/c2ccccn2)C(=O)O1		CHEMBL512538	=	Ki	nM	1370.0	CHEMBL299	Homo sapiens	Ki	nM	1370.0
	2376859	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	CCCC(CCC)C(=O)OCC1(CO)C/C(=C\c2ccccn2)C(=O)O1		CHEMBL472007	=	Ki	nM	86.3	CHEMBL299	Homo sapiens	Ki	nM	86.3
	2376860	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	COc1ccc(C(=O)OCC2(CO)C/C(=C\c3cn(C)c4ccccc34)C(=O)O2)cc1		CHEMBL488674	=	Ki	nM	212.0	CHEMBL299	Homo sapiens	Ki	nM	212.0
	2376861	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	COc1ccc(C(=O)OCC2(CO)C/C(=C/c3cnc4ccccc4c3)C(=O)O2)cc1		CHEMBL528323	=	Ki	nM	5100.0	CHEMBL299	Homo sapiens	Ki	nM	5100.0
	2377881	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	COc1ccc(C(=O)OCC2(CO)C/C(=C\c3cnc4ccccc4c3)C(=O)O2)cc1		CHEMBL488509	=	Ki	nM	144.0	CHEMBL299	Homo sapiens	Ki	nM	144.0
	2377882	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	COc1ccc(C(=O)OCC2(CO)C/C(=C/c3ccc4ccccc4n3)C(=O)O2)cc1		CHEMBL530337	=	Ki	nM	2940.0	CHEMBL299	Homo sapiens	Ki	nM	2940.0
	2377883	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	COc1ccc(C(=O)OCC2(CO)C/C(=C\c3ccc4ccccc4n3)C(=O)O2)cc1		CHEMBL487473	=	Ki	nM	132.0	CHEMBL299	Homo sapiens	Ki	nM	132.0
	2377884	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	COc1ccc(C(=O)OCC2(CO)C/C(=C/c3ccncc3)C(=O)O2)cc1		CHEMBL486457	=	Ki	nM	25400.0	CHEMBL299	Homo sapiens	Ki	nM	25400.0
	2377885	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	COc1ccc(C(=O)OCC2(CO)C/C(=C\c3ccncc3)C(=O)O2)cc1		CHEMBL487822	=	Ki	nM	1450.0	CHEMBL299	Homo sapiens	Ki	nM	1450.0
	2377886	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	COc1ccc(C(=O)OCC2(CO)C/C(=C/c3cccnc3)C(=O)O2)cc1		CHEMBL472006	=	Ki	nM	21200.0	CHEMBL299	Homo sapiens	Ki	nM	21200.0
	2377887	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	COc1ccc(C(=O)OCC2(CO)C/C(=C\c3cccnc3)C(=O)O2)cc1		CHEMBL471316	=	Ki	nM	810.0	CHEMBL299	Homo sapiens	Ki	nM	810.0
	2377888	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	COc1ccc(C(=O)OCC2(CO)C/C(=C/c3ccccn3)C(=O)O2)cc1		CHEMBL513379	=	Ki	nM	27100.0	CHEMBL299	Homo sapiens	Ki	nM	27100.0
	2377889	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	COc1ccc(C(=O)OCC2(CO)C/C(=C\c3ccccn3)C(=O)O2)cc1		CHEMBL470094	=	Ki	nM	1130.0	CHEMBL299	Homo sapiens	Ki	nM	1130.0
	2377890	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	CN(C)c1ccc(C(=O)OCC2(CO)C/C(=C\c3cn(C)c4ccccc34)C(=O)O2)cc1		CHEMBL472521	=	Ki	nM	174.0	CHEMBL299	Homo sapiens	Ki	nM	174.0
	2377891	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	CN(C)c1ccc(C(=O)OCC2(CO)C/C(=C/c3cnc4ccccc4c3)C(=O)O2)cc1		CHEMBL472351	=	Ki	nM	4880.0	CHEMBL299	Homo sapiens	Ki	nM	4880.0
	2377892	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	CN(C)c1ccc(C(=O)OCC2(CO)C/C(=C\c3cnc4ccccc4c3)C(=O)O2)cc1		CHEMBL472183	=	Ki	nM	755.0	CHEMBL299	Homo sapiens	Ki	nM	755.0
	2377893	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	CN(C)c1ccc(C(=O)OCC2(CO)C/C(=C/c3ccc4ccccc4n3)C(=O)O2)cc1		CHEMBL471142	=	Ki	nM	15800.0	CHEMBL299	Homo sapiens	Ki	nM	15800.0
	2377894	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	CN(C)c1ccc(C(=O)OCC2(CO)C/C(=C\c3ccc4ccccc4n3)C(=O)O2)cc1		CHEMBL511472	=	Ki	nM	150.0	CHEMBL299	Homo sapiens	Ki	nM	150.0
	2377895	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	CN(C)c1ccc(C(=O)OCC2(CO)C/C(=C/c3ccncc3)C(=O)O2)cc1		CHEMBL488671	=	Ki	nM	33200.0	CHEMBL299	Homo sapiens	Ki	nM	33200.0
	2377896	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	CN(C)c1ccc(C(=O)OCC2(CO)C/C(=C\c3ccncc3)C(=O)O2)cc1		CHEMBL488670	=	Ki	nM	1110.0	CHEMBL299	Homo sapiens	Ki	nM	1110.0
	2377897	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	CN(C)c1ccc(C(=O)OCC2(CO)C/C(=C/c3cccnc3)C(=O)O2)cc1		CHEMBL488506	=	Ki	nM	34100.0	CHEMBL299	Homo sapiens	Ki	nM	34100.0
	2377898	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	CN(C)c1ccc(C(=O)OCC2(CO)C/C(=C\c3cccnc3)C(=O)O2)cc1		CHEMBL487484	=	Ki	nM	790.0	CHEMBL299	Homo sapiens	Ki	nM	790.0
	2377995	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	CC(C)CC(CC(C)C)C(=O)OCC1(CO)C/C(=C\c2ccccn2)C(=O)O1		CHEMBL530110	=	Ki	nM	4.6	CHEMBL299	Homo sapiens	Ki	nM	4.6
	2377998	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	CC(C)CC(CC(C)C)C(=O)OCC1(CO)C/C(=C\c2cn(C)c3ccccc23)C(=O)O1		CHEMBL488667	=	Ki	nM	14.8	CHEMBL299	Homo sapiens	Ki	nM	14.8
	2378001	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	CN(C)c1ccc(C(=O)OCC2(CO)C/C(=C\c3ccc([N+](=O)[O-])cc3)C(=O)O2)cc1		CHEMBL488675	=	Ki	nM	343.0	CHEMBL299	Homo sapiens	Ki	nM	343.0
	2378002	CHEMBL977316	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Escherichia coli BL21-21-Gold (DE3)	B	COc1ccc(C(=O)OCC2(CO)C/C(=C\c3ccc([N+](=O)[O-])cc3)C(=O)O2)cc1		CHEMBL488668	=	Ki	nM	136.0	CHEMBL299	Homo sapiens	Ki	nM	136.0
	2409515	CHEMBL959250	Inhibition of PKCalpha	B	NC[C@H](Cc1cccc(F)c1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1		CHEMBL523586	=	IC50	nM	40.0	CHEMBL299	Homo sapiens	IC50	nM	40.0
	2417669	CHEMBL955068	Inhibition of human PKCalpha at 10 uM	B	O=C1NN(c2ccc(Cl)c(Cl)c2)C(=O)/C1=C/c1ccc(O)c([N+](=O)[O-])c1		CHEMBL511636	=	Activity	%	82.0	CHEMBL299	Homo sapiens	Activity	%	82.0
	2417670	CHEMBL955068	Inhibition of human PKCalpha at 10 uM	B	COc1cc(/C=C2\C(=O)NN(c3ccc(C#N)cc3)C2=O)ccc1O		CHEMBL498718	=	Activity	%	77.0	CHEMBL299	Homo sapiens	Activity	%	77.0
	2419147	CHEMBL1019635	Inhibition of PRKCA at 1 uM	B	C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(ccc([C@H]3C[C@@H](N(C)C)[C@H](O)[C@@H](C)O3)c1O)C2=O		CHEMBL2216825	=	Inhibition	%	16.0	CHEMBL299	Homo sapiens	INH	%	16.0
	2420221	CHEMBL994312	Inhibition of human PKCalpha	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	2420238	CHEMBL994312	Inhibition of human PKCalpha	B	CC(C)[C@H](CO)Nc1nc(Nc2ccc(C(=O)O)c(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23254	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	nM	100000.0
	2430671	CHEMBL1018244	Agonist activity at PKCalpha at 50 ug/ml	F	CC(CCCCCCCCc1ccccc1)C[C@]1(C)C[C@]2(C)OC(=O)C[C@@H]2OO1		CHEMBL460022	=	Activity	%	-19.0	CHEMBL299	Homo sapiens	Activity	%	-19.0
	2430677	CHEMBL1018250	Inhibition of PKCalpha	B	CCCCCCCCCCCCCCCC[C@@]1(OC)C=C[C@@H](CC(=O)OC)OO1		CHEMBL163015	=	IC50	ug.mL-1	36.0	CHEMBL299	Homo sapiens	IC50	ug ml-1	36.0
Not Determined	2430678	CHEMBL1018250	Inhibition of PKCalpha	B	CC(CCCCCCc1ccccc1)CC(C)C[C@]1(C)C[C@]2(C)OC(=O)C[C@@H]2OO1		CHEMBL462106		Activity			CHEMBL299	Homo sapiens	Activity		
Not Determined	2430679	CHEMBL1018250	Inhibition of PKCalpha	B	COC(=O)C[C@@]1(C)C[C@](C)(CC(C)CCCCCCc2ccccc2)OO1		CHEMBL462107		Activity			CHEMBL299	Homo sapiens	Activity		
	2451259	CHEMBL1013130	Inhibition of human PKCalpha at 10 uM	B	CCC(Nc1cc(-c2[nH]c(SC)nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL494666	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2452039	CHEMBL1013130	Inhibition of human PKCalpha at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Inhibition	%	30.0	CHEMBL299	Homo sapiens	INH	%	30.0
	2452040	CHEMBL1013130	Inhibition of human PKCalpha at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Inhibition	%	8.0	CHEMBL299	Homo sapiens	INH	%	8.0
	2452041	CHEMBL1013130	Inhibition of human PKCalpha at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Inhibition	%	11.0	CHEMBL299	Homo sapiens	INH	%	11.0
	2452042	CHEMBL1013130	Inhibition of human PKCalpha at 10 uM	B	COCCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC2CCCCC2)c1		CHEMBL481943	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2452043	CHEMBL1013130	Inhibition of human PKCalpha at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCC3CCCO3)c2)[nH]1		CHEMBL480952	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2452044	CHEMBL1013130	Inhibition of human PKCalpha at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)CCCC(C)C)c2)[nH]1		CHEMBL518964	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2452045	CHEMBL1013130	Inhibition of human PKCalpha at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCCc3cccs3)c2)[nH]1		CHEMBL519617	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2452046	CHEMBL1013130	Inhibition of human PKCalpha at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)CCc3ccccc3)c2)[nH]1		CHEMBL493669	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2452047	CHEMBL1013130	Inhibition of human PKCalpha at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCc4ccccc43)c2)[nH]1		CHEMBL494871	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	2476692	CHEMBL985405	Binding affinity to human PKCA at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582	=	Activity	%	3.4	CHEMBL299	Homo sapiens	Activity	%	3.4
Not Evaluated	2476895	CHEMBL985405	Binding affinity to human PKCA at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL299	Homo sapiens	Activity		
Not Evaluated	2478734	CHEMBL985405	Binding affinity to human PKCA at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL299	Homo sapiens	Activity		
Not Evaluated	2479589	CHEMBL985405	Binding affinity to human PKCA at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL299	Homo sapiens	Activity		
Not Evaluated	2479792	CHEMBL985405	Binding affinity to human PKCA at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167		Activity			CHEMBL299	Homo sapiens	Activity		
	2480589	CHEMBL985405	Binding affinity to human PKCA at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	2.5	CHEMBL299	Homo sapiens	Activity	%	2.5
Not Evaluated	2480791	CHEMBL985405	Binding affinity to human PKCA at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL299	Homo sapiens	Activity		
	2488591	CHEMBL951833	Inhibition of human PKCalpha by scintillation proximity assay	B	CC(=O)C1=C(O)C=C2Oc3c(C(N)=O)c(O)cc(O)c3[C@]2(C)C1=O		CHEMBL475816	=	IC50	nM	1020.0	CHEMBL299	Homo sapiens	IC50	uM	1.02
Not Active	2488627	CHEMBL1024657	Inhibition of PKCalpha at 1 uM	B	CC(=O)C1=C(O)C=C2Oc3c4c(cc(O)c3[C@]2(C)C1=O)OC(C)(C)NC4=O		CHEMBL474846		Activity			CHEMBL299	Homo sapiens	Activity		
	2509792	CHEMBL1000236	Displacement of [3H]PDBu form human PKCalpha in presence of phosphatidylserine	B	CC(C)=C1CC(CO)(COC(=O)COc2ccc(C#Cc3ccc(C)cc3)cc2)OC1=O		CHEMBL523155	=	Ki	nM	38.0	CHEMBL299	Homo sapiens	Ki	nM	38.0
	2509797	CHEMBL1000241	Displacement of [3H]PDBu form human PKCalpha in presence of plasma membrane lipid mimetic mixture	B	CC(C)=C1CC(CO)(COC(=O)COc2ccc(C#Cc3ccc(C)cc3)cc2)OC1=O		CHEMBL523155	=	Ki	nM	165.1	CHEMBL299	Homo sapiens	Ki	nM	165.1
	2509802	CHEMBL1000236	Displacement of [3H]PDBu form human PKCalpha in presence of phosphatidylserine	B	CC(C)=C1CC(CO)(COC(=O)CCOc2ccc(C#Cc3ccc(C)cc3)cc2)OC1=O		CHEMBL492118	=	Ki	nM	20.8	CHEMBL299	Homo sapiens	Ki	nM	20.8
	2509807	CHEMBL1000241	Displacement of [3H]PDBu form human PKCalpha in presence of plasma membrane lipid mimetic mixture	B	CC(C)=C1CC(CO)(COC(=O)CCOc2ccc(C#Cc3ccc(C)cc3)cc2)OC1=O		CHEMBL492118	=	Ki	nM	143.0	CHEMBL299	Homo sapiens	Ki	nM	143.0
	2509812	CHEMBL1000236	Displacement of [3H]PDBu form human PKCalpha in presence of phosphatidylserine	B	CC(C)=C1CC(CO)(COC(=O)CCCOc2ccc(C#Cc3ccc(C)cc3)cc2)OC1=O		CHEMBL489520	=	Ki	nM	19.5	CHEMBL299	Homo sapiens	Ki	nM	19.5
	2509817	CHEMBL1000241	Displacement of [3H]PDBu form human PKCalpha in presence of plasma membrane lipid mimetic mixture	B	CC(C)=C1CC(CO)(COC(=O)CCCOc2ccc(C#Cc3ccc(C)cc3)cc2)OC1=O		CHEMBL489520	=	Ki	nM	76.0	CHEMBL299	Homo sapiens	Ki	nM	76.0
	2509822	CHEMBL1000236	Displacement of [3H]PDBu form human PKCalpha in presence of phosphatidylserine	B	CC(C)=C1CC(CO)(COC(=O)c2ccc(C#Cc3ccc(C)cc3)cc2)OC1=O		CHEMBL522428	=	Ki	nM	6.0	CHEMBL299	Homo sapiens	Ki	nM	6.0
	2509827	CHEMBL1000241	Displacement of [3H]PDBu form human PKCalpha in presence of plasma membrane lipid mimetic mixture	B	CC(C)=C1CC(CO)(COC(=O)c2ccc(C#Cc3ccc(C)cc3)cc2)OC1=O		CHEMBL522428	=	Ki	nM	15.8	CHEMBL299	Homo sapiens	Ki	nM	15.8
Active	2509837	CHEMBL995915	Activation of GFP-tagged PKCalpha expressed in CHO cells assessed as isozyme translocation from cytosol to plasma membrane at 10 uM by confocal microscopy	B	CC(C)=C1CC(CO)(COC(=O)COc2ccc(C#Cc3ccc(C)cc3)cc2)OC1=O		CHEMBL523155		Activity			CHEMBL299	Homo sapiens	Activity		
Active	2509838	CHEMBL995915	Activation of GFP-tagged PKCalpha expressed in CHO cells assessed as isozyme translocation from cytosol to plasma membrane at 10 uM by confocal microscopy	B	CC(C)=C1CC(CO)(COC(=O)c2ccc(C#Cc3ccc(C)cc3)cc2)OC1=O		CHEMBL522428		Activity			CHEMBL299	Homo sapiens	Activity		
Active	2509839	CHEMBL995915	Activation of GFP-tagged PKCalpha expressed in CHO cells assessed as isozyme translocation from cytosol to plasma membrane at 10 uM by confocal microscopy	B	CC(C)=C1CC(CO)(COC(=O)CCCOc2ccc(C#Cc3ccc(C)cc3)cc2)OC1=O		CHEMBL489520		Activity			CHEMBL299	Homo sapiens	Activity		
Active	2509840	CHEMBL995915	Activation of GFP-tagged PKCalpha expressed in CHO cells assessed as isozyme translocation from cytosol to plasma membrane at 10 uM by confocal microscopy	B	CC(C)=C1CC(CO)(COC(=O)CCOc2ccc(C#Cc3ccc(C)cc3)cc2)OC1=O		CHEMBL492118		Activity			CHEMBL299	Homo sapiens	Activity		
	2511603	CHEMBL973457	Inhibition of PKCalpha	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.7	CHEMBL299	Homo sapiens	IC50	uM	0.0007
	2511618	CHEMBL973457	Inhibition of PKCalpha	B	COc1ccc(NC(=S)N/N=C2\C(=O)Nc3ccccc32)cc1		CHEMBL504574	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	2511973	CHEMBL973496	Inhibition of PKCalpha at 1 uM	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	Inhibition	%	15.0	CHEMBL299	Homo sapiens	INH	%	15.0
Not Active	2527093	CHEMBL984163	Inhibition of PKCalpha at => 3 ug/mL	B	COc1c(NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)nc3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL451523		Activity			CHEMBL299	Homo sapiens	Activity		
	2559668	CHEMBL986469	Inhibition of PKCalpha	B	Cc1c(Nc2c(C#N)cnc3sc(/C=C/C(=O)N4CCCC4)cc23)ccc2[nH]ccc12		CHEMBL477817	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	nM	50000.0
	2562284	CHEMBL984697	Inhibition of human PKCalpha at 10 uM	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1		CHEMBL477989	=	Inhibition	%	10.0	CHEMBL299	Homo sapiens	INH	%	10.0
	2562306	CHEMBL984697	Inhibition of human PKCalpha at 10 uM	B	O/N=C1\CCc2cc(-c3cc(CN4CCOCC4)oc3-c3ccncc3)ccc21		CHEMBL476732	=	Inhibition	%	3.0	CHEMBL299	Homo sapiens	INH	%	3.0
	2567272	CHEMBL975459	Inhibition of human PKCalpha assessed as residual enzyme activity at 0.1 uM	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	Activity	%	103.0	CHEMBL299	Homo sapiens	Activity	%	103.0
Not Evaluated	2577413	CHEMBL985405	Binding affinity to human PKCA at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL299	Homo sapiens	Activity		
Not Evaluated	2593618	CHEMBL985405	Binding affinity to human PKCA at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL299	Homo sapiens	Activity		
Not Evaluated	2593821	CHEMBL985405	Binding affinity to human PKCA at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL299	Homo sapiens	Activity		
Not Evaluated	2593884	CHEMBL985405	Binding affinity to human PKCA at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL299	Homo sapiens	Activity		
Not Evaluated	2594087	CHEMBL985405	Binding affinity to human PKCA at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL299	Homo sapiens	Activity		
Not Evaluated	2595030	CHEMBL985405	Binding affinity to human PKCA at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL299	Homo sapiens	Activity		
Not Evaluated	2596227	CHEMBL985405	Binding affinity to human PKCA at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL299	Homo sapiens	Activity		
Not Evaluated	2596430	CHEMBL985405	Binding affinity to human PKCA at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL299	Homo sapiens	Activity		
Not Evaluated	2597699	CHEMBL985405	Binding affinity to human PKCA at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL299	Homo sapiens	Activity		
	2597902	CHEMBL985405	Binding affinity to human PKCA at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901	=	Activity	%	26.2	CHEMBL299	Homo sapiens	Activity	%	26.2
	2613335	CHEMBL1015222	Inhibition of PKCalpha	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	2619053	CHEMBL1035824	Inhibition of human PKCalpha by IMAP assay	B	C=CCc1c(C)nc2sc3c(N)ncnc3c2c1C		CHEMBL463119	>	Ki	nM	5000.0	CHEMBL299	Homo sapiens	Ki	nM	5000.0
	2620331	CHEMBL1036685	Inhibition of PKCalpha at 100 nM	B	CCn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL26241	=	Inhibition	%	88.0	CHEMBL299	Homo sapiens	INH	%	88.0
	2620332	CHEMBL1036685	Inhibition of PKCalpha at 100 nM	B	O=c1sn(-c2ccccc2)c(=O)n1CCCl		CHEMBL449063	=	Inhibition	%	84.0	CHEMBL299	Homo sapiens	INH	%	84.0
	2620333	CHEMBL1036685	Inhibition of PKCalpha at 100 nM	B	CCOC(=O)Cn1sc(=O)n(-c2cccc(C(=O)OCC)c2)c1=O		CHEMBL458636	=	Inhibition	%	89.0	CHEMBL299	Homo sapiens	INH	%	89.0
	2620334	CHEMBL1036685	Inhibition of PKCalpha at 100 nM	B	CCOC(=O)Cn1sc(=O)n(-c2ccc(C(=O)OCC)cc2)c1=O		CHEMBL458857	=	Inhibition	%	78.0	CHEMBL299	Homo sapiens	INH	%	78.0
	2620335	CHEMBL1036685	Inhibition of PKCalpha at 100 nM	B	O=c1sn(CCc2ccccc2)c(=O)n1Cc1ccc(F)cc1		CHEMBL512208	=	Inhibition	%	51.0	CHEMBL299	Homo sapiens	INH	%	51.0
	2620336	CHEMBL1036685	Inhibition of PKCalpha at 100 nM	B	CCOC(=O)Cn1sc(=O)n(CC(=O)N2CCCCC2)c1=O		CHEMBL458210	=	Inhibition	%	93.0	CHEMBL299	Homo sapiens	INH	%	93.0
	2620337	CHEMBL1036686	Inhibition of PKCalpha	B	CCn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL26241	=	IC50	nM	13800.0	CHEMBL299	Homo sapiens	IC50	uM	13.8
	2620338	CHEMBL1036686	Inhibition of PKCalpha	B	O=c1sn(-c2ccccc2)c(=O)n1CCCl		CHEMBL449063	=	IC50	nM	5800.0	CHEMBL299	Homo sapiens	IC50	uM	5.8
	2620339	CHEMBL1036686	Inhibition of PKCalpha	B	CCOC(=O)Cn1sc(=O)n(-c2cccc(C(=O)OCC)c2)c1=O		CHEMBL458636	=	IC50	nM	5300.0	CHEMBL299	Homo sapiens	IC50	uM	5.3
	2620340	CHEMBL1036686	Inhibition of PKCalpha	B	CCOC(=O)Cn1sc(=O)n(-c2ccc(C(=O)OCC)cc2)c1=O		CHEMBL458857	=	IC50	nM	48300.0	CHEMBL299	Homo sapiens	IC50	uM	48.3
	2620341	CHEMBL1036686	Inhibition of PKCalpha	B	O=c1sn(CCc2ccccc2)c(=O)n1Cc1ccc(F)cc1		CHEMBL512208	=	IC50	nM	38700.0	CHEMBL299	Homo sapiens	IC50	uM	38.7
	2620342	CHEMBL1036686	Inhibition of PKCalpha	B	CCOC(=O)Cn1sc(=O)n(CC(=O)N2CCCCC2)c1=O		CHEMBL458210	=	IC50	nM	4100.0	CHEMBL299	Homo sapiens	IC50	uM	4.1
	2623505	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	CC(C)(C)c1ccc(COC(=O)c2cc(CO)cc(C(=O)OCc3ccc(C(C)(C)C)cc3)c2)cc1		CHEMBL494179	=	Activity	%	58.0	CHEMBL299	Homo sapiens	Activity	%	58.0
	2623506	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	O=C(OCc1cccc(Cl)c1)c1cc(CO)cc(C(=O)OCc2cccc(Cl)c2)c1		CHEMBL493003	=	Activity	%	54.7	CHEMBL299	Homo sapiens	Activity	%	54.7
	2623507	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	O=C(OCc1cccc(C(F)(F)F)c1)c1cc(CO)cc(C(=O)OCc2cccc(C(F)(F)F)c2)c1		CHEMBL466211	=	Activity	%	56.5	CHEMBL299	Homo sapiens	Activity	%	56.5
	2623508	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	CCCCCCOC(=O)c1cc(CO)cc(C(=O)OCCCCCC)c1		CHEMBL513125	=	Activity	%	59.4	CHEMBL299	Homo sapiens	Activity	%	59.4
	2623509	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	CCCC(C)COC(=O)c1cc(CO)cc(C(=O)OCC(C)CCC)c1		CHEMBL468716	=	Activity	%	59.9	CHEMBL299	Homo sapiens	Activity	%	59.9
	2623510	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	CCC[C@H](O)COC(=O)c1cc(CO)cc(C(=O)OC[C@H](O)CCC)c1		CHEMBL1162992	=	Activity	%	53.3	CHEMBL299	Homo sapiens	Activity	%	53.3
	2623511	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	CCC[C@H](C)COC(=O)c1cc(CO)cc(C(=O)OC[C@H](C)CCC)c1		CHEMBL468717	=	Activity	%	56.1	CHEMBL299	Homo sapiens	Activity	%	56.1
	2623512	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	CCC(C)CCOC(=O)c1cc(CO)cc(C(=O)OCCC(C)CC)c1		CHEMBL444698	=	Activity	%	49.6	CHEMBL299	Homo sapiens	Activity	%	49.6
	2623513	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	CC(C)CCCOC(=O)c1cc(CO)cc(C(=O)OCCCC(C)C)c1		CHEMBL466212	=	Activity	%	52.7	CHEMBL299	Homo sapiens	Activity	%	52.7
	2623514	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	CCCCC(CC)COC(=O)c1cc(CO)cc(C(=O)OCC(CC)CCCC)c1		CHEMBL513861	=	Activity	%	64.4	CHEMBL299	Homo sapiens	Activity	%	64.4
	2623515	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	O=C(OCC1CC2CCC1C2)c1cc(CO)cc(C(=O)OCC2CC3CCC2C3)c1		CHEMBL468923	=	Activity	%	59.5	CHEMBL299	Homo sapiens	Activity	%	59.5
	2623516	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	O=C(OCC1CCCCC1)c1cc(CO)cc(C(=O)OCC2CCCCC2)c1		CHEMBL468924	=	Activity	%	68.0	CHEMBL299	Homo sapiens	Activity	%	68.0
	2623517	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	CCCC(CC)OC(=O)c1cc(CO)cc(C(=O)OC(CC)CCC)c1		CHEMBL523053	=	Activity	%	45.0	CHEMBL299	Homo sapiens	Activity	%	45.0
	2623518	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	CCCCC(CC)OC(=O)c1cc(CO)cc(C(=O)OC(CC)CCCC)c1		CHEMBL494361	=	Activity	%	33.2	CHEMBL299	Homo sapiens	Activity	%	33.2
	2623519	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	CCCCC(C)OC(=O)c1cc(CO)cc(C(=O)OC(C)CCCC)c1		CHEMBL494362	=	Activity	%	56.0	CHEMBL299	Homo sapiens	Activity	%	56.0
	2623520	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	CCCCCC(C)OC(=O)c1cc(CO)cc(C(=O)OC(C)CCCCC)c1		CHEMBL523703	=	Activity	%	39.3	CHEMBL299	Homo sapiens	Activity	%	39.3
	2623521	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	O=C(OC1CCC2CCCCC2C1)c1cc(CO)cc(C(=O)OC2CCC3CCCCC3C2)c1		CHEMBL493004	=	Activity	%	73.3	CHEMBL299	Homo sapiens	Activity	%	73.3
	2623522	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	O=C(OC1CCC[C@@H]2CCCC[C@H]12)c1cc(CO)cc(C(=O)OC2CCC[C@H]3CCCC[C@@H]23)c1		CHEMBL493005	=	Activity	%	67.4	CHEMBL299	Homo sapiens	Activity	%	67.4
	2623523	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	O=C(O[C@H]1CCc2ccccc21)c1cc(CO)cc(C(=O)O[C@@H]2CCc3ccccc32)c1		CHEMBL493164	=	Activity	%	65.7	CHEMBL299	Homo sapiens	Activity	%	65.7
	2623524	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	O=C(OCCCCCO)c1cc(CO)cc(C(=O)OCCCCCO)c1		CHEMBL522332	=	Activity	%	116.7	CHEMBL299	Homo sapiens	Activity	%	116.7
	2623525	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	O=C(OCC1CCOC1)c1cc(CO)cc(C(=O)OCC2CCOC2)c1		CHEMBL467670	=	Activity	%	114.2	CHEMBL299	Homo sapiens	Activity	%	114.2
	2623526	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	CCOCCCOC(=O)c1cc(CO)cc(C(=O)OCCCOCC)c1		CHEMBL506956	=	Activity	%	90.0	CHEMBL299	Homo sapiens	Activity	%	90.0
	2623527	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	O=C(O)c1cc(CO)cc(C(=O)O)c1		CHEMBL447149	=	Activity	%	97.9	CHEMBL299	Homo sapiens	Activity	%	97.9
	2623528	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	CCOC(=O)c1cc(CO)cc(C(=O)OCC)c1		CHEMBL467882	=	Activity	%	92.4	CHEMBL299	Homo sapiens	Activity	%	92.4
	2623529	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	CCCC(C)COC(=O)c1cccc(C(=O)OCC(C)CCC)c1		CHEMBL467883	=	Activity	%	93.7	CHEMBL299	Homo sapiens	Activity	%	93.7
	2623530	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	CCCC(C)COC(=O)c1cc(C)cc(C(=O)OCC(C)CCC)c1		CHEMBL466633	=	Activity	%	96.7	CHEMBL299	Homo sapiens	Activity	%	96.7
	2623531	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	CCCC(C)COC(=O)c1cccc(C(=O)OC)c1		CHEMBL503568	=	Activity	%	92.4	CHEMBL299	Homo sapiens	Activity	%	92.4
	2623532	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	CCCC(C)COC(=O)c1cc(C(=O)OCC(C)CCC)cc([N+](=O)[O-])c1		CHEMBL513848	=	Activity	%	101.3	CHEMBL299	Homo sapiens	Activity	%	101.3
	2623533	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	O=C(OCc1cccc(C(F)(F)F)c1)c1cc(C(=O)OCc2cccc(C(F)(F)F)c2)cc([N+](=O)[O-])c1		CHEMBL466839	=	Activity	%	97.6	CHEMBL299	Homo sapiens	Activity	%	97.6
	2623534	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	CCCCCCOC(=O)c1cccc(CO)c1		CHEMBL466840	=	Activity	%	91.2	CHEMBL299	Homo sapiens	Activity	%	91.2
	2623535	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	CCCC(C)COC(=O)c1cccc(CO)c1		CHEMBL444483	=	Activity	%	98.1	CHEMBL299	Homo sapiens	Activity	%	98.1
	2623536	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	CCCCC(CC)OC(=O)c1cccc(CO)c1		CHEMBL467045	=	Activity	%	100.3	CHEMBL299	Homo sapiens	Activity	%	100.3
	2623537	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	O=C(NCc1cccc(C(F)(F)F)c1)c1cc(CO)cc(C(=O)NCc2cccc(C(F)(F)F)c2)c1		CHEMBL492961	=	Activity	%	80.6	CHEMBL299	Homo sapiens	Activity	%	80.6
	2623538	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	CCCCCCNC(=O)c1cc(CO)cc(C(=O)NCCCCCC)c1		CHEMBL492962	=	Activity	%	90.4	CHEMBL299	Homo sapiens	Activity	%	90.4
	2623539	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	CCCCCCC(=O)Nc1cc(CO)cc(NC(=O)CCCCCC)c1		CHEMBL521818	=	Activity	%	93.2	CHEMBL299	Homo sapiens	Activity	%	93.2
	2623540	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	CCCCCCC(=O)Nc1cc(NC(=O)CCCCCC)cc(C(=O)OC)c1		CHEMBL493165	=	Activity	%	102.7	CHEMBL299	Homo sapiens	Activity	%	102.7
	2623541	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	C=CCCCCCCCCC(=O)Nc1cc(CO)cc(C(=O)OC)c1		CHEMBL450870	=	Activity	%	66.3	CHEMBL299	Homo sapiens	Activity	%	66.3
	2623542	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	CCCCCCCCC(=O)Nc1cc(CO)cc(C(=O)OC)c1		CHEMBL493562	=	Activity	%	83.0	CHEMBL299	Homo sapiens	Activity	%	83.0
	2623543	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	CCCCCCC(=O)Nc1cc(CO)cc(C(=O)OC)c1		CHEMBL493563	=	Activity	%	96.5	CHEMBL299	Homo sapiens	Activity	%	96.5
	2623544	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	COC(=O)c1cc(CO)cc(NC(=O)C(C)(C)C)c1		CHEMBL493564	=	Activity	%	103.6	CHEMBL299	Homo sapiens	Activity	%	103.6
	2623545	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	COC(=O)c1cc(CO)cc(NC(C)=O)c1		CHEMBL476798	=	Activity	%	102.9	CHEMBL299	Homo sapiens	Activity	%	102.9
	2623546	CHEMBL999749	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells assessed as residual bound radioligand level at 20 uM by liquid scintillation counting relative to control	B	COC(=O)c1cc(CO)cc(C(=O)NCc2cccc(C(F)(F)F)c2)c1		CHEMBL467046	=	Activity	%	91.6	CHEMBL299	Homo sapiens	Activity	%	91.6
	2623589	CHEMBL999748	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells by liquid scintillation counting	B	O=C(OCc1cccc(C(F)(F)F)c1)c1cc(CO)cc(C(=O)OCc2cccc(C(F)(F)F)c2)c1		CHEMBL466211	=	Ki	nM	205.0	CHEMBL299	Homo sapiens	Ki	nM	205.0
	2623590	CHEMBL999748	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells by liquid scintillation counting	B	CCCC(CC)OC(=O)c1cc(CO)cc(C(=O)OC(CC)CCC)c1		CHEMBL523053	=	Ki	nM	661.0	CHEMBL299	Homo sapiens	Ki	nM	661.0
	2623591	CHEMBL999748	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells by liquid scintillation counting	B	CCCCC(CC)OC(=O)c1cc(CO)cc(C(=O)OC(CC)CCCC)c1		CHEMBL494361	=	Ki	nM	319.0	CHEMBL299	Homo sapiens	Ki	nM	319.0
Dose-dependent effect	2623595	CHEMBL999748	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells by liquid scintillation counting	B	CC(C)(C)c1ccc(COC(=O)c2cc(CO)cc(C(=O)OCc3ccc(C(C)(C)C)cc3)c2)cc1		CHEMBL494179		Activity			CHEMBL299	Homo sapiens	Activity		
Dose-dependent effect	2623597	CHEMBL999748	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells by liquid scintillation counting	B	O=C(O[C@H]1CCc2ccccc21)c1cc(CO)cc(C(=O)O[C@@H]2CCc3ccccc32)c1		CHEMBL493164		Activity			CHEMBL299	Homo sapiens	Activity		
Dose-dependent effect	2623598	CHEMBL999748	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells by liquid scintillation counting	B	O=C(OC1CCC[C@@H]2CCCC[C@H]12)c1cc(CO)cc(C(=O)OC2CCC[C@H]3CCCC[C@@H]23)c1		CHEMBL493005		Activity			CHEMBL299	Homo sapiens	Activity		
Dose-dependent effect	2623599	CHEMBL999748	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells by liquid scintillation counting	B	O=C(OC1CCC2CCCCC2C1)c1cc(CO)cc(C(=O)OC2CCC3CCCCC3C2)c1		CHEMBL493004		Activity			CHEMBL299	Homo sapiens	Activity		
Dose-dependent effect	2623600	CHEMBL999748	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells by liquid scintillation counting	B	CCCCCC(C)OC(=O)c1cc(CO)cc(C(=O)OC(C)CCCCC)c1		CHEMBL523703		Activity			CHEMBL299	Homo sapiens	Activity		
Dose-dependent effect	2623601	CHEMBL999748	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells by liquid scintillation counting	B	CCCCC(C)OC(=O)c1cc(CO)cc(C(=O)OC(C)CCCC)c1		CHEMBL494362		Activity			CHEMBL299	Homo sapiens	Activity		
Dose-dependent effect	2623602	CHEMBL999748	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells by liquid scintillation counting	B	O=C(OCC1CCCCC1)c1cc(CO)cc(C(=O)OCC2CCCCC2)c1		CHEMBL468924		Activity			CHEMBL299	Homo sapiens	Activity		
Dose-dependent effect	2623603	CHEMBL999748	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells by liquid scintillation counting	B	O=C(OCC1CC2CCC1C2)c1cc(CO)cc(C(=O)OCC2CC3CCC2C3)c1		CHEMBL468923		Activity			CHEMBL299	Homo sapiens	Activity		
Dose-dependent effect	2623604	CHEMBL999748	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells by liquid scintillation counting	B	CCCCC(CC)COC(=O)c1cc(CO)cc(C(=O)OCC(CC)CCCC)c1		CHEMBL513861		Activity			CHEMBL299	Homo sapiens	Activity		
Dose-dependent effect	2623605	CHEMBL999748	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells by liquid scintillation counting	B	CC(C)CCCOC(=O)c1cc(CO)cc(C(=O)OCCCC(C)C)c1		CHEMBL466212		Activity			CHEMBL299	Homo sapiens	Activity		
Dose-dependent effect	2623606	CHEMBL999748	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells by liquid scintillation counting	B	CCC(C)CCOC(=O)c1cc(CO)cc(C(=O)OCCC(C)CC)c1		CHEMBL444698		Activity			CHEMBL299	Homo sapiens	Activity		
Dose-dependent effect	2623607	CHEMBL999748	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells by liquid scintillation counting	B	CCC[C@H](C)COC(=O)c1cc(CO)cc(C(=O)OC[C@H](C)CCC)c1		CHEMBL468717		Activity			CHEMBL299	Homo sapiens	Activity		
Dose-dependent effect	2623608	CHEMBL999748	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells by liquid scintillation counting	B	CCC[C@H](O)COC(=O)c1cc(CO)cc(C(=O)OC[C@H](O)CCC)c1		CHEMBL1162992		Activity			CHEMBL299	Homo sapiens	Activity		
Dose-dependent effect	2623609	CHEMBL999748	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells by liquid scintillation counting	B	CCCC(C)COC(=O)c1cc(CO)cc(C(=O)OCC(C)CCC)c1		CHEMBL468716		Activity			CHEMBL299	Homo sapiens	Activity		
Dose-dependent effect	2623610	CHEMBL999748	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells by liquid scintillation counting	B	CCCCCCOC(=O)c1cc(CO)cc(C(=O)OCCCCCC)c1		CHEMBL513125		Activity			CHEMBL299	Homo sapiens	Activity		
Dose-dependent effect	2623611	CHEMBL999748	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells by liquid scintillation counting	B	O=C(OCc1cccc(Cl)c1)c1cc(CO)cc(C(=O)OCc2cccc(Cl)c2)c1		CHEMBL493003		Activity			CHEMBL299	Homo sapiens	Activity		
Dose-dependent effect	2623627	CHEMBL999748	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells by liquid scintillation counting	B	C=CCCCCCCCCC(=O)Nc1cc(CO)cc(C(=O)OC)c1		CHEMBL450870		Activity			CHEMBL299	Homo sapiens	Activity		
	2623635	CHEMBL999748	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells by liquid scintillation counting	B	CCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCC		CHEMBL55267	=	Ki	nM	40.1	CHEMBL299	Homo sapiens	Ki	nM	40.1
Not Determined	2623637	CHEMBL999748	Displacement of [3H]PDBu from human recombinant PKCalpha expressed in Sf9 cells by liquid scintillation counting	B	CCC/C=C/C=C/C(=O)O[C@H]1/C(=C/C(=O)OC)C[C@H]2C[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H]3C[C@H](OC(C)=O)C(C)(C)[C@](O)(C[C@@H]4C/C(=C/C(=O)OC)C[C@H](/C=C/C(C)(C)[C@]1(O)O2)O4)O3		CHEMBL449158		Ki			CHEMBL299	Homo sapiens	Ki		
Active	2634081	CHEMBL995456	Inhibition of human PKCalpha at 50 uM by gel electrophoresis	B	CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)N(C)C		CHEMBL322333		Activity			CHEMBL299	Homo sapiens	Activity		
Active	2634086	CHEMBL995455	Inhibition of human PKCalpha at 100 uM by gel electrophoresis	B	CCCCCCCCCCCCCC#CC(=O)[C@@H]1COC(C)(C)N1C(=O)OC(C)(C)C		CHEMBL495798		Activity			CHEMBL299	Homo sapiens	Activity		
	2635903	CHEMBL1003333	Inhibition of PKCalpha at 1 uM relative to control	B	CSc1cc(Oc2ccnc3[nH]c(=O)[nH]c23)ccc1NC(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL496009	=	Residual_activity	%	75.0	CHEMBL299	Homo sapiens	Residual_activity	%	75.0
	2635971	CHEMBL1003333	Inhibition of PKCalpha at 1 uM relative to control	B	O=C(Nc1cc(C(F)(F)F)ccc1F)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)c2ccccc12		CHEMBL498112	=	Residual_activity	%	75.0	CHEMBL299	Homo sapiens	Residual_activity	%	75.0
	2636039	CHEMBL1003333	Inhibition of PKCalpha at 1 uM relative to control	B	CC(C)(C)c1cccc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)c1		CHEMBL496073	=	Residual_activity	%	75.0	CHEMBL299	Homo sapiens	Residual_activity	%	75.0
	2638331	CHEMBL1011435	Inhibition of PKCalpha	B	C[C@@H](Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL466496	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
Not Determined	2638332	CHEMBL1011435	Inhibition of PKCalpha	B	NC(=O)C(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL467079		IC50			CHEMBL299	Homo sapiens	IC50		
	2638333	CHEMBL1011435	Inhibition of PKCalpha	B	NC(=O)C(Nc1c(Nc2ccncc2)c(=O)c1=O)c1cccc(O)c1		CHEMBL511410	=	IC50	nM	33600.0	CHEMBL299	Homo sapiens	IC50	uM	33.6
	2638334	CHEMBL1011435	Inhibition of PKCalpha	B	C[C@@H](Nc1c(Nc2ccnc(-c3ccccc3F)c2)c(=O)c1=O)c1ccccc1		CHEMBL468125	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	2638335	CHEMBL1011435	Inhibition of PKCalpha	B	C[C@@H](Nc1c(Nc2ccnc(-c3ccco3)c2)c(=O)c1=O)c1ccccc1		CHEMBL519113	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	2638336	CHEMBL1011435	Inhibition of PKCalpha	B	C[C@@H](Nc1c(Nc2ccnc(-c3ccsc3)c2)c(=O)c1=O)c1ccccc1		CHEMBL481248	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	2661601	CHEMBL1061352	Inhibition of PKCalpha after 1 hr by mobility shift electrophoresis assay	B	COC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)OC)CC4)c3n2)cc1		CHEMBL561708	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	2691870	CHEMBL1054694	Inhibition of human PKCalpha assessed as remaining activity at 10 uM	B	Cc1ccccc1-c1c(N)c(C(=O)c2ccc(F)cc2F)cc[n+]1[O-]		CHEMBL551717	=	Activity	%	84.0	CHEMBL299	Homo sapiens	Activity	%	84.0
	2704999	CHEMBL1054886	Inhibition of PKCalpha at 10 uM by HotSpot assay relative to control	B	Cc1cc(O)cc(-c2nn(CC#N)cc2-c2cc(NC[C@H](C)O)nc(-c3cccnc3)n2)c1		CHEMBL560733	=	Inhibition	%	9.23	CHEMBL299	Homo sapiens	INH	%	9.23
	2721692	CHEMBL1054319	Inhibition of PKCalpha at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
	2894506	CHEMBL1061088	Percentage PKCalpha activity remaining in the presence of 0.01uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	73.0	CHEMBL299	Homo sapiens	Activity	%	73.0
Antagonist	2894507	CHEMBL1061088	Percentage PKCalpha activity remaining in the presence of 0.01uM inhibitor	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Activity	%	6.0	CHEMBL299	Homo sapiens	Activity	%	6.0
	2894508	CHEMBL1062781	Percentage PKCalpha activity remaining in the presence of 0.1uM inhibitor	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	Activity	%	90.0	CHEMBL299	Homo sapiens	Activity	%	90.0
	2894509	CHEMBL1062781	Percentage PKCalpha activity remaining in the presence of 0.1uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	74.0	CHEMBL299	Homo sapiens	Activity	%	74.0
Antagonist	2894510	CHEMBL1062781	Percentage PKCalpha activity remaining in the presence of 0.1uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	29.0	CHEMBL299	Homo sapiens	Activity	%	29.0
	2894511	CHEMBL1062781	Percentage PKCalpha activity remaining in the presence of 0.1uM inhibitor	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Activity	%	77.0	CHEMBL299	Homo sapiens	Activity	%	77.0
Antagonist	2894512	CHEMBL1062781	Percentage PKCalpha activity remaining in the presence of 0.1uM inhibitor	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Activity	%	3.0	CHEMBL299	Homo sapiens	Activity	%	3.0
Antagonist	2894513	CHEMBL1062781	Percentage PKCalpha activity remaining in the presence of 0.1uM inhibitor	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Activity	%	2.0	CHEMBL299	Homo sapiens	Activity	%	2.0
Antagonist	2894514	CHEMBL1062781	Percentage PKCalpha activity remaining in the presence of 0.1uM inhibitor	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Activity	%	4.0	CHEMBL299	Homo sapiens	Activity	%	4.0
	2894515	CHEMBL1063727	Percentage PKCalpha activity remaining in the presence of 10uM inhibitor	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Activity	%	88.0	CHEMBL299	Homo sapiens	Activity	%	88.0
	2894516	CHEMBL1063727	Percentage PKCalpha activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Activity	%	103.0	CHEMBL299	Homo sapiens	Activity	%	103.0
	2894517	CHEMBL1063727	Percentage PKCalpha activity remaining in the presence of 10uM inhibitor	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Activity	%	80.0	CHEMBL299	Homo sapiens	Activity	%	80.0
	2894518	CHEMBL1063727	Percentage PKCalpha activity remaining in the presence of 10uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	68.0	CHEMBL299	Homo sapiens	Activity	%	68.0
	2894519	CHEMBL1063727	Percentage PKCalpha activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	94.0	CHEMBL299	Homo sapiens	Activity	%	94.0
	2894520	CHEMBL1063727	Percentage PKCalpha activity remaining in the presence of 10uM inhibitor	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Activity	%	88.0	CHEMBL299	Homo sapiens	Activity	%	88.0
	2894521	CHEMBL1063727	Percentage PKCalpha activity remaining in the presence of 10uM inhibitor	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Activity	%	77.0	CHEMBL299	Homo sapiens	Activity	%	77.0
	2894522	CHEMBL1063727	Percentage PKCalpha activity remaining in the presence of 10uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	80.0	CHEMBL299	Homo sapiens	Activity	%	80.0
	2894523	CHEMBL1063727	Percentage PKCalpha activity remaining in the presence of 10uM inhibitor	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Activity	%	73.0	CHEMBL299	Homo sapiens	Activity	%	73.0
	2894524	CHEMBL1063727	Percentage PKCalpha activity remaining in the presence of 10uM inhibitor	B	C[C@H]1CNCCN1S(=O)(=O)c1cccc2cnccc12		CHEMBL1233654	=	Activity	%	60.0	CHEMBL299	Homo sapiens	Activity	%	60.0
Antagonist	2894525	CHEMBL1063727	Percentage PKCalpha activity remaining in the presence of 10uM inhibitor	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Activity	%	39.0	CHEMBL299	Homo sapiens	Activity	%	39.0
	2894526	CHEMBL1063727	Percentage PKCalpha activity remaining in the presence of 10uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	72.0	CHEMBL299	Homo sapiens	Activity	%	72.0
	2894527	CHEMBL1063727	Percentage PKCalpha activity remaining in the presence of 10uM inhibitor	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Activity	%	58.0	CHEMBL299	Homo sapiens	Activity	%	58.0
	2894528	CHEMBL1063727	Percentage PKCalpha activity remaining in the presence of 10uM inhibitor	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Activity	%	58.0	CHEMBL299	Homo sapiens	Activity	%	58.0
	2894529	CHEMBL1063727	Percentage PKCalpha activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1sc(-c2ccsc2)cc1N		CHEMBL193093	=	Activity	%	67.0	CHEMBL299	Homo sapiens	Activity	%	67.0
Antagonist	2894530	CHEMBL1063727	Percentage PKCalpha activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	40.0	CHEMBL299	Homo sapiens	Activity	%	40.0
	2894531	CHEMBL1063727	Percentage PKCalpha activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	80.0	CHEMBL299	Homo sapiens	Activity	%	80.0
	2894532	CHEMBL1063727	Percentage PKCalpha activity remaining in the presence of 10uM inhibitor	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	89.0	CHEMBL299	Homo sapiens	Activity	%	89.0
	2894533	CHEMBL1063727	Percentage PKCalpha activity remaining in the presence of 10uM inhibitor	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	87.0	CHEMBL299	Homo sapiens	Activity	%	87.0
	2894534	CHEMBL1063727	Percentage PKCalpha activity remaining in the presence of 10uM inhibitor	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	Activity	%	90.0	CHEMBL299	Homo sapiens	Activity	%	90.0
	2894535	CHEMBL1063727	Percentage PKCalpha activity remaining in the presence of 10uM inhibitor	B	O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1		CHEMBL79004	=	Activity	%	77.0	CHEMBL299	Homo sapiens	Activity	%	77.0
	2894536	CHEMBL1063727	Percentage PKCalpha activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl.O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL540501	=	Activity	%	89.0	CHEMBL299	Homo sapiens	Activity	%	89.0
	2894537	CHEMBL1063727	Percentage PKCalpha activity remaining in the presence of 10uM inhibitor	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Activity	%	95.0	CHEMBL299	Homo sapiens	Activity	%	95.0
	2894538	CHEMBL1063727	Percentage PKCalpha activity remaining in the presence of 10uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	87.0	CHEMBL299	Homo sapiens	Activity	%	87.0
	2894539	CHEMBL1051333	Percentage PKCalpha activity remaining in the presence of 25uM inhibitor	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	90.0	CHEMBL299	Homo sapiens	Activity	%	90.0
	2894540	CHEMBL1051333	Percentage PKCalpha activity remaining in the presence of 25uM inhibitor	B	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12		CHEMBL489157	=	Activity	%	86.0	CHEMBL299	Homo sapiens	Activity	%	86.0
	2894541	CHEMBL1051334	Percentage PKCalpha activity remaining in the presence of 2uM inhibitor	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Activity	%	73.0	CHEMBL299	Homo sapiens	Activity	%	73.0
	2894542	CHEMBL1063728	Percentage PKCalpha activity remaining in the presence of 3uM inhibitor	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	Activity	%	85.0	CHEMBL299	Homo sapiens	Activity	%	85.0
	2894543	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Activity	%	62.0	CHEMBL299	Homo sapiens	Activity	%	62.0
	2894544	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Activity	%	78.0	CHEMBL299	Homo sapiens	Activity	%	78.0
	2894545	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Activity	%	82.0	CHEMBL299	Homo sapiens	Activity	%	82.0
	2894546	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	99.0	CHEMBL299	Homo sapiens	Activity	%	99.0
	2894547	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	93.0	CHEMBL299	Homo sapiens	Activity	%	93.0
	2894548	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Activity	%	87.0	CHEMBL299	Homo sapiens	Activity	%	87.0
	2894549	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Activity	%	90.0	CHEMBL299	Homo sapiens	Activity	%	90.0
	2894550	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	86.0	CHEMBL299	Homo sapiens	Activity	%	86.0
	2894551	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	69.0	CHEMBL299	Homo sapiens	Activity	%	69.0
	2894552	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Activity	%	68.0	CHEMBL299	Homo sapiens	Activity	%	68.0
	2894553	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Activity	%	89.0	CHEMBL299	Homo sapiens	Activity	%	89.0
	2894554	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Activity	%	80.0	CHEMBL299	Homo sapiens	Activity	%	80.0
	2894555	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Activity	%	87.0	CHEMBL299	Homo sapiens	Activity	%	87.0
	2894556	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	Activity	%	77.0	CHEMBL299	Homo sapiens	Activity	%	77.0
	2894557	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Activity	%	68.0	CHEMBL299	Homo sapiens	Activity	%	68.0
	2894558	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	89.0	CHEMBL299	Homo sapiens	Activity	%	89.0
	2894559	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	82.0	CHEMBL299	Homo sapiens	Activity	%	82.0
	2894560	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	CC1=NCCc2c1[nH]c1cc(O)ccc21		CHEMBL129177	=	Activity	%	92.0	CHEMBL299	Homo sapiens	Activity	%	92.0
	2894561	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	Cc1nccc2c1[nH]c1ccccc12		CHEMBL12014	=	Activity	%	90.0	CHEMBL299	Homo sapiens	Activity	%	90.0
	2894562	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c3c([nH]c2c1)C(C)=NCC3		CHEMBL340807	=	Activity	%	90.0	CHEMBL299	Homo sapiens	Activity	%	90.0
	2894563	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br		CHEMBL1794051	=	Activity	%	92.0	CHEMBL299	Homo sapiens	Activity	%	92.0
	2894564	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	80.0	CHEMBL299	Homo sapiens	Activity	%	80.0
	2894565	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Activity	%	61.0	CHEMBL299	Homo sapiens	Activity	%	61.0
	2894566	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Activity	%	92.0	CHEMBL299	Homo sapiens	Activity	%	92.0
	2894567	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	78.0	CHEMBL299	Homo sapiens	Activity	%	78.0
	2894568	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	71.0	CHEMBL299	Homo sapiens	Activity	%	71.0
	2894569	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	82.0	CHEMBL299	Homo sapiens	Activity	%	82.0
	2894570	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Activity	%	88.0	CHEMBL299	Homo sapiens	Activity	%	88.0
	2894571	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Activity	%	92.0	CHEMBL299	Homo sapiens	Activity	%	92.0
	2894572	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Activity	%	95.0	CHEMBL299	Homo sapiens	Activity	%	95.0
	2894573	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Activity	%	95.0	CHEMBL299	Homo sapiens	Activity	%	95.0
	2894574	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	108.0	CHEMBL299	Homo sapiens	Activity	%	108.0
	2894575	CHEMBL1062776	Percentage PKCalpha activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	75.0	CHEMBL299	Homo sapiens	Activity	%	75.0
	2894882	CHEMBL1061088	Percentage PKCalpha activity remaining in the presence of 0.01uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	105.0	CHEMBL299	Homo sapiens	Activity	%	105.0
	2897171	CHEMBL1063681	Percent residual PKCalpha activity in the presence of 10uM inhibitor	B	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12		CHEMBL92361	=	Activity	%	107.0	CHEMBL299	Homo sapiens	Activity	%	107.0
	2897172	CHEMBL1063681	Percent residual PKCalpha activity in the presence of 10uM inhibitor	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Activity	%	100.0	CHEMBL299	Homo sapiens	Activity	%	100.0
	2897173	CHEMBL1063681	Percent residual PKCalpha activity in the presence of 10uM inhibitor	B	Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL289277	=	Activity	%	71.0	CHEMBL299	Homo sapiens	Activity	%	71.0
	2921207	CHEMBL1057596	Inhibition of PKACalpha assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL299	Homo sapiens	Activity	%	100.0
	2924745	CHEMBL1056859	Inhibition of PKCalpha assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c3cc[nH]c3ccc21		CHEMBL567173	=	Activity	%	103.0	CHEMBL299	Homo sapiens	Activity	%	103.0
	2924746	CHEMBL1056859	Inhibition of PKCalpha assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c2ccc2cc[nH]c21		CHEMBL584980	=	Activity	%	111.0	CHEMBL299	Homo sapiens	Activity	%	111.0
	2924747	CHEMBL1056859	Inhibition of PKCalpha assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2ccc3c4ccccc4[nH]c3c12		CHEMBL575754	=	Activity	%	95.0	CHEMBL299	Homo sapiens	Activity	%	95.0
	2924748	CHEMBL1056859	Inhibition of PKCalpha assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12		CHEMBL583972	=	Activity	%	84.0	CHEMBL299	Homo sapiens	Activity	%	84.0
	2926207	CHEMBL1050219	Inhibition of PKCalpha assessed as remaining enzyme activity at 3 uM relative to DMSO	B	COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574236	=	Activity	%	97.0	CHEMBL299	Homo sapiens	Activity	%	97.0
	2928393	CHEMBL1060291	Inhibition of PKCalpha assessed as remaining enzyme activity at 1 uM relative to DMSO	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	92.0	CHEMBL299	Homo sapiens	Activity	%	92.0
	2938458	CHEMBL1041407	Inhibition of PKCalpha at 2 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	12.0	CHEMBL299	Homo sapiens	INH	%	12.0
	2943702	CHEMBL1044923	Inhibition of PKCalpha	B	C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OCCOC		CHEMBL571040	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	microM	10.0
	2943714	CHEMBL1044923	Inhibition of PKCalpha	B	C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1OCCOC		CHEMBL569880	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	microM	10.0
	2983213	CHEMBL1046255	Inhibition of PKCalpha	B	CC1(C)CC(NC(=O)c2cccc(-c3cc4nccc(Nc5cccc(O)c5)n4n3)c2)CC(C)(C)N1[O]		CHEMBL1163016	=	IC50	nM	1300.0	CHEMBL299	Homo sapiens	IC50	uM	1.3
	2992422	CHEMBL1040086	Inhibition of PKCalpha by SPA	B	CN1CCN(c2cc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3c2)CC1		CHEMBL568580	=	IC50	nM	0.9	CHEMBL299	Homo sapiens	IC50	nM	0.9
	2992427	CHEMBL1040086	Inhibition of PKCalpha by SPA	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	IC50	nM	2.1	CHEMBL299	Homo sapiens	IC50	nM	2.1
	2992430	CHEMBL1040086	Inhibition of PKCalpha by SPA	B	CN(C)CCOc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc2c1		CHEMBL565632	=	IC50	nM	2.2	CHEMBL299	Homo sapiens	IC50	nM	2.2
	2992435	CHEMBL1040086	Inhibition of PKCalpha by SPA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	IC50	nM	2.3	CHEMBL299	Homo sapiens	IC50	nM	2.3
	2992445	CHEMBL1040086	Inhibition of PKCalpha by SPA	B	CN(C)CCCn1cc(C2=C(c3cccc4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL584483	=	IC50	nM	98.0	CHEMBL299	Homo sapiens	IC50	nM	98.0
	2992446	CHEMBL1040086	Inhibition of PKCalpha by SPA	B	CN(C)CCOc1cccc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c1		CHEMBL566853	=	IC50	nM	15.0	CHEMBL299	Homo sapiens	IC50	nM	15.0
	2992447	CHEMBL1040086	Inhibition of PKCalpha by SPA	B	CN1CCN(c2cccc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL585500	=	IC50	nM	7.1	CHEMBL299	Homo sapiens	IC50	nM	7.1
	2992464	CHEMBL1040086	Inhibition of PKCalpha by SPA	B	CN(C)CCCn1cc(C2=C(c3csc4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL566424	=	IC50	nM	73.0	CHEMBL299	Homo sapiens	IC50	nM	73.0
	2992475	CHEMBL1040086	Inhibition of PKCalpha by SPA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1nc(N2CCOCC2)nc2ccccc12		CHEMBL584817	=	IC50	nM	1502.0	CHEMBL299	Homo sapiens	IC50	nM	1502.0
	2992479	CHEMBL1040086	Inhibition of PKCalpha by SPA	B	CN(C)CCCn1cc(C2=C(c3n[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL585281	>	IC50	nM	315.0	CHEMBL299	Homo sapiens	IC50	nM	315.0
	2998999	CHEMBL1041971	Inhibition of PKCalpha assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	95.0	CHEMBL299	Homo sapiens	Activity	%	95.0
	2999789	CHEMBL1041971	Inhibition of PKCalpha assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	104.0	CHEMBL299	Homo sapiens	Activity	%	104.0
	2999866	CHEMBL1048111	Inhibition of PKCalpha assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	Activity	%	110.0	CHEMBL299	Homo sapiens	Activity	%	110.0
	2999942	CHEMBL1048111	Inhibition of PKCalpha assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Activity	%	103.0	CHEMBL299	Homo sapiens	Activity	%	103.0
Not Active	3005104	CHEMBL1047303	Inhibition of PKCalpha at 10 uM	B	CCCc1cc(N2CCC(N)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL578601		Activity			CHEMBL299	Homo sapiens	Activity		
Not Active	3005105	CHEMBL1047303	Inhibition of PKCalpha at 10 uM	B	CCCc1cc(N2CCNCC2)nc2sc(C(N)=O)c(N)c12		CHEMBL568922		Activity			CHEMBL299	Homo sapiens	Activity		
Not Active	3005106	CHEMBL1047303	Inhibition of PKCalpha at 10 uM	B	CCCc1cc(N2CCC(O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL576887		Activity			CHEMBL299	Homo sapiens	Activity		
Not Active	3005107	CHEMBL1047303	Inhibition of PKCalpha at 10 uM	B	CCCc1cc(N2CCCC(O)C2)nc2sc(C(N)=O)c(N)c12		CHEMBL576989		Activity			CHEMBL299	Homo sapiens	Activity		
	3052443	CHEMBL1070478	Residual activity of PKCalpha at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	100.0	CHEMBL299	Homo sapiens	Residual activity	%	100.0
	3052695	CHEMBL1040272	Residual activity of PKCalpha at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	98.0	CHEMBL299	Homo sapiens	Residual activity	%	98.0
	3054004	CHEMBL1050335	Residual activity of PKCalpha at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	50.0	CHEMBL299	Homo sapiens	Residual activity	%	50.0
	3054256	CHEMBL1070478	Residual activity of PKCalpha at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	108.0	CHEMBL299	Homo sapiens	Residual activity	%	108.0
	3055543	CHEMBL1040272	Residual activity of PKCalpha at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	99.0	CHEMBL299	Homo sapiens	Residual activity	%	99.0
	3056848	CHEMBL1050335	Residual activity of PKCalpha at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	80.0	CHEMBL299	Homo sapiens	Residual activity	%	80.0
	3057100	CHEMBL1070478	Residual activity of PKCalpha at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	137.0	CHEMBL299	Homo sapiens	Residual activity	%	137.0
	3058420	CHEMBL1040272	Residual activity of PKCalpha at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	128.0	CHEMBL299	Homo sapiens	Residual activity	%	128.0
	3059704	CHEMBL1050335	Residual activity of PKCalpha at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	61.0	CHEMBL299	Homo sapiens	Residual activity	%	61.0
	3063550	CHEMBL1050465	Binding affinity to human PKACalpha at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	19.0	CHEMBL299	Homo sapiens	Activity	%	19.0
	3063640	CHEMBL1043369	Binding affinity to human PKACalpha at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	52.0	CHEMBL299	Homo sapiens	Activity	%	52.0
	3063730	CHEMBL1042492	Binding affinity to human PKACalpha at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	10.0	CHEMBL299	Homo sapiens	Activity	%	10.0
	3066885	CHEMBL1066091	Inhibition of PKACalpha at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	3066975	CHEMBL1066091	Inhibition of PKACalpha at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	12.0	CHEMBL299	Homo sapiens	INH	%	12.0
	3081442	CHEMBL1070641	Inhibition of PKCalpha at 10 uM	B	CCc1cccc(-c2c(-c3ccc4nccnc4c3)n(C)n(C)c2=O)c1		CHEMBL594371	=	Inhibition	%	58.0	CHEMBL299	Homo sapiens	INH	%	58.0
	3088559	CHEMBL1049484	Inhibition of PKCalpha	B	CN(C)CCOc1ccc2c(c1)CCn1nc(-c3ccc(Oc4ccccc4)cc3)c(C(N)=O)c1N2		CHEMBL591325	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	3097968	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	CCCCCCCCCCCCC/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL598861	=	Ki	nM	7.83	CHEMBL299	Homo sapiens	Ki	nM	7.83
	3097969	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	CCCCCCCCCCCCC/C=C1/CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL608439	=	Ki	nM	7.15	CHEMBL299	Homo sapiens	Ki	nM	7.15
	3097970	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	COCCCCCCC/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL598241	=	Ki	nM	191.0	CHEMBL299	Homo sapiens	Ki	nM	191.0
	3097971	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	COCCCCCCCCCCC/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL598453	=	Ki	nM	8.2	CHEMBL299	Homo sapiens	Ki	nM	8.2
	3097972	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	COCCCCCCCCCCCCCCC/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL598454	=	Ki	nM	4.4	CHEMBL299	Homo sapiens	Ki	nM	4.4
	3097973	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	COCCCCCCCCCCCCCCC/C=C1/CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL597632	=	Ki	nM	5.0	CHEMBL299	Homo sapiens	Ki	nM	5.0
	3097974	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	CCCCCOCCCCCCC/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL597633	=	Ki	nM	8.1	CHEMBL299	Homo sapiens	Ki	nM	8.1
	3097975	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	CCCCCCCCCOCCCCCCC/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL596818	=	Ki	nM	3.2	CHEMBL299	Homo sapiens	Ki	nM	3.2
	3097976	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	COCOCCCCCCC/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL596819	=	Ki	nM	198.4	CHEMBL299	Homo sapiens	Ki	nM	198.4
	3097977	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	COCCOCOCCCCCCC/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL605949	=	Ki	nM	323.0	CHEMBL299	Homo sapiens	Ki	nM	323.0
	3097978	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	CC(C)CCOCCCCCCC/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL604180	=	Ki	nM	7.74	CHEMBL299	Homo sapiens	Ki	nM	7.74
	3097979	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	CC(C)(C)C(=O)OCC1(CO)C/C(=C\CCCCCCCOC2CCCC2)C(=O)O1		CHEMBL599273	=	Ki	nM	10.2	CHEMBL299	Homo sapiens	Ki	nM	10.2
	3097980	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	CCCCCCCCCOCCC/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL599274	=	Ki	nM	7.44	CHEMBL299	Homo sapiens	Ki	nM	7.44
	3097981	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	CC(C)(C)C(=O)OCC1(CO)C/C(=C\CCCCCCCO)C(=O)O1		CHEMBL599275	=	Ki	nM	378.0	CHEMBL299	Homo sapiens	Ki	nM	378.0
	3097982	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	CC(C)(C)C(=O)OCC1(CO)C/C(=C\CCCCCCCCCCCO)C(=O)O1		CHEMBL596827	=	Ki	nM	14.5	CHEMBL299	Homo sapiens	Ki	nM	14.5
	3097983	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	CC(C)(C)C(=O)OCC1(CO)C/C(=C\CCCCCCCCCCCCCCCO)C(=O)O1		CHEMBL596828	=	Ki	nM	6.4	CHEMBL299	Homo sapiens	Ki	nM	6.4
	3097984	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	CC(C)(C)C(=O)OCC1(CO)C/C(=C/CCCCCCCCCCCCCCCO)C(=O)O1		CHEMBL596829	=	Ki	nM	8.24	CHEMBL299	Homo sapiens	Ki	nM	8.24
	3097985	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	CCCCCCCCC(O)CCCCCC/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL599698	=	Ki	nM	118.0	CHEMBL299	Homo sapiens	Ki	nM	118.0
	3097986	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	CC(C)(C)C(=O)OCC1(CO)C/C(=C\CCCCCCC=O)C(=O)O1		CHEMBL597281	=	Ki	nM	39.3	CHEMBL299	Homo sapiens	Ki	nM	39.3
	3097987	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	CC(C)(C)C(=O)OCC1(CO)C/C(=C\CCCCCCCCCCC=O)C(=O)O1		CHEMBL611974	=	Ki	nM	30.3	CHEMBL299	Homo sapiens	Ki	nM	30.3
	3097988	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	CC(C)(C)C(=O)OCC1(CO)C/C(=C\CCCCCCCCCCCCCCC=O)C(=O)O1		CHEMBL603450	=	Ki	nM	6.38	CHEMBL299	Homo sapiens	Ki	nM	6.38
	3097989	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	CC(C)(C)C(=O)OCC1(CO)C/C(=C/CCCCCCCCCCCCCCC=O)C(=O)O1		CHEMBL597082	=	Ki	nM	11.4	CHEMBL299	Homo sapiens	Ki	nM	11.4
	3097990	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	CC(C)(C)C(=O)OCC1(CO)C/C(=C\CCCCCCCCCCCCCCC(=O)O)C(=O)O1		CHEMBL597286	=	Ki	nM	29.7	CHEMBL299	Homo sapiens	Ki	nM	29.7
	3097991	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	COC(=O)CCCCCC/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL597287	=	Ki	nM	533.0	CHEMBL299	Homo sapiens	Ki	nM	533.0
	3097992	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	COC(=O)CCCCCCCCCCCCCC/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL597490	=	Ki	nM	6.83	CHEMBL299	Homo sapiens	Ki	nM	6.83
	3097993	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	CC(C)(C)C(=O)OCC1(CO)C/C(=C\CCCCCCCCCCCCCCCOC=O)C(=O)O1		CHEMBL597491	=	Ki	nM	8.0	CHEMBL299	Homo sapiens	Ki	nM	8.0
	3097994	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	CC(=O)OCCCCCCCCCCCCCCC/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL597893	=	Ki	nM	9.3	CHEMBL299	Homo sapiens	Ki	nM	9.3
	3097995	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	CC(C)(C)C(=O)OCCCCCCCCCCCCCCC/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL597696	=	Ki	nM	10.5	CHEMBL299	Homo sapiens	Ki	nM	10.5
	3097996	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	CC(C)(C)C(=O)OCC1(CO)C/C(=C\CCCCCCCCCCCCCCCN=[N+]=[N-])C(=O)O1		CHEMBL597697	=	Ki	nM	15.6	CHEMBL299	Homo sapiens	Ki	nM	15.6
	3097997	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	CC(C)(C)C(=O)OCC1(CO)C/C(=C\CCCCCCCCCCCCCCCN)C(=O)O1		CHEMBL597698	=	Ki	nM	36.4	CHEMBL299	Homo sapiens	Ki	nM	36.4
	3097998	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	CC(=O)NCCCCCCCCCCCCCCC/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL597826	=	Ki	nM	8.25	CHEMBL299	Homo sapiens	Ki	nM	8.25
	3097999	CHEMBL1074175	Displacement of [20-3H]phorbol 12,13-dibutyrate from recombinant PKCalpha	B	CC(C)CC(C/C=C1/CC(O)(COC(=O)C(C)(C)C)OC1=O)CC(C)C		CHEMBL597015	=	Ki	nM	2.9	CHEMBL299	Homo sapiens	Ki	nM	2.9
	3104132	CHEMBL1066416	Inhibition of recombinant PKCalpha by IMAP assay	B	C[C@@H](Oc1ccc2ncccc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL600795	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	3104179	CHEMBL1066416	Inhibition of recombinant PKCalpha by IMAP assay	B	C[C@@H](Oc1ccc2ncc(C3CC3C(N)=O)cc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL602472	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	3104232	CHEMBL1066416	Inhibition of recombinant PKCalpha by IMAP assay	B	C[C@@H](Oc1ccc2ncc(/C=C/C(N)=O)cc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL602471	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	3127301	CHEMBL1074379	Inhibition of PKCalpha at 1 uM	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	42.0	CHEMBL299	Homo sapiens	INH	%	42.0
	3127320	CHEMBL1074379	Inhibition of PKCalpha at 1 uM	B	CC(C)(C)c1ccc(CC2(N)CCN(c3ncnc4[nH]ccc34)CC2)cc1		CHEMBL597211	=	Inhibition	%	8.0	CHEMBL299	Homo sapiens	INH	%	8.0
	3127339	CHEMBL1074379	Inhibition of PKCalpha at 1 uM	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	42.0	CHEMBL299	Homo sapiens	INH	%	42.0
	3127414	CHEMBL1064448	Inhibition of PKCalpha by scintillation proximity assay	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	3127448	CHEMBL1064448	Inhibition of PKCalpha by scintillation proximity assay	B	CC(C)(C)C(=O)N1Cc2c(NC(=O)c3cc(F)cc(F)c3)n[nH]c2C1(C)C		CHEMBL604712	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	3130784	CHEMBL1065109	Inhibition of PKCalpha at 3 to 6 uM relative to control	B	COc1ccc(C(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1OC		CHEMBL604087	>	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
	3131788	CHEMBL1074310	Inhibition of PKCalpha	B	NC(=O)c1ccc(NC(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1		CHEMBL600852	=	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
	3186444	CHEMBL1113291	Inhibition of human PKCalpha at 20 uM	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12		CHEMBL1095040	=	Inhibition	%	14.0	CHEMBL299	Homo sapiens	INH	%	14.0
	3191068	CHEMBL1102675	Inhibition of PKCalpha at 10 uM	B	C[C@H](O)CNc1nccc(-n2ccnc2-c2cccc(NC(=O)c3ccc(Cl)c(C(F)(F)F)c3)c2)n1		CHEMBL1082876	=	Inhibition	%	1.1	CHEMBL299	Homo sapiens	INH	%	1.1
	3203275	CHEMBL1102984	Inhibition of PKCalpha	B	Cn1cc(C2=C(c3cccc(NCC(O)CO)c3)C(=O)NC2=O)c2cc(Cl)ccc21		CHEMBL1082153	=	IC50	nM	260.0	CHEMBL299	Homo sapiens	IC50	nM	260.0
	3203277	CHEMBL1102984	Inhibition of PKCalpha	B	Cn1cc(C2=C(c3cccc(NCC(O)CO)c3)C(=O)NC2=O)c2cc(F)ccc21		CHEMBL1082152	=	IC50	nM	400.0	CHEMBL299	Homo sapiens	IC50	nM	400.0
	3203279	CHEMBL1102984	Inhibition of PKCalpha	B	Cn1cc(C2=C(c3cccc(NCCCO)c3)C(=O)NC2=O)c2ccccc21		CHEMBL1082151	=	IC50	nM	740.0	CHEMBL299	Homo sapiens	IC50	nM	740.0
	3203281	CHEMBL1102984	Inhibition of PKCalpha	B	Cn1cc(C2=C(c3cccc(CC(O)CO)c3)C(=O)NC2=O)c2cc(F)ccc21		CHEMBL1081973	=	IC50	nM	2200.0	CHEMBL299	Homo sapiens	IC50	nM	2200.0
	3203283	CHEMBL1102984	Inhibition of PKCalpha	B	Cn1cc(C2=C(c3cccc(C[C@H](O)CO)c3)C(=O)NC2=O)c2ccccc21		CHEMBL1081972	=	IC50	nM	1400.0	CHEMBL299	Homo sapiens	IC50	nM	1400.0
	3203285	CHEMBL1102984	Inhibition of PKCalpha	B	Cn1cc(C2=C(c3cccc(C[C@@H](O)CO)c3)C(=O)NC2=O)c2ccccc21		CHEMBL1081294	=	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	nM	1000.0
Not Determined	3203287	CHEMBL1102984	Inhibition of PKCalpha	B	COc1cccc(C2=C(c3cn(C)c4cccc(OC)c34)C(=O)NC2=O)c1		CHEMBL1081293		IC50			CHEMBL299	Homo sapiens	IC50		
	3203289	CHEMBL1102984	Inhibition of PKCalpha	B	COc1cccc(C2=C(c3cn(C)c4cc(C)ccc34)C(=O)NC2=O)c1		CHEMBL1081128	=	IC50	nM	2900.0	CHEMBL299	Homo sapiens	IC50	nM	2900.0
	3203291	CHEMBL1102984	Inhibition of PKCalpha	B	COc1cccc(C2=C(c3cn(C)c4ccc(Cl)cc34)C(=O)NC2=O)c1		CHEMBL1081617	=	IC50	nM	1400.0	CHEMBL299	Homo sapiens	IC50	nM	1400.0
	3203293	CHEMBL1102984	Inhibition of PKCalpha	B	COc1cccc(C2=C(c3cn(C)c4cc(F)ccc34)C(=O)NC2=O)c1		CHEMBL1081616	=	IC50	nM	4200.0	CHEMBL299	Homo sapiens	IC50	nM	4200.0
Not Determined	3203295	CHEMBL1102984	Inhibition of PKCalpha	B	COc1cccc(C2=C(c3c(C)n(C)c4ccccc34)C(=O)NC2=O)c1		CHEMBL1080933		IC50			CHEMBL299	Homo sapiens	IC50		
	3203297	CHEMBL1102984	Inhibition of PKCalpha	B	COc1cccc(C2=C(c3cn(C)c4ccccc34)C(=O)NC2=O)c1		CHEMBL293542	=	IC50	nM	6000.0	CHEMBL299	Homo sapiens	IC50	nM	6000.0
Not Determined	3203299	CHEMBL1102984	Inhibition of PKCalpha	B	Cn1cc(C2=C(c3ccc(-c4ccccc4)cc3)C(=O)NC2=O)c2ccccc21		CHEMBL1086732		IC50			CHEMBL299	Homo sapiens	IC50		
	3203301	CHEMBL1102984	Inhibition of PKCalpha	B	Cn1cc(C2=C(c3cccnc3)C(=O)NC2=O)c2ccccc21		CHEMBL1087380	>	IC50	nM	30000.0	CHEMBL299	Homo sapiens	IC50	nM	30000.0
	3203303	CHEMBL1102984	Inhibition of PKCalpha	B	Cn1cc(C2=C(c3cccs3)C(=O)NC2=O)c2ccccc21		CHEMBL53745	=	IC50	nM	8900.0	CHEMBL299	Homo sapiens	IC50	nM	8900.0
	3203305	CHEMBL1102984	Inhibition of PKCalpha	B	COc1ccc(OC)c(C2=C(c3cn(C)c4ccccc34)C(=O)NC2=O)c1		CHEMBL1087243	=	IC50	nM	380.0	CHEMBL299	Homo sapiens	IC50	nM	380.0
	3203307	CHEMBL1102984	Inhibition of PKCalpha	B	COc1ccc(C2=C(c3cn(C)c4ccccc34)C(=O)NC2=O)cc1OC		CHEMBL1087242	=	IC50	nM	6600.0	CHEMBL299	Homo sapiens	IC50	nM	6600.0
	3203309	CHEMBL1102984	Inhibition of PKCalpha	B	COc1ccc(C2=C(c3cn(C)c4ccccc34)C(=O)NC2=O)c(OC)c1		CHEMBL1088149	=	IC50	nM	5500.0	CHEMBL299	Homo sapiens	IC50	nM	5500.0
	3203311	CHEMBL1102984	Inhibition of PKCalpha	B	Cn1cc(C2=C(c3cccc(N)c3)C(=O)NC2=O)c2ccccc21		CHEMBL54547	=	IC50	nM	1900.0	CHEMBL299	Homo sapiens	IC50	nM	1900.0
	3203313	CHEMBL1102984	Inhibition of PKCalpha	B	Cn1cc(C2=C(c3ccccc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL431933	=	IC50	nM	760.0	CHEMBL299	Homo sapiens	IC50	nM	760.0
	3203340	CHEMBL1102984	Inhibition of PKCalpha	B	CN(C)C[C@H]1CCn2c(c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c3ccccc32)C1		CHEMBL26501	=	IC50	nM	22.0	CHEMBL299	Homo sapiens	IC50	nM	22.0
	3203342	CHEMBL1102984	Inhibition of PKCalpha	B	Cn1cc(C2=C(c3c4n(c5ccccc35)CCN(C(N)=S)C4)C(=O)NC2=O)c2ccccc21		CHEMBL1088724	=	IC50	nM	1050.0	CHEMBL299	Homo sapiens	IC50	nM	1050.0
	3210390	CHEMBL1109435	Inhibition of PKCalpha after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL1081198	=	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
Dose-dependent effect	3211476	CHEMBL1103353	Activation of PKCalpha assessed as [32P] incorporation after 10 mins by scintillation counting	B	CC(=O)O[C@@]12[C@H](OC(=O)[C@H](C(C)C)N(C)C)[C@@H](C)[C@@]3(O)[C@@H](C=C(CO)C[C@H]4C(=O)C(C)=C[C@H]43)[C@@H]1C2(C)C		CHEMBL525601		Activity			CHEMBL299	Homo sapiens	Activity		
Not Active	3211477	CHEMBL1103353	Activation of PKCalpha assessed as [32P] incorporation after 10 mins by scintillation counting	B	CC(=O)O[C@@]12[C@H](OC(=O)CN(C)C)[C@@H](C)[C@@]3(O)[C@@H](C=C(CO)C[C@H]4C(=O)C(C)=C[C@H]43)[C@@H]1C2(C)C		CHEMBL1088330		Activity			CHEMBL299	Homo sapiens	Activity		
	3214012	CHEMBL1116760	Inhibition of PKACalpha at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	3.0	CHEMBL299	Homo sapiens	INH	%	3.0
	3214013	CHEMBL1116761	Inhibition of PKCalpha at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	-7.0	CHEMBL299	Homo sapiens	INH	%	-7.0
	3219689	CHEMBL1110440	Inhibition of PKCalpha at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1ccc(-c2ccnc(N)n2)s1)C(N)=O		CHEMBL1077375	=	Inhibition	%	92.0	CHEMBL299	Homo sapiens	INH	%	92.0
	3220013	CHEMBL1115862	Inhibition of PKCalpha	B	CN1C[C@@H]2C[C@H]1CN2c1ccc(-c2ccnc3c(-c4cccc(O)c4)c(-c4ccncc4)nn23)cc1		CHEMBL1087650	=	IC50	nM	2460.0	CHEMBL299	Homo sapiens	IC50	uM	2.46
	3224926	CHEMBL1101004	Inhibition of PKCalpha at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
	3226305	CHEMBL1101004	Inhibition of PKCalpha at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
	3228112	CHEMBL1114824	Inhibition of PKCalpha	B	CN(C)Cc1ccc(-c2cnn3c(-c4cccc(NC(=O)c5cccc(C(F)(F)F)c5)c4)ccnc23)cc1		CHEMBL1087397	>	IC50	nM	2000.0	CHEMBL299	Homo sapiens	IC50	uM	2.0
	3242226	CHEMBL1111612	Inhibition of PKCalpha	B	CC(C)N1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(C5CCOCC5)nc(N5C6CCC5COC6)n4)cc3)cc2)CC1		CHEMBL1091356	<	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	3251248	CHEMBL1107903	Inhibition of PKCalpha	B	Cn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(-c3ccc(C(=O)NCCO)cc3)ccnc21		CHEMBL1092754	=	IC50	nM	50.0	CHEMBL299	Homo sapiens	IC50	nM	50.0
Not Active	3253632	CHEMBL1114424	Inhibition of PKCalpha at 10 uM	B	FC(F)(F)c1ccc(Nc2ccnc3nc(-c4ncccc4C(F)(F)F)ccc23)nc1		CHEMBL1089119		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Not Active	3259575	CHEMBL1111693	Inhibition of PKCalpha up to 10 uM	B	CCCCCCCCCCCCc1ccc(NC(=O)C2(C(=N)N)CC2)cc1.Cl		CHEMBL1093397		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Not Active	3259576	CHEMBL1111693	Inhibition of PKCalpha up to 10 uM	B	CCCCCCCCCCCCc1ccc(C(=O)NC2(C(=N)N)CC2)cc1.Cl		CHEMBL1092481		Inhibition	%		CHEMBL299	Homo sapiens	INH		
	3260056	CHEMBL1104335	Inhibition of PKCalpha at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	81.0	CHEMBL299	Homo sapiens	Activity	%	81.0
	3260505	CHEMBL1109840	Inhibition of PKCalpha	B	O=C(Nc1cccc(-c2ccnc3cc(-c4ccncc4)nn23)c1)c1cccc(C(F)(F)F)c1		CHEMBL1089082	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	3261417	CHEMBL1104335	Inhibition of PKCalpha at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	78.0	CHEMBL299	Homo sapiens	Activity	%	78.0
	3264384	CHEMBL1104653	Inhibition of PKCalpha	B	CC(C)(C)OC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1		CHEMBL1095627	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	3271274	CHEMBL1104653	Inhibition of PKCalpha	B	COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1		CHEMBL1095626	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	3293540	CHEMBL1120766	Inhibition of PKCalpha	B	O=C(Nc1ccc(F)cc1F)c1cccnc1Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1		CHEMBL1095873	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	3306921	CHEMBL1117946	Inhibition of PKCA at 3 uM	B	O=C(Nc1cc2cc[nH]c(=O)c2cc1Cl)C(NC1CC1)c1ccccc1		CHEMBL1084106	=	Inhibition	%	85.0	CHEMBL299	Homo sapiens	INH	%	85.0
	3316803	CHEMBL1120362	Inhibition of PKCalpha at 1 uM	B	O=C(Nc1cccc(-n2ccc3c(NC(=O)c4ccccc4)nccc32)c1)c1ccc(N2CCOCC2)c(C(F)(F)F)c1		CHEMBL1084450	=	Inhibition	%	-5.0	CHEMBL299	Homo sapiens	INH	%	-5.0
	3326155	CHEMBL1168773	Inhibition of PKCalpha at 10 uM by HotSpot assay	B	CC(=O)Nc1cccc(-c2ccc(-c3ccnc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)n3)cn2)c1.Cl		CHEMBL1164847	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
	3332101	CHEMBL1166812	Inhibition of PKAC-alpha at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
	3333516	CHEMBL1166812	Inhibition of PKAC-alpha at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
	3334921	CHEMBL1166812	Inhibition of PKAC-alpha at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
	3336341	CHEMBL1166812	Inhibition of PKAC-alpha at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
	3337620	CHEMBL1166812	Inhibition of PKAC-alpha at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
	3338951	CHEMBL1166812	Inhibition of PKAC-alpha at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
	3339205	CHEMBL1166812	Inhibition of PKAC-alpha at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
	3340508	CHEMBL1166812	Inhibition of PKAC-alpha at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
	3341883	CHEMBL1166812	Inhibition of PKAC-alpha at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
	3343330	CHEMBL1166812	Inhibition of PKAC-alpha at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
Not Active	3352237	CHEMBL1175405	Inhibition of PKCalpha at 10 uM	B	CC(=O)c1cc(C(=O)N2CC(O)C2)c(Nc2ccc(I)cc2F)n1C		CHEMBL1170191		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Not Active	3352238	CHEMBL1175405	Inhibition of PKCalpha at 10 uM	B	CC(=O)c1cc(C(=O)N2CC(N)C2)c(Nc2ccc(I)cc2F)n1C		CHEMBL1172521		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Not Active	3352239	CHEMBL1175405	Inhibition of PKCalpha at 10 uM	B	CC(=O)c1cc(C(=O)N2CC[C@@H](O)C2)c(Nc2ccc(I)cc2F)n1C		CHEMBL1169631		Inhibition	%		CHEMBL299	Homo sapiens	INH		
	3358754	CHEMBL1175220	Inhibition of PKAC-alpha at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	8.4	CHEMBL299	Homo sapiens	INH	%	8.4
	3359196	CHEMBL1175220	Inhibition of PKAC-alpha at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	27.0	CHEMBL299	Homo sapiens	INH	%	27.0
	3400035	CHEMBL1217232	Inhibition of human PKCalpha at 10 uM	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL1214141	=	Inhibition	%	51.0	CHEMBL299	Homo sapiens	INH	%	51.0
	3407880	CHEMBL1219824	Inhibition of PKCalpha by TR-FRET assay	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	IC50	nM	3.7	CHEMBL299	Homo sapiens	IC50	nM	3.7
	3407881	CHEMBL1219824	Inhibition of PKCalpha by TR-FRET assay	B	NCCNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL1214929	=	IC50	nM	900.0	CHEMBL299	Homo sapiens	IC50	nM	900.0
	3407882	CHEMBL1219824	Inhibition of PKCalpha by TR-FRET assay	B	OCCCNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL1214930	=	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	nM	1000.0
	3407883	CHEMBL1219824	Inhibition of PKCalpha by TR-FRET assay	B	CNc1cc(-c2cc3cnccc3c(NCCCO)n2)ccn1		CHEMBL1214931	=	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	nM	1000.0
	3407884	CHEMBL1219824	Inhibition of PKCalpha by TR-FRET assay	B	c1cc(-c2cc3cnccc3c(N3CCNCC3)n2)ccn1		CHEMBL1214932	=	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	nM	1000.0
	3407885	CHEMBL1219824	Inhibition of PKCalpha by TR-FRET assay	B	Clc1cc(-c2cc3cnccc3c(N3CCNCC3)n2)ccn1		CHEMBL1214933	=	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	nM	1000.0
	3407886	CHEMBL1219824	Inhibition of PKCalpha by TR-FRET assay	B	c1cc2c(N3CCNCC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2cn1		CHEMBL1214998	=	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	nM	1000.0
	3419147	CHEMBL1228777	Inhibition of PKCalpha	B	NC(=O)c1sc2c([N+](=O)[O-])cc(C(F)(F)F)cc2[n+]1[O-]		CHEMBL476124	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	3419164	CHEMBL1228777	Inhibition of PKCalpha	B	NC(=O)c1sc2c([N+](=O)[O-])cc(SC(F)(F)F)cc2[n+]1[O-]		CHEMBL1222044	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	3443490	CHEMBL1244256	Inhibition of PKCalpha at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	32.0	CHEMBL299	Homo sapiens	INH	%	32.0
	3443707	CHEMBL1244256	Inhibition of PKCalpha at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	39.0	CHEMBL299	Homo sapiens	INH	%	39.0
	3444862	CHEMBL1244256	Inhibition of PKCalpha at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	40.0	CHEMBL299	Homo sapiens	INH	%	40.0
	3445256	CHEMBL1244927	Binding affinity to PKAC-alpha	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	220.0	CHEMBL299	Homo sapiens	Kd	nM	220.0
	3445486	CHEMBL1244256	Inhibition of PKCalpha at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	5.0	CHEMBL299	Homo sapiens	INH	%	5.0
	3445703	CHEMBL1244256	Inhibition of PKCalpha at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	82.0	CHEMBL299	Homo sapiens	INH	%	82.0
	3445898	CHEMBL1244256	Inhibition of PKCalpha at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	42.0	CHEMBL299	Homo sapiens	INH	%	42.0
	3446088	CHEMBL1244256	Inhibition of PKCalpha at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	13.0	CHEMBL299	Homo sapiens	INH	%	13.0
	3446538	CHEMBL1249578	Inhibition of His-tagged human PKCalpha expressed in Escherichia coli at 1 uM	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Inhibition	%	4.0	CHEMBL299	Homo sapiens	INH	%	4.0
	3446551	CHEMBL1249815	Inhibition of His-tagged human PKCalpha expressed in Escherichia coli	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	IC50	nM	33.0	CHEMBL299	Homo sapiens	IC50	nM	33.0
	3446567	CHEMBL1249578	Inhibition of His-tagged human PKCalpha expressed in Escherichia coli at 1 uM	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Inhibition	%	3.0	CHEMBL299	Homo sapiens	INH	%	3.0
	3446591	CHEMBL1249578	Inhibition of His-tagged human PKCalpha expressed in Escherichia coli at 1 uM	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Inhibition	%	99.0	CHEMBL299	Homo sapiens	INH	%	99.0
	3446616	CHEMBL1249530	Inhibition of His-tagged human PKCalpha expressed in Escherichia coli at 20 uM	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	Inhibition	%	70.0	CHEMBL299	Homo sapiens	INH	%	70.0
	3446643	CHEMBL1249554	Inhibition of His-tagged human PKCalpha expressed in Escherichia coli at 50 uM	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Inhibition	%	91.0	CHEMBL299	Homo sapiens	INH	%	91.0
	3446671	CHEMBL1249578	Inhibition of His-tagged human PKCalpha expressed in Escherichia coli at 1 uM	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Inhibition	%	100.0	CHEMBL299	Homo sapiens	INH	%	100.0
	3446697	CHEMBL1247618	Inhibition of His-tagged human PKCalpha expressed in Escherichia coli at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Inhibition	%	92.0	CHEMBL299	Homo sapiens	INH	%	92.0
	3446721	CHEMBL1247618	Inhibition of His-tagged human PKCalpha expressed in Escherichia coli at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Inhibition	%	89.0	CHEMBL299	Homo sapiens	INH	%	89.0
	3446745	CHEMBL1249554	Inhibition of His-tagged human PKCalpha expressed in Escherichia coli at 50 uM	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Inhibition	%	93.0	CHEMBL299	Homo sapiens	INH	%	93.0
	3446770	CHEMBL1247618	Inhibition of His-tagged human PKCalpha expressed in Escherichia coli at 10 uM	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Inhibition	%	99.0	CHEMBL299	Homo sapiens	INH	%	99.0
	3446802	CHEMBL1247618	Inhibition of His-tagged human PKCalpha expressed in Escherichia coli at 10 uM	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Inhibition	%	92.0	CHEMBL299	Homo sapiens	INH	%	92.0
	3446829	CHEMBL1247618	Inhibition of His-tagged human PKCalpha expressed in Escherichia coli at 10 uM	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Inhibition	%	95.0	CHEMBL299	Homo sapiens	INH	%	95.0
	3446856	CHEMBL1249530	Inhibition of His-tagged human PKCalpha expressed in Escherichia coli at 20 uM	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Inhibition	%	95.0	CHEMBL299	Homo sapiens	INH	%	95.0
	3446887	CHEMBL1249530	Inhibition of His-tagged human PKCalpha expressed in Escherichia coli at 20 uM	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Inhibition	%	86.0	CHEMBL299	Homo sapiens	INH	%	86.0
	3447264	CHEMBL1247618	Inhibition of His-tagged human PKCalpha expressed in Escherichia coli at 10 uM	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Inhibition	%	98.0	CHEMBL299	Homo sapiens	INH	%	98.0
	3447297	CHEMBL1247618	Inhibition of His-tagged human PKCalpha expressed in Escherichia coli at 10 uM	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	79.0	CHEMBL299	Homo sapiens	INH	%	79.0
	3447331	CHEMBL1249578	Inhibition of His-tagged human PKCalpha expressed in Escherichia coli at 1 uM	B	NCCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL270875	=	Inhibition	%	7.0	CHEMBL299	Homo sapiens	INH	%	7.0
	3447355	CHEMBL1249578	Inhibition of His-tagged human PKCalpha expressed in Escherichia coli at 1 uM	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Inhibition	%	57.0	CHEMBL299	Homo sapiens	INH	%	57.0
	3447379	CHEMBL1249578	Inhibition of His-tagged human PKCalpha expressed in Escherichia coli at 1 uM	B	CN1C(=O)C(c2c[nH]c3ccccc23)=C(c2c[nH]c3ccccc23)C1=O		CHEMBL291725	=	Inhibition	%	104.0	CHEMBL299	Homo sapiens	INH	%	104.0
	3447403	CHEMBL1249578	Inhibition of His-tagged human PKCalpha expressed in Escherichia coli at 1 uM	B	Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL269264	=	Inhibition	%	14.0	CHEMBL299	Homo sapiens	INH	%	14.0
	3447427	CHEMBL1249578	Inhibition of His-tagged human PKCalpha expressed in Escherichia coli at 1 uM	B	Cn1cc(C2=C(c3c4n(c5ccccc35)CCC(CN)C4)C(=O)NC2=O)c2ccccc21		CHEMBL421565	=	Inhibition	%	1.0	CHEMBL299	Homo sapiens	INH	%	1.0
	3447451	CHEMBL1249578	Inhibition of His-tagged human PKCalpha expressed in Escherichia coli at 1 uM	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Inhibition	%	7.0	CHEMBL299	Homo sapiens	INH	%	7.0
	3447475	CHEMBL1247618	Inhibition of His-tagged human PKCalpha expressed in Escherichia coli at 10 uM	B	O=C1NCc2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL16958	=	Inhibition	%	60.0	CHEMBL299	Homo sapiens	INH	%	60.0
	3447499	CHEMBL1247618	Inhibition of His-tagged human PKCalpha expressed in Escherichia coli at 10 uM	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Inhibition	%	87.0	CHEMBL299	Homo sapiens	INH	%	87.0
	3447525	CHEMBL1249578	Inhibition of His-tagged human PKCalpha expressed in Escherichia coli at 1 uM	B	CC[C@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@@H]4O		CHEMBL1242366	=	Inhibition	%	1.0	CHEMBL299	Homo sapiens	INH	%	1.0
	3448040	CHEMBL1249685	Inhibition of human PKCalpha activity at 10 uM by radiometric assay	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	3448116	CHEMBL1249685	Inhibition of human PKCalpha activity at 10 uM by radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	17.0	CHEMBL299	Homo sapiens	INH	%	17.0
	3448574	CHEMBL1244927	Binding affinity to PKAC-alpha	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL299	Homo sapiens	Kd	uM	10.0
	3449013	CHEMBL1244927	Binding affinity to PKAC-alpha	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	720.0	CHEMBL299	Homo sapiens	Kd	nM	720.0
	3449805	CHEMBL1244927	Binding affinity to PKAC-alpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL299	Homo sapiens	Kd	uM	10.0
	3450200	CHEMBL1244927	Binding affinity to PKAC-alpha	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL299	Homo sapiens	Kd	uM	10.0
	3450398	CHEMBL1244927	Binding affinity to PKAC-alpha	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL299	Homo sapiens	Kd	uM	10.0
	3451117	CHEMBL1244927	Binding affinity to PKAC-alpha	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL299	Homo sapiens	Kd	uM	10.0
	3463323	CHEMBL1252625	Inhibition of PRKCA at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	95.0	CHEMBL299	Homo sapiens	INH	%	95.0
	3463867	CHEMBL1252625	Inhibition of PRKCA at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	21.0	CHEMBL299	Homo sapiens	INH	%	21.0
	3464086	CHEMBL1252625	Inhibition of PRKCA at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	61.0	CHEMBL299	Homo sapiens	INH	%	61.0
	3504867	CHEMBL1260393	Inhibition of [3H]PDBu binding to PKC alpha C1A peptide	B	CO[C@@H](CC[C@H](C)[C@H]1O[C@@]23C[C@H](OC(=O)C[C@H]([C@@H](C)O)OC(=O)C[C@](O)(O2)[C@H](C)CC3(C)C)[C@@H]1C)c1cc(O)ccc1Br		CHEMBL1256416	=	Ki	nM	0.4	CHEMBL299	Homo sapiens	Ki	nM	0.4
	3504875	CHEMBL1260393	Inhibition of [3H]PDBu binding to PKC alpha C1A peptide	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Kd	nM	1.1	CHEMBL299	Homo sapiens	Kd	nM	1.1
	3504883	CHEMBL1260393	Inhibition of [3H]PDBu binding to PKC alpha C1A peptide	B	CC1(C)CC[C@@H]2CC(=O)O[C@@H](CO)CC(=O)O[C@@H]3C[C@@H](CCCCc4ccccc4)O[C@@]1(C3)O2		CHEMBL1258117	=	Ki	nM	120.0	CHEMBL299	Homo sapiens	Ki	nM	120.0
	3504888	CHEMBL1260393	Inhibition of [3H]PDBu binding to PKC alpha C1A peptide	B	CC1(C)CC[C@@H]2CC(=O)O[C@@H](CO)CC(=O)O[C@@H]3C[C@@H](CCCCc4cccc(O)c4)O[C@@]1(C3)O2		CHEMBL1258348	=	Ki	nM	63.0	CHEMBL299	Homo sapiens	Ki	nM	63.0
	3504896	CHEMBL1260393	Inhibition of [3H]PDBu binding to PKC alpha C1A peptide	B	O=C1C[C@H]2CCC[C@]3(C[C@@H](C[C@@H](CCCCc4ccccc4)O3)OC(=O)C[C@H](CO)O1)O2		CHEMBL1258349	=	Ki	nM	2400.0	CHEMBL299	Homo sapiens	Ki	nM	2400.0
	3521260	CHEMBL1272518	Inhibition of PKCalpha	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc([C@@H](C)N3C[C@H](C)O[C@H](C)C3)ns2)n1		CHEMBL1270399	>	IC50	nM	10.0	CHEMBL299	Homo sapiens	IC50	nM	10.0
	3525170	CHEMBL1274102	Inhibition of PKCalpha at 1 uM	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL496862	=	Inhibition	%	88.0	CHEMBL299	Homo sapiens	INH	%	88.0
	3525200	CHEMBL1274102	Inhibition of PKCalpha at 1 uM	B	O=C1Nc2ccccc2/C1=C(/Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL500435	=	Inhibition	%	29.0	CHEMBL299	Homo sapiens	INH	%	29.0
	3525230	CHEMBL1274102	Inhibition of PKCalpha at 1 uM	B	CN(C)C(=O)c1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL1272078	=	Inhibition	%	28.0	CHEMBL299	Homo sapiens	INH	%	28.0
	3525260	CHEMBL1274102	Inhibition of PKCalpha at 1 uM	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL1272128	=	Inhibition	%	100.0	CHEMBL299	Homo sapiens	INH	%	100.0
	3525290	CHEMBL1274102	Inhibition of PKCalpha at 1 uM	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL1272289	=	Inhibition	%	89.0	CHEMBL299	Homo sapiens	INH	%	89.0
	3525320	CHEMBL1274102	Inhibition of PKCalpha at 1 uM	B	CCNCc1ccc(N/C(=C2\C(=O)Nc3cc(C(=O)N(C)CC)ccc32)c2ccccc2)cc1		CHEMBL1271471	=	Inhibition	%	85.0	CHEMBL299	Homo sapiens	INH	%	85.0
	3561321	CHEMBL1287077	Inhibition of human PKCalpha at 10 uM	B	Cc1c2c(=O)n(-c3ccccc3Cl)[nH]c2cc(=O)n1Cc1ccccn1		CHEMBL1276946	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	3590881	CHEMBL1292179	Inhibition of PKCalpha	B	Cc1ccc(C(=O)Nc2ccon2)cc1NC(=O)c1cnn(-c2ccccc2F)c1N		CHEMBL1290746	>	IC50	nM	40000.0	CHEMBL299	Homo sapiens	IC50	uM	40.0
	5120280	CHEMBL1648677	Inhibition of human PKCalpha at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	93.0	CHEMBL299	Homo sapiens	INH	%	93.0
	5133713	CHEMBL1648529	Inhibition of PKCalpha assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	69.0	CHEMBL299	Homo sapiens	Activity	%	69.0
	5133808	CHEMBL1648529	Inhibition of PKCalpha assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	70.0	CHEMBL299	Homo sapiens	Activity	%	70.0
	5133863	CHEMBL1648529	Inhibition of PKCalpha assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	71.0	CHEMBL299	Homo sapiens	Activity	%	71.0
	5143848	CHEMBL1656188	Inhibition of PKCA	B	CCN(Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)C(C)(C)CO.Cl		CHEMBL1650533	>	IC50	nM	100.0	CHEMBL299	Homo sapiens	IC50	nM	100.0
	5143865	CHEMBL1656188	Inhibition of PKCA	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCC(F)(F)C3)ns2)n1.Cl		CHEMBL1650545	>	IC50	nM	100.0	CHEMBL299	Homo sapiens	IC50	nM	100.0
	5143882	CHEMBL1656188	Inhibition of PKCA	B	Cl.[2H]C([2H])(c1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)N1CCC(F)(F)C1		CHEMBL1650551	>	IC50	nM	100.0	CHEMBL299	Homo sapiens	IC50	nM	100.0
	5146708	CHEMBL1657031	Inhibition of PKCalpha	B	CC(C)(O)C(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL1650951	=	IC50	nM	13.0	CHEMBL299	Homo sapiens	IC50	nM	13.0
	5149552	CHEMBL1655854	Inhibition of PKCalpha	B	CN(C)CCN(C)[C@H]1COc2ccccc2-c2c(C3CCCCC3)c3ccc(C(=O)O)cc3n2C1		CHEMBL1233524	=	IC50	nM	59000.0	CHEMBL299	Homo sapiens	IC50	uM	59.0
	5191367	CHEMBL1664040	Inhibition of PKCalpha at 1 uM	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782	=	Inhibition	%	-3.0	CHEMBL299	Homo sapiens	INH	%	-3.0
	5191368	CHEMBL1664040	Inhibition of PKCalpha at 1 uM	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12		CHEMBL1650131	=	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
Not Active	5220331	CHEMBL1681594	Inhibition of human recombinant PKCalpha at < 10 uM after 10 mins by radiometric assay	B	O=C1NCCCc2c1oc1ccc(O)cc21		CHEMBL1450770		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Not Active	5220332	CHEMBL1681594	Inhibition of human recombinant PKCalpha at < 10 uM after 10 mins by radiometric assay	B	O=C1NCCCc2c1[nH]c1ccc(O)cc21		CHEMBL1672570		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Not Active	5220333	CHEMBL1681594	Inhibition of human recombinant PKCalpha at < 10 uM after 10 mins by radiometric assay	B	O=C1NCCSc2c1sc1ccc(O)cc21		CHEMBL1672571		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Not Active	5220334	CHEMBL1681594	Inhibition of human recombinant PKCalpha at < 10 uM after 10 mins by radiometric assay	B	COc1ccc2sc3c(c2c1)SCCNC3=O		CHEMBL319170		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Not Active	5220335	CHEMBL1681594	Inhibition of human recombinant PKCalpha at < 10 uM after 10 mins by radiometric assay	B	[N-]=[N+]=Nc1ccc2sc3c(c2c1)SCCNC3=O		CHEMBL1672572		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Not Active	5220336	CHEMBL1681594	Inhibition of human recombinant PKCalpha at < 10 uM after 10 mins by radiometric assay	B	O=C1NCCCSc2c1sc1ccc(O)cc21		CHEMBL1672573		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Not Active	5220337	CHEMBL1681594	Inhibition of human recombinant PKCalpha at < 10 uM after 10 mins by radiometric assay	B	COc1ccc2sc3c(c2c1)SCCCNC3=O		CHEMBL1672574		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Not Active	5220338	CHEMBL1681594	Inhibition of human recombinant PKCalpha at < 10 uM after 10 mins by radiometric assay	B	COc1ncc2sc3c(c2n1)SCCNC3=O		CHEMBL1672575		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Not Active	5239592	CHEMBL1686878	Inhibition of PKCalpha up to 10 uM	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025		Inhibition	%		CHEMBL299	Homo sapiens	INH		
	5243752	CHEMBL1685856	Inhibition of PKCalpha at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	77.0	CHEMBL299	Homo sapiens	INH	%	77.0
	5243860	CHEMBL1686072	Inhibition of PKCalpha at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	36.0	CHEMBL299	Homo sapiens	INH	%	36.0
	5243973	CHEMBL1685856	Inhibition of PKCalpha at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	85.0	CHEMBL299	Homo sapiens	INH	%	85.0
	5244081	CHEMBL1686072	Inhibition of PKCalpha at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	27.0	CHEMBL299	Homo sapiens	INH	%	27.0
	5244954	CHEMBL1685856	Inhibition of PKCalpha at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	103.0	CHEMBL299	Homo sapiens	INH	%	103.0
	5245062	CHEMBL1686072	Inhibition of PKCalpha at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	66.0	CHEMBL299	Homo sapiens	INH	%	66.0
	5245213	CHEMBL1685856	Inhibition of PKCalpha at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	85.0	CHEMBL299	Homo sapiens	INH	%	85.0
	5246043	CHEMBL1686072	Inhibition of PKCalpha at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	85.0	CHEMBL299	Homo sapiens	INH	%	85.0
	5293890	CHEMBL1697126	Inhibition of PKC-alpha after 60 mins by radiometric assay	B	O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O		CHEMBL1448	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
Not Active	6150865	CHEMBL1764802	Inhibition of PKCA	B	C[C@H]1C(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C(=O)N1Cc1ccnc2ccccc12		CHEMBL1738841		Inhibition	%		CHEMBL299	Homo sapiens	INH		
	6168155	CHEMBL1768515	Inhibition of human PKCalpha activity using kemptide as a substrate in presence of 50 uM ATP by mass spectrometry	B	CN(C)CCCn1cc(NC(=O)Nc2nccc(-c3ccccc3)n2)c2ccccc21		CHEMBL1766422	=	IC50	nM	95.0	CHEMBL299	Homo sapiens	IC50	nM	95.0
	6168158	CHEMBL1768515	Inhibition of human PKCalpha activity using kemptide as a substrate in presence of 50 uM ATP by mass spectrometry	B	CCN(CC)CCCn1cc(NC(=O)Nc2cccc(-c3ccccc3)n2)c2ccccc21		CHEMBL1766423	=	IC50	nM	2685.0	CHEMBL299	Homo sapiens	IC50	nM	2685.0
	6168160	CHEMBL1768515	Inhibition of human PKCalpha activity using kemptide as a substrate in presence of 50 uM ATP by mass spectrometry	B	CCN(CC)CCCn1cc(NC(=O)Nc2ccnc(-c3ccccc3)n2)c2ccccc21		CHEMBL1766424	=	IC50	nM	4810.0	CHEMBL299	Homo sapiens	IC50	nM	4810.0
	6168162	CHEMBL1768515	Inhibition of human PKCalpha activity using kemptide as a substrate in presence of 50 uM ATP by mass spectrometry	B	CCN(CC)CCCn1cc(NC(=O)Nc2cncc(-c3ccccc3)n2)c2ccccc21		CHEMBL1766425	=	IC50	nM	8070.0	CHEMBL299	Homo sapiens	IC50	nM	8070.0
	6168164	CHEMBL1768515	Inhibition of human PKCalpha activity using kemptide as a substrate in presence of 50 uM ATP by mass spectrometry	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3.0	CHEMBL299	Homo sapiens	IC50	nM	3.0
	6173422	CHEMBL1768232	Inhibition of PRKCA at 25 uM by TR-FRET assay	B	NC(=O)c1ccsc1NC(=O)Cc1csc2ccccc12		CHEMBL1767254	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	6193929	CHEMBL1776530	Inhibition of PKCalpha at 10 uM	B	Cc1c(N)ccc2[nH]c(-c3ccc(N)cc3)nc12		CHEMBL529177	=	Inhibition	%	-0.4	CHEMBL299	Homo sapiens	INH	%	-0.4
	6193940	CHEMBL1776530	Inhibition of PKCalpha at 10 uM	B	Oc1ccc(NCn2nnc3ccccc32)cc1	Outside typical range	CHEMBL1775067	=	Inhibition	%	-22.0	CHEMBL299	Homo sapiens	INH	%	-22.0
	6193949	CHEMBL1776539	Inhibition of PKCalpha at 1 uM	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Inhibition	%	97.0	CHEMBL299	Homo sapiens	INH	%	97.0
	6201881	CHEMBL1781780	Inhibition of PKCalpha assessed as FLC-SIYRRGSRRWRKL peptide phosphorylation by fluorescence polarization assay	B	CC1(C)c2cc(C3CCN(C4COC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1779202	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	6211710	CHEMBL1780758	Displacement of [3H]PDBu from human recombinant PKCalpha after 20 mins by liquid scintillation counting	B	CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(C)=O		CHEMBL279115	=	Ki	nM	6.4	CHEMBL299	Homo sapiens	Ki	uM	0.0064
	6211711	CHEMBL1780758	Displacement of [3H]PDBu from human recombinant PKCalpha after 20 mins by liquid scintillation counting	B	CCCCCCCCCCCCOc1cccc2c1C(=O)O[C@]2(CO)COC(=O)C(C(C)(C)C)C(C)(C)C		CHEMBL1778819	=	Ki	nM	43.0	CHEMBL299	Homo sapiens	Ki	uM	0.043
	6211712	CHEMBL1780758	Displacement of [3H]PDBu from human recombinant PKCalpha after 20 mins by liquid scintillation counting	B	CCCCCCCCCCCCOc1cccc2c1C(=O)O[C@]2(CO)COC(=O)CCCCCCCCCCC		CHEMBL1778820	>	Ki	nM	3000.0	CHEMBL299	Homo sapiens	Ki	uM	3.0
	6211713	CHEMBL1780758	Displacement of [3H]PDBu from human recombinant PKCalpha after 20 mins by liquid scintillation counting	B	CCCCCCCCCCCCO[C@@H]1[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](OCC#Cc2cccc3c2C(=O)O[C@]3(CO)COC(=O)C(C(C)(C)C)C(C)(C)C)[C@@H](OC(C)=O)[C@@H]1OC(C)=O		CHEMBL1778821	=	Ki	nM	2340.0	CHEMBL299	Homo sapiens	Ki	uM	2.34
	6211714	CHEMBL1780758	Displacement of [3H]PDBu from human recombinant PKCalpha after 20 mins by liquid scintillation counting	B	CCCCCCCCCCCCO[C@H]1[C@@H](OC)[C@H](OC)[C@@H](OCC#Cc2cccc3c2C(=O)O[C@]3(CO)COC(=O)C(C(C)(C)C)C(C)(C)C)[C@H](OC)[C@H]1OC		CHEMBL1778822	=	Ki	nM	600.0	CHEMBL299	Homo sapiens	Ki	uM	0.6
	6211715	CHEMBL1780758	Displacement of [3H]PDBu from human recombinant PKCalpha after 20 mins by liquid scintillation counting	B	CCCCCCCCCCCCO[C@@H]1[C@H](OCC=C(C)C)[C@@H](OC/C=C/C(C)C)[C@H](OCC#Cc2cccc3c2C(=O)O[C@]3(CO)COC(=O)C(C(C)(C)C)C(C)(C)C)[C@@H](OCC=C(C)C)[C@@H]1OCC=C(C)C		CHEMBL1778823	>	Ki	nM	20000.0	CHEMBL299	Homo sapiens	Ki	uM	20.0
	6211716	CHEMBL1780758	Displacement of [3H]PDBu from human recombinant PKCalpha after 20 mins by liquid scintillation counting	B	CCCCCCCCCCCCO[C@@H]1[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@H](OCC#Cc2cccc3c2C(=O)O[C@]3(CO)COC(=O)C(C(C)(C)C)C(C)(C)C)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1		CHEMBL1778824	>	Ki	nM	20000.0	CHEMBL299	Homo sapiens	Ki	uM	20.0
	6211717	CHEMBL1780758	Displacement of [3H]PDBu from human recombinant PKCalpha after 20 mins by liquid scintillation counting	B	CCCCCCCCCCCCO[C@@H]1[C@H](OCc2ccc(C(C)C)cc2)[C@@H](OCc2ccc(C(C)C)cc2)[C@H](OCC#Cc2cccc3c2C(=O)O[C@]3(CO)COC(=O)C(C(C)(C)C)C(C)(C)C)[C@@H](OCc2ccc(C(C)C)cc2)[C@@H]1OCc1ccc(C(C)C)cc1		CHEMBL1778825	>	Ki	nM	20000.0	CHEMBL299	Homo sapiens	Ki	uM	20.0
	6211718	CHEMBL1780758	Displacement of [3H]PDBu from human recombinant PKCalpha after 20 mins by liquid scintillation counting	B	CCCCCCCCCCCCO[C@@H]1[C@H](OCc2ccc(F)cc2)[C@@H](OCc2ccc(F)cc2)[C@H](OCC#Cc2cccc3c2C(=O)O[C@]3(CO)COC(=O)C(C(C)(C)C)C(C)(C)C)[C@@H](OCc2ccc(F)cc2)[C@@H]1OCc1ccc(F)cc1		CHEMBL1778826	>	Ki	nM	20000.0	CHEMBL299	Homo sapiens	Ki	uM	20.0
Active	6211719	CHEMBL1780759	Activation of human recombinant PKCalpha assessed as rate of phosphate incorporation into PepTag C1 peptide at 1 to 100 uM after 40 mins by agarose gel electrophoresis analysis	B	CCCCCCCCCCCCO[C@@H]1[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](OCC#Cc2cccc3c2C(=O)O[C@]3(CO)COC(=O)C(C(C)(C)C)C(C)(C)C)[C@@H](OC(C)=O)[C@@H]1OC(C)=O		CHEMBL1778821		Activity			CHEMBL299	Homo sapiens	Activity		
Active	6211720	CHEMBL1780759	Activation of human recombinant PKCalpha assessed as rate of phosphate incorporation into PepTag C1 peptide at 1 to 100 uM after 40 mins by agarose gel electrophoresis analysis	B	CCCCCCCCCCCCO[C@H]1[C@@H](OC)[C@H](OC)[C@@H](OCC#Cc2cccc3c2C(=O)O[C@]3(CO)COC(=O)C(C(C)(C)C)C(C)(C)C)[C@H](OC)[C@H]1OC		CHEMBL1778822		Activity			CHEMBL299	Homo sapiens	Activity		
Active	6211721	CHEMBL1780759	Activation of human recombinant PKCalpha assessed as rate of phosphate incorporation into PepTag C1 peptide at 1 to 100 uM after 40 mins by agarose gel electrophoresis analysis	B	CCCCCCCCCCCCO[C@@H]1[C@H](OCC=C(C)C)[C@@H](OC/C=C/C(C)C)[C@H](OCC#Cc2cccc3c2C(=O)O[C@]3(CO)COC(=O)C(C(C)(C)C)C(C)(C)C)[C@@H](OCC=C(C)C)[C@@H]1OCC=C(C)C		CHEMBL1778823		Activity			CHEMBL299	Homo sapiens	Activity		
Active	6211722	CHEMBL1780759	Activation of human recombinant PKCalpha assessed as rate of phosphate incorporation into PepTag C1 peptide at 1 to 100 uM after 40 mins by agarose gel electrophoresis analysis	B	CCCCCCCCCCCCO[C@@H]1[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@H](OCC#Cc2cccc3c2C(=O)O[C@]3(CO)COC(=O)C(C(C)(C)C)C(C)(C)C)[C@@H](OCc2ccccc2)[C@@H]1OCc1ccccc1		CHEMBL1778824		Activity			CHEMBL299	Homo sapiens	Activity		
Active	6211723	CHEMBL1780759	Activation of human recombinant PKCalpha assessed as rate of phosphate incorporation into PepTag C1 peptide at 1 to 100 uM after 40 mins by agarose gel electrophoresis analysis	B	CCCCCCCCCCCCO[C@@H]1[C@H](OCc2ccc(C(C)C)cc2)[C@@H](OCc2ccc(C(C)C)cc2)[C@H](OCC#Cc2cccc3c2C(=O)O[C@]3(CO)COC(=O)C(C(C)(C)C)C(C)(C)C)[C@@H](OCc2ccc(C(C)C)cc2)[C@@H]1OCc1ccc(C(C)C)cc1		CHEMBL1778825		Activity			CHEMBL299	Homo sapiens	Activity		
Active	6211724	CHEMBL1780759	Activation of human recombinant PKCalpha assessed as rate of phosphate incorporation into PepTag C1 peptide at 1 to 100 uM after 40 mins by agarose gel electrophoresis analysis	B	CCCCCCCCCCCCO[C@@H]1[C@H](OCc2ccc(F)cc2)[C@@H](OCc2ccc(F)cc2)[C@H](OCC#Cc2cccc3c2C(=O)O[C@]3(CO)COC(=O)C(C(C)(C)C)C(C)(C)C)[C@@H](OCc2ccc(F)cc2)[C@@H]1OCc1ccc(F)cc1		CHEMBL1778826		Activity			CHEMBL299	Homo sapiens	Activity		
	6211725	CHEMBL1780891	Activation of human recombinant PKCalpha assessed as rate of phosphate incorporation into PepTag C1 peptide at 100 uM after 40 mins by agarose gel electrophoresis analysis relative to control	B	CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(C)=O		CHEMBL279115	=	Activity	%	108.43	CHEMBL299	Homo sapiens	Activity	%	108.4295595
	6211726	CHEMBL1780892	Activation of human recombinant PKCalpha assessed as rate of phosphate incorporation into PepTag C1 peptide at 10 uM after 40 mins by agarose gel electrophoresis analysis relative to control	B	CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(C)=O		CHEMBL279115	=	Activity	%	100.0	CHEMBL299	Homo sapiens	Activity	%	100.0
	6211727	CHEMBL1780893	Activation of human recombinant PKCalpha assessed as rate of phosphate incorporation into PepTag C1 peptide at 1 uM after 40 mins by agarose gel electrophoresis analysis relative to control	B	CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(C)=O		CHEMBL279115	=	Activity	%	85.31	CHEMBL299	Homo sapiens	Activity	%	85.30660946
	6211728	CHEMBL1780894	Activation of human recombinant PKCalpha assessed as rate of phosphate incorporation into PepTag C1 peptide at 0.1 uM after 40 mins by agarose gel electrophoresis analysis relative to control	B	CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(C)=O		CHEMBL279115	=	Activity	%	80.64	CHEMBL299	Homo sapiens	Activity	%	80.6351807
	6211729	CHEMBL1780919	Activation of human recombinant PKCalpha assessed as rate of phosphate incorporation into PepTag C1 peptide at 0.01 uM after 40 mins by agarose gel electrophoresis analysis relative to control	B	CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(C)=O		CHEMBL279115	=	Activity	%	62.39	CHEMBL299	Homo sapiens	Activity	%	62.39195071
	6211730	CHEMBL1780920	Activation of human recombinant PKCalpha assessed as rate of phosphate incorporation into PepTag C1 peptide at 0.001 uM after 40 mins by agarose gel electrophoresis analysis relative to control	B	CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(C)=O		CHEMBL279115	=	Activity	%	11.14	CHEMBL299	Homo sapiens	Activity	%	11.14144703
	6211731	CHEMBL1780921	Activation of human recombinant PKCalpha assessed as rate of phosphate incorporation into PepTag C1 peptide at 0.0001 uM after 40 mins by agarose gel electrophoresis analysis relative to control	B	CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(C)=O		CHEMBL279115	=	Activity	%	0.58	CHEMBL299	Homo sapiens	Activity	%	0.579967985
	6219731	CHEMBL1787637	Binding affinity at PKCalpha after 1 hr by luminescent kinase assay	B	CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(=C\C[C@H]1OC(=O)C=C1CO)CO		CHEMBL1784623	=	IC50	nM	40350.0	CHEMBL299	Homo sapiens	IC50	uM	40.35
	6268170	CHEMBL1805362	Inhibition of PKCa	B	CSc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C)ns2)n1		CHEMBL1270795	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	6273839	CHEMBL1806019	Inhibition of PKCalpha assessed as residual enzyme activity at 10 uM	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833	=	Activity	%	96.0	CHEMBL299	Homo sapiens	Activity	%	96.0
	6297262	CHEMBL1809444	Inhibition of [3H]PDBu binding to PKCalpha-C1A domain peptide	B	C=C[C@@]1(C)CC[C@](C)(C(C)C)c2cc3c4c(c[nH]c4c21)CC(=O)NC(=O)[C@H](C(C)C)N3C		CHEMBL1807163	=	Ki	nM	600.0	CHEMBL299	Homo sapiens	Ki	nM	600.0
	6297268	CHEMBL1809450	Binding affinity to PKCalpha-C1A domain peptide using [3H]-labeled compound	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Kd	nM	1.1	CHEMBL299	Homo sapiens	Kd	nM	1.1
	6299689	CHEMBL1811586	Inhibition of PKCalpha	B	Cc1ccc(C(=O)NC2CC2)cc1Nc1ncnn2cc(C(=O)c3ccccc3)c(C)c12		CHEMBL1807446	>	IC50	nM	25000.0	CHEMBL299	Homo sapiens	IC50	uM	25.0
	6324209	CHEMBL1821183	Inhibition of TPA-induced membrane translocation of PKCalpha expressed in HEK293 cells assessed as protein found in membrane fraction at 100 uM after 2 hrs by Western blotting relative to TPA	B	Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1		CHEMBL165	=	Activity	%	60.0	CHEMBL299	Homo sapiens	Activity	%	60.0
	6324210	CHEMBL1821183	Inhibition of TPA-induced membrane translocation of PKCalpha expressed in HEK293 cells assessed as protein found in membrane fraction at 100 uM after 2 hrs by Western blotting relative to TPA	B	CCCCCCCCOc1ccc(/C=C/c2cc(O)cc(O)c2)cc1		CHEMBL1819527	=	Activity	%	85.2	CHEMBL299	Homo sapiens	Activity	%	85.2
	6324211	CHEMBL1821183	Inhibition of TPA-induced membrane translocation of PKCalpha expressed in HEK293 cells assessed as protein found in membrane fraction at 100 uM after 2 hrs by Western blotting relative to TPA	B	CCCCCCCCCCCCCCCCOc1ccc(/C=C/c2cc(O)cc(O)c2)cc1		CHEMBL1819528	=	Activity	%	79.8	CHEMBL299	Homo sapiens	Activity	%	79.8
	6324212	CHEMBL1821183	Inhibition of TPA-induced membrane translocation of PKCalpha expressed in HEK293 cells assessed as protein found in membrane fraction at 100 uM after 2 hrs by Western blotting relative to TPA	B	CCCCCCCCOc1cc(/C=C/c2ccc(O)cc2)cc(OCCCCCCCC)c1		CHEMBL1819529	=	Activity	%	65.7	CHEMBL299	Homo sapiens	Activity	%	65.7
	6324213	CHEMBL1821183	Inhibition of TPA-induced membrane translocation of PKCalpha expressed in HEK293 cells assessed as protein found in membrane fraction at 100 uM after 2 hrs by Western blotting relative to TPA	B	CCCCCCCCCCCCCCCCOc1cc(/C=C/c2ccc(O)cc2)cc(OCCCCCCCCCCCCCCCC)c1		CHEMBL1819530	=	Activity	%	78.8	CHEMBL299	Homo sapiens	Activity	%	78.8
	6324214	CHEMBL1821183	Inhibition of TPA-induced membrane translocation of PKCalpha expressed in HEK293 cells assessed as protein found in membrane fraction at 100 uM after 2 hrs by Western blotting relative to TPA	B	COc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1		CHEMBL296411	=	Activity	%	31.9	CHEMBL299	Homo sapiens	Activity	%	31.9
	6324215	CHEMBL1821183	Inhibition of TPA-induced membrane translocation of PKCalpha expressed in HEK293 cells assessed as protein found in membrane fraction at 100 uM after 2 hrs by Western blotting relative to TPA	B	COc1cc(/C=C/c2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC		CHEMBL86978	=	Activity	%	44.8	CHEMBL299	Homo sapiens	Activity	%	44.8
	6324216	CHEMBL1821183	Inhibition of TPA-induced membrane translocation of PKCalpha expressed in HEK293 cells assessed as protein found in membrane fraction at 100 uM after 2 hrs by Western blotting relative to TPA	B	Oc1cc(/C=C/c2cc(O)c(O)c(O)c2)cc(O)c1O		CHEMBL1819531	=	Activity	%	29.8	CHEMBL299	Homo sapiens	Activity	%	29.8
	6324217	CHEMBL1821183	Inhibition of TPA-induced membrane translocation of PKCalpha expressed in HEK293 cells assessed as protein found in membrane fraction at 100 uM after 2 hrs by Western blotting relative to TPA	B	CCCCCCCCCCCCCCCCOc1c(O)cc(/C=C/c2cc(O)c(O)c(O)c2)cc1O		CHEMBL1819532	=	Activity	%	68.3	CHEMBL299	Homo sapiens	Activity	%	68.3
	6324218	CHEMBL1821184	Inhibition of membrane translocation of PKCalpha expressed in HEK293 cells at 100 uM after 2 hrs by Western blotting	B	Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1		CHEMBL165	=	Inhibition	%	5.0	CHEMBL299	Homo sapiens	INH	%	5.0
	6324219	CHEMBL1821185	Inhibition of membrane translocation of PKCalpha expressed in HEK293 cells assessed as increase of protein found in membrane fraction at 100 uM after 2 hrs by Western blotting relative to resveratrol	B	CCCCCCCCOc1ccc(/C=C/c2cc(O)cc(O)c2)cc1		CHEMBL1819527	=	Activity	%	20.0	CHEMBL299	Homo sapiens	Activity	%	20.0
	6324220	CHEMBL1821185	Inhibition of membrane translocation of PKCalpha expressed in HEK293 cells assessed as increase of protein found in membrane fraction at 100 uM after 2 hrs by Western blotting relative to resveratrol	B	CCCCCCCCCCCCCCCCOc1c(O)cc(/C=C/c2cc(O)c(O)c(O)c2)cc1O		CHEMBL1819532	=	Activity	%	20.0	CHEMBL299	Homo sapiens	Activity	%	20.0
	6324221	CHEMBL1821185	Inhibition of membrane translocation of PKCalpha expressed in HEK293 cells assessed as increase of protein found in membrane fraction at 100 uM after 2 hrs by Western blotting relative to resveratrol	B	Oc1cc(/C=C/c2cc(O)c(O)c(O)c2)cc(O)c1O		CHEMBL1819531	=	Activity	%	20.0	CHEMBL299	Homo sapiens	Activity	%	20.0
	6324222	CHEMBL1821185	Inhibition of membrane translocation of PKCalpha expressed in HEK293 cells assessed as increase of protein found in membrane fraction at 100 uM after 2 hrs by Western blotting relative to resveratrol	B	COc1cc(/C=C/c2cc(OC)c(OC)c(OC)c2)cc(OC)c1OC		CHEMBL86978	=	Activity	%	20.0	CHEMBL299	Homo sapiens	Activity	%	20.0
	6324223	CHEMBL1821185	Inhibition of membrane translocation of PKCalpha expressed in HEK293 cells assessed as increase of protein found in membrane fraction at 100 uM after 2 hrs by Western blotting relative to resveratrol	B	COc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1		CHEMBL296411	=	Activity	%	20.0	CHEMBL299	Homo sapiens	Activity	%	20.0
	6324224	CHEMBL1821185	Inhibition of membrane translocation of PKCalpha expressed in HEK293 cells assessed as increase of protein found in membrane fraction at 100 uM after 2 hrs by Western blotting relative to resveratrol	B	CCCCCCCCCCCCCCCCOc1cc(/C=C/c2ccc(O)cc2)cc(OCCCCCCCCCCCCCCCC)c1		CHEMBL1819530	=	Activity	%	20.0	CHEMBL299	Homo sapiens	Activity	%	20.0
	6324225	CHEMBL1821185	Inhibition of membrane translocation of PKCalpha expressed in HEK293 cells assessed as increase of protein found in membrane fraction at 100 uM after 2 hrs by Western blotting relative to resveratrol	B	CCCCCCCCOc1cc(/C=C/c2ccc(O)cc2)cc(OCCCCCCCC)c1		CHEMBL1819529	=	Activity	%	20.0	CHEMBL299	Homo sapiens	Activity	%	20.0
	6324226	CHEMBL1821185	Inhibition of membrane translocation of PKCalpha expressed in HEK293 cells assessed as increase of protein found in membrane fraction at 100 uM after 2 hrs by Western blotting relative to resveratrol	B	CCCCCCCCCCCCCCCCOc1ccc(/C=C/c2cc(O)cc(O)c2)cc1		CHEMBL1819528	=	Activity	%	20.0	CHEMBL299	Homo sapiens	Activity	%	20.0
	6324227	CHEMBL1821186	Binding affinity to recombinant C1 domain of PKCalpha expressed in Escherichia coli BL21 (DE3) after 45 mins by fluorescence quenching assay	B	Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1	Outside typical range	CHEMBL165	=	EC50	nM	5780000.0	CHEMBL299	Homo sapiens	EC50	mM	5.78
	6324228	CHEMBL1821186	Binding affinity to recombinant C1 domain of PKCalpha expressed in Escherichia coli BL21 (DE3) after 45 mins by fluorescence quenching assay	B	CCCCCCCCCCCCCCCCOc1ccc(/C=C/c2cc(O)cc(O)c2)cc1	Outside typical range	CHEMBL1819528	=	EC50	nM	5040000.0	CHEMBL299	Homo sapiens	EC50	mM	5.04
	6324229	CHEMBL1821186	Binding affinity to recombinant C1 domain of PKCalpha expressed in Escherichia coli BL21 (DE3) after 45 mins by fluorescence quenching assay	B	COc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1	Outside typical range	CHEMBL296411	=	EC50	nM	1560000.0	CHEMBL299	Homo sapiens	EC50	mM	1.56
	6324230	CHEMBL1821186	Binding affinity to recombinant C1 domain of PKCalpha expressed in Escherichia coli BL21 (DE3) after 45 mins by fluorescence quenching assay	B	Oc1cc(/C=C/c2cc(O)c(O)c(O)c2)cc(O)c1O	Outside typical range	CHEMBL1819531	=	EC50	nM	2980000.0	CHEMBL299	Homo sapiens	EC50	mM	2.98
	6324231	CHEMBL1821186	Binding affinity to recombinant C1 domain of PKCalpha expressed in Escherichia coli BL21 (DE3) after 45 mins by fluorescence quenching assay	B	CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(C)=O	Outside typical range	CHEMBL279115	=	EC50	nM	1700000.0	CHEMBL299	Homo sapiens	EC50	mM	1.7
Active	6324232	CHEMBL1821182	Binding affinity to recombinant C1B domain of PKCalpha expressed in Escherichia coli BL21 (DE3) after 45 mins by fluorescence quenching assay	B	Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1		CHEMBL165		Activity			CHEMBL299	Homo sapiens	Activity		
Active	6324233	CHEMBL1821182	Binding affinity to recombinant C1B domain of PKCalpha expressed in Escherichia coli BL21 (DE3) after 45 mins by fluorescence quenching assay	B	Oc1cc(/C=C/c2cc(O)c(O)c(O)c2)cc(O)c1O		CHEMBL1819531		Activity			CHEMBL299	Homo sapiens	Activity		
Active	6324234	CHEMBL1821182	Binding affinity to recombinant C1B domain of PKCalpha expressed in Escherichia coli BL21 (DE3) after 45 mins by fluorescence quenching assay	B	COc1ccc(/C=C/c2cc(OC)cc(OC)c2)cc1		CHEMBL296411		Activity			CHEMBL299	Homo sapiens	Activity		
Active	6324235	CHEMBL1821182	Binding affinity to recombinant C1B domain of PKCalpha expressed in Escherichia coli BL21 (DE3) after 45 mins by fluorescence quenching assay	B	CCCCCCCCCCCCCCCCOc1ccc(/C=C/c2cc(O)cc(O)c2)cc1		CHEMBL1819528		Activity			CHEMBL299	Homo sapiens	Activity		
	6335512	CHEMBL1821104	Inhibition of N-terminal GST-fused PKCalpha (1-672) expressed in baculovirus expression system at 30 uM after 1 hr by off-chip mobility shift assay relative to control	B	CCCCCCCCCCCCCC[C@@H]1OC[C@H](N)[C@@H]1O		CHEMBL447577	=	Inhibition	%	32.7	CHEMBL299	Homo sapiens	INH	%	32.7
	6335524	CHEMBL1821104	Inhibition of N-terminal GST-fused PKCalpha (1-672) expressed in baculovirus expression system at 30 uM after 1 hr by off-chip mobility shift assay relative to control	B	CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)N(C)C		CHEMBL322333	=	Inhibition	%	35.0	CHEMBL299	Homo sapiens	INH	%	35.0
	6335538	CHEMBL1821104	Inhibition of N-terminal GST-fused PKCalpha (1-672) expressed in baculovirus expression system at 30 uM after 1 hr by off-chip mobility shift assay relative to control	B	CCCCCCCCCCCCCC[C@@H]1OC[C@@H](N)[C@@H]1O		CHEMBL1819205	=	Inhibition	%	33.1	CHEMBL299	Homo sapiens	INH	%	33.1
	6335552	CHEMBL1821104	Inhibition of N-terminal GST-fused PKCalpha (1-672) expressed in baculovirus expression system at 30 uM after 1 hr by off-chip mobility shift assay relative to control	B	CCCCCCCCCCCCCC[C@H]1OC[C@@H](N)[C@@H]1O		CHEMBL1819204	=	Inhibition	%	34.0	CHEMBL299	Homo sapiens	INH	%	34.0
	6339235	CHEMBL1828183	Inhibition of PKCA activity by fluorescence polarization assay	B	CCc1cc2c(cc1N1CCN(C3COC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1823221	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	6339236	CHEMBL1828183	Inhibition of PKCA activity by fluorescence polarization assay	B	CC1(C)c2cc(C3CCN(C4COC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1779202	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	6341112	CHEMBL1826684	Activity of PKAC-alpha kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL299	Homo sapiens	Activity	%	100.0
	6347909	CHEMBL1828477	Inhibition of human PKCalpha activity using Ser/Thr 7 peptide as substrate by FRET assay	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1	Outside typical range	CHEMBL259850	>	IC50	nM	100000000.0	CHEMBL299	Homo sapiens	IC50	mM	100.0
	6347915	CHEMBL1828477	Inhibition of human PKCalpha activity using Ser/Thr 7 peptide as substrate by FRET assay	B	COc1ccc(CNC(=O)Nc2cc(C#N)ccn2)cc1	Outside typical range	CHEMBL1824539	>	IC50	nM	100000000.0	CHEMBL299	Homo sapiens	IC50	mM	100.0
	6347921	CHEMBL1828477	Inhibition of human PKCalpha activity using Ser/Thr 7 peptide as substrate by FRET assay	B	COc1ccc(CNC(=O)Nc2nc3ccc([N+](=O)[O-])cc3s2)cc1	Outside typical range	CHEMBL1824540	>	IC50	nM	100000000.0	CHEMBL299	Homo sapiens	IC50	mM	100.0
	6347927	CHEMBL1828477	Inhibition of human PKCalpha activity using Ser/Thr 7 peptide as substrate by FRET assay	B	COc1ccc(CNC(=O)Nc2cc(-c3nnn[nH]3)ccn2)cc1	Outside typical range	CHEMBL1824334	>	IC50	nM	100000000.0	CHEMBL299	Homo sapiens	IC50	mM	100.0
	6347933	CHEMBL1828477	Inhibition of human PKCalpha activity using Ser/Thr 7 peptide as substrate by FRET assay	B	COc1ccc(CNC(=O)Nc2nc3ccc(-c4nnn[nH]4)cc3s2)cc1	Outside typical range	CHEMBL1824332	=	IC50	nM	24200000.0	CHEMBL299	Homo sapiens	IC50	mM	24.2
	6352266	CHEMBL1825914	Inhibition of PKCalpha assessed as residual activity at 10 uM by radioactivity assay in presence of 20 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	83.0	CHEMBL299	Homo sapiens	Activity	%	83.0
	6360095	CHEMBL1832353	Inhibition of PKCalpha at 5 uM assessed as remaining activity	B	CNC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(N3CCNCC3)cc2)n1		CHEMBL1830587	=	Activity	%	97.0	CHEMBL299	Homo sapiens	Activity	%	97.0
	6384614	CHEMBL1837771	Inhibition of human PKCalpha in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	<	Inhibition	%	35.0	CHEMBL299	Homo sapiens	INH	%	35.0
	6384615	CHEMBL1837771	Inhibition of human PKCalpha in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	<	Inhibition	%	35.0	CHEMBL299	Homo sapiens	INH	%	35.0
	6384616	CHEMBL1837771	Inhibition of human PKCalpha in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	<	Inhibition	%	35.0	CHEMBL299	Homo sapiens	INH	%	35.0
	6384617	CHEMBL1837771	Inhibition of human PKCalpha in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	<	Inhibition	%	35.0	CHEMBL299	Homo sapiens	INH	%	35.0
	6384618	CHEMBL1837771	Inhibition of human PKCalpha in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	<	Inhibition	%	35.0	CHEMBL299	Homo sapiens	INH	%	35.0
	6386324	CHEMBL1839917	Inhibition of recombinant PKCalpha	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7598984	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)OC[C@H]1O[C@@H](n2ncc(=O)[nH]c2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O		CHEMBL515914		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7598985	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)OC[C@H]1O[C@@H](n2ncc(=O)[nH]c2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O		CHEMBL515914		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7599130	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1		CHEMBL1200558		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7599131	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1		CHEMBL1200558		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7599267	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1		CHEMBL388590		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7599268	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1		CHEMBL388590		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7599993	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1458880		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7599994	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1458880		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7600111	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[N+](C)(C)CCOC(N)=O.[Cl-]		CHEMBL14		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7600112	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[N+](C)(C)CCOC(N)=O.[Cl-]		CHEMBL14		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7600260	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCCC[C@H]1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C		CHEMBL211501		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7600261	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCCC[C@H]1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C		CHEMBL211501		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7600925	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-]		CHEMBL12089		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7600926	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-]		CHEMBL12089		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601034	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)CCNC(=O)c1ccccc1		CHEMBL1231530		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601035	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)CCNC(=O)c1ccccc1		CHEMBL1231530		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601121	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Brc1c(NC2=NCCN2)ccc2nccnc12		CHEMBL844		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601122	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Brc1c(NC2=NCCN2)ccc2nccnc12		CHEMBL844		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601229	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl		CHEMBL1200396		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601230	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl		CHEMBL1200396		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601798	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CO[C@H]1[C@@H](O)[C@H](N)[C@@H](O[C@H]2O[C@H]([C@H](C)N)CC[C@H]2N)[C@H](O)[C@@H]1N(C)C(=O)CN		CHEMBL3084803		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601799	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CO[C@H]1[C@@H](O)[C@H](N)[C@@H](O[C@H]2O[C@H]([C@H](C)N)CC[C@H]2N)[C@H](O)[C@@H]1N(C)C(=O)CN		CHEMBL3084803		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601918	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	[N-]=[N+]=CC(=O)OC[C@H](N)C(=O)O		CHEMBL1095699		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601919	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	[N-]=[N+]=CC(=O)OC[C@H](N)C(=O)O		CHEMBL1095699		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7602061	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NCC(CC(=O)O)c1ccc(Cl)cc1		CHEMBL701		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7602062	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NCC(CC(=O)O)c1ccc(Cl)cc1		CHEMBL701		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7602177	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1.[Cl-]		CHEMBL221753		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7602178	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1.[Cl-]		CHEMBL221753		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7602928	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccccc1		CHEMBL319244		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7602929	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccccc1		CHEMBL319244		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7603202	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cc(=O)n(-c2ccccc2)n1C		CHEMBL277474		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7603203	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cc(=O)n(-c2ccccc2)n1C		CHEMBL277474		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7603851	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O		CHEMBL415690		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7603852	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O		CHEMBL415690		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7603965	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O		CHEMBL264374		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7603966	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O		CHEMBL264374		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604049	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1		CHEMBL1077		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604050	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1		CHEMBL1077		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604156	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1		CHEMBL894		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604157	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1		CHEMBL894		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604512	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)N1c2ccccc2C=Cc2ccccc21		CHEMBL108		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604513	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)N1c2ccccc2C=Cc2ccccc21		CHEMBL108		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604721	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)NCC(O)COc1ccc(CC(N)=O)cc1		CHEMBL24		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604722	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)NCC(O)COc1ccc(CC(N)=O)cc1		CHEMBL24		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604846	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1C(=O)COc2c(C(=O)NC3CN4CCC3CC4)cc(Cl)cc21		CHEMBL1598608		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604847	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1C(=O)COc2c(C(=O)NC3CN4CCC3CC4)cc(Cl)cc21		CHEMBL1598608		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604990	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1		CHEMBL1201346		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604991	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1		CHEMBL1201346		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7605091	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	c1ccc2c(c1)cc1ccc3cccc4ccc2c1c34		CHEMBL31184		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7605092	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	c1ccc2c(c1)cc1ccc3cccc4ccc2c1c34		CHEMBL31184		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7605834	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cn1c(=O)c2c(ncn2C)n(C)c1=O		CHEMBL113		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7605835	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cn1c(=O)c2c(ncn2C)n(C)c1=O		CHEMBL113		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7606108	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N=C(N)NCCCCNC(=N)N.O=S(=O)(O)O		CHEMBL1256017		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7606109	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N=C(N)NCCCCNC(=N)N.O=S(=O)(O)O		CHEMBL1256017		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7606757	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O		CHEMBL135		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7606758	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O		CHEMBL135		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7606876	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCC[C@H](CC)COC(=O)c1ccccc1C(=O)OC[C@H](CC)CCCC		CHEMBL402794		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7606877	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCC[C@H](CC)COC(=O)c1ccccc1C(=O)OC[C@H](CC)CCCC		CHEMBL402794		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7606960	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1		CHEMBL253376		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7606961	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1		CHEMBL253376		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607065	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1		CHEMBL49		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607066	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1		CHEMBL49		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607428	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)n1ccn(C)c1=S		CHEMBL508102		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607429	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)n1ccn(C)c1=S		CHEMBL508102		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607633	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O		CHEMBL1487		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607634	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O		CHEMBL1487		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607761	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[nH]c12		CHEMBL1542		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607762	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[nH]c12		CHEMBL1542		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607904	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1		CHEMBL521589		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607905	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1		CHEMBL521589		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7608003	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	c1ccc2c(c1)c1cccc3ccc4cccc2c4c31		CHEMBL1371125		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7608004	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	c1ccc2c(c1)c1cccc3ccc4cccc2c4c31		CHEMBL1371125		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7608753	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1		CHEMBL65		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7608754	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1		CHEMBL65		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7608894	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@]42OO3		CHEMBL566534		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7608895	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@]42OO3		CHEMBL566534		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7609530	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12CC[C@@H]3c4ccc(OC(=O)c5ccccc5)cc4CC[C@H]3[C@@H]1CC[C@@H]2O		CHEMBL282575		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7609531	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12CC[C@@H]3c4ccc(OC(=O)c5ccccc5)cc4CC[C@H]3[C@@H]1CC[C@@H]2O		CHEMBL282575		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7609659	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1		CHEMBL942		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7609660	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1		CHEMBL942		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7609743	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)C(Br)C(=O)NC(N)=O		CHEMBL1515611		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7609744	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)C(Br)C(=O)NC(N)=O		CHEMBL1515611		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7609842	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CS(=O)(=O)OCCCCOS(C)(=O)=O		CHEMBL820		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7609843	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CS(=O)(=O)OCCCCOS(C)(=O)=O		CHEMBL820		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610288	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=C1[C@@H]2CCC3[C@]4(C)C[C@H](O[C@@H]5O[C@H](CO)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]5OC(=O)CC(C)C)C[C@@H](C(=O)O)[C@H]4CC[C@]3(C2)[C@@H]1O.[K+].[K+]		CHEMBL499815		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610289	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=C1[C@@H]2CCC3[C@]4(C)C[C@H](O[C@@H]5O[C@H](CO)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]5OC(=O)CC(C)C)C[C@@H](C(=O)O)[C@H]4CC[C@]3(C2)[C@@H]1O.[K+].[K+]		CHEMBL499815		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610416	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1cnn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1		CHEMBL564201		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610417	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1cnn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1		CHEMBL564201		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610555	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C)c1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL270299		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610556	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C)c1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL270299		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610658	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)c1ccc(N)cc1		CHEMBL278172		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610659	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)c1ccc(N)cc1		CHEMBL278172		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7611397	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1		CHEMBL1016		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7611398	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1		CHEMBL1016		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7611422	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@@]43C)[C@@H]1CCC2=O		CHEMBL87285		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7611423	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@@]43C)[C@@H]1CCC2=O		CHEMBL87285		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7611551	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@]32OO4		CHEMBL567597		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7611552	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@]32OO4		CHEMBL567597		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612181	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1cc(-c2ccccc2)oc2ccc3ccccc3c12		CHEMBL26260		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612182	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1cc(-c2ccccc2)oc2ccc3ccccc3c12		CHEMBL26260		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612311	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(c1ccc(O)cc1)c1ccc(O)cc1		CHEMBL418971		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612312	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(c1ccc(O)cc1)c1ccc(O)cc1		CHEMBL418971		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612402	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Brc1ccccc1		CHEMBL16068		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612403	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Brc1ccccc1		CHEMBL16068		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612509	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCOC(=O)c1ccc(N)cc1		CHEMBL127516		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612510	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCOC(=O)c1ccc(N)cc1		CHEMBL127516		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613080	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2		CHEMBL517712		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613081	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2		CHEMBL517712		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613221	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O		CHEMBL529		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613222	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O		CHEMBL529		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613358	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO		CHEMBL1586		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613359	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO		CHEMBL1586		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613463	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)c1ccccc1		CHEMBL541		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613464	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)c1ccccc1		CHEMBL541		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7614215	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12C(=O)OC(=O)[C@@]1(C)[C@@H]1CC[C@H]2O1		CHEMBL48449		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7614216	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12C(=O)OC(=O)[C@@]1(C)[C@@H]1CC[C@H]2O1		CHEMBL48449		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7614366	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc(C(=O)N2CCCC2=O)cc1		CHEMBL36994		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7614367	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc(C(=O)N2CCCC2=O)cc1		CHEMBL36994		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7614495	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1O[C@H]([C@@H](O)CO)C(O)=C1O		CHEMBL196		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7614496	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1O[C@H]([C@@H](O)CO)C(O)=C1O		CHEMBL196		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615137	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNCCc1ccccn1		CHEMBL24441		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615138	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNCCc1ccccn1		CHEMBL24441		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615251	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O		CHEMBL290106		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615252	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O		CHEMBL290106		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615353	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12		CHEMBL493		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615354	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12		CHEMBL493		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615472	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12		CHEMBL990		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615473	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12		CHEMBL990		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7616040	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1366		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7616041	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1366		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7616186	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O		CHEMBL1537		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7616187	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O		CHEMBL1537		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7616323	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O		CHEMBL838		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7616324	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O		CHEMBL838		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7616411	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	c1ccc2sc(SSc3nc4ccccc4s3)nc2c1		CHEMBL508112		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7616412	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	c1ccc2sc(SSc3nc4ccccc4s3)nc2c1		CHEMBL508112		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7617173	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O		CHEMBL294199		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7617174	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O		CHEMBL294199		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7617324	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc(C2C(=O)c3ccccc3C2=O)cc1		CHEMBL712		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7617325	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc(C2C(=O)c3ccccc3C2=O)cc1		CHEMBL712		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7617452	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)Oc1ccccc1C(=O)O		CHEMBL25		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7617453	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)Oc1ccccc1C(=O)O		CHEMBL25		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7617993	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1[C@H]2CC[C@@H]1C[C@H](OC(c1ccccc1)c1ccccc1)C2		CHEMBL1201203		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7617994	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1[C@H]2CC[C@@H]1C[C@H](OC(c1ccccc1)c1ccccc1)C2		CHEMBL1201203		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618094	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO		CHEMBL632		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618095	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO		CHEMBL632		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618195	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1.[Br-]		CHEMBL4649901		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618196	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1.[Br-]		CHEMBL4649901		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618287	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL1370		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618288	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL1370		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618399	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(N)Cc1c[nH]c2ccc(OCc3cccs3)cc12		CHEMBL1255834		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618400	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(N)Cc1c[nH]c2ccc(OCc3cccs3)cc12		CHEMBL1255834		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7619000	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1		CHEMBL1489		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7619001	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1		CHEMBL1489		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7619146	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1[C@H](NC(=O)/C(=N\OC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O		CHEMBL158		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7619147	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1[C@H](NC(=O)/C(=N\OC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O		CHEMBL158		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7619283	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1		CHEMBL340978		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7619284	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1		CHEMBL340978		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7620016	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1476898		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7620017	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1476898		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7620130	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O		CHEMBL1560		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7620131	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O		CHEMBL1560		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7620280	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(C)=O)cc1		CHEMBL423192		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7620281	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(C)=O)cc1		CHEMBL423192		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7620384	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1		CHEMBL296419		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7620385	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1		CHEMBL296419		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7620970	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	OCc1ccccc1		CHEMBL720		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7620971	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	OCc1ccccc1		CHEMBL720		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621079	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O		CHEMBL1201207		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621080	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O		CHEMBL1201207		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621178	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1		CHEMBL357995		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621179	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1		CHEMBL357995		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621285	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1		CHEMBL188921		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621286	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1		CHEMBL188921		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621907	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1ccc2c3c(cccc13)C(=O)NC2=O		CHEMBL338790		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621908	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1ccc2c3c(cccc13)C(=O)NC2=O		CHEMBL338790		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621996	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc2cc(CC(=O)O)ccc2c1		CHEMBL1105		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621997	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc2cc(CC(=O)O)ccc2c1		CHEMBL1105		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622110	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)Nc1nnc(S(N)(=O)=O)s1		CHEMBL20		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622111	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)Nc1nnc(S(N)(=O)=O)s1		CHEMBL20		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622230	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)C)C[C@@H](O)C[C@@H]1O		CHEMBL1601669		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622231	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)C)C[C@@H](O)C[C@@H]1O		CHEMBL1601669		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622320	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2		CHEMBL661		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622630	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC1(CCC(C)C)C(=O)N=C(O)NC1=O		CHEMBL267894		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622631	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC1(CCC(C)C)C(=O)N=C(O)NC1=O		CHEMBL267894		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622729	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N#C[C@H](O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)c1ccccc1		CHEMBL461727		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622730	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N#C[C@H](O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)c1ccccc1		CHEMBL461727		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7623923	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)c1nc(N(C)C)nc(N(C)C)n1		CHEMBL1455		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7623924	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)c1nc(N(C)C)nc(N(C)C)n1		CHEMBL1455		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624048	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN		CHEMBL1370561		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624049	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN		CHEMBL1370561		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624439	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1		CHEMBL63560		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624440	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1		CHEMBL63560		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624526	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	c1ccc(Cn2ccnc2)cc1		CHEMBL14192		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624527	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	c1ccc(Cn2ccnc2)cc1		CHEMBL14192		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624614	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Clc1cc2c(cc1Cl)Oc1cc(Cl)c(Cl)cc1O2		CHEMBL30327		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624615	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Clc1cc2c(cc1Cl)Oc1cc(Cl)c(Cl)cc1O2		CHEMBL30327		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624856	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N[C@@H](Cc1ccc(F)cc1)C(=O)O		CHEMBL1235242		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624857	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N[C@@H](Cc1ccc(F)cc1)C(=O)O		CHEMBL1235242		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624942	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1[nH]c2ccccc2c2ccccc12		CHEMBL45245		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624943	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1[nH]c2ccccc2c2ccccc12		CHEMBL45245		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7625057	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC		CHEMBL502620		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7625058	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC		CHEMBL502620		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7625178	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1ncnc2[nH][nH]cc1-2		CHEMBL1467		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7625179	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1ncnc2[nH][nH]cc1-2		CHEMBL1467		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7625553	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2		CHEMBL1113		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7625554	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2		CHEMBL1113		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7626880	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC12CC3CC(CC(C3)C1)C2		CHEMBL660		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7626881	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC12CC3CC(CC(C3)C1)C2		CHEMBL660		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627007	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1nc(N)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2n1		CHEMBL376180		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627008	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1nc(N)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2n1		CHEMBL376180		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627151	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1		CHEMBL1399		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627152	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1		CHEMBL1399		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627378	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1onc(O)c1CC(N)C(=O)O		CHEMBL13378		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627379	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1onc(O)c1CC(N)C(=O)O		CHEMBL13378		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627459	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	S=C=Nc1cccc2ccccc12		CHEMBL1381098		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627460	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	S=C=Nc1cccc2ccccc12		CHEMBL1381098		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627556	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)Nc1cccc(O)c1		CHEMBL9419		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627557	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)Nc1cccc(O)c1		CHEMBL9419		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627800	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cn[nH]c1		CHEMBL1308		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627801	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cn[nH]c1		CHEMBL1308		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627881	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O		CHEMBL3215298		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627882	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O		CHEMBL3215298		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627999	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN1C[C@@]2(COC)[C@H]3[C@@H](OC)[C@H]4[C@H]1[C@]3([C@H](OC)C[C@H]2O)[C@@H]1C[C@]2(O)[C@@H](OC)[C@H](O)[C@@]4(OC(C)=O)[C@H]1[C@H]2OC(=O)c1ccccc1		CHEMBL2103747		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7628000	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN1C[C@@]2(COC)[C@H]3[C@@H](OC)[C@H]4[C@H]1[C@]3([C@H](OC)C[C@H]2O)[C@@H]1C[C@]2(O)[C@@H](OC)[C@H](O)[C@@]4(OC(C)=O)[C@H]1[C@H]2OC(=O)c1ccccc1		CHEMBL2103747		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7628121	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=CCO		CHEMBL234926		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7628122	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=CCO		CHEMBL234926		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7628488	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O		CHEMBL1082		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7628489	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O		CHEMBL1082		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7629677	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1		CHEMBL153479		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7629678	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1		CHEMBL153479		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7629805	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1ccc(C(=O)O)c(O)c1		CHEMBL1169		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7629806	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1ccc(C(=O)O)c(O)c1		CHEMBL1169		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630036	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)NC[C@H](O)COc1cccc2[nH]ccc12		CHEMBL117405		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630037	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)NC[C@H](O)COc1cccc2[nH]ccc12		CHEMBL117405		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630120	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=C(Cl)Cl		CHEMBL156455		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630121	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=C(Cl)Cl		CHEMBL156455		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630218	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)c1cccc(N)c1		CHEMBL81977		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630219	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)c1cccc(N)c1		CHEMBL81977		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630463	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCCCCCCc1ccc(O)cc1		CHEMBL153062		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630464	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCCCCCCc1ccc(O)cc1		CHEMBL153062		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630551	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O		CHEMBL1566		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630552	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O		CHEMBL1566		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630668	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1nc(O)c2ncn(COCCO)c2n1		CHEMBL184		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630669	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1nc(O)c2ncn(COCCO)c2n1		CHEMBL184		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630789	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O		CHEMBL1110		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630790	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O		CHEMBL1110		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7631029	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2		CHEMBL267345		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7631030	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2		CHEMBL267345		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7631551	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccc2cc3c(ccc4ccccc43)c3c2c1CC3		CHEMBL40583		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7631552	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccc2cc3c(ccc4ccccc43)c3c2c1CC3		CHEMBL40583		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7632229	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NCCCNCCSP(=O)(O)O		CHEMBL1006		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7632230	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NCCCNCCSP(=O)(O)O		CHEMBL1006		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7632572	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(c1ccccc1Cl)N1CCC(Cc2ccccc2)CC1		CHEMBL1909048		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7632573	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(c1ccccc1Cl)N1CCC(Cc2ccccc2)CC1		CHEMBL1909048		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7632661	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N=C(Nc1ccccc1)Nc1ccccc1		CHEMBL77675		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7632662	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N=C(Nc1ccccc1)Nc1ccccc1		CHEMBL77675		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7632989	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCCCCCc1ccc(O)cc1		CHEMBL195437		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7632990	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCCCCCc1ccc(O)cc1		CHEMBL195437		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633104	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1		CHEMBL642		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633105	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1		CHEMBL642		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633222	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc2c(c3oc(=O)c4c(c13)CCC4=O)[C@@H]1C=CO[C@@H]1O2		CHEMBL1697694		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633223	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc2c(c3oc(=O)c4c(c13)CCC4=O)[C@@H]1C=CO[C@@H]1O2		CHEMBL1697694		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633340	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O		CHEMBL1230813		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633341	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O		CHEMBL1230813		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633714	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1		CHEMBL633		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633715	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1		CHEMBL633		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633746	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O		CHEMBL174		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633747	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O		CHEMBL174		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7634263	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(Nc1ccc(Cl)c(Cl)c1)c1cc(Cl)cc(Cl)c1O		CHEMBL291338		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7634264	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(Nc1ccc(Cl)c(Cl)c1)c1cc(Cl)cc(Cl)c1O		CHEMBL291338		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7634938	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O		CHEMBL177		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7634939	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O		CHEMBL177		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635301	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(c1ccccc1F)N1CCC(Cc2ccccc2)CC1		CHEMBL437002		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635302	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(c1ccccc1F)N1CCC(Cc2ccccc2)CC1		CHEMBL437002		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635391	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)N1c2ccccc2CCc2ccccc21		CHEMBL41543		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635392	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)N1c2ccccc2CCc2ccccc21		CHEMBL41543		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635705	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1ccc(Cc2ccc(N)cc2)cc1		CHEMBL85728		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635706	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1ccc(Cc2ccc(N)cc2)cc1		CHEMBL85728		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635819	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl		CHEMBL93645		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635820	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl		CHEMBL93645		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635938	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC1C2CC3C4N(C)c5ccccc5C45CC(C2[C@H]5O)N3C1O		CHEMBL2105617		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635939	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC1C2CC3C4N(C)c5ccccc5C45CC(C2[C@H]5O)N3C1O		CHEMBL2105617		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7636040	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12		CHEMBL1403281		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7636041	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12		CHEMBL1403281		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7636390	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1		CHEMBL1365675		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7636391	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1		CHEMBL1365675		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7636438	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)OC(C)OC1=C(C(=O)Nc2ccccn2)N(C)S(=O)(=O)c2ccccc21		CHEMBL1566249		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7636439	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)OC(C)OC1=C(C(=O)Nc2ccccn2)N(C)S(=O)(=O)c2ccccc21		CHEMBL1566249		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7637000	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O		CHEMBL1544		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7637001	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O		CHEMBL1544		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7637669	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N=C(N)NC(=O)c1nc(Cl)c(N)nc1N		CHEMBL945		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7637670	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N=C(N)NC(=O)c1nc(Cl)c(N)nc1N		CHEMBL945		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638144	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1		CHEMBL1909049		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638145	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1		CHEMBL1909049		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638238	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1395		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638239	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1395		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638556	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F		CHEMBL917		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638557	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F		CHEMBL917		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638669	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1		CHEMBL189171		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638670	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1		CHEMBL189171		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638788	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1		CHEMBL1483		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638789	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1		CHEMBL1483		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638879	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1cc(-c2ccccc2)oc2c1ccc1ccccc12		CHEMBL283196		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638880	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1cc(-c2ccccc2)oc2c1ccc1ccccc12		CHEMBL283196		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7639214	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)CCC=C1c2ccccc2CCc2ccccc21		CHEMBL629		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7639215	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)CCC=C1c2ccccc2CCc2ccccc21		CHEMBL629		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7639299	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1		CHEMBL116		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7639300	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1		CHEMBL116		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7639817	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)CCCc1cccs1		CHEMBL1230333		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7639818	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)CCCc1cccs1		CHEMBL1230333		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7640485	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NCCCCCC(=O)O		CHEMBL1046		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7640486	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NCCCCCC(=O)O		CHEMBL1046		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7640807	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1CC[C@H](N2C(=O)c3ccccc3C2=O)C(=O)N1		CHEMBL426123		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7640808	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1CC[C@H](N2C(=O)c3ccccc3C2=O)C(=O)N1		CHEMBL426123		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7640894	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1		CHEMBL1909050		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7640895	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1		CHEMBL1909050		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7640988	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2		CHEMBL311469		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7640989	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2		CHEMBL311469		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641313	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Sc1ncnc2nc[nH]c12		CHEMBL1425		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641314	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Sc1ncnc2nc[nH]c12		CHEMBL1425		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641426	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)Nc1ccc(O)cc1		CHEMBL112		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641427	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)Nc1ccc(O)cc1		CHEMBL112		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641546	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NCCCC(O)(P(=O)(O)O)P(=O)(O)O		CHEMBL870		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641547	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NCCCC(O)(P(=O)(O)O)P(=O)(O)O		CHEMBL870		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641635	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2		CHEMBL47		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641636	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2		CHEMBL47		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641945	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl		CHEMBL1491		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641946	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl		CHEMBL1491		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7642035	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1cc(-c2ccncc2)c[nH]c1=O		CHEMBL12856		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7642036	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1cc(-c2ccncc2)c[nH]c1=O		CHEMBL12856		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7642684	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(c1ccccc1C(F)(F)F)N1CCC(Cc2ccccc2)CC1		CHEMBL1909051		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7642685	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(c1ccccc1C(F)(F)F)N1CCC(Cc2ccccc2)CC1		CHEMBL1909051		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7643233	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2		CHEMBL661		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7643357	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC1(c2ccc(N)cc2)CCC(=O)NC1=O		CHEMBL488		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7643358	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC1(c2ccc(N)cc2)CCC(=O)NC1=O		CHEMBL488		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7643737	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1CC[C@@H](N2C(=O)c3ccccc3C2=O)C(=O)N1		CHEMBL558551		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7643738	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1CC[C@@H](N2C(=O)c3ccccc3C2=O)C(=O)N1		CHEMBL558551		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7643823	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nn1nnc2ccccc21		CHEMBL101168		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7643824	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nn1nnc2ccccc21		CHEMBL101168		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7643910	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(O)COC[C@H]1O[C@@H]2O[C@@H]3[C@@H](COCC(C)O)O[C@H](O[C@@H]4[C@@H](COCC(C)O)O[C@H](O[C@@H]5[C@@H](COCC(C)O)O[C@H](O[C@@H]6[C@@H](COCC(C)O)O[C@H](O[C@@H]7[C@@H](COCC(C)O)O[C@H](O[C@@H]8[C@@H](COCC(C)O)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O		CHEMBL577294		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7643911	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(O)COC[C@H]1O[C@@H]2O[C@@H]3[C@@H](COCC(C)O)O[C@H](O[C@@H]4[C@@H](COCC(C)O)O[C@H](O[C@@H]5[C@@H](COCC(C)O)O[C@H](O[C@@H]6[C@@H](COCC(C)O)O[C@H](O[C@@H]7[C@@H](COCC(C)O)O[C@H](O[C@@H]8[C@@H](COCC(C)O)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O		CHEMBL577294		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644413	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL989		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644414	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL989		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644475	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1		CHEMBL563		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644476	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1		CHEMBL563		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644615	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2		CHEMBL659		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644616	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2		CHEMBL659		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644751	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644752	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644858	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1		CHEMBL472		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644859	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1		CHEMBL472		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644992	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL583		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644993	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL583		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7645582	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O		CHEMBL1752		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7645583	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O		CHEMBL1752		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7646172	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1		CHEMBL672		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7646173	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1		CHEMBL672		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7646313	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F		CHEMBL106		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7646314	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F		CHEMBL106		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7647305	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Clc1cc(Cl)c(OCC#CI)cc1Cl		CHEMBL1289		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7647306	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Clc1cc(Cl)c(OCC#CI)cc1Cl		CHEMBL1289		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7647417	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO		CHEMBL389621		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7647418	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO		CHEMBL389621		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7647541	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)Cn1cnc2c(N)nc3ccccc3c21		CHEMBL1282		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7647542	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)Cn1cnc2c(N)nc3ccccc3c21		CHEMBL1282		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7647882	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1		CHEMBL1902981		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7647883	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1		CHEMBL1902981		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7647949	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C		CHEMBL2220427		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7647950	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C		CHEMBL2220427		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648060	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL241694		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648061	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL241694		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648191	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC12CCC(CC1)C(C)(C)O2		CHEMBL485259		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648192	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC12CCC(CC1)C(C)(C)O2		CHEMBL485259		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648685	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C		CHEMBL1501		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648686	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C		CHEMBL1501		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648750	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1		CHEMBL806		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648751	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1		CHEMBL806		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648892	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC.[I-].[I-].[I-]		CHEMBL1200993		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648893	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC.[I-].[I-].[I-]		CHEMBL1200993		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649025	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNC(C)[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](C(C)N)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O		CHEMBL3039597		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649026	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNC(C)[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](C(C)N)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O		CHEMBL3039597		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649141	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NCC(=O)O		CHEMBL773		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649142	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NCC(=O)O		CHEMBL773		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649275	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O		CHEMBL562		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649276	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O		CHEMBL562		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649699	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=P1(NCCCl)OCCCN1CCCl		CHEMBL1024		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649700	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=P1(NCCCl)OCCCN1CCCl		CHEMBL1024		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649818	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1		CHEMBL305660		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649819	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1		CHEMBL305660		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7650476	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C(=O)O)c1cccc(Oc2ccccc2)c1		CHEMBL1297		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7650477	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C(=O)O)c1cccc(Oc2ccccc2)c1		CHEMBL1297		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7650618	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1[nH]c(=O)ncc1F		CHEMBL1463		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7650619	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1[nH]c(=O)ncc1F		CHEMBL1463		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7651624	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)C[C@](O)(CCC(C)(C)O)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4		CHEMBL433257		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7651625	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)C[C@](O)(CCC(C)(C)O)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4		CHEMBL433257		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7651733	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12		CHEMBL1535		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7651734	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12		CHEMBL1535		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7652086	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1		CHEMBL808		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7652087	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1		CHEMBL808		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7652191	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNC[C@H](O)c1ccc(O)c(O)c1		CHEMBL679		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7652192	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNC[C@H](O)c1ccc(O)c(O)c1		CHEMBL679		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7652271	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1		CHEMBL768		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7652272	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1		CHEMBL768		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7652380	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC1(C)CC(=O)NC1=O		CHEMBL696		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7652381	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC1(C)CC(=O)NC1=O		CHEMBL696		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7652511	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=CCc1ccc(O)c(OC)c1		CHEMBL42710		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7652512	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=CCc1ccc(O)c(OC)c1		CHEMBL42710		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653001	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)c1ccccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12		CHEMBL177756		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653002	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)c1ccccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12		CHEMBL177756		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653061	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21		CHEMBL2220442		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653062	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21		CHEMBL2220442		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653205	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	OC[C@H]1OC2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](CO)OC(OC9[C@@H](CO)OC(C1[C@H](O)[C@H]2O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O		CHEMBL407030		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653206	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	OC[C@H]1OC2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](CO)OC(OC9[C@@H](CO)OC(C1[C@H](O)[C@H]2O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O		CHEMBL407030		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653308	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-]		CHEMBL64894		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653309	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-]		CHEMBL64894		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653451	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)CO		CHEMBL252557		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653452	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)CO		CHEMBL252557		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653585	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccccc1OCC(O)CO		CHEMBL980		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653586	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccccc1OCC(O)CO		CHEMBL980		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7654025	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7654026	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7654785	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc(/C=C/C(=O)O)ccc1O		CHEMBL32749		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7654786	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc(/C=C/C(=O)O)ccc1O		CHEMBL32749		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7654928	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O		CHEMBL1568		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7654929	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O		CHEMBL1568		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7655904	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl		CHEMBL496		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7655905	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl		CHEMBL496		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656033	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1062		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656034	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1062		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656344	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1=NN(c2ccccc2)C(=O)C1		CHEMBL290916		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656345	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1=NN(c2ccccc2)C(=O)C1		CHEMBL290916		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656465	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1		CHEMBL417		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656466	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1		CHEMBL417		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656543	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O		CHEMBL193482		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656544	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O		CHEMBL193482		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656657	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	OCCO		CHEMBL457299		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656658	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	OCCO		CHEMBL457299		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656790	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O		CHEMBL880		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656791	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O		CHEMBL880		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657281	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C		CHEMBL1200600		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657282	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C		CHEMBL1200600		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657344	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)P(=O)(O)O		CHEMBL666		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657345	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)P(=O)(O)O		CHEMBL666		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657488	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1nc(O)c2ncn(COC(CO)CO)c2n1		CHEMBL182		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657489	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1nc(O)c2ncn(COC(CO)CO)c2n1		CHEMBL182		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657584	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)=CCC/C(C)=C/CO		CHEMBL25719		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657585	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)=CCC/C(C)=C/CO		CHEMBL25719		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657727	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C		CHEMBL441687		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657728	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C		CHEMBL441687		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657850	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N=C(N)N/N=C/c1c(Cl)cccc1Cl		CHEMBL420		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657851	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N=C(N)N/N=C/c1c(Cl)cccc1Cl		CHEMBL420		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7658329	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@@H]1O		CHEMBL1130		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7658330	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@@H]1O		CHEMBL1130		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7659035	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1		CHEMBL914		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7659036	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1		CHEMBL914		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7659176	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C		CHEMBL1201010		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7659177	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C		CHEMBL1201010		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660137	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Br.CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(O)c1ccccc1)C2		CHEMBL1319362		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660138	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Br.CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(O)c1ccccc1)C2		CHEMBL1319362		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660270	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)NO		CHEMBL467		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660271	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)NO		CHEMBL467		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660572	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21		CHEMBL50588		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660573	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21		CHEMBL50588		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660698	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/[C@H](C)C(C)C		CHEMBL1536		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660699	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/[C@H](C)C(C)C		CHEMBL1536		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660772	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O		CHEMBL1405		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660773	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O		CHEMBL1405		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660888	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C		CHEMBL1200623		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660889	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C		CHEMBL1200623		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661026	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(N)=Nc1nc(CSCC/C(N)=N/S(N)(=O)=O)cs1		CHEMBL902		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661027	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(N)=Nc1nc(CSCC/C(N)=N/S(N)(=O)=O)cs1		CHEMBL902		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661517	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1[nH]cc(F)c(=O)[nH]1		CHEMBL185		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661518	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1[nH]cc(F)c(=O)[nH]1		CHEMBL185		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661581	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1		CHEMBL1103		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661582	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1		CHEMBL1103		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661725	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12		CHEMBL31		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661726	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12		CHEMBL31		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661821	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1		CHEMBL427216		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661822	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1		CHEMBL427216		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661964	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)CNCP(=O)(O)O		CHEMBL95764		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661965	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)CNCP(=O)(O)O		CHEMBL95764		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7662082	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(N)=NCCN1CCCCCCC1		CHEMBL765		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7662083	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(N)=NCCN1CCCCCCC1		CHEMBL765		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7662568	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cn1c(=O)c2c(ncn2CC2OCCO2)n(C)c1=O		CHEMBL1527608		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7662569	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cn1c(=O)c2c(ncn2CC2OCCO2)n(C)c1=O		CHEMBL1527608		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7663271	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C		CHEMBL710		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7663272	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C		CHEMBL710		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7663412	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2		CHEMBL407		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7663413	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2		CHEMBL407		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7664390	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2		CHEMBL1255901		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7664391	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2		CHEMBL1255901		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7664521	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)Cc1ccc(C(C)C(=O)O)cc1		CHEMBL521		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7664522	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)Cc1ccc(C(C)C(=O)O)cc1		CHEMBL521		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7664825	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O		CHEMBL578		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7664826	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O		CHEMBL578		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7664940	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12		CHEMBL1385840		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7664941	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12		CHEMBL1385840		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665029	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl		CHEMBL456		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665030	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl		CHEMBL456		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665140	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C		CHEMBL1200624		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665141	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C		CHEMBL1200624		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665281	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)Cc1ccc(-c2ccccc2)cc1		CHEMBL413965		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665282	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)Cc1ccc(-c2ccccc2)cc1		CHEMBL413965		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665666	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1		CHEMBL30008		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665667	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1		CHEMBL30008		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665783	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1		CHEMBL41		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665784	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1		CHEMBL41		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665861	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl		CHEMBL35		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665862	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl		CHEMBL35		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666005	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1		CHEMBL888		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666006	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1		CHEMBL888		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666101	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O		CHEMBL1481		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666102	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O		CHEMBL1481		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666244	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL306043		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666245	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL306043		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666358	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N=C(N)NC(=O)Cc1c(Cl)cccc1Cl		CHEMBL862		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666359	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N=C(N)NC(=O)Cc1c(Cl)cccc1Cl		CHEMBL862		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666856	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1		CHEMBL53463		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666857	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1		CHEMBL53463		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7667557	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O		CHEMBL1493		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7667558	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O		CHEMBL1493		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7668648	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1)c1ccccn1		CHEMBL434063		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7668649	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1)c1ccccn1		CHEMBL434063		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7668706	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NNc1nncc2ccccc12		CHEMBL276832		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7668707	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NNc1nncc2ccccc12		CHEMBL276832		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7668838	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O		CHEMBL1117		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7668839	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O		CHEMBL1117		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669144	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21		CHEMBL826		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669145	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21		CHEMBL826		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669242	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1		CHEMBL119443		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669243	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1		CHEMBL119443		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669349	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@@H](CO)NCCN[C@@H](CC)CO		CHEMBL44884		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669350	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@@H](CO)NCCN[C@@H](CC)CO		CHEMBL44884		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669459	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(O)(P(=O)(O)O)P(=O)(O)O		CHEMBL871		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669460	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(O)(P(=O)(O)O)P(=O)(O)O		CHEMBL871		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669595	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl		CHEMBL1480		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669596	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl		CHEMBL1480		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669956	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL1512		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669957	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL1512		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670048	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1		CHEMBL726		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670049	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1		CHEMBL726		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670184	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NCC1(CC(=O)O)CCCCC1		CHEMBL940		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670185	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NCC1(CC(=O)O)CCCCC1		CHEMBL940		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670328	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1		CHEMBL457		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670329	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1		CHEMBL457		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670423	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1		CHEMBL1073		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670424	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1		CHEMBL1073		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670560	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1201469		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670561	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1201469		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7671165	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21		CHEMBL1433		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7671166	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21		CHEMBL1433		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7671876	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1		CHEMBL6273		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7671877	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1		CHEMBL6273		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7672914	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1		CHEMBL1200845		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7672915	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1		CHEMBL1200845		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7672978	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NN		CHEMBL1237174		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7672979	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NN		CHEMBL1237174		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673106	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O		CHEMBL252556		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673107	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O		CHEMBL252556		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673426	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1		CHEMBL15511		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673427	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1		CHEMBL15511		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673500	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21		CHEMBL442		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673501	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21		CHEMBL442		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673632	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCO		CHEMBL545		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673633	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCO		CHEMBL545		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673744	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3		CHEMBL622		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673745	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3		CHEMBL622		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673881	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)Nc1nc2ccc(Sc3ccccc3)cc2[nH]1		CHEMBL37161		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673882	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)Nc1nc2ccc(Sc3ccccc3)cc2[nH]1		CHEMBL37161		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674247	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H](C(=O)O)c1ccc2oc(-c3ccc(F)cc3)nc2c1		CHEMBL1614641		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674248	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H](C(=O)O)c1ccc2oc(-c3ccc(F)cc3)nc2c1		CHEMBL1614641		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674309	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL1201012		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674310	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL1201012		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674448	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1200431		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674449	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1200431		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674593	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]([C@](O)(Cn1cncn1)c1ccc(F)cc1F)S(C)(=O)=O		CHEMBL34139		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674594	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]([C@](O)(Cn1cncn1)c1ccc(F)cc1F)S(C)(=O)=O		CHEMBL34139		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674689	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)NCC(=O)O)C(=O)O		CHEMBL1372		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674690	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)NCC(=O)O)C(=O)O		CHEMBL1372		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674822	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2		CHEMBL289469		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674823	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2		CHEMBL289469		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7675426	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1		CHEMBL1108		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7675427	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1		CHEMBL1108		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7676164	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)Nc1nc2cc(C(=O)c3ccc(F)cc3)ccc2[nH]1		CHEMBL1454946		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7676165	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)Nc1nc2cc(C(=O)c3ccc(F)cc3)ccc2[nH]1		CHEMBL1454946		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677189	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1		CHEMBL54		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677190	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1		CHEMBL54		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677279	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O		CHEMBL435		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677280	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O		CHEMBL435		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677407	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I		CHEMBL788		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677408	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I		CHEMBL788		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677713	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1		CHEMBL56337		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677714	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1		CHEMBL56337		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677777	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O		CHEMBL532		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677778	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O		CHEMBL532		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677895	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C		CHEMBL691		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677896	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C		CHEMBL691		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7678022	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O		CHEMBL44657		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7678023	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O		CHEMBL44657		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7678224	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1		CHEMBL452		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7678225	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1		CHEMBL452		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7678927	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1		CHEMBL1201353		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7678928	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1		CHEMBL1201353		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679057	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COP(=O)(OC)OC=C(Cl)Cl		CHEMBL167911		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679058	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COP(=O)(OC)OC=C(Cl)Cl		CHEMBL167911		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679117	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O		CHEMBL898		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679118	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O		CHEMBL898		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679571	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12		CHEMBL723		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679572	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12		CHEMBL723		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679684	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCCCCCCCCCCCCC[n+]1ccccc1.[Br-]		CHEMBL334255		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679685	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCCCCCCCCCCCCC[n+]1ccccc1.[Br-]		CHEMBL334255		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679908	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1200528		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679909	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1200528		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7680546	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909056		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7680547	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909056		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7680683	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1		CHEMBL428880		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7680684	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1		CHEMBL428880		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7680764	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL139835		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7680765	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL139835		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7680878	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1C[C@@H]2C[C@H]1CN2c1cc2c(cc1F)c(=O)c(C(=O)O)cn2C1CC1		CHEMBL157548		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7680879	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1C[C@@H]2C[C@H]1CN2c1cc2c(cc1F)c(=O)c(C(=O)O)cn2C1CC1		CHEMBL157548		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7681497	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)CCOC(c1ccccc1)c1ccccc1		CHEMBL657		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7681498	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)CCOC(c1ccccc1)c1ccccc1		CHEMBL657		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7682298	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O		CHEMBL8		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7682299	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O		CHEMBL8		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7682363	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1		CHEMBL1626		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7682364	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1		CHEMBL1626		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7682552	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Clc1cccc(Cl)c1N=C1NCCN1		CHEMBL134		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7682553	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Clc1cccc(Cl)c1N=C1NCCN1		CHEMBL134		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683243	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1		CHEMBL248702		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683244	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1		CHEMBL248702		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683379	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl		CHEMBL139		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683380	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl		CHEMBL139		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683439	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1[C@H]2[C@@H](O[C@]13CC[C@@H](C)CO3)[C@@H](O)[C@H]1[C@@H]3CC[C@H]4C[C@@H](O[C@@H]5O[C@H](CO)[C@H](O[C@@H]6O[C@H](CO)C(O)[C@H](O[C@@H]7OC[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)C[C@]4(C)[C@H]3CC[C@@]12C		CHEMBL404811		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683440	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1[C@H]2[C@@H](O[C@]13CC[C@@H](C)CO3)[C@@H](O)[C@H]1[C@@H]3CC[C@H]4C[C@@H](O[C@@H]5O[C@H](CO)[C@H](O[C@@H]6O[C@H](CO)C(O)[C@H](O[C@@H]7OC[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)C[C@]4(C)[C@H]3CC[C@@]12C		CHEMBL404811		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683680	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O		CHEMBL1754		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683681	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O		CHEMBL1754		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683888	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Oc1ccccc1O		CHEMBL280998		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683889	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Oc1ccccc1O		CHEMBL280998		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683985	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1		CHEMBL515		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683986	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1		CHEMBL515		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7684065	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12		CHEMBL404520		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7684066	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12		CHEMBL404520		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7684209	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cc(C2CCCCC2)n(O)c(=O)c1		CHEMBL1413		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7684210	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cc(C2CCCCC2)n(O)c(=O)c1		CHEMBL1413		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7684844	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=C(C)[C@H]1[C@@H]2C(=O)O[C@H]1[C@H]1OC(=O)[C@@]34O[C@@H]3C[C@]2(O)[C@@]14C		CHEMBL47244		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7684845	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=C(C)[C@H]1[C@@H]2C(=O)O[C@H]1[C@H]1OC(=O)[C@@]34O[C@@H]3C[C@]2(O)[C@@]14C		CHEMBL47244		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7684982	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C/C=C/C(=O)N(CC)c1ccccc1C		CHEMBL1200709		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7684983	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C/C=C/C(=O)N(CC)c1ccccc1C		CHEMBL1200709		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7685059	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1nc(N)nc(NC2CC2)n1		CHEMBL1231107		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7685060	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1nc(N)nc(NC2CC2)n1		CHEMBL1231107		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7685168	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1		CHEMBL1201216		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7685169	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1		CHEMBL1201216		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7685769	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1		CHEMBL936		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7685770	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1		CHEMBL936		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7686479	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1		CHEMBL7002		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7686480	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1		CHEMBL7002		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7686569	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC		CHEMBL1729		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7686570	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC		CHEMBL1729		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7686648	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1		CHEMBL49080		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7686649	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1		CHEMBL49080		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7686837	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1		CHEMBL1771		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7686838	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1		CHEMBL1771		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7687525	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)Cc1ccc([C@H](C)C(=O)O)cc1		CHEMBL175		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7687526	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)Cc1ccc([C@H](C)C(=O)O)cc1		CHEMBL175		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7687662	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O		CHEMBL1466		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7687663	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O		CHEMBL1466		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7687724	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6CC[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O		CHEMBL254219		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7687725	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6CC[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O		CHEMBL254219		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7687955	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC		CHEMBL707		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7687956	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC		CHEMBL707		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7688179	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21		CHEMBL1201195		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7688180	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21		CHEMBL1201195		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7688276	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl		CHEMBL130		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7688277	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl		CHEMBL130		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7688355	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl		CHEMBL1055		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7688356	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl		CHEMBL1055		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7689121	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2		CHEMBL107		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7689122	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2		CHEMBL107		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7689259	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1		CHEMBL1480987		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7689260	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1		CHEMBL1480987		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7689336	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1		CHEMBL803		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7689337	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1		CHEMBL803		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7689440	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1		CHEMBL178		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7689441	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1		CHEMBL178		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7690028	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1		CHEMBL932		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7690029	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1		CHEMBL932		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7690205	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)CCC=C1c2ccccc2COc2ccccc21		CHEMBL1628227		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7690206	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)CCC=C1c2ccccc2COc2ccccc21		CHEMBL1628227		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7690744	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C(=O)CCCOc1ccc2nc(O)ccc2c1)C1CCCCC1		CHEMBL34431		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7690745	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C(=O)CCCOc1ccc2nc(O)ccc2c1)C1CCCCC1		CHEMBL34431		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7690821	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL11359		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7690822	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL11359		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7690911	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1		CHEMBL1753		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7690912	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1		CHEMBL1753		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7691096	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)NCC(O)c1ccccc1Cl		CHEMBL1902627		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7691097	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)NCC(O)c1ccccc1Cl		CHEMBL1902627		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7691795	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1		CHEMBL75435		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7691796	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1		CHEMBL75435		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7691929	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1		CHEMBL1123		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7691930	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1		CHEMBL1123		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692006	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6C[C@@H](O)[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O		CHEMBL1751		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692007	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6C[C@@H](O)[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O		CHEMBL1751		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692345	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	ClC(Cl)(Cl)Cl		CHEMBL44814		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692346	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	ClC(Cl)(Cl)Cl		CHEMBL44814		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692450	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1		CHEMBL1730		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692451	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1		CHEMBL1730		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692544	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1		CHEMBL451		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692545	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1		CHEMBL451		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692625	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1[nH]c2cc(Cl)ccc2o1		CHEMBL1371		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692626	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1[nH]c2cc(Cl)ccc2o1		CHEMBL1371		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7693403	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O		CHEMBL2221249		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7693404	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O		CHEMBL2221249		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7693538	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1CCN(C(c2ccccc2)c2ccccc2)CC1		CHEMBL648		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7693539	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1CCN(C(c2ccccc2)c2ccccc2)CC1		CHEMBL648		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7693638	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(C)[C@@H]2CC[C@@]1(C)C(=O)C2		CHEMBL504760		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7693639	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(C)[C@@H]2CC[C@@]1(C)C(=O)C2		CHEMBL504760		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7693742	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1c(O)c(=O)ccn1C		CHEMBL70927		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7693743	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1c(O)c(=O)ccn1C		CHEMBL70927		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7694335	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.[Na+]		CHEMBL487894		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7694336	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.[Na+]		CHEMBL487894		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7695048	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1		CHEMBL799		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7695049	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1		CHEMBL799		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7695111	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21		CHEMBL549		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7695112	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21		CHEMBL549		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7695215	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C		CHEMBL1159650		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7695216	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C		CHEMBL1159650		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7695394	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O		CHEMBL12131		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7695395	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O		CHEMBL12131		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696109	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3		CHEMBL52440		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696110	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3		CHEMBL52440		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696226	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1		CHEMBL1460		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696227	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1		CHEMBL1460		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696292	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CS(=O)(=O)O		CHEMBL1255837		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696293	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CS(=O)(=O)O		CHEMBL1255837		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696679	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1351		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696680	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1351		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696771	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1		CHEMBL118		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696772	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1		CHEMBL118		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696879	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL110691		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696880	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL110691		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696966	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C		CHEMBL1042		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696967	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C		CHEMBL1042		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7697754	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909057		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7697755	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909057		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7697874	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1C[C@H](C)C(=O)[C@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1		CHEMBL123292		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7697875	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1C[C@H](C)C(=O)[C@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1		CHEMBL123292		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7697976	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C.[Cl-]		CHEMBL1687		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7697977	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C.[Cl-]		CHEMBL1687		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7698080	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNCCCN1c2ccccc2CCc2ccccc21		CHEMBL72		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7698081	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNCCCN1c2ccccc2CCc2ccccc21		CHEMBL72		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7698651	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CC)C(=S)SSC(=S)N(CC)CC		CHEMBL964		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7698652	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CC)C(=S)SSC(=S)N(CC)CC		CHEMBL964		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7699382	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN/C(=N/CCSCc1nc[nH]c1C)NC#N		CHEMBL30		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7699383	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN/C(=N/CCSCc1nc[nH]c1C)NC#N		CHEMBL30		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7699440	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)CC(O)(CC(=O)O)C(=O)O		CHEMBL1261		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7699441	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)CC(O)(CC(=O)O)C(=O)O		CHEMBL1261		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7699542	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1		CHEMBL565		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7699543	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1		CHEMBL565		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7699668	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1		CHEMBL104		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7699669	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1		CHEMBL104		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7700452	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I		CHEMBL1201220		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7700453	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I		CHEMBL1201220		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7700568	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	ClC1=C(Cl)[C@]2(Cl)[C@@H]3[C@@H]4C[C@H]([C@@H]3[C@@]1(Cl)C2(Cl)Cl)[C@H]1O[C@@H]41		CHEMBL1873703		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7700569	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	ClC1=C(Cl)[C@]2(Cl)[C@@H]3[C@@H]4C[C@H]([C@@H]3[C@@]1(Cl)C2(Cl)Cl)[C@H]1O[C@@H]41		CHEMBL1873703		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7700613	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21		CHEMBL1732		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7700614	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21		CHEMBL1732		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7701005	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909054		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7701006	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909054		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7701093	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1		CHEMBL1727		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7701094	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1		CHEMBL1727		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7701199	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	ClC(Cl)Cl		CHEMBL44618		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7701200	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	ClC(Cl)Cl		CHEMBL44618		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7701286	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O		CHEMBL205596		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7701287	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O		CHEMBL205596		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7701934	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12		CHEMBL891		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702035	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO		CHEMBL1499		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702036	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO		CHEMBL1499		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702156	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=P1(N(CCCl)CCCl)NCCCO1		CHEMBL88		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702157	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=P1(N(CCCl)CCCl)NCCCO1		CHEMBL88		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702258	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)/N=N/c1[nH]cnc1C(N)=O		CHEMBL476		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702259	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)/N=N/c1[nH]cnc1C(N)=O		CHEMBL476		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702343	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1		CHEMBL1172		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702344	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1		CHEMBL1172		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702891	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1		CHEMBL23		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702892	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1		CHEMBL23		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702936	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1		CHEMBL926		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702937	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1		CHEMBL926		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7703683	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C/C=C/c1ccccc1		CHEMBL293492		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7703684	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C/C=C/c1ccccc1		CHEMBL293492		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7703741	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1=C2C(=CO[C@H](C)[C@H]2C)C(O)=C(C(=O)O)C1=O		CHEMBL510139		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7703742	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1=C2C(=CO[C@H](C)[C@H]2C)C(O)=C(C(=O)O)C1=O		CHEMBL510139		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7703843	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(Oc1ccc(Cl)cc1)C(=O)O		CHEMBL683		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7703844	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(Oc1ccc(Cl)cc1)C(=O)O		CHEMBL683		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7703964	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12		CHEMBL891		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7704748	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21		CHEMBL12		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7704749	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21		CHEMBL12		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7704832	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1		CHEMBL411		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7704833	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1		CHEMBL411		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7705307	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O		CHEMBL460499		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7705308	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O		CHEMBL460499		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7705396	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1		CHEMBL1477		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7705397	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1		CHEMBL1477		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7705502	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cc(O)cc(C)c1Cl		CHEMBL398440		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7705503	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cc(O)cc(C)c1Cl		CHEMBL398440		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7705599	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[N+](C)(C)CCOP(=O)([O-])OC[C@H](O)CO		CHEMBL1567463		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7705600	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[N+](C)(C)CCOP(=O)([O-])OC[C@H](O)CO		CHEMBL1567463		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7706263	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1		CHEMBL42		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7706264	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1		CHEMBL42		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7706395	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C		CHEMBL1650		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7706396	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C		CHEMBL1650		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7706515	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C		CHEMBL160		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7706516	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C		CHEMBL160		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7706618	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O		CHEMBL1554		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7706619	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O		CHEMBL1554		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7706695	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO		CHEMBL1766		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7706696	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO		CHEMBL1766		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7707209	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O		CHEMBL1200406		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7707210	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O		CHEMBL1200406		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7707262	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C.O.O.O		CHEMBL3545252		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7707263	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C.O.O.O		CHEMBL3545252		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7708032	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1		CHEMBL43064		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7708033	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1		CHEMBL43064		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7708118	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1		CHEMBL1619		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7708119	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1		CHEMBL1619		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7708196	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1		CHEMBL954		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7708197	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1		CHEMBL954		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7709177	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1=NS(=O)(=O)c2cc(Cl)ccc2N1		CHEMBL181		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7709178	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1=NS(=O)(=O)c2cc(Cl)ccc2N1		CHEMBL181		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7709238	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C		CHEMBL1200545		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7709239	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C		CHEMBL1200545		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7709720	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=NN(CCCl)C(=O)NCCCl		CHEMBL513		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7709721	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=NN(CCCl)C(=O)NCCCl		CHEMBL513		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7709809	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cl.NC[C@H]1CC[C@H](C(=O)Oc2ccc(CCC(=O)O)cc2)CC1		CHEMBL502896		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7709810	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cl.NC[C@H]1CC[C@H](C(=O)Oc2ccc(CCC(=O)O)cc2)CC1		CHEMBL502896		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7709876	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21		CHEMBL71		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7709877	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21		CHEMBL71		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7710021	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[N+](C)(C)CCO.[Cl-]		CHEMBL282468		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7710022	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[N+](C)(C)CCO.[Cl-]		CHEMBL282468		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7710510	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21		CHEMBL415		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7710511	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21		CHEMBL415		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7710656	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909055		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7710657	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909055		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7710792	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1ccc2ccccc2o1		CHEMBL6466		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7710793	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1ccc2ccccc2o1		CHEMBL6466		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7710891	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1		CHEMBL516		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7710892	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1		CHEMBL516		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711010	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1479		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711011	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1479		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711115	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO		CHEMBL384467		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711116	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO		CHEMBL384467		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711625	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[S+](C)[O-]		CHEMBL504		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711626	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[S+](C)[O-]		CHEMBL504		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711666	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1		CHEMBL219916		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711667	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1		CHEMBL219916		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7712201	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1		CHEMBL498		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7712202	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1		CHEMBL498		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7712430	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O		CHEMBL557555		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7712431	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O		CHEMBL557555		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7712520	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O		CHEMBL1741		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7712521	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O		CHEMBL1741		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7712804	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC		CHEMBL19224		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7712805	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC		CHEMBL19224		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7712929	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=C(C)C1(O)OC(=O)C=C1OC		CHEMBL495778		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7712930	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=C(C)C1(O)OC(=O)C=C1OC		CHEMBL495778		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7713013	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOc1ccc(NC(C)=O)cc1		CHEMBL16073		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7713014	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOc1ccc(NC(C)=O)cc1		CHEMBL16073		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7713867	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(O)CO		CHEMBL286398		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7713868	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(O)CO		CHEMBL286398		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7713946	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12		CHEMBL7568		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7713947	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12		CHEMBL7568		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7714722	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccccc1C(OCCN(C)C)c1ccccc1		CHEMBL900		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7714723	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccccc1C(OCCN(C)C)c1ccccc1		CHEMBL900		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7715387	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1N=C(O)NC1(c1ccccc1)c1ccccc1		CHEMBL16		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7715388	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1N=C(O)NC1(c1ccccc1)c1ccccc1		CHEMBL16		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7715484	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)CN1CCCC1=O		CHEMBL36715		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7715485	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)CN1CCCC1=O		CHEMBL36715		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7715626	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCOc1ccc(OCCCN2CCOCC2)cc1		CHEMBL1198		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7715627	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCOc1ccc(OCCCN2CCOCC2)cc1		CHEMBL1198		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7715745	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc(NC(C)CCCN)c2ncccc2c1		CHEMBL506		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7715746	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc(NC(C)CCCN)c2ncccc2c1		CHEMBL506		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7715845	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C		CHEMBL103		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7715846	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C		CHEMBL103		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7716291	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-]		CHEMBL54126		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7716292	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-]		CHEMBL54126		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7716417	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O		CHEMBL485549		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7716418	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O		CHEMBL485549		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7716536	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNC(=C[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1		CHEMBL3183075		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7716537	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNC(=C[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1		CHEMBL3183075		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7716615	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909071		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7716616	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909071		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7716929	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1		CHEMBL762		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7716930	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1		CHEMBL762		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7717062	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[n+]1ccc(-c2cc[n+](C)cc2)cc1.[Cl-].[Cl-]		CHEMBL458019		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7717063	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[n+]1ccc(-c2cc[n+](C)cc2)cc1.[Cl-].[Cl-]		CHEMBL458019		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7717188	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O		CHEMBL29		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7717189	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O		CHEMBL29		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7717267	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NNCCc1ccccc1		CHEMBL1089		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7717268	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NNCCc1ccccc1		CHEMBL1089		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7718128	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCc1cc(=O)[nH]c(=S)[nH]1		CHEMBL1518		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7718129	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCc1cc(=O)[nH]c(=S)[nH]1		CHEMBL1518		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7718964	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O		CHEMBL222863		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7718965	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O		CHEMBL222863		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7719645	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C		CHEMBL94		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7719646	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C		CHEMBL94		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7719743	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C		CHEMBL295416		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7719744	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C		CHEMBL295416		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7719883	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21		CHEMBL1144		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7719884	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21		CHEMBL1144		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720005	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC1(c2ccccc2)C(=O)NCNC1=O		CHEMBL856		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720006	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC1(c2ccccc2)C(=O)NCNC1=O		CHEMBL856		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720101	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1		CHEMBL316561		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720102	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1		CHEMBL316561		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720343	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O		CHEMBL1592		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720344	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O		CHEMBL1592		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720556	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O		CHEMBL1572		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720557	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O		CHEMBL1572		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720679	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1		CHEMBL56367		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720680	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1		CHEMBL56367		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720798	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)Nc1nc2ccc(C(=O)c3cccs3)cc2[nH]1		CHEMBL9514		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720799	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)Nc1nc2ccc(C(=O)c3cccs3)cc2[nH]1		CHEMBL9514		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720881	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2		CHEMBL450895		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720882	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2		CHEMBL450895		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721176	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12C/C(=C/O)C(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O		CHEMBL1200585		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721177	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12C/C(=C/O)C(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O		CHEMBL1200585		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721302	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1		CHEMBL490		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721303	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1		CHEMBL490		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721429	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1		CHEMBL55		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721430	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1		CHEMBL55		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721530	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1c2ccccc2C(=O)C1c1ccccc1		CHEMBL711		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721531	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1c2ccccc2C(=O)C1c1ccccc1		CHEMBL711		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7722403	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@H]1O[C@@H](O[C@@H]2C=C3CC[C@@H]4[C@H](CC[C@]5(C)[C@@H](c6ccc(=O)oc6)CC[C@]45O)[C@@]3(C)CC2)[C@H](O)[C@H](O)[C@H]1O		CHEMBL600325		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7722404	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@H]1O[C@@H](O[C@@H]2C=C3CC[C@@H]4[C@H](CC[C@]5(C)[C@@H](c6ccc(=O)oc6)CC[C@]45O)[C@@]3(C)CC2)[C@H](O)[C@H](O)[C@H]1O		CHEMBL600325		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7723241	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL414804		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7723242	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL414804		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7723897	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@H]1C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3/C=C/C(=O)O1)C[C@H](O)[C@H]2C(=O)O		CHEMBL1200656		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7723898	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@H]1C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3/C=C/C(=O)O1)C[C@H](O)[C@H]2C(=O)O		CHEMBL1200656		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7723995	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCn1cc(C(=O)O)c(=O)c2cnc(N3CCCC3)nc21		CHEMBL311350		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7723996	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCn1cc(C(=O)O)c(=O)c2cnc(N3CCCC3)nc21		CHEMBL311350		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724134	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3C2C1		CHEMBL976		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724135	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3C2C1		CHEMBL976		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724256	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1		CHEMBL897		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724257	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1		CHEMBL897		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724326	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)CCCN1c2ccccc2Sc2ccccc21		CHEMBL564		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724327	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)CCCN1c2ccccc2Sc2ccccc21		CHEMBL564		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724608	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909075		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724609	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909075		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724823	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1		CHEMBL57		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724824	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1		CHEMBL57		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724943	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1C(=O)CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21		CHEMBL13341		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724944	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1C(=O)CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21		CHEMBL13341		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725058	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C		CHEMBL1162		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725059	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C		CHEMBL1162		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725147	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccccc1N		CHEMBL1612004		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725148	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccccc1N		CHEMBL1612004		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725443	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Oc1cccc2cccnc12		CHEMBL310555		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725444	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Oc1cccc2cccnc12		CHEMBL310555		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725559	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=C1C(=O)O[C@H]2[C@H]1CC/C(C)=C/CC[C@@]1(C)O[C@@H]21		CHEMBL540445		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725560	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=C1C(=O)O[C@H]2[C@H]1CC/C(C)=C/CC[C@@]1(C)O[C@@H]21		CHEMBL540445		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725682	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O		CHEMBL628		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725683	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O		CHEMBL628		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725791	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC1(c2ccccc2)C(=O)NC(=O)NC1=O		CHEMBL40		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725792	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC1(c2ccccc2)C(=O)NC(=O)NC1=O		CHEMBL40		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7726584	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(CN1c2ccccc2Sc2ccccc21)N(C)C		CHEMBL643		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7726585	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(CN1c2ccccc2Sc2ccccc21)N(C)C		CHEMBL643		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7726672	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc(C[C@H](N)C(=O)N[C@@H]2[C@@H](CO)O[C@@H](n3cnc4c(N(C)C)ncnc43)[C@@H]2O)cc1		CHEMBL469912		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7726673	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc(C[C@H](N)C(=O)N[C@@H]2[C@@H](CO)O[C@@H](n3cnc4c(N(C)C)ncnc43)[C@@H]2O)cc1		CHEMBL469912		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7727511	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1		CHEMBL1071		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7727512	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1		CHEMBL1071		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7728173	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)NCC(O)COc1cccc2[nH]ccc12		CHEMBL500		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7728174	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)NCC(O)COc1cccc2[nH]ccc12		CHEMBL500		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7728274	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O		CHEMBL527		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7728275	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O		CHEMBL527		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7728406	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC		CHEMBL2		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7728407	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC		CHEMBL2		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7728542	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1		CHEMBL608		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7728543	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1		CHEMBL608		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7728996	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2O		CHEMBL757		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7728997	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2O		CHEMBL757		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729109	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)c1cccnc1		CHEMBL573		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729110	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)c1cccnc1		CHEMBL573		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729222	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1		CHEMBL1428		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729223	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1		CHEMBL1428		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729336	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C		CHEMBL1201146		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729337	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C		CHEMBL1201146		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729430	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@H](O)[C@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1		CHEMBL3350037		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729431	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@H](O)[C@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1		CHEMBL3350037		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729724	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12		CHEMBL1517		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729725	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12		CHEMBL1517		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729841	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21		CHEMBL267648		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729842	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21		CHEMBL267648		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729947	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21		CHEMBL531		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729948	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21		CHEMBL531		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7730077	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Oc1ccccc1		CHEMBL14060		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7730078	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Oc1ccccc1		CHEMBL14060		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7730832	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1		CHEMBL631		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7730833	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1		CHEMBL631		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7730948	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)c1cnccn1		CHEMBL614		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7730949	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)c1cnccn1		CHEMBL614		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7731787	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)N1c2ccccc2CC(=O)c2ccccc21		CHEMBL1068		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7731788	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)N1c2ccccc2CC(=O)c2ccccc21		CHEMBL1068		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7732452	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1		CHEMBL595		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7732453	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1		CHEMBL595		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7732555	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC		CHEMBL61		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7732556	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC		CHEMBL61		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7732682	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO		CHEMBL131		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7732683	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO		CHEMBL131		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7732820	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CC)CCNC(=O)c1ccc(N)cc1		CHEMBL640		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7732821	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CC)CCNC(=O)c1ccc(N)cc1		CHEMBL640		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733255	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc2cc([C@H](C)C(=O)O)ccc2c1		CHEMBL154		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733256	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc2cc([C@H](C)C(=O)O)ccc2c1		CHEMBL154		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733371	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)c1cccnc1		CHEMBL1140		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733372	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)c1cccnc1		CHEMBL1140		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733478	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-]		CHEMBL1726		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733479	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-]		CHEMBL1726		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733596	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21		CHEMBL9		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733597	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21		CHEMBL9		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733691	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23		CHEMBL4		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733692	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23		CHEMBL4		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733992	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C		CHEMBL428647		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733993	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C		CHEMBL428647		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734114	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC1=NC(=O)C(c2ccccc2)O1		CHEMBL1177		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734115	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC1=NC(=O)C(c2ccccc2)O1		CHEMBL1177		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734204	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1		CHEMBL75880		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734205	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1		CHEMBL75880		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734334	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	c1ccc2c(c1)Nc1ccccc1S2		CHEMBL828		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734335	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	c1ccc2c(c1)Nc1ccccc1S2		CHEMBL828		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7735106	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N		CHEMBL1196		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7735107	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N		CHEMBL1196		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7735222	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc(CN(CCN(C)C)c2ccccn2)cc1		CHEMBL511		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7735223	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc(CN(CCN(C)C)c2ccccn2)cc1		CHEMBL511		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7736081	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)Nc1nc2cc([S+]([O-])c3ccccc3)ccc2[nH]1		CHEMBL42442		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7736082	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)Nc1nc2cc([S+]([O-])c3ccccc3)ccc2[nH]1		CHEMBL42442		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7736610	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1		CHEMBL597		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7736611	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1		CHEMBL597		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7736720	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1		CHEMBL1909072		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7736721	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1		CHEMBL1909072		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7736849	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL3559671		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7736850	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL3559671		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7736973	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO		CHEMBL635		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7736974	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO		CHEMBL635		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7737114	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CC)CCOC(=O)c1ccc(N)cc1		CHEMBL569		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7737115	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CC)CCOC(=O)c1ccc(N)cc1		CHEMBL569		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7737546	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)[C@H]1CC[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1		CHEMBL783		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7737547	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)[C@H]1CC[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1		CHEMBL783		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7737664	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1CCC[C@H]1c1cccnc1		CHEMBL3		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7737665	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1CCC[C@H]1c1cccnc1		CHEMBL3		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7737769	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1		CHEMBL13209		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7737770	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1		CHEMBL13209		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7737886	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C#CC1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC		CHEMBL2107797		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7737887	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C#CC1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC		CHEMBL2107797		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7737968	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1		CHEMBL715		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7737969	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1		CHEMBL715		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738301	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(CO)C(O)C(=O)NCCCO		CHEMBL1371937		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738302	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(CO)C(O)C(=O)NCCCO		CHEMBL1371937		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738423	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1nc(O)c2ncn(CCC(CO)CO)c2n1		CHEMBL1540		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738424	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1nc(O)c2ncn(CCC(CO)CO)c2n1		CHEMBL1540		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738507	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1		CHEMBL567		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738508	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1		CHEMBL567		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7739389	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)c1cccc(C(C)C)c1O		CHEMBL526		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7739390	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)c1cccc(C(C)C)c1O		CHEMBL526		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7739502	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Oc1cccc(O)c1O		CHEMBL307145		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7739503	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Oc1cccc(O)c1O		CHEMBL307145		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7740383	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1		CHEMBL1262		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7740384	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1		CHEMBL1262		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7740925	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O		CHEMBL101		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7740926	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O		CHEMBL101		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7741022	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H](C(=O)O)C(C)(C)S[C@H]23)c2ccccc2)C(=O)C1=O		CHEMBL702		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7741023	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H](C(=O)O)C(C)(C)S[C@H]23)c2ccccc2)C(=O)C1=O		CHEMBL702		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7741157	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL2108139		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7741158	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL2108139		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7741279	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)[C@H]1[C@H](C#N)C[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1400945		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7741280	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)[C@H]1[C@H](C#N)C[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1400945		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7741424	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNNCc1ccc(C(=O)NC(C)C)cc1		CHEMBL1321		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7741425	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNNCc1ccc(C(=O)NC(C)C)cc1		CHEMBL1321		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7741862	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C		CHEMBL584		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7741863	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C		CHEMBL584		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7741992	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-]		CHEMBL193		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7741993	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-]		CHEMBL193		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742104	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1		CHEMBL475534		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742105	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1		CHEMBL475534		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742195	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNCCC=C1c2ccccc2CCc2ccccc21		CHEMBL445		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742196	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNCCC=C1c2ccccc2CCc2ccccc21		CHEMBL445		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742305	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1		CHEMBL1503		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742306	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1		CHEMBL1503		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742634	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC		CHEMBL1502		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742635	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC		CHEMBL1502		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742756	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(S)[C@@H](N)C(=O)O		CHEMBL1430		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742757	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(S)[C@@H](N)C(=O)O		CHEMBL1430		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742840	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)NC(=O)Cc1ccccc1		CHEMBL918		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742841	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)NC(=O)Cc1ccccc1		CHEMBL918		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7743726	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)NCC(O)COc1cccc2ccccc12		CHEMBL27		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7743727	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)NCC(O)COc1cccc2ccccc12		CHEMBL27		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7743838	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1		CHEMBL716		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7743839	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1		CHEMBL716		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7744697	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1		CHEMBL1231		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7744698	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1		CHEMBL1231		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7745259	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NNc1ccccc1		CHEMBL456807		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7745260	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NNc1ccccc1		CHEMBL456807		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7745362	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[N+]1(CCOC(=O)C(O)(c2ccccc2)c2ccccc2)CCCCC1.[Br-]		CHEMBL1909073		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7745363	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[N+]1(CCOC(=O)C(O)(c2ccccc2)c2ccccc2)CCCCC1.[Br-]		CHEMBL1909073		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7745504	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[n+]1ccccc1/C=N/O.[Cl-]		CHEMBL748		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7745505	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[n+]1ccccc1/C=N/O.[Cl-]		CHEMBL748		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7745624	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCNC(C)C(=O)Nc1ccccc1C		CHEMBL1194		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7745625	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCNC(C)C(=O)Nc1ccccc1C		CHEMBL1194		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7745749	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1		CHEMBL728		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7745750	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1		CHEMBL728		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746202	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O		CHEMBL184618		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746203	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O		CHEMBL184618		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746329	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1		CHEMBL63323		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746330	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1		CHEMBL63323		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746447	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1		CHEMBL572		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746448	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1		CHEMBL572		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746526	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C		CHEMBL364713		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746527	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C		CHEMBL364713		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746638	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O		CHEMBL46		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746639	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O		CHEMBL46		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746808	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O		CHEMBL580		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746809	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O		CHEMBL580		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746917	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO		CHEMBL689		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746918	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO		CHEMBL689		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7747741	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21		CHEMBL58		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7747742	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21		CHEMBL58		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7747844	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2		CHEMBL866		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7747845	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2		CHEMBL866		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7747975	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314		CHEMBL895		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7747976	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314		CHEMBL895		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7748508	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1		CHEMBL534		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7748509	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1		CHEMBL534		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7748601	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1		CHEMBL141		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7748602	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1		CHEMBL141		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7748736	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	c1ccc([C@H]2CN3CCSC3=N2)cc1		CHEMBL1454		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7748737	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	c1ccc([C@H]2CN3CCSC3=N2)cc1		CHEMBL1454		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7748866	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1		CHEMBL1447		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7748867	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1		CHEMBL1447		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749179	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNCCCC12CCC(c3ccccc31)c1ccccc12		CHEMBL21731		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749180	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNCCCC12CCC(c3ccccc31)c1ccccc12		CHEMBL21731		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749294	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cccc(Nc2ccccc2C(=O)O)c1C		CHEMBL686		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749295	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cccc(Nc2ccccc2C(=O)O)c1C		CHEMBL686		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749407	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=S(=O)([O-])CCS.[Na+]		CHEMBL975		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749408	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=S(=O)([O-])CCS.[Na+]		CHEMBL975		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749491	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1c2occc2cc2ccc(=O)oc12		CHEMBL416		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749492	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1c2occc2cc2ccc(=O)oc12		CHEMBL416		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749601	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1		CHEMBL1065		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749602	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1		CHEMBL1065		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749734	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cccc(C)c1OCC(C)N		CHEMBL558		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749735	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cccc(C)c1OCC(C)N		CHEMBL558		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7750251	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5		CHEMBL19019		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7750252	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5		CHEMBL19019		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7750298	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1		CHEMBL165790		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7750299	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1		CHEMBL165790		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7750434	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1		CHEMBL547		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7750435	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1		CHEMBL547		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7751103	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1		CHEMBL191		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7751104	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1		CHEMBL191		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7752045	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1		CHEMBL86304		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7752046	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1		CHEMBL86304		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7752146	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CC)CCOCCC1=CCC2CC1C2(C)C		CHEMBL1630579		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7752147	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CC)CCOCCC1=CCC2CC1C2(C)C		CHEMBL1630579		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7752794	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O		CHEMBL2106399		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7752795	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O		CHEMBL2106399		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7752895	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1		CHEMBL741		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7752896	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1		CHEMBL741		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753025	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O		CHEMBL1201237		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753026	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O		CHEMBL1201237		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753163	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909064		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753164	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909064		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753466	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909067		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753467	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909067		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753587	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1201139		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753588	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1201139		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753700	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C		CHEMBL1201151		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753701	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C		CHEMBL1201151		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753784	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[N+]1(C)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@H]1O[C@@H]21.[Br-]		CHEMBL1201024		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753785	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[N+]1(C)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@H]1O[C@@H]21.[Br-]		CHEMBL1201024		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753886	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC		CHEMBL86		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753887	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC		CHEMBL86		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754007	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1CCN2c3ccccc3Cc3ccccc3C2C1		CHEMBL6437		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754008	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1CCN2c3ccccc3Cc3ccccc3C2C1		CHEMBL6437		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754444	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2/C(=N/N=C2\CC[C@@]4(O)[C@H]6Cc7ccc(O)c8c7[C@@]4(CCN6CC=C)[C@H]2O8)CC[C@@]3(O)[C@H]1C5		CHEMBL1618305		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754445	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2/C(=N/N=C2\CC[C@@]4(O)[C@H]6Cc7ccc(O)c8c7[C@@]4(CCN6CC=C)[C@H]2O8)CC[C@@]3(O)[C@H]1C5		CHEMBL1618305		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754618	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)NNC(=O)c1ccncc1		CHEMBL92401		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754619	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)NNC(=O)c1ccncc1		CHEMBL92401		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754750	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O		CHEMBL64391		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754751	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O		CHEMBL64391		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7755417	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21		CHEMBL503		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7755418	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21		CHEMBL503		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7756283	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1		CHEMBL91		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7756284	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1		CHEMBL91		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7756390	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)C[S+]([O-])C(c1ccccc1)c1ccccc1		CHEMBL1373		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7756391	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)C[S+]([O-])C(c1ccccc1)c1ccccc1		CHEMBL1373		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7756494	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CC)N=O		CHEMBL164290		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7756495	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CC)N=O		CHEMBL164290		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7756754	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5		CHEMBL80		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7757144	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS		CHEMBL1221512		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7757145	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS		CHEMBL1221512		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7757258	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1		CHEMBL480		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7757259	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1		CHEMBL480		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7757385	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C		CHEMBL1201193		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7757386	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C		CHEMBL1201193		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7757517	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O		CHEMBL1237		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7757518	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O		CHEMBL1237		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7757816	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909068		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7757817	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909068		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7757933	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc2[nH]cc(CCNC(C)=O)c2c1		CHEMBL45		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7757934	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc2[nH]cc(CCNC(C)=O)c2c1		CHEMBL45		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758020	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21		CHEMBL19215		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758021	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21		CHEMBL19215		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758141	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COS(C)(=O)=O		CHEMBL313493		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758142	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COS(C)(=O)=O		CHEMBL313493		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758238	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C		CHEMBL878		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758239	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C		CHEMBL878		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758763	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5		CHEMBL80		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758941	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1		CHEMBL1513		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758942	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1		CHEMBL1513		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7759059	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O		CHEMBL1200633		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7759060	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O		CHEMBL1200633		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7759749	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1		CHEMBL19299		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7759750	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1		CHEMBL19299		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7760551	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C		CHEMBL1276308		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7760552	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C		CHEMBL1276308		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7760671	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Oc1ccc(OCc2ccccc2)cc1		CHEMBL1388		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7760672	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Oc1ccc(OCc2ccccc2)cc1		CHEMBL1388		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7760786	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)C=O		CHEMBL268291		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7760787	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)C=O		CHEMBL268291		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7761415	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(C)[C@H]2CC[C@]1(C)C(=O)C2		CHEMBL2252949		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7761416	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(C)[C@H]2CC[C@]1(C)C(=O)C2		CHEMBL2252949		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7761530	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909062		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7761531	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909062		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7761660	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[N+](C)(C)C[C@H](O)CC(=O)[O-]		CHEMBL1149		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7761661	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[N+](C)(C)C[C@H](O)CC(=O)[O-]		CHEMBL1149		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7761770	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1		CHEMBL157138		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7761771	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1		CHEMBL157138		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7762099	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909069		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7762100	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909069		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7762219	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1		CHEMBL599		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7762220	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1		CHEMBL599		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7762296	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)C(=N)NC(=N)N		CHEMBL1431		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7762297	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)C(=N)NC(=N)N		CHEMBL1431		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7762417	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)c1ccccc1O		CHEMBL108545		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7762418	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)c1ccccc1O		CHEMBL108545		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7762512	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COCCc1ccc(OCC(O)CNC(C)C)cc1		CHEMBL13		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7762513	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COCCc1ccc(OCC(O)CNC(C)C)cc1		CHEMBL13		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7763089	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1		CHEMBL406		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7763090	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1		CHEMBL406		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7763211	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC		CHEMBL481		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7763212	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC		CHEMBL481		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7763332	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O		CHEMBL1384		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7763333	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O		CHEMBL1384		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7763993	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7763994	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7764812	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1		CHEMBL189		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7764813	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1		CHEMBL189		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7764917	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1		CHEMBL787		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7764918	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1		CHEMBL787		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7765045	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	c1ccc(Nc2ccc(Nc3ccccc3)cc2)cc1		CHEMBL1333512		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7765046	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	c1ccc(Nc2ccc(Nc3ccccc3)cc2)cc1		CHEMBL1333512		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7765679	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N[C@@H](Cn1ccc(=O)c(O)c1)C(=O)O		CHEMBL245416		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7765680	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N[C@@H](Cn1ccc(=O)c(O)c1)C(=O)O		CHEMBL245416		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7765793	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909063		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7765794	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909063		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7765924	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O		CHEMBL1009		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7765925	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O		CHEMBL1009		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766029	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21		CHEMBL561		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766030	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21		CHEMBL561		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766356	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1		CHEMBL685		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766357	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1		CHEMBL685		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766479	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O		CHEMBL852		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766480	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O		CHEMBL852		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766545	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)CCN(Cc1cccs1)c1ccccn1		CHEMBL1411979		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766546	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)CCN(Cc1cccs1)c1ccccn1		CHEMBL1411979		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766684	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O		CHEMBL459		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766685	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O		CHEMBL459		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766784	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ncc([N+](=O)[O-])n1CCO		CHEMBL137		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766785	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ncc([N+](=O)[O-])n1CCO		CHEMBL137		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7767355	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O		CHEMBL115		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7767356	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O		CHEMBL115		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7767479	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1nc(N)nc(-c2cc(Cl)ccc2Cl)n1.O=C(O)/C=C\C(=O)O		CHEMBL1712923		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7767480	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1nc(N)nc(-c2cc(Cl)ccc2Cl)n1.O=C(O)/C=C\C(=O)O		CHEMBL1712923		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7767598	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNC1(c2ccccc2Cl)CCCCC1=O		CHEMBL742		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7767599	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNC1(c2ccccc2Cl)CCCCC1=O		CHEMBL742		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7768264	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC		CHEMBL1909065		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7768265	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC		CHEMBL1909065		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7769099	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1cc(N2CCCCC2)nc(N)[n+]1[O-]		CHEMBL802		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7769100	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1cc(N2CCCCC2)nc(N)[n+]1[O-]		CHEMBL802		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7769191	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1		CHEMBL60889		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7769192	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1		CHEMBL60889		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7769325	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc2cc(CCC(C)=O)ccc2c1		CHEMBL1070		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7769326	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc2cc(CCC(C)=O)ccc2c1		CHEMBL1070		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7769959	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1		CHEMBL429		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7769960	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1		CHEMBL429		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770080	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1		CHEMBL960		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770081	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1		CHEMBL960		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770213	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23		CHEMBL33		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770214	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23		CHEMBL33		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770318	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=NN(CCCl)C(=O)NC1CCCCC1		CHEMBL514		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770319	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=NN(CCCl)C(=O)NC1CCCCC1		CHEMBL514		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770637	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl		CHEMBL509		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770638	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl		CHEMBL509		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770753	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1		CHEMBL395110		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770754	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1		CHEMBL395110		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770834	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cn1cc[nH]c1=S		CHEMBL1515		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770835	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cn1cc[nH]c1=S		CHEMBL1515		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770963	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1		CHEMBL1201356		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770964	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1		CHEMBL1201356		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7771075	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C(=O)c1cccnc1)c1cccnc1		CHEMBL934		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7771076	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C(=O)c1cccnc1)c1cccnc1		CHEMBL934		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7771638	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1		CHEMBL6		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7771639	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1		CHEMBL6		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7771765	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C/C=C\c1ccc(O)c(OC)c1		CHEMBL445206		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7771766	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C/C=C\c1ccc(O)c(OC)c1		CHEMBL445206		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7771869	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1		CHEMBL157101		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7771870	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1		CHEMBL157101		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7772553	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC.N		CHEMBL2105807		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7772554	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC.N		CHEMBL2105807		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7773374	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12		CHEMBL105		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7773375	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12		CHEMBL105		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7773460	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1nc(C)nc(Cl)c1NC1=NCCN1		CHEMBL19236		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7773461	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1nc(C)nc(Cl)c1NC1=NCCN1		CHEMBL19236		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7773597	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C)NCC(O)COc1cccc2c1C[C@H](O)[C@H](O)C2		CHEMBL649		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7773598	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C)NCC(O)COc1cccc2c1C[C@H](O)[C@H](O)C2		CHEMBL649		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7774209	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1/C=C/C(=O)OC(C)(C)C		CHEMBL460291		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7774210	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1/C=C/C(=O)OC(C)(C)C		CHEMBL460291		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7774341	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1		CHEMBL1444		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7774342	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1		CHEMBL1444		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7774471	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC		CHEMBL267044		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7774472	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC		CHEMBL267044		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7774569	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1		CHEMBL841		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7774570	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1		CHEMBL841		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7774906	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1390		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7774907	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1390		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775009	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cccc(C)c1NC(=O)C1CCCCN1C		CHEMBL1087		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775010	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cccc(C)c1NC(=O)C1CCCCN1C		CHEMBL1087		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775094	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccccc1OCC(O)COC(N)=O		CHEMBL1201117		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775095	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccccc1OCC(O)COC(N)=O		CHEMBL1201117		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775216	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)c1ccc(O)cc1		CHEMBL325372		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775217	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)c1ccc(O)cc1		CHEMBL325372		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775328	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@](N)(Cc1ccc(O)cc1)C(=O)O		CHEMBL1200862		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775329	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@](N)(Cc1ccc(O)cc1)C(=O)O		CHEMBL1200862		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775890	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1201631		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775891	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1201631		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7776021	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NNC(=O)c1ccncc1		CHEMBL64		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7776022	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NNC(=O)c1ccncc1		CHEMBL64		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7776116	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1		CHEMBL571		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7776117	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1		CHEMBL571		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7776784	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1200693		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7776785	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1200693		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7777599	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1		CHEMBL1670		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7777600	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1		CHEMBL1670		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7777691	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2		CHEMBL1456		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7777692	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2		CHEMBL1456		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7777828	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(Oc1ccc(C2CCCc3ccccc32)cc1)C(=O)O		CHEMBL1909070		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7777829	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(Oc1ccc(C2CCCc3ccccc32)cc1)C(=O)O		CHEMBL1909070		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7778441	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(O)C(=O)O		CHEMBL1200559		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7778442	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(O)C(=O)O		CHEMBL1200559		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7778576	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O		CHEMBL1679		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7778577	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O		CHEMBL1679		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7778706	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CC)CC(=O)Nc1c(C)cccc1C		CHEMBL79		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7778707	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CC)CC(=O)Nc1c(C)cccc1C		CHEMBL79		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7778791	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1		CHEMBL998		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7778792	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1		CHEMBL998		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7779129	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL717		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7779130	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL717		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7779238	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12		CHEMBL127		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7779239	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12		CHEMBL127		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7779323	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1		CHEMBL34259		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7779324	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1		CHEMBL34259		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7779443	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12		CHEMBL650		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7779444	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12		CHEMBL650		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7779560	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21		CHEMBL54440		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7779561	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21		CHEMBL54440		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7780128	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Oc1c(I)cc(I)c2cccnc12		CHEMBL86754		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7780129	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Oc1c(I)cc(I)c2cccnc12		CHEMBL86754		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7780263	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)NCC(O)c1ccc(O)c(O)c1		CHEMBL434		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7780264	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)NCC(O)c1ccc(O)c(O)c1		CHEMBL434		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7780361	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O		CHEMBL469		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7780362	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O		CHEMBL469		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7781402	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)c1c[nH]c3ccccc13)C2		CHEMBL56564		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7781403	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)c1c[nH]c3ccccc13)C2		CHEMBL56564		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7781516	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1		CHEMBL865		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7781517	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1		CHEMBL865		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7781631	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1		CHEMBL159		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7781632	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1		CHEMBL159		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7781820	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)OCC(COC(C)=O)OC(C)=O		CHEMBL1489254		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7781821	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)OCC(COC(C)=O)OC(C)=O		CHEMBL1489254		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7781949	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1		CHEMBL422		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7781950	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1		CHEMBL422		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7782541	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12		CHEMBL603		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7782542	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12		CHEMBL603		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783001	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N[C@H]1[C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@H]12		CHEMBL428		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783002	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N[C@H]1[C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@H]12		CHEMBL428		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783118	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC(C)C(C(=O)OCC[N+](C)(CC)CC)c1ccccc1.[Br-]		CHEMBL2107687		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783119	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC(C)C(C(=O)OCC[N+](C)(CC)CC)c1ccccc1.[Br-]		CHEMBL2107687		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783237	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1		CHEMBL90555		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783238	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1		CHEMBL90555		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783426	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO		CHEMBL1451		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783427	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO		CHEMBL1451		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783549	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1		CHEMBL1490		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783550	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1		CHEMBL1490		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7784138	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1		CHEMBL1521		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7784139	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1		CHEMBL1521		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7784591	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc(C(=O)NC2CCCNC2)cc(OC)c1OC		CHEMBL1566956		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7784592	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc(C(=O)NC2CCCNC2)cc(OC)c1OC		CHEMBL1566956		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7784701	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCC(CCC)C(=O)O		CHEMBL109		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7784702	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCC(CCC)C(=O)O		CHEMBL109		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7784822	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1		CHEMBL238071		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7784823	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1		CHEMBL238071		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7785007	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL1504		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7785008	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL1504		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7785129	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc(CN2CCNCC2)c(OC)c1OC		CHEMBL203266		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7785130	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc(CN2CCNCC2)c(OC)c1OC		CHEMBL203266		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7785717	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCOc1ccccc1-c1nc2nn[nH]c2c(=O)[nH]1		CHEMBL28079		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7785718	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCOc1ccccc1-c1nc2nn[nH]c2c(=O)[nH]1		CHEMBL28079		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786300	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N#CC(C#N)=Cc1ccc(O)c(O)c1		CHEMBL76904		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786301	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N#CC(C#N)=Cc1ccc(O)c(O)c1		CHEMBL76904		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786411	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C		CHEMBL1069		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786412	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C		CHEMBL1069		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786531	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2		CHEMBL553025		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786532	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2		CHEMBL553025		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786737	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC[C@H]1CC[C@H](C(=O)O)CC1		CHEMBL877		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786738	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC[C@H]1CC[C@H](C(=O)O)CC1		CHEMBL877		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786847	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1		CHEMBL585		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786848	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1		CHEMBL585		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786972	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1C(=O)OC(C)(C)C1=O		CHEMBL695		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786973	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1C(=O)OC(C)(C)C1=O		CHEMBL695		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7787574	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O		CHEMBL129		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7787575	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O		CHEMBL129		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7788156	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1c(C)c2c(c(C)c1O)CCC(C)(CN1CCN(c3cc(N4CCCC4)nc(N4CCCC4)n3)CC1)O2		CHEMBL141343		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7788157	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1c(C)c2c(c(C)c1O)CCC(C)(CN1CCN(c3cc(N4CCCC4)nc(N4CCCC4)n3)CC1)O2		CHEMBL141343		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7788286	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O		CHEMBL262777		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7788287	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O		CHEMBL262777		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7788394	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7788395	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7788614	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC		CHEMBL415324		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7788615	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC		CHEMBL415324		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7788720	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(Nc1ccc(Br)cc1)c1cc(Br)cc(Br)c1O		CHEMBL24944		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7788721	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(Nc1ccc(Br)cc1)c1cc(Br)cc(Br)c1O		CHEMBL24944		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7788851	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1		CHEMBL1475		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7788852	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1		CHEMBL1475		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7789444	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(c1cc2ccccc2s1)N(O)C(N)=O		CHEMBL93		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7789445	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(c1cc2ccccc2s1)N(O)C(N)=O		CHEMBL93		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790009	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O		CHEMBL29292		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790010	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O		CHEMBL29292		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790143	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1.[Br-]		CHEMBL1200629		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790144	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1.[Br-]		CHEMBL1200629		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790249	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O		CHEMBL1464		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790250	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O		CHEMBL1464		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790467	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1386		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790468	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1386		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790581	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O		CHEMBL1054		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790582	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O		CHEMBL1054		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790707	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2		CHEMBL408		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790708	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2		CHEMBL408		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7791298	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	[Cl-].[Cl-].[Zn+2]		CHEMBL1200679		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7791299	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	[Cl-].[Cl-].[Zn+2]		CHEMBL1200679		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7791870	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(N)=O		CHEMBL462547		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7791871	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(N)=O		CHEMBL462547		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792003	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1		CHEMBL637		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792004	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1		CHEMBL637		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792110	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792111	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792311	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12		CHEMBL621		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792312	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12		CHEMBL621		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792440	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)C(Cl)(Cl)Cl		CHEMBL14053		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792441	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)C(Cl)(Cl)Cl		CHEMBL14053		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792563	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(CO)(CO)CO		CHEMBL1200391		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792564	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(CO)(CO)CO		CHEMBL1200391		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7793169	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909083		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7793170	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909083		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7793628	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1		CHEMBL1200604		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7793629	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1		CHEMBL1200604		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7793741	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21		CHEMBL1349		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7793742	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21		CHEMBL1349		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7793865	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC		CHEMBL6966		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7793866	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC		CHEMBL6966		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7793978	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21		CHEMBL15245		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7793979	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21		CHEMBL15245		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7794052	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1		CHEMBL38		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7794053	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1		CHEMBL38		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7794183	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	ClCC(Cl)Cl		CHEMBL43882		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7794184	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	ClCC(Cl)Cl		CHEMBL43882		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7795343	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1c2c(nc3ccccc13)CCCC2		CHEMBL95		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7795344	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1c2c(nc3ccccc13)CCCC2		CHEMBL95		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7795405	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)N1C(=O)/C(=C(\O)c2cccs2)c2cc(Cl)ccc21		CHEMBL1908355		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7795406	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)N1C(=O)/C(=C(\O)c2cccs2)c2cc(Cl)ccc21		CHEMBL1908355		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7796848	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@@H]21		CHEMBL1393		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7796849	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@@H]21		CHEMBL1393		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7796983	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1C[C@@H]2OCC=C3CN4CC[C@]56c7ccccc7N1[C@H]5[C@H]2[C@H]3C[C@H]46		CHEMBL227934		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7796984	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1C[C@@H]2OCC=C3CN4CC[C@]56c7ccccc7N1[C@H]5[C@H]2[C@H]3C[C@H]46		CHEMBL227934		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797100	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1		CHEMBL446		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797101	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1		CHEMBL446		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797238	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C		CHEMBL453		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797239	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C		CHEMBL453		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797711	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12		CHEMBL1440		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797712	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12		CHEMBL1440		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797839	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1nc2[nH]cnc2c(=S)[nH]1		CHEMBL727		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797840	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1nc2[nH]cnc2c(=S)[nH]1		CHEMBL727		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797909	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN1CCN(c2cc(N3CCCC3)nc(N3CCCC3)n2)CC1		CHEMBL1630578		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797910	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN1CCN(c2cc(N3CCCC3)nc(N3CCCC3)n2)CC1		CHEMBL1630578		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798050	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cccc(C2(O)CCCCC2CN(C)C)c1		CHEMBL1237044		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798051	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cccc(C2(O)CCCCC2CN(C)C)c1		CHEMBL1237044		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798263	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798264	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798393	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(N)C12CC3CC(CC(C3)C1)C2		CHEMBL959		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798394	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(N)C12CC3CC(CC(C3)C1)C2		CHEMBL959		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798500	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=[N+]([O-])c1cc([As](=O)(O)O)ccc1O		CHEMBL1321154		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798501	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=[N+]([O-])c1cc([As](=O)(O)O)ccc1O		CHEMBL1321154		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798615	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)c1ccccc1O		CHEMBL27577		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798616	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)c1ccccc1O		CHEMBL27577		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798731	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O		CHEMBL447		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798732	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O		CHEMBL447		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798829	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=[As][O-].[Na+]		CHEMBL1909078		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798830	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=[As][O-].[Na+]		CHEMBL1909078		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7799570	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC		CHEMBL269732		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7799571	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC		CHEMBL269732		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7799632	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O		CHEMBL302795		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7799633	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O		CHEMBL302795		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7800175	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1		CHEMBL1148		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7800176	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1		CHEMBL1148		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801101	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909079		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801102	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL1909079		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801236	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(C)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O		CHEMBL403		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801237	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1(C)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O		CHEMBL403		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801359	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1		CHEMBL1191		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801360	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1		CHEMBL1191		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801496	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S+](C)[O-])cc1		CHEMBL15770		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801497	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S+](C)[O-])cc1		CHEMBL15770		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801997	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1		CHEMBL468		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801998	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1		CHEMBL468		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802099	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2		CHEMBL479		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802100	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2		CHEMBL479		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802206	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O		CHEMBL1747		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802207	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O		CHEMBL1747		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802555	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC		CHEMBL772		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802556	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC		CHEMBL772		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802690	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O		CHEMBL923		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802691	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O		CHEMBL923		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802795	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O		CHEMBL1214185		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802796	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O		CHEMBL1214185		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802912	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)c1ccccc1O		CHEMBL424		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802913	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)c1ccccc1O		CHEMBL424		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7803022	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C#CCN(C)[C@H](C)Cc1ccccc1		CHEMBL972		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7803023	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C#CCN(C)[C@H](C)Cc1ccccc1		CHEMBL972		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7803125	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL136478		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7803126	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL136478		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7803862	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1		CHEMBL83		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7803863	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1		CHEMBL83		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7803979	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC		CHEMBL611		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7803980	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC		CHEMBL611		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7804508	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC1CCN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)C1		CHEMBL273348		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7804509	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC1CCN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)C1		CHEMBL273348		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7805453	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O		CHEMBL27769		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7805454	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O		CHEMBL27769		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7805572	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1		CHEMBL1221		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7805573	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1		CHEMBL1221		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7805718	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1		CHEMBL443		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7805719	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1		CHEMBL443		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7805846	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CSc1ccc(/C=C2/C(C)=C(CC(=O)O)c3cc(F)ccc32)cc1		CHEMBL18797		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7805847	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CSc1ccc(/C=C2/C(C)=C(CC(=O)O)c3cc(F)ccc32)cc1		CHEMBL18797		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7806334	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cn1c(=O)c2nc[nH]c2n(C)c1=O		CHEMBL190		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7806335	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cn1c(=O)c2nc[nH]c2n(C)c1=O		CHEMBL190		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7806413	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC		CHEMBL84158		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7806414	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC		CHEMBL84158		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7806523	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cccc(C)c1NC(=O)C(C)N		CHEMBL1762		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7806524	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cccc(C)c1NC(=O)C(C)N		CHEMBL1762		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7806863	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1		CHEMBL165		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7806864	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1		CHEMBL165		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7806995	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2		CHEMBL85		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7806996	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2		CHEMBL85		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7807115	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc(N)[nH]c2nc(-c3ccc(F)cc3)c(-c3ccncc3)c1-2		CHEMBL115769		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7807116	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc(N)[nH]c2nc(-c3ccc(F)cc3)c(-c3ccncc3)c1-2		CHEMBL115769		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7807241	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C		CHEMBL1208572		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7807242	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C		CHEMBL1208572		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7807348	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1CCC(NC(=O)N(CCCl)N=O)CC1		CHEMBL12948		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7807349	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1CCC(NC(=O)N(CCCl)N=O)CC1		CHEMBL12948		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7807455	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL179166		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7807456	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL179166		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7808134	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1		CHEMBL506247		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7808135	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1		CHEMBL506247		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7808263	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12		CHEMBL822		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7808264	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12		CHEMBL822		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7808787	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)NC[C@@H](O)COc1cccc2ccccc12		CHEMBL275742		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7808788	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)NC[C@@H](O)COc1cccc2ccccc12		CHEMBL275742		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7809733	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12Cc3c[nH]nc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O		CHEMBL2079587		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7809734	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12Cc3c[nH]nc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O		CHEMBL2079587		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7809849	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1ccc(S(=O)(=O)NC(=O)c2ccccc2)cc1		CHEMBL1243		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7809850	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1ccc(S(=O)(=O)NC(=O)c2ccccc2)cc1		CHEMBL1243		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7809995	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1ccc(S(N)(=O)=O)cc1		CHEMBL21		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7809996	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1ccc(S(N)(=O)=O)cc1		CHEMBL21		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7810118	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(C)(=O)=O)cc1		CHEMBL488025		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7810119	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(C)(=O)=O)cc1		CHEMBL488025		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7810611	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	c1ccc2[nH]c(-c3cscn3)nc2c1		CHEMBL625		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7810612	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	c1ccc2[nH]c(-c3cscn3)nc2c1		CHEMBL625		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7810688	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C#C[C@]1(O)CC[C@H]2[C@H]3[C@H](CC[C@@]21C)C1=C(CC(=O)CC1)C[C@H]3C		CHEMBL2103774		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7810689	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C#C[C@]1(O)CC[C@H]2[C@H]3[C@H](CC[C@@]21C)C1=C(CC(=O)CC1)C[C@H]3C		CHEMBL2103774		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7810807	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1		CHEMBL817		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7810808	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1		CHEMBL817		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811148	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL1643		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811149	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL1643		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811266	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1		CHEMBL163		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811267	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1		CHEMBL163		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811386	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)NC[C@H](O)COc1cccc2ccccc12		CHEMBL452861		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811387	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)NC[C@H](O)COc1cccc2ccccc12		CHEMBL452861		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811525	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(Oc1ccccc1C(=O)O)c1ccccc1O		CHEMBL154111		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811526	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(Oc1ccccc1C(=O)O)c1ccccc1O		CHEMBL154111		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811614	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21		CHEMBL809		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811615	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21		CHEMBL809		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811747	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1		CHEMBL471		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811748	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1		CHEMBL471		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7812380	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1		CHEMBL588119		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7812381	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1		CHEMBL588119		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7812424	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]1(Cn2ccnn2)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O		CHEMBL404		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7812425	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]1(Cn2ccnn2)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O		CHEMBL404		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7812550	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C)NCC(O)c1cc(O)cc(O)c1		CHEMBL1760		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7812551	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C)NCC(O)c1cc(O)cc(O)c1		CHEMBL1760		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7813080	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)Cc1ccc([C@@H](C)C(=O)O)cc1		CHEMBL427526		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7813081	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)Cc1ccc([C@@H](C)C(=O)O)cc1		CHEMBL427526		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814017	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O		CHEMBL991		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814018	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O		CHEMBL991		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814133	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1		CHEMBL439		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814134	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1		CHEMBL439		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814278	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1		CHEMBL1109		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814279	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1		CHEMBL1109		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814912	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CS(=O)(=O)c1ccc([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)cc1		CHEMBL1236282		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814913	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CS(=O)(=O)c1ccc([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)cc1		CHEMBL1236282		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814979	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Clc1ccccc1CN1CCc2sccc2C1		CHEMBL833		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814980	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Clc1ccccc1CN1CCc2sccc2C1		CHEMBL833		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815102	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1		CHEMBL1020		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815103	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1		CHEMBL1020		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815447	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O		CHEMBL444633		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815448	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O		CHEMBL444633		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815558	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCOc1cc(CC2CNC(=O)N2)ccc1OC		CHEMBL18701		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815559	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCOc1cc(CC2CNC(=O)N2)ccc1OC		CHEMBL18701		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815674	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N[C@H](CSC(=S)NCc1ccccc1)C(=O)O		CHEMBL1909076		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815675	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	N[C@H](CSC(=S)NCc1ccccc1)C(=O)O		CHEMBL1909076		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815809	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1		CHEMBL114		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815810	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1		CHEMBL114		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815897	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1		CHEMBL1419		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815898	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1		CHEMBL1419		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7816039	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1		CHEMBL850		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7816040	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1		CHEMBL850		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7816646	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC		CHEMBL26		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7816647	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC		CHEMBL26		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7816704	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1[nH]c(=O)n(C2CCCO2)cc1F		CHEMBL20883		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7816705	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=c1[nH]c(=O)n(C2CCCO2)cc1F		CHEMBL20883		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7816803	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1		CHEMBL1306		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7816804	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1		CHEMBL1306		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7817368	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C		CHEMBL1219		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7817369	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C		CHEMBL1219		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7818313	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O		CHEMBL372795		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7818314	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O		CHEMBL372795		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7818429	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1		CHEMBL62193		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7818430	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1		CHEMBL62193		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7818574	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O		CHEMBL421		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7818575	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O		CHEMBL421		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819068	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1		CHEMBL17157		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819069	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1		CHEMBL17157		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819184	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL508338		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819185	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B			CHEMBL508338		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819258	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl		CHEMBL267744		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819259	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl		CHEMBL267744		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819384	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1		CHEMBL83668		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819385	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1		CHEMBL83668		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819624	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12		CHEMBL81		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819625	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12		CHEMBL81		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819741	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C		CHEMBL374478		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819742	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C		CHEMBL374478		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819851	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1		CHEMBL122		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819852	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1		CHEMBL122		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819968	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O.O		CHEMBL1200748		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819969	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O.O		CHEMBL1200748		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820095	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)c1cn(-c2ccc(F)cc2)c2cc(N3CCNCC3)c(F)cc2c1=O		CHEMBL37858		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820096	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)c1cn(-c2ccc(F)cc2)c2cc(N3CCNCC3)c(F)cc2c1=O		CHEMBL37858		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820178	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12		CHEMBL192		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820179	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12		CHEMBL192		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820320	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C1CCN2C[C@H]3C[C@H](CN4CCCC[C@H]34)[C@@H]2C1		CHEMBL412873		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820321	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C1CCN2C[C@H]3C[C@H](CN4CCCC[C@H]34)[C@@H]2C1		CHEMBL412873		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820927	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1		CHEMBL128		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820928	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1		CHEMBL128		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820985	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)N[C@@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@@H](CO)[C@@H](O)[C@@H]1O		CHEMBL2367892		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820986	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=O)N[C@@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@@H](CO)[C@@H](O)[C@@H]1O		CHEMBL2367892		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7822578	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(N=O)C(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O		CHEMBL1651906		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7822579	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(N=O)C(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O		CHEMBL1651906		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7822693	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC		CHEMBL1539		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7822694	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC		CHEMBL1539		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7822833	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1ccc(S(=O)(=O)Nc2nccs2)cc1		CHEMBL437		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7822834	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1ccc(S(=O)(=O)Nc2nccs2)cc1		CHEMBL437		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823314	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O		CHEMBL386630		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823315	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O		CHEMBL386630		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823437	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=N)S		CHEMBL38737		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823438	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(=N)S		CHEMBL38737		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823510	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1		CHEMBL499		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823511	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1		CHEMBL499		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823634	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1		CHEMBL1076211		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823635	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1		CHEMBL1076211		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823853	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21		CHEMBL1168		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823854	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21		CHEMBL1168		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823980	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C		CHEMBL1660		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823981	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C		CHEMBL1660		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7824089	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1		CHEMBL121		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7824090	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1		CHEMBL121		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7824204	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=CCc1ccc2c(c1)OCO2		CHEMBL242273		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7824205	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=CCc1ccc2c(c1)OCO2		CHEMBL242273		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7824324	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7824325	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7824421	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21		CHEMBL1064		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7824422	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21		CHEMBL1064		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7824564	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN[C@H]1[C@@H](O)[C@@H](NC)[C@H](O)[C@H]2O[C@@H]3O[C@H](C)CC(=O)[C@]3(O)O[C@H]12		CHEMBL1167		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7824565	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN[C@H]1[C@@H](O)[C@@H](NC)[C@H](O)[C@H]2O[C@@H]3O[C@H](C)CC(=O)[C@]3(O)O[C@H]12		CHEMBL1167		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7825168	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-]		CHEMBL983		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7825169	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-]		CHEMBL983		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7825229	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)CCN1		CHEMBL277100		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7825230	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)CCN1		CHEMBL277100		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7826800	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O.O.O.O.O.O.[Cl-].[Cl-].[Sr+2]		CHEMBL1909080		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7826801	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O.O.O.O.O.O.[Cl-].[Cl-].[Sr+2]		CHEMBL1909080		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7826915	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1		CHEMBL438		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7826916	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1		CHEMBL438		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827055	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1		CHEMBL832		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827056	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1		CHEMBL832		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827538	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCNc1ccc(C(=O)OCCN(C)C)cc1		CHEMBL698		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827539	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCCCNc1ccc(C(=O)OCCN(C)C)cc1		CHEMBL698		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827664	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)CCCC[C@@H]1CCSS1		CHEMBL134342		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827665	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	O=C(O)CCCC[C@@H]1CCSS1		CHEMBL134342		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827736	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C		CHEMBL1220		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827737	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C		CHEMBL1220		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827859	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1		CHEMBL84		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827860	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1		CHEMBL84		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828079	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1		CHEMBL1790041		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828080	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1		CHEMBL1790041		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828205	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1nc2ccc(OC(F)(F)F)cc2s1		CHEMBL744		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828206	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Nc1nc2ccc(OC(F)(F)F)cc2s1		CHEMBL744		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828313	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=C(C)[C@H]1Cc2c(ccc3c2O[C@@H]2COc4cc(OC)c(OC)cc4[C@@H]2C3=O)O1		CHEMBL429023		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828314	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	C=C(C)[C@H]1Cc2c(ccc3c2O[C@@H]2COc4cc(OC)c(OC)cc4[C@@H]2C3=O)O1		CHEMBL429023		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828429	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C)NCC(O)c1ccc(O)c(CO)c1		CHEMBL714		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828430	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CC(C)(C)NCC(O)c1ccc(O)c(CO)c1		CHEMBL714		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828544	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ncc([N+](=O)[O-])n1CC(C)O		CHEMBL498847		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828545	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	Cc1ncc([N+](=O)[O-])n1CC(C)O		CHEMBL498847		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828641	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O		CHEMBL221886		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828642	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O		CHEMBL221886		Ki			CHEMBL299	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828779	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1		CHEMBL70586		IC50			CHEMBL299	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828780	CHEMBL1909198	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	B	CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1		CHEMBL70586		Ki			CHEMBL299	Homo sapiens	Ki		
	7922722	CHEMBL1919217	Inhibition of human recombinant PRKCA at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	1.0	CHEMBL299	Homo sapiens	INH	%	1.0
	7931128	CHEMBL1919465	Inhibition of PRKCA relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	Inhibition	%	-6.0	CHEMBL299	Homo sapiens	INH	%	-6.0
	7939952	CHEMBL1919621	Inhibition of human PKCalpha	B	[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)ccnc2c1-c1c(Cl)cccc1Cl		CHEMBL1916359	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	7961111	CHEMBL1931537	Inhibition of PKCalpha	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL299	Homo sapiens	IC50	uM	30.0
	7961112	CHEMBL1931537	Inhibition of PKCalpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL299	Homo sapiens	IC50	uM	30.0
	7969783	CHEMBL1929884	Inhibition of PKCalpha assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	112.0	CHEMBL299	Homo sapiens	Activity	%	112.0
Active	7996844	CHEMBL1941735	Inhibition of PKCalpha at 10 uM by colorimetric analysis	B	Clc1ccc(-n2cc(-c3ccncc3)nn2)cc1		CHEMBL1938953		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Active	7996845	CHEMBL1941735	Inhibition of PKCalpha at 10 uM by colorimetric analysis	B	Clc1cccc(-n2cc(-c3ccncc3)nn2)c1		CHEMBL1938954		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Active	7996846	CHEMBL1941735	Inhibition of PKCalpha at 10 uM by colorimetric analysis	B	Clc1ccc(-n2nncc2-c2ccncc2)cc1		CHEMBL62965		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Active	7996847	CHEMBL1941735	Inhibition of PKCalpha at 10 uM by colorimetric analysis	B	Clc1cccc(-n2nncc2-c2ccncc2)c1		CHEMBL303351		Inhibition	%		CHEMBL299	Homo sapiens	INH		
	8004483	CHEMBL1943915	Inhibition of PKCalpha at 1 uM	B	O=c1c2ccccc2[se]n1-c1ccccc1		CHEMBL51085	=	Inhibition	%	25.0	CHEMBL299	Homo sapiens	INH	%	25.0
	8004527	CHEMBL1943915	Inhibition of PKCalpha at 1 uM	B	CC(=O)OC[C@H]1O[C@@H](O[C@H]2[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](n3[se]c4ccccc4c3=O)O[C@@H]2COC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H]1OC(C)=O		CHEMBL1940993	=	Inhibition	%	95.0	CHEMBL299	Homo sapiens	INH	%	95.0
	8004559	CHEMBL1944086	Inhibition of PKCalpha	B	CC(=O)OC[C@H]1O[C@@H](O[C@H]2[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](n3[se]c4ccccc4c3=O)O[C@@H]2COC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H]1OC(C)=O		CHEMBL1940993	=	IC50	nM	220.0	CHEMBL299	Homo sapiens	IC50	uM	0.22
	8005191	CHEMBL1943915	Inhibition of PKCalpha at 1 uM	B	CC(=O)OC[C@H]1O[C@@H](NC(=O)CCCn2[se]c3ccccc3c2=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O		CHEMBL1940997	=	Inhibition	%	77.0	CHEMBL299	Homo sapiens	INH	%	77.0
	8005223	CHEMBL1944086	Inhibition of PKCalpha	B	CC(=O)OC[C@H]1O[C@@H](NC(=O)CCCn2[se]c3ccccc3c2=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O		CHEMBL1940997	=	IC50	nM	740.0	CHEMBL299	Homo sapiens	IC50	uM	0.74
	8005234	CHEMBL1943915	Inhibition of PKCalpha at 1 uM	B	O=C(CCCn1[se]c2ccccc2c1=O)N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O		CHEMBL1940999	=	Inhibition	%	74.0	CHEMBL299	Homo sapiens	INH	%	74.0
	8005266	CHEMBL1944086	Inhibition of PKCalpha	B	O=C(CCCn1[se]c2ccccc2c1=O)N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O		CHEMBL1940999	=	IC50	nM	730.0	CHEMBL299	Homo sapiens	IC50	uM	0.73
	8013072	CHEMBL1947859	Inhibition of PKCalpha using ATP as substrate	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	=	IC50	nM	2200.0	CHEMBL299	Homo sapiens	IC50	uM	2.2
	8018876	CHEMBL1948964	Inhibition of PKC-alpha assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CC1CCOCC1		CHEMBL1945953	=	Activity	%	86.0	CHEMBL299	Homo sapiens	Activity	%	86.0
	8018877	CHEMBL1948964	Inhibition of PKC-alpha assessed as activity remaining at 10 uM	B	CC(C)(O)c1ccc(-c2cnc3[nH]c(=O)n(CC4CCCCC4)c3n2)cc1		CHEMBL1945950	=	Activity	%	83.0	CHEMBL299	Homo sapiens	Activity	%	83.0
	8018878	CHEMBL1948964	Inhibition of PKC-alpha assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1		CHEMBL1946262	=	Activity	%	82.0	CHEMBL299	Homo sapiens	Activity	%	82.0
	8039810	CHEMBL1952846	Inhibition of PKCalpha by IMAP assay	B	COc1ccc(N2Cc3cnc(Nc4ccccc4)nc3N([C@@H]3CC[C@@H](O)C3)C2=O)cc1	Outside typical range	CHEMBL1952210	>	IC50	nM	125000.0	CHEMBL299	Homo sapiens	IC50	nM	125000.0
	8042797	CHEMBL1952647	Activity at human PKCalpha at 10 uM	B	CCS(=O)(=O)n1c2c(c3cc(C(=O)N4CCC(C)CC4)ccc31)CN(C1CCOCC1)CC2		CHEMBL1950351	<	Activity	%	50.0	CHEMBL299	Homo sapiens	Activity	%	50.0
	8045865	CHEMBL1959344	Inhibition of human PKCa catalytic domain after by scintillation counting	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	IC50	nM	13000.0	CHEMBL299	Homo sapiens	IC50	uM	13.0
	8047159	CHEMBL1959384	Inhibition of PKC-alpha at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
	8061230	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	0.75	CHEMBL299	Homo sapiens	Inhibition	%	0.75
	8061407	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	3.5	CHEMBL299	Homo sapiens	Inhibition	%	3.5
	8061631	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	0.22	CHEMBL299	Homo sapiens	Inhibition	%	0.22
	8061738	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	65.21	CHEMBL299	Homo sapiens	Inhibition	%	65.21
	8061929	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	1.0	CHEMBL299	Homo sapiens	Inhibition	%	1.0
	8062153	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	1.29	CHEMBL299	Homo sapiens	Inhibition	%	1.29
	8062269	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	0.48	CHEMBL299	Homo sapiens	Inhibition	%	0.48
	8062655	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	0.43	CHEMBL299	Homo sapiens	Inhibition	%	0.43
	8062977	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.33	CHEMBL299	Homo sapiens	Inhibition	%	0.33
	8063109	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	2.46	CHEMBL299	Homo sapiens	Inhibition	%	2.46
	8063500	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	-0.2	CHEMBL299	Homo sapiens	Inhibition	%	-0.2
	8063608	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.23	CHEMBL299	Homo sapiens	Inhibition	%	1.23
	8063832	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	3.42	CHEMBL299	Homo sapiens	Inhibition	%	3.42
	8064014	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	0.53	CHEMBL299	Homo sapiens	Inhibition	%	0.53
	8064129	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.7	CHEMBL299	Homo sapiens	Inhibition	%	2.7
	8064353	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	0.56	CHEMBL299	Homo sapiens	Inhibition	%	0.56
	8064563	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.13	CHEMBL299	Homo sapiens	Inhibition	%	1.13
	8064701	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	1.08	CHEMBL299	Homo sapiens	Inhibition	%	1.08
	8064925	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	4.51	CHEMBL299	Homo sapiens	Inhibition	%	4.51
	8065091	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	-0.95	CHEMBL299	Homo sapiens	Inhibition	%	-0.95
	8065431	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.04	CHEMBL299	Homo sapiens	Inhibition	%	1.04
	8065606	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.32	CHEMBL299	Homo sapiens	Inhibition	%	1.32
	8065945	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	7.8	CHEMBL299	Homo sapiens	Inhibition	%	7.8
	8066155	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.25	CHEMBL299	Homo sapiens	Inhibition	%	1.25
	8066515	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	12.42	CHEMBL299	Homo sapiens	Inhibition	%	12.42
	8066681	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	-0.98	CHEMBL299	Homo sapiens	Inhibition	%	-0.98
	8067029	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.61	CHEMBL299	Homo sapiens	Inhibition	%	1.61
	8067204	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.42	CHEMBL299	Homo sapiens	Inhibition	%	0.42
	8067549	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.75	CHEMBL299	Homo sapiens	Inhibition	%	0.75
	8067759	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.71	CHEMBL299	Homo sapiens	Inhibition	%	2.71
	8068118	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	63.99	CHEMBL299	Homo sapiens	Inhibition	%	63.99
	8068282	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	-0.44	CHEMBL299	Homo sapiens	Inhibition	%	-0.44
	8068506	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	0.37	CHEMBL299	Homo sapiens	Inhibition	%	0.37
	8068631	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.43	CHEMBL299	Homo sapiens	Inhibition	%	0.43
	8068805	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	-0.51	CHEMBL299	Homo sapiens	Inhibition	%	-0.51
	8069029	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.25	CHEMBL299	Homo sapiens	Inhibition	%	0.25
	8069154	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	3.12	CHEMBL299	Homo sapiens	Inhibition	%	3.12
	8069449	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	26.39	CHEMBL299	Homo sapiens	Inhibition	%	26.39
	8069834	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	0.07	CHEMBL299	Homo sapiens	Inhibition	%	0.07
	8069960	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-0.26	CHEMBL299	Homo sapiens	Inhibition	%	-0.26
	8070356	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.94	CHEMBL299	Homo sapiens	Inhibition	%	0.94
	8070481	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.02	CHEMBL299	Homo sapiens	Inhibition	%	0.02
	8070705	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.23	CHEMBL299	Homo sapiens	Inhibition	%	1.23
	8070779	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	77.34	CHEMBL299	Homo sapiens	Inhibition	%	77.34
	8071160	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	-0.61	CHEMBL299	Homo sapiens	Inhibition	%	-0.61
	8071286	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.19	CHEMBL299	Homo sapiens	Inhibition	%	0.19
	8071510	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-0.46	CHEMBL299	Homo sapiens	Inhibition	%	-0.46
	8071683	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	0.29	CHEMBL299	Homo sapiens	Inhibition	%	0.29
	8072032	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-0.14	CHEMBL299	Homo sapiens	Inhibition	%	-0.14
	8072113	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.13	CHEMBL299	Homo sapiens	Inhibition	%	0.13
	8072122	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.42	CHEMBL299	Homo sapiens	Inhibition	%	0.42
	8072346	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.96	CHEMBL299	Homo sapiens	Inhibition	%	0.96
	8072503	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	-0.02	CHEMBL299	Homo sapiens	Inhibition	%	-0.02
	8072852	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.03	CHEMBL299	Homo sapiens	Inhibition	%	-0.03
	8073019	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	0.28	CHEMBL299	Homo sapiens	Inhibition	%	0.28
	8073368	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	9.89	CHEMBL299	Homo sapiens	Inhibition	%	9.89
	8073711	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-0.36	CHEMBL299	Homo sapiens	Inhibition	%	-0.36
	8073944	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	2.29	CHEMBL299	Homo sapiens	Inhibition	%	2.29
	8074096	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	0.51	CHEMBL299	Homo sapiens	Inhibition	%	0.51
	8074450	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.21	CHEMBL299	Homo sapiens	Inhibition	%	0.21
	8074607	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.35	CHEMBL299	Homo sapiens	Inhibition	%	0.35
	8074831	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.51	CHEMBL299	Homo sapiens	Inhibition	%	1.51
	8074958	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-0.39	CHEMBL299	Homo sapiens	Inhibition	%	-0.39
	8075293	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.44	CHEMBL299	Homo sapiens	Inhibition	%	1.44
	8075530	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	6.77	CHEMBL299	Homo sapiens	Inhibition	%	6.77
	8075671	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	0.36	CHEMBL299	Homo sapiens	Inhibition	%	0.36
	8075895	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	0.21	CHEMBL299	Homo sapiens	Inhibition	%	0.21
	8076037	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.07	CHEMBL299	Homo sapiens	Inhibition	%	0.07
	8076409	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	0.95	CHEMBL299	Homo sapiens	Inhibition	%	0.95
	8076543	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	1.71	CHEMBL299	Homo sapiens	Inhibition	%	1.71
	8076869	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.07	CHEMBL299	Homo sapiens	Inhibition	%	1.07
	8077116	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	15.82	CHEMBL299	Homo sapiens	Inhibition	%	15.82
	8077468	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	0.5	CHEMBL299	Homo sapiens	Inhibition	%	0.5
	8077619	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.04	CHEMBL299	Homo sapiens	Inhibition	%	0.04
	8077986	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.14	CHEMBL299	Homo sapiens	Inhibition	%	1.14
	8078125	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-0.97	CHEMBL299	Homo sapiens	Inhibition	%	-0.97
	8078349	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	0.4	CHEMBL299	Homo sapiens	Inhibition	%	0.4
	8078451	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.13	CHEMBL299	Homo sapiens	Inhibition	%	1.13
	8078701	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	69.69	CHEMBL299	Homo sapiens	Inhibition	%	69.69
	8079041	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	0.89	CHEMBL299	Homo sapiens	Inhibition	%	0.89
	8079199	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.25	CHEMBL299	Homo sapiens	Inhibition	%	-0.25
	8079423	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	3.02	CHEMBL299	Homo sapiens	Inhibition	%	3.02
	8079565	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.47	CHEMBL299	Homo sapiens	Inhibition	%	0.47
	8079928	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	0.66	CHEMBL299	Homo sapiens	Inhibition	%	0.66
	8080033	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	2.47	CHEMBL299	Homo sapiens	Inhibition	%	2.47
	8080257	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	3.2	CHEMBL299	Homo sapiens	Inhibition	%	3.2
	8080285	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	1.15	CHEMBL299	Homo sapiens	Inhibition	%	1.15
	8080509	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	7.21	CHEMBL299	Homo sapiens	Inhibition	%	7.21
	8080624	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	-0.06	CHEMBL299	Homo sapiens	Inhibition	%	-0.06
	8081012	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.33	CHEMBL299	Homo sapiens	Inhibition	%	1.33
	8081147	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.52	CHEMBL299	Homo sapiens	Inhibition	%	1.52
	8081515	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	16.63	CHEMBL299	Homo sapiens	Inhibition	%	16.63
	8081842	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	6.33	CHEMBL299	Homo sapiens	Inhibition	%	6.33
	8082094	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	2.45	CHEMBL299	Homo sapiens	Inhibition	%	2.45
	8082207	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.22	CHEMBL299	Homo sapiens	Inhibition	%	1.22
	8082431	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.23	CHEMBL299	Homo sapiens	Inhibition	%	1.23
	8082604	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	21.71	CHEMBL299	Homo sapiens	Inhibition	%	21.71
	8082727	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.19	CHEMBL299	Homo sapiens	Inhibition	%	0.19
	8082951	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	-0.23	CHEMBL299	Homo sapiens	Inhibition	%	-0.23
	8083107	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	0.48	CHEMBL299	Homo sapiens	Inhibition	%	0.48
	8083430	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.79	CHEMBL299	Homo sapiens	Inhibition	%	0.79
	8083684	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	38.38	CHEMBL299	Homo sapiens	Inhibition	%	38.38
	8084018	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	10.64	CHEMBL299	Homo sapiens	Inhibition	%	10.64
	8084203	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	0.41	CHEMBL299	Homo sapiens	Inhibition	%	0.41
	8084545	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	-0.01	CHEMBL299	Homo sapiens	Inhibition	%	-0.01
	8084706	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	3.66	CHEMBL299	Homo sapiens	Inhibition	%	3.66
	8085028	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.61	CHEMBL299	Homo sapiens	Inhibition	%	1.61
	8085284	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-0.63	CHEMBL299	Homo sapiens	Inhibition	%	-0.63
	8085616	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	19.36	CHEMBL299	Homo sapiens	Inhibition	%	19.36
	8085805	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	3.78	CHEMBL299	Homo sapiens	Inhibition	%	3.78
	8086144	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.82	CHEMBL299	Homo sapiens	Inhibition	%	0.82
	8086306	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	-2.91	CHEMBL299	Homo sapiens	Inhibition	%	-2.91
	8086530	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	7.49	CHEMBL299	Homo sapiens	Inhibition	%	7.49
	8086629	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.39	CHEMBL299	Homo sapiens	Inhibition	%	0.39
	8086853	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.41	CHEMBL299	Homo sapiens	Inhibition	%	0.41
	8087064	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	-2.28	CHEMBL299	Homo sapiens	Inhibition	%	-2.28
	8087222	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	-0.25	CHEMBL299	Homo sapiens	Inhibition	%	-0.25
	8087560	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	0.95	CHEMBL299	Homo sapiens	Inhibition	%	0.95
	8087698	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.87	CHEMBL299	Homo sapiens	Inhibition	%	1.87
	8087922	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-3.5	CHEMBL299	Homo sapiens	Inhibition	%	-3.5
	8088064	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	1.73	CHEMBL299	Homo sapiens	Inhibition	%	1.73
	8088436	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.59	CHEMBL299	Homo sapiens	Inhibition	%	1.59
	8088564	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	1.75	CHEMBL299	Homo sapiens	Inhibition	%	1.75
	8088881	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	5.52	CHEMBL299	Homo sapiens	Inhibition	%	5.52
	8089233	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	11.2	CHEMBL299	Homo sapiens	Inhibition	%	11.2
	8089381	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	0.96	CHEMBL299	Homo sapiens	Inhibition	%	0.96
	8089725	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.48	CHEMBL299	Homo sapiens	Inhibition	%	0.48
	8089905	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	1.25	CHEMBL299	Homo sapiens	Inhibition	%	1.25
	8090129	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.15	CHEMBL299	Homo sapiens	Inhibition	%	0.15
	8090294	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.01	CHEMBL299	Homo sapiens	Inhibition	%	1.01
	8090461	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	-0.23	CHEMBL299	Homo sapiens	Inhibition	%	-0.23
	8090824	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	0.02	CHEMBL299	Homo sapiens	Inhibition	%	0.02
	8091029	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	0.5	CHEMBL299	Homo sapiens	Inhibition	%	0.5
	8091390	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	0.33	CHEMBL299	Homo sapiens	Inhibition	%	0.33
	8091545	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.8	CHEMBL299	Homo sapiens	Inhibition	%	0.8
	8091769	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	0.53	CHEMBL299	Homo sapiens	Inhibition	%	0.53
	8091885	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	1.01	CHEMBL299	Homo sapiens	Inhibition	%	1.01
	8092246	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-0.8	CHEMBL299	Homo sapiens	Inhibition	%	-0.8
	8092397	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	0.73	CHEMBL299	Homo sapiens	Inhibition	%	0.73
	8092769	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-0.17	CHEMBL299	Homo sapiens	Inhibition	%	-0.17
	8092898	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	3.87	CHEMBL299	Homo sapiens	Inhibition	%	3.87
	8093122	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-2.81	CHEMBL299	Homo sapiens	Inhibition	%	-2.81
	8093210	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.43	CHEMBL299	Homo sapiens	Inhibition	%	0.43
	8093574	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-2.77	CHEMBL299	Homo sapiens	Inhibition	%	-2.77
	8093713	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	1.29	CHEMBL299	Homo sapiens	Inhibition	%	1.29
	8093937	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-3.01	CHEMBL299	Homo sapiens	Inhibition	%	-3.01
	8094057	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.87	CHEMBL299	Homo sapiens	Inhibition	%	1.87
	8094461	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.97	CHEMBL299	Homo sapiens	Inhibition	%	0.97
	8094636	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	0.54	CHEMBL299	Homo sapiens	Inhibition	%	0.54
	8094792	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	0.9	CHEMBL299	Homo sapiens	Inhibition	%	0.9
	8095016	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	0.46	CHEMBL299	Homo sapiens	Inhibition	%	0.46
	8095156	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	0.85	CHEMBL299	Homo sapiens	Inhibition	%	0.85
	8095359	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	1.49	CHEMBL299	Homo sapiens	Inhibition	%	1.49
	8095583	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.15	CHEMBL299	Homo sapiens	Inhibition	%	0.15
	8095724	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	6.13	CHEMBL299	Homo sapiens	Inhibition	%	6.13
	8096096	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	0.88	CHEMBL299	Homo sapiens	Inhibition	%	0.88
	8096213	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	0.04	CHEMBL299	Homo sapiens	Inhibition	%	0.04
	8096437	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	3.09	CHEMBL299	Homo sapiens	Inhibition	%	3.09
	8096576	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.05	CHEMBL299	Homo sapiens	Inhibition	%	0.05
	8096732	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	1.44	CHEMBL299	Homo sapiens	Inhibition	%	1.44
	8096956	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	1.07	CHEMBL299	Homo sapiens	Inhibition	%	1.07
	8097103	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.09	CHEMBL299	Homo sapiens	Inhibition	%	0.09
	8097410	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	2.81	CHEMBL299	Homo sapiens	Inhibition	%	2.81
	8097634	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	0.02	CHEMBL299	Homo sapiens	Inhibition	%	0.02
	8097784	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	8.94	CHEMBL299	Homo sapiens	Inhibition	%	8.94
	8098141	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-3.65	CHEMBL299	Homo sapiens	Inhibition	%	-3.65
	8098261	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.54	CHEMBL299	Homo sapiens	Inhibition	%	-0.54
	8098485	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	Inhibition	%	0.0
	8098665	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-0.04	CHEMBL299	Homo sapiens	Inhibition	%	-0.04
	8098850	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	6.72	CHEMBL299	Homo sapiens	Inhibition	%	6.72
	8099218	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.78	CHEMBL299	Homo sapiens	Inhibition	%	1.78
	8099360	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	-0.12	CHEMBL299	Homo sapiens	Inhibition	%	-0.12
	8099584	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	0.82	CHEMBL299	Homo sapiens	Inhibition	%	0.82
	8099778	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.24	CHEMBL299	Homo sapiens	Inhibition	%	1.24
	8099925	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	0.52	CHEMBL299	Homo sapiens	Inhibition	%	0.52
	8100295	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-4.06	CHEMBL299	Homo sapiens	Inhibition	%	-4.06
	8100635	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	0.69	CHEMBL299	Homo sapiens	Inhibition	%	0.69
	8100775	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.88	CHEMBL299	Homo sapiens	Inhibition	%	0.88
	8101159	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	1.9	CHEMBL299	Homo sapiens	Inhibition	%	1.9
	8101301	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-0.31	CHEMBL299	Homo sapiens	Inhibition	%	-0.31
	8101710	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-1.38	CHEMBL299	Homo sapiens	Inhibition	%	-1.38
	8101963	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	4.24	CHEMBL299	Homo sapiens	Inhibition	%	4.24
	8102118	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-0.39	CHEMBL299	Homo sapiens	Inhibition	%	-0.39
	8102473	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	0.46	CHEMBL299	Homo sapiens	Inhibition	%	0.46
	8102817	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.25	CHEMBL299	Homo sapiens	Inhibition	%	1.25
	8102995	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.05	CHEMBL299	Homo sapiens	Inhibition	%	0.05
	8103191	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	3.82	CHEMBL299	Homo sapiens	Inhibition	%	3.82
	8103415	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	32.29	CHEMBL299	Homo sapiens	Inhibition	%	32.29
	8103553	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.15	CHEMBL299	Homo sapiens	Inhibition	%	0.15
	8103927	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	0.09	CHEMBL299	Homo sapiens	Inhibition	%	0.09
	8104112	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.15	CHEMBL299	Homo sapiens	Inhibition	%	0.15
	8104260	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	1.66	CHEMBL299	Homo sapiens	Inhibition	%	1.66
	8104484	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	1.11	CHEMBL299	Homo sapiens	Inhibition	%	1.11
	8104630	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-1.84	CHEMBL299	Homo sapiens	Inhibition	%	-1.84
	8104968	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	2.61	CHEMBL299	Homo sapiens	Inhibition	%	2.61
	8105108	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.46	CHEMBL299	Homo sapiens	Inhibition	%	0.46
	8105332	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	2.11	CHEMBL299	Homo sapiens	Inhibition	%	2.11
	8105498	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-3.4	CHEMBL299	Homo sapiens	Inhibition	%	-3.4
	8105636	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	1.1	CHEMBL299	Homo sapiens	Inhibition	%	1.1
	8105860	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	1.19	CHEMBL299	Homo sapiens	Inhibition	%	1.19
	8105916	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	0.9	CHEMBL299	Homo sapiens	Inhibition	%	0.9
	8106140	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.2	CHEMBL299	Homo sapiens	Inhibition	%	2.2
	8106305	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-2.9	CHEMBL299	Homo sapiens	Inhibition	%	-2.9
	8106461	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	14.57	CHEMBL299	Homo sapiens	Inhibition	%	14.57
	8106685	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	1.06	CHEMBL299	Homo sapiens	Inhibition	%	1.06
	8106814	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	1.64	CHEMBL299	Homo sapiens	Inhibition	%	1.64
	8107159	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	2.76	CHEMBL299	Homo sapiens	Inhibition	%	2.76
	8107331	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.19	CHEMBL299	Homo sapiens	Inhibition	%	0.19
	8107756	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	0.24	CHEMBL299	Homo sapiens	Inhibition	%	0.24
	8107891	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	4.54	CHEMBL299	Homo sapiens	Inhibition	%	4.54
	8108273	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	0.93	CHEMBL299	Homo sapiens	Inhibition	%	0.93
	8108448	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-0.86	CHEMBL299	Homo sapiens	Inhibition	%	-0.86
	8108819	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	5.2	CHEMBL299	Homo sapiens	Inhibition	%	5.2
	8108961	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.23	CHEMBL299	Homo sapiens	Inhibition	%	0.23
	8109299	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	0.78	CHEMBL299	Homo sapiens	Inhibition	%	0.78
	8109653	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.77	CHEMBL299	Homo sapiens	Inhibition	%	-0.77
	8109824	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	0.64	CHEMBL299	Homo sapiens	Inhibition	%	0.64
	8110180	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	1.72	CHEMBL299	Homo sapiens	Inhibition	%	1.72
	8110459	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	0.96	CHEMBL299	Homo sapiens	Inhibition	%	0.96
	8110625	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-2.14	CHEMBL299	Homo sapiens	Inhibition	%	-2.14
	8111007	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	4.21	CHEMBL299	Homo sapiens	Inhibition	%	4.21
	8111130	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.7	CHEMBL299	Homo sapiens	Inhibition	%	0.7
	8111354	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.72	CHEMBL299	Homo sapiens	Inhibition	%	0.72
	8111481	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	2.42	CHEMBL299	Homo sapiens	Inhibition	%	2.42
	8111647	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.07	CHEMBL299	Homo sapiens	Inhibition	%	1.07
	8111871	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-0.39	CHEMBL299	Homo sapiens	Inhibition	%	-0.39
	8112076	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	3.41	CHEMBL299	Homo sapiens	Inhibition	%	3.41
	8112213	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.84	CHEMBL299	Homo sapiens	Inhibition	%	-0.84
	8112437	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-1.11	CHEMBL299	Homo sapiens	Inhibition	%	-1.11
	8112605	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	-0.67	CHEMBL299	Homo sapiens	Inhibition	%	-0.67
	8112777	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.16	CHEMBL299	Homo sapiens	Inhibition	%	-0.16
	8113001	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.23	CHEMBL299	Homo sapiens	Inhibition	%	0.23
	8113153	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	0.49	CHEMBL299	Homo sapiens	Inhibition	%	0.49
	8113289	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.58	CHEMBL299	Homo sapiens	Inhibition	%	0.58
	8113513	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.09	CHEMBL299	Homo sapiens	Inhibition	%	0.09
	8113637	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	1.91	CHEMBL299	Homo sapiens	Inhibition	%	1.91
	8113977	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.05	CHEMBL299	Homo sapiens	Inhibition	%	-0.05
	8114153	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	1.05	CHEMBL299	Homo sapiens	Inhibition	%	1.05
	8114509	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	1.33	CHEMBL299	Homo sapiens	Inhibition	%	1.33
	8114785	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.17	CHEMBL299	Homo sapiens	Inhibition	%	2.17
	8114951	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	0.16	CHEMBL299	Homo sapiens	Inhibition	%	0.16
	8115175	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	0.52	CHEMBL299	Homo sapiens	Inhibition	%	0.52
	8115340	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	1.1	CHEMBL299	Homo sapiens	Inhibition	%	1.1
	8115684	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	0.29	CHEMBL299	Homo sapiens	Inhibition	%	0.29
	8115817	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	18.35	CHEMBL299	Homo sapiens	Inhibition	%	18.35
	8116200	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	0.27	CHEMBL299	Homo sapiens	Inhibition	%	0.27
	8116403	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	3.68	CHEMBL299	Homo sapiens	Inhibition	%	3.68
	8116761	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.57	CHEMBL299	Homo sapiens	Inhibition	%	-0.57
	8116933	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	2.74	CHEMBL299	Homo sapiens	Inhibition	%	2.74
	8117328	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.11	CHEMBL299	Homo sapiens	Inhibition	%	0.11
	8117486	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.55	CHEMBL299	Homo sapiens	Inhibition	%	3.55
	8117840	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-0.42	CHEMBL299	Homo sapiens	Inhibition	%	-0.42
	8117978	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-3.02	CHEMBL299	Homo sapiens	Inhibition	%	-3.02
	8118202	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-0.82	CHEMBL299	Homo sapiens	Inhibition	%	-0.82
	8118318	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	0.59	CHEMBL299	Homo sapiens	Inhibition	%	0.59
	8118490	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	2.11	CHEMBL299	Homo sapiens	Inhibition	%	2.11
	8118714	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	1.31	CHEMBL299	Homo sapiens	Inhibition	%	1.31
	8118850	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	1.21	CHEMBL299	Homo sapiens	Inhibition	%	1.21
	8119121	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.34	CHEMBL299	Homo sapiens	Inhibition	%	1.34
	8119504	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	0.49	CHEMBL299	Homo sapiens	Inhibition	%	0.49
	8119671	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	0.59	CHEMBL299	Homo sapiens	Inhibition	%	0.59
	8120014	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	0.92	CHEMBL299	Homo sapiens	Inhibition	%	0.92
	8120153	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.21	CHEMBL299	Homo sapiens	Inhibition	%	0.21
	8120377	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.55	CHEMBL299	Homo sapiens	Inhibition	%	1.55
	8120537	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.54	CHEMBL299	Homo sapiens	Inhibition	%	0.54
	8120738	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	30.38	CHEMBL299	Homo sapiens	Inhibition	%	30.38
	8121090	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.11	CHEMBL299	Homo sapiens	Inhibition	%	0.11
	8121262	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	0.96	CHEMBL299	Homo sapiens	Inhibition	%	0.96
	8121486	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	4.81	CHEMBL299	Homo sapiens	Inhibition	%	4.81
	8121653	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.43	CHEMBL299	Homo sapiens	Inhibition	%	0.43
	8121816	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	1.58	CHEMBL299	Homo sapiens	Inhibition	%	1.58
	8122161	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-0.04	CHEMBL299	Homo sapiens	Inhibition	%	-0.04
	8122523	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	1.26	CHEMBL299	Homo sapiens	Inhibition	%	1.26
	8122643	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	1.5	CHEMBL299	Homo sapiens	Inhibition	%	1.5
	8123034	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	4.73	CHEMBL299	Homo sapiens	Inhibition	%	4.73
	8123176	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	-3.16	CHEMBL299	Homo sapiens	Inhibition	%	-3.16
	8123400	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	-2.48	CHEMBL299	Homo sapiens	Inhibition	%	-2.48
	8123454	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	5.42	CHEMBL299	Homo sapiens	Inhibition	%	5.42
	8123678	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.01	CHEMBL299	Homo sapiens	Inhibition	%	0.01
	8123828	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	3.62	CHEMBL299	Homo sapiens	Inhibition	%	3.62
	8123995	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-2.58	CHEMBL299	Homo sapiens	Inhibition	%	-2.58
	8124219	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-3.28	CHEMBL299	Homo sapiens	Inhibition	%	-3.28
	8124338	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	6.2	CHEMBL299	Homo sapiens	Inhibition	%	6.2
	8124701	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	Inhibition	%	0.0
	8124866	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.04	CHEMBL299	Homo sapiens	Inhibition	%	-0.04
	8125067	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	0.98	CHEMBL299	Homo sapiens	Inhibition	%	0.98
	8125291	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	7.86	CHEMBL299	Homo sapiens	Inhibition	%	7.86
	8125421	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.19	CHEMBL299	Homo sapiens	Inhibition	%	-0.19
	8125813	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.22	CHEMBL299	Homo sapiens	Inhibition	%	1.22
	8125977	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.7	CHEMBL299	Homo sapiens	Inhibition	%	-0.7
	8126141	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	2.92	CHEMBL299	Homo sapiens	Inhibition	%	2.92
	8126365	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	0.47	CHEMBL299	Homo sapiens	Inhibition	%	0.47
	8126480	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-0.37	CHEMBL299	Homo sapiens	Inhibition	%	-0.37
	8126840	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	3.04	CHEMBL299	Homo sapiens	Inhibition	%	3.04
	8126962	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	1.36	CHEMBL299	Homo sapiens	Inhibition	%	1.36
	8127186	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	4.49	CHEMBL299	Homo sapiens	Inhibition	%	4.49
	8127353	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	1.28	CHEMBL299	Homo sapiens	Inhibition	%	1.28
	8127719	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	0.88	CHEMBL299	Homo sapiens	Inhibition	%	0.88
	8128007	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.77	CHEMBL299	Homo sapiens	Inhibition	%	0.77
	8128159	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	0.28	CHEMBL299	Homo sapiens	Inhibition	%	0.28
	8128550	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.42	CHEMBL299	Homo sapiens	Inhibition	%	0.42
	8128669	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	43.38	CHEMBL299	Homo sapiens	Inhibition	%	43.38
	8129030	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.77	CHEMBL299	Homo sapiens	Inhibition	%	1.77
	8129201	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.04	CHEMBL299	Homo sapiens	Inhibition	%	-0.04
	8129425	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	1.32	CHEMBL299	Homo sapiens	Inhibition	%	1.32
	8129614	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	-0.39	CHEMBL299	Homo sapiens	Inhibition	%	-0.39
	8129753	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	2.33	CHEMBL299	Homo sapiens	Inhibition	%	2.33
	8130138	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.56	CHEMBL299	Homo sapiens	Inhibition	%	2.56
	8130310	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.27	CHEMBL299	Homo sapiens	Inhibition	%	0.27
	8130694	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	17.76	CHEMBL299	Homo sapiens	Inhibition	%	17.76
	8130810	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	0.53	CHEMBL299	Homo sapiens	Inhibition	%	0.53
	8131034	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	2.33	CHEMBL299	Homo sapiens	Inhibition	%	2.33
	8131173	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	1.33	CHEMBL299	Homo sapiens	Inhibition	%	1.33
	8131517	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-3.28	CHEMBL299	Homo sapiens	Inhibition	%	-3.28
	8131684	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	3.32	CHEMBL299	Homo sapiens	Inhibition	%	3.32
	8132049	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	1.68	CHEMBL299	Homo sapiens	Inhibition	%	1.68
	8132335	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-3.0	CHEMBL299	Homo sapiens	Inhibition	%	-3.0
	8132482	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.71	CHEMBL299	Homo sapiens	Inhibition	%	1.71
	8132706	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	0.41	CHEMBL299	Homo sapiens	Inhibition	%	0.41
	8132874	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-0.07	CHEMBL299	Homo sapiens	Inhibition	%	-0.07
	8132995	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.92	CHEMBL299	Homo sapiens	Inhibition	%	0.92
	8133219	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	4.19	CHEMBL299	Homo sapiens	Inhibition	%	4.19
	8133357	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	0.66	CHEMBL299	Homo sapiens	Inhibition	%	0.66
	8133753	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.76	CHEMBL299	Homo sapiens	Inhibition	%	-0.76
	8133933	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	0.75	CHEMBL299	Homo sapiens	Inhibition	%	0.75
	8134081	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.88	CHEMBL299	Homo sapiens	Inhibition	%	-0.88
	8134305	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	3.0	CHEMBL299	Homo sapiens	Inhibition	%	3.0
	8134465	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-0.03	CHEMBL299	Homo sapiens	Inhibition	%	-0.03
	8134649	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-0.53	CHEMBL299	Homo sapiens	Inhibition	%	-0.53
	8134873	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	0.61	CHEMBL299	Homo sapiens	Inhibition	%	0.61
	8135033	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	0.99	CHEMBL299	Homo sapiens	Inhibition	%	0.99
	8135372	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	0.59	CHEMBL299	Homo sapiens	Inhibition	%	0.59
	8135513	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	1.42	CHEMBL299	Homo sapiens	Inhibition	%	1.42
	8135858	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-2.01	CHEMBL299	Homo sapiens	Inhibition	%	-2.01
	8136026	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	0.12	CHEMBL299	Homo sapiens	Inhibition	%	0.12
	8136250	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	0.85	CHEMBL299	Homo sapiens	Inhibition	%	0.85
	8136394	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	1.59	CHEMBL299	Homo sapiens	Inhibition	%	1.59
	8136684	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-2.59	CHEMBL299	Homo sapiens	Inhibition	%	-2.59
	8137043	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	1.24	CHEMBL299	Homo sapiens	Inhibition	%	1.24
	8137206	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	0.98	CHEMBL299	Homo sapiens	Inhibition	%	0.98
	8137550	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-2.57	CHEMBL299	Homo sapiens	Inhibition	%	-2.57
	8137698	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.58	CHEMBL299	Homo sapiens	Inhibition	%	1.58
	8138088	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	1.15	CHEMBL299	Homo sapiens	Inhibition	%	1.15
	8138267	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	-0.15	CHEMBL299	Homo sapiens	Inhibition	%	-0.15
	8138639	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-0.49	CHEMBL299	Homo sapiens	Inhibition	%	-0.49
	8138797	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.82	CHEMBL299	Homo sapiens	Inhibition	%	0.82
	8139206	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	0.27	CHEMBL299	Homo sapiens	Inhibition	%	0.27
	8139365	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	3.52	CHEMBL299	Homo sapiens	Inhibition	%	3.52
	8139703	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	0.28	CHEMBL299	Homo sapiens	Inhibition	%	0.28
	8139844	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	1.17	CHEMBL299	Homo sapiens	Inhibition	%	1.17
	8140068	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	1.29	CHEMBL299	Homo sapiens	Inhibition	%	1.29
	8140191	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	0.88	CHEMBL299	Homo sapiens	Inhibition	%	0.88
	8140574	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	0.46	CHEMBL299	Homo sapiens	Inhibition	%	0.46
	8140717	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.68	CHEMBL299	Homo sapiens	Inhibition	%	3.68
	8141019	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.7	CHEMBL299	Homo sapiens	Inhibition	%	0.7
	8141373	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-0.2	CHEMBL299	Homo sapiens	Inhibition	%	-0.2
	8141533	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	1.45	CHEMBL299	Homo sapiens	Inhibition	%	1.45
	8141876	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-1.89	CHEMBL299	Homo sapiens	Inhibition	%	-1.89
	8142037	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-1.17	CHEMBL299	Homo sapiens	Inhibition	%	-1.17
	8142261	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.51	CHEMBL299	Homo sapiens	Inhibition	%	0.51
	8142429	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	0.1	CHEMBL299	Homo sapiens	Inhibition	%	0.1
	8142605	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	-0.72	CHEMBL299	Homo sapiens	Inhibition	%	-0.72
	8142829	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	0.74	CHEMBL299	Homo sapiens	Inhibition	%	0.74
	8142978	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	0.46	CHEMBL299	Homo sapiens	Inhibition	%	0.46
	8143133	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.42	CHEMBL299	Homo sapiens	Inhibition	%	0.42
	8143357	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.03	CHEMBL299	Homo sapiens	Inhibition	%	1.03
	8143544	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	0.59	CHEMBL299	Homo sapiens	Inhibition	%	0.59
	8143703	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	1.57	CHEMBL299	Homo sapiens	Inhibition	%	1.57
	8143927	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	10.6	CHEMBL299	Homo sapiens	Inhibition	%	10.6
	8144041	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-3.83	CHEMBL299	Homo sapiens	Inhibition	%	-3.83
	8144404	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	0.9	CHEMBL299	Homo sapiens	Inhibition	%	0.9
	8144534	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.21	CHEMBL299	Homo sapiens	Inhibition	%	1.21
	8144758	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	1.16	CHEMBL299	Homo sapiens	Inhibition	%	1.16
	8144911	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.02	CHEMBL299	Homo sapiens	Inhibition	%	1.02
	8145048	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	1.39	CHEMBL299	Homo sapiens	Inhibition	%	1.39
	8145272	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	2.12	CHEMBL299	Homo sapiens	Inhibition	%	2.12
	8145361	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.9	CHEMBL299	Homo sapiens	Inhibition	%	1.9
	8145585	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	0.7	CHEMBL299	Homo sapiens	Inhibition	%	0.7
	8145709	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.41	CHEMBL299	Homo sapiens	Inhibition	%	0.41
	8145870	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	1.14	CHEMBL299	Homo sapiens	Inhibition	%	1.14
	8146094	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	2.02	CHEMBL299	Homo sapiens	Inhibition	%	2.02
	8146214	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.22	CHEMBL299	Homo sapiens	Inhibition	%	0.22
	8146598	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	1.91	CHEMBL299	Homo sapiens	Inhibition	%	1.91
	8146765	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	9.63	CHEMBL299	Homo sapiens	Inhibition	%	9.63
	8147158	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	11.16	CHEMBL299	Homo sapiens	Inhibition	%	11.16
	8147300	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	-0.27	CHEMBL299	Homo sapiens	Inhibition	%	-0.27
	8147677	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	0.27	CHEMBL299	Homo sapiens	Inhibition	%	0.27
	8147864	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	0.87	CHEMBL299	Homo sapiens	Inhibition	%	0.87
	8148246	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	1.37	CHEMBL299	Homo sapiens	Inhibition	%	1.37
	8148360	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-2.95	CHEMBL299	Homo sapiens	Inhibition	%	-2.95
	8148584	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	0.55	CHEMBL299	Homo sapiens	Inhibition	%	0.55
	8148723	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	4.89	CHEMBL299	Homo sapiens	Inhibition	%	4.89
	8149085	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	2.25	CHEMBL299	Homo sapiens	Inhibition	%	2.25
	8149244	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-3.93	CHEMBL299	Homo sapiens	Inhibition	%	-3.93
	8149602	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	15.5	CHEMBL299	Homo sapiens	Inhibition	%	15.5
	8149924	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	2.8	CHEMBL299	Homo sapiens	Inhibition	%	2.8
	8150049	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-3.29	CHEMBL299	Homo sapiens	Inhibition	%	-3.29
	8150433	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-0.17	CHEMBL299	Homo sapiens	Inhibition	%	-0.17
	8150553	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.15	CHEMBL299	Homo sapiens	Inhibition	%	0.15
	8150777	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.45	CHEMBL299	Homo sapiens	Inhibition	%	0.45
	8150942	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	10.19	CHEMBL299	Homo sapiens	Inhibition	%	10.19
	8151105	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-0.47	CHEMBL299	Homo sapiens	Inhibition	%	-0.47
	8151329	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	0.07	CHEMBL299	Homo sapiens	Inhibition	%	0.07
	8151506	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	0.35	CHEMBL299	Homo sapiens	Inhibition	%	0.35
	8151644	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	0.87	CHEMBL299	Homo sapiens	Inhibition	%	0.87
	8151868	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	0.95	CHEMBL299	Homo sapiens	Inhibition	%	0.95
	8152022	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.31	CHEMBL299	Homo sapiens	Inhibition	%	1.31
	8152210	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	2.31	CHEMBL299	Homo sapiens	Inhibition	%	2.31
	8152434	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	-3.64	CHEMBL299	Homo sapiens	Inhibition	%	-3.64
	8152592	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	2.47	CHEMBL299	Homo sapiens	Inhibition	%	2.47
	8152930	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	1.48	CHEMBL299	Homo sapiens	Inhibition	%	1.48
	8153069	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	0.64	CHEMBL299	Homo sapiens	Inhibition	%	0.64
	8153430	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	0.92	CHEMBL299	Homo sapiens	Inhibition	%	0.92
	8153587	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-3.34	CHEMBL299	Homo sapiens	Inhibition	%	-3.34
	8153811	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.46	CHEMBL299	Homo sapiens	Inhibition	%	0.46
	8153944	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	58.16	CHEMBL299	Homo sapiens	Inhibition	%	58.16
	8154265	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	0.44	CHEMBL299	Homo sapiens	Inhibition	%	0.44
	8154391	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-2.22	CHEMBL299	Homo sapiens	Inhibition	%	-2.22
	8154615	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.7	CHEMBL299	Homo sapiens	Inhibition	%	0.7
	8154774	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.64	CHEMBL299	Homo sapiens	Inhibition	%	0.64
	8155118	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.6	CHEMBL299	Homo sapiens	Inhibition	%	0.6
	8155294	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.05	CHEMBL299	Homo sapiens	Inhibition	%	0.05
	8155679	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	3.39	CHEMBL299	Homo sapiens	Inhibition	%	3.39
	8155857	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.73	CHEMBL299	Homo sapiens	Inhibition	%	1.73
	8156219	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	0.74	CHEMBL299	Homo sapiens	Inhibition	%	0.74
	8156431	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	0.9	CHEMBL299	Homo sapiens	Inhibition	%	0.9
	8156581	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	0.95	CHEMBL299	Homo sapiens	Inhibition	%	0.95
	8156805	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	-0.51	CHEMBL299	Homo sapiens	Inhibition	%	-0.51
	8156948	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	1.96	CHEMBL299	Homo sapiens	Inhibition	%	1.96
	8157292	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	7.98	CHEMBL299	Homo sapiens	Inhibition	%	7.98
	8157433	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	-0.1	CHEMBL299	Homo sapiens	Inhibition	%	-0.1
	8157657	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	1.99	CHEMBL299	Homo sapiens	Inhibition	%	1.99
	8157787	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	1.1	CHEMBL299	Homo sapiens	Inhibition	%	1.1
	8158172	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-2.39	CHEMBL299	Homo sapiens	Inhibition	%	-2.39
	8158422	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	5.69	CHEMBL299	Homo sapiens	Inhibition	%	5.69
	8158580	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	-0.77	CHEMBL299	Homo sapiens	Inhibition	%	-0.77
	8158973	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	1.99	CHEMBL299	Homo sapiens	Inhibition	%	1.99
	8159108	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	0.97	CHEMBL299	Homo sapiens	Inhibition	%	0.97
	8159452	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-2.65	CHEMBL299	Homo sapiens	Inhibition	%	-2.65
	8159807	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	2.24	CHEMBL299	Homo sapiens	Inhibition	%	2.24
	8159948	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.8	CHEMBL299	Homo sapiens	Inhibition	%	1.8
	8160309	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	5.72	CHEMBL299	Homo sapiens	Inhibition	%	5.72
	8160459	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	0.74	CHEMBL299	Homo sapiens	Inhibition	%	0.74
	8160753	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	0.92	CHEMBL299	Homo sapiens	Inhibition	%	0.92
	8161127	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	-0.33	CHEMBL299	Homo sapiens	Inhibition	%	-0.33
	8161270	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	2.47	CHEMBL299	Homo sapiens	Inhibition	%	2.47
	8161494	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	20.36	CHEMBL299	Homo sapiens	Inhibition	%	20.36
	8161619	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	0.83	CHEMBL299	Homo sapiens	Inhibition	%	0.83
	8161981	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	0.02	CHEMBL299	Homo sapiens	Inhibition	%	0.02
	8162111	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	9.05	CHEMBL299	Homo sapiens	Inhibition	%	9.05
	8162495	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-1.52	CHEMBL299	Homo sapiens	Inhibition	%	-1.52
	8162748	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	45.46	CHEMBL299	Homo sapiens	Inhibition	%	45.46
	8162896	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	1.14	CHEMBL299	Homo sapiens	Inhibition	%	1.14
	8163120	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	8.8	CHEMBL299	Homo sapiens	Inhibition	%	8.8
	8163289	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	0.26	CHEMBL299	Homo sapiens	Inhibition	%	0.26
	8163423	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	-4.52	CHEMBL299	Homo sapiens	Inhibition	%	-4.52
	8163647	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	1.0	CHEMBL299	Homo sapiens	Inhibition	%	1.0
	8163770	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-2.48	CHEMBL299	Homo sapiens	Inhibition	%	-2.48
	8164128	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	15.88	CHEMBL299	Homo sapiens	Inhibition	%	15.88
	8164268	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.96	CHEMBL299	Homo sapiens	Inhibition	%	0.96
	8164492	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	2.63	CHEMBL299	Homo sapiens	Inhibition	%	2.63
	8164647	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	26.17	CHEMBL299	Homo sapiens	Inhibition	%	26.17
	8164791	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	10.25	CHEMBL299	Homo sapiens	Inhibition	%	10.25
	8165015	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.17	CHEMBL299	Homo sapiens	Inhibition	%	1.17
	8165085	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	1.68	CHEMBL299	Homo sapiens	Inhibition	%	1.68
	8165309	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	10.7	CHEMBL299	Homo sapiens	Inhibition	%	10.7
	8165450	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	0.29	CHEMBL299	Homo sapiens	Inhibition	%	0.29
	8165817	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.06	CHEMBL299	Homo sapiens	Inhibition	%	0.06
	8165943	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	3.41	CHEMBL299	Homo sapiens	Inhibition	%	3.41
	8166305	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	1.69	CHEMBL299	Homo sapiens	Inhibition	%	1.69
	8166435	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	0.69	CHEMBL299	Homo sapiens	Inhibition	%	0.69
	8166659	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	3.01	CHEMBL299	Homo sapiens	Inhibition	%	3.01
	8166760	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	10.24	CHEMBL299	Homo sapiens	Inhibition	%	10.24
	8167072	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.09	CHEMBL299	Homo sapiens	Inhibition	%	3.09
	8167437	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	4.21	CHEMBL299	Homo sapiens	Inhibition	%	4.21
	8167601	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.22	CHEMBL299	Homo sapiens	Inhibition	%	1.22
	8167958	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	1.33	CHEMBL299	Homo sapiens	Inhibition	%	1.33
	8168082	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	0.69	CHEMBL299	Homo sapiens	Inhibition	%	0.69
	8168306	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	0.39	CHEMBL299	Homo sapiens	Inhibition	%	0.39
	8168447	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	1.39	CHEMBL299	Homo sapiens	Inhibition	%	1.39
	8168807	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-0.24	CHEMBL299	Homo sapiens	Inhibition	%	-0.24
	8168971	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	72.84	CHEMBL299	Homo sapiens	Inhibition	%	72.84
	8169337	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.78	CHEMBL299	Homo sapiens	Inhibition	%	1.78
	8169641	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	1.52	CHEMBL299	Homo sapiens	Inhibition	%	1.52
	8169775	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.25	CHEMBL299	Homo sapiens	Inhibition	%	3.25
	8170144	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.45	CHEMBL299	Homo sapiens	Inhibition	%	0.45
	8170269	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	0.55	CHEMBL299	Homo sapiens	Inhibition	%	0.55
	8170493	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	5.16	CHEMBL299	Homo sapiens	Inhibition	%	5.16
	8170633	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-1.9	CHEMBL299	Homo sapiens	Inhibition	%	-1.9
	8170992	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	0.38	CHEMBL299	Homo sapiens	Inhibition	%	0.38
	8171189	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	1.29	CHEMBL299	Homo sapiens	Inhibition	%	1.29
	8171406	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	34.09	CHEMBL299	Homo sapiens	Inhibition	%	34.09
	8171771	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	34.32	CHEMBL299	Homo sapiens	Inhibition	%	34.32
	8171924	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-3.02	CHEMBL299	Homo sapiens	Inhibition	%	-3.02
	8172148	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-2.41	CHEMBL299	Homo sapiens	Inhibition	%	-2.41
	8172280	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	0.57	CHEMBL299	Homo sapiens	Inhibition	%	0.57
	8172632	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.35	CHEMBL299	Homo sapiens	Inhibition	%	0.35
	8172774	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	11.0	CHEMBL299	Homo sapiens	Inhibition	%	11.0
	8173134	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	0.92	CHEMBL299	Homo sapiens	Inhibition	%	0.92
	8173299	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	2.71	CHEMBL299	Homo sapiens	Inhibition	%	2.71
	8173523	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	8.07	CHEMBL299	Homo sapiens	Inhibition	%	8.07
	8173664	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	1.72	CHEMBL299	Homo sapiens	Inhibition	%	1.72
	8173975	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	5.32	CHEMBL299	Homo sapiens	Inhibition	%	5.32
	8174107	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	0.98	CHEMBL299	Homo sapiens	Inhibition	%	0.98
	8174331	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	1.39	CHEMBL299	Homo sapiens	Inhibition	%	1.39
	8174479	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.02	CHEMBL299	Homo sapiens	Inhibition	%	1.02
	8174825	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	0.4	CHEMBL299	Homo sapiens	Inhibition	%	0.4
	8174968	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	13.38	CHEMBL299	Homo sapiens	Inhibition	%	13.38
	8175328	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	6.9	CHEMBL299	Homo sapiens	Inhibition	%	6.9
	8175584	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	1.82	CHEMBL299	Homo sapiens	Inhibition	%	1.82
	8175747	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	1.0	CHEMBL299	Homo sapiens	Inhibition	%	1.0
	8175971	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	6.39	CHEMBL299	Homo sapiens	Inhibition	%	6.39
	8176124	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	4.7	CHEMBL299	Homo sapiens	Inhibition	%	4.7
	8176497	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	0.48	CHEMBL299	Homo sapiens	Inhibition	%	0.48
	8176629	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	2.34	CHEMBL299	Homo sapiens	Inhibition	%	2.34
	8176983	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.47	CHEMBL299	Homo sapiens	Inhibition	%	0.47
	8177125	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	-2.41	CHEMBL299	Homo sapiens	Inhibition	%	-2.41
	8177349	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	-0.54	CHEMBL299	Homo sapiens	Inhibition	%	-0.54
	8177487	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	4.27	CHEMBL299	Homo sapiens	Inhibition	%	4.27
	8177875	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	1.13	CHEMBL299	Homo sapiens	Inhibition	%	1.13
	8178015	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.45	CHEMBL299	Homo sapiens	Inhibition	%	2.45
	8178327	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	0.57	CHEMBL299	Homo sapiens	Inhibition	%	0.57
	8178678	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	0.47	CHEMBL299	Homo sapiens	Inhibition	%	0.47
	8178827	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	0.96	CHEMBL299	Homo sapiens	Inhibition	%	0.96
	8179174	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.1	CHEMBL299	Homo sapiens	Inhibition	%	1.1
	8179318	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	0.49	CHEMBL299	Homo sapiens	Inhibition	%	0.49
	8179542	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	2.27	CHEMBL299	Homo sapiens	Inhibition	%	2.27
	8179679	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.08	CHEMBL299	Homo sapiens	Inhibition	%	0.08
	8179936	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	0.67	CHEMBL299	Homo sapiens	Inhibition	%	0.67
	8180314	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-3.29	CHEMBL299	Homo sapiens	Inhibition	%	-3.29
	8180470	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	41.02	CHEMBL299	Homo sapiens	Inhibition	%	41.02
	8180842	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.56	CHEMBL299	Homo sapiens	Inhibition	%	1.56
	8180975	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	1.78	CHEMBL299	Homo sapiens	Inhibition	%	1.78
	8181199	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	11.17	CHEMBL299	Homo sapiens	Inhibition	%	11.17
	8181330	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	0.02	CHEMBL299	Homo sapiens	Inhibition	%	0.02
	8181694	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	0.99	CHEMBL299	Homo sapiens	Inhibition	%	0.99
	8181833	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	28.68	CHEMBL299	Homo sapiens	Inhibition	%	28.68
	8182057	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	0.39	CHEMBL299	Homo sapiens	Inhibition	%	0.39
	8182220	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	2.9	CHEMBL299	Homo sapiens	Inhibition	%	2.9
	8182360	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.5	CHEMBL299	Homo sapiens	Inhibition	%	1.5
	8182584	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	2.09	CHEMBL299	Homo sapiens	Inhibition	%	2.09
	8182676	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	-0.37	CHEMBL299	Homo sapiens	Inhibition	%	-0.37
	8183022	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	1.43	CHEMBL299	Homo sapiens	Inhibition	%	1.43
	8183171	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	1.39	CHEMBL299	Homo sapiens	Inhibition	%	1.39
	8183395	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	5.21	CHEMBL299	Homo sapiens	Inhibition	%	5.21
	8183524	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	0.99	CHEMBL299	Homo sapiens	Inhibition	%	0.99
	8183890	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	0.69	CHEMBL299	Homo sapiens	Inhibition	%	0.69
	8184026	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.04	CHEMBL299	Homo sapiens	Inhibition	%	1.04
	8184250	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-3.07	CHEMBL299	Homo sapiens	Inhibition	%	-3.07
	8184292	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	1.72	CHEMBL299	Homo sapiens	Inhibition	%	1.72
	8184516	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	0.88	CHEMBL299	Homo sapiens	Inhibition	%	0.88
	8184663	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-1.9	CHEMBL299	Homo sapiens	Inhibition	%	-1.9
	8184820	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	1.5	CHEMBL299	Homo sapiens	Inhibition	%	1.5
	8185044	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	15.27	CHEMBL299	Homo sapiens	Inhibition	%	15.27
	8185193	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.2	CHEMBL299	Homo sapiens	Inhibition	%	0.2
	8185548	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	-2.51	CHEMBL299	Homo sapiens	Inhibition	%	-2.51
	8185679	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	0.38	CHEMBL299	Homo sapiens	Inhibition	%	0.38
	8185903	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	0.82	CHEMBL299	Homo sapiens	Inhibition	%	0.82
	8186042	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	1.87	CHEMBL299	Homo sapiens	Inhibition	%	1.87
	8186407	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	1.74	CHEMBL299	Homo sapiens	Inhibition	%	1.74
	8186571	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	1.46	CHEMBL299	Homo sapiens	Inhibition	%	1.46
	8186934	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	1.06	CHEMBL299	Homo sapiens	Inhibition	%	1.06
	8187032	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.24	CHEMBL299	Homo sapiens	Inhibition	%	1.24
	8187256	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.91	CHEMBL299	Homo sapiens	Inhibition	%	1.91
	8187380	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	1.34	CHEMBL299	Homo sapiens	Inhibition	%	1.34
	8187752	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.01	CHEMBL299	Homo sapiens	Inhibition	%	1.01
	8187881	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	1.28	CHEMBL299	Homo sapiens	Inhibition	%	1.28
	8188105	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	0.19	CHEMBL299	Homo sapiens	Inhibition	%	0.19
	8188248	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	1.45	CHEMBL299	Homo sapiens	Inhibition	%	1.45
	8188607	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-0.59	CHEMBL299	Homo sapiens	Inhibition	%	-0.59
	8188881	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.52	CHEMBL299	Homo sapiens	Inhibition	%	2.52
	8189029	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	0.6	CHEMBL299	Homo sapiens	Inhibition	%	0.6
	8189409	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	0.98	CHEMBL299	Homo sapiens	Inhibition	%	0.98
	8189558	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.17	CHEMBL299	Homo sapiens	Inhibition	%	1.17
	8189914	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	0.29	CHEMBL299	Homo sapiens	Inhibition	%	0.29
	8190270	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	1.73	CHEMBL299	Homo sapiens	Inhibition	%	1.73
	8190410	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	1.21	CHEMBL299	Homo sapiens	Inhibition	%	1.21
	8190771	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	1.14	CHEMBL299	Homo sapiens	Inhibition	%	1.14
	8190935	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	3.07	CHEMBL299	Homo sapiens	Inhibition	%	3.07
	8191297	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	1.51	CHEMBL299	Homo sapiens	Inhibition	%	1.51
	8191617	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.25	CHEMBL299	Homo sapiens	Inhibition	%	1.25
	8191739	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	12.7	CHEMBL299	Homo sapiens	Inhibition	%	12.7
	8191963	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	1.22	CHEMBL299	Homo sapiens	Inhibition	%	1.22
	8192112	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	3.13	CHEMBL299	Homo sapiens	Inhibition	%	3.13
	8192465	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	0.76	CHEMBL299	Homo sapiens	Inhibition	%	0.76
	8192609	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	0.63	CHEMBL299	Homo sapiens	Inhibition	%	0.63
	8192969	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.42	CHEMBL299	Homo sapiens	Inhibition	%	0.42
	8193241	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	0.16	CHEMBL299	Homo sapiens	Inhibition	%	0.16
	8193386	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	2.74	CHEMBL299	Homo sapiens	Inhibition	%	2.74
	8193610	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	Inhibition	%	0.0
	8193767	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	2.84	CHEMBL299	Homo sapiens	Inhibition	%	2.84
	8193916	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.23	CHEMBL299	Homo sapiens	Inhibition	%	-0.23
	8194140	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.84	CHEMBL299	Homo sapiens	Inhibition	%	0.84
	8194271	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	1.06	CHEMBL299	Homo sapiens	Inhibition	%	1.06
	8194626	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	0.86	CHEMBL299	Homo sapiens	Inhibition	%	0.86
	8194769	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	4.38	CHEMBL299	Homo sapiens	Inhibition	%	4.38
	8194993	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	1.27	CHEMBL299	Homo sapiens	Inhibition	%	1.27
	8195126	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	6.57	CHEMBL299	Homo sapiens	Inhibition	%	6.57
	8195290	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	1.38	CHEMBL299	Homo sapiens	Inhibition	%	1.38
	8195514	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	3.32	CHEMBL299	Homo sapiens	Inhibition	%	3.32
	8195653	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	1.27	CHEMBL299	Homo sapiens	Inhibition	%	1.27
	8195975	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.09	CHEMBL299	Homo sapiens	Inhibition	%	2.09
	8196316	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	4.52	CHEMBL299	Homo sapiens	Inhibition	%	4.52
	8196466	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	1.15	CHEMBL299	Homo sapiens	Inhibition	%	1.15
	8196818	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-2.88	CHEMBL299	Homo sapiens	Inhibition	%	-2.88
	8196959	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	1.68	CHEMBL299	Homo sapiens	Inhibition	%	1.68
	8197183	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	0.12	CHEMBL299	Homo sapiens	Inhibition	%	0.12
	8197320	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	5.31	CHEMBL299	Homo sapiens	Inhibition	%	5.31
	8197595	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.21	CHEMBL299	Homo sapiens	Inhibition	%	1.21
	8197959	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	1.42	CHEMBL299	Homo sapiens	Inhibition	%	1.42
	8198116	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-2.53	CHEMBL299	Homo sapiens	Inhibition	%	-2.53
	8198478	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	0.45	CHEMBL299	Homo sapiens	Inhibition	%	0.45
	8198608	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	3.24	CHEMBL299	Homo sapiens	Inhibition	%	3.24
	8198832	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	1.42	CHEMBL299	Homo sapiens	Inhibition	%	1.42
	8198963	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	1.6	CHEMBL299	Homo sapiens	Inhibition	%	1.6
	8199335	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	2.33	CHEMBL299	Homo sapiens	Inhibition	%	2.33
	8199469	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	1.03	CHEMBL299	Homo sapiens	Inhibition	%	1.03
	8199856	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	0.14	CHEMBL299	Homo sapiens	Inhibition	%	0.14
	8199994	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	2.06	CHEMBL299	Homo sapiens	Inhibition	%	2.06
	8200218	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	0.94	CHEMBL299	Homo sapiens	Inhibition	%	0.94
	8200322	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.23	CHEMBL299	Homo sapiens	Inhibition	%	1.23
	8200661	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	0.03	CHEMBL299	Homo sapiens	Inhibition	%	0.03
	8200811	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	11.3	CHEMBL299	Homo sapiens	Inhibition	%	11.3
	8201035	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	1.17	CHEMBL299	Homo sapiens	Inhibition	%	1.17
	8201165	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-2.59	CHEMBL299	Homo sapiens	Inhibition	%	-2.59
	8201524	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	1.77	CHEMBL299	Homo sapiens	Inhibition	%	1.77
	8201657	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.33	CHEMBL299	Homo sapiens	Inhibition	%	0.33
	8201936	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	1.25	CHEMBL299	Homo sapiens	Inhibition	%	1.25
	8202300	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-0.01	CHEMBL299	Homo sapiens	Inhibition	%	-0.01
	8202467	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-1.43	CHEMBL299	Homo sapiens	Inhibition	%	-1.43
	8202816	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	0.88	CHEMBL299	Homo sapiens	Inhibition	%	0.88
	8203170	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	8.34	CHEMBL299	Homo sapiens	Inhibition	%	8.34
	8203301	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	-2.47	CHEMBL299	Homo sapiens	Inhibition	%	-2.47
	8203671	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	0.87	CHEMBL299	Homo sapiens	Inhibition	%	0.87
	8203805	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	1.01	CHEMBL299	Homo sapiens	Inhibition	%	1.01
	8204029	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	0.46	CHEMBL299	Homo sapiens	Inhibition	%	0.46
	8204195	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	0.77	CHEMBL299	Homo sapiens	Inhibition	%	0.77
	8204556	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	1.06	CHEMBL299	Homo sapiens	Inhibition	%	1.06
	8204661	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	-0.09	CHEMBL299	Homo sapiens	Inhibition	%	-0.09
	8204885	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	1.13	CHEMBL299	Homo sapiens	Inhibition	%	1.13
	8205000	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	3.59	CHEMBL299	Homo sapiens	Inhibition	%	3.59
	8205373	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	6.27	CHEMBL299	Homo sapiens	Inhibition	%	6.27
	8205509	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	-0.03	CHEMBL299	Homo sapiens	Inhibition	%	-0.03
	8205872	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	0.78	CHEMBL299	Homo sapiens	Inhibition	%	0.78
	8206004	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	1.35	CHEMBL299	Homo sapiens	Inhibition	%	1.35
	8206228	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-0.16	CHEMBL299	Homo sapiens	Inhibition	%	-0.16
	8206280	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	1.29	CHEMBL299	Homo sapiens	Inhibition	%	1.29
	8206504	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-3.05	CHEMBL299	Homo sapiens	Inhibition	%	-3.05
	8206647	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	1.51	CHEMBL299	Homo sapiens	Inhibition	%	1.51
	8206827	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	0.8	CHEMBL299	Homo sapiens	Inhibition	%	0.8
	8207051	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.62	CHEMBL299	Homo sapiens	Inhibition	%	3.62
	8207177	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	1.05	CHEMBL299	Homo sapiens	Inhibition	%	1.05
	8207531	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	5.38	CHEMBL299	Homo sapiens	Inhibition	%	5.38
	8207663	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	-0.96	CHEMBL299	Homo sapiens	Inhibition	%	-0.96
	8207887	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	1.18	CHEMBL299	Homo sapiens	Inhibition	%	1.18
	8208032	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.26	CHEMBL299	Homo sapiens	Inhibition	%	2.26
	8208388	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	2.09	CHEMBL299	Homo sapiens	Inhibition	%	2.09
	8208554	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	1.26	CHEMBL299	Homo sapiens	Inhibition	%	1.26
	8208911	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.78	CHEMBL299	Homo sapiens	Inhibition	%	1.78
	8209240	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	1.66	CHEMBL299	Homo sapiens	Inhibition	%	1.66
	8209356	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.07	CHEMBL299	Homo sapiens	Inhibition	%	1.07
	8209580	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.65	CHEMBL299	Homo sapiens	Inhibition	%	1.65
	8209730	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	0.82	CHEMBL299	Homo sapiens	Inhibition	%	0.82
	8209866	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	1.03	CHEMBL299	Homo sapiens	Inhibition	%	1.03
	8210090	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	-0.04	CHEMBL299	Homo sapiens	Inhibition	%	-0.04
	8210231	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	1.96	CHEMBL299	Homo sapiens	Inhibition	%	1.96
	8210591	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	0.74	CHEMBL299	Homo sapiens	Inhibition	%	0.74
	8210850	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-1.62	CHEMBL299	Homo sapiens	Inhibition	%	-1.62
	8210994	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	0.62	CHEMBL299	Homo sapiens	Inhibition	%	0.62
	8211388	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	0.78	CHEMBL299	Homo sapiens	Inhibition	%	0.78
	8211511	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	1.4	CHEMBL299	Homo sapiens	Inhibition	%	1.4
	8211735	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-2.86	CHEMBL299	Homo sapiens	Inhibition	%	-2.86
	8211864	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	36.94	CHEMBL299	Homo sapiens	Inhibition	%	36.94
	8212220	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	1.96	CHEMBL299	Homo sapiens	Inhibition	%	1.96
	8212361	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	0.82	CHEMBL299	Homo sapiens	Inhibition	%	0.82
	8212585	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	2.18	CHEMBL299	Homo sapiens	Inhibition	%	2.18
	8212718	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	0.65	CHEMBL299	Homo sapiens	Inhibition	%	0.65
	8212888	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	1.61	CHEMBL299	Homo sapiens	Inhibition	%	1.61
	8213112	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.03	CHEMBL299	Homo sapiens	Inhibition	%	1.03
	8213241	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	15.68	CHEMBL299	Homo sapiens	Inhibition	%	15.68
	8213569	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.02	CHEMBL299	Homo sapiens	Inhibition	%	-0.02
	8213906	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	0.58	CHEMBL299	Homo sapiens	Inhibition	%	0.58
	8214053	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	0.13	CHEMBL299	Homo sapiens	Inhibition	%	0.13
	8214414	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	0.09	CHEMBL299	Homo sapiens	Inhibition	%	0.09
	8214548	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	-1.9	CHEMBL299	Homo sapiens	Inhibition	%	-1.9
	8214772	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	8.24	CHEMBL299	Homo sapiens	Inhibition	%	8.24
	8214924	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	2.22	CHEMBL299	Homo sapiens	Inhibition	%	2.22
	8215175	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	0.84	CHEMBL299	Homo sapiens	Inhibition	%	0.84
	8215328	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	1.49	CHEMBL299	Homo sapiens	Inhibition	%	1.49
	8215552	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	0.29	CHEMBL299	Homo sapiens	Inhibition	%	0.29
	8215716	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.63	CHEMBL299	Homo sapiens	Inhibition	%	2.63
	8216059	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-2.46	CHEMBL299	Homo sapiens	Inhibition	%	-2.46
	8216178	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	0.78	CHEMBL299	Homo sapiens	Inhibition	%	0.78
	8216402	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	1.26	CHEMBL299	Homo sapiens	Inhibition	%	1.26
	8216538	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	1.24	CHEMBL299	Homo sapiens	Inhibition	%	1.24
	8216900	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-0.98	CHEMBL299	Homo sapiens	Inhibition	%	-0.98
	8217034	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	1.45	CHEMBL299	Homo sapiens	Inhibition	%	1.45
	8217432	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.47	CHEMBL299	Homo sapiens	Inhibition	%	1.47
	8217563	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	1.33	CHEMBL299	Homo sapiens	Inhibition	%	1.33
	8217888	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.11	CHEMBL299	Homo sapiens	Inhibition	%	-0.11
	8218227	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	1.61	CHEMBL299	Homo sapiens	Inhibition	%	1.61
	8218354	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	1.03	CHEMBL299	Homo sapiens	Inhibition	%	1.03
	8218578	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	9.37	CHEMBL299	Homo sapiens	Inhibition	%	9.37
	8218721	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	0.71	CHEMBL299	Homo sapiens	Inhibition	%	0.71
	8219076	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	0.3	CHEMBL299	Homo sapiens	Inhibition	%	0.3
	8219236	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	1.97	CHEMBL299	Homo sapiens	Inhibition	%	1.97
	8219486	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	4.5	CHEMBL299	Homo sapiens	Inhibition	%	4.5
	8219871	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	1.92	CHEMBL299	Homo sapiens	Inhibition	%	1.92
	8220040	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	0.66	CHEMBL299	Homo sapiens	Inhibition	%	0.66
	8220393	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	0.95	CHEMBL299	Homo sapiens	Inhibition	%	0.95
	8220731	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	0.91	CHEMBL299	Homo sapiens	Inhibition	%	0.91
	8220869	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	2.87	CHEMBL299	Homo sapiens	Inhibition	%	2.87
	8221229	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	16.88	CHEMBL299	Homo sapiens	Inhibition	%	16.88
	8221362	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	1.38	CHEMBL299	Homo sapiens	Inhibition	%	1.38
	8221586	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	2.23	CHEMBL299	Homo sapiens	Inhibition	%	2.23
	8221751	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.68	CHEMBL299	Homo sapiens	Inhibition	%	2.68
	8221882	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	2.72	CHEMBL299	Homo sapiens	Inhibition	%	2.72
	8222106	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	1.36	CHEMBL299	Homo sapiens	Inhibition	%	1.36
	8222204	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	0.74	CHEMBL299	Homo sapiens	Inhibition	%	0.74
	8222562	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	Inhibition	%	0.0
	8222904	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	0.72	CHEMBL299	Homo sapiens	Inhibition	%	0.72
	8223048	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	1.62	CHEMBL299	Homo sapiens	Inhibition	%	1.62
	8223401	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	1.8	CHEMBL299	Homo sapiens	Inhibition	%	1.8
	8223562	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	1.05	CHEMBL299	Homo sapiens	Inhibition	%	1.05
	8223786	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	1.13	CHEMBL299	Homo sapiens	Inhibition	%	1.13
	8223812	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	1.11	CHEMBL299	Homo sapiens	Inhibition	%	1.11
	8224036	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	6.73	CHEMBL299	Homo sapiens	Inhibition	%	6.73
	8224198	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	-2.31	CHEMBL299	Homo sapiens	Inhibition	%	-2.31
	8224368	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	2.3	CHEMBL299	Homo sapiens	Inhibition	%	2.3
	8224592	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	0.67	CHEMBL299	Homo sapiens	Inhibition	%	0.67
	8224727	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	0.67	CHEMBL299	Homo sapiens	Inhibition	%	0.67
	8225065	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	1.52	CHEMBL299	Homo sapiens	Inhibition	%	1.52
	8225199	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	1.01	CHEMBL299	Homo sapiens	Inhibition	%	1.01
	8225423	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	1.85	CHEMBL299	Homo sapiens	Inhibition	%	1.85
	8225561	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.9	CHEMBL299	Homo sapiens	Inhibition	%	0.9
	8225920	CHEMBL1961898	GSK_PKIS: PKC-alpha mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	2.23	CHEMBL299	Homo sapiens	Inhibition	%	2.23
	8226078	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	28.99	CHEMBL299	Homo sapiens	Inhibition	%	28.99
	8226427	CHEMBL1961899	GSK_PKIS: PKC-alpha mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	1.81	CHEMBL299	Homo sapiens	Inhibition	%	1.81
	10839454	CHEMBL2015485	Inhibition of PKCalpha at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	26.0	CHEMBL299	Homo sapiens	INH	%	26.0
	10839655	CHEMBL2016321	Inhibition of PKCalpha assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	109.0	CHEMBL299	Homo sapiens	Activity	%	109.0
	10840433	CHEMBL2015797	Inhibition of PKCalpha assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	122.0	CHEMBL299	Homo sapiens	Activity	%	122.0
Not Active	10843553	CHEMBL2016354	Inhibition of PKCalpha at 10 uM	B	Cn1c(Nc2ccc(I)cc2F)c(C(=O)NOC[C@H](O)CO)c2c1C(=O)CCC2		CHEMBL2012892		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Not Active	10843554	CHEMBL2016354	Inhibition of PKCalpha at 10 uM	B	C#Cc1ccc(Nc2c(C(=O)NOCCO)c3c(n2C)C(=O)CCC3)c(F)c1		CHEMBL2012899		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Not Active	10843555	CHEMBL2016354	Inhibition of PKCalpha at 10 uM	B	C#Cc1ccc(Nc2c(C(=O)NOCCO)c3c(n2C)C(=O)CC3)c(F)c1		CHEMBL2012901		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Not Active	10843556	CHEMBL2016354	Inhibition of PKCalpha at 10 uM	B	O=C(NOCCO)c1c(Nc2ccc(I)cc2F)c(F)c(=O)n2c1CCC2		CHEMBL2012902		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Not Active	10843557	CHEMBL2016354	Inhibition of PKCalpha at 10 uM	B	O=C(NOC[C@@H](O)CO)c1c(Nc2ccc(I)cc2F)c(F)c(=O)n2c1CCC2		CHEMBL2012904		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Not Active	10843558	CHEMBL2016354	Inhibition of PKCalpha at 10 uM	B	Cc1c(Nc2ccc(I)cc2F)c(C(=O)NOCCO)c2n(c1=O)CCC2		CHEMBL2012908		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Active	10896662	CHEMBL2034153	Modulation of PKCalpha in human K562 cells assessed as protein down-regulation after 24 hrs by Western blotting analysis	B	CCC/C=C/C=C/C(=O)O[C@H]1/C(=C/C(=O)OC)C[C@H]2C[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H]3C[C@H](OC(C)=O)C(C)(C)[C@](O)(C[C@@H]4C/C(=C/C(=O)OC)C[C@H](/C=C/C(C)(C)[C@]1(O)O2)O4)O3		CHEMBL449158		Activity			CHEMBL299	Homo sapiens	Activity		
	10898374	CHEMBL2039490	Inhibition of human PKC alpha assessed as inhibition of [33P] incorporation into substrate after 60 mins by scintillation counting	B	COc1cc(O)c(CC=C(C)C)c2c1C(=O)CC(c1ccc(O)cc1)O2		CHEMBL492828	=	IC50	nM	45300.0	CHEMBL299	Homo sapiens	IC50	uM	45.3
	10898375	CHEMBL2039490	Inhibition of human PKC alpha assessed as inhibition of [33P] incorporation into substrate after 60 mins by scintillation counting	B	COc1cc(O)c(CC=C(C)C)c(O)c1C(=O)/C=C/c1ccc(O)cc1		CHEMBL253896	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	10926132	CHEMBL2046215	Inhibition of human PKCalpha assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	CC(C)Nc1cc(-c2oc3ccccc3c(=O)c2-c2ccc(F)cc2)ccn1		CHEMBL2041958	=	Activity	%	96.0	CHEMBL299	Homo sapiens	Activity	%	96.0
	10926133	CHEMBL2046215	Inhibition of human PKCalpha assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12		CHEMBL2041962	=	Activity	%	102.0	CHEMBL299	Homo sapiens	Activity	%	102.0
	10941226	CHEMBL2049839	Inhibition of PKCalpha	B	CC(C)C[C@H]1CN(c2cccc(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046640	=	Ki	nM	54.0	CHEMBL299	Homo sapiens	Ki	uM	0.054
	10941227	CHEMBL2049839	Inhibition of PKCalpha	B	CC(C)C[C@H]1CN(c2ccc(C(F)(F)F)c(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046643	=	Ki	nM	76.0	CHEMBL299	Homo sapiens	Ki	uM	0.076
	10941228	CHEMBL2049839	Inhibition of PKCalpha	B	CC(C)C[C@H]1CN(c2ccc(Cl)c(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046644	=	Ki	nM	49.0	CHEMBL299	Homo sapiens	Ki	uM	0.049
	10941229	CHEMBL2049839	Inhibition of PKCalpha	B	CC(C)C[C@H]1CN(c2ccc(C3CC3)c(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046645	=	Ki	nM	2650.0	CHEMBL299	Homo sapiens	Ki	uM	2.65
	10941230	CHEMBL2049839	Inhibition of PKCalpha	B	CC(C)C[C@H]1CN(c2ccc(OC(F)F)c(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046646	=	Ki	nM	459.0	CHEMBL299	Homo sapiens	Ki	uM	0.459
	10941231	CHEMBL2049839	Inhibition of PKCalpha	B	CC(C)C[C@H]1CN(c2ccc(OCC(F)(F)F)c(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046647	>	Ki	nM	1250.0	CHEMBL299	Homo sapiens	Ki	uM	1.25
	10941232	CHEMBL2049839	Inhibition of PKCalpha	B	CCCc1ccc(N2CCN[C@@H](CC(C)C)C2)nc1C(=O)c1cccnc1N		CHEMBL2046648	=	Ki	nM	1230.0	CHEMBL299	Homo sapiens	Ki	uM	1.23
	10941233	CHEMBL2049839	Inhibition of PKCalpha	B	CC(C)C[C@H]1CN(c2ccc(-c3ccccc3)c(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046649	=	Ki	nM	10.0	CHEMBL299	Homo sapiens	Ki	uM	0.01
	10941234	CHEMBL2049839	Inhibition of PKCalpha	B	CC(C)C[C@H]1CN(c2ccc(Cc3ccccc3)c(C(=O)c3cccnc3N)n2)CCN1		CHEMBL2046650	>	Ki	nM	1250.0	CHEMBL299	Homo sapiens	Ki	uM	1.25
	10941235	CHEMBL2049839	Inhibition of PKCalpha	B	Cc1cc(C(=O)c2cccnc2N)nc(N2CCN[C@@H](CC(C)C)C2)c1		CHEMBL2046651	=	Ki	nM	459.0	CHEMBL299	Homo sapiens	Ki	uM	0.459
	10978510	CHEMBL2066814	Inhibition of human recombinant PKCalpha by FRET assay	B	COC(=O)c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064520	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	10978511	CHEMBL2066814	Inhibition of human recombinant PKCalpha by FRET assay	B	c1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2064531	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	10978512	CHEMBL2066814	Inhibition of human recombinant PKCalpha by FRET assay	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1		CHEMBL2064533	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	10978513	CHEMBL2066814	Inhibition of human recombinant PKCalpha by FRET assay	B	N#Cc1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1		CHEMBL2064532	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	10978514	CHEMBL2066814	Inhibition of human recombinant PKCalpha by FRET assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2064515	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	10978515	CHEMBL2066814	Inhibition of human recombinant PKCalpha by FRET assay	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064534	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	10978516	CHEMBL2066814	Inhibition of human recombinant PKCalpha by FRET assay	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccncc3)o2)cc1		CHEMBL2064536	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	10978517	CHEMBL2066814	Inhibition of human recombinant PKCalpha by FRET assay	B	N#Cc1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064535	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	10978518	CHEMBL2066814	Inhibition of human recombinant PKCalpha by FRET assay	B	COCC1COc2ccc(-c3nnc(SCc4ccc(-c5ccccc5C#N)cc4)o3)cc2O1		CHEMBL2064537	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	10978519	CHEMBL2066814	Inhibition of human recombinant PKCalpha by FRET assay	B	COC[C@@H]1COc2ccc(-c3nnc(SCc4ccc(-c5ccccc5C#N)cc4)o3)cc2O1		CHEMBL2064538	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	10978521	CHEMBL2066814	Inhibition of human recombinant PKCalpha by FRET assay	B	COC[C@H]1COc2ccc(-c3nnc(SCc4ccc(-c5ccccc5C#N)cc4)o3)cc2O1		CHEMBL2064539	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
Not Active	10986936	CHEMBL2072240	Inhibition of PKCalpha at 10 uM	B	NS(=O)(=O)c1cc(-c2nc3ccccc3s2)cs1		CHEMBL2069711		Inhibition	%		CHEMBL299	Homo sapiens	INH		
	12035037	CHEMBL2150055	Inhibition of recombinant human PKCalpha assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NCCNc1nc(-c2ccncc2)cc2ccncc12		CHEMBL2147533	>	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	nM	1000.0
	12035038	CHEMBL2150055	Inhibition of recombinant human PKCalpha assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NCCNc1nc(-c2ccncc2)cc2ccccc12		CHEMBL2147531	>	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	nM	1000.0
	12035039	CHEMBL2150055	Inhibition of recombinant human PKCalpha assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NCCNc1nc(-c2ccncc2)cc2ncccc12		CHEMBL2147532	>	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	nM	1000.0
	12035040	CHEMBL2150055	Inhibition of recombinant human PKCalpha assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NCCNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL1214929	=	IC50	nM	900.0	CHEMBL299	Homo sapiens	IC50	nM	900.0
	12035041	CHEMBL2150055	Inhibition of recombinant human PKCalpha assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NCCNc1cc(-c2ccncc2)cc2cnccc12		CHEMBL2147534	>	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	nM	1000.0
	12035042	CHEMBL2150055	Inhibition of recombinant human PKCalpha assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NCCNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL2147535	>	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	nM	1000.0
	12035043	CHEMBL2150055	Inhibition of recombinant human PKCalpha assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NCCOc1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147536	>	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	nM	1000.0
	12035044	CHEMBL2150055	Inhibition of recombinant human PKCalpha assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	C[C@H](N)CNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147537	=	IC50	nM	829.0	CHEMBL299	Homo sapiens	IC50	nM	829.0
	12035045	CHEMBL2150055	Inhibition of recombinant human PKCalpha assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	CC(C)(N)CNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147538	=	IC50	nM	967.0	CHEMBL299	Homo sapiens	IC50	nM	967.0
	12035046	CHEMBL2150055	Inhibition of recombinant human PKCalpha assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NC(CNc1nc(-c2ccncc2)cc2cnccc12)Cc1ccccc1		CHEMBL2147539	=	IC50	nM	818.0	CHEMBL299	Homo sapiens	IC50	nM	818.0
	12035047	CHEMBL2150055	Inhibition of recombinant human PKCalpha assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	CN(CCN)c1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147540	>	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	nM	1000.0
	12035048	CHEMBL2150055	Inhibition of recombinant human PKCalpha assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	CNCCNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147541	>	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	nM	1000.0
	12035049	CHEMBL2150055	Inhibition of recombinant human PKCalpha assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	c1cc(-c2cc3cnccc3c(N3CCNCC3)n2)ccn1		CHEMBL1214932	>	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	nM	1000.0
	12035050	CHEMBL2150055	Inhibition of recombinant human PKCalpha assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	c1cc(-c2cc3cnccc3c(N3CCCNCC3)n2)ccn1		CHEMBL2147542	=	IC50	nM	433.0	CHEMBL299	Homo sapiens	IC50	nM	433.0
	12035051	CHEMBL2150055	Inhibition of recombinant human PKCalpha assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NC1CCCN(c2nc(-c3ccncc3)cc3cnccc23)C1		CHEMBL2147543	=	IC50	nM	771.0	CHEMBL299	Homo sapiens	IC50	nM	771.0
	12035052	CHEMBL2150055	Inhibition of recombinant human PKCalpha assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	NCCCNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147544	=	IC50	nM	676.0	CHEMBL299	Homo sapiens	IC50	nM	676.0
	12035053	CHEMBL2150055	Inhibition of recombinant human PKCalpha assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	OCCNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147545	>	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	nM	1000.0
	12035054	CHEMBL2150055	Inhibition of recombinant human PKCalpha assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	O=C1CN(c2nc(-c3ccncc3)cc3cnccc23)CCN1		CHEMBL2147546	>	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	nM	1000.0
	12035055	CHEMBL2150055	Inhibition of recombinant human PKCalpha assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	CC(C)(N)CNc1nc(-c2cccnc2)cc2cnccc12		CHEMBL2147547	>	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	nM	1000.0
	12035056	CHEMBL2150055	Inhibition of recombinant human PKCalpha assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	CC(C)(N)CNc1nc(-c2ccnc(N)c2)cc2cnccc12		CHEMBL2147548	=	IC50	nM	378.0	CHEMBL299	Homo sapiens	IC50	nM	378.0
	12035057	CHEMBL2150055	Inhibition of recombinant human PKCalpha assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	CC(C)Nc1cc(-c2cc3cnccc3c(NCC(C)(C)N)n2)ccn1		CHEMBL2147549	>	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	nM	1000.0
	12035058	CHEMBL2150055	Inhibition of recombinant human PKCalpha assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	CC(C)(N)CNc1nc(-c2ccncc2F)cc2cnccc12		CHEMBL2147550	>	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	nM	1000.0
	12035059	CHEMBL2150055	Inhibition of recombinant human PKCalpha assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	CC(C)(N)CNc1nc(-c2ccncc2Cl)cc2cnccc12		CHEMBL2147551	>	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	nM	1000.0
	12035060	CHEMBL2150055	Inhibition of recombinant human PKCalpha assessed as [33P]-ATP incorporation into tridecapeptide substrate after 60 mins by scintillation proximity assay	B	Cc1cnccc1-c1cc2cnccc2c(NCC(C)(C)N)n1		CHEMBL2147552	>	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	nM	1000.0
	12035184	CHEMBL2150527	Inhibition of recombinant human PKCalpha at 1 uM	B	C[C@H](N)CNc1nc(-c2ccncc2)cc2cnccc12		CHEMBL2147537	>	Inhibition	%	80.0	CHEMBL299	Homo sapiens	INH	%	80.0
Active	12037013	CHEMBL2149976	Inhibition of PKCalpha at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1c[nH]c3ncccc13)C2=O		CHEMBL2147767		Inhibition	%		CHEMBL299	Homo sapiens	INH		
	12039650	CHEMBL2148237	Inhibition of [3H]PDBu binding to PKCalpha C1A domain	B	CO[C@@H](CC[C@H](C)[C@H]1O[C@@]23C[C@H](OC(=O)C[C@H]([C@@H](C)O)OC(=O)C[C@](O)(O2)[C@H](C)CC3(C)C)[C@@H]1C)c1cccc(O)c1		CHEMBL2148106	=	Ki	nM	0.26	CHEMBL299	Homo sapiens	Ki	nM	0.26
	12039672	CHEMBL2148237	Inhibition of [3H]PDBu binding to PKCalpha C1A domain	B	CC1(C)CC[C@@H]2CC(=O)O[C@@H](CO)CC(=O)O[C@@H]3C[C@@H](CCCCc4cccc(O)c4)O[C@@]1(C3)O2		CHEMBL1258348	=	Ki	nM	63.0	CHEMBL299	Homo sapiens	Ki	nM	63.0
	12039689	CHEMBL2148237	Inhibition of [3H]PDBu binding to PKCalpha C1A domain	B	C[C@@H]1CC(C)(C)[C@@]23C[C@@H](C[C@@H](CCCCc4cccc(O)c4)O2)OC(=O)C[C@H](CO)OC(=O)C[C@@H]1O3		CHEMBL2148107	=	Ki	nM	15.0	CHEMBL299	Homo sapiens	Ki	nM	15.0
	12039707	CHEMBL2148237	Inhibition of [3H]PDBu binding to PKCalpha C1A domain	B	C[C@H]1[C@@H]2C[C@@]3(O[C@H](CCC3(C)C)CC(=O)O[C@@H](CO)CC(=O)O2)O[C@@H]1CCCCc1cccc(O)c1		CHEMBL2148108	=	Ki	nM	4.7	CHEMBL299	Homo sapiens	Ki	nM	4.7
	12047312	CHEMBL2157337	Inhibition of PKCalpha at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	12.1	CHEMBL299	Homo sapiens	INH	%	12.1
	12049490	CHEMBL2156011	Inhibition of PKCalpha by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	IC50	nM	2.1	CHEMBL299	Homo sapiens	IC50	nM	2.1
	12049499	CHEMBL2156011	Inhibition of PKCalpha by scintillation proximity assay	B	CN1CCN(c2cc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3c2)CC1		CHEMBL568580	=	IC50	nM	0.9	CHEMBL299	Homo sapiens	IC50	nM	0.9
	12049508	CHEMBL2156011	Inhibition of PKCalpha by scintillation proximity assay	B	CN1CCN(c2cc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL2153747	=	IC50	nM	3.6	CHEMBL299	Homo sapiens	IC50	nM	3.6
	12049517	CHEMBL2156011	Inhibition of PKCalpha by scintillation proximity assay	B	CN1CCN(c2cc3ccccc3c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)n2)CC1		CHEMBL2153748	=	IC50	nM	1.4	CHEMBL299	Homo sapiens	IC50	nM	1.4
	12049526	CHEMBL2156011	Inhibition of PKCalpha by scintillation proximity assay	B	Cc1cccc2nc(N3CCN(C)CC3)nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c12		CHEMBL2153749	=	IC50	nM	3.6	CHEMBL299	Homo sapiens	IC50	nM	3.6
	12049532	CHEMBL2156011	Inhibition of PKCalpha by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3cc(F)ccc3n2)CC1		CHEMBL2153750	=	IC50	nM	1.0	CHEMBL299	Homo sapiens	IC50	nM	1.0
	12049538	CHEMBL2156011	Inhibition of PKCalpha by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3cc(Cl)ccc3n2)CC1		CHEMBL2153751	=	IC50	nM	1.7	CHEMBL299	Homo sapiens	IC50	nM	1.7
	12049544	CHEMBL2156011	Inhibition of PKCalpha by scintillation proximity assay	B	Cc1ccc2nc(N3CCN(C)CC3)nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL2153752	=	IC50	nM	7.5	CHEMBL299	Homo sapiens	IC50	nM	7.5
	12049550	CHEMBL2156011	Inhibition of PKCalpha by scintillation proximity assay	B	CC(C)c1ccc2nc(N3CCN(C)CC3)nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL2153753	>	IC50	nM	316.0	CHEMBL299	Homo sapiens	IC50	nM	316.0
	12049556	CHEMBL2156011	Inhibition of PKCalpha by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3cc(C(C)(C)C)ccc3n2)CC1		CHEMBL2153754	>	IC50	nM	316.0	CHEMBL299	Homo sapiens	IC50	nM	316.0
	12049562	CHEMBL2156011	Inhibition of PKCalpha by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccc(F)cc3n2)CC1		CHEMBL2153755	=	IC50	nM	4.5	CHEMBL299	Homo sapiens	IC50	nM	4.5
	12049568	CHEMBL2156011	Inhibition of PKCalpha by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccc(Cl)cc3n2)CC1		CHEMBL2153756	=	IC50	nM	280.0	CHEMBL299	Homo sapiens	IC50	nM	280.0
	12049574	CHEMBL2156011	Inhibition of PKCalpha by scintillation proximity assay	B	Cc1cccc2c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)nc(N3CCN(C)CC3)nc12		CHEMBL2151406	=	IC50	nM	235.0	CHEMBL299	Homo sapiens	IC50	nM	235.0
	12049580	CHEMBL2156011	Inhibition of PKCalpha by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5cccc(Cl)c45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL2151407	=	IC50	nM	202.0	CHEMBL299	Homo sapiens	IC50	nM	202.0
	12049586	CHEMBL2156011	Inhibition of PKCalpha by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccc(Cl)cc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL2151408	=	IC50	nM	8.3	CHEMBL299	Homo sapiens	IC50	nM	8.3
	12049592	CHEMBL2156011	Inhibition of PKCalpha by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5cc(Cl)ccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL2151409	=	IC50	nM	8.5	CHEMBL299	Homo sapiens	IC50	nM	8.5
	12049598	CHEMBL2156011	Inhibition of PKCalpha by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5c(Cl)cccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL2151410	=	IC50	nM	9.1	CHEMBL299	Homo sapiens	IC50	nM	9.1
	12049604	CHEMBL2156011	Inhibition of PKCalpha by scintillation proximity assay	B	Cc1cccc2c(C3=C(c4nc(N5CCN(C)CC5)nc5ccccc45)C(=O)NC3=O)c[nH]c12		CHEMBL2151411	=	IC50	nM	0.4	CHEMBL299	Homo sapiens	IC50	nM	0.4
	12050500	CHEMBL2156011	Inhibition of PKCalpha by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL2151412	=	IC50	nM	6.4	CHEMBL299	Homo sapiens	IC50	nM	6.4
	12050506	CHEMBL2156011	Inhibition of PKCalpha by scintillation proximity assay	B	CC(C)n1cc(C2=C(c3nc(N4CCN(C)CC4)nc4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL2151413	=	IC50	nM	11.0	CHEMBL299	Homo sapiens	IC50	nM	11.0
	12050512	CHEMBL2156011	Inhibition of PKCalpha by scintillation proximity assay	B	Cc1[nH]c2ccccc2c1C1=C(c2nc(N3CCN(C)CC3)nc3ccccc23)C(=O)NC1=O		CHEMBL2151414	=	IC50	nM	63.0	CHEMBL299	Homo sapiens	IC50	nM	63.0
	12050520	CHEMBL2156011	Inhibition of PKCalpha by scintillation proximity assay	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1nc(N2CCNCC2)nc2ccccc12		CHEMBL1996510	=	IC50	nM	0.5	CHEMBL299	Homo sapiens	IC50	nM	0.5
	12050528	CHEMBL2156011	Inhibition of PKCalpha by scintillation proximity assay	B	Cn1cc(C2=C(c3nc(N4CCNCC4)nc4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL2151415	=	IC50	nM	1.4	CHEMBL299	Homo sapiens	IC50	nM	1.4
	12074650	CHEMBL2161212	Inhibition of PKCalpha at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
	12081892	CHEMBL2166772	Inhibition of PKCalpha	B	Oc1ccc2oc3ncc(O)c(-c4ccccc4)c3c2c1	Outside typical range	CHEMBL2163772	>	Ki	nM	1000000.0	CHEMBL299	Homo sapiens	Ki	uM	1000.0
	12094384	CHEMBL2166164	Inhibition of human PKCalpha at 10 uM	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CCCNC3)nc3ccnn23)cc1		CHEMBL1235213	=	Inhibition	%	5.0	CHEMBL299	Homo sapiens	INH	%	5.0
Not Active	12102842	CHEMBL2175777	Activation of human GFP-tagged PKCalpha expressed in HEK293 cells assessed as translocation from cytoplasm to membrane at 1 uM after 30 mins by Hoechst staining-based fluorescence microscopy in presence of GF109203X	B	CC(C)CC(=O)O[C@H]1/C=C/C=C/C(=O)O[C@H]2[C@@H](C)C[C@@H]3[C@]2(O)[C@H](O)[C@@]2(CO)O[C@H]2[C@H]2[C@H]4OC5(c6ccccc6)O[C@@H]([C@@H](C)[C@@]23O5)[C@@]4(O)[C@](C)(O)C[C@H]2CC[C@H]1[C@H]2C		CHEMBL454246		Activity			CHEMBL299	Homo sapiens	Activity		
Active	12102843	CHEMBL2175776	Activation of human GFP-tagged PKCalpha expressed in HEK293 cells assessed as translocation from cytoplasm to membrane at 1 uM after 30 mins by Hoechst staining-based fluorescence microscopy	B	CC(C)CC(=O)O[C@H]1/C=C/C=C/C(=O)O[C@H]2[C@@H](C)C[C@@H]3[C@]2(O)[C@H](O)[C@@]2(CO)O[C@H]2[C@H]2[C@H]4OC5(c6ccccc6)O[C@@H]([C@@H](C)[C@@]23O5)[C@@]4(O)[C@](C)(O)C[C@H]2CC[C@H]1[C@H]2C		CHEMBL454246		Activity			CHEMBL299	Homo sapiens	Activity		
	12145305	CHEMBL2186677	Inhibition of PKCalpha using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1		CHEMBL2177819	>	Inhibition	%	25.0	CHEMBL299	Homo sapiens	INH	%	25.0
	12145306	CHEMBL2186677	Inhibition of PKCalpha using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1		CHEMBL2177818	>	Inhibition	%	25.0	CHEMBL299	Homo sapiens	INH	%	25.0
	12150578	CHEMBL2188515	Inhibition of human recombinant PKCalpha by radiometric kinase assay	B	CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n(C5CCCC5)c4n3)cc2)CC1		CHEMBL2178352	=	IC50	nM	6700.0	CHEMBL299	Homo sapiens	IC50	uM	6.7
	12152499	CHEMBL2182403	Inhibition of PKCalpha assessed as enzyme residual activity at 10 uM relative to untreated control	B	COc1cc(C2=C(c3c[nH]c4cnccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL2180882	=	Activity	%	80.0	CHEMBL299	Homo sapiens	Activity	%	80.0
	12152514	CHEMBL2182403	Inhibition of PKCalpha assessed as enzyme residual activity at 10 uM relative to untreated control	B	COc1cc(C2=C(c3c[nH]c4ncccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL2180878	=	Activity	%	89.0	CHEMBL299	Homo sapiens	Activity	%	89.0
Active	12156397	CHEMBL2188387	Inhibition of PKCalpha in human U937 cells assessed as p21WAF1/CIP1 expression at 5 uM after 30 hrs by cytofluorimetric analysis	B	O=C(CCc1c[nH]c2ccc(Br)cc12)NCCSSCCNC(=O)CCc1c[nH]c2ccc(Br)cc12		CHEMBL2178755		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Active	12156398	CHEMBL2188387	Inhibition of PKCalpha in human U937 cells assessed as p21WAF1/CIP1 expression at 5 uM after 30 hrs by cytofluorimetric analysis	B	CSCCNC(=O)/C(Cc1c[nH]c2ccc(Br)cc12)=N/O		CHEMBL2178775		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Active	12158206	CHEMBL2188387	Inhibition of PKCalpha in human U937 cells assessed as p21WAF1/CIP1 expression at 5 uM after 30 hrs by cytofluorimetric analysis	B	Cn1cc(C/C(=N\O)C(=O)NCCSSCCNC(=O)/C(Cc2cn(C)c3ccc(Br)cc23)=N/O)c2cc(Br)ccc21		CHEMBL2178767		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Active	12158207	CHEMBL2188387	Inhibition of PKCalpha in human U937 cells assessed as p21WAF1/CIP1 expression at 5 uM after 30 hrs by cytofluorimetric analysis	B	O=C(NCCSSCCNC(=O)/C(Cc1c[nH]c2c(Br)cccc12)=N/O)/C(Cc1c[nH]c2c(Br)cccc12)=N/O		CHEMBL2178766		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Active	12158208	CHEMBL2188387	Inhibition of PKCalpha in human U937 cells assessed as p21WAF1/CIP1 expression at 5 uM after 30 hrs by cytofluorimetric analysis	B	O=C(NCCSSCCNC(=O)/C(Cc1c[nH]c2cc(Br)ccc12)=N/O)/C(Cc1c[nH]c2cc(Br)ccc12)=N/O		CHEMBL2178765		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Active	12158209	CHEMBL2188387	Inhibition of PKCalpha in human U937 cells assessed as p21WAF1/CIP1 expression at 5 uM after 30 hrs by cytofluorimetric analysis	B	O=C(NCCSSCCNC(=O)/C(Cc1c[nH]c2ccc(OCc3ccccc3)cc12)=N/O)/C(Cc1c[nH]c2ccc(OCc3ccccc3)cc12)=N/O		CHEMBL2178763		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Active	12158210	CHEMBL2188387	Inhibition of PKCalpha in human U937 cells assessed as p21WAF1/CIP1 expression at 5 uM after 30 hrs by cytofluorimetric analysis	B	COc1ccc2[nH]cc(C/C(=N\O)C(=O)NCCSSCCNC(=O)/C(Cc3c[nH]c4ccc(OC)cc34)=N/O)c2c1		CHEMBL2178762		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Active	12158211	CHEMBL2188387	Inhibition of PKCalpha in human U937 cells assessed as p21WAF1/CIP1 expression at 5 uM after 30 hrs by cytofluorimetric analysis	B	O=C(NCCSSCCNC(=O)/C(Cc1c[nH]c2ccc(I)cc12)=N/O)/C(Cc1c[nH]c2ccc(I)cc12)=N/O		CHEMBL2178761		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Active	12158212	CHEMBL2188387	Inhibition of PKCalpha in human U937 cells assessed as p21WAF1/CIP1 expression at 5 uM after 30 hrs by cytofluorimetric analysis	B	O=C(NCCSSCCNC(=O)/C(Cc1c[nH]c2ccc(Cl)cc12)=N/O)/C(Cc1c[nH]c2ccc(Cl)cc12)=N/O		CHEMBL2178760		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Not Active	12158213	CHEMBL2188387	Inhibition of PKCalpha in human U937 cells assessed as p21WAF1/CIP1 expression at 5 uM after 30 hrs by cytofluorimetric analysis	B	O=C(NCCSSCCNC(=O)/C(Cc1c[nH]c2ccc(F)cc12)=N/O)/C(Cc1c[nH]c2ccc(F)cc12)=N/O		CHEMBL2178759		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Active	12158214	CHEMBL2188387	Inhibition of PKCalpha in human U937 cells assessed as p21WAF1/CIP1 expression at 5 uM after 30 hrs by cytofluorimetric analysis	B	O=C(NCCSSCCNC(=O)/C(Cc1c[nH]c2ccccc12)=N/O)/C(Cc1c[nH]c2ccccc12)=N/O		CHEMBL2178758		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Active	12158215	CHEMBL2188387	Inhibition of PKCalpha in human U937 cells assessed as p21WAF1/CIP1 expression at 5 uM after 30 hrs by cytofluorimetric analysis	B	O=C(NCCSSCCNC(=O)/C(Cc1c[nH]c2ccc(Br)cc12)=N/O)/C(Cc1c[nH]c2ccc(Br)cc12)=N/O		CHEMBL2178757		Inhibition	%		CHEMBL299	Homo sapiens	INH		
	12170748	CHEMBL2209469	Inhibition of PKCa assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	93.0	CHEMBL299	Homo sapiens	Activity	%	93.0
	12170879	CHEMBL2213198	Inhibition of PKCa assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	94.0	CHEMBL299	Homo sapiens	Activity	%	94.0
	12172263	CHEMBL2212493	Inhibition of PKAC-alpha assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL299	Homo sapiens	Activity	%	100.0
	12183829	CHEMBL2214431	Inhibition of PRKCA	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL299	Homo sapiens	pIC50		5.0
	12260718	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	106.0	CHEMBL299	Homo sapiens	Residual Activity	%	106.0
	12260719	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	26.0	CHEMBL299	Homo sapiens	Residual Activity	%	26.0
	12260720	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	102.0	CHEMBL299	Homo sapiens	Residual Activity	%	102.0
	12260721	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	98.0	CHEMBL299	Homo sapiens	Residual Activity	%	98.0
	12260722	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	106.0	CHEMBL299	Homo sapiens	Residual Activity	%	106.0
	12260723	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	97.0	CHEMBL299	Homo sapiens	Residual Activity	%	97.0
	12260724	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	108.0	CHEMBL299	Homo sapiens	Residual Activity	%	108.0
	12260725	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	103.0	CHEMBL299	Homo sapiens	Residual Activity	%	103.0
	12260726	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	111.0	CHEMBL299	Homo sapiens	Residual Activity	%	111.0
	12260727	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	101.0	CHEMBL299	Homo sapiens	Residual Activity	%	101.0
	12260728	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	103.0	CHEMBL299	Homo sapiens	Residual Activity	%	103.0
	12260729	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	104.0	CHEMBL299	Homo sapiens	Residual Activity	%	104.0
	12260730	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	100.0	CHEMBL299	Homo sapiens	Residual Activity	%	100.0
	12260731	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	93.0	CHEMBL299	Homo sapiens	Residual Activity	%	93.0
	12260732	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	45.0	CHEMBL299	Homo sapiens	Residual Activity	%	45.0
	12260733	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	108.0	CHEMBL299	Homo sapiens	Residual Activity	%	108.0
	12260734	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	112.0	CHEMBL299	Homo sapiens	Residual Activity	%	112.0
	12260735	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	110.0	CHEMBL299	Homo sapiens	Residual Activity	%	110.0
	12260736	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	106.0	CHEMBL299	Homo sapiens	Residual Activity	%	106.0
	12260737	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	65.0	CHEMBL299	Homo sapiens	Residual Activity	%	65.0
	12260738	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	106.0	CHEMBL299	Homo sapiens	Residual Activity	%	106.0
	12260739	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	104.0	CHEMBL299	Homo sapiens	Residual Activity	%	104.0
	12260740	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	111.0	CHEMBL299	Homo sapiens	Residual Activity	%	111.0
	12260741	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	104.0	CHEMBL299	Homo sapiens	Residual Activity	%	104.0
	12260742	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	109.0	CHEMBL299	Homo sapiens	Residual Activity	%	109.0
	12260743	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	107.0	CHEMBL299	Homo sapiens	Residual Activity	%	107.0
	12260744	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	104.0	CHEMBL299	Homo sapiens	Residual Activity	%	104.0
	12260745	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	107.0	CHEMBL299	Homo sapiens	Residual Activity	%	107.0
	12260746	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	99.0	CHEMBL299	Homo sapiens	Residual Activity	%	99.0
	12260747	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	6.0	CHEMBL299	Homo sapiens	Residual Activity	%	6.0
	12260748	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	110.0	CHEMBL299	Homo sapiens	Residual Activity	%	110.0
	12260749	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	108.0	CHEMBL299	Homo sapiens	Residual Activity	%	108.0
	12260750	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	104.0	CHEMBL299	Homo sapiens	Residual Activity	%	104.0
	12260751	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	102.0	CHEMBL299	Homo sapiens	Residual Activity	%	102.0
	12260752	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	103.0	CHEMBL299	Homo sapiens	Residual Activity	%	103.0
	12260753	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	105.0	CHEMBL299	Homo sapiens	Residual Activity	%	105.0
	12260754	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	104.0	CHEMBL299	Homo sapiens	Residual Activity	%	104.0
	12260755	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	99.0	CHEMBL299	Homo sapiens	Residual Activity	%	99.0
	12260756	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	106.0	CHEMBL299	Homo sapiens	Residual Activity	%	106.0
	12260757	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	104.0	CHEMBL299	Homo sapiens	Residual Activity	%	104.0
	12260758	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	112.0	CHEMBL299	Homo sapiens	Residual Activity	%	112.0
	12260759	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	101.0	CHEMBL299	Homo sapiens	Residual Activity	%	101.0
	12260760	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	1.0	CHEMBL299	Homo sapiens	Residual Activity	%	1.0
	12260761	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	87.0	CHEMBL299	Homo sapiens	Residual Activity	%	87.0
	12260762	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	99.0	CHEMBL299	Homo sapiens	Residual Activity	%	99.0
	12260763	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	98.0	CHEMBL299	Homo sapiens	Residual Activity	%	98.0
	12260764	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	102.0	CHEMBL299	Homo sapiens	Residual Activity	%	102.0
	12260765	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	100.0	CHEMBL299	Homo sapiens	Residual Activity	%	100.0
	12260766	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	113.0	CHEMBL299	Homo sapiens	Residual Activity	%	113.0
	12260767	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	106.0	CHEMBL299	Homo sapiens	Residual Activity	%	106.0
	12260768	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	-1.0	CHEMBL299	Homo sapiens	Residual Activity	%	-1.0
	12260769	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	102.0	CHEMBL299	Homo sapiens	Residual Activity	%	102.0
	12260770	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	67.0	CHEMBL299	Homo sapiens	Residual Activity	%	67.0
	12260771	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	99.0	CHEMBL299	Homo sapiens	Residual Activity	%	99.0
	12260772	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	109.0	CHEMBL299	Homo sapiens	Residual Activity	%	109.0
	12260773	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	102.0	CHEMBL299	Homo sapiens	Residual Activity	%	102.0
	12260774	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	117.0	CHEMBL299	Homo sapiens	Residual Activity	%	117.0
	12260775	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	108.0	CHEMBL299	Homo sapiens	Residual Activity	%	108.0
	12260776	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	102.0	CHEMBL299	Homo sapiens	Residual Activity	%	102.0
	12260777	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	105.0	CHEMBL299	Homo sapiens	Residual Activity	%	105.0
	12260778	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	101.0	CHEMBL299	Homo sapiens	Residual Activity	%	101.0
	12260779	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	36.0	CHEMBL299	Homo sapiens	Residual Activity	%	36.0
	12262425	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	109.0	CHEMBL299	Homo sapiens	Residual Activity	%	109.0
	12262426	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	102.0	CHEMBL299	Homo sapiens	Residual Activity	%	102.0
	12262427	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	115.0	CHEMBL299	Homo sapiens	Residual Activity	%	115.0
	12262428	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	103.0	CHEMBL299	Homo sapiens	Residual Activity	%	103.0
	12262429	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	110.0	CHEMBL299	Homo sapiens	Residual Activity	%	110.0
	12262430	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	105.0	CHEMBL299	Homo sapiens	Residual Activity	%	105.0
	12262431	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	108.0	CHEMBL299	Homo sapiens	Residual Activity	%	108.0
	12262432	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	91.0	CHEMBL299	Homo sapiens	Residual Activity	%	91.0
	12262433	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	106.0	CHEMBL299	Homo sapiens	Residual Activity	%	106.0
	12262434	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	95.0	CHEMBL299	Homo sapiens	Residual Activity	%	95.0
	12262435	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	1.0	CHEMBL299	Homo sapiens	Residual Activity	%	1.0
	12262436	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	117.0	CHEMBL299	Homo sapiens	Residual Activity	%	117.0
	12262437	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	101.0	CHEMBL299	Homo sapiens	Residual Activity	%	101.0
	12262438	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	103.0	CHEMBL299	Homo sapiens	Residual Activity	%	103.0
	12262439	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	106.0	CHEMBL299	Homo sapiens	Residual Activity	%	106.0
	12262440	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	100.0	CHEMBL299	Homo sapiens	Residual Activity	%	100.0
	12262441	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	104.0	CHEMBL299	Homo sapiens	Residual Activity	%	104.0
	12262442	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	1.0	CHEMBL299	Homo sapiens	Residual Activity	%	1.0
	12262443	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	93.0	CHEMBL299	Homo sapiens	Residual Activity	%	93.0
	12262444	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	63.0	CHEMBL299	Homo sapiens	Residual Activity	%	63.0
	12262445	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	102.0	CHEMBL299	Homo sapiens	Residual Activity	%	102.0
	12262446	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	94.0	CHEMBL299	Homo sapiens	Residual Activity	%	94.0
	12262447	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	105.0	CHEMBL299	Homo sapiens	Residual Activity	%	105.0
	12262448	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	106.0	CHEMBL299	Homo sapiens	Residual Activity	%	106.0
	12262449	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	109.0	CHEMBL299	Homo sapiens	Residual Activity	%	109.0
	12262450	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	107.0	CHEMBL299	Homo sapiens	Residual Activity	%	107.0
	12262451	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	95.0	CHEMBL299	Homo sapiens	Residual Activity	%	95.0
	12262452	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	93.0	CHEMBL299	Homo sapiens	Residual Activity	%	93.0
	12262453	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	102.0	CHEMBL299	Homo sapiens	Residual Activity	%	102.0
	12262454	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	97.0	CHEMBL299	Homo sapiens	Residual Activity	%	97.0
	12262455	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	99.0	CHEMBL299	Homo sapiens	Residual Activity	%	99.0
	12262456	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	107.0	CHEMBL299	Homo sapiens	Residual Activity	%	107.0
	12262457	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	108.0	CHEMBL299	Homo sapiens	Residual Activity	%	108.0
	12262458	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	106.0	CHEMBL299	Homo sapiens	Residual Activity	%	106.0
	12262459	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	108.0	CHEMBL299	Homo sapiens	Residual Activity	%	108.0
	12262460	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	88.0	CHEMBL299	Homo sapiens	Residual Activity	%	88.0
	12262461	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	106.0	CHEMBL299	Homo sapiens	Residual Activity	%	106.0
	12262462	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	102.0	CHEMBL299	Homo sapiens	Residual Activity	%	102.0
	12262463	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	97.0	CHEMBL299	Homo sapiens	Residual Activity	%	97.0
	12262464	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	19.0	CHEMBL299	Homo sapiens	Residual Activity	%	19.0
	12262465	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	113.0	CHEMBL299	Homo sapiens	Residual Activity	%	113.0
	12262466	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	96.0	CHEMBL299	Homo sapiens	Residual Activity	%	96.0
	12262467	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	100.0	CHEMBL299	Homo sapiens	Residual Activity	%	100.0
	12262468	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	99.0	CHEMBL299	Homo sapiens	Residual Activity	%	99.0
	12262469	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	101.0	CHEMBL299	Homo sapiens	Residual Activity	%	101.0
	12262470	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	106.0	CHEMBL299	Homo sapiens	Residual Activity	%	106.0
	12262471	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	104.0	CHEMBL299	Homo sapiens	Residual Activity	%	104.0
	12262472	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	90.0	CHEMBL299	Homo sapiens	Residual Activity	%	90.0
	12262473	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	110.0	CHEMBL299	Homo sapiens	Residual Activity	%	110.0
	12262474	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	113.0	CHEMBL299	Homo sapiens	Residual Activity	%	113.0
	12262475	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	92.0	CHEMBL299	Homo sapiens	Residual Activity	%	92.0
	12262476	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	106.0	CHEMBL299	Homo sapiens	Residual Activity	%	106.0
	12262477	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	99.0	CHEMBL299	Homo sapiens	Residual Activity	%	99.0
	12262478	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	85.0	CHEMBL299	Homo sapiens	Residual Activity	%	85.0
	12262479	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	91.0	CHEMBL299	Homo sapiens	Residual Activity	%	91.0
	12262480	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	107.0	CHEMBL299	Homo sapiens	Residual Activity	%	107.0
	12262481	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	105.0	CHEMBL299	Homo sapiens	Residual Activity	%	105.0
	12262482	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	104.0	CHEMBL299	Homo sapiens	Residual Activity	%	104.0
	12262483	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	97.0	CHEMBL299	Homo sapiens	Residual Activity	%	97.0
	12262484	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	89.0	CHEMBL299	Homo sapiens	Residual Activity	%	89.0
	12262485	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	101.0	CHEMBL299	Homo sapiens	Residual Activity	%	101.0
	12262486	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	96.0	CHEMBL299	Homo sapiens	Residual Activity	%	96.0
	12262487	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	96.0	CHEMBL299	Homo sapiens	Residual Activity	%	96.0
	12262488	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	116.0	CHEMBL299	Homo sapiens	Residual Activity	%	116.0
	12262489	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	104.0	CHEMBL299	Homo sapiens	Residual Activity	%	104.0
	12262490	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	110.0	CHEMBL299	Homo sapiens	Residual Activity	%	110.0
	12262491	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	96.0	CHEMBL299	Homo sapiens	Residual Activity	%	96.0
	12262492	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	51.0	CHEMBL299	Homo sapiens	Residual Activity	%	51.0
	12262493	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	34.0	CHEMBL299	Homo sapiens	Residual Activity	%	34.0
	12262494	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	102.0	CHEMBL299	Homo sapiens	Residual Activity	%	102.0
	12262495	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	98.0	CHEMBL299	Homo sapiens	Residual Activity	%	98.0
	12262496	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	103.0	CHEMBL299	Homo sapiens	Residual Activity	%	103.0
	12262497	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	109.0	CHEMBL299	Homo sapiens	Residual Activity	%	109.0
	12262498	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	83.0	CHEMBL299	Homo sapiens	Residual Activity	%	83.0
	12262499	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	101.0	CHEMBL299	Homo sapiens	Residual Activity	%	101.0
	12262500	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	95.0	CHEMBL299	Homo sapiens	Residual Activity	%	95.0
	12262501	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	98.0	CHEMBL299	Homo sapiens	Residual Activity	%	98.0
	12262502	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	101.0	CHEMBL299	Homo sapiens	Residual Activity	%	101.0
	12262503	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	107.0	CHEMBL299	Homo sapiens	Residual Activity	%	107.0
	12262504	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	111.0	CHEMBL299	Homo sapiens	Residual Activity	%	111.0
	12262505	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	99.0	CHEMBL299	Homo sapiens	Residual Activity	%	99.0
	12262506	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	101.0	CHEMBL299	Homo sapiens	Residual Activity	%	101.0
	12262507	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	90.0	CHEMBL299	Homo sapiens	Residual Activity	%	90.0
	12262508	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	105.0	CHEMBL299	Homo sapiens	Residual Activity	%	105.0
	12262509	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	105.0	CHEMBL299	Homo sapiens	Residual Activity	%	105.0
	12262510	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	102.0	CHEMBL299	Homo sapiens	Residual Activity	%	102.0
	12262511	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	108.0	CHEMBL299	Homo sapiens	Residual Activity	%	108.0
	12262512	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	114.0	CHEMBL299	Homo sapiens	Residual Activity	%	114.0
	12262513	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	108.0	CHEMBL299	Homo sapiens	Residual Activity	%	108.0
	12262514	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	105.0	CHEMBL299	Homo sapiens	Residual Activity	%	105.0
	12262515	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	100.0	CHEMBL299	Homo sapiens	Residual Activity	%	100.0
	12262516	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	103.0	CHEMBL299	Homo sapiens	Residual Activity	%	103.0
	12262517	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	109.0	CHEMBL299	Homo sapiens	Residual Activity	%	109.0
	12262518	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	103.0	CHEMBL299	Homo sapiens	Residual Activity	%	103.0
	12262519	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	112.0	CHEMBL299	Homo sapiens	Residual Activity	%	112.0
	12262520	CHEMBL2219398	Millipore: Percentage of residual kinase activity of PRKCA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	98.0	CHEMBL299	Homo sapiens	Residual Activity	%	98.0
	12262521	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	93.0	CHEMBL299	Homo sapiens	Residual Activity	%	93.0
	12262522	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	4.0	CHEMBL299	Homo sapiens	Residual Activity	%	4.0
	12262523	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	101.0	CHEMBL299	Homo sapiens	Residual Activity	%	101.0
	12262524	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	98.0	CHEMBL299	Homo sapiens	Residual Activity	%	98.0
	12262525	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	95.0	CHEMBL299	Homo sapiens	Residual Activity	%	95.0
	12262526	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	97.0	CHEMBL299	Homo sapiens	Residual Activity	%	97.0
	12262527	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	104.0	CHEMBL299	Homo sapiens	Residual Activity	%	104.0
	12262528	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	108.0	CHEMBL299	Homo sapiens	Residual Activity	%	108.0
	12262529	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	96.0	CHEMBL299	Homo sapiens	Residual Activity	%	96.0
	12262530	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	98.0	CHEMBL299	Homo sapiens	Residual Activity	%	98.0
	12262531	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	96.0	CHEMBL299	Homo sapiens	Residual Activity	%	96.0
	12262532	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	102.0	CHEMBL299	Homo sapiens	Residual Activity	%	102.0
	12262533	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	91.0	CHEMBL299	Homo sapiens	Residual Activity	%	91.0
	12262534	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	93.0	CHEMBL299	Homo sapiens	Residual Activity	%	93.0
	12262535	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	8.0	CHEMBL299	Homo sapiens	Residual Activity	%	8.0
	12262536	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	105.0	CHEMBL299	Homo sapiens	Residual Activity	%	105.0
	12262537	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	103.0	CHEMBL299	Homo sapiens	Residual Activity	%	103.0
	12262538	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	100.0	CHEMBL299	Homo sapiens	Residual Activity	%	100.0
	12262539	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	100.0	CHEMBL299	Homo sapiens	Residual Activity	%	100.0
	12262540	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	62.0	CHEMBL299	Homo sapiens	Residual Activity	%	62.0
	12262541	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	108.0	CHEMBL299	Homo sapiens	Residual Activity	%	108.0
	12262542	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	101.0	CHEMBL299	Homo sapiens	Residual Activity	%	101.0
	12262543	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	111.0	CHEMBL299	Homo sapiens	Residual Activity	%	111.0
	12262544	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	101.0	CHEMBL299	Homo sapiens	Residual Activity	%	101.0
	12262545	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	101.0	CHEMBL299	Homo sapiens	Residual Activity	%	101.0
	12262546	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	97.0	CHEMBL299	Homo sapiens	Residual Activity	%	97.0
	12262547	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	93.0	CHEMBL299	Homo sapiens	Residual Activity	%	93.0
	12262548	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	109.0	CHEMBL299	Homo sapiens	Residual Activity	%	109.0
	12262549	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	103.0	CHEMBL299	Homo sapiens	Residual Activity	%	103.0
	12262550	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	2.0	CHEMBL299	Homo sapiens	Residual Activity	%	2.0
	12262551	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	100.0	CHEMBL299	Homo sapiens	Residual Activity	%	100.0
	12262552	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	101.0	CHEMBL299	Homo sapiens	Residual Activity	%	101.0
	12262553	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	104.0	CHEMBL299	Homo sapiens	Residual Activity	%	104.0
	12262554	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	96.0	CHEMBL299	Homo sapiens	Residual Activity	%	96.0
	12262555	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	100.0	CHEMBL299	Homo sapiens	Residual Activity	%	100.0
	12262556	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	103.0	CHEMBL299	Homo sapiens	Residual Activity	%	103.0
	12262557	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	99.0	CHEMBL299	Homo sapiens	Residual Activity	%	99.0
	12262558	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	99.0	CHEMBL299	Homo sapiens	Residual Activity	%	99.0
	12262559	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	108.0	CHEMBL299	Homo sapiens	Residual Activity	%	108.0
	12262560	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	105.0	CHEMBL299	Homo sapiens	Residual Activity	%	105.0
	12262561	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	107.0	CHEMBL299	Homo sapiens	Residual Activity	%	107.0
	12262562	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	102.0	CHEMBL299	Homo sapiens	Residual Activity	%	102.0
	12262563	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	3.0	CHEMBL299	Homo sapiens	Residual Activity	%	3.0
	12262564	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	45.0	CHEMBL299	Homo sapiens	Residual Activity	%	45.0
	12262565	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	99.0	CHEMBL299	Homo sapiens	Residual Activity	%	99.0
	12262566	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	80.0	CHEMBL299	Homo sapiens	Residual Activity	%	80.0
	12262567	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	104.0	CHEMBL299	Homo sapiens	Residual Activity	%	104.0
	12262568	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	104.0	CHEMBL299	Homo sapiens	Residual Activity	%	104.0
	12262569	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	93.0	CHEMBL299	Homo sapiens	Residual Activity	%	93.0
	12262570	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	98.0	CHEMBL299	Homo sapiens	Residual Activity	%	98.0
	12262571	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	0.0	CHEMBL299	Homo sapiens	Residual Activity	%	0.0
	12262572	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	98.0	CHEMBL299	Homo sapiens	Residual Activity	%	98.0
	12262573	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	18.0	CHEMBL299	Homo sapiens	Residual Activity	%	18.0
	12262574	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	85.0	CHEMBL299	Homo sapiens	Residual Activity	%	85.0
	12262575	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	109.0	CHEMBL299	Homo sapiens	Residual Activity	%	109.0
	12262576	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	102.0	CHEMBL299	Homo sapiens	Residual Activity	%	102.0
	12262577	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	107.0	CHEMBL299	Homo sapiens	Residual Activity	%	107.0
	12262578	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	105.0	CHEMBL299	Homo sapiens	Residual Activity	%	105.0
	12262579	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	109.0	CHEMBL299	Homo sapiens	Residual Activity	%	109.0
	12262580	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	100.0	CHEMBL299	Homo sapiens	Residual Activity	%	100.0
	12262581	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	82.0	CHEMBL299	Homo sapiens	Residual Activity	%	82.0
	12262582	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	14.0	CHEMBL299	Homo sapiens	Residual Activity	%	14.0
	12262583	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	105.0	CHEMBL299	Homo sapiens	Residual Activity	%	105.0
	12262584	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	103.0	CHEMBL299	Homo sapiens	Residual Activity	%	103.0
	12262585	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	110.0	CHEMBL299	Homo sapiens	Residual Activity	%	110.0
	12262586	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	101.0	CHEMBL299	Homo sapiens	Residual Activity	%	101.0
	12262587	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	107.0	CHEMBL299	Homo sapiens	Residual Activity	%	107.0
	12262588	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	102.0	CHEMBL299	Homo sapiens	Residual Activity	%	102.0
	12262589	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	88.0	CHEMBL299	Homo sapiens	Residual Activity	%	88.0
	12262590	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	96.0	CHEMBL299	Homo sapiens	Residual Activity	%	96.0
	12262591	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	109.0	CHEMBL299	Homo sapiens	Residual Activity	%	109.0
	12262592	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	66.0	CHEMBL299	Homo sapiens	Residual Activity	%	66.0
	12262593	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	1.0	CHEMBL299	Homo sapiens	Residual Activity	%	1.0
	12262594	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	114.0	CHEMBL299	Homo sapiens	Residual Activity	%	114.0
	12262595	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	110.0	CHEMBL299	Homo sapiens	Residual Activity	%	110.0
	12262596	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	88.0	CHEMBL299	Homo sapiens	Residual Activity	%	88.0
	12262597	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	102.0	CHEMBL299	Homo sapiens	Residual Activity	%	102.0
	12262598	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	83.0	CHEMBL299	Homo sapiens	Residual Activity	%	83.0
	12262599	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	99.0	CHEMBL299	Homo sapiens	Residual Activity	%	99.0
	12262600	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL299	Homo sapiens	Residual Activity	%	0.0
	12262601	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	95.0	CHEMBL299	Homo sapiens	Residual Activity	%	95.0
	12262602	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	18.0	CHEMBL299	Homo sapiens	Residual Activity	%	18.0
	12262603	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	103.0	CHEMBL299	Homo sapiens	Residual Activity	%	103.0
	12262604	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	84.0	CHEMBL299	Homo sapiens	Residual Activity	%	84.0
	12262605	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	98.0	CHEMBL299	Homo sapiens	Residual Activity	%	98.0
	12262606	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	108.0	CHEMBL299	Homo sapiens	Residual Activity	%	108.0
	12262607	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	106.0	CHEMBL299	Homo sapiens	Residual Activity	%	106.0
	12262608	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	90.0	CHEMBL299	Homo sapiens	Residual Activity	%	90.0
	12262609	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	86.0	CHEMBL299	Homo sapiens	Residual Activity	%	86.0
	12262610	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	86.0	CHEMBL299	Homo sapiens	Residual Activity	%	86.0
	12262611	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	101.0	CHEMBL299	Homo sapiens	Residual Activity	%	101.0
	12262612	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	91.0	CHEMBL299	Homo sapiens	Residual Activity	%	91.0
	12262613	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	63.0	CHEMBL299	Homo sapiens	Residual Activity	%	63.0
	12262614	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	101.0	CHEMBL299	Homo sapiens	Residual Activity	%	101.0
	12262615	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	96.0	CHEMBL299	Homo sapiens	Residual Activity	%	96.0
	12262616	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	88.0	CHEMBL299	Homo sapiens	Residual Activity	%	88.0
	12262617	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	102.0	CHEMBL299	Homo sapiens	Residual Activity	%	102.0
	12262618	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	93.0	CHEMBL299	Homo sapiens	Residual Activity	%	93.0
	12262619	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	105.0	CHEMBL299	Homo sapiens	Residual Activity	%	105.0
	12262620	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	92.0	CHEMBL299	Homo sapiens	Residual Activity	%	92.0
	12262621	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	84.0	CHEMBL299	Homo sapiens	Residual Activity	%	84.0
	12262622	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL299	Homo sapiens	Residual Activity	%	0.0
	12262623	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	104.0	CHEMBL299	Homo sapiens	Residual Activity	%	104.0
	12262624	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	98.0	CHEMBL299	Homo sapiens	Residual Activity	%	98.0
	12262625	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	105.0	CHEMBL299	Homo sapiens	Residual Activity	%	105.0
	12262626	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	102.0	CHEMBL299	Homo sapiens	Residual Activity	%	102.0
	12262627	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	99.0	CHEMBL299	Homo sapiens	Residual Activity	%	99.0
	12262628	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	98.0	CHEMBL299	Homo sapiens	Residual Activity	%	98.0
	12262629	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	90.0	CHEMBL299	Homo sapiens	Residual Activity	%	90.0
	12262630	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	70.0	CHEMBL299	Homo sapiens	Residual Activity	%	70.0
	12262631	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	99.0	CHEMBL299	Homo sapiens	Residual Activity	%	99.0
	12262632	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	101.0	CHEMBL299	Homo sapiens	Residual Activity	%	101.0
	12262633	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	94.0	CHEMBL299	Homo sapiens	Residual Activity	%	94.0
	12262634	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	95.0	CHEMBL299	Homo sapiens	Residual Activity	%	95.0
	12262635	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	90.0	CHEMBL299	Homo sapiens	Residual Activity	%	90.0
	12262636	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	3.0	CHEMBL299	Homo sapiens	Residual Activity	%	3.0
	12262637	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	54.0	CHEMBL299	Homo sapiens	Residual Activity	%	54.0
	12262638	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	94.0	CHEMBL299	Homo sapiens	Residual Activity	%	94.0
	12262639	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	39.0	CHEMBL299	Homo sapiens	Residual Activity	%	39.0
	12262640	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	102.0	CHEMBL299	Homo sapiens	Residual Activity	%	102.0
	12262641	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	100.0	CHEMBL299	Homo sapiens	Residual Activity	%	100.0
	12262642	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	58.0	CHEMBL299	Homo sapiens	Residual Activity	%	58.0
	12262643	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	63.0	CHEMBL299	Homo sapiens	Residual Activity	%	63.0
	12262644	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	95.0	CHEMBL299	Homo sapiens	Residual Activity	%	95.0
	12262645	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	65.0	CHEMBL299	Homo sapiens	Residual Activity	%	65.0
	12262646	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	99.0	CHEMBL299	Homo sapiens	Residual Activity	%	99.0
	12262647	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	97.0	CHEMBL299	Homo sapiens	Residual Activity	%	97.0
	12262648	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	101.0	CHEMBL299	Homo sapiens	Residual Activity	%	101.0
	12262649	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	100.0	CHEMBL299	Homo sapiens	Residual Activity	%	100.0
	12262650	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	18.0	CHEMBL299	Homo sapiens	Residual Activity	%	18.0
	12262651	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	13.0	CHEMBL299	Homo sapiens	Residual Activity	%	13.0
	12262652	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	101.0	CHEMBL299	Homo sapiens	Residual Activity	%	101.0
	12262653	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	73.0	CHEMBL299	Homo sapiens	Residual Activity	%	73.0
	12262654	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	3.0	CHEMBL299	Homo sapiens	Residual Activity	%	3.0
	12262655	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	97.0	CHEMBL299	Homo sapiens	Residual Activity	%	97.0
	12262656	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	97.0	CHEMBL299	Homo sapiens	Residual Activity	%	97.0
	12262657	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	105.0	CHEMBL299	Homo sapiens	Residual Activity	%	105.0
	12262658	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	58.0	CHEMBL299	Homo sapiens	Residual Activity	%	58.0
	12262659	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	104.0	CHEMBL299	Homo sapiens	Residual Activity	%	104.0
	12264301	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	97.0	CHEMBL299	Homo sapiens	Residual Activity	%	97.0
	12264302	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	96.0	CHEMBL299	Homo sapiens	Residual Activity	%	96.0
	12264303	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	83.0	CHEMBL299	Homo sapiens	Residual Activity	%	83.0
	12264304	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	98.0	CHEMBL299	Homo sapiens	Residual Activity	%	98.0
	12264305	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	107.0	CHEMBL299	Homo sapiens	Residual Activity	%	107.0
	12264306	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	96.0	CHEMBL299	Homo sapiens	Residual Activity	%	96.0
	12264307	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	107.0	CHEMBL299	Homo sapiens	Residual Activity	%	107.0
	12264308	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	101.0	CHEMBL299	Homo sapiens	Residual Activity	%	101.0
	12264309	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	82.0	CHEMBL299	Homo sapiens	Residual Activity	%	82.0
	12264310	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	86.0	CHEMBL299	Homo sapiens	Residual Activity	%	86.0
	12264311	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	105.0	CHEMBL299	Homo sapiens	Residual Activity	%	105.0
	12264312	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	88.0	CHEMBL299	Homo sapiens	Residual Activity	%	88.0
	12264313	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	102.0	CHEMBL299	Homo sapiens	Residual Activity	%	102.0
	12264314	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	107.0	CHEMBL299	Homo sapiens	Residual Activity	%	107.0
	12264315	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	95.0	CHEMBL299	Homo sapiens	Residual Activity	%	95.0
	12264316	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	98.0	CHEMBL299	Homo sapiens	Residual Activity	%	98.0
	12264317	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	103.0	CHEMBL299	Homo sapiens	Residual Activity	%	103.0
	12264318	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	92.0	CHEMBL299	Homo sapiens	Residual Activity	%	92.0
	12264319	CHEMBL2219399	Millipore: Percentage of residual kinase activity of PRKCA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mM CaCl2, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	55.0	CHEMBL299	Homo sapiens	Residual Activity	%	55.0
	12659901	CHEMBL2327343	Inhibition of PKCalpha (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 100 uM ATP	B	c1cc2c(ncc3nnc(C4CCCCC4)n32)[nH]1		CHEMBL2322141	=	IC50	nM	18000.0	CHEMBL299	Homo sapiens	IC50	uM	18.0
	12659902	CHEMBL2327343	Inhibition of PKCalpha (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 100 uM ATP	B	FC(F)(F)c1nc2cnc3[nH]ccc3c2n1C1CCCCC1		CHEMBL2322139	=	IC50	nM	1700.0	CHEMBL299	Homo sapiens	IC50	uM	1.7
	12659903	CHEMBL2327343	Inhibition of PKCalpha (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 100 uM ATP	B	Cc1nc2cnc3[nH]ccc3c2n1C1CCCCC1		CHEMBL2159198	=	IC50	nM	1300.0	CHEMBL299	Homo sapiens	IC50	uM	1.3
	12659904	CHEMBL2327343	Inhibition of PKCalpha (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 100 uM ATP	B	c1cc2c(ncc3ncn(C4CCCCC4)c32)[nH]1		CHEMBL2322138	=	IC50	nM	1700.0	CHEMBL299	Homo sapiens	IC50	uM	1.7
	12659905	CHEMBL2327343	Inhibition of PKCalpha (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 100 uM ATP	B	c1cc2c(ncc3onc(C4CCCCC4)c32)[nH]1		CHEMBL2322137	=	IC50	nM	2800.0	CHEMBL299	Homo sapiens	IC50	uM	2.8
	12659906	CHEMBL2327343	Inhibition of PKCalpha (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 100 uM ATP	B	Cn1nc(C2CCCCC2)c2c3cc[nH]c3ncc21		CHEMBL2322136	=	IC50	nM	2600.0	CHEMBL299	Homo sapiens	IC50	uM	2.6
	12659907	CHEMBL2327343	Inhibition of PKCalpha (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 100 uM ATP	B	c1cc2c(ncc3[nH]nc(C4CCCCC4)c32)[nH]1		CHEMBL2322135	=	IC50	nM	1300.0	CHEMBL299	Homo sapiens	IC50	uM	1.3
	12662188	CHEMBL2330914	Inhibition of PKC alpha (unknown origin) using RRRRRKGSFKRKA as substrate after 15 mins by spectrophotometry in presence of ATP	B	c1cc(-c2n[nH]c3ncccc23)nc(N2CCNCC2)c1		CHEMBL2326014	=	Ki	nM	1230.0	CHEMBL299	Homo sapiens	Ki	nM	1230.0
	12663465	CHEMBL2330914	Inhibition of PKC alpha (unknown origin) using RRRRRKGSFKRKA as substrate after 15 mins by spectrophotometry in presence of ATP	B	CC(C)[C@@](C)(O)[C@@H]1CN(c2nc(-c3n[nH]c4ncccc34)c(F)cc2Cl)CCN1		CHEMBL2326002	=	Ki	nM	356.0	CHEMBL299	Homo sapiens	Ki	nM	356.0
	12663466	CHEMBL2330914	Inhibition of PKC alpha (unknown origin) using RRRRRKGSFKRKA as substrate after 15 mins by spectrophotometry in presence of ATP	B	CC(C)[C@@](C)(O)[C@@H]1CN(c2nc(-c3n[nH]c4ncccc34)c(F)cc2F)CCN1		CHEMBL2326001	=	Ki	nM	198.0	CHEMBL299	Homo sapiens	Ki	nM	198.0
	12663467	CHEMBL2330914	Inhibition of PKC alpha (unknown origin) using RRRRRKGSFKRKA as substrate after 15 mins by spectrophotometry in presence of ATP	B	CC(C)[C@@](C)(O)[C@@H]1CN(c2nc(-c3n[nH]c4ncccc34)c(F)cc2CO)CCN1		CHEMBL2326000	=	Ki	nM	205.0	CHEMBL299	Homo sapiens	Ki	nM	205.0
	12663468	CHEMBL2330914	Inhibition of PKC alpha (unknown origin) using RRRRRKGSFKRKA as substrate after 15 mins by spectrophotometry in presence of ATP	B	CC(C)[C@@](C)(O)[C@@H]1CN(c2nc(-c3n[nH]c4ncccc34)c(F)cc2C#N)CCN1		CHEMBL2325999	>	Ki	nM	1250.0	CHEMBL299	Homo sapiens	Ki	nM	1250.0
	12663469	CHEMBL2330914	Inhibition of PKC alpha (unknown origin) using RRRRRKGSFKRKA as substrate after 15 mins by spectrophotometry in presence of ATP	B	CC(C)[C@@](C)(O)[C@@H]1CN(c2nc(-c3n[nH]c4ncccc34)c(F)cc2O)CCN1		CHEMBL2325998	=	Ki	nM	56.0	CHEMBL299	Homo sapiens	Ki	nM	56.0
	12663470	CHEMBL2330914	Inhibition of PKC alpha (unknown origin) using RRRRRKGSFKRKA as substrate after 15 mins by spectrophotometry in presence of ATP	B	CC(C)[C@@](C)(O)[C@@H]1CN(c2ccc(C(F)(F)F)c(-c3n[nH]c4ncccc34)n2)CCN1		CHEMBL2326013	>	Ki	nM	1250.0	CHEMBL299	Homo sapiens	Ki	nM	1250.0
	12663471	CHEMBL2330914	Inhibition of PKC alpha (unknown origin) using RRRRRKGSFKRKA as substrate after 15 mins by spectrophotometry in presence of ATP	B	CC(C)[C@@](C)(O)[C@@H]1CN(c2ccc(Cl)c(-c3n[nH]c4ncccc34)n2)CCN1		CHEMBL2326012	=	Ki	nM	1240.0	CHEMBL299	Homo sapiens	Ki	nM	1240.0
	12663472	CHEMBL2330914	Inhibition of PKC alpha (unknown origin) using RRRRRKGSFKRKA as substrate after 15 mins by spectrophotometry in presence of ATP	B	CC(C)[C@@](C)(O)[C@@H]1CN(c2ccc(F)c(-c3n[nH]c4ncccc34)n2)CCN1		CHEMBL2326007	=	Ki	nM	549.0	CHEMBL299	Homo sapiens	Ki	nM	549.0
	12663473	CHEMBL2330914	Inhibition of PKC alpha (unknown origin) using RRRRRKGSFKRKA as substrate after 15 mins by spectrophotometry in presence of ATP	B	Fc1ccc(N2CCNCC2)nc1-c1n[nH]c2ncccc12		CHEMBL2326015	>	Ki	nM	1250.0	CHEMBL299	Homo sapiens	Ki	nM	1250.0
	12663474	CHEMBL2330914	Inhibition of PKC alpha (unknown origin) using RRRRRKGSFKRKA as substrate after 15 mins by spectrophotometry in presence of ATP	B	Nc1ncccc1C(=O)c1cccc(N2CCNCC2)n1		CHEMBL2046626	=	Ki	nM	418.0	CHEMBL299	Homo sapiens	Ki	nM	418.0
	12663475	CHEMBL2330914	Inhibition of PKC alpha (unknown origin) using RRRRRKGSFKRKA as substrate after 15 mins by spectrophotometry in presence of ATP	B	Nc1ncccc1C(=O)c1cccc(N2CCCNCC2)n1		CHEMBL2046624	=	Ki	nM	428.0	CHEMBL299	Homo sapiens	Ki	nM	428.0
	12670836	CHEMBL2346205	Inhibition of PKCalpha (unknown origin) at 100 uM relative to control	B	O=C1CC(Cc2ccccc2)Sc2ccccc2N1Cc1ccccc1[N+](=O)[O-]		CHEMBL2334795	=	Inhibition	%	12.0	CHEMBL299	Homo sapiens	INH	%	12.0
	12672921	CHEMBL2341628	Inhibition of recombinant PKCalpha (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	68.0	CHEMBL299	Homo sapiens	Activity	%	68.0
	12672922	CHEMBL2341628	Inhibition of recombinant PKCalpha (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	71.0	CHEMBL299	Homo sapiens	Activity	%	71.0
	12693194	CHEMBL2343436	Inhibition of PKCalpha (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
Not Active	12706286	CHEMBL2340729	Binding affinity to PKC alpha (unknown origin)	B	C=C1CC[C@H]2C(C)(C)CCC[C@]2(C)[C@H]1C[C@@]12C[C@H]3C(=O)N4CCC[C@H]4C(=O)N3[C@@H]1Nc1ccccc12		CHEMBL2333539		Activity			CHEMBL299	Homo sapiens	Activity		
Not Active	12706287	CHEMBL2340729	Binding affinity to PKC alpha (unknown origin)	B	C=C1CC[C@H]2C(C)(C)CCC[C@]2(C)[C@H]1C[C@@]12C[C@H]3C(=O)N(C)[C@@H](C(C)C)C(=O)N3[C@@H]1N(C=O)c1ccccc12		CHEMBL2333538		Activity			CHEMBL299	Homo sapiens	Activity		
Not Active	12706288	CHEMBL2340729	Binding affinity to PKC alpha (unknown origin)	B	CC(C)[C@H]1C(=O)N[C@@H](C[C@]23C[C@H]4C(=C[C@H]2N(C=O)c2ccccc23)CC[C@H]2C(C)(C)CCC[C@@]24C)C(=O)N1C		CHEMBL2333540		Activity			CHEMBL299	Homo sapiens	Activity		
	12716043	CHEMBL2350815	Inhibition of PKCalpha (unknown origin)	B	CNc1nc(C)c(-c2nc(Nc3cccc(N4CCCNCC4)c3)ncc2C#N)s1		CHEMBL2312185	>	IC50	nM	5000.0	CHEMBL299	Homo sapiens	IC50	nM	5000.0
	12718796	CHEMBL2350681	Inhibition of PKC alpha (unknown origin) using PIP2 as substrate after 1 hr by Kinase-Glo assay	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	IC50	nM	0.98	CHEMBL299	Homo sapiens	IC50	nM	0.98
	12718820	CHEMBL2350704	Inhibition of PKC alpha (unknown origin) using PIP2 as substrate at 3 uM after 1 hr by Kinase-Glo assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	Inhibition	%	4.4	CHEMBL299	Homo sapiens	INH	%	4.4
	12718843	CHEMBL2350999	Inhibition of PKC alpha (unknown origin) using PIP2 as substrate at 10 uM after 1 hr by Kinase-Glo assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	Inhibition	%	13.0	CHEMBL299	Homo sapiens	INH	%	13.0
	12721802	CHEMBL2353786	Inhibition of PKAC-a (unknown origin) at 1 uM relative to control	B	CCNC(=O)Nc1nc2ccc(-c3ccccc3OC)cc2s1		CHEMBL2347710	=	Inhibition	%	100.0	CHEMBL299	Homo sapiens	INH	%	100.0
	12727691	CHEMBL2351404	Inhibition of PKCalpha (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	86.0	CHEMBL299	Homo sapiens	Activity	%	86.0
	12728977	CHEMBL2350154	Inhibition of PKCalpha (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	96.0	CHEMBL299	Homo sapiens	Activity	%	96.0
	12729858	CHEMBL2352444	Inhibition of PKCa (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	86.0	CHEMBL299	Homo sapiens	Activity	%	86.0
	12730120	CHEMBL2351404	Inhibition of PKCalpha (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	96.0	CHEMBL299	Homo sapiens	Activity	%	96.0
	13311856	CHEMBL2384678	Inhibition of human PKCA	B	COc1ccc2c(c1)C(=O)N(c1nc(C(=O)Nc3cnccc3N3CCNCC3)cs1)C2		CHEMBL2381116	>	IC50	nM	30000.0	CHEMBL299	Homo sapiens	IC50	nM	30000.0
	13321301	CHEMBL2389955	Inhibition of PKCA (unknown origin)	B	O=C1c2oc(-c3ccc(Cl)cc3)cc2Cc2cc(N3CCNCC3)ccc2N1Cc1ccccc1-c1cccnc1		CHEMBL2385543	=	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	13337522	CHEMBL2393649	Inhibition of human recombinant PKCalpha by FRET assay	B	CC(=O)Nc1cc(-c2nnc(SCc3ccc(-c4ccccc4C#N)cc3)o2)ccn1		CHEMBL2391102	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	13337523	CHEMBL2393649	Inhibition of human recombinant PKCalpha by FRET assay	B	CC(=O)Nc1cc(-c2nnc(SCc3cccc(C#N)c3)o2)ccn1		CHEMBL2391101	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	13337524	CHEMBL2393649	Inhibition of human recombinant PKCalpha by FRET assay	B	CC(=O)Nc1cc(-c2nnc(SCc3ccccc3)o2)ccn1		CHEMBL2391100	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	13337525	CHEMBL2393649	Inhibition of human recombinant PKCalpha by FRET assay	B	c1ccc(-c2ccc(CSc3nnc(-c4ccncc4)o3)cc2)cc1		CHEMBL2391099	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	13337526	CHEMBL2393649	Inhibition of human recombinant PKCalpha by FRET assay	B	N#Cc1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccncc3)o2)cc1		CHEMBL2391098	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	13337527	CHEMBL2393649	Inhibition of human recombinant PKCalpha by FRET assay	B	COc1ccc(-c2ccc(CSc3nnc(-c4ccncc4)o3)cc2)cc1		CHEMBL2391131	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	13337528	CHEMBL2393649	Inhibition of human recombinant PKCalpha by FRET assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccncc4)o3)cc2)cc1		CHEMBL2390958	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	13337529	CHEMBL2393649	Inhibition of human recombinant PKCalpha by FRET assay	B	N#Cc1cccc(-c2ccc(CSc3nnc(-c4ccncc4)o3)cc2)c1		CHEMBL2391132	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	13337530	CHEMBL2393649	Inhibition of human recombinant PKCalpha by FRET assay	B	O=[N+]([O-])c1ccccc1-c1ccc(CSc2nnc(-c3ccncc3)o2)cc1		CHEMBL2391133	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	13337531	CHEMBL2393649	Inhibition of human recombinant PKCalpha by FRET assay	B	Fc1cc(F)cc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)c1		CHEMBL2391117	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	13337532	CHEMBL2393649	Inhibition of human recombinant PKCalpha by FRET assay	B	COc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)c(C#N)c1		CHEMBL2391118	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	13337533	CHEMBL2393649	Inhibition of human recombinant PKCalpha by FRET assay	B	COc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2391119	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	13337534	CHEMBL2393649	Inhibition of human recombinant PKCalpha by FRET assay	B	O=[N+]([O-])c1cccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)c1		CHEMBL2391120	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	13337535	CHEMBL2393649	Inhibition of human recombinant PKCalpha by FRET assay	B	N#Cc1cccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)c1		CHEMBL2391121	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	13337536	CHEMBL2393649	Inhibition of human recombinant PKCalpha by FRET assay	B	O=[N+]([O-])c1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1		CHEMBL2391122	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	13337537	CHEMBL2393649	Inhibition of human recombinant PKCalpha by FRET assay	B	c1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)cc1		CHEMBL2391123	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	13337538	CHEMBL2393649	Inhibition of human recombinant PKCalpha by FRET assay	B	Fc1cc(F)cc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)c1		CHEMBL2391124	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	13337539	CHEMBL2393649	Inhibition of human recombinant PKCalpha by FRET assay	B	COc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)c(C#N)c1		CHEMBL2391125	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	13337540	CHEMBL2393649	Inhibition of human recombinant PKCalpha by FRET assay	B	COc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)cc1		CHEMBL2391126	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	13337541	CHEMBL2393649	Inhibition of human recombinant PKCalpha by FRET assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)cc1		CHEMBL2391127	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	13337542	CHEMBL2393649	Inhibition of human recombinant PKCalpha by FRET assay	B	O=[N+]([O-])c1cccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)c1		CHEMBL2391128	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	13337543	CHEMBL2393649	Inhibition of human recombinant PKCalpha by FRET assay	B	N#Cc1cccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)c1		CHEMBL2391130	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	13337544	CHEMBL2393649	Inhibition of human recombinant PKCalpha by FRET assay	B	O=[N+]([O-])c1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2391129	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	13351568	CHEMBL2399775	Inhibition of human PKCalpha at 10 uM relative to control	B	Cl.O=c1[nH]nc2c(NCCCc3ccncc3)cc(Cl)cn12		CHEMBL2397859	=	Inhibition	%	18.0	CHEMBL299	Homo sapiens	INH	%	18.0
	13374384	CHEMBL2406515	Inhibition of PKCalpha (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	13.0	CHEMBL299	Homo sapiens	INH	%	13.0
	13413167	CHEMBL2421509	Displacement of [3H]PDBu from PKCalpha C1A domain (unknown origin)	B	C[C@@H](CCCc1cccc(O)c1)[C@H]1O[C@@]23C[C@H](OC(=O)C[C@H]([C@@H](C)O)OC(=O)C[C@](O)(O2)[C@H](C)CC3(C)C)[C@@H]1C		CHEMBL2418196	=	Ki	nM	1.0	CHEMBL299	Homo sapiens	Ki	nM	1.0
	13419754	CHEMBL2422284	Inhibition of PKCalpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	35.0	CHEMBL299	Homo sapiens	INH	%	35.0
	13419755	CHEMBL2422284	Inhibition of PKCalpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	78.0	CHEMBL299	Homo sapiens	INH	%	78.0
	13419756	CHEMBL2422284	Inhibition of PKCalpha (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	59.0	CHEMBL299	Homo sapiens	INH	%	59.0
	13434558	CHEMBL2424236	Inhibition of PKCalpha in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL299	Homo sapiens	INH	%	35.0
	13434559	CHEMBL2424236	Inhibition of PKCalpha in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL299	Homo sapiens	INH	%	35.0
	13434560	CHEMBL2424236	Inhibition of PKCalpha in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL299	Homo sapiens	INH	%	35.0
	13434561	CHEMBL2424236	Inhibition of PKCalpha in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL299	Homo sapiens	INH	%	35.0
	13434562	CHEMBL2424236	Inhibition of PKCalpha in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL299	Homo sapiens	INH	%	35.0
	13434563	CHEMBL2424236	Inhibition of PKCalpha in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL299	Homo sapiens	INH	%	35.0
	13434564	CHEMBL2424236	Inhibition of PKCalpha in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	<	Inhibition	%	35.0	CHEMBL299	Homo sapiens	INH	%	35.0
	13434565	CHEMBL2424236	Inhibition of PKCalpha in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL299	Homo sapiens	INH	%	35.0
	13434566	CHEMBL2424236	Inhibition of PKCalpha in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL299	Homo sapiens	INH	%	35.0
	13434567	CHEMBL2424236	Inhibition of PKCalpha in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	<	Inhibition	%	35.0	CHEMBL299	Homo sapiens	INH	%	35.0
	13434568	CHEMBL2424236	Inhibition of PKCalpha in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	<	Inhibition	%	35.0	CHEMBL299	Homo sapiens	INH	%	35.0
	13434569	CHEMBL2424236	Inhibition of PKCalpha in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	<	Inhibition	%	35.0	CHEMBL299	Homo sapiens	INH	%	35.0
	13440837	CHEMBL2429580	Inhibition of PKC-a (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc4c(N)ncnc43)cc2)cc1		CHEMBL2425144	=	Inhibition	%	1.0	CHEMBL299	Homo sapiens	INH	%	1.0
	13453015	CHEMBL2429580	Inhibition of PKC-a (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3cccnc3)cc2)cc1		CHEMBL2425156	=	Inhibition	%	-10.0	CHEMBL299	Homo sapiens	INH	%	-10.0
	13453063	CHEMBL2429580	Inhibition of PKC-a (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc(C)c3)cc2)cc1	Outside typical range	CHEMBL2425145	=	Inhibition	%	-14.0	CHEMBL299	Homo sapiens	INH	%	-14.0
	13464322	CHEMBL2433453	Inhibition of human PKCalpha assessed as residual activity at 1 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	79.0	CHEMBL299	Homo sapiens	Activity	%	79.0
	13464349	CHEMBL2433483	Inhibition of human PKCalpha assessed as residual activity at 10 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	81.0	CHEMBL299	Homo sapiens	Activity	%	81.0
	13465293	CHEMBL2433264	Inhibition of human PKCalpha assessed as residual activity at 25 uM relative to control	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	90.0	CHEMBL299	Homo sapiens	Activity	%	90.0
	13465316	CHEMBL2433483	Inhibition of human PKCalpha assessed as residual activity at 10 uM relative to control	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	94.0	CHEMBL299	Homo sapiens	Activity	%	94.0
	13465342	CHEMBL2433453	Inhibition of human PKCalpha assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	94.04	CHEMBL299	Homo sapiens	Activity	%	94.04
	13465373	CHEMBL2433483	Inhibition of human PKCalpha assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	99.88	CHEMBL299	Homo sapiens	Activity	%	99.88
	13465404	CHEMBL2433453	Inhibition of human PKCalpha assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	124.12	CHEMBL299	Homo sapiens	Activity	%	124.12
	13465435	CHEMBL2433483	Inhibition of human PKCalpha assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	103.85	CHEMBL299	Homo sapiens	Activity	%	103.85
	13508475	CHEMBL2447348	Inhibition of PKCalpha (unknown origin) at 30 uM	B	O=C(Nc1ccc2c(c1)B(O)OC2)c1c(C(F)(F)F)ccc(Cl)c1F		CHEMBL2441375	=	Inhibition	%	62.0	CHEMBL299	Homo sapiens	INH	%	62.0
	13866135	CHEMBL3100614	Inhibition of human PRKCA at 100 uM relative to control	B	COc1ccc(CNC(=O)c2cc(-c3cc(Cl)cc(Cl)c3)cnc2-c2cccnc2)cc1OC		CHEMBL3099899	=	Inhibition	%	29.0	CHEMBL299	Homo sapiens	INH	%	29.0
	13871780	CHEMBL3101241	Inhibition of human PKCalpha assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	88.0	CHEMBL299	Homo sapiens	Activity	%	88.0
	13953263	CHEMBL3130709	Inhibition of human PKCalpha assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	101.0	CHEMBL299	Homo sapiens	Activity	%	101.0
	13953333	CHEMBL3130709	Inhibition of human PKCalpha assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	91.0	CHEMBL299	Homo sapiens	Activity	%	91.0
	13953348	CHEMBL3130709	Inhibition of human PKCalpha assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	89.0	CHEMBL299	Homo sapiens	Activity	%	89.0
	13965686	CHEMBL3135236	Inhibition of human truncated PKC alpha expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	56.0	CHEMBL299	Homo sapiens	INH	%	56.0
	13966064	CHEMBL3136901	Inhibition of human truncated PKC alpha expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	43.0	CHEMBL299	Homo sapiens	INH	%	43.0
	13973339	CHEMBL3135208	Inhibition of human truncated PKC alpha expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	13974057	CHEMBL3134717	Inhibition of human truncated PKC alpha expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	13974148	CHEMBL3136362	Inhibition of human truncated PKC alpha expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	14.5	CHEMBL299	Homo sapiens	INH	%	14.5
	13974239	CHEMBL3135464	Inhibition of human truncated PKC alpha expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	41.0	CHEMBL299	Homo sapiens	INH	%	41.0
	13974977	CHEMBL3135143	Inhibition of human truncated PKC alpha expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	64.5	CHEMBL299	Homo sapiens	INH	%	64.5
	13975068	CHEMBL3136713	Inhibition of human truncated PKC alpha expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	13975159	CHEMBL3134942	Inhibition of human truncated PKC alpha expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	30.0	CHEMBL299	Homo sapiens	INH	%	30.0
	13975250	CHEMBL3136531	Inhibition of human truncated PKC alpha expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	18.0	CHEMBL299	Homo sapiens	INH	%	18.0
	13975893	CHEMBL3136138	Inhibition of human truncated PKC alpha expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	56.5	CHEMBL299	Homo sapiens	INH	%	56.5
	13975986	CHEMBL3136295	Inhibition of human truncated PKC alpha expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	77.5	CHEMBL299	Homo sapiens	INH	%	77.5
	13976077	CHEMBL3136177	Inhibition of human truncated PKC alpha expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	69.5	CHEMBL299	Homo sapiens	INH	%	69.5
	14553632	CHEMBL3225772	Inhibition of PKCalpha (unknown origin) at 10 uM assessed as residual enzyme activity	B	COc1ccc(-c2n[nH]c3ncc(-c4ccc(Cl)cc4N)cc23)cc1		CHEMBL3220823	=	Activity	%	84.5	CHEMBL299	Homo sapiens	Activity	%	84.5
	14582583	CHEMBL3241647	Inhibition of human PKCalpha assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	97.0	CHEMBL299	Homo sapiens	Activity	%	97.0
	14648074	CHEMBL3266638	Inhibition of human PKCalpha at 1 uM relative to control	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1		CHEMBL2380687	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
	14648075	CHEMBL3266638	Inhibition of human PKCalpha at 1 uM relative to control	B	N[C@H]1CC[C@H](Nc2ccc3ncc(-c4cnc(Nc5ncccc5F)nc4)n3n2)CC1		CHEMBL3264059	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
	14659149	CHEMBL3269724	Inhibition of PKCalpha (unknown origin) at 50 uM	B	CC(=O)c1cccc(NC(=O)c2sc3nc4cc5c(cc4cc3c2N)OCCO5)c1		CHEMBL3261343	=	Inhibition	%	80.0	CHEMBL299	Homo sapiens	INH	%	80.0
	14659379	CHEMBL3267955	Inhibition of PKCalpha (unknown origin) at 1 uM	B	CCOP(=O)(CC)Cc1cccc(Nc2cc(-c3ccccc3OC)ncn2)c1		CHEMBL3264107	=	Inhibition	%	8.0	CHEMBL299	Homo sapiens	INH	%	8.0
	14659380	CHEMBL3267955	Inhibition of PKCalpha (unknown origin) at 1 uM	B	CCCP(=O)(Cc1cccc(Nc2cc(-c3ccccc3OC)ncn2)c1)OCC		CHEMBL3264108	=	Inhibition	%	9.0	CHEMBL299	Homo sapiens	INH	%	9.0
	14717276	CHEMBL3294517	Displacement of [3H]PDBu from recombinant human PKC-alpha after 5 mins by scintillation counting analysis in presence of phosphatidylserine	B	CCCC(CCC)C(=O)OCC1(CO)C/C(=C\c2cn(C)c3ccccc23)C(=O)O1		CHEMBL519741	=	Ki	nM	16.2	CHEMBL299	Homo sapiens	Ki	nM	16.2
	14717277	CHEMBL3294517	Displacement of [3H]PDBu from recombinant human PKC-alpha after 5 mins by scintillation counting analysis in presence of phosphatidylserine	B	CCCC(CCC)C(=O)OCC1(CO)C/C(=C\c2cccc3c2ccn3C)C(=O)O1		CHEMBL3289011	=	Ki	nM	17.8	CHEMBL299	Homo sapiens	Ki	nM	17.8
	14717278	CHEMBL3294517	Displacement of [3H]PDBu from recombinant human PKC-alpha after 5 mins by scintillation counting analysis in presence of phosphatidylserine	B	CCCC(CCC)C(=O)OCC1(CO)C/C(=C\c2ccc3c(ccn3C)c2)C(=O)O1		CHEMBL3289012	=	Ki	nM	8.25	CHEMBL299	Homo sapiens	Ki	nM	8.25
	14717279	CHEMBL3294517	Displacement of [3H]PDBu from recombinant human PKC-alpha after 5 mins by scintillation counting analysis in presence of phosphatidylserine	B	CCCC(CCC)C(=O)OCC1(CO)C/C(=C\c2ccc3ccn(C)c3c2)C(=O)O1		CHEMBL3289013	=	Ki	nM	7.5	CHEMBL299	Homo sapiens	Ki	nM	7.5
	14717280	CHEMBL3294517	Displacement of [3H]PDBu from recombinant human PKC-alpha after 5 mins by scintillation counting analysis in presence of phosphatidylserine	B	CCCC(CCC)C(=O)OCC1(CO)C/C(=C\c2cccc3ccn(C)c23)C(=O)O1		CHEMBL3289014	=	Ki	nM	12.9	CHEMBL299	Homo sapiens	Ki	nM	12.9
Active	14719333	CHEMBL3294533	Binding affinity to recombinant human GFP-tagged PKC-alpha expressed in CHOK1 cells assessed as induction of protein translocation from plasma membrane to internal membrane at 10000 nM after 5 to 15 mins by confocal microscopic analysis	B	CCCC(CCC)C(=O)OCC1(CO)C/C(=C\c2cn(C)c3ccccc23)C(=O)O1		CHEMBL519741		Activity			CHEMBL299	Homo sapiens	Activity		
Active	14719334	CHEMBL3294533	Binding affinity to recombinant human GFP-tagged PKC-alpha expressed in CHOK1 cells assessed as induction of protein translocation from plasma membrane to internal membrane at 10000 nM after 5 to 15 mins by confocal microscopic analysis	B	CCCC(CCC)C(=O)OCC1(CO)C/C(=C\c2cccc3c2ccn3C)C(=O)O1		CHEMBL3289011		Activity			CHEMBL299	Homo sapiens	Activity		
Active	14719335	CHEMBL3294533	Binding affinity to recombinant human GFP-tagged PKC-alpha expressed in CHOK1 cells assessed as induction of protein translocation from plasma membrane to internal membrane at 10000 nM after 5 to 15 mins by confocal microscopic analysis	B	CCCC(CCC)C(=O)OCC1(CO)C/C(=C\c2ccc3c(ccn3C)c2)C(=O)O1		CHEMBL3289012		Activity			CHEMBL299	Homo sapiens	Activity		
Active	14719336	CHEMBL3294533	Binding affinity to recombinant human GFP-tagged PKC-alpha expressed in CHOK1 cells assessed as induction of protein translocation from plasma membrane to internal membrane at 10000 nM after 5 to 15 mins by confocal microscopic analysis	B	CCCC(CCC)C(=O)OCC1(CO)C/C(=C\c2ccc3ccn(C)c3c2)C(=O)O1		CHEMBL3289013		Activity			CHEMBL299	Homo sapiens	Activity		
Active	14719337	CHEMBL3294533	Binding affinity to recombinant human GFP-tagged PKC-alpha expressed in CHOK1 cells assessed as induction of protein translocation from plasma membrane to internal membrane at 10000 nM after 5 to 15 mins by confocal microscopic analysis	B	CCCC(CCC)C(=O)OCC1(CO)C/C(=C\c2cccc3ccn(C)c23)C(=O)O1		CHEMBL3289014		Activity			CHEMBL299	Homo sapiens	Activity		
Active	14719338	CHEMBL3294534	Binding affinity to recombinant human GFP-tagged PKC-alpha expressed in CHOK1 cells assessed as induction of protein translocation from plasma membrane to internal membrane at 10000 nM after 2 to 5 mins by confocal microscopic analysis	B	CCCC(CCC)C(=O)OCC1(CO)C/C(=C\c2ccc3ccn(C)c3c2)C(=O)O1		CHEMBL3289013		Activity			CHEMBL299	Homo sapiens	Activity		
Active	14719339	CHEMBL3294535	Binding affinity to recombinant human GFP-tagged PKC-alpha expressed in CHOK1 cells assessed as induction of protein translocation from plasma membrane to internal membrane at 1000 nM after 5 to 15 mins by confocal microscopic analysis	B	CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(C)=O		CHEMBL279115		Activity			CHEMBL299	Homo sapiens	Activity		
Active	14719340	CHEMBL3294535	Binding affinity to recombinant human GFP-tagged PKC-alpha expressed in CHOK1 cells assessed as induction of protein translocation from plasma membrane to internal membrane at 1000 nM after 5 to 15 mins by confocal microscopic analysis	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768		Activity			CHEMBL299	Homo sapiens	Activity		
Not Active	14730363	CHEMBL3292436	Inhibition of PKC-alpha (unknown origin) at 0.5 uM by [33P]-ATP filter binding assay	B	C=CC(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cn2)c1		CHEMBL3290142		Inhibition	%		CHEMBL299	Homo sapiens	INH		
	14980856	CHEMBL3372438	Inhibition of PKCalpha (unknown origin) in presence of 1 mM ATP	B	CN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1		CHEMBL3355482	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
	14992856	CHEMBL3372233	Inhibition of recombinant PKC alpha (unknown origin) after 60 mins by z'-lyte kinase assay	B	O=C1/C(=C\c2ccc(O)c(O)c2)Oc2ccccc21		CHEMBL3361128	=	IC50	nM	26800.0	CHEMBL299	Homo sapiens	IC50	uM	26.8
	14994859	CHEMBL3372471	Inhibition of PKCalpha (unknown origin) at 100 uM	B	CCCCCCCCCCCC(=O)NNC(=O)C1Sc2ccccc2N(Cc2ccccc2)C1=O		CHEMBL3358803	=	Inhibition	%	13.0	CHEMBL299	Homo sapiens	INH	%	13.0
	14999381	CHEMBL3368459	Inhibition of human PKCalpha at 10 uM relative to control	B	CC(C)(C)C1=NN(c2cccc(Cl)c2)C(c2ccc(F)c(O)c2)C1		CHEMBL3323358	=	Inhibition	%	4.0	CHEMBL299	Homo sapiens	INH	%	4.0
	15008090	CHEMBL3369107	Inhibition of human PKCalpha at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)Cc4ccccc4)cc23)c1		CHEMBL3330255	=	Inhibition	%	1.0	CHEMBL299	Homo sapiens	INH	%	1.0
	15008091	CHEMBL3369107	Inhibition of human PKCalpha at 1 uM by radiometric Assay	B	COC(C(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1)c1ccccc1		CHEMBL3330401	=	Inhibition	%	-7.0	CHEMBL299	Homo sapiens	INH	%	-7.0
	15008092	CHEMBL3369107	Inhibition of human PKCalpha at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)C(c4ccsc4)N4CCCC4)cc23)c1		CHEMBL3330410	=	Inhibition	%	-3.0	CHEMBL299	Homo sapiens	INH	%	-3.0
	15016126	CHEMBL3362645	Inhibition of human recombinant PKCalpha expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	CC1C(=O)NN=C2COc3cc(C(F)(F)F)c(NC4CNC4)cc3N21		CHEMBL3356467	=	IC50	nM	2200.0	CHEMBL299	Homo sapiens	IC50	uM	2.2
	15016127	CHEMBL3362645	Inhibition of human recombinant PKCalpha expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	CC1C(=O)NN=C2COc3cc(C(F)(F)F)c(OC4CNC4)cc3N21		CHEMBL3356468	=	IC50	nM	3000.0	CHEMBL299	Homo sapiens	IC50	uM	3.0
	15016152	CHEMBL3362645	Inhibition of human recombinant PKCalpha expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@H]1C(=O)NN=C2COc3cc(C(F)(F)F)c(NC4CNC4)cc3N21		CHEMBL3356475	=	IC50	nM	2900.0	CHEMBL299	Homo sapiens	IC50	uM	2.9
	15016153	CHEMBL3362645	Inhibition of human recombinant PKCalpha expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@@H]1C(=O)NN=C2COc3cc(C(F)(F)F)c(NC4CNC4)cc3N21		CHEMBL3356474	=	IC50	nM	4600.0	CHEMBL299	Homo sapiens	IC50	uM	4.6
	15016154	CHEMBL3362645	Inhibition of human recombinant PKCalpha expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@H]1C(=O)NN=C2COc3cc(-c4ccccc4)c(NC4CNC4)cc3N21		CHEMBL3356473	=	IC50	nM	6600.0	CHEMBL299	Homo sapiens	IC50	uM	6.6
	15016155	CHEMBL3362645	Inhibition of human recombinant PKCalpha expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@@H]1C(=O)NN=C2COc3cc(-c4ccccc4)c(NC4CNC4)cc3N21		CHEMBL3356472	=	IC50	nM	1800.0	CHEMBL299	Homo sapiens	IC50	uM	1.8
	15016156	CHEMBL3362645	Inhibition of human recombinant PKCalpha expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	Cc1cc2c(cc1NC1CNC1)N1C(=NNC(=O)[C@@H]1C)CO2		CHEMBL3356471	=	IC50	nM	3000.0	CHEMBL299	Homo sapiens	IC50	uM	3.0
	15016157	CHEMBL3362645	Inhibition of human recombinant PKCalpha expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	Cc1cc2c(cc1NC1CNC1)N1C(=NNC(=O)[C@H]1C)CO2		CHEMBL3356470	=	IC50	nM	5100.0	CHEMBL299	Homo sapiens	IC50	uM	5.1
	15016158	CHEMBL3362645	Inhibition of human recombinant PKCalpha expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	CC1C(=O)NN=C2COc3cc(C(F)(F)F)c(CC4CNC4)cc3N21		CHEMBL3356469	=	IC50	nM	1600.0	CHEMBL299	Homo sapiens	IC50	uM	1.6
	15016197	CHEMBL3362645	Inhibition of human recombinant PKCalpha expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	CC(C)c1cc2c(cc1NC1CNC1)N1C(=NNC(=O)C1C)CO2		CHEMBL3356466	=	IC50	nM	2200.0	CHEMBL299	Homo sapiens	IC50	uM	2.2
	15016198	CHEMBL3362645	Inhibition of human recombinant PKCalpha expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	CC1C(=O)NN=C2COc3cc(F)c(NC4CNC4)cc3N21		CHEMBL3356465	=	IC50	nM	6900.0	CHEMBL299	Homo sapiens	IC50	uM	6.9
	15018668	CHEMBL3361560	Inhibition of PKC alpha (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	15.3	CHEMBL299	Homo sapiens	INH	%	15.3
	15019196	CHEMBL3364389	Inhibition of PKCalpha (unknown origin) at 1 uM in presence of 100 uM ATP	B	C=CC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C		CHEMBL3298512	=	Inhibition	%	18.0	CHEMBL299	Homo sapiens	INH	%	18.0
	15020478	CHEMBL3362645	Inhibition of human recombinant PKCalpha expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	Cc1cc2c(cc1NC1CNC1)N1C(=NNC(=O)C1C)CO2		CHEMBL3356464	=	IC50	nM	4100.0	CHEMBL299	Homo sapiens	IC50	uM	4.1
	15020479	CHEMBL3362645	Inhibition of human recombinant PKCalpha expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	O=C1NN=C2COc3ccc(NC4CNC4)cc3N2C1c1ccccc1		CHEMBL3356463	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	15020480	CHEMBL3362645	Inhibition of human recombinant PKCalpha expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	O=C1NN=C2COc3ccc(NC4CNC4)cc3N2C1C1CC1		CHEMBL3356462	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	15020481	CHEMBL3362645	Inhibition of human recombinant PKCalpha expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	CCC1C(=O)NN=C2COc3ccc(NC4CNC4)cc3N21		CHEMBL3352857	=	IC50	nM	5400.0	CHEMBL299	Homo sapiens	IC50	uM	5.4
	15020482	CHEMBL3362645	Inhibition of human recombinant PKCalpha expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	CC1C(=O)NN=C2COc3ccc(NC4CNC4)cc3N21		CHEMBL3356461	=	IC50	nM	9400.0	CHEMBL299	Homo sapiens	IC50	uM	9.4
	15020483	CHEMBL3362645	Inhibition of human recombinant PKCalpha expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	O=C1CN2C(=NN1)COc1ccccc12		CHEMBL1968515	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	15020618	CHEMBL3362645	Inhibition of human recombinant PKCalpha expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@@H]1C(=O)NN=C2COc3cc(C(F)(F)F)c(NC4(C)CNC4)cc3N21		CHEMBL3355112	=	IC50	nM	1700.0	CHEMBL299	Homo sapiens	IC50	uM	1.7
	15020635	CHEMBL3362645	Inhibition of human recombinant PKCalpha expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	O=C1CN2C(=NN1)COc1ccc(NC3CNC3)cc12		CHEMBL3356085	=	IC50	nM	7100.0	CHEMBL299	Homo sapiens	IC50	uM	7.1
	15053967	CHEMBL3369598	Inhibition of PKCA (unknown origin)	B	Clc1ccc(-c2ccc(-c3nccn3-c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL3314140	>	IC50	nM	30000.0	CHEMBL299	Homo sapiens	IC50	uM	30.0
Not Active	15062583	CHEMBL3370296	Inhibition of human PKCalpha by Off-chip mobility shift assay	B	O=C(Cc1c(F)cccc1Cl)Nc1onc(-c2ccc(F)cc2)c1-c1ccncn1		CHEMBL3310142		Inhibition	%		CHEMBL299	Homo sapiens	INH		
	15072473	CHEMBL3380101	Inhibition of PKCalpha (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	110.0	CHEMBL299	Homo sapiens	Activity	%	110.0
	15105975	CHEMBL3388419	Inhibition of human recombinant PKCalpha expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	C[C@H]1CN(C)CC[C@H]1c1cc2c(cc1-c1ccccc1F)OCC1=NNC(=O)[C@@H](C)N12		CHEMBL3355127	=	IC50	nM	310.0	CHEMBL299	Homo sapiens	IC50	uM	0.31
	15105976	CHEMBL3388419	Inhibition of human recombinant PKCalpha expressed in Sf21 cells using Bio-cdc peptide substrate and ATP after 60 mins by time-resolved fluorescence in-vitro kinase assay	B	COc1ccc(-c2cc3c(cc2[C@@H]2CCN(C)C[C@@H]2C)N2C(=NNC(=O)[C@H]2C)CO3)c(F)c1		CHEMBL3355138	=	IC50	nM	450.0	CHEMBL299	Homo sapiens	IC50	uM	0.45
Not Active	15107525	CHEMBL3375321	Inhibition of human PKCalpha assessed as enzyme activity at 10 uM	B	CN(CCc1c[nH]c2ccccc12)C(=O)c1ccc(-c2ccccc2)cc1		CHEMBL213805		Inhibition	%		CHEMBL299	Homo sapiens	INH		
	15116499	CHEMBL3377053	Inhibition of PKCA (unknown origin)	B	CC(=O)c1ccc(N2CCN(C(=O)CN3CC[C@@H](C(=O)Nc4ccc(O)c(Cl)c4)C3)CC2)cc1		CHEMBL3356117	>	IC50	nM	30000.0	CHEMBL299	Homo sapiens	IC50	uM	30.0
	15122494	CHEMBL3367700	Inhibition of human PKCalpha assessed as residual activity at 10 uM by KinaseProfiler assay	B	CCOC(=O)C1=C(C)N=c2s/c(=C\c3ccc(O)c(O)c3)c(=O)n2C1c1ccc(Cl)cc1		CHEMBL3331445	=	Activity	%	91.0	CHEMBL299	Homo sapiens	Activity	%	91.0
	15126971	CHEMBL3367700	Inhibition of human PKCalpha assessed as residual activity at 10 uM by KinaseProfiler assay	B	CCOC(=O)C1=C(C)N=c2s/c(=C\c3cc(O)c(O)c(O)c3)c(=O)n2C1c1ccc(Cl)cc1		CHEMBL3331446	=	Activity	%	91.0	CHEMBL299	Homo sapiens	Activity	%	91.0
	15127003	CHEMBL3367700	Inhibition of human PKCalpha assessed as residual activity at 10 uM by KinaseProfiler assay	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Activity	%	106.0	CHEMBL299	Homo sapiens	Activity	%	106.0
	15142864	CHEMBL3396875	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of 100 ug/ml 100% phosphatidylserine	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Kd	nM	0.28	CHEMBL299	Homo sapiens	Kd	nM	0.28
	15142865	CHEMBL3396875	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of 100 ug/ml 100% phosphatidylserine	B	CCCCCCCCCCCCCCCCC/C=C1/CC(=O)OC1(CO)COC(=O)C(C)(C)C		CHEMBL3393758	=	Ki	nM	24.5	CHEMBL299	Homo sapiens	Ki	nM	24.5
	15142866	CHEMBL3396875	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of 100 ug/ml 100% phosphatidylserine	B	CCCCCCCCCCCCCCCCC/C=C1\CC(=O)OC1(CO)COC(=O)C(C)(C)C		CHEMBL3393757	=	Ki	nM	31.6	CHEMBL299	Homo sapiens	Ki	nM	31.6
	15142867	CHEMBL3396875	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of 100 ug/ml 100% phosphatidylserine	B	CC(C)CC(C/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O)CC(C)C		CHEMBL137386	=	Ki	nM	8.3	CHEMBL299	Homo sapiens	Ki	nM	8.3
	15142868	CHEMBL3396875	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of 100 ug/ml 100% phosphatidylserine	B	CCCCCC1CC1CC1CC1CCCCCCC/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL3393756	=	Ki	nM	26.7	CHEMBL299	Homo sapiens	Ki	nM	26.7
	15142869	CHEMBL3396875	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of 100 ug/ml 100% phosphatidylserine	B	CCCCCC1CC1CC1CC1CCCCCCC/C=C1/CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL3393755	=	Ki	nM	33.1	CHEMBL299	Homo sapiens	Ki	nM	33.1
	15142870	CHEMBL3396875	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of 100 ug/ml 100% phosphatidylserine	B	CCCCC/C=C\C/C=C\CCCCCCC/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL3393754	=	Ki	nM	8.26	CHEMBL299	Homo sapiens	Ki	nM	8.26
	15142871	CHEMBL3396875	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of 100 ug/ml 100% phosphatidylserine	B	CCCCC/C=C\C/C=C\CCCCCCC/C=C1/CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL3393753	=	Ki	nM	7.2	CHEMBL299	Homo sapiens	Ki	nM	7.2
	15142872	CHEMBL3396875	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of 100 ug/ml 100% phosphatidylserine	B	CCCCCCC#CC#CCCCCCCCC(=O)OCC1(CO)C/C(=C\CC(C)C)C(=O)O1		CHEMBL3393752	=	Ki	nM	8.31	CHEMBL299	Homo sapiens	Ki	nM	8.31
	15142873	CHEMBL3396875	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of 100 ug/ml 100% phosphatidylserine	B	CCCCCCC#CC#CCCCCCCCC(=O)OCC1(CO)C/C(=C/CC(C)C)C(=O)O1		CHEMBL3393751	=	Ki	nM	9.8	CHEMBL299	Homo sapiens	Ki	nM	9.8
	15142874	CHEMBL3396875	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of 100 ug/ml 100% phosphatidylserine	B	CCCCCCCCC#CCCCCCCCC(=O)OCC1(CO)C/C(=C\CC(C)C)C(=O)O1		CHEMBL3393750	=	Ki	nM	8.7	CHEMBL299	Homo sapiens	Ki	nM	8.7
	15142875	CHEMBL3396875	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of 100 ug/ml 100% phosphatidylserine	B	CCCCCCCCC#CCCCCCCCC(=O)OCC1(CO)C/C(=C/CC(C)C)C(=O)O1		CHEMBL3393749	=	Ki	nM	12.6	CHEMBL299	Homo sapiens	Ki	nM	12.6
	15142876	CHEMBL3396875	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of 100 ug/ml 100% phosphatidylserine	B	CC(C)C/C=C1\CC(CO)(COC(=O)CC(CC(C)C)CC(C)C)OC1=O		CHEMBL3393748	=	Ki	nM	2.78	CHEMBL299	Homo sapiens	Ki	nM	2.78
	15142877	CHEMBL3396875	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of 100 ug/ml 100% phosphatidylserine	B	CC(C)C/C=C1/CC(CO)(COC(=O)CC(CC(C)C)CC(C)C)OC1=O		CHEMBL230048	=	Ki	nM	4.74	CHEMBL299	Homo sapiens	Ki	nM	4.74
	15142878	CHEMBL3396875	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of 100 ug/ml 100% phosphatidylserine	B	CCCCCCCCCCCCCCCCCC(=O)OCC1(CO)C/C(=C\CC(C)C)C(=O)O1		CHEMBL3393747	=	Ki	nM	30.8	CHEMBL299	Homo sapiens	Ki	nM	30.8
	15142879	CHEMBL3396875	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of 100 ug/ml 100% phosphatidylserine	B	CCCCCCCCCCCCCCCCCC(=O)OCC1(CO)C/C(=C/CC(C)C)C(=O)O1		CHEMBL3393746	=	Ki	nM	43.9	CHEMBL299	Homo sapiens	Ki	nM	43.9
	15142880	CHEMBL3396875	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of 100 ug/ml 100% phosphatidylserine	B	CCCCCC1OC1CC1OC1CCCCCCCC(=O)OCC1(CO)C/C(=C\CC(C)C)C(=O)O1		CHEMBL3393745	=	Ki	nM	13.2	CHEMBL299	Homo sapiens	Ki	nM	13.2
	15142881	CHEMBL3396875	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of 100 ug/ml 100% phosphatidylserine	B	CCCCCC1OC1CC1OC1CCCCCCCC(=O)OCC1(CO)C/C(=C/CC(C)C)C(=O)O1		CHEMBL3393744	=	Ki	nM	16.5	CHEMBL299	Homo sapiens	Ki	nM	16.5
	15142882	CHEMBL3396875	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of 100 ug/ml 100% phosphatidylserine	B	CCCCCC1CC1CC1CC1CCCCCCCC(=O)OCC1(CO)C/C(=C\CC(C)C)C(=O)O1		CHEMBL3393743	=	Ki	nM	10.2	CHEMBL299	Homo sapiens	Ki	nM	10.2
	15142883	CHEMBL3396875	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of 100 ug/ml 100% phosphatidylserine	B	CCCCCC1CC1CC1CC1CCCCCCCC(=O)OCC1(CO)C/C(=C/CC(C)C)C(=O)O1		CHEMBL3393742	=	Ki	nM	15.4	CHEMBL299	Homo sapiens	Ki	nM	15.4
	15142884	CHEMBL3396875	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of 100 ug/ml 100% phosphatidylserine	B	CCCCC/C=C/C/C=C/CCCCCCCC(=O)OCC1(CO)C/C(=C\CC(C)C)C(=O)O1		CHEMBL3393741	=	Ki	nM	4.33	CHEMBL299	Homo sapiens	Ki	nM	4.33
	15142885	CHEMBL3396875	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of 100 ug/ml 100% phosphatidylserine	B	CCCCC/C=C/C/C=C/CCCCCCCC(=O)OCC1(CO)C/C(=C/CC(C)C)C(=O)O1		CHEMBL3393654	=	Ki	nM	7.05	CHEMBL299	Homo sapiens	Ki	nM	7.05
	15142936	CHEMBL3394956	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of nuclear membrane mimetic lipid mixture	B	CCCCC/C=C/C/C=C/CCCCCCCC(=O)OCC1(CO)C/C(=C/CC(C)C)C(=O)O1		CHEMBL3393654	=	Ki	nM	26.2	CHEMBL299	Homo sapiens	Ki	nM	26.2
	15142937	CHEMBL3394956	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of nuclear membrane mimetic lipid mixture	B	CCCCC/C=C/C/C=C/CCCCCCCC(=O)OCC1(CO)C/C(=C\CC(C)C)C(=O)O1		CHEMBL3393741	=	Ki	nM	24.7	CHEMBL299	Homo sapiens	Ki	nM	24.7
	15142938	CHEMBL3394956	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of nuclear membrane mimetic lipid mixture	B	CCCCCC1CC1CC1CC1CCCCCCCC(=O)OCC1(CO)C/C(=C/CC(C)C)C(=O)O1		CHEMBL3393742	=	Ki	nM	44.0	CHEMBL299	Homo sapiens	Ki	nM	44.0
	15142939	CHEMBL3394956	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of nuclear membrane mimetic lipid mixture	B	CCCCCC1CC1CC1CC1CCCCCCCC(=O)OCC1(CO)C/C(=C\CC(C)C)C(=O)O1		CHEMBL3393743	=	Ki	nM	60.0	CHEMBL299	Homo sapiens	Ki	nM	60.0
	15142940	CHEMBL3394956	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of nuclear membrane mimetic lipid mixture	B	CCCCCC1OC1CC1OC1CCCCCCCC(=O)OCC1(CO)C/C(=C/CC(C)C)C(=O)O1		CHEMBL3393744	=	Ki	nM	103.0	CHEMBL299	Homo sapiens	Ki	nM	103.0
	15142941	CHEMBL3394956	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of nuclear membrane mimetic lipid mixture	B	CCCCCC1OC1CC1OC1CCCCCCCC(=O)OCC1(CO)C/C(=C\CC(C)C)C(=O)O1		CHEMBL3393745	=	Ki	nM	116.0	CHEMBL299	Homo sapiens	Ki	nM	116.0
	15142942	CHEMBL3394956	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of nuclear membrane mimetic lipid mixture	B	CCCCCCCCCCCCCCCCCC(=O)OCC1(CO)C/C(=C/CC(C)C)C(=O)O1		CHEMBL3393746	=	Ki	nM	106.0	CHEMBL299	Homo sapiens	Ki	nM	106.0
	15142943	CHEMBL3394956	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of nuclear membrane mimetic lipid mixture	B	CCCCCCCCCCCCCCCCCC(=O)OCC1(CO)C/C(=C\CC(C)C)C(=O)O1		CHEMBL3393747	=	Ki	nM	99.0	CHEMBL299	Homo sapiens	Ki	nM	99.0
	15142944	CHEMBL3394956	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of nuclear membrane mimetic lipid mixture	B	CC(C)C/C=C1/CC(CO)(COC(=O)CC(CC(C)C)CC(C)C)OC1=O		CHEMBL230048	=	Ki	nM	57.0	CHEMBL299	Homo sapiens	Ki	nM	57.0
	15142945	CHEMBL3394956	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of nuclear membrane mimetic lipid mixture	B	CC(C)C/C=C1\CC(CO)(COC(=O)CC(CC(C)C)CC(C)C)OC1=O		CHEMBL3393748	=	Ki	nM	15.4	CHEMBL299	Homo sapiens	Ki	nM	15.4
	15142946	CHEMBL3394956	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of nuclear membrane mimetic lipid mixture	B	CCCCCCCCC#CCCCCCCCC(=O)OCC1(CO)C/C(=C/CC(C)C)C(=O)O1		CHEMBL3393749	=	Ki	nM	38.7	CHEMBL299	Homo sapiens	Ki	nM	38.7
	15142947	CHEMBL3394956	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of nuclear membrane mimetic lipid mixture	B	CCCCCCCCC#CCCCCCCCC(=O)OCC1(CO)C/C(=C\CC(C)C)C(=O)O1		CHEMBL3393750	=	Ki	nM	43.8	CHEMBL299	Homo sapiens	Ki	nM	43.8
	15142948	CHEMBL3394956	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of nuclear membrane mimetic lipid mixture	B	CCCCCCC#CC#CCCCCCCCC(=O)OCC1(CO)C/C(=C/CC(C)C)C(=O)O1		CHEMBL3393751	=	Ki	nM	44.8	CHEMBL299	Homo sapiens	Ki	nM	44.8
	15142949	CHEMBL3394956	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of nuclear membrane mimetic lipid mixture	B	CCCCCCC#CC#CCCCCCCCC(=O)OCC1(CO)C/C(=C\CC(C)C)C(=O)O1		CHEMBL3393752	=	Ki	nM	60.8	CHEMBL299	Homo sapiens	Ki	nM	60.8
	15142950	CHEMBL3394956	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of nuclear membrane mimetic lipid mixture	B	CCCCC/C=C\C/C=C\CCCCCCC/C=C1/CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL3393753	=	Ki	nM	31.1	CHEMBL299	Homo sapiens	Ki	nM	31.1
	15142951	CHEMBL3394956	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of nuclear membrane mimetic lipid mixture	B	CCCCC/C=C\C/C=C\CCCCCCC/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL3393754	=	Ki	nM	25.7	CHEMBL299	Homo sapiens	Ki	nM	25.7
	15142952	CHEMBL3394956	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of nuclear membrane mimetic lipid mixture	B	CCCCCC1CC1CC1CC1CCCCCCC/C=C1/CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL3393755	=	Ki	nM	73.0	CHEMBL299	Homo sapiens	Ki	nM	73.0
	15142953	CHEMBL3394956	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of nuclear membrane mimetic lipid mixture	B	CCCCCC1CC1CC1CC1CCCCCCC/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O		CHEMBL3393756	=	Ki	nM	110.3	CHEMBL299	Homo sapiens	Ki	nM	110.3
	15142954	CHEMBL3394956	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of nuclear membrane mimetic lipid mixture	B	CC(C)CC(C/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O)CC(C)C		CHEMBL137386	=	Ki	nM	46.0	CHEMBL299	Homo sapiens	Ki	nM	46.0
	15142955	CHEMBL3394956	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of nuclear membrane mimetic lipid mixture	B	CCCCCCCCCCCCCCCCC/C=C1\CC(=O)OC1(CO)COC(=O)C(C)(C)C		CHEMBL3393757	=	Ki	nM	84.1	CHEMBL299	Homo sapiens	Ki	nM	84.1
	15142956	CHEMBL3394956	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of nuclear membrane mimetic lipid mixture	B	CCCCCCCCCCCCCCCCC/C=C1/CC(=O)OC1(CO)COC(=O)C(C)(C)C		CHEMBL3393758	=	Ki	nM	117.0	CHEMBL299	Homo sapiens	Ki	nM	117.0
	15143000	CHEMBL3394956	Displacement of [20-3H] phorbol 12, 13-dibutylate from recombinant PKCalpha (unknown origin) in presence of nuclear membrane mimetic lipid mixture	B	CCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(=O)CCC		CHEMBL27768	=	Kd	nM	1.44	CHEMBL299	Homo sapiens	Kd	nM	1.44
	15150123	CHEMBL3396179	Inhibition of PRKCA (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CC2)ccn1		CHEMBL3394102	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
	15150124	CHEMBL3396179	Inhibition of PRKCA (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CCCCC2)ccn1		CHEMBL3394105	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
	15150125	CHEMBL3396179	Inhibition of PRKCA (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CCCO2)ccn1		CHEMBL3394108	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
	15150126	CHEMBL3396179	Inhibition of PRKCA (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	COC(Cn1c(SC2CCC(C(=O)O)CC2O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC		CHEMBL3394112	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
	15150127	CHEMBL3396179	Inhibition of PRKCA (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(Sc3cccc(I)n3)n2C2CCCCC2)ccn1		CHEMBL3394118	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
	15183846	CHEMBL3406100	Inhibition of PKC-alpha (unknown origin)	B	Cc1c(Cc2cccc(N(C)S(=O)(=O)CCCNCCCCCC(=O)N3CCN(c4nc(N5CCOCC5)nc(-n5c(C(F)F)nc6ccccc65)n4)CC3)c2)c(=O)oc2cc(OC(=O)N(C)C)ccc12		CHEMBL3400291	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	15225332	CHEMBL3419944	Inhibition of human PKCalpha	B	NC(=O)c1cnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc(-n2nccn2)c1		CHEMBL2177736	=	IC50	nM	90.0	CHEMBL299	Homo sapiens	IC50	nM	90.0
	15251839	CHEMBL3428242	Inhibition of PKCalpha (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	69.0	CHEMBL299	Homo sapiens	Activity	%	69.0
	15251958	CHEMBL3428242	Inhibition of PKCalpha (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	91.0	CHEMBL299	Homo sapiens	Activity	%	91.0
	15252060	CHEMBL3428242	Inhibition of PKCalpha (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	91.0	CHEMBL299	Homo sapiens	Activity	%	91.0
	15252705	CHEMBL3428242	Inhibition of PKCalpha (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	77.0	CHEMBL299	Homo sapiens	Activity	%	77.0
	15252807	CHEMBL3428242	Inhibition of PKCalpha (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	56.0	CHEMBL299	Homo sapiens	Activity	%	56.0
	15252909	CHEMBL3428242	Inhibition of PKCalpha (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	65.0	CHEMBL299	Homo sapiens	Activity	%	65.0
	15253199	CHEMBL3430058	Inhibition of human PKCalpha	B	CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c2c(N)ncnc21		CHEMBL3426225	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	15253583	CHEMBL3428242	Inhibition of PKCalpha (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	76.0	CHEMBL299	Homo sapiens	Activity	%	76.0
	15253685	CHEMBL3428242	Inhibition of PKCalpha (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	87.0	CHEMBL299	Homo sapiens	Activity	%	87.0
	15253787	CHEMBL3428242	Inhibition of PKCalpha (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	80.0	CHEMBL299	Homo sapiens	Activity	%	80.0
	15254453	CHEMBL3428242	Inhibition of PKCalpha (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	87.0	CHEMBL299	Homo sapiens	Activity	%	87.0
	15254555	CHEMBL3428242	Inhibition of PKCalpha (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	82.0	CHEMBL299	Homo sapiens	Activity	%	82.0
	15254657	CHEMBL3428242	Inhibition of PKCalpha (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	67.0	CHEMBL299	Homo sapiens	Activity	%	67.0
	15255348	CHEMBL3428242	Inhibition of PKCalpha (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	67.0	CHEMBL299	Homo sapiens	Activity	%	67.0
	15255450	CHEMBL3428242	Inhibition of PKCalpha (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	89.0	CHEMBL299	Homo sapiens	Activity	%	89.0
	15256182	CHEMBL3428242	Inhibition of PKCalpha (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	83.0	CHEMBL299	Homo sapiens	Activity	%	83.0
	15256284	CHEMBL3428242	Inhibition of PKCalpha (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	90.0	CHEMBL299	Homo sapiens	Activity	%	90.0
	15615279	CHEMBL3582655	Inhibition of [20-3H]phorbol 12,13-dibutyrate binding to human PKCalpha by scintillation counting based poly(ethylene) glycol precipitation assay	B	CCCCCCCC(=O)O[C@H]1/C(=C/C(=O)OC)C[C@H]2C[C@@H](O)[C@@H](C)OC(=O)C[C@H](O)C[C@@H]3C[C@H](OC(C)=O)C(C)(C)[C@](O)(CCOC(=O)/C=C/C(C)(C)[C@]1(O)O2)O3		CHEMBL3581528	=	Ki	nM	13.8	CHEMBL299	Homo sapiens	Ki	nM	13.8
	15615280	CHEMBL3582655	Inhibition of [20-3H]phorbol 12,13-dibutyrate binding to human PKCalpha by scintillation counting based poly(ethylene) glycol precipitation assay	B	CCC/C=C/C=C/C(=O)O[C@H]1/C(=C/C(=O)OC)C[C@H]2C[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H]3C[C@H](OC(C)=O)C(C)(C)[C@](O)(C[C@@H]4C/C(=C/C(=O)OC)C[C@H](/C=C/C(C)(C)[C@]1(O)O2)O4)O3		CHEMBL449158	=	Ki	nM	0.48	CHEMBL299	Homo sapiens	Ki	nM	0.48
	15615281	CHEMBL3582655	Inhibition of [20-3H]phorbol 12,13-dibutyrate binding to human PKCalpha by scintillation counting based poly(ethylene) glycol precipitation assay	B	COC(=O)/C=C1/C[C@H]2C[C@]3(O)O[C@@H](C[C@H](OC(=O)C(C)(C)C)C3(C)C)C[C@@H](O)CC(=O)O[C@H](C)[C@H](O)C[C@@H]3C[C@@H]4CC(=O)O[C@@]4(O3)C(=O)C(C)(C)/C=C/[C@@H](C1)O2		CHEMBL3581527	=	Ki	nM	21.2	CHEMBL299	Homo sapiens	Ki	nM	21.2
	15649108	CHEMBL3595093	Inhibition of PKCalpha (unknown origin)	B	N#Cc1ccc(N2CC[C@@H](Nc3c(C(N)=O)cnc4[nH]ccc34)[C@@H](F)C2)nc1		CHEMBL3593777	=	IC50	nM	130.0	CHEMBL299	Homo sapiens	IC50	nM	130.0
	15651988	CHEMBL3595436	Inhibition of recombinant human PKCalpha at 1 uM relative to control	B	C[C@H]1CN(C)C(=O)[C@@H]1c1cc(Nc2ccnc(N(C)C[C@H]3CC[C@H](N)CC3)n2)n[nH]1		CHEMBL3594181	<	Inhibition	%	75.0	CHEMBL299	Homo sapiens	INH	%	75.0
	15654943	CHEMBL3599521	Inhibition of PKCalpha (unknown origin) at 0.5 uM relative to control	B	Nc1nccc(-c2c[nH]c3ccccc23)n1		CHEMBL48082	=	Inhibition	%	8.5	CHEMBL299	Homo sapiens	INH	%	8.5
	15654944	CHEMBL3599521	Inhibition of PKCalpha (unknown origin) at 0.5 uM relative to control	B	Nc1nccc(-c2cn(C(=O)N3CCOCC3)c3ccc(Br)cc23)n1		CHEMBL3133762	=	Inhibition	%	26.5	CHEMBL299	Homo sapiens	INH	%	26.5
	15654945	CHEMBL3599521	Inhibition of PKCalpha (unknown origin) at 0.5 uM relative to control	B	Cc1noc(C)c1Cn1cc(-c2ccnc(N)n2)c2ccccc21		CHEMBL3133770	=	Inhibition	%	36.9	CHEMBL299	Homo sapiens	INH	%	36.9
	15756857	CHEMBL3630926	Inhibition of PKCalpha (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	-7.51	CHEMBL299	Homo sapiens	INH	%	-7.51
	15757866	CHEMBL3630926	Inhibition of PKCalpha (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	-5.32	CHEMBL299	Homo sapiens	INH	%	-5.32
	15758845	CHEMBL3630926	Inhibition of PKCalpha (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	-4.59	CHEMBL299	Homo sapiens	INH	%	-4.59
	15762298	CHEMBL3635283	Displacement of [3H]PDBu from recombinant human PKCalpha C1 domain expressed in baculovirus infected insect Sf9 cells assessed as residual radiolabeled binding at 100 uM after 10 mins by liquid scintillation counting analysis relative to control	B	CC(C)(C)C(=O)OCC(CO)c1ccc(OCc2ccccc2)cc1		CHEMBL3632674	=	Activity	%	41.6	CHEMBL299	Homo sapiens	Activity	%	41.6
	15762299	CHEMBL3635283	Displacement of [3H]PDBu from recombinant human PKCalpha C1 domain expressed in baculovirus infected insect Sf9 cells assessed as residual radiolabeled binding at 100 uM after 10 mins by liquid scintillation counting analysis relative to control	B	O=C(Cc1ccccc1)OCC(CO)c1ccc(OCc2ccccc2)cc1		CHEMBL3632675	=	Activity	%	51.3	CHEMBL299	Homo sapiens	Activity	%	51.3
	15762300	CHEMBL3635283	Displacement of [3H]PDBu from recombinant human PKCalpha C1 domain expressed in baculovirus infected insect Sf9 cells assessed as residual radiolabeled binding at 100 uM after 10 mins by liquid scintillation counting analysis relative to control	B	O=C(CC(CO)c1ccc(OCc2ccccc2)cc1)OCc1ccccc1		CHEMBL3632676	=	Activity	%	73.9	CHEMBL299	Homo sapiens	Activity	%	73.9
	15762301	CHEMBL3635283	Displacement of [3H]PDBu from recombinant human PKCalpha C1 domain expressed in baculovirus infected insect Sf9 cells assessed as residual radiolabeled binding at 100 uM after 10 mins by liquid scintillation counting analysis relative to control	B	O=C(CC(CO)c1cccc(OCc2ccccc2)c1)OCc1ccccc1		CHEMBL3632677	=	Activity	%	67.4	CHEMBL299	Homo sapiens	Activity	%	67.4
	15762302	CHEMBL3635283	Displacement of [3H]PDBu from recombinant human PKCalpha C1 domain expressed in baculovirus infected insect Sf9 cells assessed as residual radiolabeled binding at 100 uM after 10 mins by liquid scintillation counting analysis relative to control	B	O=C(CC(CO)c1ccc(-c2ccccc2)cc1)OCc1ccccc1		CHEMBL3632678	=	Activity	%	64.4	CHEMBL299	Homo sapiens	Activity	%	64.4
	15762303	CHEMBL3635283	Displacement of [3H]PDBu from recombinant human PKCalpha C1 domain expressed in baculovirus infected insect Sf9 cells assessed as residual radiolabeled binding at 100 uM after 10 mins by liquid scintillation counting analysis relative to control	B	CCN(CC)C(=O)CC(CO)c1ccc(OCc2ccccc2)cc1		CHEMBL3632679	=	Activity	%	100.5	CHEMBL299	Homo sapiens	Activity	%	100.5
	15762304	CHEMBL3635283	Displacement of [3H]PDBu from recombinant human PKCalpha C1 domain expressed in baculovirus infected insect Sf9 cells assessed as residual radiolabeled binding at 100 uM after 10 mins by liquid scintillation counting analysis relative to control	B	CCN(CC)C(=O)CC(CO)c1cccc(OCc2ccccc2)c1		CHEMBL3632680	=	Activity	%	90.0	CHEMBL299	Homo sapiens	Activity	%	90.0
	15762305	CHEMBL3635283	Displacement of [3H]PDBu from recombinant human PKCalpha C1 domain expressed in baculovirus infected insect Sf9 cells assessed as residual radiolabeled binding at 100 uM after 10 mins by liquid scintillation counting analysis relative to control	B	CCN(CC)C(=O)CC(CO)c1ccc(-c2ccccc2)cc1		CHEMBL3632681	=	Activity	%	84.4	CHEMBL299	Homo sapiens	Activity	%	84.4
	15762306	CHEMBL3635283	Displacement of [3H]PDBu from recombinant human PKCalpha C1 domain expressed in baculovirus infected insect Sf9 cells assessed as residual radiolabeled binding at 100 uM after 10 mins by liquid scintillation counting analysis relative to control	B	CN(Cc1ccccc1)C(=O)CC(CO)c1ccc(OCc2ccccc2)cc1		CHEMBL3632682	=	Activity	%	80.6	CHEMBL299	Homo sapiens	Activity	%	80.6
	15762307	CHEMBL3635283	Displacement of [3H]PDBu from recombinant human PKCalpha C1 domain expressed in baculovirus infected insect Sf9 cells assessed as residual radiolabeled binding at 100 uM after 10 mins by liquid scintillation counting analysis relative to control	B	CN(Cc1ccccc1)C(=O)CC(CO)c1cccc(OCc2ccccc2)c1		CHEMBL3632683	=	Activity	%	72.4	CHEMBL299	Homo sapiens	Activity	%	72.4
	15762308	CHEMBL3635283	Displacement of [3H]PDBu from recombinant human PKCalpha C1 domain expressed in baculovirus infected insect Sf9 cells assessed as residual radiolabeled binding at 100 uM after 10 mins by liquid scintillation counting analysis relative to control	B	CN(Cc1ccccc1)C(=O)CC(CO)c1ccc(-c2ccccc2)cc1		CHEMBL3632684	=	Activity	%	76.1	CHEMBL299	Homo sapiens	Activity	%	76.1
	15762309	CHEMBL3635283	Displacement of [3H]PDBu from recombinant human PKCalpha C1 domain expressed in baculovirus infected insect Sf9 cells assessed as residual radiolabeled binding at 100 uM after 10 mins by liquid scintillation counting analysis relative to control	B	O=C(CC(CO)c1ccc(OCc2ccccc2)cc1)N1CCOCC1		CHEMBL3632685	=	Activity	%	106.7	CHEMBL299	Homo sapiens	Activity	%	106.7
	15762310	CHEMBL3635283	Displacement of [3H]PDBu from recombinant human PKCalpha C1 domain expressed in baculovirus infected insect Sf9 cells assessed as residual radiolabeled binding at 100 uM after 10 mins by liquid scintillation counting analysis relative to control	B	O=C(CC(CO)c1cccc(OCc2ccccc2)c1)N1CCOCC1		CHEMBL3632686	=	Activity	%	99.7	CHEMBL299	Homo sapiens	Activity	%	99.7
	15762311	CHEMBL3635283	Displacement of [3H]PDBu from recombinant human PKCalpha C1 domain expressed in baculovirus infected insect Sf9 cells assessed as residual radiolabeled binding at 100 uM after 10 mins by liquid scintillation counting analysis relative to control	B	O=C(CC(CO)c1ccc(-c2ccccc2)cc1)N1CCOCC1		CHEMBL3632687	=	Activity	%	86.6	CHEMBL299	Homo sapiens	Activity	%	86.6
	15762325	CHEMBL3635285	Displacement of [3H]PDBu from recombinant human PKCalpha C1 domain expressed in baculovirus infected insect Sf9 cells after 10 mins by liquid scintillation counting analysis	B	CC(C)(C)C(=O)OCC(CO)c1ccc(OCc2ccccc2)cc1		CHEMBL3632674	=	IC50	nM	37500.0	CHEMBL299	Homo sapiens	IC50	uM	37.5
	15762326	CHEMBL3635285	Displacement of [3H]PDBu from recombinant human PKCalpha C1 domain expressed in baculovirus infected insect Sf9 cells after 10 mins by liquid scintillation counting analysis	B	O=C(Cc1ccccc1)OCC(CO)c1ccc(OCc2ccccc2)cc1		CHEMBL3632675	=	IC50	nM	73900.0	CHEMBL299	Homo sapiens	IC50	uM	73.9
Dose-dependent effect	15762328	CHEMBL3635285	Displacement of [3H]PDBu from recombinant human PKCalpha C1 domain expressed in baculovirus infected insect Sf9 cells after 10 mins by liquid scintillation counting analysis	B	O=C(Cc1ccccc1)OCC(CO)c1ccc(OCc2ccccc2)cc1		CHEMBL3632675		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Dose-dependent effect	15762329	CHEMBL3635285	Displacement of [3H]PDBu from recombinant human PKCalpha C1 domain expressed in baculovirus infected insect Sf9 cells after 10 mins by liquid scintillation counting analysis	B	O=C(CC(CO)c1ccc(OCc2ccccc2)cc1)OCc1ccccc1		CHEMBL3632676		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Dose-dependent effect	15762330	CHEMBL3635285	Displacement of [3H]PDBu from recombinant human PKCalpha C1 domain expressed in baculovirus infected insect Sf9 cells after 10 mins by liquid scintillation counting analysis	B	O=C(CC(CO)c1cccc(OCc2ccccc2)c1)OCc1ccccc1		CHEMBL3632677		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Dose-dependent effect	15762331	CHEMBL3635285	Displacement of [3H]PDBu from recombinant human PKCalpha C1 domain expressed in baculovirus infected insect Sf9 cells after 10 mins by liquid scintillation counting analysis	B	O=C(CC(CO)c1ccc(-c2ccccc2)cc1)OCc1ccccc1		CHEMBL3632678		Inhibition	%		CHEMBL299	Homo sapiens	INH		
	15762337	CHEMBL3635287	Displacement of [3H]PDBu from recombinant human PKCalpha C1 domain expressed in baculovirus infected insect Sf9 cells at 100 uM after 10 mins by liquid scintillation counting analysis relative to control	B	CC(C)(C)C(=O)OCC(CO)c1ccc(OCc2ccccc2)cc1		CHEMBL3632674	=	Inhibition	%	34.6	CHEMBL299	Homo sapiens	INH	%	34.6
	15762338	CHEMBL3635287	Displacement of [3H]PDBu from recombinant human PKCalpha C1 domain expressed in baculovirus infected insect Sf9 cells at 100 uM after 10 mins by liquid scintillation counting analysis relative to control	B	CC(C)(C)C(=O)OCC(CO)c1ccc(OCc2ccccc2)cc1		CHEMBL3632674	=	Inhibition	%	36.3	CHEMBL299	Homo sapiens	INH	%	36.3
	15762339	CHEMBL3635287	Displacement of [3H]PDBu from recombinant human PKCalpha C1 domain expressed in baculovirus infected insect Sf9 cells at 100 uM after 10 mins by liquid scintillation counting analysis relative to control	B	O=C(Cc1ccccc1)OCC(CO)c1ccc(OCc2ccccc2)cc1		CHEMBL3632675	=	Inhibition	%	27.3	CHEMBL299	Homo sapiens	INH	%	27.3
	15762340	CHEMBL3635287	Displacement of [3H]PDBu from recombinant human PKCalpha C1 domain expressed in baculovirus infected insect Sf9 cells at 100 uM after 10 mins by liquid scintillation counting analysis relative to control	B	O=C(Cc1ccccc1)OCC(CO)c1ccc(OCc2ccccc2)cc1		CHEMBL3632675	=	Inhibition	%	26.3	CHEMBL299	Homo sapiens	INH	%	26.3
	16379689	CHEMBL3739161	Inhibition of PKCalpha (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735816	=	Inhibition	%	82.5	CHEMBL299	Homo sapiens	INH	%	82.5
	16379690	CHEMBL3739161	Inhibition of PKCalpha (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1C(C)N1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735890	=	Inhibition	%	83.6	CHEMBL299	Homo sapiens	INH	%	83.6
	16388319	CHEMBL3737494	Inhibition of PKCalpha (unknown origin) at 1 uM by selectscreen kinase profiling assay in presence of ATP	B	COc1cc2c(cc1OC)CN(CC(=O)Nc1ccc3c(c1)/C(=C/c1cnc[nH]1)C(=O)N3)CC2		CHEMBL3091673	=	Inhibition	%	-2.0	CHEMBL299	Homo sapiens	INH	%	-2.0
	16417277	CHEMBL3750771	Inhibition of PKCalpha (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCN(S(C)(=O)=O)CC3)nc21		CHEMBL3747699	=	Inhibition	%	10.0	CHEMBL299	Homo sapiens	INH	%	10.0
	16417278	CHEMBL3750771	Inhibition of PKCalpha (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(Nc3ccc(N4CCC(O)CC4)cc3)nc21		CHEMBL3746959	=	Inhibition	%	13.0	CHEMBL299	Homo sapiens	INH	%	13.0
	16417279	CHEMBL3750771	Inhibition of PKCalpha (unknown origin) at 10 uM	B	CN1CCN(CCCNc2ncc3cc(Oc4ccc(F)cc4F)c(=O)n(C)c3n2)CC1		CHEMBL3746022	=	Inhibition	%	13.0	CHEMBL299	Homo sapiens	INH	%	13.0
	16417280	CHEMBL3750771	Inhibition of PKCalpha (unknown origin) at 10 uM	B	CN1CCN(c2ccc(Nc3ncc4cc(Oc5ccc(F)cc5F)c(=O)n(C)c4n3)cc2)CC1		CHEMBL3745734	=	Inhibition	%	12.0	CHEMBL299	Homo sapiens	INH	%	12.0
	16417281	CHEMBL3750771	Inhibition of PKCalpha (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2c(Cl)cccc2Cl)cc2cnc(NC3CCOCC3)nc21		CHEMBL3747351	=	Inhibition	%	5.0	CHEMBL299	Homo sapiens	INH	%	5.0
	16417282	CHEMBL3750771	Inhibition of PKCalpha (unknown origin) at 10 uM	B	CN1CCN(c2ccc(Nc3ncc4cc(Oc5c(Cl)cccc5Cl)c(=O)n(C)c4n3)cc2)CC1		CHEMBL3747023	=	Inhibition	%	8.0	CHEMBL299	Homo sapiens	INH	%	8.0
	16417283	CHEMBL3750771	Inhibition of PKCalpha (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NCCc3ccccn3)nc21		CHEMBL3746951	=	Inhibition	%	8.0	CHEMBL299	Homo sapiens	INH	%	8.0
	16417284	CHEMBL3750771	Inhibition of PKCalpha (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(Nc3ccc(N4CCCCC4)cc3)nc21		CHEMBL3746973	=	Inhibition	%	14.0	CHEMBL299	Homo sapiens	INH	%	14.0
	16417285	CHEMBL3750771	Inhibition of PKCalpha (unknown origin) at 10 uM	B	CN(C)CCNc1ncc2cc(Oc3ccc(F)cc3F)c(=O)n(C)c2n1		CHEMBL3745857	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	16421939	CHEMBL3750422	Inhibition of PKCalpha (unknown origin)	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	16425259	CHEMBL3751125	Inhibition of PKC alpha (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	-2.1	CHEMBL299	Homo sapiens	INH	%	-2.1
	16429068	CHEMBL3750806	Inhibition of PKCalpha (unknown origin) at 1 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCN(S(N)(=O)=O)CC3)nc21		CHEMBL3747489	=	Inhibition	%	10.0	CHEMBL299	Homo sapiens	INH	%	10.0
	16431961	CHEMBL3748054	Inhibition of human PKCalpha using histone H1 as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	16451570	CHEMBL3760867	Inhibition of PKCalpha (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	7.0	CHEMBL299	Homo sapiens	INH	%	7.0
	16458592	CHEMBL3761598	Inhibition of PRKCA (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccccc3C(N)=O)cc12)c1ccccc1		CHEMBL3759085	=	Inhibition	%	8.0	CHEMBL299	Homo sapiens	INH	%	8.0
	16458593	CHEMBL3761598	Inhibition of PRKCA (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccc(C(=O)NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3758800	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	16458594	CHEMBL3761598	Inhibition of PRKCA (unknown origin) at 500 nM	B	CN(C)CCNC(=O)c1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3s2)cc1	Outside typical range	CHEMBL3758376	=	Inhibition	%	-18.0	CHEMBL299	Homo sapiens	INH	%	-18.0
	16458595	CHEMBL3761598	Inhibition of PRKCA (unknown origin) at 500 nM	B	COc1cc(C(N)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3759480	=	Inhibition	%	-4.0	CHEMBL299	Homo sapiens	INH	%	-4.0
	16458596	CHEMBL3761598	Inhibition of PRKCA (unknown origin) at 500 nM	B	COc1ccc(C(=O)NCCN(C)C)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1	Outside typical range	CHEMBL3758582	=	Inhibition	%	-12.0	CHEMBL299	Homo sapiens	INH	%	-12.0
Not Determined	16458597	CHEMBL3761598	Inhibition of PRKCA (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3759559		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Not Determined	16458598	CHEMBL3761598	Inhibition of PRKCA (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3758682		Inhibition	%		CHEMBL299	Homo sapiens	INH		
	16458599	CHEMBL3761598	Inhibition of PRKCA (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccccc3)ncnc2s1		CHEMBL3758768	=	Inhibition	%	-1.0	CHEMBL299	Homo sapiens	INH	%	-1.0
	16458600	CHEMBL3761598	Inhibition of PRKCA (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3sc(-c4ccc(CO)cc4OC)cc23)c1		CHEMBL3758802	=	Inhibition	%	-7.0	CHEMBL299	Homo sapiens	INH	%	-7.0
	16458601	CHEMBL3761598	Inhibition of PRKCA (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3758351	=	Inhibition	%	2.0	CHEMBL299	Homo sapiens	INH	%	2.0
	16458602	CHEMBL3761598	Inhibition of PRKCA (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	2.0	CHEMBL299	Homo sapiens	INH	%	2.0
	16474709	CHEMBL3767329	Inhibition of PKCalpha (unknown origin) at 10 uM	B	CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5ccc(F)cc5)cc4)SC3=S)cc2)CC1		CHEMBL3765499	=	Inhibition	%	18.4	CHEMBL299	Homo sapiens	INH	%	18.4
	16495183	CHEMBL3777511	Inhibition of N-terminal His6-tagged recombinant human PKCalpha expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	1.0	CHEMBL299	Homo sapiens	Activity	%	1.0
	16496102	CHEMBL3777511	Inhibition of N-terminal His6-tagged recombinant human PKCalpha expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-1.0	CHEMBL299	Homo sapiens	Activity	%	-1.0
Not Active	16496875	CHEMBL3776610	Inhibition of human PKCalpha (1 to 672 residues) at 1 uM by radioactive [33P]-ATP filter binding assay	B	O=c1[nH]cnc2c(-n3cc(CCN4CCC(c5cccc(Cl)c5)CC4)cn3)nccc12		CHEMBL3774537		Inhibition	%		CHEMBL299	Homo sapiens	INH		
	16498636	CHEMBL3777216	Binding affinity to human PKC-alpha at 10 uM	B	CCCCCCNC(=O)Oc1cccc(-c2ccc([C@H](C)C(=O)O)cc2F)c1		CHEMBL3774784	=	Activity	%	-26.1	CHEMBL299	Homo sapiens	Activity	%	-26.1
	16507179	CHEMBL3778997	Inhibition of recombinant PKCalpha (unknown origin) assessed as residual activity at 1 uM relative to control	B	CC(O)CNc1nc(NCc2ccc(-c3ccccn3)cc2)c2[nH]nc(C(C)C)c2n1		CHEMBL3774632	>=	Activity	%	100.0	CHEMBL299	Homo sapiens	Activity	%	100.0
	16508289	CHEMBL3777511	Inhibition of N-terminal His6-tagged recombinant human PKCalpha expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-8.0	CHEMBL299	Homo sapiens	Activity	%	-8.0
	16525662	CHEMBL3790304	Inhibition of PRKCA (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787112	=	IC50	nM	53.0	CHEMBL299	Homo sapiens	IC50	uM	0.053
	16525663	CHEMBL3790304	Inhibition of PRKCA (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCC34CCC(CC3)O4)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3785500	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	16525664	CHEMBL3790304	Inhibition of PRKCA (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cccc(OC[C@@H]5CCCO5)c4F)c4c(N)ncnc43)C2)CC1		CHEMBL3786167	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	16525665	CHEMBL3790304	Inhibition of PRKCA (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	16559751	CHEMBL3794948	Inhibition of full length human N-terminal GST-tagged PKCalpha (1 to 672 residues) expressed in baculovirus expression system using fluorescence labelled PKC peptide substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccccc1)c1n[nH]c2ccccc12		CHEMBL508964	=	Inhibition	%	2.4	CHEMBL299	Homo sapiens	INH	%	2.4
	16559752	CHEMBL3794948	Inhibition of full length human N-terminal GST-tagged PKCalpha (1 to 672 residues) expressed in baculovirus expression system using fluorescence labelled PKC peptide substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(C(=O)N2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3793843	=	Inhibition	%	10.6	CHEMBL299	Homo sapiens	INH	%	10.6
	16559753	CHEMBL3794948	Inhibition of full length human N-terminal GST-tagged PKCalpha (1 to 672 residues) expressed in baculovirus expression system using fluorescence labelled PKC peptide substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(CN2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3792850	=	Inhibition	%	-0.9	CHEMBL299	Homo sapiens	INH	%	-0.9
	16565457	CHEMBL3802856	Inhibition of N-terminal FLAG-tagged PKCalpha (unknown origin) expressed in baculovirus preincubated for 5 mins using fluorescein-PKC substrate measured after 60 mins in presence of ATP by TR-FRET assay	B	C[C@H](c1ccccc1)N1c2cc(-n3c(=O)[nH]c4ncccc43)ccc2C(=O)NC1(C)C		CHEMBL3798011	>	IC50	nM	10.0	CHEMBL299	Homo sapiens	IC50	nM	10.0
	16578361	CHEMBL3804620	Inhibition of partial length wild type human PKACalpha expressed in bacterial system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	94.0	CHEMBL299	Homo sapiens	Activity	%	94.0
	16593517	CHEMBL3812369	Inhibition of full length human recombinant PKCalpha expressed in baculovirus using Fluorescein-PKC as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL299	Homo sapiens	INH	%	40.0
	16612670	CHEMBL3815507	Inhibition of human PKCalpha (1 to 672 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-28.0	CHEMBL299	Homo sapiens	Activity	%	-28.0
	16612671	CHEMBL3815507	Inhibition of human PKCalpha (1 to 672 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	=	Activity	%	-18.0	CHEMBL299	Homo sapiens	Activity	%	-18.0
	16612672	CHEMBL3815507	Inhibition of human PKCalpha (1 to 672 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3814140	=	Activity	%	-73.0	CHEMBL299	Homo sapiens	Activity	%	-73.0
	16612673	CHEMBL3815507	Inhibition of human PKCalpha (1 to 672 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	Activity	%	-55.0	CHEMBL299	Homo sapiens	Activity	%	-55.0
	16614591	CHEMBL3815947	Inhibition of human PKCalpha at 1 uM using histone H1 as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	-4.0	CHEMBL299	Homo sapiens	INH	%	-4.0
	16615491	CHEMBL3815555	Inhibition of human full length (His)6-tagged PKCalpha expressed in insect Sf21 cells using histone H1 as substrate assessed as residual enzyme activity at 1 uM measured for 30 mins by [gamma-33P]ATP-based kinase assay	B	O=c1[nH][nH]c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c12		CHEMBL3814919	=	Activity	%	107.0	CHEMBL299	Homo sapiens	Activity	%	107.0
	16615492	CHEMBL3815555	Inhibition of human full length (His)6-tagged PKCalpha expressed in insect Sf21 cells using histone H1 as substrate assessed as residual enzyme activity at 1 uM measured for 30 mins by [gamma-33P]ATP-based kinase assay	B	c1ccc2c(-c3cn[nH]c3-c3c[nH]c4ccccc34)c[nH]c2c1		CHEMBL3813923	=	Activity	%	112.0	CHEMBL299	Homo sapiens	Activity	%	112.0
	16615493	CHEMBL3815555	Inhibition of human full length (His)6-tagged PKCalpha expressed in insect Sf21 cells using histone H1 as substrate assessed as residual enzyme activity at 1 uM measured for 30 mins by [gamma-33P]ATP-based kinase assay	B	O=c1[nH][nH]c(-c2c[nH]c3ccccc23)c1-c1c[nH]c2ccccc12		CHEMBL3813808	=	Activity	%	117.0	CHEMBL299	Homo sapiens	Activity	%	117.0
	16615494	CHEMBL3815555	Inhibition of human full length (His)6-tagged PKCalpha expressed in insect Sf21 cells using histone H1 as substrate assessed as residual enzyme activity at 1 uM measured for 30 mins by [gamma-33P]ATP-based kinase assay	B	c1ccc2c(c1)[nH]c1c3[nH]c4ccccc4c3c3[nH]ncc3c21		CHEMBL3814423	=	Activity	%	103.0	CHEMBL299	Homo sapiens	Activity	%	103.0
	16615495	CHEMBL3815554	Inhibition of human full length (His)6-tagged PKCalpha expressed in insect Sf21 cells using histone H1 as substrate assessed as residual enzyme activity at 10 uM measured for 30 mins by [gamma-33P]ATP-based kinase assay	B	O=c1[nH][nH]c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c12		CHEMBL3814919	=	Activity	%	110.0	CHEMBL299	Homo sapiens	Activity	%	110.0
	16615496	CHEMBL3815554	Inhibition of human full length (His)6-tagged PKCalpha expressed in insect Sf21 cells using histone H1 as substrate assessed as residual enzyme activity at 10 uM measured for 30 mins by [gamma-33P]ATP-based kinase assay	B	c1ccc2c(-c3cn[nH]c3-c3c[nH]c4ccccc34)c[nH]c2c1		CHEMBL3813923	=	Activity	%	100.0	CHEMBL299	Homo sapiens	Activity	%	100.0
	16615497	CHEMBL3815554	Inhibition of human full length (His)6-tagged PKCalpha expressed in insect Sf21 cells using histone H1 as substrate assessed as residual enzyme activity at 10 uM measured for 30 mins by [gamma-33P]ATP-based kinase assay	B	O=c1[nH][nH]c(-c2c[nH]c3ccccc23)c1-c1c[nH]c2ccccc12		CHEMBL3813808	=	Activity	%	93.0	CHEMBL299	Homo sapiens	Activity	%	93.0
	16615498	CHEMBL3815554	Inhibition of human full length (His)6-tagged PKCalpha expressed in insect Sf21 cells using histone H1 as substrate assessed as residual enzyme activity at 10 uM measured for 30 mins by [gamma-33P]ATP-based kinase assay	B	c1ccc2c(c1)[nH]c1c3[nH]c4ccccc4c3c3[nH]ncc3c21		CHEMBL3814423	=	Activity	%	108.0	CHEMBL299	Homo sapiens	Activity	%	108.0
	16618108	CHEMBL3816390	Inhibition of full length recombinant human PKC-alpha expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
	16619690	CHEMBL3820258	Inhibition of recombinant human full length PKCalpha expressed in Baculovirus at 1 uM relative to control	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Inhibition	%	75.0	CHEMBL299	Homo sapiens	INH	%	75.0
	16621527	CHEMBL3820666	Inhibition of PKCalpha (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21		CHEMBL3818247	>	IC50	nM	30000.0	CHEMBL299	Homo sapiens	IC50	nM	30000.0
	16622234	CHEMBL3820666	Inhibition of PKCalpha (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.2	CHEMBL299	Homo sapiens	IC50	nM	1.2
	16627562	CHEMBL3820357	Inhibition of full length recombinant human N-terminal His6-tagged PKC-alpha expressed in baculovirus infected Sf21 cells at 1 uM by radiometric assay relative to control	B	Cc1cc(-c2cnn3c(NCC4CCOCC4)nc(Oc4ccccc4)nc23)ccc1C(=O)NC1CC1		CHEMBL3819210	=	Inhibition	%	-6.0	CHEMBL299	Homo sapiens	INH	%	-6.0
	16627563	CHEMBL3820357	Inhibition of full length recombinant human N-terminal His6-tagged PKC-alpha expressed in baculovirus infected Sf21 cells at 1 uM by radiometric assay relative to control	B	O=C(N[C@@H](c1ccccn1)C1CC1)c1ccc2[nH]nc(-c3ccc(N4C5CCC4CC(O)C5)cc3)c2c1	Outside typical range	CHEMBL3818239	=	Inhibition	%	-12.0	CHEMBL299	Homo sapiens	INH	%	-12.0
	16628515	CHEMBL3820631	Inhibition of human recombinant full-length PKCa expressed in insect Sf21 cells at 1 uM using histone H1 as substrate after 30 mins	B	O=C(Nc1cc(Nc2c(Cl)cnc3c2OCO3)ccn1)C1CC1		CHEMBL3818173	<	Inhibition	%	80.0	CHEMBL299	Homo sapiens	INH	%	80.0
	16642010	CHEMBL3826421	Inhibition of His-tagged full-length human PRKACA expressed in Escherichia coli system at 100 nM by Z-lyte assay	B	O=C(CNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL3824119	=	Inhibition	%	-5.0	CHEMBL299	Homo sapiens	INH	%	-5.0
	16642011	CHEMBL3826422	Inhibition of full-length human PRKCA expressed in baculovirus system at 100 nM by Z-lyte assay	B	O=C(CNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL3824119	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	16654166	CHEMBL3830969	Inhibition of human PKCalpha (1 to 672 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	78.0	CHEMBL299	Homo sapiens	Activity	%	78.0
	16667583	CHEMBL3854628	Inhibition of recombinant full-length human N-terminal GST tagged PKCalpha expressed in Baculovirus infected Sf9 insect cells using KRREILSRRPSYR as substrate incubated for 30 mins by ADP-Glo assay	B	Cl.Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1	Outside typical range	CHEMBL1708	=	IC50	nM	220000.0	CHEMBL299	Homo sapiens	IC50	uM	220.0
	16667608	CHEMBL3854610	Binding affinity to PKCalpha (unknown origin) using Lys-Arg-Thr-Leu-Arg-Arg as substrate after 8 mins in presence of [gamma-32P]ATP by liquid scintillation spectrometry	B	O=C(N[C@@H]1CNCCC[C@H]1OC(=O)c1cc(O)c(C(=O)c2c(O)cccc2C(=O)O)c(O)c1)c1ccc(O)cc1		CHEMBL60254	=	Kd	nM	6.4	CHEMBL299	Homo sapiens	Kd	nM	6.4
	16737967	CHEMBL3856684	Inhibition of recombinant human PKC-alpha expressed in insect Sf9 cells assessed as remaining activity at 10 uM preincubated for 15 mins followed by Histone substrate addition for 30 mins in presence of [gamma-32P]ATP by TR-FRET assay	B	CNCCOc1ccc(-c2sc3nc(-c4cccs4)nc(NN4C(=O)C=C(C)C4=O)c3c2C)cc1.Cl		CHEMBL3966536	=	Activity	%	81.0	CHEMBL299	Homo sapiens	Activity	%	81.0
	16739522	CHEMBL3857073	Inhibition of recombinant full length human PRKCA expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3901622	=	Inhibition	%	-9.0	CHEMBL299	Homo sapiens	INH	%	-9.0
	16739523	CHEMBL3857073	Inhibition of recombinant full length human PRKCA expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN4CCCCC4)cc3)cc12)c1ccccc1	Outside typical range	CHEMBL3891846	=	Inhibition	%	-15.0	CHEMBL299	Homo sapiens	INH	%	-15.0
	16739524	CHEMBL3857073	Inhibition of recombinant full length human PRKCA expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	2.0	CHEMBL299	Homo sapiens	INH	%	2.0
412043	17776758	CHEMBL3888686	Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 μM at maximum. Firstly, a 50-fold concentration (i.e. 500 μM) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 μM, 100 μM, 20 μM, 4 μM, and 0.8 μM). After diluting with 1-fold kinase buffer by 10 folds, 5 μl of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 μl of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 μl/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 Î¼l/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 μl/well. The plate was incubated at 28° C. for a certain period. 25 μl termination solution was added to terminate the reaction.	B	Nc1ccc(-c2ccc3ncc4c(=O)[nH]c(=O)n(-c5cccc(C(F)(F)F)c5)c4c3n2)cn1		CHEMBL3903725	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
438112	17797857	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3890986	=	IC50	nM	1.3	CHEMBL299	Homo sapiens	IC50	nM	1.3
438113	17797858	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncccc2OC(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3915489	=	IC50	nM	0.25	CHEMBL299	Homo sapiens	IC50	nM	0.25
438114	17797859	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COCC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3C(F)(F)F)cnc2N)CC1		CHEMBL3961086	=	IC50	nM	7.4	CHEMBL299	Homo sapiens	IC50	nM	7.4
438115	17797860	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(N4CCOCC4)cc4ccccc34)cnc2N)CC1		CHEMBL3892099	=	IC50	nM	0.13	CHEMBL299	Homo sapiens	IC50	nM	0.13
438116	17797861	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)(CO)CC1		CHEMBL3968672	=	IC50	nM	5.9	CHEMBL299	Homo sapiens	IC50	nM	5.9
438117	17797862	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncccc2OC(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)(CO)CC1		CHEMBL3901073	=	IC50	nM	0.22	CHEMBL299	Homo sapiens	IC50	nM	0.22
438118	17797863	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2nc(N3CCOCC3)ncc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3984070	=	IC50	nM	0.13	CHEMBL299	Homo sapiens	IC50	nM	0.13
438119	17797864	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2csc(N3CCOCC3)n2)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3914252	=	IC50	nM	1.0	CHEMBL299	Homo sapiens	IC50	nM	1.0
438120	17797865	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3C(F)(F)F)cnc2N)CC1		CHEMBL3982723	=	IC50	nM	1.9	CHEMBL299	Homo sapiens	IC50	nM	1.9
438121	17797866	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3OC(F)(F)F)cnc2N)CC1		CHEMBL3954062	=	IC50	nM	0.9	CHEMBL299	Homo sapiens	IC50	nM	0.9
438122	17797867	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(N4CCOCC4)ncc3C(F)(F)F)cnc2N)CC1		CHEMBL3893839	=	IC50	nM	0.3	CHEMBL299	Homo sapiens	IC50	nM	0.3
438123	17797868	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Cc1nc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c2cc(F)ccc2n1		CHEMBL3959314	=	IC50	nM	0.9	CHEMBL299	Homo sapiens	IC50	nM	0.9
438124	17797869	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c1C(F)(F)F		CHEMBL3899197	=	IC50	nM	1.3	CHEMBL299	Homo sapiens	IC50	nM	1.3
438125	17797870	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(C4CC(F)(F)C4)ccc3C(F)(F)F)cnc2N)CC1		CHEMBL3970381	=	IC50	nM	0.68	CHEMBL299	Homo sapiens	IC50	nM	0.68
438126	17797871	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(C4CC4)ccc3C(F)(F)F)cnc2N)CC1		CHEMBL3908251	=	IC50	nM	0.4	CHEMBL299	Homo sapiens	IC50	nM	0.4
438127	17797872	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COc1ccc(C(F)(F)F)c(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)n1		CHEMBL3981769	=	IC50	nM	0.63	CHEMBL299	Homo sapiens	IC50	nM	0.63
438128	17797873	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CCC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3C(F)(F)F)cnc2N)CC1		CHEMBL3920740	=	IC50	nM	2.1	CHEMBL299	Homo sapiens	IC50	nM	2.1
438129	17797874	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3Cl)cnc2N)CC1		CHEMBL3892736	=	IC50	nM	0.7	CHEMBL299	Homo sapiens	IC50	nM	0.7
438130	17797875	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3F)cnc2N)CC1		CHEMBL3896642	=	IC50	nM	1.7	CHEMBL299	Homo sapiens	IC50	nM	1.7
438131	17797876	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2nc(N3CCOCC3)ccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1C[C@@H]2CC[C@H](C1)[C@H]2N		CHEMBL3928145	=	IC50	nM	0.5	CHEMBL299	Homo sapiens	IC50	nM	0.5
438132	17797877	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c1F		CHEMBL3891166	=	IC50	nM	0.55	CHEMBL299	Homo sapiens	IC50	nM	0.55
438133	17797878	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COCC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3F)cnc2N)CC1		CHEMBL3919244	=	IC50	nM	0.86	CHEMBL299	Homo sapiens	IC50	nM	0.86
438134	17797879	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(C#N)ccc3F)cnc2N)CC1		CHEMBL3918138	=	IC50	nM	1.9	CHEMBL299	Homo sapiens	IC50	nM	1.9
438135	17797880	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3C#N)cnc2N)CC1		CHEMBL3942560	=	IC50	nM	0.4	CHEMBL299	Homo sapiens	IC50	nM	0.4
438136	17797881	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CCC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3OC(F)(F)F)cnc2N)CC1		CHEMBL3905583	=	IC50	nM	0.6	CHEMBL299	Homo sapiens	IC50	nM	0.6
438137	17797882	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c1C#N		CHEMBL3933598	=	IC50	nM	1.0	CHEMBL299	Homo sapiens	IC50	nM	1.0
438138	17797883	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COCC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3OC(F)(F)F)cnc2N)CC1		CHEMBL3932525	=	IC50	nM	3.4	CHEMBL299	Homo sapiens	IC50	nM	3.4
438139	17797884	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)(CCO)CC1		CHEMBL3935905	=	IC50	nM	1.9	CHEMBL299	Homo sapiens	IC50	nM	1.9
438140	17797885	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2nc(N3CCOCC3)ccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1C[C@@H]2CO[C@H](C1)[C@H]2N		CHEMBL4115475	=	IC50	nM	0.24	CHEMBL299	Homo sapiens	IC50	nM	0.24
438141	17797886	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncnc3c2CCCC3)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3909349	=	IC50	nM	0.43	CHEMBL299	Homo sapiens	IC50	nM	0.43
438142	17797887	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncnc3sccc23)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3924825	=	IC50	nM	0.84	CHEMBL299	Homo sapiens	IC50	nM	0.84
438143	17797888	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncccc2F)nc1C(=O)Nc1ncccc1N1CCC(N)(CCO)CC1		CHEMBL3933423	=	IC50	nM	0.88	CHEMBL299	Homo sapiens	IC50	nM	0.88
438144	17797889	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CN(C)c1ccc(C(F)(F)F)c(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)n1		CHEMBL3919379	=	IC50	nM	0.55	CHEMBL299	Homo sapiens	IC50	nM	0.55
438145	17797890	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2nc(N3CCOCC3)ccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1C[C@@H]2CC[C@H](C1)[C@H]2N		CHEMBL3928145	=	IC50	nM	0.5	CHEMBL299	Homo sapiens	IC50	nM	0.5
438146	17797891	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nccc(C#N)c3F)cnc2N)CC1		CHEMBL3943631	=	IC50	nM	0.99	CHEMBL299	Homo sapiens	IC50	nM	0.99
438147	17797892	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COCCC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3C(F)(F)F)cnc2N)CC1		CHEMBL3964163	=	IC50	nM	9.3	CHEMBL299	Homo sapiens	IC50	nM	9.3
438148	17797893	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(N4CCOCC4)ccc3C(F)(F)F)cnc2N)CC1		CHEMBL3968875	=	IC50	nM	0.57	CHEMBL299	Homo sapiens	IC50	nM	0.57
438149	17797894	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncnc4ccc(F)cc34)cnc2N)CC1		CHEMBL3916984	=	IC50	nM	1.5	CHEMBL299	Homo sapiens	IC50	nM	1.5
438150	17797895	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncnc3[nH]cc(F)c23)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3904204	=	IC50	nM	0.33	CHEMBL299	Homo sapiens	IC50	nM	0.33
438151	17797896	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2cccc(N3CCOCC3)c2)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3932204	=	IC50	nM	0.13	CHEMBL299	Homo sapiens	IC50	nM	0.13
438152	17797897	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2nc(C(F)(F)F)ccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3909775	=	IC50	nM	0.46	CHEMBL299	Homo sapiens	IC50	nM	0.46
438153	17797898	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3cc(N4CCOCC4)ccc3C(F)(F)F)cnc2N)CC1		CHEMBL3970893	=	IC50	nM	0.17	CHEMBL299	Homo sapiens	IC50	nM	0.17
438154	17797899	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncccc2OC(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)C(F)C1		CHEMBL3946659	=	IC50	nM	0.3	CHEMBL299	Homo sapiens	IC50	nM	0.3
438155	17797900	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ccnc(N3CCOCC3)n2)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3975977	=	IC50	nM	0.29	CHEMBL299	Homo sapiens	IC50	nM	0.29
438156	17797901	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(C4=CCOCC4)ncc3C(F)(F)F)cnc2N)CC1		CHEMBL3958761	=	IC50	nM	0.13	CHEMBL299	Homo sapiens	IC50	nM	0.13
438157	17797902	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(N4CCOCC4)nc4ccccc34)cnc2N)CC1		CHEMBL3984009	=	IC50	nM	0.13	CHEMBL299	Homo sapiens	IC50	nM	0.13
438158	17797903	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Cn1ncc2c(-c3cnc(N)c(C(=O)Nc4ncccc4N4CCC(N)CC4)n3)ncnc21		CHEMBL3967547	=	IC50	nM	0.27	CHEMBL299	Homo sapiens	IC50	nM	0.27
438159	17797904	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nccc4ccc(F)cc34)cnc2N)CC1		CHEMBL3896330	=	IC50	nM	2.3	CHEMBL299	Homo sapiens	IC50	nM	2.3
438160	17797905	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncccc2F)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3950697	=	IC50	nM	0.33	CHEMBL299	Homo sapiens	IC50	nM	0.33
438161	17797906	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2cccc(N3CCOCC3)n2)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3976541	=	IC50	nM	0.19	CHEMBL299	Homo sapiens	IC50	nM	0.19
438162	17797907	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2cccc(N3CCOCC3)c2)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3932204	=	IC50	nM	0.2	CHEMBL299	Homo sapiens	IC50	nM	0.2
438163	17797908	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nccc4ccc(Cl)cc34)cnc2N)CC1		CHEMBL3968031	=	IC50	nM	1.8	CHEMBL299	Homo sapiens	IC50	nM	1.8
438164	17797909	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2nc(N3CCC3)ccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3957149	=	IC50	nM	0.2	CHEMBL299	Homo sapiens	IC50	nM	0.2
438165	17797910	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncccc2OC(F)(F)F)nc1C(=O)Nc1ncccc1N1CC[C@@H](N)[C@@H](F)C1		CHEMBL3960459	=	IC50	nM	0.25	CHEMBL299	Homo sapiens	IC50	nM	0.25
438166	17797911	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2cccc3[nH]c(C(F)(F)F)cc23)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3951893	=	IC50	nM	0.13	CHEMBL299	Homo sapiens	IC50	nM	0.13
438167	17797912	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2cc(N3CCOCC3)ccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3980746	=	IC50	nM	0.13	CHEMBL299	Homo sapiens	IC50	nM	0.13
438168	17797913	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CN(C)c1ccc(C(F)(F)F)c(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(N)CC3)n2)n1		CHEMBL3943147	=	IC50	nM	0.13	CHEMBL299	Homo sapiens	IC50	nM	0.13
438169	17797914	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(N4CCC(F)(F)CC4)ncc3F)cnc2N)CC1		CHEMBL3970090	=	IC50	nM	0.13	CHEMBL299	Homo sapiens	IC50	nM	0.13
438170	17797915	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CCC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3F)cnc2N)CC1		CHEMBL3975025	=	IC50	nM	0.86	CHEMBL299	Homo sapiens	IC50	nM	0.86
438171	17797916	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(N4CCOCC4)ncc3F)cnc2N)CC1		CHEMBL3945647	=	IC50	nM	0.14	CHEMBL299	Homo sapiens	IC50	nM	0.14
438172	17797917	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Cn1ccc2c(-c3cnc(N)c(C(=O)Nc4ncccc4N4CCC(N)CC4)n3)cccc21		CHEMBL3983009	=	IC50	nM	0.13	CHEMBL299	Homo sapiens	IC50	nM	0.13
438173	17797918	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2cccc3[nH]ncc23)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3957715	=	IC50	nM	0.13	CHEMBL299	Homo sapiens	IC50	nM	0.13
438174	17797919	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nccc(C#N)c3C(F)(F)F)cnc2N)CC1		CHEMBL3889877	=	IC50	nM	0.8	CHEMBL299	Homo sapiens	IC50	nM	0.8
438175	17797920	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2nc(N3CCOCC3)nc3ccc(F)cc23)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3958917	=	IC50	nM	0.13	CHEMBL299	Homo sapiens	IC50	nM	0.13
438176	17797921	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Cc1cc2c(-c3cnc(N)c(C(=O)Nc4ncccc4N4CCC(N)CC4)n3)cccc2[nH]1		CHEMBL3969856	=	IC50	nM	0.13	CHEMBL299	Homo sapiens	IC50	nM	0.13
438177	17797922	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2nc(N3CCOCC3)ccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3966643	=	IC50	nM	0.13	CHEMBL299	Homo sapiens	IC50	nM	0.13
438178	17797923	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CCOc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c1C(F)(F)F		CHEMBL3967601	=	IC50	nM	1.3	CHEMBL299	Homo sapiens	IC50	nM	1.3
438179	17797924	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(C(N)=O)ncc3F)cnc2N)CC1		CHEMBL3937993	=	IC50	nM	0.4	CHEMBL299	Homo sapiens	IC50	nM	0.4
438180	17797925	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(C#N)ncc3C(F)(F)F)cnc2N)CC1		CHEMBL3977690	=	IC50	nM	0.48	CHEMBL299	Homo sapiens	IC50	nM	0.48
438181	17797926	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(N)ncc3Cl)cnc2N)CC1		CHEMBL3907088	=	IC50	nM	0.35	CHEMBL299	Homo sapiens	IC50	nM	0.35
438182	17797927	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2cccc3[nH]ccc23)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3982497	=	IC50	nM	0.13	CHEMBL299	Homo sapiens	IC50	nM	0.13
438183	17797928	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2nc(N3CCOCC3)cc3ccccc23)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3966595	=	IC50	nM	0.13	CHEMBL299	Homo sapiens	IC50	nM	0.13
438184	17797929	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2cc(N3CCOCC3)cc(C(F)(F)F)c2)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3893533	=	IC50	nM	0.13	CHEMBL299	Homo sapiens	IC50	nM	0.13
438185	17797930	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nccc(Cl)c3C(F)(F)F)cnc2N)CC1		CHEMBL3921551	=	IC50	nM	0.5	CHEMBL299	Homo sapiens	IC50	nM	0.5
438186	17797931	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c1C#N		CHEMBL3933598	=	IC50	nM	0.97	CHEMBL299	Homo sapiens	IC50	nM	0.97
438187	17797932	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2cc(N3CCOCC3)ccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3980746	=	IC50	nM	0.13	CHEMBL299	Homo sapiens	IC50	nM	0.13
438188	17797933	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2nc(N3CCOCC3)ccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3966643	=	IC50	nM	0.13	CHEMBL299	Homo sapiens	IC50	nM	0.13
438189	17797934	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2nc(N3CCOCC3)cc3ccccc23)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3966595	=	IC50	nM	0.13	CHEMBL299	Homo sapiens	IC50	nM	0.13
438190	17797935	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Cc1ccc(N2CCC(N)CC2)c(NC(=O)c2nc(-c3ncccc3OC(F)(F)F)cnc2N)n1		CHEMBL3903385	=	IC50	nM	4.9	CHEMBL299	Homo sapiens	IC50	nM	4.9
438191	17797936	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Cc1ccc(N2CCC(N)CC2)c(NC(=O)c2nc(-c3ncccc3C(F)(F)F)cnc2N)n1		CHEMBL3977527	=	IC50	nM	32.0	CHEMBL299	Homo sapiens	IC50	nM	32.0
438192	17797937	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COC1CN(c2cccnc2NC(=O)c2nc(-c3ncccc3OC(F)(F)F)cnc2N)CCC1N		CHEMBL3965722	=	IC50	nM	0.36	CHEMBL299	Homo sapiens	IC50	nM	0.36
438193	17797938	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Cc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c1F		CHEMBL3935812	=	IC50	nM	4.9	CHEMBL299	Homo sapiens	IC50	nM	4.9
438194	17797939	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CCOc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c1F		CHEMBL3912781	=	IC50	nM	1.1	CHEMBL299	Homo sapiens	IC50	nM	1.1
438195	17797940	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nccc(CO)c3C(F)(F)F)cnc2N)CC1		CHEMBL3926882	=	IC50	nM	19.0	CHEMBL299	Homo sapiens	IC50	nM	19.0
438196	17797941	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COCc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c1C(F)(F)F		CHEMBL3949255	=	IC50	nM	13.0	CHEMBL299	Homo sapiens	IC50	nM	13.0
438197	17797942	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(C#N)ccc3F)cnc2N)CC1		CHEMBL3918138	=	IC50	nM	1.9	CHEMBL299	Homo sapiens	IC50	nM	1.9
438198	17797943	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1CN(c2ccc(C(F)(F)F)c(-c3cnc(N)c(C(=O)Nc4ncccc4N4CCC(C)(N)CC4)n3)n2)CCO1		CHEMBL3939304	=	IC50	nM	0.51	CHEMBL299	Homo sapiens	IC50	nM	0.51
438199	17797944	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CCOCC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3C(F)(F)F)cnc2N)CC1		CHEMBL3914762	=	IC50	nM	6.3	CHEMBL299	Homo sapiens	IC50	nM	6.3
438200	17797945	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CCOCC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3OC(F)(F)F)cnc2N)CC1		CHEMBL3987185	=	IC50	nM	0.16	CHEMBL299	Homo sapiens	IC50	nM	0.16
438201	17797946	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)(COC(F)F)CC1		CHEMBL3971305	=	IC50	nM	11.0	CHEMBL299	Homo sapiens	IC50	nM	11.0
438202	17797947	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncccc2OC(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)(COC(F)F)CC1		CHEMBL3981979	=	IC50	nM	4.2	CHEMBL299	Homo sapiens	IC50	nM	4.2
438203	17797948	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2cc3ccccc3c(N3CCOCC3)n2)nc1C(=O)Nc1ncccc1N1CCC(N)(CO)CC1		CHEMBL3912038	=	IC50	nM	0.25	CHEMBL299	Homo sapiens	IC50	nM	0.25
438204	17797949	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2nc(N3CCOCC3)ccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)(CO)CC1		CHEMBL3920517	=	IC50	nM	0.13	CHEMBL299	Homo sapiens	IC50	nM	0.13
438205	17797950	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC(C)Oc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c1C#N		CHEMBL3935341	=	IC50	nM	1.8	CHEMBL299	Homo sapiens	IC50	nM	1.8
438206	17797951	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nccc(OC4CC4)c3C#N)cnc2N)CC1		CHEMBL3963597	=	IC50	nM	1.0	CHEMBL299	Homo sapiens	IC50	nM	1.0
438207	17797952	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(N)(CO)CC3)n2)c1C#N		CHEMBL3925357	=	IC50	nM	1.3	CHEMBL299	Homo sapiens	IC50	nM	1.3
438208	17797953	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	N#Cc1cccnc1-c1cnc(N)c(C(=O)Nc2ncccc2N2CCC(N)(CO)CC2)n1		CHEMBL3928682	=	IC50	nM	0.85	CHEMBL299	Homo sapiens	IC50	nM	0.85
438209	17797954	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nccc(OC(F)(F)F)c3C#N)cnc2N)CC1		CHEMBL3919287	=	IC50	nM	0.6	CHEMBL299	Homo sapiens	IC50	nM	0.6
438210	17797955	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nccc(Oc4ccccc4)c3C#N)cnc2N)CC1		CHEMBL3891200	=	IC50	nM	23.0	CHEMBL299	Homo sapiens	IC50	nM	23.0
438211	17797956	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COc1cnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c(C(F)(F)F)c1		CHEMBL3928191	=	IC50	nM	5.1	CHEMBL299	Homo sapiens	IC50	nM	5.1
438212	17797957	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3C(F)(F)F)cnc2N)CC1F		CHEMBL3896683	=	IC50	nM	37.0	CHEMBL299	Homo sapiens	IC50	nM	37.0
438213	17797958	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(N4CC(O)C4)ccc3C(F)(F)F)cnc2N)CC1		CHEMBL3933646	=	IC50	nM	5.2	CHEMBL299	Homo sapiens	IC50	nM	5.2
438214	17797959	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	N#CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3OC(F)(F)F)cnc2N)CC1		CHEMBL3905625	=	IC50	nM	4.4	CHEMBL299	Homo sapiens	IC50	nM	4.4
438215	17797960	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	N#CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3C(F)(F)F)cnc2N)CC1		CHEMBL3942617	=	IC50	nM	12.0	CHEMBL299	Homo sapiens	IC50	nM	12.0
438216	17797961	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3OC(F)(F)F)cnc2N)CC1F		CHEMBL3918192	=	IC50	nM	2.7	CHEMBL299	Homo sapiens	IC50	nM	2.7
438217	17797962	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	C[C@@H]1COCCN1c1ccc(C(F)(F)F)c(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)n1		CHEMBL4113858	=	IC50	nM	0.89	CHEMBL299	Homo sapiens	IC50	nM	0.89
438218	17797963	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	C[C@H]1COCCN1c1ccc(C(F)(F)F)c(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)n1		CHEMBL3893246	=	IC50	nM	0.32	CHEMBL299	Homo sapiens	IC50	nM	0.32
438219	17797964	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(N4C5CCC4COC5)ccc3C(F)(F)F)cnc2N)CC1		CHEMBL3915095	=	IC50	nM	0.94	CHEMBL299	Homo sapiens	IC50	nM	0.94
438220	17797965	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	C[C@@]1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3OC(F)(F)F)cnc2N)C[C@@H]1F		CHEMBL3943074	=	IC50	nM	14.0	CHEMBL299	Homo sapiens	IC50	nM	14.0
438221	17797966	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CCOc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c1C#N		CHEMBL3927615	=	IC50	nM	3.6	CHEMBL299	Homo sapiens	IC50	nM	3.6
438222	17797967	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ncccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)(CCO)C(F)C1		CHEMBL3900688	=	IC50	nM	21.0	CHEMBL299	Homo sapiens	IC50	nM	21.0
438223	17797968	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(N)(CC#N)CC3)n2)c1C#N		CHEMBL3928668	=	IC50	nM	0.53	CHEMBL299	Homo sapiens	IC50	nM	0.53
438224	17797969	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	C[C@H](CO)Nc1ccc(C(F)(F)F)c(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)n1		CHEMBL4109540	=	IC50	nM	0.26	CHEMBL299	Homo sapiens	IC50	nM	0.26
438225	17797970	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	C[C@@H](CO)Nc1ccc(C(F)(F)F)c(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)n1		CHEMBL3892068	=	IC50	nM	2.0	CHEMBL299	Homo sapiens	IC50	nM	2.0
438226	17797971	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(NCCO)ccc3C(F)(F)F)cnc2N)CC1		CHEMBL3922907	=	IC50	nM	0.84	CHEMBL299	Homo sapiens	IC50	nM	0.84
438227	17797972	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(OCCO)ccc3C(F)(F)F)cnc2N)CC1		CHEMBL3889579	=	IC50	nM	2.3	CHEMBL299	Homo sapiens	IC50	nM	2.3
438228	17797973	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COC1CN(c2ccc(C(F)(F)F)c(-c3cnc(N)c(C(=O)Nc4ncccc4N4CCC(C)(N)CC4)n3)n2)C1		CHEMBL3952413	=	IC50	nM	4.8	CHEMBL299	Homo sapiens	IC50	nM	4.8
438346	17798091	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ccccc2C(F)(F)F)nc1C(=O)Nc1cnccc1N1CCCC(N)C1		CHEMBL3949162	=	IC50	nM	50.0	CHEMBL299	Homo sapiens	IC50	nM	50.0
438347	17798092	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ccccc2F)nc1C(=O)Nc1cnccc1N1CCC(N)CC1		CHEMBL3895998	=	IC50	nM	0.13	CHEMBL299	Homo sapiens	IC50	nM	0.13
438348	17798093	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ccccc2)nc1C(=O)Nc1ccccc1N1CCC(N)CC1		CHEMBL3943813	=	IC50	nM	0.15	CHEMBL299	Homo sapiens	IC50	nM	0.15
438349	17798094	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ccccc2)nc1C(=O)Nc1cnccc1N1CCC(N)CC1		CHEMBL3963605	=	IC50	nM	0.13	CHEMBL299	Homo sapiens	IC50	nM	0.13
438350	17798095	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	COc1ccc(-c2cnc(N)c(C(=O)Nc3cnccc3N3CCC(N)CC3)n2)cc1		CHEMBL3942619	=	IC50	nM	0.19	CHEMBL299	Homo sapiens	IC50	nM	0.19
438351	17798096	CHEMBL3889158	In Vitro Inhibition Activity Assay: The compounds of formula I were tested for their activity on different PKC isoforms according to a published method (D. Geiges et al. Biochem. Pharmacol. 1997; 53:865-875) The assay is performed in a 96-well polypropylene microtiterplate (Costar 3794) that has been previously siliconized with Sigmacote (Sigma SL-2). The reaction mixture (50 μL) contains 10 μL of the relevant PKC isozyme together with 25 μL of the PKC inhibitor compound and 15 μL of a mix solution that contains 200 μg/mL protamine sulfate, 10 mM Mg(NO3)2, 10 μM ATP (Boehringer 519987) and 3750 Bq of 33P-ATP (Hartmann Analytic SFC301, 110 TBq/mmol) in 20 mM Tris-buffer pH 7.4+0.1% BSA. Incubation was performed for 15 minutes at 32° C. in a microtiterplate shaking incubator (Biolabo Scientific Instruments). Reaction was stopped by adding 10 μl of 0.5 M Na2EDTA, pH 7.4. 50 μl of mixture are pipetted onto a pre-wetted phosphocellulose paper (Whatmann 3698-915) under gentle pressure.	B	Nc1ncc(-c2ccccc2F)nc1C(=O)Nc1cnccc1N1CCNCC1		CHEMBL3957649	=	IC50	nM	0.8	CHEMBL299	Homo sapiens	IC50	nM	0.8
Inactive	17929737	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929738	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929739	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929740	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929741	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929742	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Active	17929743	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	23.0	CHEMBL299	Homo sapiens	Kd apparent	nM	23.0
Inactive	17929744	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929745	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929746	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929747	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929748	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929749	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929750	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929751	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Active	17929752	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	1609.0	CHEMBL299	Homo sapiens	Kd apparent	nM	1609.0
Inactive	17929753	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929754	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929755	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929756	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929757	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929758	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929759	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929760	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929761	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929762	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929763	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Active	17929764	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	873.0	CHEMBL299	Homo sapiens	Kd apparent	nM	873.0
Inactive	17929765	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Active	17929766	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	2275.0	CHEMBL299	Homo sapiens	Kd apparent	nM	2275.0
Inactive	17929767	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929768	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929769	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929770	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929771	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929772	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Active	17929773	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	=	Kd	nM	2134.0	CHEMBL299	Homo sapiens	Kd apparent	nM	2134.0
Active	17929774	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	Kd	nM	591.0	CHEMBL299	Homo sapiens	Kd apparent	nM	591.0
Inactive	17929775	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929776	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929777	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929778	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929779	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929780	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929781	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929782	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929783	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929784	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929785	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929786	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Active	17929787	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Kd	nM	35.0	CHEMBL299	Homo sapiens	Kd apparent	nM	35.0
Active	17929788	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	164.0	CHEMBL299	Homo sapiens	Kd apparent	nM	164.0
Inactive	17929789	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929790	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929791	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929792	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929793	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929794	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929795	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929796	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929797	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929798	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929799	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929800	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929801	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929802	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929803	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929804	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929805	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929806	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929807	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929808	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929809	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929810	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929811	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929812	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929813	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929814	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929815	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929816	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929817	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929818	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929819	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929820	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929821	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929822	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929823	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929824	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929825	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929826	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929827	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929828	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929829	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929830	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929831	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929832	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929833	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929834	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929835	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Active	17929836	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	=	Kd	nM	2071.0	CHEMBL299	Homo sapiens	Kd apparent	nM	2071.0
Inactive	17929837	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Active	17929838	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	=	Kd	nM	885.0	CHEMBL299	Homo sapiens	Kd apparent	nM	885.0
Inactive	17929839	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929840	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929841	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929842	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929843	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929844	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929845	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929846	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929847	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929848	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929849	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929850	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Active	17929851	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	=	Kd	nM	21773.0	CHEMBL299	Homo sapiens	Kd apparent	nM	21773.0
Inactive	17929852	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929853	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929854	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Active	17929855	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	=	Kd	nM	1667.0	CHEMBL299	Homo sapiens	Kd apparent	nM	1667.0
Inactive	17929856	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929857	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929858	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929859	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Active	17929860	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	=	Kd	nM	3276.0	CHEMBL299	Homo sapiens	Kd apparent	nM	3276.0
Inactive	17929861	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929862	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929863	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929864	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929865	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929866	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929867	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929868	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929869	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929870	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929871	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929872	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929873	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929874	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929875	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929876	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929877	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929878	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929879	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929880	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Active	17929881	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	=	Kd	nM	21352.0	CHEMBL299	Homo sapiens	Kd apparent	nM	21352.0
Inactive	17929882	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929883	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929884	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929885	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929886	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Active	17929887	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	Kd	nM	524.0	CHEMBL299	Homo sapiens	Kd apparent	nM	524.0
Inactive	17929888	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929889	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929890	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929891	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929892	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929893	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929894	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Active	17929895	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	=	Kd	nM	1733.0	CHEMBL299	Homo sapiens	Kd apparent	nM	1733.0
Inactive	17929896	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929897	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929898	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929899	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929900	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929901	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929902	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929903	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929904	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929905	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929906	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929907	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929908	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Active	17929909	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	16494.0	CHEMBL299	Homo sapiens	Kd apparent	nM	16494.0
Inactive	17929910	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929911	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929912	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929913	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929914	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929915	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929916	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929917	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929918	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929919	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929920	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929921	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929922	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929923	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929924	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Active	17929925	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	Kd	nM	13.0	CHEMBL299	Homo sapiens	Kd apparent	nM	13.0
Active	17929926	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	1543.0	CHEMBL299	Homo sapiens	Kd apparent	nM	1543.0
Inactive	17929927	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929928	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929929	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929930	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929931	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929932	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929933	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Active	17929934	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	=	Kd	nM	1557.0	CHEMBL299	Homo sapiens	Kd apparent	nM	1557.0
Inactive	17929935	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929936	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929937	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929938	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929939	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929940	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929941	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929942	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929943	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929944	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929945	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929946	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929947	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929948	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929949	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Active	17929950	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	2280.0	CHEMBL299	Homo sapiens	Kd apparent	nM	2280.0
Active	17929951	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	1799.0	CHEMBL299	Homo sapiens	Kd apparent	nM	1799.0
Inactive	17929952	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929953	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929954	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929955	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929956	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Active	17929957	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	=	Kd	nM	934.0	CHEMBL299	Homo sapiens	Kd apparent	nM	934.0
Inactive	17929958	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929959	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17929960	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Kd	nM	28098.0	CHEMBL299	Homo sapiens	Kd apparent	nM	28098.0
Active	17929961	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	=	Kd	nM	117.0	CHEMBL299	Homo sapiens	Kd apparent	nM	117.0
Inactive	17929962	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Active	17929963	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	566.0	CHEMBL299	Homo sapiens	Kd apparent	nM	566.0
Inactive	17929964	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929965	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929966	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929967	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929968	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929969	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929970	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929971	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Active	17929972	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Kd	nM	530.0	CHEMBL299	Homo sapiens	Kd apparent	nM	530.0
Inactive	17929973	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929974	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929975	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929976	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929977	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929978	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17929979	CHEMBL3991842	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL299	Homo sapiens	Kd apparent	nM	30000.0
	17978444	CHEMBL3997622	Inhibition of full length recombinant human N-terminal GST-tagged PKCalpha (1 to 672 residues) expressed in baculovirus infected sf21 cells at 200 nM using PKC peptide as substrate by electrophoretic mobility shift assay relative to control	B	CCc1ccc2c(/C=C3\Oc4c(ccc(OC)c4CN4CCNCC4)C3=O)c[nH]c2n1		CHEMBL4074201	=	Inhibition	%	10.0	CHEMBL299	Homo sapiens	INH	%	10.0
	17978445	CHEMBL3997622	Inhibition of full length recombinant human N-terminal GST-tagged PKCalpha (1 to 672 residues) expressed in baculovirus infected sf21 cells at 200 nM using PKC peptide as substrate by electrophoretic mobility shift assay relative to control	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1c[nH]c3nc(C)ccc13)C2=O		CHEMBL4060711	=	Inhibition	%	10.0	CHEMBL299	Homo sapiens	INH	%	10.0
	17978446	CHEMBL3997622	Inhibition of full length recombinant human N-terminal GST-tagged PKCalpha (1 to 672 residues) expressed in baculovirus infected sf21 cells at 200 nM using PKC peptide as substrate by electrophoretic mobility shift assay relative to control	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1c[nH]c3ncccc13)C2=O		CHEMBL2147767	>	Inhibition	%	75.0	CHEMBL299	Homo sapiens	INH	%	75.0
	18012411	CHEMBL4004231	Inhibition of recombinant full length human N-terminal GST-tagged PKCalpha (1 to 351 residues) expressed in baculovirus expression system	B	COc1cc2ncccc2cc1NC(=O)c1csc2cncnc12		CHEMBL3822972	>	IC50	nM	50000.0	CHEMBL299	Homo sapiens	IC50	uM	50.0
	18014586	CHEMBL4004540	Inhibition of PKCalpha (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	Cn1cc(C2=C(c3cccc4ccc(CN)cc34)C(=O)NC2=O)c2ccccc21		CHEMBL4083182	=	IC50	nM	73.0	CHEMBL299	Homo sapiens	IC50	nM	73.0
	18014587	CHEMBL4004540	Inhibition of PKCalpha (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	NCc1ccc2cccc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL4061321	=	IC50	nM	36.0	CHEMBL299	Homo sapiens	IC50	nM	36.0
	18014588	CHEMBL4004540	Inhibition of PKCalpha (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	Cn1cc(C2=C(c3cccc4cc(CN)ccc34)C(=O)NC2=O)c2ccccc21		CHEMBL4072709	=	IC50	nM	136.0	CHEMBL299	Homo sapiens	IC50	nM	136.0
	18014589	CHEMBL4004540	Inhibition of PKCalpha (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	Cc1ccc2ccc(CN)cc2c1C1=C(c2c[nH]c3ccccc23)C(=O)NC1=O		CHEMBL4099609	=	IC50	nM	49.0	CHEMBL299	Homo sapiens	IC50	nM	49.0
	18014590	CHEMBL4004540	Inhibition of PKCalpha (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	Cc1ccc2ccc(CN)cc2c1C1=C(c2cn(C)c3ccccc23)C(=O)NC1=O		CHEMBL4078759	=	IC50	nM	95.0	CHEMBL299	Homo sapiens	IC50	nM	95.0
	18014591	CHEMBL4004540	Inhibition of PKCalpha (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	Cn1cc(C2=C(c3c(Cl)ccc4ccc(CN)cc34)C(=O)NC2=O)c2ccccc21		CHEMBL4089665	=	IC50	nM	4.7	CHEMBL299	Homo sapiens	IC50	nM	4.7
	18014592	CHEMBL4004540	Inhibition of PKCalpha (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CN(C)Cc1ccc2ccc(Cl)c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL4077967	=	IC50	nM	4.0	CHEMBL299	Homo sapiens	IC50	nM	4.0
	18014593	CHEMBL4004540	Inhibition of PKCalpha (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CN(C)Cc1ccc2ccc(Cl)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL4102228	=	IC50	nM	0.5	CHEMBL299	Homo sapiens	IC50	nM	0.5
	18014594	CHEMBL4004540	Inhibition of PKCalpha (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CN(C)Cc1ccc2c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c(Cl)ccc2c1		CHEMBL4085837	=	IC50	nM	1.8	CHEMBL299	Homo sapiens	IC50	nM	1.8
	18014595	CHEMBL4004540	Inhibition of PKCalpha (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CN(C)Cc1ccc2c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c(Cl)ccc2c1		CHEMBL4064291	=	IC50	nM	3.7	CHEMBL299	Homo sapiens	IC50	nM	3.7
	18014596	CHEMBL4004540	Inhibition of PKCalpha (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	IC50	nM	2.1	CHEMBL299	Homo sapiens	IC50	nM	2.1
	18014597	CHEMBL4004540	Inhibition of PKCalpha (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CNCc1ccc2ccc(Cl)c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL4072879	=	IC50	nM	0.5	CHEMBL299	Homo sapiens	IC50	nM	0.5
	18014598	CHEMBL4004540	Inhibition of PKCalpha (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	COCCNCc1ccc2ccc(Cl)c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL4101316	=	IC50	nM	2.8	CHEMBL299	Homo sapiens	IC50	nM	2.8
	18014599	CHEMBL4004540	Inhibition of PKCalpha (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CC(C)NCc1ccc2ccc(Cl)c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL4083319	=	IC50	nM	2.7	CHEMBL299	Homo sapiens	IC50	nM	2.7
	18014600	CHEMBL4004540	Inhibition of PKCalpha (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	Cn1cc(C2=C(c3c(Cl)ccc4ccc(CN5CCC5)cc34)C(=O)NC2=O)c2ccccc21		CHEMBL4089217	=	IC50	nM	3.4	CHEMBL299	Homo sapiens	IC50	nM	3.4
	18014601	CHEMBL4004540	Inhibition of PKCalpha (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CN1CCN(Cc2ccc3ccc(Cl)c(C4=C(c5cn(C)c6ccccc56)C(=O)NC4=O)c3c2)CC1		CHEMBL4068028	=	IC50	nM	20.0	CHEMBL299	Homo sapiens	IC50	nM	20.0
	18014602	CHEMBL4004540	Inhibition of PKCalpha (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CC(=O)N(C)Cc1ccc2ccc(Cl)c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL4100747	=	IC50	nM	63.0	CHEMBL299	Homo sapiens	IC50	nM	63.0
	18014603	CHEMBL4004540	Inhibition of PKCalpha (unknown origin) after 60 mins in presence of [gamma33P]ATP by scintillation proximity assay	B	CN(Cc1ccc2ccc(Cl)c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c2c1)C1CC1		CHEMBL4073977	=	IC50	nM	63.0	CHEMBL299	Homo sapiens	IC50	nM	63.0
	18014702	CHEMBL4004553	Reversible competitive inhibition of PKCalpha (unknown origin)	B	CN(C)Cc1ccc2ccc(Cl)c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c2c1		CHEMBL4077967	=	Ki	nM	1.0	CHEMBL299	Homo sapiens	Ki	nM	1.0
	18094975	CHEMBL4020948	Displacement of [20-3H]phorbol 12,13-dibutyrate from PKCalpha (unknown origin) in the presence of porcine brain phosphatidylserine by scintillation counting	B	Cc1ccc(C#Cc2ccc(C=C3CC(CO)(COC(=O)c4cn(C)c5ccccc45)OC3=O)cc2)cc1		CHEMBL4097154	=	Ki	nM	116.0	CHEMBL299	Homo sapiens	Ki	nM	116.0
	18094976	CHEMBL4020948	Displacement of [20-3H]phorbol 12,13-dibutyrate from PKCalpha (unknown origin) in the presence of porcine brain phosphatidylserine by scintillation counting	B	Cc1ccc(C#Cc2ccc(/C=C3\CC(CO)(COC(=O)c4cn(C)c5ccccc45)OC3=O)cc2)cc1		CHEMBL4069954	=	Ki	nM	257.0	CHEMBL299	Homo sapiens	Ki	nM	257.0
	18094977	CHEMBL4020948	Displacement of [20-3H]phorbol 12,13-dibutyrate from PKCalpha (unknown origin) in the presence of porcine brain phosphatidylserine by scintillation counting	B	CC(C)C(C/C=C1/CC(CO)(COC(=O)c2cn(C)c3ccccc23)OC1=O)C(C)C		CHEMBL4070999	=	Ki	nM	83.1	CHEMBL299	Homo sapiens	Ki	nM	83.1
	18094978	CHEMBL4020948	Displacement of [20-3H]phorbol 12,13-dibutyrate from PKCalpha (unknown origin) in the presence of porcine brain phosphatidylserine by scintillation counting	B	CC(C)C(C/C=C1\CC(CO)(COC(=O)c2cn(C)c3ccccc23)OC1=O)C(C)C		CHEMBL4075373	=	Ki	nM	73.0	CHEMBL299	Homo sapiens	Ki	nM	73.0
	18094979	CHEMBL4020948	Displacement of [20-3H]phorbol 12,13-dibutyrate from PKCalpha (unknown origin) in the presence of porcine brain phosphatidylserine by scintillation counting	B	CCCC(/C=C1\CC(CO)(COC(=O)c2cn(C)c3ccccc23)OC1=O)CCC		CHEMBL4081576	=	Ki	nM	504.0	CHEMBL299	Homo sapiens	Ki	nM	504.0
	18094980	CHEMBL4020948	Displacement of [20-3H]phorbol 12,13-dibutyrate from PKCalpha (unknown origin) in the presence of porcine brain phosphatidylserine by scintillation counting	B	CCCCCCCCC/C=C1\CC(CO)(COC(=O)c2cn(C)c3ccccc23)OC1=O		CHEMBL4099579	=	Ki	nM	106.0	CHEMBL299	Homo sapiens	Ki	nM	106.0
	18094981	CHEMBL4020948	Displacement of [20-3H]phorbol 12,13-dibutyrate from PKCalpha (unknown origin) in the presence of porcine brain phosphatidylserine by scintillation counting	B	CC(C)=C1CC(CO)(COC(=O)c2cn(C)c3ccccc23)OC1=O		CHEMBL4066764	=	Ki	nM	698.0	CHEMBL299	Homo sapiens	Ki	nM	698.0
	18094982	CHEMBL4020948	Displacement of [20-3H]phorbol 12,13-dibutyrate from PKCalpha (unknown origin) in the presence of porcine brain phosphatidylserine by scintillation counting	B	CCCC(CCC)C(=O)OCC1(CO)C/C(=C\c2cn(C)c3ccccc23)C(=O)O1		CHEMBL519741	=	Ki	nM	12.9	CHEMBL299	Homo sapiens	Ki	nM	12.9
	18096493	CHEMBL4021284	Inhibition of PKCalpha (unknown origin)	B	N#CCCn1c2ccccc2c2c3c(c4c5ccccc5[nH]c4c21)C(=O)NC3	Non standard unit for type	CHEMBL292746	=	INH	nM	2.3	CHEMBL299	Homo sapiens	INH	nM	2.3
	18099880	CHEMBL4021787	Inhibition of PKC alpha (unknown origin)	B	Cc1ccc(CNc2nc(N)nc3[nH]c4cc(C)c(O)cc4c23)cc1		CHEMBL4098682	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
Not Determined	18184579	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(CNc1ccccc1)N/N=C/c1ccncc1		CHEMBL3727506		IC50			CHEMBL299	Homo sapiens	IC50		
Not Determined	18184580	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(CNc1ccccc1Cl)N/N=C/c1ccncc1		CHEMBL4103971		IC50			CHEMBL299	Homo sapiens	IC50		
Not Determined	18184581	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(CNc1cccc(Cl)c1)N/N=C/c1ccncc1		CHEMBL3728445		IC50			CHEMBL299	Homo sapiens	IC50		
Not Determined	18184582	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(CNc1ccc(Cl)cc1)N/N=C/c1ccncc1		CHEMBL3731521		IC50			CHEMBL299	Homo sapiens	IC50		
Not Determined	18184583	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	COc1ccccc1NCC(=O)N/N=C/c1ccncc1		CHEMBL3730059		IC50			CHEMBL299	Homo sapiens	IC50		
Not Determined	18184584	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	COc1cccc(NCC(=O)N/N=C/c2ccncc2)c1		CHEMBL3728772		IC50			CHEMBL299	Homo sapiens	IC50		
Not Determined	18184585	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	COc1ccc(NCC(=O)N/N=C/c2ccncc2)cc1		CHEMBL4101520		IC50			CHEMBL299	Homo sapiens	IC50		
Not Determined	18184586	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(CNc1ccccc1)N/N=C1\CCCc2cnccc21		CHEMBL4100576		IC50			CHEMBL299	Homo sapiens	IC50		
	18184587	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	COc1cccc(NCC(=O)N/N=C2\CCCc3cnccc32)c1		CHEMBL4082559	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184588	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	CCOc1cccc(NCC(=O)N/N=C2\CCCc3cnccc32)c1		CHEMBL4063621	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184589	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(CNc1cccc(Oc2ccccc2)c1)N/N=C1\CCCc2cnccc21		CHEMBL4085247	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184590	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(CNc1cccc(OCc2ccccc2)c1)N/N=C1\CCCc2cnccc21		CHEMBL4072224	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
Not Determined	18184591	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(CNc1cccc(C(=O)N2CCOCC2)c1)N/N=C1\CCCc2cnccc21		CHEMBL4092989		IC50			CHEMBL299	Homo sapiens	IC50		
	18184592	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(CNc1cccc(C(=O)NCc2ccccc2)c1)N/N=C1\CCCc2cnccc21		CHEMBL4082713	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
Not Determined	18184593	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	Clc1ccc(SCc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL4100707		IC50			CHEMBL299	Homo sapiens	IC50		
Not Determined	18184594	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	Clc1cccc(OCc2n[nH]c(-c3ccncc3)n2)c1		CHEMBL1563842		IC50			CHEMBL299	Homo sapiens	IC50		
	18184595	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	Clc1ccc(NCc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL4062560	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
Not Determined	18184596	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	Clc1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL4098243		IC50			CHEMBL299	Homo sapiens	IC50		
Not Determined	18184597	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	Clc1ccc(CNc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL4071201		IC50			CHEMBL299	Homo sapiens	IC50		
Not Determined	18184598	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(Nc1nc(-c2ccncc2)n[nH]1)c1ccc(Cl)cc1		CHEMBL4101676		IC50			CHEMBL299	Homo sapiens	IC50		
Not Determined	18184599	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	c1ccc(CNCc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL4083675		IC50			CHEMBL299	Homo sapiens	IC50		
Not Determined	18184600	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	Clc1ccc(NCCc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL4063622		IC50			CHEMBL299	Homo sapiens	IC50		
	18184601	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	c1ccc(NCc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL4091451	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184602	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	COc1ccccc1NCc1nc(-c2ccncc2)n[nH]1		CHEMBL4077117	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184603	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	COc1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4062967	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184604	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	COc1ccc(NCc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL4082714	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184605	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	Clc1ccccc1NCc1nc(-c2ccncc2)n[nH]1		CHEMBL4060836	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184606	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	Clc1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4093686	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184607	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	NS(=O)(=O)c1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4072686	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184608	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	NS(=O)(=O)c1ccc(NCc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL4100891	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184609	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	c1ccc(Oc2cccc(NCc3nc(-c4ccncc4)n[nH]3)c2)cc1		CHEMBL4074131	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184610	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	c1ccc(COc2cccc(NCc3nc(-c4ccncc4)n[nH]3)c2)cc1		CHEMBL4093174	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184611	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	c1ccc(CCOc2cccc(NCc3nc(-c4ccncc4)n[nH]3)c2)cc1		CHEMBL4065514	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184612	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	c1ccc(CSc2cccc(NCc3nc(-c4ccncc4)n[nH]3)c2)cc1		CHEMBL4064596	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
Not Determined	18184613	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=S(=O)(NCc1ccccc1)c1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4091566		IC50			CHEMBL299	Homo sapiens	IC50		
Not Determined	18184614	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=S(=O)(Cc1ccccc1)c1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4075183		IC50			CHEMBL299	Homo sapiens	IC50		
	18184615	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	CNC(=O)c1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4095595	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184616	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(Nc1ccccc1)c1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4076320	=	IC50	nM	680.0	CHEMBL299	Homo sapiens	IC50	nM	680.0
	18184617	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(NCc1ccccc1)c1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4082775	=	IC50	nM	6300.0	CHEMBL299	Homo sapiens	IC50	nM	6300.0
	18184618	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(NCCc1ccccc1)c1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4101739	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184619	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(NCCCc1ccccc1)c1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4075063	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184620	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	CN(Cc1ccccc1)C(=O)c1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4063713	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
Not Determined	18184621	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	CC(=O)Nc1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4085317		IC50			CHEMBL299	Homo sapiens	IC50		
	18184622	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	CC(=O)Nc1cc(NCc2nc(-c3ccncc3)n[nH]2)ccc1Cl		CHEMBL4072308	=	IC50	nM	8300.0	CHEMBL299	Homo sapiens	IC50	nM	8300.0
	18184623	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(Cc1ccccc1)Nc1cc(NCc2nc(-c3ccncc3)n[nH]2)ccc1Cl		CHEMBL4093075	=	IC50	nM	1700.0	CHEMBL299	Homo sapiens	IC50	nM	1700.0
	18184624	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(NCc1ccccc1)Nc1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1		CHEMBL4082805	=	IC50	nM	2700.0	CHEMBL299	Homo sapiens	IC50	nM	2700.0
	18184625	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(Cc1cccc(NCc2nc(-c3ccncc3)n[nH]2)c1)NCc1ccccc1		CHEMBL4100779	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184626	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	Cc1cc(-c2n[nH]c(CNc3ccc(Cl)cc3)n2)ccn1		CHEMBL4090612	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184627	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	Cc1cnccc1-c1n[nH]c(CNc2cccc(C(=O)NCc3ccccc3)c2)n1		CHEMBL4062649	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184628	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(NCc1ccccc1)c1cccc(NCc2nc(-c3ccncc3CO)n[nH]2)c1		CHEMBL4098177	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
Not Determined	18184629	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	OCCc1cnccc1-c1n[nH]c(CNc2ccc(Cl)cc2)n1		CHEMBL4080151		IC50			CHEMBL299	Homo sapiens	IC50		
Not Determined	18184630	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	NC(=O)OCc1cnccc1-c1n[nH]c(CNc2cccc(C(=O)NCc3ccccc3)c2)n1		CHEMBL4090462		IC50			CHEMBL299	Homo sapiens	IC50		
Not Determined	18184631	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	CC(=O)Nc1cc(-c2nnc(CNc3cccc(C(=O)NCc4ccccc4C(F)(F)F)c3)n2C)ccn1		CHEMBL4069432		IC50			CHEMBL299	Homo sapiens	IC50		
Not Determined	18184632	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	CNc1cc(-c2nnc(CNc3cccc(C(=O)NCc4c(F)cccc4F)c3)n2C)ccn1		CHEMBL4066027		IC50			CHEMBL299	Homo sapiens	IC50		
	18184633	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	Cn1c(CNc2cccc(C(=O)NCc3c(F)cccc3F)c2)nnc1-c1ccnc(NCc2ccccc2)c1		CHEMBL4095742	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
Not Determined	18184634	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	Cn1c(CNc2cccc(C(=O)NCc3c(F)cccc3F)c2)nnc1-c1ccnc(NCCc2ccccc2)c1		CHEMBL4059737		IC50			CHEMBL299	Homo sapiens	IC50		
	18184635	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	Cn1c(CNc2cccc(C(=O)NCc3c(F)cccc3F)c2)nnc1-c1ccnc(NCCCc2ccccc2)c1		CHEMBL4088026	=	IC50	nM	2500.0	CHEMBL299	Homo sapiens	IC50	nM	2500.0
	18184636	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(NCc1ccccc1)c1cccc(NCc2cc(-c3ccncc3)n[nH]2)c1		CHEMBL4087117	=	IC50	nM	7200.0	CHEMBL299	Homo sapiens	IC50	nM	7200.0
	18184637	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	Cc1c(-c2ccncc2)n[nH]c1CNc1cccc(C(=O)NCc2ccccc2)c1		CHEMBL4065690	=	IC50	nM	4800.0	CHEMBL299	Homo sapiens	IC50	nM	4800.0
	18184638	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(NCc1ccccc1)c1cccc(NCc2nc(-c3ccncc3)c[nH]2)c1		CHEMBL4067877	=	IC50	nM	3600.0	CHEMBL299	Homo sapiens	IC50	nM	3600.0
	18184639	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(NCc1ccccc1)c1cccc(NCc2cc(-c3ccncc3)on2)c1		CHEMBL4089087	=	IC50	nM	2500.0	CHEMBL299	Homo sapiens	IC50	nM	2500.0
	18184640	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(NCc1ccccc1)c1cccc(NCc2cc(-c3ccncc3)no2)c1		CHEMBL4105466	=	IC50	nM	8300.0	CHEMBL299	Homo sapiens	IC50	nM	8300.0
Not Determined	18184641	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(NCc1ccccc1)c1cccc(NCc2c[nH]c(-c3ccncc3)n2)c1		CHEMBL4081217		IC50			CHEMBL299	Homo sapiens	IC50		
	18184642	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	Cn1c(CNc2cccc(C(=O)NCc3ccccc3)c2)nnc1-c1ccncc1		CHEMBL4086619	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184643	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(NCc1ccccc1)c1cccc(NCc2cc(-c3ccncc3)c[nH]2)c1		CHEMBL4104512	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
Not Determined	18184644	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(NCc1ccccc1)c1cccc(NCc2ccn(-c3ccncc3)c2)c1		CHEMBL4078768		IC50			CHEMBL299	Homo sapiens	IC50		
	18184645	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(NCc1ccccc1)c1cccc(NCc2nnc(-c3ccncc3)o2)c1		CHEMBL4096791	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184646	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(NCc1ccccc1)c1cccc(NCc2nc(-c3ccncc3)no2)c1		CHEMBL4082173	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184647	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(NCc1ccccc1)c1cccc(NCc2nc(-c3ccncc3)cs2)c1		CHEMBL4100175	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184648	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(NCc1ccccc1)c1cccc(NCc2csc(-c3ccncc3)n2)c1		CHEMBL4072362	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
Not Determined	18184649	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(NCc1ccccc1)c1cccc(NCc2[nH]nc(-c3ccncc3)c2-c2ccccc2)c1		CHEMBL4099309		IC50			CHEMBL299	Homo sapiens	IC50		
	18184650	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	COc1ccc(CNC(=O)c2cccc(NCc3nnc(-c4ccncc4)[nH]3)c2)cc1		CHEMBL4082853	=	IC50	nM	7100.0	CHEMBL299	Homo sapiens	IC50	nM	7100.0
	18184651	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	COc1cccc(CNC(=O)c2cccc(NCc3nnc(-c4ccncc4)[nH]3)c2)c1		CHEMBL4060973	=	IC50	nM	3200.0	CHEMBL299	Homo sapiens	IC50	nM	3200.0
	18184652	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	COc1ccccc1CNC(=O)c1cccc(NCc2nnc(-c3ccncc3)[nH]2)c1		CHEMBL4095659	=	IC50	nM	3300.0	CHEMBL299	Homo sapiens	IC50	nM	3300.0
	18184653	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(NCc1ccccc1Cl)c1cccc(NCc2nnc(-c3ccncc3)[nH]2)c1		CHEMBL4077447	=	IC50	nM	1100.0	CHEMBL299	Homo sapiens	IC50	nM	1100.0
	18184654	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	Cn1c(CNc2cccc(C(=O)NCc3ccc(C(F)(F)F)cc3)c2)nnc1-c1ccncc1		CHEMBL4063774	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184655	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	Cn1c(CNc2cccc(C(=O)NCc3cccc(C(F)(F)F)c3)c2)nnc1-c1ccncc1		CHEMBL4091573	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184656	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	Cn1c(CNc2cccc(C(=O)NCc3ccccc3C(F)(F)F)c2)nnc1-c1ccncc1		CHEMBL1738877	=	IC50	nM	8100.0	CHEMBL299	Homo sapiens	IC50	nM	8100.0
	18184657	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	COc1ccccc1CNC(=O)c1cccc(NCc2nnc(-c3ccncc3)n2C)c1		CHEMBL4075992	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184658	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	Cn1c(CNc2cccc(C(=O)NCc3ccccc3Cl)c2)nnc1-c1ccncc1		CHEMBL4061438	=	IC50	nM	8700.0	CHEMBL299	Homo sapiens	IC50	nM	8700.0
	18184659	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	CCn1c(CNc2cccc(C(=O)NCc3ccccc3)c2)nnc1-c1ccncc1		CHEMBL4083276	=	IC50	nM	2900.0	CHEMBL299	Homo sapiens	IC50	nM	2900.0
	18184660	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	CCCn1c(CNc2cccc(C(=O)NCc3ccccc3)c2)nnc1-c1ccncc1		CHEMBL4070100	=	IC50	nM	5700.0	CHEMBL299	Homo sapiens	IC50	nM	5700.0
	18184661	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	CC(C)n1c(CNc2cccc(C(=O)NCc3ccccc3)c2)nnc1-c1ccncc1		CHEMBL4091067	=	IC50	nM	4800.0	CHEMBL299	Homo sapiens	IC50	nM	4800.0
Not Determined	18184662	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(NCc1ccccc1)c1cccc(NCc2nnc(-c3ccncc3)n2Cc2ccccc2)c1		CHEMBL4091972		IC50			CHEMBL299	Homo sapiens	IC50		
	18184663	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	COCCn1c(CNc2cccc(C(=O)NCc3ccccc3)c2)nnc1-c1ccncc1		CHEMBL4064232	=	IC50	nM	7400.0	CHEMBL299	Homo sapiens	IC50	nM	7400.0
	18184664	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(NCc1ccccc1C(F)(F)F)c1cccc(NCc2nnc(-c3ccncc3)n2CCO)c1		CHEMBL4071398	=	IC50	nM	7600.0	CHEMBL299	Homo sapiens	IC50	nM	7600.0
Not Determined	18184665	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(NCc1ccccc1C(F)(F)F)c1cccc(NCc2nnc3n2CCOc2cnccc2-3)c1		CHEMBL4072828		IC50			CHEMBL299	Homo sapiens	IC50		
Not Determined	18184666	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	O=C(NCc1c(F)cccc1F)c1cccc(NCc2nnc3n2CCOc2cnccc2-3)c1		CHEMBL4073882		IC50			CHEMBL299	Homo sapiens	IC50		
	18184667	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	Cn1c(CNc2cccc(C(=O)NCc3ccccc3C(F)(F)F)c2)nnc1-c1ccncn1		CHEMBL4094447	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184668	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	Cn1c(CNc2cccc(C(=O)NCc3c(F)cccc3F)c2)nnc1-c1ccncn1		CHEMBL4103972	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18184669	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	CCCn1c(CNc2cccc(C(=O)NCc3ccccc3C(F)(F)F)c2)nnc1-c1ccncn1		CHEMBL4086046	=	IC50	nM	1200.0	CHEMBL299	Homo sapiens	IC50	nM	1200.0
	18184670	CHEMBL4040376	Inhibition of human PKCalpha active using MBP as substrate after 60 mins in presence of [gamma-32]ATP by scintillation counting	B	CCCn1c(CNc2cccc(C(=O)NCc3c(F)cccc3F)c2)nnc1-c1ccncn1		CHEMBL1738878	=	IC50	nM	250.0	CHEMBL299	Homo sapiens	IC50	nM	250.0
Active	18194797	CHEMBL4042041	Induction of PKC-alpha translocation from cytosol to plasma membrane in human platelet at 0.1 uM measured after 1 min by Western blot analysis	B	C/C=C(/C)C(=O)O[C@H]1C(C)=C[C@]23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]12O)[C@H]1[C@@H](C[C@H]3C)C1(C)C		CHEMBL1863513		Activity			CHEMBL299	Homo sapiens	Activity		
Active	18194798	CHEMBL4042041	Induction of PKC-alpha translocation from cytosol to plasma membrane in human platelet at 0.1 uM measured after 1 min by Western blot analysis	B	CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(C)=O		CHEMBL279115		Activity			CHEMBL299	Homo sapiens	Activity		
Active	18194799	CHEMBL4042042	Induction of PKC-alpha translocation from cytosol to plasma membrane in human platelet at 1 to 10 uM measured after 1 min by Western blot analysis	B	C/C=C(/C)C(=O)OC[C@]1(C)[C@H]2[C@@H]3C=C(COC(C)=O)C[C@]4(O)C(=O)C(C)=C[C@H]4[C@@]3(O)[C@H](C)C[C@]21OCC(C)C		CHEMBL4104319		Activity			CHEMBL299	Homo sapiens	Activity		
Active	18194800	CHEMBL4042042	Induction of PKC-alpha translocation from cytosol to plasma membrane in human platelet at 1 to 10 uM measured after 1 min by Western blot analysis	B	C/C=C(/C)C(=O)O[C@H]1C(C)=C[C@]23C(=O)[C@@H](C=C(C)[C@@H](O)[C@]12O)[C@H]1[C@@H](C[C@H]3C)C1(C)C		CHEMBL4071723		Activity			CHEMBL299	Homo sapiens	Activity		
Active	18194801	CHEMBL4042042	Induction of PKC-alpha translocation from cytosol to plasma membrane in human platelet at 1 to 10 uM measured after 1 min by Western blot analysis	B	CC(=O)O[C@@]12C[C@@H](C)[C@@]3(O)[C@@H](C=C(CO)C[C@]4(O)C(=O)C(C)=C[C@H]43)[C@@H]1C2(C)C		CHEMBL170518		Activity			CHEMBL299	Homo sapiens	Activity		
Active	18194826	CHEMBL4042058	Induction of PKC-alpha translocation from cytosol to plasma membrane in human platelet at 1 uM measured after 1 min by Western blot analysis	B	C/C=C(/C)C(=O)O[C@H]1C(C)=C[C@]23C(=O)[C@@H](C=C(CO)[C@@H](O)[C@]12O)[C@H]1[C@@H](C[C@H]3C)C1(C)C		CHEMBL1863513		Activity			CHEMBL299	Homo sapiens	Activity		
	18211710	CHEMBL4045806	Inhibition of PKCa conserved Lys2 (DLKLDNVMLDSEGHIK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-7.4	CHEMBL299	Homo sapiens	INH	%	-7.4
	18211951	CHEMBL4046047	Inhibition of PKCa conserved Lys2 (DLKLDNVMLDSEGHIK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-19.8	CHEMBL299	Homo sapiens	INH	%	-19.8
	18212134	CHEMBL4046152	Inhibition of PKCalpha (unknown origin) at 1 uM relative to control	B	Cc1c(-c2ccncc2)c[nH]c1C(N)=O		CHEMBL4100387	<	Inhibition	%	20.0	CHEMBL299	Homo sapiens	INH	%	20.0
	18231704	CHEMBL4050196	Inhibition of human PKCa using histone H1 as substrate in presence of [gamma-32P]ATP	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.542	CHEMBL299	Homo sapiens	IC50	10'-10M	5.42
Not Determined	18231734	CHEMBL4050196	Inhibition of human PKCa using histone H1 as substrate in presence of [gamma-32P]ATP	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339		IC50			CHEMBL299	Homo sapiens	IC50		
	18232121	CHEMBL4050381	Inhibition of human PKCa assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	93.0	CHEMBL299	Homo sapiens	Activity	%	93.0
	18248614	CHEMBL4053897	Inhibition of PRKCA (unknown origin) at 1 uM relative to control	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4104658	=	Inhibition	%	1.0	CHEMBL299	Homo sapiens	INH	%	1.0
	18250434	CHEMBL4054251	Inhibition of recombinant human PKCalpha using biotinyl-beta Abeta Abeta AKIQASFRGHMARKK as substrate at 100 uM after 10 mins in presence of ATP relative to control	B	CCCCCCCCCCCCCCC(=O)NC1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4081419	=	Inhibition	%	-7.0	CHEMBL299	Homo sapiens	INH	%	-7.0
	18282115	CHEMBL4120070	Inhibition of recombinant full length human PKCalpha expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	30.3	CHEMBL299	Homo sapiens	INH	%	30.3
	18282434	CHEMBL4120070	Inhibition of recombinant full length human PKCalpha expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	22.4	CHEMBL299	Homo sapiens	INH	%	22.4
	18286325	CHEMBL4121560	Inhibition of recombinant full length human PKCalpha expressed in baculovirus expression system at 10 uM in presence of ATP relative to control	B	CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12		CHEMBL4128926	=	Inhibition	%	-1.0	CHEMBL299	Homo sapiens	INH	%	-1.0
	18298998	CHEMBL4124326	Inhibition of human PKCalpha	B	CC(=O)C1=C(O)C=C2Oc3c(C(N)=O)c(O)cc(O)c3[C@]2(C)C1=O		CHEMBL475816	=	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	uM	1.0
Active	18299004	CHEMBL4124329	Inhibition of human PKCalpha at 100 uM pre-incubated for 15 mins by ELISA-based PKC kinase activity assay	B	NC(=O)c1c(O)cc(O)c2c1oc1c(=O)[nH]cnc12		CHEMBL4128587		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Active	18299005	CHEMBL4124329	Inhibition of human PKCalpha at 100 uM pre-incubated for 15 mins by ELISA-based PKC kinase activity assay	B	NC(=O)c1c(O)cc(O)c2c1oc1c(=O)[nH]c(=O)[nH]c12		CHEMBL4129279		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Active	18299006	CHEMBL4124329	Inhibition of human PKCalpha at 100 uM pre-incubated for 15 mins by ELISA-based PKC kinase activity assay	B	NC(=O)c1c(O)cc(O)c2c1oc1c(N)ncnc12		CHEMBL4127885		Inhibition	%		CHEMBL299	Homo sapiens	INH		
	18299007	CHEMBL4124329	Inhibition of human PKCalpha at 100 uM pre-incubated for 15 mins by ELISA-based PKC kinase activity assay	B	CC(=O)C1=C(O)C=C2Oc3c(C(N)=O)c(O)cc(O)c3[C@]2(C)C1=O		CHEMBL475816	=	Inhibition	%	65.0	CHEMBL299	Homo sapiens	INH	%	65.0
	18335820	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	CC(C)Cn1cc(/C=C2\CC(CO)(COC(=O)C(C)(C)C)OC2=O)c2ccccc21		CHEMBL4167900	=	Ki	nM	15.6	CHEMBL299	Homo sapiens	Ki	nM	15.6
	18335821	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	CCCCn1cc(/C=C2\CC(CO)(COC(=O)C(C)(C)C)OC2=O)c2ccccc21		CHEMBL4160540	=	Ki	nM	25.65	CHEMBL299	Homo sapiens	Ki	nM	25.65
	18335822	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	Cn1cc(/C=C/C(=O)OCC2(CO)C/C(=C\c3cn(C)c4ccccc34)C(=O)O2)c2ccccc21		CHEMBL4170226	=	Ki	nM	375.0	CHEMBL299	Homo sapiens	Ki	nM	375.0
	18335823	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	Cn1cc(/C=C2\CC(CO)(COC(=O)/C=C/c3ccccn3)OC2=O)c2ccccc21		CHEMBL4170651	=	Ki	nM	2308.0	CHEMBL299	Homo sapiens	Ki	nM	2308.0
	18335824	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	Cn1cc(/C=C2\CC(CO)(COC(=O)/C=C/c3ccccc3)OC2=O)c2ccccc21		CHEMBL4160009	=	Ki	nM	439.0	CHEMBL299	Homo sapiens	Ki	nM	439.0
	18335825	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	CC(C)CC(CC(C)C)C(=O)OCC1(CO)C/C(=C\c2cn(C)c3ccccc23)C(=O)O1		CHEMBL488667	=	Ki	nM	39.0	CHEMBL299	Homo sapiens	Ki	nM	39.0
	18335826	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	CCCC(CCC)C(=O)OCC1(CO)C/C(=C\c2cn(C)c3ccccc23)C(=O)O1		CHEMBL519741	=	Ki	nM	31.7	CHEMBL299	Homo sapiens	Ki	nM	31.7
	18335827	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	Cn1cc(/C=C2\CC(CO)(COC(=O)C3CCCCC3)OC2=O)c2ccccc21		CHEMBL4163809	=	Ki	nM	112.0	CHEMBL299	Homo sapiens	Ki	nM	112.0
	18335828	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	Cn1cc(/C=C2\CC(CO)(COC(=O)C3CCC(C(C)(C)C)CC3)OC2=O)c2ccccc21		CHEMBL4161221	=	Ki	nM	31.3	CHEMBL299	Homo sapiens	Ki	nM	31.3
	18335829	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	CCCCCCC(=O)OCC1(CO)C/C(=C\c2cn(C)c3ccccc23)C(=O)O1		CHEMBL4167264	=	Ki	nM	135.0	CHEMBL299	Homo sapiens	Ki	nM	135.0
	18335830	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	CN(C)c1ccc(C(=O)OCC2(CO)C/C(=C\c3ccc(Cl)cc3)C(=O)O2)cc1		CHEMBL4175128	=	Ki	nM	30.4	CHEMBL299	Homo sapiens	Ki	nM	30.4
	18335831	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	COc1ccc(C(=O)OCC2(CO)C/C(=C\c3ccc(Cl)cc3)C(=O)O2)cc1		CHEMBL4175934	=	Ki	nM	27.6	CHEMBL299	Homo sapiens	Ki	nM	27.6
	18335832	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	O=C1OC(CO)(COC(=O)c2ccc(Cl)cc2)C/C1=C\c1ccc(Cl)cc1		CHEMBL4172461	=	Ki	nM	25.2	CHEMBL299	Homo sapiens	Ki	nM	25.2
	18335833	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	CC(C)(C)C(=O)OCC1(CO)C/C(=C\c2ccc(Cl)cc2)C(=O)O1		CHEMBL4160361	=	Ki	nM	13.6	CHEMBL299	Homo sapiens	Ki	nM	13.6
	18335834	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	COc1ccc(/C=C2\CC(CO)(COC(=O)c3ccc(N(C)C)cc3)OC2=O)cc1		CHEMBL461374	=	Ki	nM	82.2	CHEMBL299	Homo sapiens	Ki	nM	82.2
	18335835	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	COc1ccc(/C=C2\CC(CO)(COC(=O)c3ccc(OC)cc3)OC2=O)cc1		CHEMBL461754	=	Ki	nM	84.7	CHEMBL299	Homo sapiens	Ki	nM	84.7
	18335836	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	COc1ccc(/C=C2\CC(CO)(COC(=O)c3ccc(Cl)cc3)OC2=O)cc1		CHEMBL4174397	=	Ki	nM	30.1	CHEMBL299	Homo sapiens	Ki	nM	30.1
	18335837	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	COc1ccc(/C=C2\CC(CO)(COC(=O)C(C)(C)C)OC2=O)cc1		CHEMBL4163130	=	Ki	nM	72.0	CHEMBL299	Homo sapiens	Ki	nM	72.0
	18335838	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	CN(C)c1ccc(/C=C2\CC(CO)(COC(=O)c3ccc(N(C)C)cc3)OC2=O)cc1		CHEMBL452307	=	Ki	nM	252.0	CHEMBL299	Homo sapiens	Ki	nM	252.0
	18335839	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	COc1ccc(C(=O)OCC2(CO)C/C(=C\c3ccc(N(C)C)cc3)C(=O)O2)cc1		CHEMBL508870	=	Ki	nM	128.0	CHEMBL299	Homo sapiens	Ki	nM	128.0
	18335840	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	CN(C)c1ccc(/C=C2\CC(CO)(COC(=O)c3ccc(Cl)cc3)OC2=O)cc1		CHEMBL4167589	=	Ki	nM	25.4	CHEMBL299	Homo sapiens	Ki	nM	25.4
	18335841	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	CN(C)c1ccc(/C=C2\CC(CO)(COC(=O)C(C)(C)C)OC2=O)cc1		CHEMBL4162516	=	Ki	nM	65.9	CHEMBL299	Homo sapiens	Ki	nM	65.9
	18335842	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	CN(C)c1ccc(C(=O)OCC2(CO)C/C(=C\c3ccccn3)C(=O)O2)cc1		CHEMBL487483	=	Ki	nM	1480.0	CHEMBL299	Homo sapiens	Ki	nM	1480.0
	18335843	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	Cn1cc(/C=C2\CC(CO)(COC(=O)C(C)(C)C)OC2=O)c2ccccc21		CHEMBL4169454	=	Ki	nM	127.0	CHEMBL299	Homo sapiens	Ki	nM	127.0
	18335844	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	Cn1cc(/C=C2\CC(CO)(COC(=O)c3ccc(Cl)cc3)OC2=O)c2ccccc21		CHEMBL4168968	=	Ki	nM	146.0	CHEMBL299	Homo sapiens	Ki	nM	146.0
	18335845	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	COc1ccc(C(=O)OCC2(CO)C/C(=C\c3cn(C)c4ccccc34)C(=O)O2)cc1		CHEMBL488674	=	Ki	nM	446.0	CHEMBL299	Homo sapiens	Ki	nM	446.0
	18335846	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	CN(C)c1ccc(C(=O)OCC2(CO)C/C(=C\c3cn(C)c4ccccc34)C(=O)O2)cc1		CHEMBL472521	=	Ki	nM	186.0	CHEMBL299	Homo sapiens	Ki	nM	186.0
	18335847	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	CC(C)(C)C(=O)OCC1(CO)C/C(=C\c2ccccn2)C(=O)O1		CHEMBL4173300	=	Ki	nM	3640.0	CHEMBL299	Homo sapiens	Ki	nM	3640.0
	18335848	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	O=C1OC(CO)(COC(=O)c2ccc(Cl)cc2)C/C1=C\c1ccccn1		CHEMBL4175742	=	Ki	nM	383.0	CHEMBL299	Homo sapiens	Ki	nM	383.0
	18335849	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	COc1ccc(C(=O)OCC2(CO)C/C(=C\c3ccccn3)C(=O)O2)cc1		CHEMBL470094	=	Ki	nM	1188.0	CHEMBL299	Homo sapiens	Ki	nM	1188.0
	18335854	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	Cn1cc(/C=C2/CC(CO)(COC(=O)C(C)(C)C)OC2=O)c2cc([N+](=O)[O-])ccc21		CHEMBL4164472	>	Ki	nM	30000.0	CHEMBL299	Homo sapiens	Ki	nM	30000.0
	18335856	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	Cn1cc(/C=C2\CC(CO)(COC(=O)C(C)(C)C)OC2=O)c2cc([N+](=O)[O-])ccc21		CHEMBL4168982	>	Ki	nM	30000.0	CHEMBL299	Homo sapiens	Ki	nM	30000.0
	18335857	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	CC(C)(C)C(=O)OCC1(CO)C/C(=C\c2cn(CC3CC3)c3ccccc23)C(=O)O1		CHEMBL4175761	=	Ki	nM	29.0	CHEMBL299	Homo sapiens	Ki	nM	29.0
	18335858	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	COc1ccc2c(c1)c(/C=C1\CC(CO)(COC(=O)C(C)(C)C)OC1=O)cn2C		CHEMBL4171253	=	Ki	nM	249.0	CHEMBL299	Homo sapiens	Ki	nM	249.0
	18335859	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	Cn1cc(/C=C2\CC(CO)(COC(=O)C(C)(C)C)OC2=O)c2cc(Cl)ccc21		CHEMBL4160647	=	Ki	nM	42.3	CHEMBL299	Homo sapiens	Ki	nM	42.3
	18335860	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	Cn1cc(/C=C2/CC(CO)(COC(=O)C(C)(C)C)OC2=O)c2cc(Cl)ccc21		CHEMBL4161062	=	Ki	nM	79.1	CHEMBL299	Homo sapiens	Ki	nM	79.1
	18335861	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	CC(C)(C)C(=O)OCC1(CO)C/C(=C\c2coc3ccccc23)C(=O)O1		CHEMBL4165117	=	Ki	nM	114.0	CHEMBL299	Homo sapiens	Ki	nM	114.0
	18335862	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	CC(C)(C)C(=O)OCC1(CO)C/C(=C/c2coc3ccccc23)C(=O)O1		CHEMBL4164402	=	Ki	nM	62.5	CHEMBL299	Homo sapiens	Ki	nM	62.5
	18335863	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	CC(C)(C)C(=O)OCC1(CO)C/C(=C\c2csc3ccccc23)C(=O)O1		CHEMBL4174723	=	Ki	nM	28.77	CHEMBL299	Homo sapiens	Ki	nM	28.77
	18335864	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	CC(C)(C)C(=O)OCC1(CO)C/C(=C/c2csc3ccccc23)C(=O)O1		CHEMBL4175333	=	Ki	nM	37.0	CHEMBL299	Homo sapiens	Ki	nM	37.0
	18335865	CHEMBL4137134	Displacement of [3H]PDBu from full length recombinant human PKCalpha expressed in baculovirus expression system after 5 mins by scintillation counting	B	Cn1nc(/C=C2\CC(CO)(COC(=O)C(C)(C)C)OC2=O)c2ccccc21		CHEMBL4167457	=	Ki	nM	183.8	CHEMBL299	Homo sapiens	Ki	nM	183.8
	18379940	CHEMBL4145841	Inhibition of PKCalpha (unknown origin) at 10 uM relative to control	B	COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1	Outside typical range	CHEMBL4159506	=	Inhibition	%	-11.33	CHEMBL299	Homo sapiens	INH	%	-11.33
	18379992	CHEMBL4145893	Inhibition of PKCalpha (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.37	CHEMBL299	Homo sapiens	IC50	nM	0.37
	18434145	CHEMBL4156127	Inhibition of recombinant human full length untagged PKCalpha expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2sc(-c3ccc(O)cc3)cc12)c1ccccc1		CHEMBL4177361	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	18434199	CHEMBL4156127	Inhibition of recombinant human full length untagged PKCalpha expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	CCC(=O)Nc1ccc(-c2c[nH]c3ncnc(N[C@H](C)c4ccccc4)c23)cc1		CHEMBL4167749	=	Inhibition	%	21.0	CHEMBL299	Homo sapiens	INH	%	21.0
	18434259	CHEMBL4156127	Inhibition of recombinant human full length untagged PKCalpha expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	CN(C)CCn1cc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL4159505	=	Inhibition	%	15.0	CHEMBL299	Homo sapiens	INH	%	15.0
	18434331	CHEMBL4156127	Inhibition of recombinant human full length untagged PKCalpha expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	OCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1		CHEMBL4175024	=	Inhibition	%	6.0	CHEMBL299	Homo sapiens	INH	%	6.0
	18443284	CHEMBL4157926	Inhibition of human PKCalpha assessed as enzyme residual activity at 100 nM by radiometric filter binding assay relative to control	B	NCCCC[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)CCCCCNC(=O)CCC(=O)Nc1ncc(-c2ccc(C(=O)O)cc2)s1)C(=O)O		CHEMBL4177303	=	Activity	%	95.0	CHEMBL299	Homo sapiens	Activity	%	95.0
	18449492	CHEMBL4177943	Inhibition of PKCalpha (unknown origin) at 1 uM	B	CCOC(=O)C1=C(CN2CCOCC2)NC(c2nccs2)=NC1c1ccc(F)cc1Br		CHEMBL3742114	=	Inhibition	%	1.0	CHEMBL299	Homo sapiens	INH	%	1.0
	18449849	CHEMBL4178003	Inhibition of human PKCalpha (1 to 672 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	112.0	CHEMBL299	Homo sapiens	Activity	%	112.0
	18462190	CHEMBL4180877	Inhibition of recombinant human full length His6-tagged PKCa expressed in Sf21 insect cells assessed as residual activity at 1 uM using His6tone H1 as substrate after 30 mins in presence of [gamma-33P]ATP relative to control	B	CC(C)=CCC/C(C)=C/Cn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4203120	=	Activity	%	92.0	CHEMBL299	Homo sapiens	Activity	%	92.0
	18502226	CHEMBL4189552	Inhibition of full-length N-terminal GST-fused human PKC-alpha expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	COc1cc2c(cc1-n1cnc3ccc(-c4ccnc5[nH]ccc45)cc31)CNC2		CHEMBL4213984	=	IC50	nM	280.0	CHEMBL299	Homo sapiens	IC50	uM	0.28
	18502227	CHEMBL4189552	Inhibition of full-length N-terminal GST-fused human PKC-alpha expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	COc1cc2c(cc1-n1cnc3ccc(-c4ccnc5[nH]ccc45)nc31)CNC2		CHEMBL4212934	=	IC50	nM	430.0	CHEMBL299	Homo sapiens	IC50	uM	0.43
	18502228	CHEMBL4189552	Inhibition of full-length N-terminal GST-fused human PKC-alpha expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	COc1cc2c(cc1-n1cnc3cnc(-c4ccnc5[nH]ccc45)cc31)CNC2		CHEMBL4208028	=	IC50	nM	250.0	CHEMBL299	Homo sapiens	IC50	uM	0.25
	18502229	CHEMBL4189552	Inhibition of full-length N-terminal GST-fused human PKC-alpha expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	COc1cc2c(cc1-c1cnc3ccc(-c4ccnc5[nH]ccc45)nn13)CNC2		CHEMBL4214431	=	IC50	nM	1400.0	CHEMBL299	Homo sapiens	IC50	uM	1.4
	18502230	CHEMBL4189552	Inhibition of full-length N-terminal GST-fused human PKC-alpha expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	COc1cc2c(cc1-c1cnn3ccc(-c4ccnc5[nH]ccc45)nc13)CNC2		CHEMBL4211722	=	IC50	nM	350.0	CHEMBL299	Homo sapiens	IC50	uM	0.35
	18502231	CHEMBL4189552	Inhibition of full-length N-terminal GST-fused human PKC-alpha expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	COc1cc2c(cc1-c1cnc3ccc(-c4ccnc5[nH]ccc45)cn13)CNC2		CHEMBL4206023	=	IC50	nM	340.0	CHEMBL299	Homo sapiens	IC50	uM	0.34
	18502232	CHEMBL4189552	Inhibition of full-length N-terminal GST-fused human PKC-alpha expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	COc1cc2c(cc1-c1cnn3ccc(-c4ccnc5[nH]ccc45)cc13)CNC2		CHEMBL4216507	=	IC50	nM	110.0	CHEMBL299	Homo sapiens	IC50	uM	0.11
	18502233	CHEMBL4189552	Inhibition of full-length N-terminal GST-fused human PKC-alpha expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	COc1ccc2c(c1)C(=O)N(c1cnn3ccc(-c4ccnc5[nH]ccc45)cc13)C2		CHEMBL4203536	=	IC50	nM	2500.0	CHEMBL299	Homo sapiens	IC50	uM	2.5
	18502234	CHEMBL4189552	Inhibition of full-length N-terminal GST-fused human PKC-alpha expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	COc1cc2c(cc1-c1cnn3ccc(-c4ccnc5[nH]ccc45)cc13)CN(C(C)=O)C2		CHEMBL4215391	=	IC50	nM	380.0	CHEMBL299	Homo sapiens	IC50	uM	0.38
	18502235	CHEMBL4189552	Inhibition of full-length N-terminal GST-fused human PKC-alpha expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	COc1cc2c(cc1-c1cnn3ccc(-c4ccnc5[nH]ccc45)cc13)CN(C)C2		CHEMBL4206065	=	IC50	nM	140.0	CHEMBL299	Homo sapiens	IC50	uM	0.14
	18502236	CHEMBL4189552	Inhibition of full-length N-terminal GST-fused human PKC-alpha expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	COc1cc2c(cc1-c1cnn3ccc(-c4ccnc5[nH]ccc45)cc13)CNCC2		CHEMBL4202753	=	IC50	nM	71.0	CHEMBL299	Homo sapiens	IC50	uM	0.071
	18502237	CHEMBL4189552	Inhibition of full-length N-terminal GST-fused human PKC-alpha expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	COc1cc2c(cc1-c1cnn3ccc(-c4ccnc5[nH]ccc45)cc13)CNC(C)C2		CHEMBL4208685	=	IC50	nM	64.0	CHEMBL299	Homo sapiens	IC50	uM	0.064
	18502238	CHEMBL4189552	Inhibition of full-length N-terminal GST-fused human PKC-alpha expressed in baculovirus expression system using (5FAM) RFARKGSLRQKNV as substrate after 60 mins by caliper assay	B	COc1cc2c(cc1-c1cnn3ccc(-c4ccnc5[nH]ccc45)cc13)CNC(CF)C2		CHEMBL4212424	=	IC50	nM	45.0	CHEMBL299	Homo sapiens	IC50	uM	0.045
	18507654	CHEMBL4191137	Inhibition of recombinant full-length human PKCalpha at 1 uM using histone H1 as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-1.0	CHEMBL299	Homo sapiens	INH	%	-1.0
	18577626	CHEMBL4222212	Inhibition of recombinant human full length untagged PKCalpha expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(N4CCC(N5CCOCC5)CC4)cc3OC)n2)c1		CHEMBL4225781	=	Inhibition	%	10.6	CHEMBL299	Homo sapiens	INH	%	10.6
	18577650	CHEMBL4222212	Inhibition of recombinant human full length untagged PKCalpha expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	=	Inhibition	%	5.2	CHEMBL299	Homo sapiens	INH	%	5.2
	18577674	CHEMBL4222212	Inhibition of recombinant human full length untagged PKCalpha expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3699588	=	Inhibition	%	-0.3	CHEMBL299	Homo sapiens	INH	%	-0.3
	18578820	CHEMBL4222464	Inhibition of PKCA (unknown origin)	B	CCN(CCO)Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL4228240	>	IC50	nM	500.0	CHEMBL299	Homo sapiens	IC50	nM	500.0
	18578821	CHEMBL4222464	Inhibition of PKCA (unknown origin)	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3ccccn3)ns2)n1		CHEMBL4227082	>	IC50	nM	500.0	CHEMBL299	Homo sapiens	IC50	nM	500.0
	18578822	CHEMBL4222464	Inhibition of PKCA (unknown origin)	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(NC(C)(C)C)c3ccccn3)ns2)n1		CHEMBL4225923	>	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	uM	1.0
	18653431	CHEMBL4230188	Inhibition of PKC-alpha (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	-7.0	CHEMBL299	Homo sapiens	INH	%	-7.0
	18653432	CHEMBL4230188	Inhibition of PKC-alpha (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	2.0	CHEMBL299	Homo sapiens	INH	%	2.0
	18665509	CHEMBL4233385	Inhibition of PKCalpha (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	18668765	CHEMBL4234424	Inhibition of DAG-activated human PKCalpha after 10 mins in presence of [32P]ATP by beta scintillation counting method	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	IC50	nM	360.0	CHEMBL299	Homo sapiens	IC50	nM	360.0
	18668771	CHEMBL4234418	Inhibition of PKCalpha (unknown origin)	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	IC50	nM	39.0	CHEMBL299	Homo sapiens	IC50	nM	39.0
	18706575	CHEMBL4256095	Inhibition of PKCalpha (unknown origin) by HTRF assay	B	COC1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccc(O)cc3c21		CHEMBL4284275	=	IC50	nM	1400.0	CHEMBL299	Homo sapiens	IC50	uM	1.4
	18706576	CHEMBL4256095	Inhibition of PKCalpha (unknown origin) by HTRF assay	B	O=C1NCc2c1c1c3cc(O)ccc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL4294912	=	IC50	nM	3200.0	CHEMBL299	Homo sapiens	IC50	uM	3.2
	18706577	CHEMBL4256095	Inhibition of PKCalpha (unknown origin) by HTRF assay	B	O=C1NCc2c1c1c3ccccc3[nH]c1c1[nH]c3ccc(O)cc3c21		CHEMBL4284524	=	IC50	nM	980.0	CHEMBL299	Homo sapiens	IC50	uM	0.98
	18706588	CHEMBL4256095	Inhibition of PKCalpha (unknown origin) by HTRF assay	B	CC(=O)N[C@@H]1C[C@H](n2c3ccccc3c3c4c(c5c6cc(O)ccc6[nH]c5c32)CNC4=O)O[C@@H](C)[C@@H]1O		CHEMBL4279758	=	IC50	nM	97.0	CHEMBL299	Homo sapiens	IC50	uM	0.097
	18706589	CHEMBL4256095	Inhibition of PKCalpha (unknown origin) by HTRF assay	B	CC(=O)N[C@@H]1C[C@H](n2c3ccc(O)cc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)O[C@@H](C)[C@@H]1O		CHEMBL4287662	=	IC50	nM	460.0	CHEMBL299	Homo sapiens	IC50	uM	0.46
	18706590	CHEMBL4256095	Inhibition of PKCalpha (unknown origin) by HTRF assay	B	C[C@@H]1O[C@@H](n2c3ccc(O)cc3c3c4c(c5c6ccccc6[nH]c5c32)CNC4=O)C[C@@H](N)[C@H]1O		CHEMBL4288105	=	IC50	nM	79.0	CHEMBL299	Homo sapiens	IC50	uM	0.079
	18706591	CHEMBL4256095	Inhibition of PKCalpha (unknown origin) by HTRF assay	B	CC(=O)N[C@H]1C[C@H]2O[C@@](C)([C@@H]1O)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4277459	=	IC50	nM	92.0	CHEMBL299	Homo sapiens	IC50	uM	0.092
	18706592	CHEMBL4256095	Inhibition of PKCalpha (unknown origin) by HTRF assay	B	C[C@@H]1O[C@@H]2C[C@](O)([C@H]1O)n1c3ccccc3c3c4c(c5c6cc(O)ccc6n2c5c31)C(=O)NC4		CHEMBL4291517	=	IC50	nM	2100.0	CHEMBL299	Homo sapiens	IC50	uM	2.1
	18706593	CHEMBL4256095	Inhibition of PKCalpha (unknown origin) by HTRF assay	B	C[C@H]1O[C@@H]2C[C@](O)([C@H]1O)n1c3ccccc3c3c4c(c5c6cc(O)ccc6n2c5c31)C(=O)NC4		CHEMBL4280872	=	IC50	nM	1400.0	CHEMBL299	Homo sapiens	IC50	uM	1.4
	18706594	CHEMBL4256095	Inhibition of PKCalpha (unknown origin) by HTRF assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.4	CHEMBL299	Homo sapiens	IC50	uM	0.0024
Not Active	18723842	CHEMBL4258708	Inhibition of human PKCalpha at 100 uM after 40 mins in presence of [gamma-33P-ATP] by scintillation counting analysis	B	CCOc1c(S(=O)(=O)NC2CC(C)(C)NC(C)(C)C2)ccc(Cl)c1Cl		CHEMBL1502722		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Not Active	18726724	CHEMBL4259279	Inhibition of PKCalpha (unknown origin) at 10 uM	B	Oc1ccc(C2=NN(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)C2)cc1O		CHEMBL4283413		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Not Active	18728878	CHEMBL4259708	Inhibition of PKCalpha (unknown origin) at 1 uM after 40 mins by scintillation counting method relative to control	B	O=C(N1CCN(c2ncnc3[nH]nc(Cl)c23)CC1)C1(c2ccc(Cl)c(Cl)c2)CCNCC1		CHEMBL4285143		Inhibition	%		CHEMBL299	Homo sapiens	INH		
	18751200	CHEMBL4263909	Inhibition of PKC-ALPHA (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	4.0	CHEMBL299	Homo sapiens	INH	%	4.0
	18761566	CHEMBL4266617	Inhibition of recombinant human N-terminal His6-tagged full length PKCalpha expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	6.0	CHEMBL299	Homo sapiens	INH	%	6.0
	18761837	CHEMBL4266617	Inhibition of recombinant human N-terminal His6-tagged full length PKCalpha expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	1.0	CHEMBL299	Homo sapiens	INH	%	1.0
	18762000	CHEMBL4266617	Inhibition of recombinant human N-terminal His6-tagged full length PKCalpha expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	3.0	CHEMBL299	Homo sapiens	INH	%	3.0
	18763081	CHEMBL4266878	Inhibition of PKCalpha (unknown origin) at 1 uM	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)N(C)C)cc2c1C(N)=O		CHEMBL4290876	=	Inhibition	%	17.94	CHEMBL299	Homo sapiens	INH	%	17.94
	18763114	CHEMBL4266911	Inhibition of PKCalpha (unknown origin) at 10 uM	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)c3cccs3)cc2c1C(N)=O		CHEMBL4288081	=	Inhibition	%	21.44	CHEMBL299	Homo sapiens	INH	%	21.44
	18764479	CHEMBL4267062	Inhibition of human PKCalpha at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4288103	<	Inhibition	%	70.0	CHEMBL299	Homo sapiens	INH	%	70.0
	18764480	CHEMBL4267062	Inhibition of human PKCalpha at 100 nM	B	CN1CCC(c2nc(-c3cccc(S(C)(=O)=O)c3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4286880	<	Inhibition	%	70.0	CHEMBL299	Homo sapiens	INH	%	70.0
	18764481	CHEMBL4267062	Inhibition of human PKCalpha at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1		CHEMBL4286841	<	Inhibition	%	70.0	CHEMBL299	Homo sapiens	INH	%	70.0
	18782856	CHEMBL4270722	Inhibition of PKCalpha (unknown origin) assessed as residual enzyme activity at 1 uM relative to untreated control	B	Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)C(C)C(C)(C)C3)n1		CHEMBL4277021	>	Activity	%	80.0	CHEMBL299	Homo sapiens	Activity	%	80.0
	18786935	CHEMBL4271849	Inhibition of PKCalpha (unknown origin) at 30 uM relative to control	B	O=c1cc(-c2ccc(-c3ccccc3)cc2)c2ccc(N3CCC(NCCc4ccccc4)CC3)cc2o1		CHEMBL4276817	=	Inhibition	%	11.49	CHEMBL299	Homo sapiens	INH	%	11.49
	18811789	CHEMBL4276093	Inhibition of recombinant N-terminal GST-fused full-length human PKCalpha expressed in Baculovirus expression system using STK1-biotin as substrate after 1 hr in presence of ATP by TR-FRET analysis	B	N#Cc1cnc(NCc2ccccc2OC(F)(F)F)nc1NC[C@@]12C[C@H]3C[C@@H](C1)[C@H](NCCO)[C@H](C3)C2		CHEMBL4289707	=	IC50	nM	84.0	CHEMBL299	Homo sapiens	IC50	nM	84.0
	18811980	CHEMBL4276182	Inhibition of human PKCalpha at 100 uM	B	O=C(NCc1ccccc1)c1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4281295	=	Inhibition	%	12.0	CHEMBL299	Homo sapiens	INH	%	12.0
	18811981	CHEMBL4276182	Inhibition of human PKCalpha at 100 uM	B	O=C1CC(c2ccc(C(=O)NCc3cccc(Cl)c3)cc2)Sc2ccccc2N1		CHEMBL4277682	=	Inhibition	%	2.0	CHEMBL299	Homo sapiens	INH	%	2.0
Not Active	18883541	CHEMBL4312750	Activity at human PKCalpha at 10 uM	B	CS(=O)(=O)c1ccc(Oc2cc(F)cc(C#N)c2)c2c1[C@H](O)[C@H](F)[C@@H]2F		CHEMBL4585668		Activity			CHEMBL299	Homo sapiens	Activity		
	18892686	CHEMBL4314563	Inhibition of recombinant full-length human PKCalpha assessed as residual activity at 10 uM using histone H1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	88.5	CHEMBL299	Homo sapiens	Activity	%	88.5
	18919556	CHEMBL4322912	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged PRKCA (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	92.0	CHEMBL299	Homo sapiens	Kd	nM	92.0
	18919744	CHEMBL4322912	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged PRKCA (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	43.0	CHEMBL299	Homo sapiens	Kd	nM	43.0
	18934103	CHEMBL4326635	Inhibition of human PKCalpha at 10 uM using ERMRPRKRQGSVRRRV as substrate by [gamma-33P]-ATP assay relative to control	B	CC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(N4Cc5cccc(N(C)S(C)(=O)=O)c5C4)n3)cc2)CC1		CHEMBL4476226	=	Inhibition	%	19.3	CHEMBL299	Homo sapiens	INH	%	19.3
	18938213	CHEMBL4327833	Inhibition of human PKCalpha assessed as residual activity at 1 uM using ERMRPRKRQGSVRRRV as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	93.87	CHEMBL299	Homo sapiens	Activity	%	93.87
	18938214	CHEMBL4327833	Inhibition of human PKCalpha assessed as residual activity at 1 uM using ERMRPRKRQGSVRRRV as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	93.95	CHEMBL299	Homo sapiens	Activity	%	93.95
	18938678	CHEMBL4328197	Inhibition of human PKCalpha assessed as residual activity at 100 uM using ERMRPRKRQGSVRRRV as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL299	Homo sapiens	Activity	%	65.0
	18939062	CHEMBL4328561	Inhibition of human PKCalpha using ERMRPRKRQGSVRRRV as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.506	CHEMBL299	Homo sapiens	IC50	10'-10M	5.06
	18953669	CHEMBL4331948	Inhibition of PKCa (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(NC3CCCCC3)c12		CHEMBL4440433	=	Inhibition	%	25.0	CHEMBL299	Homo sapiens	INH	%	25.0
	18953735	CHEMBL4331948	Inhibition of PKCa (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccccc3F)c12		CHEMBL4449552	=	Inhibition	%	26.0	CHEMBL299	Homo sapiens	INH	%	26.0
	18953862	CHEMBL4331948	Inhibition of PKCa (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(OC3CCCCC3)c12		CHEMBL4524629	=	Inhibition	%	61.0	CHEMBL299	Homo sapiens	INH	%	61.0
	18953954	CHEMBL4332007	Inhibition of PKCa (unknown origin) at 1 uM relative to control	B	CC(C)n1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cn1		CHEMBL4589022	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	18954018	CHEMBL4332007	Inhibition of PKCa (unknown origin) at 1 uM relative to control	B	c1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cc(N2CCOCC2)n1		CHEMBL4460272	=	Inhibition	%	0.0	CHEMBL299	Homo sapiens	INH	%	0.0
	18954085	CHEMBL4331948	Inhibition of PKCa (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccc4ncsc4c3)c12		CHEMBL4588446	=	Inhibition	%	1.0	CHEMBL299	Homo sapiens	INH	%	1.0
	18957395	CHEMBL4332974	Inhibition of PKCalpha (unknown origin) at 1 uM after 60 mins by Z-LYTE assay relative to control	B	C=CC(=O)N1CCN(c2ccc([N+](=O)[O-])c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4450627	>	Inhibition	%	80.0	CHEMBL299	Homo sapiens	INH	%	80.0
	18964592	CHEMBL4335237	Inhibition of recombinant human full length PKCalpha assessed as residual activity at 1 uM using histone H1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	97.0	CHEMBL299	Homo sapiens	Activity	%	97.0
	18964593	CHEMBL4335237	Inhibition of recombinant human full length PKCalpha assessed as residual activity at 1 uM using histone H1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	96.0	CHEMBL299	Homo sapiens	Activity	%	96.0
	18972050	CHEMBL4337060	Inhibition of recombinant human full length PKCalpha assessed as residual activity at 10 uM using histone H1 as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	77.0	CHEMBL299	Homo sapiens	Activity	%	77.0
Not Active	19040108	CHEMBL4352012	Inhibition of recombinant full-length human PKCalpha at 10 uM using histone H1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Active	19041239	CHEMBL4352500	Inhibition of human PKCalpha at 10 uM using ERMRPRKRQGSVRRRV as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL299	Homo sapiens	INH		
	19092071	CHEMBL4366545	Inhibition of human PKCalpha at 100 nM using ERMRPRKRQGSVRRRV as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1	Outside typical range	CHEMBL4528675	=	Inhibition	%	-21.01	CHEMBL299	Homo sapiens	INH	%	-21.01
	19144754	CHEMBL4377770	Inhibition of recombinant full-length human PKCalpha at 1 uM using histone H1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	68.0	CHEMBL299	Homo sapiens	INH	%	68.0
	19146929	CHEMBL4378863	Inhibition of full-length recombinant human PKCalpha at 10 uM using histone H1 as substrate after 40 mins by in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	3.0	CHEMBL299	Homo sapiens	INH	%	3.0
	19147994	CHEMBL4379236	Inhibition of recombinant human full length PKCalpha using histone as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	uM	10.0
	19181114	CHEMBL4387325	Inhibition of recombinant human GST-tagged PKCalpha expressed in insect expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	77.5	CHEMBL299	Homo sapiens	INH	%	77.5
	19181339	CHEMBL4387325	Inhibition of recombinant human GST-tagged PKCalpha expressed in insect expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	33.0	CHEMBL299	Homo sapiens	INH	%	33.0
	19240651	CHEMBL4399585	Inhibition of recombinant full length PKC alpha (unknown origin) using RRRRRKGSFKRKA peptide as substrate measured after 15 mins in presence of ATP by spectrophotometric analysis	B	CC(C)(C#N)c1cccc(-c2ccnc3[nH]ccc23)n1		CHEMBL4453941	=	Ki	nM	110.0	CHEMBL299	Homo sapiens	Ki	nM	110.0
	19240652	CHEMBL4399585	Inhibition of recombinant full length PKC alpha (unknown origin) using RRRRRKGSFKRKA peptide as substrate measured after 15 mins in presence of ATP by spectrophotometric analysis	B	CC(C)(C#N)c1cccc(-c2ccnc3[nH]ncc23)n1		CHEMBL4539521	=	Ki	nM	465.0	CHEMBL299	Homo sapiens	Ki	nM	465.0
Not Determined	19240653	CHEMBL4399585	Inhibition of recombinant full length PKC alpha (unknown origin) using RRRRRKGSFKRKA peptide as substrate measured after 15 mins in presence of ATP by spectrophotometric analysis	B	CC(C)(C#N)c1cccc(-c2ccnc3[nH]ncc23)c1		CHEMBL4559701		Ki			CHEMBL299	Homo sapiens	Ki		
	19240654	CHEMBL4399585	Inhibition of recombinant full length PKC alpha (unknown origin) using RRRRRKGSFKRKA peptide as substrate measured after 15 mins in presence of ATP by spectrophotometric analysis	B	Cc1cc(-c2ccnc3[nH]nc(C(F)(F)F)c23)cc(C2(CN)CCC2)c1		CHEMBL4590477	=	Ki	nM	60.0	CHEMBL299	Homo sapiens	Ki	nM	60.0
	19240655	CHEMBL4399585	Inhibition of recombinant full length PKC alpha (unknown origin) using RRRRRKGSFKRKA peptide as substrate measured after 15 mins in presence of ATP by spectrophotometric analysis	B	NCC1(c2cccc(-c3ccnc4[nH]nc(C(F)(F)F)c34)c2)CCC1		CHEMBL4589844	=	Ki	nM	57.0	CHEMBL299	Homo sapiens	Ki	nM	57.0
	19240656	CHEMBL4399585	Inhibition of recombinant full length PKC alpha (unknown origin) using RRRRRKGSFKRKA peptide as substrate measured after 15 mins in presence of ATP by spectrophotometric analysis	B	NCC1(c2cccc(-c3ccnc4[nH]nc(C(F)(F)F)c34)c2)CCOCC1		CHEMBL4457150	=	Ki	nM	468.0	CHEMBL299	Homo sapiens	Ki	nM	468.0
	19240657	CHEMBL4399585	Inhibition of recombinant full length PKC alpha (unknown origin) using RRRRRKGSFKRKA peptide as substrate measured after 15 mins in presence of ATP by spectrophotometric analysis	B	Cc1cc(-c2ccnc3[nH]nc(C(F)(F)F)c23)cc(C2(CN)COC2)c1		CHEMBL4587816	=	Ki	nM	286.0	CHEMBL299	Homo sapiens	Ki	nM	286.0
	19240658	CHEMBL4399585	Inhibition of recombinant full length PKC alpha (unknown origin) using RRRRRKGSFKRKA peptide as substrate measured after 15 mins in presence of ATP by spectrophotometric analysis	B	NCC1(c2cccc(-c3ccnc4[nH]nc(C(F)(F)F)c34)c2)COC1		CHEMBL4461649	=	Ki	nM	1020.0	CHEMBL299	Homo sapiens	Ki	nM	1020.0
	19242745	CHEMBL4400080	Inhibition of recombinant full length human PKCalpha assessed as residual activity at 10 uM using histone H1 as substrate incubated for 40 mins in presence of [gamma-33P]ATP at Km concentration by radiometric assay relative to control	B	COc1ccc2c(CCNc3nc(NCc4ccc(=O)[nH]c4)c4nc[nH]c4n3)c[nH]c2c1		CHEMBL4555782	=	Activity	%	86.0	CHEMBL299	Homo sapiens	Activity	%	86.0
	19276097	CHEMBL4408100	Inhibition of recombinant human full length PKCalpha at 1 uM using histone H1 as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	70.0	CHEMBL299	Homo sapiens	INH	%	70.0
	19294320	CHEMBL4412077	Inhibition of human PKCalpha assessed as enzyme activity at 30 uM using ERMRPRKRQGSVRRRV as substrate by [gamma-33P]-ATP assay relative to control	B	O=C1C=CC2(C=C1)OCC(Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(=O)N2c1ccccc1		CHEMBL4476753	=	Activity	%	44.81	CHEMBL299	Homo sapiens	Activity	%	44.81
	19294336	CHEMBL4412093	Inhibition of human PKCalpha using ERMRPRKRQGSVRRRV as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.474	CHEMBL299	Homo sapiens	IC50	10'-10M	4.74
	19303773	CHEMBL4414225	Inhibition of PKCalpha (unknown origin) assessed as residual activity at 50 uM relative to control	B	O=C(O)c1ccc(Nc2nc(-c3cccc([N+](=O)[O-])c3)cs2)cc1		CHEMBL4462082	=	Activity	%	86.0	CHEMBL299	Homo sapiens	Activity	%	86.0
	19303825	CHEMBL4414225	Inhibition of PKCalpha (unknown origin) assessed as residual activity at 50 uM relative to control	B	O=C(O)c1ccc(Nc2nc(-c3cccc(Br)c3)cs2)cc1		CHEMBL4458300	=	Activity	%	92.0	CHEMBL299	Homo sapiens	Activity	%	92.0
	19371151	CHEMBL4424903	Inhibition of human full-length N-terminal His6-tagged PKCalpha expressed in baculovirus infected Sf21 insect cells using Histone H1 as substrate	A	COc1cc(C2CN(C(=O)c3cc(COC[C@@H](O)CO)ccn3)C2)ccc1OCc1ccc(C2CC2)cc1		CHEMBL4474690	>	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	nM	1000.0
	19411437	CHEMBL4427728	Inhibition of PKCalpha (unknown origin)	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	>=	IC50	nM	5000.0	CHEMBL299	Homo sapiens	IC50	uM	5.0
	19411493	CHEMBL4427672	Inhibition of PKCalpha (unknown origin) at 1 uM relative to control	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	<=	Inhibition	%	16.0	CHEMBL299	Homo sapiens	INH	%	16.0
	20600637	CHEMBL4603589	Inhibition of recombinant human GST-tagged PKCalpha expressed in insect expression system using serine/threonine-7 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL299	Homo sapiens	IC50	uM	100.0
Active	20650609	CHEMBL4615633	Displacement of [3H]PDBu from recombinant human PKCalpha expressed in baculovirus infected Sf9 insect cells incubated for 10 mins by liquid scintillation counting method	B	CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(C)=O		CHEMBL279115		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Active	20650610	CHEMBL4615633	Displacement of [3H]PDBu from recombinant human PKCalpha expressed in baculovirus infected Sf9 insect cells incubated for 10 mins by liquid scintillation counting method	B	CC(=O)O[C@@]12[C@H](OC(=O)CCCCCCCCCCCNC(=O)C[C@H](N)C(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)C(=O)O)C(=O)O)[C@@H](C)[C@@]3(O)[C@@H](C=C(CO)C[C@]4(O)C(=O)C(C)=C[C@@H]34)[C@@H]1C2(C)C		CHEMBL4633670		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Not Active	20650611	CHEMBL4615633	Displacement of [3H]PDBu from recombinant human PKCalpha expressed in baculovirus infected Sf9 insect cells incubated for 10 mins by liquid scintillation counting method	B	CC(=O)O[C@@]12[C@H](OC(=O)CCCCCCCCCCCNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)N3CCOCC3)[C@@H](C)[C@@]3(O)[C@@H](C=C(CO)C[C@]4(O)C(=O)C(C)=C[C@@H]34)[C@@H]1C2(C)C		CHEMBL4645497		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Active	20650612	CHEMBL4615633	Displacement of [3H]PDBu from recombinant human PKCalpha expressed in baculovirus infected Sf9 insect cells incubated for 10 mins by liquid scintillation counting method	B	CC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(C)=O		CHEMBL4638146		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Active	20650613	CHEMBL4615633	Displacement of [3H]PDBu from recombinant human PKCalpha expressed in baculovirus infected Sf9 insect cells incubated for 10 mins by liquid scintillation counting method	B	CC(=O)O[C@@]12[C@H](OC(=O)CCCCCCCCCCCNC(=O)C[C@H](N)C(C)C)[C@@H](C)[C@@]3(O)[C@@H](C=C(CO)C[C@]4(O)C(=O)C(C)=C[C@@H]34)[C@@H]1C2(C)C		CHEMBL4649401		Inhibition	%		CHEMBL299	Homo sapiens	INH		
Active	20650614	CHEMBL4615633	Displacement of [3H]PDBu from recombinant human PKCalpha expressed in baculovirus infected Sf9 insect cells incubated for 10 mins by liquid scintillation counting method	B	CC(=O)O[C@@]12[C@H](OC(=O)CCCCCCCCCCCNC(=O)[C@@H](N)CC(C)C)[C@@H](C)[C@@]3(O)[C@@H](C=C(CO)C[C@]4(O)C(=O)C(C)=C[C@@H]34)[C@@H]1C2(C)C		CHEMBL4641733		Inhibition	%		CHEMBL299	Homo sapiens	INH		
	22391665	CHEMBL4666961	Inhibition of recombinant human His-tagged full length PKCalpha expressed in Escherichia coli expression system using Ser/Thr 07 as substrate at 0.1 uM incubated for 60 mins by Z'-lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc(Cl)ccc1OC(F)F)c1cnn2cccnc12		CHEMBL4744172	=	Inhibition	%	12.0	CHEMBL299	Homo sapiens	INH	%	12.0
	22391666	CHEMBL4666961	Inhibition of recombinant human His-tagged full length PKCalpha expressed in Escherichia coli expression system using Ser/Thr 07 as substrate at 0.1 uM incubated for 60 mins by Z'-lyte assay relative to control	B	Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2OC(F)F)n1		CHEMBL4777342	=	Inhibition	%	11.0	CHEMBL299	Homo sapiens	INH	%	11.0
	22391667	CHEMBL4666961	Inhibition of recombinant human His-tagged full length PKCalpha expressed in Escherichia coli expression system using Ser/Thr 07 as substrate at 0.1 uM incubated for 60 mins by Z'-lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc2ccccc2cc1OC(F)F)c1cnn2cccnc12		CHEMBL4745474	=	Inhibition	%	1.0	CHEMBL299	Homo sapiens	INH	%	1.0
	22392134	CHEMBL4667229	Inhibition of recombinant human His-tagged full length PKCalpha expressed in Escherichia coli expression system using Ser/Thr 07 as substrate at 10 uM incubated for 60 mins by Z'-lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	-9.5	CHEMBL299	Homo sapiens	INH	%	-9.5
Not Active	22417544	CHEMBL4672624	Inhibition of PKCalpha phosphorylation in human BXPC-3 cells at 1 uM incubated for 4 hrs by Western blot analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4=O		CHEMBL4763675		Inhibition	%		CHEMBL299	Homo sapiens	INH		
	22423329	CHEMBL4674240	Inhibition of human PKCalpha using ERMRPRKRQGSVRRRV as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	93.25	CHEMBL299	Homo sapiens	Activity	%	93.25
	22423330	CHEMBL4674240	Inhibition of human PKCalpha using ERMRPRKRQGSVRRRV as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	66.63	CHEMBL299	Homo sapiens	Activity	%	66.63
	22433024	CHEMBL4676907	Inhibition of human protein kinase Ca at 10 uM relative to control	B	CN1C(=O)CC[C@H]1c1cccnc1		CHEMBL578211	<	Inhibition	%	50.0	CHEMBL299	Homo sapiens	INH	%	50.0
	22768200	CHEMBL4703612	Inhibition of human PKCalpha	B	COc1cccc(Cn2cnc3ccc(-c4cn[nH]c4)cc3c2=O)c1		CHEMBL4742990	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	22768201	CHEMBL4703612	Inhibition of human PKCalpha	B	COc1cccc(Cn2ncc3ccc(-c4cn[nH]c4)cc3c2=O)c1		CHEMBL4744858	>	IC50	nM	10000.0	CHEMBL299	Homo sapiens	IC50	nM	10000.0
	22809794	CHEMBL4713329	Inhibition of recombinant full length human PKCalpha assessed as residual activity at 1 uM using histone H1 as substrate incubated for 40 mins in presence of Km ATP by radiometric scintillation counting analysis relative to control	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	Activity	%	100.0	CHEMBL299	Homo sapiens	Activity	%	100.0
	22820554	CHEMBL4716279	Inhibition of recombinant full length N-terminal His6-tagged human PKCalpha expressed in baculovirus infected Sf21 insect cells assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	123.0	CHEMBL299	Homo sapiens	Activity	%	123.0
	22820555	CHEMBL4716279	Inhibition of recombinant full length N-terminal His6-tagged human PKCalpha expressed in baculovirus infected Sf21 insect cells assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	94.0	CHEMBL299	Homo sapiens	Activity	%	94.0
	22836372	CHEMBL4718884	Inhibition of human full length GST-tagged PRKCA expressed in insect cells at 500 nM using Ser/Thr 07 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	2.0	CHEMBL299	Homo sapiens	INH	%	2.0
	22836373	CHEMBL4718884	Inhibition of human full length GST-tagged PRKCA expressed in insect cells at 500 nM using Ser/Thr 07 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OCC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4786776	=	Inhibition	%	-9.0	CHEMBL299	Homo sapiens	INH	%	-9.0
	22836374	CHEMBL4718884	Inhibition of human full length GST-tagged PRKCA expressed in insect cells at 500 nM using Ser/Thr 07 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CN(C)CCNCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1F	Outside typical range	CHEMBL4748367	=	Inhibition	%	-14.0	CHEMBL299	Homo sapiens	INH	%	-14.0
	22836375	CHEMBL4718884	Inhibition of human full length GST-tagged PRKCA expressed in insect cells at 500 nM using Ser/Thr 07 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CCOc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4776396	=	Inhibition	%	1.0	CHEMBL299	Homo sapiens	INH	%	1.0
	22836376	CHEMBL4718884	Inhibition of human full length GST-tagged PRKCA expressed in insect cells at 500 nM using Ser/Thr 07 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	COc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4783569	=	Inhibition	%	15.0	CHEMBL299	Homo sapiens	INH	%	15.0
	22836377	CHEMBL4718884	Inhibition of human full length GST-tagged PRKCA expressed in insect cells at 500 nM using Ser/Thr 07 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4780286	=	Inhibition	%	17.0	CHEMBL299	Homo sapiens	INH	%	17.0
	22843610	CHEMBL4720596	Inhibition of human PKCalpha using ERMRPRKRQGSVRRRV as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.305	CHEMBL299	Homo sapiens	IC50	10^-10M	3.05
	22843955	CHEMBL4720941	Inhibition of human PKCalpha assessed as residual activity using ERMRPRKRQGSVRRRV as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	93.8	CHEMBL299	Homo sapiens	Activity	%	93.8
	22844826	CHEMBL4721501	Inhibition of PKCalpha (unknown origin) assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	95.46	CHEMBL299	Homo sapiens	Activity	%	95.46
	22905073	CHEMBL4732804	Inhibition of human recombinant PKCalpha at 10 uM by radiometric assay	B	COc1ccc2c(Nc3cc(OC)c(OC)c(OC)c3)n[nH]c2c1		CHEMBL4759658	=	Inhibition	%	24.0	CHEMBL299	Homo sapiens	INH	%	24.0
	22922119	CHEMBL4736850	Inhibition of PKCalpha (unknown origin) assessed as enzyme remaining activity at 5 uM relative to control	B	COc1ccc(-c2ccnc(N[C@H]3CO[C@@H]4[C@@H](NC(=O)Nc5ccc(C(C)=O)cc5)CO[C@H]34)n2)cc1		CHEMBL4758751	>	Activity	%	50.0	CHEMBL299	Homo sapiens	Activity	%	50.0
	22949354	CHEMBL4765786	Inhibition of human PKCalpha assessed as residual activity at 0.1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	101.0	CHEMBL299	Homo sapiens	Activity	%	101.0
	22949355	CHEMBL4765786	Inhibition of human PKCalpha assessed as residual activity at 0.1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	96.0	CHEMBL299	Homo sapiens	Activity	%	96.0
	22949356	CHEMBL4765786	Inhibition of human PKCalpha assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	93.0	CHEMBL299	Homo sapiens	Activity	%	93.0
	22949357	CHEMBL4765786	Inhibition of human PKCalpha assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	104.0	CHEMBL299	Homo sapiens	Activity	%	104.0
	22949358	CHEMBL4765786	Inhibition of human PKCalpha assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	91.0	CHEMBL299	Homo sapiens	Activity	%	91.0
	22949359	CHEMBL4765786	Inhibition of human PKCalpha assessed as residual activity at 0.1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	106.0	CHEMBL299	Homo sapiens	Activity	%	106.0
	22949360	CHEMBL4765787	Inhibition of human PKCalpha assessed as residual activity at 1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	103.0	CHEMBL299	Homo sapiens	Activity	%	103.0
	22949361	CHEMBL4765787	Inhibition of human PKCalpha assessed as residual activity at 1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	103.0	CHEMBL299	Homo sapiens	Activity	%	103.0
	22949362	CHEMBL4765787	Inhibition of human PKCalpha assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	95.0	CHEMBL299	Homo sapiens	Activity	%	95.0
	22949363	CHEMBL4765787	Inhibition of human PKCalpha assessed as residual activity at 1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	87.0	CHEMBL299	Homo sapiens	Activity	%	87.0
	22949364	CHEMBL4765787	Inhibition of human PKCalpha assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	102.0	CHEMBL299	Homo sapiens	Activity	%	102.0
	22949365	CHEMBL4765787	Inhibition of human PKCalpha assessed as residual activity at 1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	94.0	CHEMBL299	Homo sapiens	Activity	%	94.0
	22952957	CHEMBL4766894	Inhibition of recombinant human full length PKCalpha assessed as residual activity at 10 uM using histone H1 as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	101.0	CHEMBL299	Homo sapiens	Activity	%	101.0
	23128452	CHEMBL4807959	Inhibition of PKCalpha (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL299	Homo sapiens	Activity	%	75.0
	23128453	CHEMBL4807959	Inhibition of PKCalpha (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL299	Homo sapiens	Activity	%	75.0
	23128454	CHEMBL4807959	Inhibition of PKCalpha (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL299	Homo sapiens	Activity	%	75.0
Not Active	23149864	CHEMBL4810254	Inhibition of human PKCa at 0.1 to 1 uM	A	CCN1C(=O)N(c2c(F)c(OC)cc(OC)c2F)Cc2cnc3[nH]c(CN4CCOCC4)cc3c21		CHEMBL4297522		Inhibition	%		CHEMBL299	Homo sapiens	INH		
	23235066	CHEMBL4827846	Inhibition of PKC-alpha (unknown origin)	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3C(F)(F)F)cnc2N)CC1		CHEMBL3982723	=	IC50	nM	1.9	CHEMBL299	Homo sapiens	IC50	nM	1.9
	23248230	CHEMBL4830411	Inhibition of human PKCalpha using ERMRPRKRQGSVRRRV as substrate incubated for 2 hrs by [gamma-33P]-ATP assay	B	CC(C)c1c2cc(-c3ccnc(Nc4ccc5c(N6CCN(C)CC6)ccnc5c4)n3)ccc2nn1C		CHEMBL4856177	=	IC50	nM	6.3	CHEMBL299	Homo sapiens	IC50	nM	6.3
	23248231	CHEMBL4830411	Inhibition of human PKCalpha using ERMRPRKRQGSVRRRV as substrate incubated for 2 hrs by [gamma-33P]-ATP assay	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	IC50	nM	1000.0	CHEMBL299	Homo sapiens	IC50	nM	1000.0
Not Active	23248232	CHEMBL4830411	Inhibition of human PKCalpha using ERMRPRKRQGSVRRRV as substrate incubated for 2 hrs by [gamma-33P]-ATP assay	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840		IC50			CHEMBL299	Homo sapiens	IC50		
	23248240	CHEMBL4830417	Inhibition of human PKCalpha using ERMRPRKRQGSVRRRV as substrate assessed as enzyme activity incubated for 2 hrs by [gamma-33P]-ATP assay relative to control	B	CC(C)c1c2cc(-c3ccnc(Nc4ccc5c(N6CCN(C)CC6)ccnc5c4)n3)ccc2nn1C		CHEMBL4856177	<	Activity	%	20.0	CHEMBL299	Homo sapiens	Activity	%	20.0
Not Active	23270429	CHEMBL4835223	Inhibition of PKCalpha (unknown origin) at 10 uM	B	C[C@H]1CN(C(=O)CC[C@@]2(C3CC3)NC(=O)NC2=O)CCN1c1cc(F)cc(F)c1		CHEMBL4650334		Inhibition	%		CHEMBL299	Homo sapiens	INH		
	23295522	CHEMBL4840534	Inhibition of recombinant GST-tagged human full length PRKCA expressed in insect expression system at 1 uM measured by select screen assay relative to control	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(Cc3cc(F)cc(F)c3)C4(C)C)cc2)CC1		CHEMBL4849505	=	Inhibition	%	3.0	CHEMBL299	Homo sapiens	INH	%	3.0
Not Active	23324099	CHEMBL4880718	PKCalpha (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	18.0	CHEMBL299	Homo sapiens	% inhibition	%	18.0
Not Active	23327054	CHEMBL4880889	Protein Serine/Threonine Kinase, PRKCA (PKCα) Eurofins-Panlabs enzyme assay	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		Inhibition	%	16.0	CHEMBL299	Homo sapiens	% inhibition	%	16.0
Not Active	23329480	CHEMBL4881187	PKCalpha (h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	107.0	CHEMBL299	Homo sapiens	% residual kinase activity	%	107.0
Not Active	23334936	CHEMBL4881558	PKCalpha (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	6.0	CHEMBL299	Homo sapiens	% inhibition	%	6.0
Not Active	23337734	CHEMBL4882105	PRKCA Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	101.5	CHEMBL299	Homo sapiens	% Ctrl	%	101.5
Not Active	23352187	CHEMBL4882876	PRKCA (PKC alpha) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	-4.078	CHEMBL299	Homo sapiens	% Inhibition	%	-4.0784
Not Active	23353505	CHEMBL4883005	Protein Serine/Threonine Kinase, PRKCA (PKCα) Eurofins-Panlabs enzyme assay	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		Inhibition	%	29.0	CHEMBL299	Homo sapiens	% inhibition	%	29.0
Not Active	23363302	CHEMBL4883267	PRKCA (PKC alpha) Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	3.746	CHEMBL299	Homo sapiens	% inhibition	%	3.7456
Not Active	23363303	CHEMBL4883267	PRKCA (PKC alpha) Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	4.38	CHEMBL299	Homo sapiens	% inhibition	%	4.3795
Not Active	23367702	CHEMBL4884055	PKC-alpha ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	96.0	CHEMBL299	Homo sapiens	% Residual activity with Skepinone-L	%	96.0
Not Active	23370196	CHEMBL4884438	PKCalpha (h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	44.0	CHEMBL299	Homo sapiens	% residual kinase activity	%	44.0
	23372859	CHEMBL4884824	PKCalpha(PRKALGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL299	Homo sapiens	pIC50		6.0
	23373268	CHEMBL4885115	PKCalpha(PRKALGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL299	Homo sapiens	pIC50		6.0
	23373624	CHEMBL4885401	PKCalpha(PRKALGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL299	Homo sapiens	pIC50		6.0
Not Active	23375069	CHEMBL4886057	PKC_alpha Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	11.0	CHEMBL299	Homo sapiens	% Inhibition	%	11.0
Not Active	23375342	CHEMBL4886324	protein kinase C, alpha  Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	15.0	CHEMBL299	Homo sapiens	% inhibition	%	15.0
Slightly Active	23379384	CHEMBL4883005	Protein Serine/Threonine Kinase, PRKCA (PKCα) Eurofins-Panlabs enzyme assay	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		Inhibition	%	52.0	CHEMBL299	Homo sapiens	% inhibition	%	52.0
	23379385	CHEMBL4883005	Protein Serine/Threonine Kinase, PRKCA (PKCα) Eurofins-Panlabs enzyme assay	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1	Non standard unit for type	CHEMBL1800285		IC50	µM	91.5	CHEMBL299	Homo sapiens	IC50	µM	91.5
Not Active	23379386	CHEMBL4883005	Protein Serine/Threonine Kinase, PRKCA (PKCα) Eurofins-Panlabs enzyme assay	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		Inhibition	%	11.0	CHEMBL299	Homo sapiens	% inhibition	%	11.0
Not Active	23379387	CHEMBL4883005	Protein Serine/Threonine Kinase, PRKCA (PKCα) Eurofins-Panlabs enzyme assay	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		Inhibition	%	-3.0	CHEMBL299	Homo sapiens	% inhibition	%	-3.0
Not Active	23379388	CHEMBL4883005	Protein Serine/Threonine Kinase, PRKCA (PKCα) Eurofins-Panlabs enzyme assay	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		Inhibition	%	-9.0	CHEMBL299	Homo sapiens	% inhibition	%	-9.0
Not Active	23383946	CHEMBL4887554	PRKCA Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	85.0	CHEMBL299	Homo sapiens	% Ctrl	%	85.0
Not Active	23384062	CHEMBL4887660	PKCA DUNDEE kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	66.9	CHEMBL299	Homo sapiens	% Ctrl	%	66.9
Not Active	23384417	CHEMBL4888012	PKCalpha(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	16.24	CHEMBL299	Homo sapiens	% inhibition	%	16.24
Not Active	23384688	CHEMBL4888214	PRKCA (PKC alpha) SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	10.0	CHEMBL299	Homo sapiens	% Inhibition	%	10.0
Not Active	23385903	CHEMBL4888376	PKCalpha Invitrogen kinase panel	B	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1		CHEMBL4802042		Inhibition	%	4.0	CHEMBL299	Homo sapiens	% inhibition	%	4.0
